doc_id	sent_id	words	positions
journal.pgen.1003588.pdf	1	{p,E,p,l,GENETICS}	{NULL}
journal.pgen.1003588.pdf	2	{Alu,Elements,in,ANRIL,Non-Coding,RNA,at,Chromosome,9p21,Modulate,Atherogenic,Cell,Functions,through,Trans-Regulation,of,Gene,Networks,OPEN,8,ACCESS,Freely,available,online}	{NULL}
journal.pgen.1003588.pdf	3	{Lesca,M.,Holdt,"\\"",2,',3,",",Steve,Hoffmann,”,",",Kristina,Sassz,",",David,Langenberger,”,",",Markus,Scho,|,z,"\\"",5,",",Knut,Krohn1,',°,",",Knut,Finstermeierm,",",Anika,Stahringer2,',3,",",Wolfgang,Wilfert2,',3,",",Frank,Beutner,"\\"",2,',7,",",Stephan,Gie,|,en,"\\"",7,",",Gerhard,Schu,|,er,"\\"",7,",",Gabor,Géibels,",",Hendrik,Bergerts,",",lngo,Bechmann9,",",Peter,F.,Stadler,"\\"","\\"",',1,°,',"\\"",",",Joachim,Thiery,"\\"",2,",",Daniel,Teupser,"\\"",2,',3,*}	{NULL}
journal.pgen.1003588.pdf	4	{1,LIFE,—,Leipzig,Research,Center,for,Civilization,Diseases,",",Universitat,Leipzig,",",Leipzig,",",Germany,",",Zlnstitute,of,Laboratory,Medicine,",",Clinical,Chemistry,and,Molecular,Diagnostics,",",University,Hospital,Leipzig,",",Leipzig,",",Germany,",",3,Institute,of,Laboratory,Medicine,",",Ludwig,.}	{NULL}
journal.pgen.1003588.pdf	5	{—,.}	{NULL}
journal.pgen.1003588.pdf	6	{Maximi,|,ians,.}	{NULL}
journal.pgen.1003588.pdf	7	{—,.}	{NULL}
journal.pgen.1003588.pdf	8	{University,Munich,",",Munich,",",Germany,",",4Transcriptome,Bioinformatics,Group,and,Interdisciplinary,Centre,for,Bioinformatics,",",University,Leipzig,",",Leipzig,",",Germany,",",5,Institute,for,Medical,Informatics,",",Statistics,and,Epidemiology,",",University,Leipzig,",",Leipzig,",",Germany,",",6,Interdisciplinary,Center,for,Clinical,Research,",",University,Leipzig,",",Leipzig,",",Germany,",",7,Department,of,Internal,Medicine/Cardiology,",",Heart,Center,",",University,Leipzig,",",Leipzig,",",Germany,",",8Department,of,General,",",Thoracic,",",and,Vascular,Surgery,",",University,Dresden,",",Dresden,",",Germany,",",9,|,nstitute,of,Anatomy,",",University,Leipzig,",",Leipzig,",",Germany,",",10Max,Planck,Institute,for,Mathematics,in,the,Sciences,",",Leipzig,",",Germany,",",11,Santa,Fe,Institute,",",Santa,Fe,",",New,Mexico,",",United,States,of,America}	{NULL}
journal.pgen.1003588.pdf	9	{Abstract}	{NULL}
journal.pgen.1003588.pdf	10	{The,chromosome,9p21,(,Chr9p21,),locus,of,coronary,artery,disease,has,been,identified,in,the,first,surge,of,genome,—,wide,association,and,is,the,strongest,genetic,factor,of,atherosclerosis,known,today,.}	{8|9|10}
journal.pgen.1003588.pdf	11	{Chr9p21,encodes,the,long,non,—,coding,RNA,(,ncRNA,),antisense,non,—,coding,RNA,in,the,INK4,locus,(,ANRIL,),.}	{NULL}
journal.pgen.1003588.pdf	12	{ANRIL,expression,is,associated,with,the,Chr9p21,genotype,and,correlated,with,atherosclerosis,severity,.}	{NULL}
journal.pgen.1003588.pdf	13	{Here,",",we,report,on,the,molecular,mechanisms,through,which,ANRIL,regulates,target,—,genes,in,trans,",",leading,to,increased,cell,proliferation,",",increased,cell,adhesion,and,decreased,apoptosis,",",which,are,all,essential,mechanisms,of,atherogenesis,.}	{NULL}
journal.pgen.1003588.pdf	14	{Importantly,",",trans,—,regu,|,ation,was,dependent,on,Alu,motifs,",",which,marked,the,promoters,of,ANRIL,target,genes,and,were,mirrored,in,ANRIL,RNA,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	15	{ANRIL,bound,Polycomb,group,proteins,that,were,highly,enriched,in,the,proximity,of,Alu,motifs,across,the,genome,and,were,recruited,to,promoters,of,target,genes,upon,ANRIL,over,—,expression,.}	{NULL}
journal.pgen.1003588.pdf	16	{The,functional,relevance,of,Alu,motifs,in,ANRIL,was,confirmed,by,deletion,and,mutagenesis,",",reversing,trans,—,regu,|,ation,and,atherogenic,cell,functions,.}	{NULL}
journal.pgen.1003588.pdf	17	{ANRIL,—,regu,|,ated,networks,were,conﬁrmed,in,2280,individuals,with,and,without,coronary,artery,disease,and,functionally,validated,in,primary,cells,from,patients,carrying,the,Chr9p21,risk,allele,.}	{NULL}
journal.pgen.1003588.pdf	18	{Our,study,provides,a,molecular,mechanism,for,pro,—,atherogenic,effects,ofANRIL,at,Chr9p21,and,suggests,a,novel,role,for,Alu,elements,in,epigenetic,gene,regulation,by,long,ncRNAs,.}	{NULL}
journal.pgen.1003588.pdf	19	{Citation,:,Holdt,LM,",",Hoffmann,S,",",Sass,K,",",Langenberger,D,",",Scholz,M,",",et,al.,(,2013,),Alu,Elements,in,ANRIL,Non,»,Coding,RNA,at,Chromosome,9p21,Modulate,Atherogenic,Cell,Functions,through,Trans,.}	{NULL}
journal.pgen.1003588.pdf	20	{—,.}	{NULL}
journal.pgen.1003588.pdf	21	{Regu,|,ation,of,Gene,Networks,.}	{NULL}
journal.pgen.1003588.pdf	22	{PLoS,Genet,9,(,7,),:,e1003588,.}	{NULL}
journal.pgen.1003588.pdf	23	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	24	{pgen,.1003588,Editor,:,Mark,I.,McCarthy,",",University,of,Oxford,",",United,Kingdom,Received,February,12,",",2013,;,Accepted,May,9,",",2013,;,Published,July,4,",",2013,Copyright,:,©,2013,Holdt,et,al.,.}	{NULL}
journal.pgen.1003588.pdf	25	{This,is,an,open,—,access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pgen.1003588.pdf	26	{Funding,:,This,study,was,supported,by,MSD,SHARP,&,DOHME,scholarship,(,MSD,.}	{NULL}
journal.pgen.1003588.pdf	27	{—,.}	{NULL}
journal.pgen.1003588.pdf	28	{Stipendium,2010,.}	{NULL}
journal.pgen.1003588.pdf	29	{—,.}	{NULL}
journal.pgen.1003588.pdf	30	{Arteriosk,|,erose,",",Wilhelm,.}	{NULL}
journal.pgen.1003588.pdf	31	{—,.}	{NULL}
journal.pgen.1003588.pdf	32	{Stoffe,|,»,Stipendium,;,LMH,),",",and,LIFE,—,Leipzig,Research,Center,for,Civilization,Diseases,",",Universitat,Leipzig,(,LMH,SH,DL,MS,KK,KF,FB,SG,GS,PFS,JT,DT,),.}	{NULL}
journal.pgen.1003588.pdf	33	{LIFE,is,funded,by,the,European,Union,",",the,European,Regional,Development,Fund,(,ERDF,),and,the,Free,State,of,Saxony,within,its,initiative,of,excellence,.}	{NULL}
journal.pgen.1003588.pdf	34	{Part,of,the,study,was,funded,by,a,grant,from,the,German,Ministry,of,Education,and,Research,through,NGFN,»,p,|,us,(,DT,),.}	{NULL}
journal.pgen.1003588.pdf	35	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pgen.1003588.pdf	36	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pgen.1003588.pdf	37	{*,E,—,mai,|,:,danie,|,.}	{NULL}
journal.pgen.1003588.pdf	38	{teupser@med.uni—muenchen.de}	{NULL}
journal.pgen.1003588.pdf	39	{|,nt,|,-,oduction,region,.}	{NULL}
journal.pgen.1003588.pdf	40	{While,these,genes,are,expressed,in,atherosclerotic,lesions,[,7,],",",the,majority,of,studies,in,humans,speak,against,a,cis-regulation}	{NULL}
journal.pgen.1003588.pdf	41	{The,chromosome,9p21,(,Chr9p21,),locus,is,the,strongest,genetic,risk,factor,of,atherosclerosis,known,today,",",yet,",",the,responsible,mechanisms,still,remain,unclear,.}	{NULL}
journal.pgen.1003588.pdf	42	{Chr9p21,lacks,associations,with,common,cardiovascular,risk,factors,",",such,as,lipids,and,hypertension,",",indicating,that,the,locus,exerts,its,effect,through,an,alternative,mechanism,[,l,—,4,],.}	{NULL}
journal.pgen.1003588.pdf	43	{The,risk,region,spans,~,50,kb,of,DNA,sequence,and,does,not,encode,protein-coding,genes,but,the,long,non,—,coding,RNA,(,ncRNA,),amfisense,non,—,coding,RNA,in,the,INK4,locus,(,ANRIL,;,Figure,1A,),[,"5,6",],.}	{NULL}
journal.pgen.1003588.pdf	44	{CDKA/2BAS,or,CDKN2B,.}	{NULL}
journal.pgen.1003588.pdf	45	{—,.}	{NULL}
journal.pgen.1003588.pdf	46	{AS,],are,used,as,synonyms,for,ANRIL,.}	{NULL}
journal.pgen.1003588.pdf	47	{The,closest,neighbouring,genes,are,the,cyclin,—,dependent,kinase,inhibitors,‘,CDKA/2A,and,CDKA/2B,",",which,are,located,~,lOO,kb,proximal,of,the,Chr9p21,atherosclerosis,risk,of,CDKA/2A,and,CDKA/2B,by,Chr9p21,(,reviewed,by,f,p,Studies,in,mice,revealed,no,effect,on,atherosclerosis,development,[,9,",",l0,],.}	{NULL}
journal.pgen.1003588.pdf	48	{In,contrast,",",a,clear,association,of,ANRIL,with,the,Chr9p21,genotype,has,been,established,in,several,studies,",",even,though,the,direction,of,effects,is,still,a,matter,of,dispute,[,"5,6,8",",",l,l,—,l3,],.}	{NULL}
journal.pgen.1003588.pdf	49	{Moreover,",",a,correlation,of,ANRIL,expression,with,atherosclerosis,severity,has,been,described,[,"2,8",],.}	{NULL}
journal.pgen.1003588.pdf	50	{Based,on,these,clinical,and,experimental,data,",",ANRIL,must,be,considered,as,a,prime,functional,candidate,for,modifying,atherosclerosis,susceptibility,at,the,Chr9p21,locus,.}	{NULL}
journal.pgen.1003588.pdf	51	{ANRIL,belongs,to,the,family,of,long,ncRNAs,",",which,are,arbitrarily,deﬁned,and,distinguished,from,short,ncRNA,",",such,as,microRNA,",",by,their,length,of,>,200,bp,[,l4,—,l6,],.}	{NULL}
journal.pgen.1003588.pdf	52	{Long,ncRNAs}	{NULL}
journal.pgen.1003588.pdf	53	{Author,Summary}	{NULL}
journal.pgen.1003588.pdf	54	{Chromosome,9p21,is,the,strongest,genetic,factor,for,coronary,artery,disease,and,encodes,the,long,non,—,coding,RNA,(,ncRNA,),ANRIL,.}	{8|9|10}
journal.pgen.1003588.pdf	55	{Here,",",we,show,that,increased,ANRIL,expression,mediates,atherosclerosis,risk,through,transregulation,of,gene,networks,leading,to,pro,—,atherogenic,cellular,properties,",",such,as,increased,proliferation,and,adhesion,.}	{NULL}
journal.pgen.1003588.pdf	56	{ANRIL,may,act,as,a,scaffold,",",guiding,effectorproteins,to,chromatin,.}	{NULL}
journal.pgen.1003588.pdf	57	{These,functions,depend,on,an,Alu,motif,present,in,ANRIL,RNA,and,mirrored,several,thousand,—,fo,|,d,in,the,genome,.}	{NULL}
journal.pgen.1003588.pdf	58	{Alu,elements,are,a,family,of,primate,—,speciﬁc,short,interspersed,repeat,elements,(,S,|,NEs,),and,have,been,linked,with,genetic,disease,.}	{NULL}
journal.pgen.1003588.pdf	59	{Current,models,propose,that,either,exonisation,of,Alu,elements,or,changes,of,cis,—,regu,|,ation,of,adjacent,genes,are,the,underlying,disease,mechanisms,.}	{NULL}
journal.pgen.1003588.pdf	60	{Our,work,extends,the,function,of,Alu,transposons,to,regulatory,components,of,long,ncRNAs,with,a,central,role,in,epigenetic,transregulation,.}	{NULL}
journal.pgen.1003588.pdf	61	{Furthermore,",",it,implies,a,pivotal,role,for,Alu,elements,in,genetically,determined,vascular,disease,and,describes,a,plausible,molecular,mechanism,for,a,proatherogenic,function,of,ANRIL,at,chromosome,9p21,.}	{NULL}
journal.pgen.1003588.pdf	62	{have,been,implicated,in,diverse,functions,in,gene,regulation,",",such,as,chromosome,dosage-compensation,",",imprinting,",",epigenetic,regulation,",",cell,cycle,control,",",nuclear,and,cytoplasmic,trafficking,",",transcription,",",translation,",",splicing,and,cell,differentiation,[,l5,",",l7,—,19,],.}	{NULL}
journal.pgen.1003588.pdf	63	{These,effects,are,mediated,by,RNA-RNA,",",RNA-DNA,or,RNA-protein,interactions,[,l7,—,l9,],.}	{NULL}
journal.pgen.1003588.pdf	64	{Previous,mechanistic,work,on,ANRIL,in,prostate,tissue,and,cell,lines,has,focused,on,its,role,in,cissuppression,of,CDIfN2A,and,CDKN2B,[,"3,20",],.}	{NULL}
journal.pgen.1003588.pdf	65	{Using,RNAi,against,ANRIL,",",these,studies,showed,impaired,recruitment,of,chromobox,homolog,7,(,CBX7,),",",a,member,of,Polycomb,repressive,complex,1,(,PRC1,),[,3,],",",and,of,suppressor,of,zeste,12,(,SUZl2,),",",a,member,of,PRC2,[,20,],",",to,the,Chr9p2l,region,.}	{NULL}
journal.pgen.1003588.pdf	66	{PRCs,are,multiprotein,complexes,",",responsible,for,initiating,and,maintaining,epigenetic,chromatin,modiﬁcations,and,thereby,controlling,gene,expression,[,21,],.}	{NULL}
journal.pgen.1003588.pdf	67	{Yap,et,al,found,that,knock-down,of,ANRIL,decreased,trimethylation,of,lysine,27,residues,in,histone,3,(,H3K27me3,),and,was,associated,with,increased,CDKN2A,expression,",",while,CDKN2B,remained,unchanged,[,3,],.}	{NULL}
journal.pgen.1003588.pdf	68	{In,contrast,",",Kotake,et,al,showed,that,shRNA-mediated,ANRIL,knock-down,disrupted,SUZl2,binding,to,the,Chr9p2l,locus,and,led,to,increased,CDKN2B,expression,whereas,CDKN2A,remained,unaffected,[,20,],.}	{NULL}
journal.pgen.1003588.pdf	69	{While,results,of,ANRIL,knock-down,are,conﬂicting,with,regard,to,expression,of,CDKN2A,and,CDKN2B,",",both,studies,demonstrated,a,signiﬁcant,reduction,of,cell,proliferation,[,"3,20",],",",a,key,mechanism,in,atherogenesis,[,22,],.}	{NULL}
journal.pgen.1003588.pdf	70	{In,these,studies,",",however,",",potential,effects,of,ANRIL,knock-down,on,trans-regulation,were,not,investigated,.}	{NULL}
journal.pgen.1003588.pdf	71	{Sato,et,al,transiently,over-expressed,one,speciﬁc,ANRIL,transcript,in,HeLa,cells,and,found,effects,on,expression,levels,of,various,genes,in,trans,[,23,],.}	{NULL}
journal.pgen.1003588.pdf	72	{Even,though,the,molecular,mechanisms,were,not,investigated,in,that,work,",",this,ﬁnding,was,of,interest,because,tramregulation,of,target,genes,has,been,proposed,as,a,key,mechanism,for,biological,effects,of,other,long,non,—,coding,RNA,such,as,HOTAIR,[,24,~,26,],.}	{NULL}
journal.pgen.1003588.pdf	73	{It,is,believed,that,these,long,ncRNAs,mediate,their,effects,through,targeting,epigenetic,modiﬁer,proteins,to,speciﬁc,sites,in,the,genome,[,l7,",19,27",],.}	{NULL}
journal.pgen.1003588.pdf	74	{Taken,together,",",the,previously,available,data,suggested,that,ANRIL,might,inﬂuence,gene,expression,by,modulating,chromatin,modiﬁcation,and,thereby,affect,cardiovascular,risk,.}	{NULL}
journal.pgen.1003588.pdf	75	{The,aim,of,the,present,study,was,to,investigate,the,role,of,ANRIL,in,gene,regulation,and,cellular,functions,related,to,atherogenesis,on,a,mechanistic,level,.}	{NULL}
journal.pgen.1003588.pdf	76	{To,this,end,",",we,performed,genome-wide,expression,analyses,in,cell,lines,over-expressing,distinct,ANRIL,transcripts,that,were,associated,with,Chr9p2,l.,"\\\\",/,V,e,studied,the,molecular,mechanisms,of,ANRIL-mediated,gene,regulation,by,investigating,ANRIL,binding,to,epigenetic,effector,proteins,and,their,distribution,across,the,genome,.}	{NULL}
journal.pgen.1003588.pdf	77	{Using,bioinformatics,studies,",",we,identiﬁed,a,regulatory,motif,characteristic,for,ANRIL-regulated,genes,.}	{NULL}
journal.pgen.1003588.pdf	78	{Finally,",",the,functional,relevance,of,the,motif,was,conﬁrmed,by,deletion,and,mutagenesis,and,results,were,validated,in,primary,human,cells,from,patients,with,and,without,the,Chr9p2l,atherosclerosis,risk,allele,.}	{NULL}
journal.pgen.1003588.pdf	79	{Results}	{NULL}
journal.pgen.1003588.pdf	80	{ANRIL,isoforms,trans,—,regu,|,ate,target,genes,and,modulate,mechanisms,of,atherogenesis,Using,rapid,ampliﬁcation,of,CDNA,ends,(,RACE,),and,subsequent,PCR,experiments,",",we,identiﬁed,four,major,groups,of,ANRIL,transcripts,in,human,peripheral,blood,mononuclear,cells,(,PBMC,),and,the,monocytic,cell,line,MonoMac,(,Figure,S1,",",Figure,1C,),.}	{NULL}
journal.pgen.1003588.pdf	81	{Consensus,transcripts,designated,ANRIL,],-4,",",comprising,the,most,frequently,occurring,exon-combinations,and,most,strongly,expressed,in,MonoMac,cells,(,Figure,SlE,),",",are,shown,in,Figure,2A,.}	{NULL}
journal.pgen.1003588.pdf	82	{Association,of,these,transcripts,with,Chr9p2l,was,conﬁrmed,in,PBMC,(,n,=,2280,),and,whole,blood,(,n,=,960,),of,patients,with,and,without,coronary,artery,disease,(,CAD,),in,the,Leipzig,LIFE,Heart,Study,[,28,],and,in,endarterectomy,specimens,(,n,=,193,),(,Figures,1D,and,1E,),.}	{NULL}
journal.pgen.1003588.pdf	83	{The,Chr9p2l,risk,allele,was,associated,with,increased,ANRIL,expression,(,Figure,1E,),and,different,isoforms,were,positively,correlated,with,each,other,(,Figure,S2,),.}	{NULL}
journal.pgen.1003588.pdf	84	{Using,an,assay,detecting,a,common,exon-exon,boundary,present,in,the,majority,of,ANRIL,isoforms,(,Exl-5,),",",we,found,a,26,%,overall,increase,of,ANRIL,expression,per,CAD-risk,allele,(,P,=,2.04,l,>,<,10,‘,33,),in,PBMC,of,the,Leipzig,LIFE,Heart,Study,.}	{NULL}
journal.pgen.1003588.pdf	85	{Strongest,isoform,speciﬁc,effects,were,found,for,ANRIL,?}	{NULL}
journal.pgen.1003588.pdf	86	{(,5,%,increase,per,risk,allele,;,P,=,0.002,),and,ANRIL4,(,8,%,increase,per,risk,allele,",",P,:,3.02,>,<,l0_6,),(,Figure,1E,),.}	{NULL}
journal.pgen.1003588.pdf	87	{To,investigate,the,functional,role,of,distinct,ANRIL,transcripts,",",we,generated,stably,over-expressing,cells,lines,(,Figure,2B,",",Figure,S3,),.}	{NULL}
journal.pgen.1003588.pdf	88	{ANRIL,overexpression,led,to,signiﬁcant,changes,of,gene,expression,in,trans,as,determined,by,genome-wide,mRNA,expression,analysis,(,Figure,2C,),.}	{NULL}
journal.pgen.1003588.pdf	89	{219,transcripts,were,down,-,and,708,transcripts,were,up-regulated,in,ANRILl-4,cell,lines,with,average,fold-changes,smaller,than,0.5,and,greater,than,2,compared,to,vector,control,",",respectively,(,Table,S1,and,Table,S2,),.}	{NULL}
journal.pgen.1003588.pdf	90	{These,genes,were,distributed,across,the,genome,and,there,was,no,evidence,for,regulation,of,CDK,],"\\\\",/,2A,/,B,in,the,Chr9p2l,region,(,Figure,S4,),.}	{NULL}
journal.pgen.1003588.pdf	91	{Gene,set,enrichment,analysis,predicted,an,effect,of,ANRIL,overexpression,on,movement,/,adhesion,",",growth,/,proliferation,and,cell,death/apoptosis,(,Table,l,),",",which,are,central,mechanisms,of,atherogenesis,[,22,],.}	{NULL}
journal.pgen.1003588.pdf	92	{"\\\\",/,V,e,therefore,aimed,to,experimentally,validate,these,predictions,in,ANRIL,over-expressing,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	93	{Studies,conﬁrmed,that,ANRIL,led,to,increased,cell,adhesion,with,strongest,effects,observed,for,cell,lines,over-expressing,ANRIL4,(,Figures,2D,—,2F,),.}	{NULL}
journal.pgen.1003588.pdf	94	{Over-expression,of,ANRIL,further,promoted,cell,growth,and,metabolic,activity,(,Figures,2G,—,2I,),.}	{NULL}
journal.pgen.1003588.pdf	95	{Apoptosis,",",as,determined,by,ﬂow,cytometric,analysis,of,AnnexinV-positive,cells,(,Figure,2,],),",",caspase-3,activity,(,Figure,2K,),and,caspase-3,immunohistochemical,staining,(,Figure,2L,),was,attenuated,.}	{NULL}
journal.pgen.1003588.pdf	96	{Greatest,biological,effects,were,consistently,found,in,cell,lines,over-expressing,isoforms,ANRIL,?}	{NULL}
journal.pgen.1003588.pdf	97	{and,4,",",the,same,isoforms,",",which,also,revealed,the,strongest,associations,with,the,Chr9p2l,risk,genotype,(,Figure,1E,),.}	{NULL}
journal.pgen.1003588.pdf	98	{Moreover,",",we,demonstrated,a,dose-dependent,effect,on,these,mechanisms,in,independently,established,cell,lines,over-expressing,these,isoforms,(,Figure,S5,),.}	{NULL}
journal.pgen.1003588.pdf	99	{Effects,on,cell,adhesion,",",proliferation}	{NULL}
journal.pgen.1003588.pdf	100	{D,Association,of,ANRIL,expression,with}	{NULL}
journal.pgen.1003588.pdf	101	{Chr9p21,genotype}	{NULL}
journal.pgen.1003588.pdf	102	{$,Ta,A,Leipzig,LIFE,Heart,Study,PBMC,(,n,=,2280,)}	{NULL}
journal.pgen.1003588.pdf	103	{Significant,association,with,Chr9p21,haplotype,?}	{NULL}
journal.pgen.1003588.pdf	104	{A,Chr9p21,atherosclerosis,haplotype,structure}	{NULL}
journal.pgen.1003588.pdf	105	{Leipzig,LIFE,Heart,Study,Whole,blood,(,n,=,960,)}	{NULL}
journal.pgen.1003588.pdf	106	{B,Initially,annotated}	{NULL}
journal.pgen.1003588.pdf	107	{ANRIL,isoforms,*,EU741058,","}	{NULL}
journal.pgen.1003588.pdf	108	{DQ485454,Vascular,tissue,(,n,=,193,)}	{NULL}
journal.pgen.1003588.pdf	109	{NR_003529}	{NULL}
journal.pgen.1003588.pdf	110	{/,I}	{NULL}
journal.pgen.1003588.pdf	111	{1,15,1617,”,20,E,_,_}	{NULL}
journal.pgen.1003588.pdf	112	{C,1319,Leipzig,LIFE,Heart,Study}	{NULL}
journal.pgen.1003588.pdf	113	{PBMC,Whole,Blood,Vascular,tissue}	{NULL}
journal.pgen.1003588.pdf	114	{Exons,1,2,3,9,10,11,12,13,13b,14,15,15,17,18,19,20,P-Value,Em,’,-,Cl,P-Value,Em,’,-,Cl,P-Value,E,"\\"",?}	{NULL}
journal.pgen.1003588.pdf	115	{-,‘,Cl,L1,L2,X,L3,ANRIL1,Ex7b,--,a,ms,24,L4,*,L5,L6,Z,L7,XX,Q9/5,%,?}	{NULL}
journal.pgen.1003588.pdf	116	{XX,L8,Z,L9,2,L10,ANRIL3,EXm_13bL11,Liz,Z,L13,L14,X,L15,X,L16,X,L17,ANR/L4,1,o,EX18,—,79,Linear,isoforms,"5,1,5",.}	{NULL}
journal.pgen.1003588.pdf	117	{.....,.....,.....,.....,...,...}	{NULL}
journal.pgen.1003588.pdf	118	{Figure,1,.}	{NULL}
journal.pgen.1003588.pdf	119	{Annotated,ANRIL,transcripts,in,the,Chr9p21,region,",",transcript,structure,and,association,of,ANRIL,isoforms,with,Chr9p21,genotype,.}	{NULL}
journal.pgen.1003588.pdf	120	{(,A,),Chr9p21,haplotype,structure,(,HapMap,CEU,",",r2,),and,core,atherosclerosis,region,(,between,rs12555547,and,rs1333050,),.}	{NULL}
journal.pgen.1003588.pdf	121	{(,B,),Exons,of,initially,discovered,ANRIL,transcripts,and,their,relative,position,in,the,Chr9p21,region,.}	{NULL}
journal.pgen.1003588.pdf	122	{*,A,full,list,of,currently,annotated,ANRIL,isoforms,is,given,in,Figure,S1B,.}	{NULL}
journal.pgen.1003588.pdf	123	{(,C,),ANRIL,transcripts,identified,by,RACE,and,PCR,ampliﬁcation,(,L1,.}	{NULL}
journal.pgen.1003588.pdf	124	{—,.}	{NULL}
journal.pgen.1003588.pdf	125	{L17,),.}	{NULL}
journal.pgen.1003588.pdf	126	{4,major,isoform,groups,with,4,distinct,transcriptions,ends,were,identified,.}	{NULL}
journal.pgen.1003588.pdf	127	{Frequency,of,exon,occurrence/isoform,group,is,co,|,or,—,coded,and,given,in,%,.}	{NULL}
journal.pgen.1003588.pdf	128	{ANRlL1,—,4,denote,highly,expressed,consensus,transcripts,harbouring,exons,found,in,>,50,%,transcripts,of,the,respective,isoform,group,(,red,),.}	{NULL}
journal.pgen.1003588.pdf	129	{Dotted,lines,indicate,positions,of,transcript,—,speciﬁc,qRT,.}	{NULL}
journal.pgen.1003588.pdf	130	{—,.}	{NULL}
journal.pgen.1003588.pdf	131	{PCR,assays,.}	{NULL}
journal.pgen.1003588.pdf	132	{(,D,),Study,design,of,ANRIL,expression,and,association,with,Chr9p21,.}	{NULL}
journal.pgen.1003588.pdf	133	{(,E,),Association,of,ANRIL,isoforms,with,Chr9p21,in,human,PBMC,",",whole,blood,and,vascular,tissue,(,effect,",",%,change/risk,allele,defined,by,rs10757274,",",rs2383206,",",rs2383297,",",and,rs10757278,),.}	{NULL}
journal.pgen.1003588.pdf	134	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	135	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	136	{g0O1}	{NULL}
journal.pgen.1003588.pdf	137	{and,apoptosis,could,be,reversed,by,RNAi-mediated,knock-down,of,ANRIL,as,shown,in,ANRIL2,and,ANRIL4,cell,lines,(,Figures,2M,—,20,",",Figure,S6,),",",further,supporting,a,pivotal,role,of,ANRIL,in,these,pro-atherogenic,cellular,functions,.}	{NULL}
journal.pgen.1003588.pdf	138	{PRC,but,not,CoREST/REST,proteins,bind,to,ANRIL,and,are,recruited,to,target,gene,promoters,upon,ANRIL,overexpression,To,systematically,identify,ANRIL-associated,epigenetic,effector,proteins,",",we,next,screened,ANRIL,binding,to,Polycomb,group,(,PcG,),proteins,(,AEBP2,",",BMI1,",",CBX7,",",EED,",",EZH2,",",JARID2,",",MELl8,",",PHF1,",",PHF19,",",RBAP46,",",RINGIB,",",RYBP,",",SUZ12,",",YY1,),and,CoREST,/,REST,(,CoREST,",",REST,",",LSD1,),using,RNA,immunoprecipitation,(,RIP,),in,nuclear,extracts,from,ANRIL2,and,4,cells,(,Figures,3A,~,3B,),.}	{NULL}
journal.pgen.1003588.pdf	139	{ANRIL,did,not,bind,to,CoREST,/,REST,repressor,proteins,but,bound,to,PRC1,proteins,CBX7and,RINGIB,and,to,PRC2,proteins,EEDJARID2,",",RBAP46,",",and,SUZ12,.}	{NULL}
journal.pgen.1003588.pdf	140	{ANRIL,also,bound,to,PRC-associated,proteins,RYBP,and,YY1,which,have,been,shown,to,induce,gene,expression,[,"29,30",],.}	{NULL}
journal.pgen.1003588.pdf	141	{To,investigate,genome-wide,distribution,of,Polycomb,complexes,",",we,chose,CBX7,[,3,],and,SUZl2,[,20,],as,representative,PcG,proteins,and,performed,chromatin,immunoprecipitation,followed,by,high-throughput,sequencing,(,ChIP-seq,),in,ANRIL2,cells,.}	{NULL}
journal.pgen.1003588.pdf	142	{Analysis,of,PcG,distribution,patterns,in,ANRIL-target,gene,promoters,revealed,reduced,SUZ12,and,CBX7,occupancy,compared,to,not-regulated,genes,",",following,a,wave-shaped,binding,pattern,(,Figure,3C,and,Figure,S7,),.}	{NULL}
journal.pgen.1003588.pdf	143	{Reduced,SUZl2,and,CBX7,binding,",",as,well,as,identical,occupancy,pattern,",",was,replicated,in,publicly,available,data,from,BGO3,cells,(,Figure,3D,),.}	{NULL}
journal.pgen.1003588.pdf	144	{Over-expression,of,ANRIL,increased,SUZl2,and,CBX7,binding,to,promoters,of,up-regulated,genes,(,Figures,3E,—,3F,),",",concordant,with,a,recently,described,role,of,PRCs,in,regulation,of,active,genes,[,31,],.}	{NULL}
journal.pgen.1003588.pdf	145	{In,further,support,",",RNAi,against,CBX7,and,SUZ12,largely,reversed,expression,patterns,not,only,of,ANRILrepressed,",",but,also,induced,genes,in,ANRIL2,cells,(,Figure,3G,),.}	{NULL}
journal.pgen.1003588.pdf	146	{Whereas,ANRIL,binding,to,CBX7,and,SUZ12,has,previously,been,demonstrated,in,the,context,of,cis-repression,[,"3,20",],",",our,experiments,now,extent,the,role,of,these,proteins,to,ANRIL-mediated,trans-regulation,of,gene,networks,pivotal,in,atherogenesis,.}	{NULL}
journal.pgen.1003588.pdf	147	{Genome,—,wide,PRC,binding,is,dependent,on,an,Alu,motif,marking,promoters,of,ANRIL,target,—,genes,and,contained,within,ANRIL,RNA,transcripts,To,address,",",which,additional,factors,might,be,relevant,for,ANRIL-mediated,trans-regulation,",",we,performed,bioinformatic}	{NULL}
journal.pgen.1003588.pdf	148	{A,7b,D,E,F,ANRIL1,41,-,.}	{NULL}
journal.pgen.1003588.pdf	149	{»,E3,.6,>,<,10,“,»,:,«,3.6,>,<,104,g3,.6,x104,EX7b,It-G,"\\"",’,"\\"",V,1,’,E,2}	{NULL}
journal.pgen.1003588.pdf	150	{ANRIL2,|,T,|,|,.}	{NULL}
journal.pgen.1003588.pdf	151	{—,.}	{NULL}
journal.pgen.1003588.pdf	152	{|,.}	{NULL}
journal.pgen.1003588.pdf	153	{—,.}	{NULL}
journal.pgen.1003588.pdf	154	{|,?}	{NULL}
journal.pgen.1003588.pdf	155	{g2,.4,>,<,10,“,$,?}	{NULL}
journal.pgen.1003588.pdf	156	{g24,>,<,10,“,"7,3",2.4,>,<,10,"\\"",E,),(,7.13,.}	{NULL}
journal.pgen.1003588.pdf	157	{.....,.....,.}	{NULL}
journal.pgen.1003588.pdf	158	{.}	{NULL}
journal.pgen.1003588.pdf	159	{.}	{NULL}
journal.pgen.1003588.pdf	160	{.}	{NULL}
journal.pgen.1003588.pdf	161	{|,oΕ,E,‘,E,E,ANRU,lelpkljl,g1,.2,x1o4,H43,A,g12,>,<,104,%,",",j1,.2,>,<,1o4,Ex10,—,13b,o,--------------,«,-,I,%,-,‘,E,%}	{NULL}
journal.pgen.1003588.pdf	162	{EV1,‘,/,£,;,L4,“,Adhesion,.}	{NULL}
journal.pgen.1003588.pdf	163	{—,.}	{NULL}
journal.pgen.1003588.pdf	164	{PBS,Adhesion,—,co,|,|,agen}	{NULL}
journal.pgen.1003588.pdf	165	{Annotated,ljH,—,lH-llllll,—,l,:,ll,—,ll-Ill,3,24,8}	{NULL}
journal.pgen.1003588.pdf	166	{I,I,"\\\\",lI,"\\\\",lI,"\\\\",|,I,/,1,/,"\\\\",I,“,>}	{NULL}
journal.pgen.1003588.pdf	167	{ANRILeX,°,ns,1,2,3,4s67s9,|,ll2,13,1415,1e17J,|,2o,g,E,18,—,§,1011,19,3,E,"\\\\",o,E,V,12,3,/,=,3,>,.}	{NULL}
journal.pgen.1003588.pdf	168	{Cell,line,ANRIL1,ANR,|,L2,ANR,|,L3,ANRIL4,vector,8,8,6,P6,"\\""}	{NULL}
journal.pgen.1003588.pdf	169	{5,;,E,"\\"",‘,"\\"",5r,’,§,”,',‘,;,§,’,§,:,Z,‘,1,;,f,‘,ri,;,‘,§,r,;,w,5,o,5,RT,PCRs,8,1,_,2,3,Ex7b,-,.}	{NULL}
journal.pgen.1003588.pdf	170	{.}	{NULL}
journal.pgen.1003588.pdf	171	{-,.}	{NULL}
journal.pgen.1003588.pdf	172	{.}	{NULL}
journal.pgen.1003588.pdf	173	{.}	{NULL}
journal.pgen.1003588.pdf	174	{_,-,_,J,K,L,tlme,(,d,),Ex7-13,~,-,-,-,—,-,ﬂ,20,5,7500,Caspase/DAPI,Ex1o-13b,.}	{NULL}
journal.pgen.1003588.pdf	175	{-,oo,-,g,8,15,1,%,Ex18-19,....,-,ia,gn,5000}	{NULL}
journal.pgen.1003588.pdf	176	{.5,§,10,“’,E}	{NULL}
journal.pgen.1003588.pdf	177	{BA,I,----,In,---,u,----,an,---,n,§,§,"\\"",’,2500,GAPDH,Odnonnuuucnnuunn,.}	{NULL}
journal.pgen.1003588.pdf	178	{—,.}	{NULL}
journal.pgen.1003588.pdf	179	{.}	{NULL}
journal.pgen.1003588.pdf	180	{—,.}	{NULL}
journal.pgen.1003588.pdf	181	{-,n,E,5,5}	{NULL}
journal.pgen.1003588.pdf	182	{C,COL3A1,o,o}	{NULL}
journal.pgen.1003588.pdf	183	{—,_,+,—,_,+,vector,ANR,|,L2}	{NULL}
journal.pgen.1003588.pdf	184	{<,o,5,(,old,Staurosporlne,(,0.25,l.,lM,),Staurosporlne,(,0.25,l.,lM,),>,2.0,fold}	{NULL}
journal.pgen.1003588.pdf	185	{M,"\\\\",125,*,*,N,125,O,"\\\\",200,*,*,2,2,*,1,;,g,",5",€,"2,100",-,E,‘,z100,85150,5,',5,75,"\\"",735,75,$,5,100,5,",1",50,ڊ,",1",50,o,*,=,o,o,_,9,“,50,2,(,D,U,),o.,2,SCR/ANRIL,slRNA,),E,a}	{NULL}
journal.pgen.1003588.pdf	186	{o,O,4,-,SCR/ANRlL,slRNA,o@���,<,o}	{NULL}
journal.pgen.1003588.pdf	187	{2,siRNA,SCR,+,-,+,-,Q,1,2,3,4,siRNA,SCR,+,~,+,siRNA,ANRIL,.}	{NULL}
journal.pgen.1003588.pdf	188	{+,.}	{NULL}
journal.pgen.1003588.pdf	189	{+,(,imam,),siRNA,ANRIL,—,+,.}	{NULL}
journal.pgen.1003588.pdf	190	{+}	{NULL}
journal.pgen.1003588.pdf	191	{E,],ANR,|,L1,:,exons1-5-6-7b,El,ANR,|,L3,:,exons1-5-6-7-10-13b,|,:,|,p,vector,I,ANR,|,L2,:,exons1-5-6-7-13,I,ANR,|,L4,:,exons1,—,5,—,6,—,16,—,18,—,19,—,2O}	{NULL}
journal.pgen.1003588.pdf	192	{Figure,2,.}	{NULL}
journal.pgen.1003588.pdf	193	{ANRIL,regulates,gene,expression,in,trans,and,affects,cell,adhesion,",",metabolic,activity,",",proliferation,",",and,apoptosis,.}	{NULL}
journal.pgen.1003588.pdf	194	{(,A,),Consensus,transcripts,of4,ANRIL,isoform,groups,identiﬁed,by,RACE,and,PCR,(,Figure,51,),.}	{NULL}
journal.pgen.1003588.pdf	195	{Dotted,lines,indicate,positions,of,transcript,—,speciﬁc,qRT,.}	{NULL}
journal.pgen.1003588.pdf	196	{—,.}	{NULL}
journal.pgen.1003588.pdf	197	{PCR,assays,.}	{NULL}
journal.pgen.1003588.pdf	198	{(,B,),RT,.}	{NULL}
journal.pgen.1003588.pdf	199	{—,.}	{NULL}
journal.pgen.1003588.pdf	200	{PCR,confirmation,of,ANRIL,over,—,expression,in,stable,ANR,|,L1,—,4,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	201	{3-4,cell,lines,per,ANRIL,isoform,were,established,",",no,effect,on,house,—,keeping,gene,expression,was,found,(,beta,—,actin,(,BA,),;,glyceraldehyde,—,3,—,phosphate,dehydrogenase,(,GAPDH,),),.}	{NULL}
journal.pgen.1003588.pdf	202	{(,C,),Heatmap,of,ANRIL,transregulated,transcripts,corresponding,to,panel,B.,Transcripts,with,average,down,—,(,<,0.5,—,fo,|,d,",",red,),and,up,—,(,>,2,—,fo,|,d,",",green,),regulation,relative,to,vector,control,are,shown,.}	{NULL}
journal.pgen.1003588.pdf	203	{(,D,.}	{NULL}
journal.pgen.1003588.pdf	204	{—,.}	{NULL}
journal.pgen.1003588.pdf	205	{F,),Adhesion,of,ANRIL,over,—,expressing,cell,lines,to,PBS,—,",",Matrige,|,.}	{NULL}
journal.pgen.1003588.pdf	206	{—,.}	{NULL}
journal.pgen.1003588.pdf	207	{",",and,co,|,|,agen,—,coated,wells,(,P,<,0.01,for,comparison,of,ANRIL1,",",2,",",3,",",4,vs.,vector,control,),.}	{NULL}
journal.pgen.1003588.pdf	208	{(,G,—,|,),Cell,proliferation,and,metabolic,activity,determined,by,(,G,),absolute,cell,numbers,",",(,*,/,#,P,<,0.05,for,ANR,|,L2,and,ANRIL4,vs.,vector,control,),",",(,H,),glucose,utilisation,",",and,(,I,),viability,assay,.}	{NULL}
journal.pgen.1003588.pdf	209	{(,J,.}	{NULL}
journal.pgen.1003588.pdf	210	{—,.}	{NULL}
journal.pgen.1003588.pdf	211	{L,),Apoptosis,determined,by,(,J,),AnnexinV,—,positive,cells,",",(,K,),caspase,activity,",",and,(,L,),caspase-3,staining,.}	{NULL}
journal.pgen.1003588.pdf	212	{(,H,.}	{NULL}
journal.pgen.1003588.pdf	213	{—,.}	{NULL}
journal.pgen.1003588.pdf	214	{K,),P,<,0.05,for,ANR,|,L2,and,ANRIL4,vs.,vector,control,.}	{NULL}
journal.pgen.1003588.pdf	215	{(,M,.}	{NULL}
journal.pgen.1003588.pdf	216	{—,.}	{NULL}
journal.pgen.1003588.pdf	217	{O,),Reversal,of,effects,by,RNAi,against,ANRIL,(,*,P,<,0.05,;,SCR,—,scrambled,control,),.}	{NULL}
journal.pgen.1003588.pdf	218	{(,D,.}	{NULL}
journal.pgen.1003588.pdf	219	{—,.}	{NULL}
journal.pgen.1003588.pdf	220	{K,),At,least,triplicate,measurements,per,pool,of,3-4,biological,replicates,were,performed,.}	{NULL}
journal.pgen.1003588.pdf	221	{For,details,on,experimental,setup,and,P,—,va,|,ues,please,see,Table,S3,.}	{NULL}
journal.pgen.1003588.pdf	222	{(,M,.}	{NULL}
journal.pgen.1003588.pdf	223	{—,.}	{NULL}
journal.pgen.1003588.pdf	224	{O,),n,=,3/group,.}	{NULL}
journal.pgen.1003588.pdf	225	{Validation,of,siRNA,knock,—,down,is,shown,in,Figure,56,.}	{NULL}
journal.pgen.1003588.pdf	226	{Error,bars,indicate,s.e.m.,doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	227	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	228	{g0O2}	{NULL}
journal.pgen.1003588.pdf	229	{Table,1,.}	{NULL}
journal.pgen.1003588.pdf	230	{Gene,set,enrichment,analysis,of,ANRIL,trans,—,regu,|,ated,genes,in,cell,lines,ANR,|,L1,—,4,.}	{NULL}
journal.pgen.1003588.pdf	231	{Function,ANRIL1,ANRlL2,ANR,|,L3,ANRIL4,Cellular,Development,1.43,x1o,’,°,“,7,.}	{NULL}
journal.pgen.1003588.pdf	232	{o2x1o,’”,3.43,>,<,1o,’,°,“,2.52,>,<,1o,’,°,9,Cellular,Movement/Adhesion,4.53,x1o,’,°,3,4.21,x10,’,°,5,2.18,x1o,’,°,“,1,.}	{NULL}
journal.pgen.1003588.pdf	233	{o7x1o,’,°,7,Cellular,Growth,and,Proliferation,1.71,x1o,’,°,5,5.24,x10,’,°,9,4.9,o,>,<,1o,’,°,"\\"",’,9.91,x1o,’,°,7,Cell,Death/Apoptosis,6.27,x1o,’,°,“,8.29,x10,’,°,8,2.38,x1o,’,°,5,4.54,x1o,’,°,"\\"",’,Ce,|,|,.}	{NULL}
journal.pgen.1003588.pdf	234	{—,.}	{NULL}
journal.pgen.1003588.pdf	235	{To,.}	{NULL}
journal.pgen.1003588.pdf	236	{—,.}	{NULL}
journal.pgen.1003588.pdf	237	{Ce,|,|,Signaling,and,Interaction,3.49,x1o,’,°,3,3.00,x1o,’,°,“,2.14,x1o,’,°,“,1.52,x1o,’,°,5,Cellular,Assembly,and,Organization,1.21,x1o,’,°,3,5.77,x10,’,°,“,9.71,x1o,’,°,“,3,.}	{NULL}
journal.pgen.1003588.pdf	238	{o3x1o,’,°,5,Cellular,Function,and,Maintenance,1.21,x1o,’,°,3,4.78,x1o,’,°,“,7.29,>,<,1o,’,°,“,7.21,>,<,1o,’,°,5,Gene,Expression,1.21,x1o,’,°,3,1.83,x1o,’,°,3,2.95,x1o,’,°,“,1.32,x1o,’,°,“,Cell,Morphology,5.01,x1o,’,°,3,6.65,x1o,’,°,“,5.99,>,<,1o,’,°,“,7.4,ox1o,’,°,“}	{NULL}
journal.pgen.1003588.pdf	239	{Genes,with,expression,changes,of,<,0.5,and,>,2,in,ANRIL,over,—,expressing,cell,lines,1-4,compared,to,vector,control,were,included,in,the,analysis,:,ANR,|,L1,—,n,=,893,(,2,n,=,454,compared,to,control,),",",ANR,|,L2,—,n,=,2658,(,<,0.5,n,=,1116,/,>,2,n,=,1542,compared,to,control,),",",ANRIL,3,»,n,=,1830,(,<,0.5,n,=,1054,/,>,2,n,=,776,compared,to,control,),",",and,ANR,|,L4,—,n,=,2982,(,<,0.5,n,=,1514,/,>,2,n,=,1468,compared,to,control,),.}	{NULL}
journal.pgen.1003588.pdf	240	{P,—,va,|,ues,for,enrichment,of,trans,—,regu,|,ated,genes,(,www.ingenuity.com,),are,given,.}	{NULL}
journal.pgen.1003588.pdf	241	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	242	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	243	{tOO1}	{NULL}
journal.pgen.1003588.pdf	244	{PLOS,Genetics,|,www,.}	{NULL}
journal.pgen.1003588.pdf	245	{p,|,osgenetics.org,4,July,2013,|,Volume,9,|,Issue,7,|,e1003588}	{NULL}
journal.pgen.1003588.pdf	246	{A,/,‘,"\\\\",PRC1,PRC2,CORESTI,|,gG,$,520,a,“,°,3,2.,;,3910,:,‘,ME,23,‘,(,Eo}	{NULL}
journal.pgen.1003588.pdf	247	{:7,"\\\\",O3mQ,.}	{NULL}
journal.pgen.1003588.pdf	248	{“,:,"\\\\",|,FK,"\\\\",|,(,"\\\\",l,"\\\\",.}	{NULL}
journal.pgen.1003588.pdf	249	{—,.}	{NULL}
journal.pgen.1003588.pdf	250	{o,),go,(,‘,l,"\\\\",.}	{NULL}
journal.pgen.1003588.pdf	251	{—,.,'}	{NULL}
journal.pgen.1003588.pdf	252	{.}	{NULL}
journal.pgen.1003588.pdf	253	{—,.}	{NULL}
journal.pgen.1003588.pdf	254	{l,.}	{NULL}
journal.pgen.1003588.pdf	255	{—,.}	{NULL}
journal.pgen.1003588.pdf	256	{(,_,',),(,D,(,D,2é,:5,$,§,%,BE,.9,“,$,Ea'K,.}	{NULL}
journal.pgen.1003588.pdf	257	{g,:,’d,$,%,’,9g,‘,°,o,',-,Uzi,:,u.nu.iI-uEEn,.}	{NULL}
journal.pgen.1003588.pdf	258	{I,_,in,:,n,:,E}	{NULL}
journal.pgen.1003588.pdf	259	{EE,4,",",mg,”,),8}	{NULL}
journal.pgen.1003588.pdf	260	{B,A,PRC1,PRC2,CORESTI,|,gG,D,u,;,£,10,.}	{NULL}
journal.pgen.1003588.pdf	261	{Q,3Q-4,-,!}	{NULL}
journal.pgen.1003588.pdf	262	{‘,),3,3.,;,E25,«,I,m,-,%,22,<,90}	{NULL}
journal.pgen.1003588.pdf	263	{-,~,"\\\\","\\\\","\\\\",.}	{NULL}
journal.pgen.1003588.pdf	264	{—,.}	{NULL}
journal.pgen.1003588.pdf	265	{lS,%,§,9,§,:,$,a,%,E$,E,’,:,’,§,3e,$,E,‘,.}	{NULL}
journal.pgen.1003588.pdf	266	{—,.}	{NULL}
journal.pgen.1003588.pdf	267	{=,°,»,°,.}	{NULL}
journal.pgen.1003588.pdf	268	{—,.}	{NULL}
journal.pgen.1003588.pdf	269	{=,°,»,3,°,°,o,',-,$,421,?}	{NULL}
journal.pgen.1003588.pdf	270	{|,|,_,uL,|,JED,.}	{NULL}
journal.pgen.1003588.pdf	271	{E$,32ECQ,°,C,5,°,’}	{NULL}
journal.pgen.1003588.pdf	272	{o,:,"\\"",3,',>,",1",Q}	{NULL}
journal.pgen.1003588.pdf	273	{G}	{NULL}
journal.pgen.1003588.pdf	274	{SICBX7,-,+,siSUZ12,siCBX7,siSUZ12,SISCR,SISCR,SlSCR,ANRIL-repressed,genes}	{NULL}
journal.pgen.1003588.pdf	275	{ANR/L,—,induced,genes}	{NULL}
journal.pgen.1003588.pdf	276	{O}	{NULL}
journal.pgen.1003588.pdf	277	{SUZ12,vector,(,density,),SUZ12,BGO3,(,density,)}	{NULL}
journal.pgen.1003588.pdf	278	{0.07,T,§,5,A,0.06,T,§,S,0.06,‘,2,.}	{NULL}
journal.pgen.1003588.pdf	279	{-2,.,'}	{NULL}
journal.pgen.1003588.pdf	280	{0.05,o,:,2,0.04,E,%,0.03,g,g,331,9,9,-,>,o.,oo,"\\"",’}	{NULL}
journal.pgen.1003588.pdf	281	{-5000,-3000,-1000,1000,Distance,from,TSS,(,bp,)}	{NULL}
journal.pgen.1003588.pdf	282	{-5000,-3000,-1000,1000,Distance,from,TSS,(,bp,),‘,I1}	{NULL}
journal.pgen.1003588.pdf	283	{0.4,T,§,3,",",A,0.07,T,§,S,‘,§,é,0.06,"\\""}	{NULL}
journal.pgen.1003588.pdf	284	{0-3,E,jg,"0,05",2,0.04}	{NULL}
journal.pgen.1003588.pdf	285	{0.2,<,3,o,",",2,5,8,'83,.}	{NULL}
journal.pgen.1003588.pdf	286	{‘,-7,",",2,',3,2,0.01,o.o,‘,o.,oo,-5000,-3000,-1000,1000,Distance,from,TSS,(,bp,)}	{NULL}
journal.pgen.1003588.pdf	287	{-5000,-3000,-1000,1000,Distance,from,TSS,(,bp,)}	{NULL}
journal.pgen.1003588.pdf	288	{Figure,3,.}	{NULL}
journal.pgen.1003588.pdf	289	{ANRIL,binds,to,PRC1,and,2,proteins,and,recruits,CBX7,and,SUZ12,to,promoters,of,target,genes,.}	{NULL}
journal.pgen.1003588.pdf	290	{(,A,",",B,),RNA,immunoprecipitation,(,RIP,),followed,by,qRT,.}	{NULL}
journal.pgen.1003588.pdf	291	{—,.}	{NULL}
journal.pgen.1003588.pdf	292	{PCR,demonstrating,ANRIL,binding,to,PRC,but,not,to,CoREST/REST,proteins,in,(,A,),ANR,|,L2,and,(,B,),ANRIL4,cells,.}	{NULL}
journal.pgen.1003588.pdf	293	{Copies,of,ANRIL,relative,to,input,control,are,given,in,(,A,),blue,and,(,B,),red,",",nuclear,ncRNA,U1,(,white,),was,used,as,negative,control,.}	{NULL}
journal.pgen.1003588.pdf	294	{r,|,gG/m,|,gG,/,g,|,gG,—,rabbit/mouse/goat,|,gG,controls,.}	{NULL}
journal.pgen.1003588.pdf	295	{Error,bars,indicate,s.e.m.,(,C,",",D,),SUZ12,binding,in,promoters,of,ANRIL,up,—,(,green,),",",down,—,(,red,),",",and,not,(,black,),regulated,genes,in,(,C,),vector,control,cell,line,and,(,D,),in,BGO3,cells,(,GSM602674,),.}	{NULL}
journal.pgen.1003588.pdf	296	{TSS,—,transcription,start,site,.}	{NULL}
journal.pgen.1003588.pdf	297	{(,E,",",F,),Effect,of,ANRIL,over,—,expression,on,(,E,),SUZ12,and,(,F,),CBX7,binding,in,promoters,of,up,—,regu,|,ated,genes,(,vector,control,—,dotted,line,vs.,ANR,|,L2,—,straight,line,),.}	{NULL}
journal.pgen.1003588.pdf	298	{(,G,),Reversal,of,ANRIL,transregulation,by,RNAi,against,SUZ12,and,CBX7,in,ANR,|,L2,cells,.}	{NULL}
journal.pgen.1003588.pdf	299	{SCR,—,scrambled,siRNA,control,.}	{NULL}
journal.pgen.1003588.pdf	300	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	301	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	302	{g0O3}	{NULL}
journal.pgen.1003588.pdf	303	{analyses,of,promoter,regions,of,ANRIL,up,-,and,down-regulated,target,genes,.}	{NULL}
journal.pgen.1003588.pdf	304	{To,this,end,",",we,used,the,MEME,algorithm,searching,for,differences,in,motif,abundance,and,identiﬁed,two,partially,overlapping,DNA,motifs,(,Figure,4A,),.}	{NULL}
journal.pgen.1003588.pdf	305	{Combined,analysis,of,all,trans-regulated,genes,validated,the,core,motif,CACGCCTGTAATCCCAGCACTTTGG,(,Figure,4A,),.}	{NULL}
journal.pgen.1003588.pdf	306	{The,identiﬁed,motif,is,an,Alu-DEIN,element,[,3Q,",33",],with,approximately,60.000,copies,per,human,genome,[,34,],.}	{NULL}
journal.pgen.1003588.pdf	307	{Since,MEME,does,not,provide,information,whether,a,motif,is,enriched,or,depleted,",",we,quantitatively,tested,motif,occurrence,and,found,a,signiﬁcant,depletion,in,up,-,and,down-regulated,genes,compared,to,genes,not,regulated,by,ANRIL,over,—,expression,(,4,vs.,6,occurrences,per,5,kb,promoter,",",respectively,",",P,<,l0,—,15,;,Figure,4B,),.}	{NULL}
journal.pgen.1003588.pdf	308	{These,data,were,consistent,with,decreased,PcG,occupancy,in,target-gene,promoters,(,Figures,3C,—,3D,),.}	{NULL}
journal.pgen.1003588.pdf	309	{Notably,",",strong,enrichment,of,PcG,binding,was,found,~,l50,bp,downstream,of,the,Alu,motif,compared,to,random,DNA,control,(,Figure,4C,),.}	{NULL}
journal.pgen.1003588.pdf	310	{This,ﬁnding,was,replicated,in,the,independent,dataset,for,SUZ12,in,BGO3,cells,(,Figure,4D,),suggesting,Alu,element-dependent,binding,of,PcG,proteins,as,a,general,mechanism,.}	{NULL}
journal.pgen.1003588.pdf	311	{Due,to,the,repetitive,nature,of,the,investigated,Alu,motif,",",the,signiﬁcant,spatial,coherence,between,the,motif,and,PcG,occupancy,was,not,detected,when,analyses,were,masked,for,repetitive,elements,(,Figure,4E,),.}	{NULL}
journal.pgen.1003588.pdf	312	{Importantly,",",the,same,Alu,motif,which,was,found,in,the,DNA,promoter,sequence,of,ANRIL-regulated,genes,was,also,present,in,ANRIL,transcripts,(,Figure,S8,),.}	{NULL}
journal.pgen.1003588.pdf	313	{Here,",",it,was,predicted,to,form,a,stem-loop,structure,in,ANRIL,RNA,(,Figure,4F,),suggesting,RNA-chromatin,interactions,as,a,potential,effector,mechanism,[,16,],.}	{NULL}
journal.pgen.1003588.pdf	314	{Using,RIP,",",we,show,that,ANRIL,co-immunoprecipitates,with,H3,and,trimethylated,lysine,Q7,of,histone,3,(,H3KQ7me3,),(,Figure,4G,),.}	{NULL}
journal.pgen.1003588.pdf	315	{These,results,speak,further,in,favor,of,ANRIL-chromatin,interaction,at,genomic,sites,where,PRC-mediated,epigenetic,histone,methylation,takes,place,.}	{NULL}
journal.pgen.1003588.pdf	316	{Alu,motif,in,ANRIL,ncRNA,is,essential,for,trans,—,regu,|,ation,and,pro,—,atherogenic,functions,To,validate,the,functional,relevance,of,Alu,sequences,implemented,in,ANRIL,transcripts,",",we,generated,stably,over-expressing,cell,lines,devoid,of,exons,containing,these,sequences,(,Figure,5A,",",Figure,S9,),.}	{NULL}
journal.pgen.1003588.pdf	317	{Over-expression,of,mutant,isoforms,ANRILQa-c,and,ANRIL4a,",",b,reversed,expression,changes,of,representative,transcripts,that,were,otherwise,induced,(,TSCQQD3,;,Figure,QC,and,Figure,5B,),or,suppressed,(,COL3A,],;,Figure,QC,and,Figure,5C,),in,AN,RILQ,and,4,cells,.}	{NULL}
journal.pgen.1003588.pdf	318	{Increased,cell,adhesion,in,AN,RILQ,and,4,was,abolished,in,cell,lines,lacking,the,Alu,motif,(,Figure,5D,),.}	{NULL}
journal.pgen.1003588.pdf	319	{Consistent,with,this,ﬁnding,",",ANRILQa-c,and,ANRIL4a,",",b,cell,lines,showed,increased,apoptosis,and,proliferated,more,slowly,compared,to,AN,RILQ,and,4,(,Figures,5E,—,5F,),.}	{NULL}
journal.pgen.1003588.pdf	320	{To,exclude,that,depletion,of,whole,exons,led,to,signiﬁcant,changes,in,ANRIL,secondary,structure,and,thus,impaired,ANRIL,function,",",we,next,generated,cell,lines,stably,over-expressing,ANRIL,isoforms,with,single-base,mutations,of,Q5,%,",",33,%,",",and,100,%,of,nucleotides,in,the,identiﬁed,Alu,motif,(,Figure,5G,",",Figure,S9,),.}	{NULL}
journal.pgen.1003588.pdf	321	{Over-expression,of,these,ANRIL,isoforms,conﬁrmed,the,important,role,of,the,Alu,motif,by,reversing,expression,changes,of,ANRIL,trans-regulated,genes,(,TSCQQD3,",",Figure,QC,and,Figure,5H,;,C013/l,],",",Figure,QC,and,Figure,51,),compared,to,ANRILQ,cells,.}	{NULL}
journal.pgen.1003588.pdf	322	{Moreover,",",ANRIL-mediated,effects,on,adhesion,",",apoptosis,and,proliferation,were,attenuated,(,Figures,5,],5L,),",",further,supporting,the,functional,relevance,of,ANRIL,Alu,motifs,in,pro,—,atherogenic,cellular,functions,.}	{NULL}
journal.pgen.1003588.pdf	323	{ANR,|,L2,ANRIL4}	{NULL}
journal.pgen.1003588.pdf	324	{A,Motifs,in,promoters,of,ANRIL,trans-regulated,genes,B,0.12,39,$,F,oow,~,~,cicA.,:,gccieilATcccAecic,"}",D5,"}",D5,up,*,Tcccleciictlieeelaecerglﬁegmalici,A,"\\"",',VCA,<,;,§,CCTGTMTCCCAGCACHTGG,',o,2,4,6,8,10}	{NULL}
journal.pgen.1003588.pdf	325	{_,"\\\\",U,’,!}	{NULL}
journal.pgen.1003588.pdf	326	{ANRIL,copies,o,relative,to,input,(,%,),O,U,‘,!}	{NULL}
journal.pgen.1003588.pdf	327	{3}	{NULL}
journal.pgen.1003588.pdf	328	{SE,‘,:2,.}	{NULL}
journal.pgen.1003588.pdf	329	{‘,3,<,33,‘,:2,.}	{NULL}
journal.pgen.1003588.pdf	330	{8,<,2,",",Motifs,in,promoter,(,n,),t,E,E,t,E,E,(,"\\\\",l,(,"\\\\",l,X,M,<,o,<,o,I,I,C,0.3,Motif,ЗyD5,D,4,Motif,E,002,Motif-masked,§,15,ANRIL2,ANRIL4,V,‘,"\\"",_,‘,to,’,2,’,E502,CW,/,§,3,8,3310,9,',3,-,an,§,:,o,§,Q-E,‘,C3,5,N,E,2,N,&,O,01,8,",9",N,‘,<,3,0.1,"\\"",V,',V,“,<,o,5,3,9,1,»,~,»,§,1,«,$,2,",",2,%,o.o,‘,o,‘,o.,oo,’,9,o,-1000,-400,o,400,1000,-1000,-400,o,"400 1000 4000400",o,400,1000,2,%,",",?}	{NULL}
journal.pgen.1003588.pdf	331	{<,g,",",$,cg,",",$,<,3,",",Distance,from,motif,(,bp,),Distance,from,motif,(,bp,),Distance,from,motif,(,bp,),7,E,E,I,E,E,Q,Q,o,',),o,',),I,I}	{NULL}
journal.pgen.1003588.pdf	332	{Figure,4,.}	{NULL}
journal.pgen.1003588.pdf	333	{Identification,of,Alu,motifs,in,promoters,of,ANRIL,trans-regulated,genes,and,ANRIL,RNA,and,their,spatial,relation,to,PcG,protein,binding,.}	{NULL}
journal.pgen.1003588.pdf	334	{(,A,),DNA,motif,in,promoters,(,5,kb,),of,trans,—,regu,|,ated,genes,representing,an,A,|,u,.}	{NULL}
journal.pgen.1003588.pdf	335	{—,.}	{NULL}
journal.pgen.1003588.pdf	336	{DE,|,N,repeat,[,33,],.}	{NULL}
journal.pgen.1003588.pdf	337	{(,B,),Number,of,Alu,motifs,in,promoters,of,trans,—,and,not,regulated,transcripts,(,n,per,5,kb,),.}	{NULL}
journal.pgen.1003588.pdf	338	{(,C,),Ch,|,P,—,seq,enrichment,of,SUZ12,and,CBX7,binding,distal,to,Alu,motif,",",demonstrating,a,specific,spatial,relation,of,motif,occurrence,to,PcG,protein,binding,.}	{NULL}
journal.pgen.1003588.pdf	339	{RPM,—,reads,per,million,mapped,reads,",",CTR,—,random,DNA,control,sequence,.}	{NULL}
journal.pgen.1003588.pdf	340	{(,D,),Motif,—,associated,SUZ12,signal,peaks,in,an,independent,data,set,from,BGO3,cells,.}	{NULL}
journal.pgen.1003588.pdf	341	{The,actual,signal,peak,only,becomes,apparent,",",if,a,multiple,matching,policy,is,adopted,.}	{NULL}
journal.pgen.1003588.pdf	342	{(,E,),Using,a,strict,unique,—,matches,only,policy,",",a,substantial,signal,reduction,is,seen,downstream,of,the,motif,.}	{NULL}
journal.pgen.1003588.pdf	343	{Please,note,differences,in,y,—,axis,scaling,in,(,D,",",E,),.}	{NULL}
journal.pgen.1003588.pdf	344	{(,F,),Secondary,RNA,structure,prediction,for,ANR,|,L2,using,the,Vienna,RNA,package,[,58,],.}	{NULL}
journal.pgen.1003588.pdf	345	{Within,the,minimum,free,energy,structure,",",the,A,|,u,.}	{NULL}
journal.pgen.1003588.pdf	346	{—,.}	{NULL}
journal.pgen.1003588.pdf	347	{DE,|,N,motif,is,located,in,a,stem,—,loop,structure,(,arrow,),.}	{NULL}
journal.pgen.1003588.pdf	348	{(,G,),RIP,demonstrating,ANRIL,binding,to,histone,H3,(,H3,),and,trimethylated,lysine,27,of,histone,3,(,H3K27me3,),in,ANR,|,L2,(,blue,),and,ANRIL4,(,red,),cells,.}	{NULL}
journal.pgen.1003588.pdf	349	{U1,was,used,as,negative,control,.}	{NULL}
journal.pgen.1003588.pdf	350	{m,|,gG/r,|,gG,—,mouse/rabbit,|,gG,control,.}	{NULL}
journal.pgen.1003588.pdf	351	{Error,bars,indicate,s.e.m.,doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	352	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	353	{gOO4}	{NULL}
journal.pgen.1003588.pdf	354	{N,g,3,8,V,E,g,<,(,9_0x105,TSC22D3,W3_6x104,§,150,Synonym,§,§,',§,',§,:,',&,',En,=,:,',5,°,“,§,5A,z,z,z,z,z,2,z,E,‘,5,"10,105",i,-,E,2,-,‘,V104,A,‘,M,3.05100}	{NULL}
journal.pgen.1003588.pdf	355	{RTPCIES1,E,210x104,g,‘,E,A,3o,.}	{NULL}
journal.pgen.1003588.pdf	356	{-,4,o,%}	{NULL}
journal.pgen.1003588.pdf	357	{5:5,/,5,1,—,--,a,__,.}	{NULL}
journal.pgen.1003588.pdf	358	{—,.}	{NULL}
journal.pgen.1003588.pdf	359	{.}	{NULL}
journal.pgen.1003588.pdf	360	{—,.}	{NULL}
journal.pgen.1003588.pdf	361	{-,g,‘,1.0,X104,§,1,',2x10,W,§,V,50,Exons,1,+,+,+,+,o,o,O,o}	{NULL}
journal.pgen.1003588.pdf	362	{5,+,+,+,+,+,+,ANR,|,L2,2a,2b,2c,4,4a4b,v,ANRIL,2a,2b,20,v,ANRIL,2,2a,2b,2c,v,6,-1,-,+,+,+,+,+,C,7,1.5,x104,COL3A1,3.6,>,<,10,"\\"",3,150,o,+,+,s,.}	{NULL}
journal.pgen.1003588.pdf	363	{=,:,A,:,%,r,"\\\\",10,+,«,",5",10x10,‘,3,2.4,x104,49,A4,«,(,E,100,15,"\\"",E,5,A,ﬁﬁ,’,",",19,+,+,+,13,5.0,x103,212x104,a5,50,20,$,5,PE,5,ANRIL,motif,|,:,|,o,o,o}	{NULL}
journal.pgen.1003588.pdf	364	{ANR,|,L2,2a,2b,2c,4,4a,4b,v,ANRIL,4a,4b,v,ANRIL,4,4a,4b,v}	{NULL}
journal.pgen.1003588.pdf	365	{O,IO,U,),C}	{NULL}
journal.pgen.1003588.pdf	366	{G,9,‘,5,"\\"",1,',H,4.0,»,<,104,T302203,J,3,.}	{NULL}
journal.pgen.1003588.pdf	367	{ex104,K,150,LA1000}	{NULL}
journal.pgen.1003588.pdf	368	{—,_,—,—,av,4,—,',o,=,",",«}	{NULL}
journal.pgen.1003588.pdf	369	{synonym,3,S,S,3,8,ES,3,0zSD5,3,ANRILZ,%,°,z,‘,%,§,g,“,*,o,3,',0,"\\"",”,§,2.4,x1o4,ﬂggqgsno,35100,§,750,-25,RTPCEs1,E,2_ox1o4,§,30,o,"\\\\",:,500,.33}	{NULL}
journal.pgen.1003588.pdf	370	{X,~,-,V,-,.}	{NULL}
journal.pgen.1003588.pdf	371	{_,<,o,4,m,°,"\\\\",°,",",:,T,g,1.0,x104,§,1,',2,"\\"",1,°,§,~,50,§,250,1.100}	{NULL}
journal.pgen.1003588.pdf	372	{Motif,(,bp,),o,o,°,o,S,o}	{NULL}
journal.pgen.1003588.pdf	373	{ANR,|,L2,‘,25,‘,33,“,l00v,ANR,|,L,"\\"",25,*,33,*,100,v,ANR,|,L2,*,25,*,33,‘,100v,o,1,2,3,4}	{NULL}
journal.pgen.1003588.pdf	374	{time,(,d,)}	{NULL}
journal.pgen.1003588.pdf	375	{I,4-0x103,COL3A1,35,30.103,-,ANR,|,L2,:,ex1,—,5,—,6,—,7,—,13,-,ANRIL4,:,ex1,—,5,—,6,—,16,—,18,—,19,—,2O,-,ANR,|,L2,*,25,:,motifwith,25,%,change,E,2,>,0x103,-,ANR,|,L2a,:,ex1-5-6,~,13,-,ANR,|,L4a,:,ex1,—,5-6-19-20,-,ANR,|,L2,*,33,.}	{NULL}
journal.pgen.1003588.pdf	376	{motifwith,33,%,change,LD5,1,(,M03,|,],ANRiL2b,:,ex1-5-6,I,:,IANR,|,L4b,:,ex5,—,6,~,19,—,2O,|,:,|,ANRiL2,*,100,:,mot1rwiih,100,%,change}	{NULL}
journal.pgen.1003588.pdf	377	{?}	{NULL}
journal.pgen.1003588.pdf	378	{8,o,UANRILZC,:,ex1,I,],vector/v,I,en,lCa,Z,mutated,_,ANRIL,2,*,25,*,aa,*,100,v}	{NULL}
journal.pgen.1003588.pdf	379	{Figure,5,.}	{NULL}
journal.pgen.1003588.pdf	380	{Pivotal,role,for,Alu,motif,in,ANRIL,RNA,function,.}	{NULL}
journal.pgen.1003588.pdf	381	{(,A,),Cell,lines,over,—,expressing,variants,of,ANRILZ,(,ANR,|,L2a,",",2b,",",2c,),and,ANRIL4,(,ANR,|,L4a,",",4b,),devoid,of,Alu,motif,sequences,highlighted,by,boxes,.}	{NULL}
journal.pgen.1003588.pdf	382	{Validation,of,over,—,expression,using,qRT,.}	{NULL}
journal.pgen.1003588.pdf	383	{—,.}	{NULL}
journal.pgen.1003588.pdf	384	{PCR,assays,.}	{NULL}
journal.pgen.1003588.pdf	385	{(,B,),Reversal,of,up,—,regu,|,ation,(,TSC22D3,),and,(,C,),down,—,regu,|,ation,(,COL3A1,),of,ANRIL,target,—,gene,mRNA,expression,in,ANR,|,L2a,—,2c,and,ANR,|,L4a,",4",b,compared,to,ANR,|,L2,and,ANRIL4,.}	{NULL}
journal.pgen.1003588.pdf	386	{Reversal,of,(,D,),cell,adhesion,",",(,E,),apoptosis,",",and,(,F,),proliferation,in,cell,lines,over,—,expressing,mutant,ANRIL,isoforms,.}	{NULL}
journal.pgen.1003588.pdf	387	{(,G,),Stable,cell,lines,containing,mutated,forms,of,the,Alu,motif,in,ANRILZ,.}	{NULL}
journal.pgen.1003588.pdf	388	{Positions,of,nucleotide,exchanges,(,o,",",25,%,",",33,%,",",and,100,%,),in,the,48,base,—,pair,Alu,motif,are,indicated,in,red,.}	{NULL}
journal.pgen.1003588.pdf	389	{(,H,",",|,),Reversal,of,trans,—,regulation,in,mutant,cell,lines,compared,to,ANR,|,L2,.}	{NULL}
journal.pgen.1003588.pdf	390	{(,J,),Cell,adhesion,",",(,K,),apoptosis,",",and,(,L,),proliferation,in,mutant,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	391	{(,B,",",C,",",H,",",|,",",F,",",L,),3-4,biological,replicates/isoform,.}	{NULL}
journal.pgen.1003588.pdf	392	{(,D,",",E,",",J,",",K,),quadruplicate,measurements,per,pool,of,2-3,biological,replicates,.}	{NULL}
journal.pgen.1003588.pdf	393	{Error,bars,indicate,s.e.m.,doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	394	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	395	{g0O5}	{NULL}
journal.pgen.1003588.pdf	396	{PLOS,Genetics,|,www,.}	{NULL}
journal.pgen.1003588.pdf	397	{p,|,osgenetics.org,6,July,2013,|,Volume,9,|,Issue,7,|,e1003588}	{NULL}
journal.pgen.1003588.pdf	398	{Validation,of,ANRIL,—,associated,gene,networks,and,proatherogenic,cell,functions,in,primary,cells,of,patients,of,the,Leipzig,LIFE,Heart,Study,To,investigate,whether,ﬁndings,from,cell,culture,studies,could,be,translated,into,the,human,situation,",",we,investigated,genomewide,transcript,expression,in,PBMC,from,2280,subjects,of,the,Leipzig,LIFE,Heart,Study,and,associated,gene,expression,with,the,Chr9p2l,haplotype,and,ANRIL,expression,.}	{NULL}
journal.pgen.1003588.pdf	399	{While,no,transcripts,were,signiﬁcantly,associated,with,Chr9p2l,on,a,genome-wide,level,",",gene,set,enrichment,analyses,of,genes,correlated,with,ANRIL,expression,(,n,=,5066,;,P,valueSo,.}	{NULL}
journal.pgen.1003588.pdf	400	{ol,),and,associated,at,a,nominal,signiﬁcance,level,with,Chr9p2l,(,n,=,1698,;,P-valueS0,.05,),revealed,comparable,pathways,to,those,identiﬁed,in,ANRIL,over-expressing,cell,lines,(,Table,2,),.}	{NULL}
journal.pgen.1003588.pdf	401	{"\\\\",/,V,e,next,investigated,adhesion,and,apoptosis,in,PBMC,from,patients,",",which,were,either,homozygous,for,the,protective,or,the,CAD-risk,allele,at,Chr9p2l,(,Figures,6A,—,6B,),.}	{NULL}
journal.pgen.1003588.pdf	402	{Consistent,with,our,earlier,cell,culture,studies,",",the,risk,allele,",",which,was,associated,with,increased,expression,of,linear,ANRIL,transcripts,(,Figure,1,),",",led,to,increased,adhesion,(,P,=,0.001,;,Figure,6A,),and,decreased,apoptosis,(,P,=,0.001,;,Figure,6B,),compared,to,PBMCs,from,carriers,of,the,protective,allele,.}	{NULL}
journal.pgen.1003588.pdf	403	{Discussion}	{NULL}
journal.pgen.1003588.pdf	404	{Here,we,show,that,the,same,ANRIL,isoforms,",",which,were,upregulated,in,patients,carrying,the,Chr9p2l,atherosclerosis,risk,haplotype,",",modulate,gene,networks,in,tram,leading,to,proatherogenic,cellular,properties,.}	{NULL}
journal.pgen.1003588.pdf	405	{At,the,molecular,level,",",we,provide,strong,evidence,for,an,Alu,sequence,(,Figure,4A,),as,the,key,regulatory,element,responsible,for,ANRIL-mediated,mmsregulation,(,Figure,6C,),.}	{NULL}
journal.pgen.1003588.pdf	406	{This,Alu,motif,was,not,only,expressed,in,ANRIL,RNA,transcripts,but,also,marked,promoters,of,target-genes,and,was,associated,with,epigenetic,effector,protein,binding,.}	{NULL}
journal.pgen.1003588.pdf	407	{Depletion,and,mutagenesis,of,the,motif,reversed,trans-regulation,and,normalized,cellular,functions,.}	{NULL}
journal.pgen.1003588.pdf	408	{More,generally,",",the,proposed,mechanism,of,ANRIL,in,atherogenesis,highlights,a,novel,role,of,Alu,elements,in,epigenetic,tram-regulation,of,gene,networks,",",which,might,be,relevant,for,other,long,ncRNAs,as,well,.}	{NULL}
journal.pgen.1003588.pdf	409	{To,the,best,of,our,knowledge,",",this,is,the,ﬁrst,study,investigating,the,role,of,distinct,ANRIL,isoforms,in,several,key,mechanisms,of,atherogenesis,using,stable,over-expression,and,knock-down,approaches,(,Figure,1,and,Figure,2,),.}	{NULL}
journal.pgen.1003588.pdf	410	{All,investigated,ANRIL,isoforms,had,more,or,less,pronounced,effects,on,cellular,functions,(,Figure,2,",",Table,S3,),",",but,strongest,effects,were,consistently,found,in,cell,lines,over-expressing,ANRIL,isoforms,which,were,upregulated,in,patients,carrying,the,Chr9p2l,risk,allele,(,Figure,1,),.}	{NULL}
journal.pgen.1003588.pdf	411	{These,effects,were,also,dose-dependent,(,Figure,S5,),.}	{NULL}
journal.pgen.1003588.pdf	412	{Importantly,",",results,from,cell,culture,studies,were,validated,in,primary,cells,from,patients,with,and,without,the,Chr9p2l,risk,haplotype,(,Figure,6,),.}	{NULL}
journal.pgen.1003588.pdf	413	{So,far,",",mechanistic,work,on,ANRIL,has,focused,on,cell,proliferation,using,RNAi,approaches,[,"3,20,35,36",],.}	{NULL}
journal.pgen.1003588.pdf	414	{In,these,studies,down-regulation,of,ANRIL,led,to,decreased,proliferation,in,different,cell,culture,models,",",which,is,well,in,line,with,our,observation,of,increased,proliferation,in,stable,ANRIL,overexpressing,cell,lines,(,Figure,2,),.}	{NULL}
journal.pgen.1003588.pdf	415	{Network,analyses,of,trans-regulated,genes,in,the,present,study,indicated,that,in,addition,to,proliferation,",",cell,adhesion,and,apoptosis,were,also,affected,in,ANRIL,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	416	{These,predictions,were,functionally,validated,revealing,that,ANRIL,over-expression,led,to,increased,adhesion,and,decreased,apoptosis,.}	{NULL}
journal.pgen.1003588.pdf	417	{Again,",",effects,were,greatest,for,those,isoforms,showing,the,strongest,associations,with,the,Chr9p2l,risk,genotype,and,could,be,reversed,by,RNAi,against,ANRIL,(,Figure,2,),.}	{NULL}
journal.pgen.1003588.pdf	418	{Moreover,",",the,direction,of,atherogenic,cell,functions,(,increased,cell,adhesion,",",increased,proliferation,and,decreased,apoptosis,)}	{NULL}
journal.pgen.1003588.pdf	419	{Table,2,.}	{NULL}
journal.pgen.1003588.pdf	420	{Gene,set,enrichment,analysis,of,ANRIL,—,corre,|,ated,",",Chr9p21,—,associated,genes,in,2280,probands,of,the,Leipzig,LIFE,Heart,Study,.}	{NULL}
journal.pgen.1003588.pdf	421	{Function,ANRIL,correlated,Ch9p21,associated}	{NULL}
journal.pgen.1003588.pdf	422	{Cellular,Development,5.24,>,<,10,’”,1.05,>,<,10,’,°,3,Cellular,Growth,and,524x107,”,3.71,x1o,’,°,2,Proliferation}	{NULL}
journal.pgen.1003588.pdf	423	{Cell,Death/Apoptosis,8.27,x1o,’”,4.73,x1o,’,°,3,Cell,Cycle,4.74,x10,’“,2.21,x1o,’,°,“,Gene,Expression,2.23,>,<,10,’,1,°,1.64,>,<,10,’,°,"\\"",Cellular,Function,and,9.89,x10,"\\"",°,2.21,x1o,’,°,“,Maintenance}	{NULL}
journal.pgen.1003588.pdf	424	{Ce,|,|,.}	{NULL}
journal.pgen.1003588.pdf	425	{—,.}	{NULL}
journal.pgen.1003588.pdf	426	{To,.}	{NULL}
journal.pgen.1003588.pdf	427	{—,.}	{NULL}
journal.pgen.1003588.pdf	428	{Ce,|,|,Signaling,and,1.51,>,<,10,”,°,7,2.21,>,<,10,”,°,“,Interaction}	{NULL}
journal.pgen.1003588.pdf	429	{Post-Translational,4.28,x10,’,°,7,9.75,x1o,’,°,3,Modiﬁcation}	{NULL}
journal.pgen.1003588.pdf	430	{Cellular,Movementl,3.7,ox1o,’,°,“,2.4,ox1o,’,°,“,Adhesion}	{NULL}
journal.pgen.1003588.pdf	431	{Genes,correlated,with,ANRIL,expression,(,assays,Exl,—,5,",",Ex18,—,19,;,P,<,0.01,",",n,=,5066,),and,associated,with,the,Chr9p21,genotype,(,P,<,0.05,",",n,=,1698,),in,PBMC,(,n,=,2280,),of,the,Leipzig,LIFE,Heart,Study,were,included,in,the,analysis,.}	{NULL}
journal.pgen.1003588.pdf	432	{Pvalues,for,enrichment,of,genes,(,www.ingenuity.com,),are,given,.}	{NULL}
journal.pgen.1003588.pdf	433	{doizl0,.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	434	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	435	{t0O2}	{NULL}
journal.pgen.1003588.pdf	436	{nicely,ﬁts,with,evidence,for,a,potential,pro-atherogenic,role,of,ANRIL,from,patient,studies,[,"6,22",],.}	{NULL}
journal.pgen.1003588.pdf	437	{Taken,together,",",our,data,provide,a,plausible,mechanism,for,pro-atherogenic,functions,of,Chr9p2,l-associated,ANRIL,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	438	{In,previous,studies,",",it,has,been,shown,that,long,ncRNA,may,affect,gene,expression,of,target,genes,[,24,~,"26,37",—,39,],.}	{NULL}
journal.pgen.1003588.pdf	439	{Among,the,best,studied,examples,is,the,long,ncRNA,HOTAIR,",",which,is,transcribed,from,the,HOXC,cluster,and,was,shown,to,repress,genes,in,the,HOXD,cluster,in,trans,[,"25,26",],.}	{NULL}
journal.pgen.1003588.pdf	440	{A,potential,role,of,ANRIL,in,trans-regulation,has,previously,been,postulated,by,Sato,et,al,",",investigating,genome-wide,mRNA,expression,in,HeLa,cells,upon,transient,over-expression,of,a,single,ANRIL,isoform,[,23,],.}	{NULL}
journal.pgen.1003588.pdf	441	{In,the,current,work,",",we,used,a,model,of,stable,over-expressing,cell,lines,and,found,evidence,for,trans-regulation,of,distinct,gene,networks,that,overlapped,between,different,ANRIL,isoforms,(,Table,1,),.}	{NULL}
journal.pgen.1003588.pdf	442	{To,translate,these,ﬁnding,to,patients,with,coronary,artery,disease,",",we,performed,pathway,analysis,of,genes,that,were,correlated,with,ANRIL,expression,and,associated,with,the,Chr9p2l,risk,genotype,in,2280,participants,of,the,Leipzig,LIFE,Heart,Study,.}	{NULL}
journal.pgen.1003588.pdf	443	{While,no,transcript,was,associated,with,Chr9p2l,at,a,genome-wide,level,of,signiﬁcance,",",we,found,almost,identical,pathways,in,patients,with,high,ANRIL,expression,and,high,genetic,risk,at,Chr9p2l,as,in,stable,ANRIL,over-expressing,cell,lines,(,Table,2,),.}	{NULL}
journal.pgen.1003588.pdf	444	{The,lack,of,signiﬁcant,associations,of,gene,expression,with,Chr9p2l,has,also,been,observed,by,Zeller,et,al,[,40,],and,might,be,explained,by,the,rather,subtle,modulation,of,ANRIL,by,Chr9p2l,with,slighter,effects,on,trans-regulation,as,opposed,to,stronger,over-expression,in,the,investigated,cell,culture,models,.}	{NULL}
journal.pgen.1003588.pdf	445	{Nevertheless,",",permanently,elevated,ANRIL,levels,might,activate,the,observed,gene,networks,leading,to,subtle,changes,of,cellular,functions,(,Figure,6,),and,thereby,increasing,cardiovascular,risk,over,time,.}	{NULL}
journal.pgen.1003588.pdf	446	{On,the,mechanistic,level,",",it,has,been,postulated,that,long,ncRNA,may,serve,as,a,scaffold,",",guiding,effector-proteins,to,chromatin,[,24,~,"26,37",—,39,],.}	{NULL}
journal.pgen.1003588.pdf	447	{Indeed,",",previous,work,has,demonstrated,ANRIL,binding,to,CBX7,[,3,],and,SUZI2,[,20,],",",which,are,proteins,contained,in,PRC,],and,PRC2,",",respectively,.}	{NULL}
journal.pgen.1003588.pdf	448	{Both}	{NULL}
journal.pgen.1003588.pdf	449	{U,?}	{NULL}
journal.pgen.1003588.pdf	450	{so,A,350}	{NULL}
journal.pgen.1003588.pdf	451	{(,I,),O,=,",",“,",5",300,8,:,;,60,-5,-,",",;,3,C,250,*,5,cm,‘,%,-,.}	{NULL}
journal.pgen.1003588.pdf	452	{‘,.}	{NULL}
journal.pgen.1003588.pdf	453	{—,.}	{NULL}
journal.pgen.1003588.pdf	454	{3,200,Q5,40,cu,o,150,g,3,o,3,-,av,20,.5,100,<,50,o,o}	{NULL}
journal.pgen.1003588.pdf	455	{AAAA,GGGG,.}	{NULL}
journal.pgen.1003588.pdf	456	{+,Chr9p21,haplotype,additional}	{NULL}
journal.pgen.1003588.pdf	457	{Suppression,.4,gene,networks}	{NULL}
journal.pgen.1003588.pdf	458	{H,"\\"",Induction,gene,networks}	{NULL}
journal.pgen.1003588.pdf	459	{Figure,6,.}	{NULL}
journal.pgen.1003588.pdf	460	{Validation,of,ANR/L-associated,cellular,effects,in,primary,cells,and,schematic,of,molecular,scaffolding,by,ANRIL,.}	{NULL}
journal.pgen.1003588.pdf	461	{(,A,),PBMC,from,carriers,of,the,Chr9p21,CAD,—,risk,allele,defined,by,rs10757274,",",rs2383206,",",rs2383297,",",and,rs10757278,(,n,=,8,),showed,increased,adhesion,(,P,=,0.001,),and,(,B,),decreased,apoptosis,(,P,=,0.008,),compared,to,cells,of,carriers,of,the,protective,allele,(,n,=,8,),.}	{NULL}
journal.pgen.1003588.pdf	462	{(,C,),Schematic,of,molecular,scaffolding,by,ANRIL,mediated,through,potential,chromatin,.}	{NULL}
journal.pgen.1003588.pdf	463	{—,.}	{NULL}
journal.pgen.1003588.pdf	464	{RNA,interaction,by,Alu,motifs,.}	{NULL}
journal.pgen.1003588.pdf	465	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pgen.1003588.pdf	466	{pgen,.1003588,.}	{NULL}
journal.pgen.1003588.pdf	467	{gOO6}	{NULL}
journal.pgen.1003588.pdf	468	{O,.}	{NULL}
journal.pgen.1003588.pdf	469	{ANR/L-bound,PcG,proteins,previous,papers,focused,on,ANRIL-mediated,cir-repression,of,CDKN2A,and,CDKN2B,using,RNAi,but,did,not,investigate,potential,trzms-regulatory,effects,[,"3,20",],.}	{NULL}
journal.pgen.1003588.pdf	470	{In,the,current,work,",",we,found,no,effect,of,ANRIL,over-expression,on,expression,of,CDKN2A,and,CD10,),/,2B,(,Figure,S4,),.}	{NULL}
journal.pgen.1003588.pdf	471	{Thus,",",the,spatial,coherence,of,ANRIL,transcription,with,adjacent,protein-coding,genes,might,be,relevant,for,sis-suppression,.}	{NULL}
journal.pgen.1003588.pdf	472	{This,is,the,ﬁrst,study,systematically,investigating,ANRIL,binding,to,17,different,proteins,contained,in,chromatin,modifying,complexes,PRCI,",",PRC2,and,COREST/Rest,(,Figure,3,),.}	{NULL}
journal.pgen.1003588.pdf	473	{"\\\\",Ne,demonstrated,binding,to,predominantly,inhibitory,(,CBX7,",",RINGIB,",",EED,",",jARID2,",",RBAP46,",",SUZl2,),[,41,],and,potentially,activating,factors,(,RYBP,",",YYl,),[,"29,30",],.}	{NULL}
journal.pgen.1003588.pdf	474	{CBX7,and,SUZIQ,were,selected,as,representative,proteins,for,PRCI,and,2,",",respectively,",",and,were,followed,up,in,genome-wide,ChIP-seq,experiments,(,Figure,3,and,Figure,4,),.}	{NULL}
journal.pgen.1003588.pdf	475	{Notably,",",ANRIL,over-expression,was,accompanied,with,changes,of,CBX7,and,SUZIQ,distribution,in,ANRIL,target-gene,promoters,(,Figure,3,),.}	{NULL}
journal.pgen.1003588.pdf	476	{The,role,of,PRCs,in,ANRIL-mediated,gene,regulation,was,further,proven,by,RNAi,against,CBX7,and,SUZIQ,which,reversed,trans-regulation,of,down,-,and,also,of,up-regulated,target,genes,in,ANRIL,cells,(,Figure,3G,),.}	{NULL}
journal.pgen.1003588.pdf	477	{Induction,of,gene,expression,through,PcG,proteins,might,seem,at,odds,with,the,current,understanding,of,PRCmediated,gene,silencing,.}	{NULL}
journal.pgen.1003588.pdf	478	{However,",",binding,of,PcG,proteins,in,active,genes,has,been,described,in,earlier,studies,[,31,],.}	{NULL}
journal.pgen.1003588.pdf	479	{Moreover,",",Morey,et,al,demonstrated,reduced,gene,repression,in,distinct,PRCI,compexes,containing,RYBP,",",which,was,shown,to,associate,with,ANRIL,(,Figure,3,),[,42,],.}	{NULL}
journal.pgen.1003588.pdf	480	{Alternatively,",",ANRIL-bound,activating,factors,RYBP,and,YYl,may,directly,activate,gene,expression,[,"29,30",],or,ANRIL,might,bind,other,activating,epigenetic,effector,proteins,[,43,],.}	{NULL}
journal.pgen.1003588.pdf	481	{Taken,together,",",we,demonstrate,a,central,role,of,PRCI,and,PRC,?}	{NULL}
journal.pgen.1003588.pdf	482	{but,not,CoREST,/,Rest,in,ANRIL-mediated,repression,and,induction,of,genes,but,additional,work,is,clearly,warranted,to,unravel,the,complex,nature,of,these,tram-regulatory,mechanisms,.}	{NULL}
journal.pgen.1003588.pdf	483	{A,key,limitation,in,the,current,understanding,of,long,ncRNA,function,",",in,particular,with,regard,to,their,trans-regulatory,effects,",",is,the,lack,of,knowledge,about,speciﬁc,regulatory,sequences,or,structural,motifs,.}	{NULL}
journal.pgen.1003588.pdf	484	{These,sequences,might,be,responsible,for,targeting,long,ncRNA,to,distinct,regulatory,sites,in,the,genome,.}	{NULL}
journal.pgen.1003588.pdf	485	{Here,",",we,provide,ﬁrst,evidence,for,an,important,role,of,Alu,motifs,in,this,process,",",which,mark,the,promoters,of,ANRIL,trans-regulated,genes,(,Figure,4,),.}	{NULL}
journal.pgen.1003588.pdf	486	{Additionally,",",genome-wide,ChIP-seq,analysis,revealed,binding,of,ANRIL-associated,PcG,effector,proteins,in,close,proximity,to,the,Alu,motif,Importantly,",",the,same,Alu,motif,was,included,in,ANRIL,ncRNA,transcripts,and,predicted,to,be,located,in,a,central,stem-loop,like,structure,(,Figure,4F,),.}	{NULL}
journal.pgen.1003588.pdf	487	{Additional,evidence,for,ANRIL,binding,to,chromatin,comes,from,its,association,with,histone,H3,and,H3K27me3,(,Figure,4G,),.}	{NULL}
journal.pgen.1003588.pdf	488	{In,previous,work,",",Alu-like,",",CG,-,and,GA-rich,sequences,were,proposed,as,potential,RNA-DNA,interaction,sites,associated,with,RNA,:,DNA,:,DNA,triplex,formation,[,"44,45",],.}	{NULL}
journal.pgen.1003588.pdf	489	{Paradoxically,",",Alu,occurrence,was,signiﬁcantly,depleted,in,ANRIL-regulated,genes,",",suggesting,that,a,certain,spatial,patterning,or,additional,co-factors,in,promoter,regions,rather,than,motif,abundance,alone,might,be,relevant,(,Figure,4,",",Figure,6C,),.}	{NULL}
journal.pgen.1003588.pdf	490	{Functional,relevance,of,the,motif,was,proven,by,depletion,and,mutagenesis,in,ANRIL,RNA,",",which,reversed,trans-regulation,and,pro-atherogenic,cellular,properties,(,Figure,5,),.}	{NULL}
journal.pgen.1003588.pdf	491	{Thus,",",our,data,suggest,that,ANRIL,may,bind,to,chromatin,through,interaction,via,its,Alu,motif,",",thereby,guiding,PRC,proteins,to,ANRIL-regulated,genes,(,Figure,6C,),.}	{NULL}
journal.pgen.1003588.pdf	492	{Despite,long,consideration,as,“,genomic,junk,”,",",Alu,elements,are,coming,into,the,focus,of,intense,research,.}	{NULL}
journal.pgen.1003588.pdf	493	{Alu,enrichment,occurred,over,the,course,of,evolution,[,46,],and,integration,at,genomic,sites,was,associated,with,maturation,and,gain-of-function,of,ncRNAs,[,47,],.}	{NULL}
journal.pgen.1003588.pdf	494	{Alu,elements,as,well,as,distal,ANRIL,exons,are,not,conserved,in,the,orthologous,chromosomal,region,on,mouse,chromosome,4,",",which,might,be,an,explanation,for,the,lack,of,effect,on,atherosclerosis,when,deleting,that,region,[,48,],.}	{NULL}
journal.pgen.1003588.pdf	495	{Recent,work,byjeck,et,al,has,also,demonstrated,preferred,inclusion,of,Alu,motifs,in,non-coding,RNA,lariats,which,are,commonly,thought,to,represent,inactive,forms,of,ncRNAs,[,49,],.}	{NULL}
journal.pgen.1003588.pdf	496	{Whether,implementation,of,Alu,motifs,in,ncRNA,lariats,leads,to,silencing,of,the,effector,sequences,or,not,remains,to,be,determined,.}	{NULL}
journal.pgen.1003588.pdf	497	{In,summary,",",our,work,extends,the,function,of,Alu,motifs,to,regulatory,components,of,ncRNAs,with,a,central,role,in,ncRNAmediated,epigenetic,trans-regulation,.}	{NULL}
journal.pgen.1003588.pdf	498	{Furthermore,",",it,implies,a,pivotal,role,for,Alu,elements,in,genetically,determined,vascular,disease,and,describes,a,plausible,molecular,mechanism,for,proatherogenic,ANRIL,function,at,Chr9p21,.}	{NULL}
journal.pgen.1003588.pdf	499	{Materials,and,Methods}	{NULL}
journal.pgen.1003588.pdf	500	{Ethics,statement,The,Leipzig,LIFE,Heart,Study,has,been,approved,by,the,Ethics,Committee,of,the,Medical,Faculty,of,the,University,Leipzig,(,Reg,.}	{NULL}
journal.pgen.1003588.pdf	501	{No,276-2005,),and,was,described,previously,[,28,],.}	{NULL}
journal.pgen.1003588.pdf	502	{RNA,from,peripheral,blood,mononuclear,cells,(,PBMC,;,n,=,2280,),and,whole,blood,(,n,=,960,),from,the,same,patients,of,this,study,was,isolated,as,described,[,6,],.}	{NULL}
journal.pgen.1003588.pdf	503	{Human,endarteryectomy,specimens,(,n,=,193,),were,collected,in,an,independent,cohort,of,patients,undergoing,vascular,surgery,and,the,utilization,of,human,vascular,tissues,was,approved,by,the,Ethics,Committee,of,the,Medical,Faculty,Carl,Gustav,Carus,of,the,Technical,University,Dresden,(,EK3l6l22008,),[,7,],.}	{NULL}
journal.pgen.1003588.pdf	504	{Genotyping,Genotyping,of,single,nucleotide,polymorphisms,rsl0757274,",",rs2383206,",",rs2383297,",",and,rsl0757278,in,2280,probands,of,the,Leipzig,LIFE,Heart,Study,and,in,vascular,tissue,was,performed,as,described,[,"6,7",],.}	{NULL}
journal.pgen.1003588.pdf	505	{Cell,culture,Initial,screening,of,human,cell,lines,MonoMac,",",THP1,",",U937,",",HEK293,",",HepG2,",",CaCo2,",",and,Hutu80,for,Chr9p2l,gene,expression,(,MTAP,",",CDKA/2A,",",CDKA/2B,",",ANRIL,",",qRT-PCR,assays,were,described,in,[,6,],),revealed,that,MonoMac,and,HEK293,cells,expressed,all,Chr9p2l,transcripts,(,data,not,shown,),.}	{NULL}
journal.pgen.1003588.pdf	506	{This,suggested,that,these,genes,might,be,functionally,relevant,in,these,cells,whereas,all,other,investigated,cell,lines,were,lacking,expression,of,at,least,one,of,the,Chr9p2l,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	507	{HEK293,cells,(,DMSZ,",",ACC305,),were,cultured,in,DMEM,(,Life,Technologies,),containing,10,%,fetal,calf,serum,(,FCS,",",Biochrom,),",",1,%,penici11in,/,streptomycin,(,P,/,S,",",Life,Technologies,),.}	{NULL}
journal.pgen.1003588.pdf	508	{MonoMac,cells,(,DSMZ,",",ACCl24,),were,cultured,in,RPMI,1640,(,Biochrom,),containing,10,%,FCS,",",1,%,P,/,S,",",1,%,MEM,(,Life,Technologies,),",",and,1,%,OPI,(,Sigma,),.}	{NULL}
journal.pgen.1003588.pdf	509	{Cryopreserved,PBMC,(,n,=,32,),were,thawed,",",cultured,in,RPMI,1640,(,Biochrom,),containing,10,%,FCS,",",1,%,P,/,S,and,functional,assays,were,performed,within,48,hours,.}	{NULL}
journal.pgen.1003588.pdf	510	{Generation,of,stable,cell,lines,ANRIL,isoforms,were,cloned,in,the,bicistronic,pBI-CMV2,(,Clontech,),or,pTRACER-SV40,(,Life,Technologies,),vectors,allowing,parallel,expression,of,a,green,ﬂuorescent,protein,(,GFP,),and,ANRIL,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	511	{Using,Lipofectamine,2000,(,Life,Technologies,),",",HEK293,cells,were,either,co-transfected,with,ANRIL-pBI-CMV2,vectors,/,empty,vector,control,and,neomycin-encoding,vector,or,transfected,with,ANRIL-pTRACER,vectors,/,empty,vector,control,encoding,a,GFP-Zeocin,resistance,gene,.}	{NULL}
journal.pgen.1003588.pdf	512	{Transfected,cells,were,selected,with,geneticindisulfate,(,G418,",",Roth,),or,Zeocin,(,Life,Technologies,),.}	{NULL}
journal.pgen.1003588.pdf	513	{After,2,weeks,",",stably,transfected,cells,were,selected,by,ﬂow,cytometry,and,over-expression,of,ANRIL,was,validated,by,quantitative,RT-PCR,.}	{NULL}
journal.pgen.1003588.pdf	514	{On,average,",",2,—,4,cell,lines,were,generated,per,ANRIL,isoform,and,vector,control,",",respectively,.}	{NULL}
journal.pgen.1003588.pdf	515	{Cell,culture,functional,assays,Cell,adhesion,assays,were,performed,in,96-well,plates,coated,with,collagen,(,Roche,),",",Matrigel,(,BD,),or,PBS,.}	{NULL}
journal.pgen.1003588.pdf	516	{Cells,were,allowed,to,adhere,for,40,min,",",quadruplicate,measurements,/,cell,line,were,performed,.}	{NULL}
journal.pgen.1003588.pdf	517	{Numbers,of,adherent,cells,were,determined,using,Ce11Titer-B1ue,/,Ce11Titer-Glo,(,Promega,),in,relation,to,standard,curves,of,the,respective,cell,line,.}	{NULL}
journal.pgen.1003588.pdf	518	{PBMC,adhesion,assays,were,performed,accordingly,.}	{NULL}
journal.pgen.1003588.pdf	519	{Quadruplicate,measurements,/,subject,were,performed,.}	{NULL}
journal.pgen.1003588.pdf	520	{Cellular,proliferation,was,either,determined,by,counting,absolute,cell,numbers,(,trypan,blue,staining,),or,viability,assays,(,CellTiter-Blue/CellTiter-Glo,",",Promega,),.}	{NULL}
journal.pgen.1003588.pdf	521	{Glucose,in,the,cell,culture,supernatants,was,determined,using,standard,chemistry,(,Roche,),.}	{NULL}
journal.pgen.1003588.pdf	522	{Apoptosis,was,determined,using,ﬂow-cytometric,detection,of,AnnexinV,positive,cells,(,GFP-Certiﬁed,Apoptosis,/,Necrosis,Detection,Kit,",",ENZO,),",",caspase-3,activity,(,Caspase-3,/,CPP32}	{NULL}
journal.pgen.1003588.pdf	523	{Fluorometric,Assay,Kit,",",BioVision,;,CaspaseGlo,3/7,",",Promega,),and,caspase-3,staining,.}	{NULL}
journal.pgen.1003588.pdf	524	{RNAi,siRNA,knock-down,of,ANRIL,(,n272l58,",",Life,Technologies,),",",CBX7,(,s23926,",",Life,Technologies,),",",SUZl2,(,s23967,",",Life,Technologies,),was,performed,using,Lipofectamine,2000,(,Life,Technologies,),.}	{NULL}
journal.pgen.1003588.pdf	525	{Knock-down,eﬂiciency,was,determined,by,quantitative,RT-PCR,and,Western,blotting,.}	{NULL}
journal.pgen.1003588.pdf	526	{Rapid,amplification,of,cDNA,ends,(,RACE,),and,sequencing,Of,ANRIL,10,pg,RNA,from,human,PBMC,and,from,MonoMac,cells,were,reverse,transcribed,using,the,ExactSTART,Eukaryotic,mRNA,5,’,&,3,’,-,RACE,Kit,(,Epicentre,Biotechnologies,),according,to,the,manufacturer,’s,instructions,.}	{NULL}
journal.pgen.1003588.pdf	527	{RACE,PCR,reactions,were,prepared,using,Advantage,2,Polymerase,Mix,(,Clontech,),and,subcloned,(,pCR2.l-TOPO,Vector,",",Life,Technologies,),.}	{NULL}
journal.pgen.1003588.pdf	528	{Primers,used,for,RACE,experiments,are,listed,in,Table,S4,.}	{NULL}
journal.pgen.1003588.pdf	529	{Ampliﬁcation,of,fulllength,isoforms,was,performed,using,primers,listed,in,Table,S5,(,schematic,in,Figure,S1,),.}	{NULL}
journal.pgen.1003588.pdf	530	{Sequencing,of,PCR,products,was,performed,with,an,automated,DNA,sequencer,(,Applied,Biosystems,),.}	{NULL}
journal.pgen.1003588.pdf	531	{Quantitative,RT,.}	{NULL}
journal.pgen.1003588.pdf	532	{—,.}	{NULL}
journal.pgen.1003588.pdf	533	{PCRs,Quantitative,RT,.}	{NULL}
journal.pgen.1003588.pdf	534	{—,.}	{NULL}
journal.pgen.1003588.pdf	535	{PCRs,and,analysis,of,data,were,performed,as,described,[,6,],.}	{NULL}
journal.pgen.1003588.pdf	536	{Primers,and,probes,for,ANRIL,isoforms,(,n,=,5,),",",TSC22D3,",",COL3AI,",",and,U,],are,given,in,Table,S6,.}	{NULL}
journal.pgen.1003588.pdf	537	{Expression,profiling,RNA,from,cell,lines,ANRIL1-4,and,Vector,control,cell,line,",",siRNA-treated,ANRIL2,cells,",",and,RNA,from,PBMC,(,n,=,2280,),was,labeled,and,hybridized,to,Illumina,HumanHT-l2,v4,BeadChips,.}	{NULL}
journal.pgen.1003588.pdf	538	{Arrays,were,scanned,with,an,Illumina,iScan,microarray,scanner,.}	{NULL}
journal.pgen.1003588.pdf	539	{Bead,level,data,preprocessing,was,done,in,Illumina,GenomeStudio,.}	{NULL}
journal.pgen.1003588.pdf	540	{Antibodies,Antibodies,against,AEBP2,(,11232-2-AP,",",Proteintech,),",",BMIl,(,05-637,",",Millipore,),",",CBX7,(,ab2l873,",",Abcam,),",",EED,(,03-196,",",Millipore,),",",EZH2,(,ACC-3147,",",Cell,Signaling,),",",JARID2,(,NBl002214,",",Novus,Biologicals,),",",MEL18,(,ab5267,",",Abcam,),",",PHF1,(,sc101,107,",",Santa,Cruz,),",",PHFl9,(,11895-1-AP,",",Proteintech,),",",RBAP46,(,MAl-23277,",",Thermo,Scientiﬁc,),",",RINGlB,(,NBPl-49966,",",Novus,Biologicals,),",",RYBP,(,NBP1-97742,",",Novus,Biologicals,),",",SUZl2,(,abl2073,",",Abcam,),",",YY1,(,NBP1-46218,",",Novus,Biologicals,),",",LSD1,(,39186,",",Active,Motif,),",",REST,(,07-579,",",Millipore,),",",CoREST,(,07455,",",Millipore,),",",H3,(,abl79l,",",Abcam,),",",H3K27me3,(,ab6002,",",Abcam,),",",rabbit,control,IgG,(,kch-504-250,",",Diagenode,),",",mouse,control,IgG,(,kch-819-015,",",Diagenode,),",",and,goat,control,IgG,(,sc2346,",",Santa,Cruz,),were,used,.}	{NULL}
journal.pgen.1003588.pdf	541	{RNA,immunoprecipitation,The,immunoprecipitation,reaction,followed,with,some,modifications,previously,described,protocols,[,"50,5",l,],:,2,>,<,with,low-salt,",",3,>,<,with,high-salt,and,l,>,<,Li-salt,buffers,.}	{NULL}
journal.pgen.1003588.pdf	542	{The,retrieved,RNA,was,quantitated,",",reverse,transcribed,using,random,hexamer,primers,",",and,analyzed,by,qRT-PCR,with,ANRIL-specific,primers,(,Ex,],.}	{NULL}
journal.pgen.1003588.pdf	543	{—,.}	{NULL}
journal.pgen.1003588.pdf	544	{5}	{NULL}
journal.pgen.1003588.pdf	545	{assay,",",Table,S6,),.}	{NULL}
journal.pgen.1003588.pdf	546	{U,],-,speciﬁc,primers,were,used,as,negative,control,(,Table,S6,),.}	{NULL}
journal.pgen.1003588.pdf	547	{Chromatin,immunoprecipitation,and,next,—,generation,sequencing,2,~,5,X107,ANRIL2,and,vector,control,cells,were,ﬁxed,with,1,%,formaldehyde,for,10,min,at,23,°,C.,Cross-linking,reaction,was,stopped,by,adding,glycine,to,a,ﬁnal,concentration,of,0.125,M,for,5,min,followed,by,three,washes,with,ice-cold,PBS,.}	{NULL}
journal.pgen.1003588.pdf	548	{Cells,were,harvested,",",suspended,in,50,mM,Hepes-KOH,",",pH,7.5,",",100,mM,NaCl,",",1,mM,EDTA,",",pH,8.0,",",0.5,mM,EGTA,",",pH,8.0,and,incubated,for,10,min,at,4,°,C.,Cells,were,washed,with,10,mM,Tris-HCl,",",pH,8.0,",",200,mM,NaCl,",",1,mM,EDTA,",",pH,8.0,",",0.5,mM,EGTA,",",pH,8.0,for,10,min,",",pelleted,by,centrifugation,and,the,nuclei,lysed,in,10,mM,Tris-HCl,",",pH,8.0,",",200,mM,NaCl,",",1,mM,EDTA,",",pH,8.0,",",0.5,mM,EGTA,pH,8.0,",",0.1,%,NaDeoxycholate,",",0.5,%,N-lauroylsarcosine,for,10,min,at,4,°,C.,Samples,were,sonicated,with,Diagenode,Bioruptor,UCD-300TO,(,High,level,",",8,>,<,5,cycles,30,sec,on/30,sec,off,",",4,°,C,),",",centrifuged,at,"15,000",>,<,g,for,10,min,at,4,°,C,and,the,supernatant,was,shockfrozen,in,liquid,nitrogen,and,stored,at,—,80,°,C.,Nuclear,extracts,were,preadsorbed,with,non-immune,IgG,for,1,h,and,treated,with,SUZ12,",",CBX7,",",and,control,IgG,antibodies,overnight,at,4,°,C.,Precipitates,were,processed,with,the,HighCell,#ChIP,kit,(,Diagenode,),and,Illumina,DNA,sequencing,libraries,were,generated,using,the,ChIP-seq,Sample,Preparation,Kit,(,IP-102-1001,",",Illumina,),.}	{NULL}
journal.pgen.1003588.pdf	549	{Purity,and,quantity,was,measured,on,an,Agilent,Technologies,2100,Bioanalyzer,.}	{NULL}
journal.pgen.1003588.pdf	550	{Sequencing,was,performed,with,the,Illumina,Genome,Analyzer,II,platform,.}	{NULL}
journal.pgen.1003588.pdf	551	{Bioinformatics,and,statistical,analysis,Processing,of,genome-wide,expression,data,.}	{NULL}
journal.pgen.1003588.pdf	552	{Illumina,HumanHT-12,v4,BeadChips,arrays,were,used,for,expression,proﬁling,.}	{NULL}
journal.pgen.1003588.pdf	553	{For,data,from,cell,lines,",",bead,level,data,preprocessing,was,done,in,Illumina,GenomeStudio,followed,by,quantile,normalization,and,background,reduction,according,to,standard,procedures,in,the,software,.}	{NULL}
journal.pgen.1003588.pdf	554	{Preprocessing,of,genome-wide,expression,data,in,PBMC,of,the,Leipzig,LIFE,Heart,Study,comprised,selection,of,expressed,features,",",outlier,detection,",",normalization,",",and,batch,correction,as,described,[,"52,53",],.}	{NULL}
journal.pgen.1003588.pdf	555	{Association,analysis,.}	{NULL}
journal.pgen.1003588.pdf	556	{Genotyping,quality,of,SNPs,rsl0757274,",",rs2383206,",",rs2383207,",",and,rs10757278,was,determined,as,described,[,6,],and,haplotypes,were,inferred,using,fastphase,1.2.9,.}	{NULL}
journal.pgen.1003588.pdf	557	{Associations,of,haplotypes,with,expression,proﬁles,",",and,correlation,with,ANRIL,(,ExI,—,5,",",ExI8,.}	{NULL}
journal.pgen.1003588.pdf	558	{—,.}	{NULL}
journal.pgen.1003588.pdf	559	{I9,),were,calculated,using,robust,linear,regression,models,as,described,(,please,refer,to,Supplemental,Materials,in,P,with,the,R,software,for,statistical,computing,[,54,],.}	{NULL}
journal.pgen.1003588.pdf	560	{Gene,set,enrichment,analysis,.}	{NULL}
journal.pgen.1003588.pdf	561	{Genome-wide,expression,proﬁling,in,ANRIL,over-expressing,cell,lines,1,—,4,was,used,to,identify,transcripts,with,expression,changes,of,<,0.5,and,>,2,compared,to,vector,control,in,each,cell,line,.}	{NULL}
journal.pgen.1003588.pdf	562	{Please,refer,to,legend,of,Table,1,for,absolute,numbers,of,transcripts,per,analysis,.}	{NULL}
journal.pgen.1003588.pdf	563	{Association,of,genome-wide,expression,data,with,Chr9p2l,haplotypes,revealed,1698,transcripts,with,P,<,0.05,",",correlation,of,transcript,expression,with,ANRIL,assays,ExI,—,5,and,ExI8,.}	{NULL}
journal.pgen.1003588.pdf	564	{—,.}	{NULL}
journal.pgen.1003588.pdf	565	{I9,revealed,5066,transcripts,with,P,<,0.01,.}	{NULL}
journal.pgen.1003588.pdf	566	{Gene,set,enrichment,analysis,was,performed,separately,for,each,dataset,using,the,Ingenuity,Pathways,Analysis,(,www.ingenuity.com,),to,identify,most,signiﬁcantly,enriched,biological,functions,.}	{NULL}
journal.pgen.1003588.pdf	567	{Comparison,of,pathways,between,different,analyses,was,performed,according,to,standard,procedures,in,the,software,(,Table,1,",",Table,2,),.}	{NULL}
journal.pgen.1003588.pdf	568	{Levels,of,signiﬁcance,were,determined,using,Fisher,’s,exact,tests,implemented,in,the,software,.}	{NULL}
journal.pgen.1003588.pdf	569	{Comparison,of,groups,.}	{NULL}
journal.pgen.1003588.pdf	570	{Normality,of,distribution,was,tested,using,the,Kolmogorov-Smirnov,test,implemented,in,the,PRISM,statistical,software,(,GraphPad,),.}	{NULL}
journal.pgen.1003588.pdf	571	{Comparison,of,multiple,groups,was,done,using,AN,OVA,",",and,Tukey,was,performed,as,post-test,.}	{NULL}
journal.pgen.1003588.pdf	572	{Comparison,of,2,groups,was,done,using,a,t-test,.}	{NULL}
journal.pgen.1003588.pdf	573	{ChIP-seq,analysis,.}	{NULL}
journal.pgen.1003588.pdf	574	{ChIP-seq,reads,were,aligned,to,the,H.,sa/Jiens,assembly,version,hgl8,(,NCBI36,),genome,using,the,segeme/zl,aligner,[,55,],with,a,minimum,required,accuracy,of,85,%,.}	{NULL}
journal.pgen.1003588.pdf	575	{Best,mapping,reads,were,retained,for,downstream,analysis,of,SUZ12,",",CBX7,samples,",",and,input,DNA,(,for,read,numbers,see,Table,S7,),to,account,for,ChIP-seq,signals,in,repetitive,regions,(,Figure,3,and,Figure,4,),.}	{NULL}
journal.pgen.1003588.pdf	576	{After,mapping,",",the,read,counts,were,normalized,to,the,total,number,of,mapped,reads,in,each,library,",",converted,to,WIGﬁles,and,analyzed,using,sitepro,from,the,CEAS,package,[,56,],to,test,for,speciﬁc,enrichments,in,vicinity,to,the,previously,detected,motif,To,ﬁnd,signals,close,to,the,predicted,binding,sites,",",a,region,of,"10,000",nts,(,.}	{NULL}
journal.pgen.1003588.pdf	577	{—,.}	{NULL}
journal.pgen.1003588.pdf	578	{span,10000,),",",a,base,speciﬁc,resolution,of,the,resulting,plot,(,.}	{NULL}
journal.pgen.1003588.pdf	579	{—,.}	{NULL}
journal.pgen.1003588.pdf	580	{pf-res,1,),and,the,usage,of,the,direction,of,the,motifs,(,.}	{NULL}
journal.pgen.1003588.pdf	581	{—,.}	{NULL}
journal.pgen.1003588.pdf	582	{dir,),were,set,.}	{NULL}
journal.pgen.1003588.pdf	583	{Motif,analysis,.}	{NULL}
journal.pgen.1003588.pdf	584	{The,MEME,package,[,5,7,],was,used,to,search,for,differences,in,motifs,abundance,in,promoters,(,5,kb,),of,differentially,regulated,genes,.}	{NULL}
journal.pgen.1003588.pdf	585	{To,analyze,the,promoter,regions,",",the,width,of,expected,motif,was,set,between,8,and,30,(,-,minw,8,and,—,maxw,30,),",",the,expected,occurrence,to,’,zero,or,one,’,(,-,mod,zoops,),and,the,maximum,number,of,motifs,to,search,for,to,1,(,nmotifs,1,),.}	{NULL}
journal.pgen.1003588.pdf	586	{A,bootstrapping,approach,was,chosen,to,overcome,computational,limitations,to,test,for,motif,occurrence,within,promoters,of,differentially,and,not-regulated,genes,.}	{NULL}
journal.pgen.1003588.pdf	587	{Promoter,sequences,of,up,-,",",down,-,and,not-regulated,genes,were,chopped,into,pieces,of,100,nt,.}	{NULL}
journal.pgen.1003588.pdf	588	{250,chops,of,each,group,were,repeatedly,sampled,and,scanned,for,motif,occurrences,using,the,F,IMO,tool,[,5,7,],of,the,MEME,package,.}	{NULL}
journal.pgen.1003588.pdf	589	{The,process,was,repeated,1000,times,for,each,of,the,three,groups,and,a,p-value,of,le_4,(,.}	{NULL}
journal.pgen.1003588.pdf	590	{—,.}	{NULL}
journal.pgen.1003588.pdf	591	{outputpthresh,le-4,),was,used,.}	{NULL}
journal.pgen.1003588.pdf	592	{Differences,in,motif,occurrence,in,ANRIL,up,-,and,down,-,and,not-regulated,gene,sets,were,evaluated,using,the,Kolmogorov-Smirnov,test,provided,by,the,R,software,for,statistical,computing,[,54,],.}	{NULL}
journal.pgen.1003588.pdf	593	{Accession,numbers,ChIP-seq,data,are,deposited,in,the,Sequence,Read,Archive,(,SRA,),under,accession,number,SRA052089,.}	{NULL}
journal.pgen.1003588.pdf	594	{l.,BGO3,(,GSM602674,),data,are,publicly,available,at,(,http://www.ncbi,.}	{NULL}
journal.pgen.1003588.pdf	595	{nlm,.}	{NULL}
journal.pgen.1003588.pdf	596	{nih,.}	{NULL}
journal.pgen.1003588.pdf	597	{gov/geo,),.}	{NULL}
journal.pgen.1003588.pdf	598	{Supporting,Information}	{NULL}
journal.pgen.1003588.pdf	599	{Figure,S1,Rapid,ampliﬁcation,of,cDNA,ends,(,RACE,),and,PCR,experiments,.}	{NULL}
journal.pgen.1003588.pdf	600	{(,A,),Initially,and,(,B,),currently,annotated,ANRIL,transcripts,and,exon,labeling,.}	{NULL}
journal.pgen.1003588.pdf	601	{(,C,),Position,of,5,',-,and,3,’,-,RACE,primers,.}	{NULL}
journal.pgen.1003588.pdf	602	{RNA,from,human,peripheral,blood,mononuclear,cells,(,PBMC,),and,monocytic,cell,line,MonoMac,was,used,.}	{NULL}
journal.pgen.1003588.pdf	603	{Exon,7b,(,22.046.252-22,.047.065,bp,;,NCBI36/hgl8,),",",exon,13b,(,22.077.273-22,.077.650,bp,;,NCBI36/hgl8,),.}	{NULL}
journal.pgen.1003588.pdf	604	{(,D,),Positions,of,PCR,primers,used,for,ampliﬁcation,of,full-length,ANRIL,isoforms,.}	{NULL}
journal.pgen.1003588.pdf	605	{E,PCR,products,and,summary,of,sequencing,results,of,ANRIL,isoforms,(,common,forward,primer,in,exon,1,",",reverse,primers,in,exon,7b,",",13,",",13b,",",or,20,),.}	{NULL}
journal.pgen.1003588.pdf	606	{ANRIL,isoforms,l,—,4,showed,strongest,expression,and,are,highlighted,in,gel,.}	{NULL}
journal.pgen.1003588.pdf	607	{LM,-,DNA,Molecular,Weight,Marker,X,(,Roche,),.}	{NULL}
journal.pgen.1003588.pdf	608	{(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	609	{Figure,S2,Pearson,correlation,coefﬁcients,for,expression,levels,of,different,ANRIL,isoforms,in,peripheral,mononuclear,cells,of,patients,of,the,Leipzig,LIFE,Heart,Study,(,n,:,2280,),.}	{NULL}
journal.pgen.1003588.pdf	610	{The,following,qRT-PCR,assays,were,used,:,ANRIL,Ex7b,(,isoform,1,),","}	{NULL}
journal.pgen.1003588.pdf	611	{Ex7,.}	{NULL}
journal.pgen.1003588.pdf	612	{—,.}	{NULL}
journal.pgen.1003588.pdf	613	{I3,(,isoform,2,),",",ExI0,.}	{NULL}
journal.pgen.1003588.pdf	614	{—,.}	{NULL}
journal.pgen.1003588.pdf	615	{I3b,(,isoform,3,),",",Ex,I8,—,],9,(,isoform,4,),",",and,Ex,],.}	{NULL}
journal.pgen.1003588.pdf	616	{—,.}	{NULL}
journal.pgen.1003588.pdf	617	{5,(,all,isoforms,),.}	{NULL}
journal.pgen.1003588.pdf	618	{Coeiﬁcients,between,0.20,and,0.30,are,highlighted,in,grey,",",coeiﬁcients,greater,than,0.30,are,highlighted,in,black,.}	{NULL}
journal.pgen.1003588.pdf	619	{(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	620	{Figure,S3,Absolute,quantiﬁcation,of,ANRIL,expression,in,stably,over-expressing,cell,lines,ANRILI-4,",",vector,control,",",and,HEK,cells,.}	{NULL}
journal.pgen.1003588.pdf	621	{(,A,),Graphical,summary,of,exons,included,in,ANRILI-4,isoforms,.}	{NULL}
journal.pgen.1003588.pdf	622	{ANRIL,expression,levels,were,determined,by,qRT-PCR,assays,(,B,),Ex,],(,ANRIL1-4,),",",(,C,),Ex7b,(,ANRILl,),",",(,D,),Ex,],0,—,],3b,(,ANRIL3,),",","{",ExI8,.}	{NULL}
journal.pgen.1003588.pdf	623	{—,.}	{NULL}
journal.pgen.1003588.pdf	624	{I9,(,ANRIL4,),.}	{NULL}
journal.pgen.1003588.pdf	625	{Cell,lines,lacking,overexpression,of,respective,isoform,are,highlighted,in,red,.}	{NULL}
journal.pgen.1003588.pdf	626	{3,—,4,cell,lines/isoform,",",quadruplicate,measurements,/,cell,line,.}	{NULL}
journal.pgen.1003588.pdf	627	{Error,bars,indicate,s.e.m.,(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	628	{Figure,S4,mRNA,expression,of,Chr9p2l,genes,CDKN2A,and,CDKN2B,in,ANRIL,],-4,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	629	{mRNA,expression,of,CDK,],"\\\\",/,2A,transcripts,(,A,),pI6,”,m,“,",",(,B,),p144,”,",",and,(,C,),CDIf,],"\\\\",/,2B,(,p15,””,‘”,),was,not,signiﬁcantly,altered,in,cell,lines,ANRILI-4,compared,to,control,.}	{NULL}
journal.pgen.1003588.pdf	630	{Copies,of,each,transcript,were,normalized,to,106,copies,of,the,house-keeping,gene,beta-actin,(,B,),.}	{NULL}
journal.pgen.1003588.pdf	631	{(,A,.}	{NULL}
journal.pgen.1003588.pdf	632	{—,.}	{NULL}
journal.pgen.1003588.pdf	633	{C,),4,replicates,/,isoform,.}	{NULL}
journal.pgen.1003588.pdf	634	{Error,bars,indicate,s.e.m.,(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	635	{Figure,S5,Dose-dependency,of,cellular,phenotypes,in,independently,established,ANRIL2,and,4,over-expressing,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	636	{(,A,),ANRIL,expression,levels,were,determined,by,qRT-PCR,assay,Ex,],.}	{NULL}
journal.pgen.1003588.pdf	637	{ANRIL2,and,ANRIL4,cell,lines,with,high,(,ANRIL2h,",",AN,RIL4h,),and,low,(,ANRIL2l,",",ANRIL/ll,),expression,and,vector,(,v,),control,.}	{NULL}
journal.pgen.1003588.pdf	638	{(,B,),Adhesion,",",(,C,),proliferation,",",and,(,D,),apoptosis,in,independently,established,ANRIL,cell,lines,.}	{NULL}
journal.pgen.1003588.pdf	639	{Error,bars,indicate,s.e.m.,(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	640	{Figure,S6,siRNA-mediated,knockdown,of,ANRIL,expression,in,ANRIL2,and,ANRIL4,cells,.}	{NULL}
journal.pgen.1003588.pdf	641	{(,A,),Corresponds,to,Figure,2M,and,O,",",(,B,),corresponds,to,Figure,2N,.}	{NULL}
journal.pgen.1003588.pdf	642	{ANRIL,expression,levels,were,determined,by,qRT-PCR,assays,spanning,exon,7,—,l3,(,ANRIL2,),and,exon,6,—,16,(,ANRIL4,),",",respectively,",",and,were,normalized,to,106,copies,of,the,house-keeping,gene,betwactin,(,BA,),.}	{NULL}
journal.pgen.1003588.pdf	643	{P-values,for,differences,of,expression,compared,to,SCR,(,scrambled,),control,are,given,.}	{NULL}
journal.pgen.1003588.pdf	644	{Error,bars,indicate,s.e.m.,(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	645	{Figure,S7,CBX7,binding,in,promoters,of,ANRIL,trans-regulated,genes,in,vector,control,cell,line,.}	{NULL}
journal.pgen.1003588.pdf	646	{Up,-,(,green,),",",down,-,(,red,),",",and,not,(,black,),regulated,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	647	{TSS,-,transcription,start,site,.}	{NULL}
journal.pgen.1003588.pdf	648	{(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	649	{Figure,S8,Alu-DEIN,core,motif,in,ANRIL,?}	{NULL}
journal.pgen.1003588.pdf	650	{and,ANRIL4,RNA,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	651	{(,A,),Sequence,of,core,motif,and,reverse-complementary,motif,sequence,found,in,ANRIL4,and,ANRIL,?}	{NULL}
journal.pgen.1003588.pdf	652	{transcripts,",",respectively,.}	{NULL}
journal.pgen.1003588.pdf	653	{One,core,motif,per,ANRIL,isoform,was,identiﬁed,.}	{NULL}
journal.pgen.1003588.pdf	654	{(,B,),ANRIL2,isoform,with,highlighted,motif,sequence,in,exon,7,.}	{NULL}
journal.pgen.1003588.pdf	655	{(,C,)}	{NULL}
journal.pgen.1003588.pdf	656	{References,l.,Helgadottir,A,",",Thorleifsson,G,",",l,"\\\\",’,Ianolescu,A,",",Gretarsdottir,S,",",Blondal,T,",",et,al.,(,2007,),A,common,variant,on,chromosome,9p2l,affects,the,risk,of,myocardial,infarction,.}	{NULL}
journal.pgen.1003588.pdf	657	{Science,316,:,l49l,~,l493,.}	{NULL}
journal.pgen.1003588.pdf	658	{2,.}	{NULL}
journal.pgen.1003588.pdf	659	{NIcPherson,R,",",Pertsemlidis,A,",",Kavaslar,N,",",Stewart,A,",",Roberts,R,",",et,al.,(,2007,),A,common,allele,on,chromosome,9,associated,with,coronary,heart,disease,.}	{NULL}
journal.pgen.1003588.pdf	660	{Science,316,:,14884491,.}	{NULL}
journal.pgen.1003588.pdf	661	{3,.}	{NULL}
journal.pgen.1003588.pdf	662	{Yap,KL,",",Li,S,",","l\\\\/Iunoz-Cabello",AIVI,",",Raguz,S,",",Zeng,L,",",et,al.,(,2010,),Nlolecular,interplay,of,the,noncoding,RNA,ANRIL,and,methylated,histone,H3,lysine,27,by,polycoml,),CBX7,in,transcriptional,silencing,of,INK4a,.}	{NULL}
journal.pgen.1003588.pdf	663	{Nlol,Cell,38,:,662,—,674,.}	{NULL}
journal.pgen.1003588.pdf	664	{ANRIL4,isoform,with,highlighted,motif,sequence,in,exons,1,/,16,/,18,.}	{NULL}
journal.pgen.1003588.pdf	665	{(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	666	{Figure,S9,Absolute,quantiﬁcation,of,ANRIL,expression,in,stably,over-expressing,cell,lines,ANRIL2,",",2a,—,c,",",ANRIL4,",",4a,",",4b,",",ANRIL2,*,25,/,*,33,/,*,l00,",",vector,control,",",and,HEK,cells,.}	{NULL}
journal.pgen.1003588.pdf	667	{(,A,),Graphical,summary,of,exons,included,in,ANRIL2,",",2a,—,c,",",ANRIL4,",",4a,",",4b,isoforms,.}	{NULL}
journal.pgen.1003588.pdf	668	{ANRIL,expression,levels,were,determined,by,qRT-PCR,assays,(,B,),Ex,],and,(,C,),Ex5,—,6,.}	{NULL}
journal.pgen.1003588.pdf	669	{(,D,),Graphical,summary,of,exons,included,in,ANRIL2,and,AN,RIL,2,cell,lines,with,25,%,(,*,25,),",",33,%,(,*,33,),",",and,100,%,(,*,loo,),nucleotide,exchanges,in,the,48,base-pair,Alu,motif,(,Figure,5G,),.}	{NULL}
journal.pgen.1003588.pdf	670	{ANRIL,expression,levels,were,determined,by,qRT-PCR,assay,Ex,],.}	{NULL}
journal.pgen.1003588.pdf	671	{Cell,lines,lacking,over-expression,of,respective,isoform,are,highlighted,in,red,.}	{NULL}
journal.pgen.1003588.pdf	672	{2,—,4,cell,lines/isoform,",",quadruplicate,measurements,/,cell,line,.}	{NULL}
journal.pgen.1003588.pdf	673	{Error,bars,indicate,s.e.m.,(,TIF,)}	{NULL}
journal.pgen.1003588.pdf	674	{Table,S1,ANRIL,target-genes,with,average,down-regulation,<,0.5,fold,compared,to,vector,control,(,n,=,219,),.}	{NULL}
journal.pgen.1003588.pdf	675	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	676	{Table,S2,ANRIL,target-genes,with,average,up-regulation,>,2,fold,compared,to,vector,control,(,n,=,708,),.}	{NULL}
journal.pgen.1003588.pdf	677	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	678	{Table,S3,Experimental,setup,and,P-values,of,experiments,shown,in,Figure,2,.}	{NULL}
journal.pgen.1003588.pdf	679	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	680	{Table,S4,ANRIL,RACE,primers,.}	{NULL}
journal.pgen.1003588.pdf	681	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	682	{Table,S5,Primers,used,for,PCR,ampliﬁcation,of,ANRIL,transcripts,.}	{NULL}
journal.pgen.1003588.pdf	683	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	684	{Table,S6,Quantitative,RT-PCR,primers,and,probes,.}	{NULL}
journal.pgen.1003588.pdf	685	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	686	{Table,S7,Mapping,of,ChIP-seq,reads,.}	{NULL}
journal.pgen.1003588.pdf	687	{(,DOC}	{NULL}
journal.pgen.1003588.pdf	688	{Acknowledgments}	{NULL}
journal.pgen.1003588.pdf	689	{W76,thank,K.,Kothe,",",lVI,.}	{NULL}
journal.pgen.1003588.pdf	690	{Fritsche,",",K.,Ullrich,",",C.,Dohring,",",K.,Olischer,",",A.,Schink,",",F.,Jeromin,",",C.,Gebhardt,",","l\\\\/I",.}	{NULL}
journal.pgen.1003588.pdf	691	{Oehlert,",",and,NI,.}	{NULL}
journal.pgen.1003588.pdf	692	{Siegemund,for,their,technical,assistance,",",aI1d,lVI,.}	{NULL}
journal.pgen.1003588.pdf	693	{Gericke,",",Institute,of,Anatomy,",",University,Leipzig,",",for,help,with,immunohistochemical,caspase-3,staining,.}	{NULL}
journal.pgen.1003588.pdf	694	{Author,Contributions}	{NULL}
journal.pgen.1003588.pdf	695	{Conceived,and,designed,the,experiments,:,LMH,KS,DT,.}	{NULL}
journal.pgen.1003588.pdf	696	{Performed,the,experiments,:,LlVlH,KS,KK,KF,AS,WW,.}	{NULL}
journal.pgen.1003588.pdf	697	{Analyzed,the,data,:,LlV,[,H,SH,KS,DL,MS,PFS,DT,.}	{NULL}
journal.pgen.1003588.pdf	698	{Contributed,reagents,/,materials,/,analysis,tools,:,LMH,SH,DL,FB,SG,GS,GG,HB,IB,PFS,JT,DT,.}	{NULL}
journal.pgen.1003588.pdf	699	{Wlrote,the,paper,:,LMH,DT,.}	{NULL}
journal.pgen.1003588.pdf	700	{Critically,revised,and,approved,the,ﬁnal,version,of,the,manuscript,:,LMH,SH,KS,DL,MS,KK,KF,AS,W,',W,FB,SG,GS,GG,HB,IB,PFS,JT,DT,.}	{NULL}
journal.pgen.1003588.pdf	701	{4,.}	{NULL}
journal.pgen.1003588.pdf	702	{Samani,NJ,",",Erdmann,J,",",Hall,AS,",",Hengstenberg,C,",","l\\\\/Iangino",lVi,",",et,al.,(,2007,),Genome-wide,association,analysis,of,coronary,artery,disease,.}	{NULL}
journal.pgen.1003588.pdf	703	{New,Englj,Nled,357,:,443,—,453,.}	{NULL}
journal.pgen.1003588.pdf	704	{5,.}	{NULL}
journal.pgen.1003588.pdf	705	{Folkersen,L,",",Kyriakou,T,",",Goel,A,",",Peden,J,",",l,"\\\\",’,Ialarstig,A,",",et,al.,(,2009,),Relationship,between,CAD,risk,genotype,in,the,chromosome,9p2l,locus,and,gene,expression,.}	{NULL}
journal.pgen.1003588.pdf	706	{Identification,ofeight,new,ANRIL,splice,Variants,.}	{NULL}
journal.pgen.1003588.pdf	707	{PLoS,One,4,:,e7677,.}	{NULL}
journal.pgen.1003588.pdf	708	{6,.}	{NULL}
journal.pgen.1003588.pdf	709	{Holdt,Ll,"\\\\",’,I,",",Beutner,F,",",Scholz,l,"\\\\",’,I,",",Gielen,S,",",Gahel,G,",",et,al.,(,2010,),ANRIL,expression,is,associated,with,atherosclerosis,risk,at,chromosome,9p2l,.}	{NULL}
journal.pgen.1003588.pdf	710	{Arterioscler,Thromh,Vasc,Biol,30,:,6204327,.}	{NULL}
journal.pgen.1003588.pdf	711	{Holdt,Ll,"\\\\",’,I,",",Sass,K,",",Gabel,G,",",Bergert,H,",",ThieryJ,",",et,a.l.,(,2011,),Expression,of,Chr9p21,genes,CDKN2B,(,p1,.5,(,INK4b,),),",",CDKN2A,(,p16,(,INK4a,),",",p14,(,ARF,),),and,l,"\\\\",’,ITAP,in,human,atherosclerotic,plaque,.}	{NULL}
journal.pgen.1003588.pdf	712	{Atherosclerosis,214,:,2644270,.}	{NULL}
journal.pgen.1003588.pdf	713	{Holdt,LIVI,",",Teupser,D,(,2012,),Recent,studies,of,the,human,chromosome,9p21,locus,",",which,is,associated,with,atherosclerosis,in,human,populations,.}	{NULL}
journal.pgen.1003588.pdf	714	{Arterioscler,Thromb,Vasc,Biol,32,:,1964206,.}	{NULL}
journal.pgen.1003588.pdf	715	{Fuster,J,],",",l,"\\\\",’,Iolina-Sanchez,P,",",Jovani,D,",",Vinue,A,",",Serrano,l,"\\\\",’,I,",",et,al.,(,2012,),Increased,gene,dosage,of,the,Ink4/Arf,locus,does,not,attenuate,atherosclerosis,development,in,hypercholesterolaemic,mice,.}	{NULL}
journal.pgen.1003588.pdf	716	{Atherosclerosis,221,:,984105,.}	{NULL}
journal.pgen.1003588.pdf	717	{KimJB,",",Deluna,A,",","l\\\\/Iungrue",IN,",",Vu,C,",",Pouldar,D,",",et,al.,(,2012,),Ellect,o1I9p2l,.3,coronary,artery,disease,locus,neighboring,genes,on,atherosclerosis,in,mice,.}	{NULL}
journal.pgen.1003588.pdf	718	{Circulation,126,:,189641906,.}	{NULL}
journal.pgen.1003588.pdf	719	{Cunnington,l,"\\\\",’,IS,",",Santil,),anez,Koref,NI,",",l,"\\\\",’,Iayosi,BN1,",",Burn,J,",",Keavney,B,(,2010,),Chromosome,9p2l,SNPs,Associated,with,l,"\\\\",’,Iultiple,Disease,Phenotypes,Correlate,with,ANRIL,Expression,.}	{NULL}
journal.pgen.1003588.pdf	720	{PLoS,Genet,6,:,el000899,.}	{NULL}
journal.pgen.1003588.pdf	721	{.}	{NULL}
journal.pgen.1003588.pdf	722	{Jarinova,O,",",Stewart,AF,",",Roberts,R,",",V,"\\\\",lel1s,G,",",Lau,P,",",et,al.,(,2009,),Functiona,.}	{NULL}
journal.pgen.1003588.pdf	723	{l,analysis,of,the,chromosome,9p21,.3,coronary,artery,disease,risk,locus,.}	{NULL}
journal.pgen.1003588.pdf	724	{Arterioscler,Thromb,Vasc,Biol,29,:,167141677,.}	{NULL}
journal.pgen.1003588.pdf	725	{Liu,Y,",",Sanoff,HK,",",Cho,H,",",Burd,CE,",",Torrice,C,",",et,a.l.,(,2009,),INK4/ARF,transcript,expression,is,associated,with,chromosome,9p21,variants,linked,to,atherosclerosis,.}	{NULL}
journal.pgen.1003588.pdf	726	{PLoS,One,4,:,e5027,.}	{NULL}
journal.pgen.1003588.pdf	727	{Kapranov,P,",",ChengJ,",",Dike,S,",",Nix,DA,",",Duttagupta,R,",",et,a.l.,(,2007,),RNA,maps,reveal,new,RNA,classes,and,a,possible,function,lor,pervasive,transcription,.}	{NULL}
journal.pgen.1003588.pdf	728	{Science,316,:,148441488,.}	{NULL}
journal.pgen.1003588.pdf	729	{Nlattick,@P,g,(,2009,),The,genetic,signatures,of,noncoding,RNAs,.}	{NULL}
journal.pgen.1003588.pdf	730	{PLoS,Genet,5,:,e10004,.59,.}	{NULL}
journal.pgen.1003588.pdf	731	{Nlercer,TR,",",Dinger,l,"\\\\",’,IE,",",l,"\\\\",’,Iattick,JS,(,2009,),Long,non,~,coding,RNAs,:,insights,into,functions,.}	{NULL}
journal.pgen.1003588.pdf	732	{Nat,Rev,Genet,10,:,1554159,.}	{NULL}
journal.pgen.1003588.pdf	733	{Hung,T,",",Chang,HY,(,2010,),Long,noncoding,RNA,in,genome,regulation,:,prospects,and,mechanisms,.}	{NULL}
journal.pgen.1003588.pdf	734	{RNA,Biol,7,:,5824.585,.}	{NULL}
journal.pgen.1003588.pdf	735	{Lee,JT,(,2012,),Epigenetic,regulation,by,long,noncoding,RNAs,.}	{NULL}
journal.pgen.1003588.pdf	736	{Science,338,:,143541439,.}	{NULL}
journal.pgen.1003588.pdf	737	{VVapinski,O,",",Chang,HY,(,201,1,),Long,noncoding,RNAs,and,human,disease,(,vol,21,",",pg,354,",",2011,),.}	{NULL}
journal.pgen.1003588.pdf	738	{Trends,in,Cell,Biology,21,:,5614561,.}	{NULL}
journal.pgen.1003588.pdf	739	{.}	{NULL}
journal.pgen.1003588.pdf	740	{Kotake,Y,",",Na,.}	{NULL}
journal.pgen.1003588.pdf	741	{kagawa,T,",",Kitagawa,K,",",Suzuki,S,",",Liu,N,",",et,al.,(,2011,),Long,noncoding,RNA,ANRIL,is,required,lor,the,PRC2,recruitment,to,and,silencing,of,pl5,(,INK4B,),tumor,suppressor,gene,.}	{NULL}
journal.pgen.1003588.pdf	742	{Oncogene,30,:,195641962,.}	{NULL}
journal.pgen.1003588.pdf	743	{.}	{NULL}
journal.pgen.1003588.pdf	744	{Nlargueron,R,",",Reinberg,D,(,201,1,),The,Polycomb,complex,PRC2,and,its,mark,in,life,.}	{NULL}
journal.pgen.1003588.pdf	745	{Nature,469,:,3434349,.}	{NULL}
journal.pgen.1003588.pdf	746	{Lusis,AJ,(,2000,),Atherosclerosis,.}	{NULL}
journal.pgen.1003588.pdf	747	{Nature,407,:,2334241,.}	{NULL}
journal.pgen.1003588.pdf	748	{Sato,K,",",Nakagawa,H,",",Tajima,A,",",Yoshida,K,",",Inoue,I,(,2010,),ANRIL,is,implicated,in,the,regulation,of,nucleus,and,potential,transcriptional,target,of,E2F1,.}	{NULL}
journal.pgen.1003588.pdf	749	{Oncol,Rep,24,:,7014707,.}	{NULL}
journal.pgen.1003588.pdf	750	{.}	{NULL}
journal.pgen.1003588.pdf	751	{Khalil,"Al\\\\/I",",",Guttman,NI,",",Huarte,NI,",",Garber,NI,",",Raj,A,",",et,al.,(,2009,),l,"\\\\",’,Iany,human,large,intergenic,noncoding,RNAs,associate,with,chromatin,»,modifying,complexes,and,affect,gene,expression,.}	{NULL}
journal.pgen.1003588.pdf	752	{Proc,Natl,Acad,Sci,U,S,A,106,:,116674,1,1672,.}	{NULL}
journal.pgen.1003588.pdf	753	{.}	{NULL}
journal.pgen.1003588.pdf	754	{Rinn,JL,",",Kertesz,l,"\\\\",’,I,",",‘,Vang,JK,",",Squazzo,SL,",",Xu,X,",",et,a.l.,(,2007,),Functional,demarcation,of,active,and,silent,chromatin,domains,in,human,HOX,loci,by,noncoding,RNAs,.}	{NULL}
journal.pgen.1003588.pdf	755	{Cell,129,:,131141323,.}	{NULL}
journal.pgen.1003588.pdf	756	{.}	{NULL}
journal.pgen.1003588.pdf	757	{Tsai,RIC,",","l\\\\/Ianor",O,",",VVan,Y,",",Nlosammaparast,N,",",V,"\\\\",langJK,",",et,al.,(,2010,),Long,noncoding,RNA,as,modular,scaffold,ofhistone,modiﬁcation,complexes,.}	{NULL}
journal.pgen.1003588.pdf	758	{Science,329,:,6894693,.}	{NULL}
journal.pgen.1003588.pdf	759	{.}	{NULL}
journal.pgen.1003588.pdf	760	{Bracken,AP,",",Helin,K,(,2009,),Polycoml,),group,proteins,:,navigators,of,lineage,pathways,led,astray,in,cancer,.}	{NULL}
journal.pgen.1003588.pdf	761	{Nat,Rev,Cancer,9,:,7734784,.}	{NULL}
journal.pgen.1003588.pdf	762	{.}	{NULL}
journal.pgen.1003588.pdf	763	{Beutner,F,",",Teupser,D,",",Gielen,S,",",Holdt,Ll,"\\\\",’,I,",",Scholz,NI,",",et,al.,(,2011,),Rationale,and,design,of,the,Leipzig,(,LIFE,),Heart,Study,:,phenotyping,and,cardiovascular,characteristics,of,patients,with,coronary,artery,disease,.}	{NULL}
journal.pgen.1003588.pdf	764	{PLoS,One,6,:,e29070,.}	{NULL}
journal.pgen.1003588.pdf	765	{.}	{NULL}
journal.pgen.1003588.pdf	766	{Gonzalez,I,",",Busturia,A,(,2009,),High,levels,of,dRYBP,induce,apoptosis,in,Drosophila,imaginal,cells,through,the,activation,of,reaper,and,the,requirement,of,trithorax,",",dredd,and,dFADD,.}	{NULL}
journal.pgen.1003588.pdf	767	{Cell,Res,19,:,7474757,.}	{NULL}
journal.pgen.1003588.pdf	768	{Gregoire,S,",",Karra,R,",",Passer,D,",",Deutsch,KIA,",",Krane,IVI,",",et,a.l.,(,2013,),Essential,and,Unexpected,Role,of,YY1,to,Promote,lVIesoderma1,Cardiac,Dillerentiation,.}	{NULL}
journal.pgen.1003588.pdf	769	{Circ,Res,112,:,9004910,.}	{NULL}
journal.pgen.1003588.pdf	770	{Brookes,E,",",de,Santiago,I,",",Hel,),enstreit,D,",","l\\\\/Iorris",KJ,",",Carroll,T,",",et,a.l.,(,2012,),Polycomb,associates,genome-wide,with,a,speciﬁc,RNA,polymerase,II,variant,",",and,regulates,metabolic,genes,in,ESCs,.}	{NULL}
journal.pgen.1003588.pdf	771	{Cell,Stem,Cell,10,:,1574170,.}	{NULL}
journal.pgen.1003588.pdf	772	{Rudiger,NS,",",Gregersen,N,",",Kielland,~,Brandt,"l\\\\/IC",(,1995,),One,short,well,conserved,region,of,Alu-sequences,is,involved,in,human,gene,rearrangements,and,has,homology,with,prokaryotic,chi,.}	{NULL}
journal.pgen.1003588.pdf	773	{Nucleic,Acids,Res,23,:,2.564260,.}	{NULL}
journal.pgen.1003588.pdf	774	{Deininger,PL,",",Jolly,DJ,",",Rul,),in,"Cl\\\\/I",",",Friedmann,T,",",Schmid,CVV,(,1981,),Base,sequence,studies,of,300,nucleotide,renatured,repeated,human,DNA,clones,.}	{NULL}
journal.pgen.1003588.pdf	775	{J,"l\\\\/Iol",Biol,151,:,17433,.}	{NULL}
journal.pgen.1003588.pdf	776	{VVeibrecht,I,",",Gavrilovic,l,"\\\\",’,I,",",Lindl,),om,L,",",Landegren,U,",",Wlahlby,C,",",et,al.,(,2012,),Visualising,individual,sequence-speciﬁc,protein-DNA,interactions,in,situ,.}	{NULL}
journal.pgen.1003588.pdf	777	{N,Biotechnol,29,:,5894598,.}	{NULL}
journal.pgen.1003588.pdf	778	{Congrains,A,",",Kamide,K,",",Katsuya,T,",",Yasuda,O,",",Oguro,R,",",et,al.,(,2012,),CVD,~,associated,non,~,coding,RNA,",",ANRIL,",",modulates,expression,of,atherogenic,pathways,in,"VSl\\\\/IC",.}	{NULL}
journal.pgen.1003588.pdf	779	{Biochem,Biophys,Res,Commun,419,:,6124616,.}	{NULL}
journal.pgen.1003588.pdf	780	{Congrains,A,",",Kamide,K,",",Oguro,R,",",Yasuda,O,",",lVIiyata,K,",",et,al.,(,2012,),Genetic,variants,at,the,9p2l,locus,contribute,to,atherosclerosis,through,modulation,of,ANRIL,and,CDKN2A/B,.}	{NULL}
journal.pgen.1003588.pdf	781	{Atherosclerosis,220,:,4494455,.}	{NULL}
journal.pgen.1003588.pdf	782	{Gupta,RA,",",Shah,N,",",VVang,KC,",",KimJ,",",Horlings,"Hl\\\\/I",",",et,al.,(,2010,),Long,non,»,coding,RNA,HOTAIR,reprograms,chromatin,state,to,promote,cancer,metastasis,.}	{NULL}
journal.pgen.1003588.pdf	783	{Nature,464,:,107141076,.}	{NULL}
journal.pgen.1003588.pdf	784	{Nagano,T,",",NIitchel1JA,",",Sanz,LA,",",Pauler,Fl,"\\\\",’,I,",",Ferguson-Smith,AC,",",et,al.,(,2008,),The,Air,noncoding,RNA,epigenetically,silences,transcription,by,targeting,G9a,to,chromatin,.}	{NULL}
journal.pgen.1003588.pdf	785	{Science,322,:,171741720,.}	{NULL}
journal.pgen.1003588.pdf	786	{Zhao,J,",",Sun,BK,",",ErwinJA,",",SongJ,],",",LeeJT,(,2008,),Polycomb,proteins,targeted,by,a,short,repeat,RNA,to,the,mouse,X,chromosome,.}	{NULL}
journal.pgen.1003588.pdf	787	{Science,322,:,7504756,.}	{NULL}
journal.pgen.1003588.pdf	788	{Zeller,T,",","\\\\",Vild,P,",",Szymczak,S,",",Rotiva,.}	{NULL}
journal.pgen.1003588.pdf	789	{l,l,"\\\\",’,I,",",Schillert,A,",",et,a.l.,(,2010,),Genetics,and,beyond4the,transcriptome,of,human,monocytes,and,disease,susceptibility,.}	{NULL}
journal.pgen.1003588.pdf	790	{PLoS,One,5,:,e10693,.}	{NULL}
journal.pgen.1003588.pdf	791	{SimonJA,",",Kingston,RE,(,2009,),Nlechanisms,ofpolycomb,gene,silencing,:,knowns,and,unknowns,.}	{NULL}
journal.pgen.1003588.pdf	792	{Nat,Rev,lVIol,Cell,Biol,10,:,6974708,.}	{NULL}
journal.pgen.1003588.pdf	793	{.}	{NULL}
journal.pgen.1003588.pdf	794	{"\\\\",Iorey,L,",",Aloia,L,",",Cozzuto,L,",",Benitah,SA,",",Di,Croce,L,(,2013,),RYBP,and,Cbx7,Deﬁne,Speciﬁc,Biological,Functions,of,Polycomb,Complexes,in,Nlouse,Embryonic,Stem,Cells,.}	{NULL}
journal.pgen.1003588.pdf	795	{Cell,Rep,3,:,60469,.}	{NULL}
journal.pgen.1003588.pdf	796	{House1eyJ,",",Rubl,),i,L,",",Grunstein,NI,",",Tollervey,D,",",Vogelauer,NI,(,2008,),A,ncRNA,modulates,histone,modiﬁcation,and,mRNA,induction,in,the,yeast,GAL,gene,cluster,.}	{NULL}
journal.pgen.1003588.pdf	797	{l,"\\\\",’,Io1,Cell,32,:,6854695,.}	{NULL}
journal.pgen.1003588.pdf	798	{Buske,FA,",",l,"\\\\",’,Iattick,JS,",",Bailey,TL,(,2011,),Potential,in,vivo,roles,of,nucleic,acid,triple-helices,.}	{NULL}
journal.pgen.1003588.pdf	799	{RNA,Biol,8,:,4274439,.}	{NULL}
journal.pgen.1003588.pdf	800	{Chu,C,",",Qu,K,",",Zhong,FL,",",Artandi,SE,",",Chang,HY,(,2011,),Genomic,maps,of,long,noncoding,RNA,occupancy,reveal,principles,of,RNA-chromatin,interactions,.}	{NULL}
journal.pgen.1003588.pdf	801	{Mol,Cell,44,:,6674678,.}	{NULL}
journal.pgen.1003588.pdf	802	{Cowley,IVI,",",Oakey,RJ,(,2013,),Transposal,),le,Elements,Re,~,VVire,and,Fine-Tune,the,Transcriptome,.}	{NULL}
journal.pgen.1003588.pdf	803	{PLoS,Genet,9,(,1,),:,el003234,.}	{NULL}
journal.pgen.1003588.pdf	804	{Amaral,PP,",",l,"\\\\",’,Iattick,JS,(,2008,),Noncoding,RNA,in,development,.}	{NULL}
journal.pgen.1003588.pdf	805	{l,"\\\\",’,Iamm,Genome,19,:,4544492,.}	{NULL}
journal.pgen.1003588.pdf	806	{Visel,A,",",Zhu,Y,",","l\\\\/Iay",D,",",Afzal,V,",",Gong,E,",",et,al.,(,2010,),Targeted,deletion,of,the,9p2l,non-coding,coronary,artery,disease,risk,interval,in,mice,.}	{NULL}
journal.pgen.1003588.pdf	807	{Nature,464,:,4094,412,.}	{NULL}
journal.pgen.1003588.pdf	808	{Jeck,VVR,",",SorrentinoJA,",",VVang,K,",",Slevin,l,"\\\\",’,IK,",",Burd,CE,",",et,al.,(,2013,),Circular,RNAs,are,abundant,",",conserved,",",and,associated,with,ALU,repeats,.}	{NULL}
journal.pgen.1003588.pdf	809	{RNA,19,:,1414157,.}	{NULL}
journal.pgen.1003588.pdf	810	{Bernstein,BE,",",Ka,.}	{NULL}
journal.pgen.1003588.pdf	811	{mal,NI,",",Lindblad,»,Toh,K,",",Bekiranov,S,",",Bailey,DK,",",et,al.,(,2005,),Genomic,maps,and,comparative,analysis,of,histone,modifications,in,human,and,mouse,.}	{NULL}
journal.pgen.1003588.pdf	812	{Cell,120,:,1694181,.}	{NULL}
journal.pgen.1003588.pdf	813	{Niranjanakumari,S,",",Lasda,E,",",Brazas,R,",",Garcia-Blanco,"l\\\\/IA",(,2002,),Reversible,cross,—,linking,combined,with,immunoprecipitation,to,study,RNA-protein,interactions,in,vivo,.}	{NULL}
journal.pgen.1003588.pdf	814	{l,"\\\\",’,Iethods,26,:,1824190,.}	{NULL}
journal.pgen.1003588.pdf	815	{Johnson,VVE,",",Li,C,",",Rabinovic,A,(,2007,),Adjusting,batch,e1Iects,in,microarray,expression,data,using,empirical,Bayes,methods,.}	{NULL}
journal.pgen.1003588.pdf	816	{Biostatistics,8,:,1184127,.}	{NULL}
journal.pgen.1003588.pdf	817	{Schmid,R,",",Baum,P,",",Ittrich,1,",",Fundel-Clemens,K,",",Huber,VV,",",et,al.,(,2010,),Comparison,of,normalization,methods,for,Illumina,BeadChip,HumanHT,»,12,V3,.}	{NULL}
journal.pgen.1003588.pdf	818	{Bl,"\\\\",’,IC,Genomics,11,:,349,.}	{NULL}
journal.pgen.1003588.pdf	819	{Ihaka,R,",",Gentleman,R,(,1996,),R,a,language,for,data,analysis,and,graphics,.}	{NULL}
journal.pgen.1003588.pdf	820	{J,Comp,Graph,Stat,5,:,2994314,.}	{NULL}
journal.pgen.1003588.pdf	821	{HofImann,S,",",Otto,C,",",Kurtz,S,",",Sharma,"Cl\\\\/I",",",Khaitovich,P,",",et,a.l.,(,2009,),Fast,mapping,of,short,sequences,with,mismatches,",",insertions,and,deletions,using,index,structures,.}	{NULL}
journal.pgen.1003588.pdf	822	{PLoS,Comput,Biol,5,:,e1000502,.}	{NULL}
journal.pgen.1003588.pdf	823	{Shin,H,",",Liu,T,",",Manrai,AK,",",Liu,XS,(,2009,),CEAS,:,cis-regulatory,element,annotation,system,.}	{NULL}
journal.pgen.1003588.pdf	824	{Bioinformatics,25,:,260542606,.}	{NULL}
journal.pgen.1003588.pdf	825	{Bailey,TL,",",Boden,l,"\\\\",’,I,",",Buske,FA,",",Frith,IVI,",",Grant,CE,",",et,al.,(,2009,),l,"\\\\",’,IEl,"\\\\",’,IE,SUITE,:,tools,for,motif,discovery,and,searching,.}	{NULL}
journal.pgen.1003588.pdf	826	{Nucleic,Acids,Res,37,:,VV2024,208,.}	{NULL}
journal.pgen.1003588.pdf	827	{Tacker,l,"\\\\",’,I,",",Fontana,VV,",",Stadler,PF,",",Schuster,P,(,1994,),Statistics,of,RNA,melting,kinetics,.}	{NULL}
journal.pgen.1003588.pdf	828	{Eur,BiophysJ,23,:,29438,.}	{NULL}
journal.pmed.1001425.pdf	1	{OPEN,8,ACCESS,Freely,available,online,‘,.39,?}	{NULL}
journal.pmed.1001425.pdf	2	{-,PLOS,l,ME,°,',°,',”,E}	{NULL}
journal.pmed.1001425.pdf	3	{Preeclampsia,as,a,Risk,Factor,for,Diabetes,:,A,PopulationBased,Cohort,Study}	{NULL}
journal.pmed.1001425.pdf	4	{Denice,S.,Feig,"\\"",2,',3,"\\"","\\"",5,*,",",Baiju,R.,Shah,"\\"",2,',3,',°,",",Lorraine,L.,Lipscombe,"\\"",2,',3,',7,",",C.,Fangyun,Wu3,",",Joel,G.,Ray,"\\"",2,',3,',8,",",Julia,Lowe,“,",",Jeremiah,Hwee3,",",Gillian,L.,Booth1,’,2,',3,’,8,',9}	{NULL}
journal.pmed.1001425.pdf	5	{1,Department,of,Medicine,",",University,of,Toronto,",",Toronto,",",Canada,",",2,Department,of,Health,Policy,",",Management,and,Evaluation,",",University,of,Toronto,",",Toronto,",",Canada,",",3,Institute,for,Clinical,Evaluative,Sciences,",",Toronto,",",Canada,",",4,Department,of,Obstetrics,&,Gynecology,",",University,of,Toronto,",",Toronto,",",Canada,",",5,Division,of,Endocrinology,and,Metabolism,",",Mount,Sinai,Hospital,",",Toronto,",",Canada,",",6Division,of,Endocrinology,and,Metabolism,",",Sunnybrook,Health,Sciences,Centre,",",Toronto,",",Canada,",",7Women,’s,College,Research,Institute,and,the,Division,of,Endocrinology,and,Metabolism,",",Women,'s,College,Hospital,",",Toronto,",",Canada,",",8Keenan,Research,Centre,",",Li,Ka,Shing,Knowledge,Institute,",",St.,Michael,'s,Hospital,",",Toronto,",",Canada,",",9,Division,of,Endocrinology,and,Metabolism,",",St.,Michael,'s,Hospital,",",Toronto,",",Canada}	{NULL}
journal.pmed.1001425.pdf	6	{Abstract}	{NULL}
journal.pmed.1001425.pdf	7	{Background,:,Women,with,preeclampsia,(,PEC,),and,gestational,hypertension,(,GH,),exhibit,insulin,resistance,during,pregnancy,",",independent,of,obesity,and,glucose,intolerance,.}	{NULL}
journal.pmed.1001425.pdf	8	{Our,aim,was,to,determine,whether,women,with,PEC,or,GH,during,pregnancy,have,an,increased,risk,of,developing,diabetes,after,pregnancy,",",and,whether,the,presence,of,PEC/GH,in,addition,to,gestational,diabetes,(,GDM,),increases,the,risk,of,future,(,postpartum,),diabetes,.}	{NULL}
journal.pmed.1001425.pdf	9	{Methods,and,Findings,:,We,performed,a,population,—,based,",",retrospective,cohort,study,for,"1,010,068",pregnant,women,who,delivered,in,Ontario,",",Canada,between,April,1994,and,March,2008,.}	{NULL}
journal.pmed.1001425.pdf	10	{Women,were,categorized,as,having,PEC,alone,(,n,=,"22,933",),",",GH,alone,(,n,=,"27,605",),",",GDM,alone,(,n,=,"30,852",),",",GDM+PEC,(,n,:,"1,476",),",",GDM+GH,(,n,=,"2,100",),",",or,none,of,these,conditions,(,n,=,"925,102",),.}	{NULL}
journal.pmed.1001425.pdf	11	{Our,main,outcome,was,a,new,diagnosis,of,diabetes,postpartum,in,the,following,years,",",up,until,March,2011,",",based,on,new,records,in,the,Ontario,Diabetes,Database,.}	{NULL}
journal.pmed.1001425.pdf	12	{The,incidence,rate,of,diabetes,per,"1,000",person,—,years,was,6.47,for,women,with,PEC,and,5.26,for,GH,compared,with,2.81,in,women,with,neither,of,these,conditions,.}	{NULL}
journal.pmed.1001425.pdf	13	{In,the,multivariable,analysis,",",both,PEC,alone,(,hazard,ratio,[,HR,],:,2.08,;,95,%,CI,1.97-2,.19,),and,GH,alone,(,HR,=,1.95,;,95,%,CI,1.83-2,.07,),were,risk,factors,for,subsequent,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	14	{Women,with,GDM,alone,were,at,elevated,risk,of,developing,diabetes,postpartum,(,HR,=,12.77,;,95,%,CI,12.44-13,.10,),;,however,",",the,co-presence,of,PEC,or,GH,in,addition,to,GDM,further,elevated,this,risk,(,HR,=,15.75,;,95,%,CI,14.52-17,.07,",",and,HR,:,18.49,;,95,%,CI,17.12-19,.96,",",respectively,),.}	{NULL}
journal.pmed.1001425.pdf	15	{Data,on,obesity,were,not,available,.}	{NULL}
journal.pmed.1001425.pdf	16	{Conclusions,:,Women,with,PEC/GH,have,a,2-fold,increased,risk,of,developing,diabetes,when,followed,up,to,16.5,years,after,pregnancy,",",even,in,the,absence,of,GDM,.}	{NULL}
journal.pmed.1001425.pdf	17	{The,presence,of,PEC/GH,in,the,setting,of,GDM,also,raised,the,risk,of,diabetes,significantly,beyond,that,seen,with,GDM,alone,.}	{NULL}
journal.pmed.1001425.pdf	18	{A,history,of,PEC/GH,during,pregnancy,should,alert,clinicians,to,the,need,for,preventative,counseling,and,more,vigilant,screening,for,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	19	{Please,see,later,in,the,article,for,the,Editors,’,Summary,.}	{NULL}
journal.pmed.1001425.pdf	20	{Citation,:,Feig,DS,",",Shah,BR,",",Lipscombe,LL,",",Wu,CF,",",Ray,JG,",",et,al.,(,2013,),Preeclampsia,as,a,Risk,Factor,for,Diabetes,:,A,Population-Based,Cohort,Study,.}	{NULL}
journal.pmed.1001425.pdf	21	{PLoS,Med,10,(,4,),:,e100l425,.}	{NULL}
journal.pmed.1001425.pdf	22	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	23	{pmed,.100,l425,Academic,Editor,:,Philippa,Middleton,",",The,University,of,Adelaide,",",Australia,Received,October,14,",",2012,;,Accepted,March,5,",",2013,;,Published,April,16,",",2013,Copyright,:,©,2013,Feig,et,al.,.}	{NULL}
journal.pmed.1001425.pdf	24	{This,is,an,open-access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pmed.1001425.pdf	25	{Funding,:,This,study,was,funded,by,the,Canadian,Diabetes,Association,",",grant,#OG,.}	{NULL}
journal.pmed.1001425.pdf	26	{—,.}	{NULL}
journal.pmed.1001425.pdf	27	{2-10,.}	{NULL}
journal.pmed.1001425.pdf	28	{—,.}	{NULL}
journal.pmed.1001425.pdf	29	{3000,.}	{NULL}
journal.pmed.1001425.pdf	30	{—,.}	{NULL}
journal.pmed.1001425.pdf	31	{DF,(,http://www.diabetes.ca/,),.}	{NULL}
journal.pmed.1001425.pdf	32	{This,study,was,supported,by,the,Institute,for,Clinical,Evaluative,Sciences,(,ICES,),",",which,is,funded,by,an,annual,grant,from,the,Ontario,Ministry,of,Health,and,Long,.}	{NULL}
journal.pmed.1001425.pdf	33	{—,.}	{NULL}
journal.pmed.1001425.pdf	34	{Term,Care,.}	{NULL}
journal.pmed.1001425.pdf	35	{BRS,and,LL,are,supported,by,Canadian,Institute,of,Health,Research,New,Investigator,awards,.}	{NULL}
journal.pmed.1001425.pdf	36	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pmed.1001425.pdf	37	{The,opinions,",",results,",",and,conclusions,reported,in,this,paper,are,those,of,the,authors,and,are,independent,from,the,funding,sources,.}	{NULL}
journal.pmed.1001425.pdf	38	{No,endorsement,by,ICES,or,the,Ontario,Ministry,of,Health,and,Long,.}	{NULL}
journal.pmed.1001425.pdf	39	{—,.}	{NULL}
journal.pmed.1001425.pdf	40	{Term,Care,is,intended,or,should,be,inferred,.}	{NULL}
journal.pmed.1001425.pdf	41	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pmed.1001425.pdf	42	{Abbreviations,:,GDM,",",gestational,diabetes,;,GH,",",gestational,hypertension,;,HR,",",hazard,ratio,;,PEC,",",preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	43	{*,E,—,mai,|,:,d.feig@utoronto.ca}	{NULL}
journal.pmed.1001425.pdf	44	{PLOS,Medicine,|,www,.}	{NULL}
journal.pmed.1001425.pdf	45	{p,|,osmedicine.org,1,April,2013,|,Volume,10,|,Issue,4,|,e1001425}	{NULL}
journal.pmed.1001425.pdf	46	{Introduction}	{NULL}
journal.pmed.1001425.pdf	47	{The,prevalence,of,type,2,diabetes,is,increasing,dramatically,worldwide,[,1,],with,the,greatest,rise,in,incidence,occurring,in,adults,under,the,age,of,50,",",including,young,women,[,2,],.}	{NULL}
journal.pmed.1001425.pdf	48	{Randomized,trials,have,shown,that,type,2,diabetes,can,be,prevented,or,delayed,in,high-risk,groups,by,a,variety,of,lifestyle,and,therapeutic,interventions,[,"3,4",],.}	{NULL}
journal.pmed.1001425.pdf	49	{However,",",identifying,at,risk,populations,to,screen,for,type,2,diabetes,is,a,critical,step,in,translating,these,ﬁndings,into,clinical,practice,.}	{NULL}
journal.pmed.1001425.pdf	50	{Gestational,diabetes,is,a,major,risk,factor,for,the,development,of,diabetes,[,5,],and,thus,women,with,this,condition,are,an,ideal,population,to,target,diabetes,prevention,strategies,.}	{NULL}
journal.pmed.1001425.pdf	51	{Similarly,",",other,disorders,of,pregnancy,associated,with,insulin,resistance,may,heighten,the,propensity,for,women,to,develop,diabetes,in,the,years,following,pregnancy,",",and,such,women,may,also,be,suitable,targets,for,diabetes,prevention,.}	{NULL}
journal.pmed.1001425.pdf	52	{Hypertensive,disorders,in,pregnancy,",",including,gestational,hypertension,(,GH,),and,preeclampsia,(,PEC,),",",affect,approximately,8,%,of,all,pregnancies,[,6,],.}	{NULL}
journal.pmed.1001425.pdf	53	{More,recently,",",women,with,PEC/GH,have,been,noted,to,exhibit,insulin,resistance,during,pregnancy,that,is,independent,of,obesity,and,glucose,intolerance,[,"7,8",],.}	{NULL}
journal.pmed.1001425.pdf	54	{Studies,done,during,pregnancy,suggest,that,insulin,resistance,predates,the,development,of,PEG,",",implying,that,insulin,resistance,may,play,a,role,in,its,etiology,[,"7,8",],.}	{NULL}
journal.pmed.1001425.pdf	55	{Moreover,",",women,with,other,disorders,associated,with,insulin,resistance,tend,to,have,increased,rates,of,PEC/GH,.}	{NULL}
journal.pmed.1001425.pdf	56	{For,example,",",several,studies,have,shown,that,women,with,gestational,diabetes,mellitus,(,GDM,),have,an,increased,risk,of,PEG/GH,[,9,",",l0,],",",as,do,women,with,polycystic,ovary,syndrome,[,11,],.}	{NULL}
journal.pmed.1001425.pdf	57	{The,risk,of,PEC/GH,also,increases,with,increasing,glucose,intolerance,[,l0,",",l2,",",l3,],.}	{NULL}
journal.pmed.1001425.pdf	58	{Given,the,ﬁnding,of,insulin,resistance,in,women,with,PEC/GH,",",and,the,association,of,PEC/GH,with,other,disorders,associated,with,insulin,resistance,in,pregnancy,",",these,conditions,may,be,a,marker,of,future,diabetes,risk,",",even,in,the,absence,of,GDM,.}	{NULL}
journal.pmed.1001425.pdf	59	{A,few,studies,have,looked,at,this,association,but,have,failed,to,take,into,account,the,presence,of,GDM,.}	{NULL}
journal.pmed.1001425.pdf	60	{This,study,sought,to,examine,whether,women,with,PEG,or,GH,during,pregnancy,have,an,increased,risk,of,developing,diabetes,in,the,years,following,pregnancy,even,in,the,absence,of,GDM,",",and,to,determine,whether,the,combination,of,PEC/GH,and,GDM,confers,a,greater,risk,of,postpartum,diabetes,",",over,and,above,the,risk,seen,with,GDM,alone,.}	{NULL}
journal.pmed.1001425.pdf	61	{Methods}	{NULL}
journal.pmed.1001425.pdf	62	{Ethics,Statement,This,protocol,received,ethical,approval,from,the,Institutional,Review,Board,at,Sunnybrook,Health,Sciences,Centre,in,Toronto,.}	{NULL}
journal.pmed.1001425.pdf	63	{Data,Sources,We,conducted,a,population-based,cohort,study,using,administrative,health,claims,to,examine,the,impact,of,PEC/GH,on,the,subsequent,risk,of,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	64	{The,Government,of,Ontario,acts,as,a,single,payer,for,all,medically,necessary,services,across,a,full,spectrum,of,providers,and,hospitals,to,provide,all,residents,of,Ontario,(,approximately,12,million,residents,),with,universal,public,health,insurance,.}	{NULL}
journal.pmed.1001425.pdf	65	{Large,provincial,health,administrative,databases,are,used,to,capture,the,details,of,this,utilization,and,can,be,linked,anonymously,on,an,individual,level,using,a,unique,personal,identiﬁer,to,provide,a,complete,health,services,use,proﬁle,for,each,resident,.}	{NULL}
journal.pmed.1001425.pdf	66	{Study,Population,and,Eligibility,We,identiﬁed,all,women,age,15,to,50,y,of,age,who,delivered,in,an,Ontario,hospital,between,April,1,",",l994,and,March,31,",",2008,from,the,Canadian,Institute,for,Health,Information,Discharge,Abstract,Database,.}	{NULL}
journal.pmed.1001425.pdf	67	{For,women,who,had,multiple,deliveries,during,the,time,period,",",one,delivery,was,chosen,at,random,to,be,the,index,episode,from,which,they,were,followed,forward,in,time,.}	{NULL}
journal.pmed.1001425.pdf	68	{Women,with,a,diagnosis,of,diabetes,before,their,pregnancy,were,identiﬁed,and,excluded,from,the,study,using,the,Ontario,Diabetes,Database,[,14,],",",an,administrative,data,derived,registry,of,Ontario,residents,diagnosed,with,non-gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	69	{The,database,has,been,validated,against,primary,care,charts,and,was,shown,to,have,a,sensitivity,of,86,%,and,a,speciﬁcity,of,greater,than,97,%,[,14,],.}	{NULL}
journal.pmed.1001425.pdf	70	{We,restricted,the,cohort,to,women,who,were,residents,of,Ontario,and,had,coverage,under,the,province,’s,health,plan,for,a,full,2,y,prior,to,baseline,so,that,we,could,reliably,determine,their,diabetes,status,.}	{NULL}
journal.pmed.1001425.pdf	71	{Women,in,our,cohort,were,categorized,as,having,PEC,",",GH,",",or,GDM,on,the,basis,of,their,hospitalization,records,and,outpatient,data,from,physicians,’,services,claims,.}	{NULL}
journal.pmed.1001425.pdf	72	{Women,who,were,diagnosed,with,both,PEC,and,GH,were,assigned,to,the,PEC,group,.}	{NULL}
journal.pmed.1001425.pdf	73	{Women,assigned,to,the,GH,group,had,GH,alone,.}	{NULL}
journal.pmed.1001425.pdf	74	{Women,whose,hospitalization,record,at,the,time,of,delivery,included,a,diagnostic,code,for,diabetes,or,who,had,three,or,more,outpatient,medical,claims,for,diabetes,up,to,120,d,prior,to,their,delivery,were,identiﬁed,as,having,GDM,.}	{NULL}
journal.pmed.1001425.pdf	75	{"\\\\",/,Vomen,were,considered,to,have,a,premature,delivery,if,the,delivery,was,<,37,wk,gestation,.}	{NULL}
journal.pmed.1001425.pdf	76	{Baseline,Variables,and,Study,Outcomes,Women,in,our,cohort,were,followed,from,180,d,post,delivery,(,to,avoid,the,potential,misclassiﬁcation,of,women,with,GDM,undergoing,routine,postpartum,follow-up,),until,March,31,",",2011,for,the,development,of,diabetes,",",on,the,basis,of,the,presence,of,a,new,record,in,the,Ontario,Diabetes,Database,.}	{NULL}
journal.pmed.1001425.pdf	77	{We,gathered,demographic,and,clinical,characteristics,from,administrative,data,to,be,applied,in,our,adjusted,multivariable,models,(,see,Text,S1,for,codes,used,),.}	{NULL}
journal.pmed.1001425.pdf	78	{The,age,of,the,women,was,obtained,through,the,Registered,Persons,Database,",",which,contains,demographic,and,residential,information,on,all,residents,of,Ontario,.}	{NULL}
journal.pmed.1001425.pdf	79	{The,johns,Hopkins,Adjusted,Clinical,Groups,(,ACG,),System,[,15,],was,used,to,create,separate,case-mix,categories,(,known,as,collapsed,ambulatory,diagnostic,groups,[,CADGs,],),that,reﬂect,an,individual,’s,underlying,level,of,morbidity,.}	{NULL}
journal.pmed.1001425.pdf	80	{These,groups,were,created,using,diagnostic,codes,from,hospitalization,records,and,physicians,’,services,claims,from,the,period,2,y,prior,to,but,excluding,the,delivery,date,.}	{NULL}
journal.pmed.1001425.pdf	81	{This,system,is,a,widely,used,method,for,case-mix,adjustment,and,correlates,well,with,health,care,utilization,.}	{NULL}
journal.pmed.1001425.pdf	82	{The,stable,chronic,medical,category,includes,a,variety,of,chronic,conditions,such,as,hypercholesterolemia,",",mitral,valve,disorders,",",atrioventricular,block,",",and,simple,chronic,bronchitis,.}	{NULL}
journal.pmed.1001425.pdf	83	{The,unstable,chronic,disease,includes,such,conditions,as,ischemic,heart,disease,",",chronic,obstructive,lung,disease,",",chronic,liver,disease,",",chronic,kidney,disease,",",and,malignancy,",",among,others,(,see,Table,S1,for,a,listing,of,all,categories,),.}	{NULL}
journal.pmed.1001425.pdf	84	{Diagnostic,codes,for,diabetes,and,hypertension,were,not,included,in,the,creation,of,the,case-mix,categories,.}	{NULL}
journal.pmed.1001425.pdf	85	{Hypertension,prior,to,pregnancy,was,assessed,using,the,Ontario,Hypertension,Database,",",a,validated,database,that,identiﬁes,all,individuals,in,Ontario,who,have,been,diagnosed,with,hypertension,with,sensitivity,of,73,%,and,a,speciﬁcity,of,95,%,[,16,],.}	{NULL}
journal.pmed.1001425.pdf	86	{For,the,purpose,of,our,study,",",a,woman,was,identiﬁed,to,have,prior,hypertension,if,the,diagnosis,date,was,greater,than,280,d,before,the,delivery,.}	{NULL}
journal.pmed.1001425.pdf	87	{Women,found,to,be,in,the,Hypertension,Database,and,diagnosed,with,GH,were,removed,from,the,cohort,","}	{NULL}
journal.pmed.1001425.pdf	88	{as,women,",",by,deﬁnition,",",can,not,have,GH,and,have,hypertension,prior,to,pregnancy,.}	{NULL}
journal.pmed.1001425.pdf	89	{Information,on,individual-level,income,was,not,available,in,our,data,sources,;,therefore,",",neighborhood,characteristics,derived,from,the,Canadian,census,were,used,as,a,proxy,.}	{NULL}
journal.pmed.1001425.pdf	90	{The,median,household,income,level,of,each,woman,’s,neighborhood,of,residence,was,attributed,to,them,using,their,postal,code,at,the,time,of,their,delivery,.}	{NULL}
journal.pmed.1001425.pdf	91	{Baseline,parity,was,only,available,for,a,subgroup,of,women,in,our,cohort,who,delivered,between,April,1,",",2002,and,March,31,",",2008,",",therefore,a,sensitivity,analysis,was,performed,in,this,subset,to,assess,the,inﬂuence,of,parity,on,the,association,between,PEG,and,diabetes,incidence,.}	{NULL}
journal.pmed.1001425.pdf	92	{To,test,whether,the,severity,of,PEG,modiﬁed,the,association,between,PEG,and,diabetes,incidence,",",we,stratiﬁed,our,population,of,women,with,this,condition,(,with,or,without,concomitant,GDM,),on,the,basis,of,whether,or,not,they,had,a,premature,delivery,.}	{NULL}
journal.pmed.1001425.pdf	93	{Statistical,Analysis,We,calculated,descriptive,statistics,and,used,one-way,AN,OVA,",",the,Kruska1,—,"\\\\",/,Vallis,test,",",and,the,chi-square,test,to,compare,the,baseline,characteristics,of,women,in,our,different,exposure,groups,.}	{NULL}
journal.pmed.1001425.pdf	94	{Incidence,rates,were,expressed,on,the,basis,of,the,number,of,new,cases,of,diabetes,per,"1,000",person-years,of,follow-up,.}	{NULL}
journal.pmed.1001425.pdf	95	{A,Cox,proportional,hazards,model,was,used,to,examine,the,impact,of,PEG,",",GH,",",or,GDM,(,with,or,without,concomitant,PEG,or,GH,),on,the,risk,of,developing,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	96	{Women,were,censored,when,follow-up,was,terminated,;,this,happened,at,the,time,of,death,",",loss,of,health,care,coverage,if,the,women,moved,out,of,the,province,",",if,they,experienced,an,outcome,event,",",or,at,the,end,of,the,observation,window,.}	{NULL}
journal.pmed.1001425.pdf	97	{The,covariates,included,in,our,model,were,age,",",socioeconomic,status,",",hypertension,(,prior,to,pregnancy,),",",comorbidity,",",and,parity,(,for,the,subset,of,women,for,whom,it,was,available,),.}	{NULL}
journal.pmed.1001425.pdf	98	{The,proportional,hazards,assumption,was,tested,[,17,],",",and,interaction,terms,using,a,time-dependent,covariate,were,inserted,into,the,model,in,a,second,sensitivity,analysis,.}	{NULL}
journal.pmed.1001425.pdf	99	{Parity,was,felt,to,be,an,important,covariate,but,was,only,available,after,2002,.}	{NULL}
journal.pmed.1001425.pdf	100	{For,this,reason,a,sensitivity,analysis,was,done,to,assess,the,inﬂuence,of,parity,on,the,risk,of,development,of,diabetes,during,the,period,after,2002,.}	{NULL}
journal.pmed.1001425.pdf	101	{"\\\\",/,V,omen,with,PEG,who,deliver,early,are,considered,to,have,more,severe,PEG,.}	{NULL}
journal.pmed.1001425.pdf	102	{Using,PEG,along,with,preterm,delivery,as}	{NULL}
journal.pmed.1001425.pdf	103	{Number,of,births,in,Ontario,from,April,1994,to}	{NULL}
journal.pmed.1001425.pdf	104	{March,2008,(,n,=,"1,709,019",)}	{NULL}
journal.pmed.1001425.pdf	105	{jm,.}	{NULL}
journal.pmed.1001425.pdf	106	{Total,recruited,(,n,=,"1,562,564",)}	{NULL}
journal.pmed.1001425.pdf	107	{Final,sample,of,women,available,for,analysis}	{NULL}
journal.pmed.1001425.pdf	108	{(,n,=,"1,010,068",)}	{NULL}
journal.pmed.1001425.pdf	109	{a,proxy,for,PEG,severity,",",we,performed,a,sub-analysis,.}	{NULL}
journal.pmed.1001425.pdf	110	{Number,needed,to,follow,was,also,calculated,among,a,random,sample,of,"100,000",women,[,18,],.}	{NULL}
journal.pmed.1001425.pdf	111	{The,analyses,were,done,using,SAS,version,92,(,SAS,Institute,Inc,),.}	{NULL}
journal.pmed.1001425.pdf	112	{Results}	{NULL}
journal.pmed.1001425.pdf	113	{A,total,of,"1,709,019",deliveries,were,captured,in,Ontario,from,April,1994,to,March,2008,.}	{NULL}
journal.pmed.1001425.pdf	114	{Among,those,that,were,excluded,from,the,study,",",1.3,%,had,pregestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	115	{A,further,7.3,%,were,excluded,because,they,were,not,Ontario,residents,or,lacked,coverage,under,Ontario,’s,Health,Insurance,Plan,for,a,full,2,y,prior,to,delivery,(,see,Figure,1,),.}	{NULL}
journal.pmed.1001425.pdf	116	{Among,the,"1,010,068",pregnant,women,available,for,analysis,",","22,933",cases,of,PEG,alone,",","27,605",cases,of,GH,alone,",","30,852",cases,of,GDM,alone,",","2,100",cases,of,GDM+GH,",",and,"1,476",cases,of,GDM+PEG,were,identiﬁed,.}	{NULL}
journal.pmed.1001425.pdf	117	{The,range,of,follow-up,was,1,d,to,16.5,y,",",with,a,median,follow-up,of,8.5,y.,Overall,"35,077",women,developed,diabetes,(,3.5,%,),.}	{NULL}
journal.pmed.1001425.pdf	118	{Demographic,and,clinical,characteristics,of,women,included,in,the,study,",",stratiﬁed,by,their,PEG,",",GH,",",and,GDM,status,is,presented,in,Table,1,.}	{NULL}
journal.pmed.1001425.pdf	119	{"\\\\",/,V,omen,with,GDM,tended,to,be,older,and,were,more,often,in,the,lowest,income,quintile,.}	{NULL}
journal.pmed.1001425.pdf	120	{Previous,hypertension,was,more,common,in,women,with,GH,or,PEG,than,women,without,either,",",particularly,if,they,had,concomitant,GDM,.}	{NULL}
journal.pmed.1001425.pdf	121	{The,level,of,co-morbidity,was,low,across,all,groups,but,somewhat,higher,in,those,with,GDM+GH,and,GDM+PEG,compared,to,women,without,these,conditions,.}	{NULL}
journal.pmed.1001425.pdf	122	{The,unadjusted,cumulative,incidence,of,diabetes,",",stratiﬁed,by,GDM,",",GH,",",and,PEG,status,",",is,presented,in,Figure,2,.}	{NULL}
journal.pmed.1001425.pdf	123	{Among,women,in,our,cohort,",",both,PEG,and,GH,were,associated,with,an,elevated,cumulative,probability,of,developing,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	124	{Women,with,GDM,had,an,even,higher,cumulative,probability,of,developing,diabetes,but,this,appeared,to,be,heightened,by,the,co-presence,of,PEG,or,GH,.}	{NULL}
journal.pmed.1001425.pdf	125	{The,incidence,rate,of,diabetes,per,"1,000",person-years,is,illustrated,in,Table,2,.}	{NULL}
journal.pmed.1001425.pdf	126	{Women,with,GH,or,PEG,had,higher,incidence,rates,of,diabetes,than,those,without,either,(,5.26,per,"1,000",person-years,",",6.47,per,"1,000",person-years,",",and,2.81,per,"1,000",person-years,",",respectively,),.}	{NULL}
journal.pmed.1001425.pdf	127	{Those,with,GDM,had,a,much,higher,incidence,rate,than,those,without,GDM,.}	{NULL}
journal.pmed.1001425.pdf	128	{Women,with,GDM,and,either,PEG,or,GH,had,a,higher,incidence,rate,than}	{NULL}
journal.pmed.1001425.pdf	129	{EXCLUDED,(,Total,=,"146,455",),:,-,Invalid,postal,code,(,n,=,"2,007",),-,No,health,insurance,*,(,n,=,"122,731",),-,Pregestational,diabetes,(,n,=,"21,411",),-,Data,quality,(,n,=,306,)}	{NULL}
journal.pmed.1001425.pdf	130	{OBSERVATIONS,REMOVED,(,Total,=,"552,496",),:,-,Number,of,multiple,births,by,women,",",one,chosen,at,random,(,n,=,"548,398",),-,Defined,as,having,both,gestational,hypertension,and,hypertension,(,n,=,"4,098",)}	{NULL}
journal.pmed.1001425.pdf	131	{Figure,1,.}	{NULL}
journal.pmed.1001425.pdf	132	{Cohort,flow,chart,illustrating,the,inclusion,and,exclusion,of,participants,into,the,study,.}	{NULL}
journal.pmed.1001425.pdf	133	{*,Mothers,either,lacked,coverage,under,Ontario,'s,Health,Insurance,Plan,at,the,admission,delivery,date,or,had,health,insurance,for,less,than,2,y,prior,to,their,delivery,.}	{NULL}
journal.pmed.1001425.pdf	134	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	135	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	136	{g0O1}	{NULL}
journal.pmed.1001425.pdf	137	{3,April,2013,|,Volume,10,|,Issue,4,|,e1001425}	{NULL}
journal.pmed.1001425.pdf	138	{Table,1,.}	{NULL}
journal.pmed.1001425.pdf	139	{Demographic,and,clinical,characteristics,of,women,stratified,by,gestational,diabetes,diagnosis,.}	{NULL}
journal.pmed.1001425.pdf	140	{Women,with,No,GDM}	{NULL}
journal.pmed.1001425.pdf	141	{Women,with,GDM}	{NULL}
journal.pmed.1001425.pdf	142	{Characteristics,p-Value,n,No,GH,or,PEC,n,GDM,(,%,),(,%,),n,GH,(,%,),n,PEC,(,%,),Alone,n,GDM+GH,(,%,),n,GDM+PEC,(,%,)}	{NULL}
journal.pmed.1001425.pdf	143	{n,=,"925,102",n,=,"27,605",n,=,"22,933",n,=,"30,852",n,:,"2,100",n,:,"1,476"}	{NULL}
journal.pmed.1001425.pdf	144	{Age,in,years,mean,(,SD,),29.54,(,5.58,),29.55,(,5.76,),29.51,5.88,),32.15,(,5.17,),32.01,(,5.54,),31.64,(,5.73,),<,0.001,Income,quintile,",",n,(,%,),<,0.001,1,(,lowest,),"201,597",(,21.8,),"5,598",(,20.3,),"4,901",21.4,),"8,236",(,26.7,),540,(,25.7,),387,(,26.2,)}	{NULL}
journal.pmed.1001425.pdf	145	{4,"187,369",(,20.3,),"5,721",(,20.7,),"4,667",20.4,),"5,640",(,18.3,),379,(,18.0,),272,(,18.4,),5,(,highest,),"156,503",(,16.9,),"4,616",(,16.7,),"3,694",16.1,),"3,728",(,12.1,),308,(,14.7,),172,(,11.7,),Missing,"3,456",(,0.4,),114,(,0.4,),133,(,0.6,),162,(,0.5,),16,(,0.8,),16,(,1.1,),Prior,hypertension,"12,447",(,1.3,),o,(,o.,o,),"1,458",6.4,),988,(,3.2,),o,(,o.,o,),146,(,9.9,),<,0.001,Co-morbidity,CADG,index,“,Chronic,medical,unstable,"94,212",(,10.2,),"3,103",(,11.2,),"2,854",12.4,),"5,443",(,17.6,),489,(,23.3,),346,(,23.4,),<,0.001,Chronic,medical,stable,"205,115",(,22.2,),"7,090",(,25.7,),"6,221",27.1,),"9,231",(,29.9,),667,(,31.8,),538,(,36.4,),<,0.001}	{NULL}
journal.pmed.1001425.pdf	146	{aNote,only,the,two,collapsed,ambulatory,diagnostic,groups,(,CADGS,),relating,to,chronic,medical,conditions,are,presented,in,Table,1,.}	{NULL}
journal.pmed.1001425.pdf	147	{Nine,other,CADGs,",",relating,to,other,categories,of,medical,conditions,",",were,included,in,the,fully,adjusted,models,.}	{NULL}
journal.pmed.1001425.pdf	148	{Pregnancy,",",however,",",was,excluded,.}	{NULL}
journal.pmed.1001425.pdf	149	{See,Table,S1,.}	{NULL}
journal.pmed.1001425.pdf	150	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	151	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	152	{t001}	{NULL}
journal.pmed.1001425.pdf	153	{women,with,GDM,alone,(,55.02,per,"1,000",person-years,",",55.09,per,"1,000",person-years,versus,39.77,per,"1,000",person-years,",",respectively,),.}	{NULL}
journal.pmed.1001425.pdf	154	{The,mean,age,at,diagnosis,of,diabetes,overall,was,37.34,",",with,a,median,age,of,37.0,.}	{NULL}
journal.pmed.1001425.pdf	155	{The,number,needed,to,follow,for,5,y,to,detect,one,case,of,diabetes,was,"4,511",for,GH,alone,",",123,for,PEC,alone,",",68,for,GDM,alone,",",105,for,GDM+GH,",",and,31,for,GDM+PEC,(,see,Table,3,),.}	{NULL}
journal.pmed.1001425.pdf	156	{In,the,unadjusted,Cox,proportional,hazards,model,",",women,who,had,GH,or,PEC,during,pregnancy,had,double,the,risk,of,developing,diabetes,in,the,16.5,y,following,delivery,",",compared,to,women,who,had,neither,during,pregnancy,(,Table,2,),.}	{NULL}
journal.pmed.1001425.pdf	157	{Women,with,GDM,had,a,15-fold,increased,rate,of,developing,diabetes,over,those,without,GDM,",",PEC,",",or,GH,",",while,women,with,GDM+PEC,and,GDM+GH,during,pregnancy,had,the,highest,rates,with,a,20to,21-fold,increased,rate,.}	{NULL}
journal.pmed.1001425.pdf	158	{These,effects,were,only,modestly,reduced,after,adjusting,for,age,",",income,quintile,",",hypertension,prior,to,pregnancy,",",and,co-morbidity,",",(,hazard,ratio,[,HR,],1.95,[,1.83,—,2.07,],for,GH,alone,",",HR,2.08,[,l.,97,—,2,.}	{NULL}
journal.pmed.1001425.pdf	159	{l9,],for,PEC,alone,",",HR,12.77,[,l2,.44,~,l3,.10,],for,GDM,alone,",",HR,18.49,[,17,.}	{NULL}
journal.pmed.1001425.pdf	160	{l2,*,19.96,],for,GDM+GH,",",HR,15.75,[,14.52,—,l7,.07,],for,GDM+PEC,),(,Table,2,),.}	{NULL}
journal.pmed.1001425.pdf	161	{See,Table,S2,for,the,number,of,women,at,risk,at,the,end,of,each,follow-up,year,.}	{NULL}
journal.pmed.1001425.pdf	162	{A,sensitivity,analysis,was,done,to,assess,the,inﬂuence,of,parity,on,the,risk,of,development,of,diabetes,using,data,from,2002,—,2008,.}	{NULL}
journal.pmed.1001425.pdf	163	{The,association,between,future,DM,and,GH/PEC,and,GDM,became,even,stronger,when,adjusting,for,parity,(,along,with,age,",",income,quintile,",",prior,hypertension,",",and,co-morbidity,),(,HR,for,GH,alone,1.82,[,95,%,CI,l.,63,—,2.03,],",",HR,for,PEC,alone,1.92,[,95,%,CI,1.63,—,2.28,],",",HR,for,GDM,alone,16.56,[,95,%,CI,l5,',81,—,l7,.34,],",",HR,for,GDM+GH,23.48,[,2l,.01,—,26.24,],",",HR,for,GDM+PEC,22.53,[,l8,.54,~,27.38,],),.}	{NULL}
journal.pmed.1001425.pdf	164	{In,the,second,sensitivity,analysis,",",a,time-dependent,covariate,was,added,into,the,adjusted,model,as,an,interaction,term,.}	{NULL}
journal.pmed.1001425.pdf	165	{There,was,a,time-varying,effect,among,the,groups,on,the,risk,of,developing,diabetes,",",especially,those,with,GDM,.}	{NULL}
journal.pmed.1001425.pdf	166	{The,risk,for,developing,diabetes,in,women,with,GH,and,PEG,stayed,fairly,stable,at,the,2-y,",",and,median,follow-up,times,(,GH,HR,=,1.99,for,all,times,;,PEC,HR,=,2.26,and,HR,=,2.01,",",respectively,),.}	{NULL}
journal.pmed.1001425.pdf	167	{For,those,with,GDM,",",however,",",the,risk,of,developing,diabetes,decreased,over,time,compared,with,the,women,without,GH/PEC,or,GDM,(,HR,=,19.09,at,2,y,",",HR,=,8.20,",",at,median,follow-up,of,8.5,y,),.}	{NULL}
journal.pmed.1001425.pdf	168	{Similar,patterns,were,seen,in,the,GDM+GH,and,the,GDM+PEC,groups,(,HR,=,25.28,",",HR,=,12.86,;,and,HR,=,24.54,",",HR,=,11.13,",",at,2,and,8.5,y,",",respectively,),.}	{NULL}
journal.pmed.1001425.pdf	169	{A,sub-analysis,was,performed,looking,at,PEC,severity,by,assessing,PEC,along,with,preterm,delivery,.}	{NULL}
journal.pmed.1001425.pdf	170	{There,was,a,trend,towards,a,greater,incidence,of,diabetes,among,women,with,PEG,who,had,a,preterm,delivery,(,Figure,3,),.}	{NULL}
journal.pmed.1001425.pdf	171	{Those,women,with,GDM,and,PEG,and,preterm,delivery,experienced,the,highest,risk,of,developing,diabetes,",",HR,30.73,(,95,%,CI,23.73,—,39.78,),(,Figure,3,),.}	{NULL}
journal.pmed.1001425.pdf	172	{Discussion}	{NULL}
journal.pmed.1001425.pdf	173	{In,this,study,the,presence,of,PEG,or,GH,",",in,the,absence,of,GDM,",",was,associated,with,a,2-fold,increased,incidence,of,diabetes,when,followed,up,to,16.5,years,after,pregnancy,",",after,controlling,for,several,important,confounding,variables,.}	{NULL}
journal.pmed.1001425.pdf	174	{In,the,setting,of,GDM,",",these,conditions,were,associated,with,a,further,elevation,in,diabetes,risk,",",over,and,above,the,already,substantial,(,~,13-fold,),increase,resulting,from,GDM,alone,.}	{NULL}
journal.pmed.1001425.pdf	175	{This,risk,was,even,higher,in,the,setting,of,preterm,delivery,",",suggesting,that,diabetes,incidence,rises,with,increasing,severity,of,these,hypertensive,disorders,.}	{NULL}
journal.pmed.1001425.pdf	176	{These,ﬁndings,highlight,a,possible,new,risk,factor,for,diabetes,",",and,support,the,need,to,counsel,patients,with,hypertensive,disorders,of,pregnancy,regarding,postpartum,diabetes,screening,prevention,.}	{NULL}
journal.pmed.1001425.pdf	177	{Common,pathogenic,pathways,may,underlie,the,association,between,both,GDM,and,PEC/GH,leading,to,an,increased,risk,of,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	178	{Firstly,",",each,of,these,conditions,is,associated,with,insulin,resistance,[,"7,8,1","1,19,20",],.}	{9|10}
journal.pmed.1001425.pdf	179	{Not,only,do,women,with,PEC/GH,have,insulin,resistance,during,pregnancy,",",several,studies,have,also,found,higher,levels,of,insulin,resistance,in,women,with,a,history,of,PEC/GH,years,after,delivery,",",even,after,controlling,for,body,mass,index,and,excluding,women,with,previous,GDM,[,"21,22",],.}	{NULL}
journal.pmed.1001425.pdf	180	{Women,with,a,history,of,PEC/GH,also,show,manifestations,of,the}	{NULL}
journal.pmed.1001425.pdf	181	{0.2,Cumulative,probability,of,diabetes,mellitus,0.1}	{NULL}
journal.pmed.1001425.pdf	182	{.....,.....,.....,.....,.....,.....,.....,.....,.....,.....,.....,....,“,Gestational,hyertension}	{NULL}
journal.pmed.1001425.pdf	183	{Fol,low-up,(,years,),*}	{NULL}
journal.pmed.1001425.pdf	184	{Gestational,hypertension,+,GDM}	{NULL}
journal.pmed.1001425.pdf	185	{`,P,Pre,—,ec,|,ampsia,+,GDM}	{NULL}
journal.pmed.1001425.pdf	186	{GDM}	{NULL}
journal.pmed.1001425.pdf	187	{Pre-eclampsia}	{NULL}
journal.pmed.1001425.pdf	188	{No,hypertension,or,GDM}	{NULL}
journal.pmed.1001425.pdf	189	{Figure,2,.}	{NULL}
journal.pmed.1001425.pdf	190	{Cumulative,future,risk,of,diabetes,mellitus,in,association,with,a,pregnancy,affected,by,preeclampsia,",",gestational,hypertension,",",and,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	191	{*,Fo,|,|,ow,—,up,period,begins,180,d,postpartum,.}	{NULL}
journal.pmed.1001425.pdf	192	{This,figure,was,produced,using,a,competing,risk,method,.}	{NULL}
journal.pmed.1001425.pdf	193	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	194	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	195	{g0O2}	{NULL}
journal.pmed.1001425.pdf	196	{metabolic,syndrome,years,after,delivery,",",a,syndrome,known,for,its,association,with,insulin,resistance,[,23,—,26,],.}	{13|14}
journal.pmed.1001425.pdf	197	{Endothelial,dysfunction,and,markers,of,chronic,vascular,inﬂammation,have,been,found,in,women,with,PEG,as,well,as,women,with,GDM,",",both,during,and,after,pregnancy,[,27,—,30,],.}	{NULL}
journal.pmed.1001425.pdf	198	{These,entities,have,been,shown,to,precede,the,development,of,overt,hyperglycemia,in,patients,at,risk,for,type,2,diabetes,[,30,],.}	{NULL}
journal.pmed.1001425.pdf	199	{"\\\\",/,V,e,hypothesize,that,these,common,mediators,are,likely,to,increase,the,risk,of,type,2,diabetes,in,women,with,a,history,of,PEG,.}	{NULL}
journal.pmed.1001425.pdf	200	{We,found,that,the,risk,of,developing,diabetes,over,the,years,was,stable,for,those,with,GH,and,PEG,alone,;,however,",",the,risk,decreased,over,time,in,women,with,GDM,.}	{NULL}
journal.pmed.1001425.pdf	201	{It,may,be,that,those,with,a,very,high,risk,develop,diabetes,early,on,.}	{NULL}
journal.pmed.1001425.pdf	202	{Those,who,remain,have,an,inherently,lower,risk,leading,to,the,lower,HR,ratio,observed,.}	{NULL}
journal.pmed.1001425.pdf	203	{This,finding,is,consistent,with,what,we,know,about,the,natural,history,of,diabetes,postpartum,.}	{NULL}
journal.pmed.1001425.pdf	204	{Some,groups,develop,diabetes,at,a,very,high,rate,early,on,(,50,%,within,5,y,of,delivery,),[,31,],.}	{NULL}
journal.pmed.1001425.pdf	205	{Three,previous,studies,looked,at,the,risk,of,developing,type,2,diabetes,in,women,with,a,history,of,PEC/GH,.}	{NULL}
journal.pmed.1001425.pdf	206	{In,one,study,",",women,enrolled,in,the,Mater,.}	{NULL}
journal.pmed.1001425.pdf	207	{—,.}	{NULL}
journal.pmed.1001425.pdf	208	{University,of,Queensland,Study,of,Pregnancy,between,1981,and,1984,who,had,PEC/GH,at,baseline,were,1.76,times,more,likely,to,report,having,developing,diabetes,21,y,later,[,32,],.}	{NULL}
journal.pmed.1001425.pdf	209	{However,",",approximately,one-half,of,their,original,cohort,were,lost,to,follow-up,.}	{NULL}
journal.pmed.1001425.pdf	210	{In,a,Danish,cohort,of,women,with,PEG,or,GH,",",the,risk,of,diabetes,postpartum,was,also,found,to,be,increased,over,a,median,of,14.6,years,[,33,],.}	{NULL}
journal.pmed.1001425.pdf	211	{Neither,of,these,preceding,studies,were,able,to,isolate,the,risk,imparted,by,PEC,/,GH,from,that,of,GDM,.}	{NULL}
journal.pmed.1001425.pdf	212	{A,third,registry,study,of,women,with,PEC,in,Norway,also,found,an,increased,risk,of,diabetes,in,women,with,PEC,",",however,follow-up,was,short,",",only,3.7,y,",",and,the,diagnosis,of,diabetes,was,made,in,women,using,medications,for,diabetes,",",possibly,under-estimating,the,true,incidence,of,diabetes,[,34,],.}	{NULL}
journal.pmed.1001425.pdf	213	{Strengths,of,our,study,include,that,this,study,was,a,large,",",population-based,study,with,long,and,complete,follow-up,(,over}	{NULL}
journal.pmed.1001425.pdf	214	{Table,2,.}	{NULL}
journal.pmed.1001425.pdf	215	{Multivariable,Cox,proportional,hazards,models,evaluating,the,relationship,among,preeclampsia,",",gestational,hypertension,",",and,gestational,diabetes,in,the,development,of,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	216	{n,Developed,Incidence,Rate,per}	{NULL}
journal.pmed.1001425.pdf	217	{Characteristic,Diabetes,(,%,),"1,000",Person-Years,Unadjuﬂed,Analysis,Adjusmd,Anawsisa}	{NULL}
journal.pmed.1001425.pdf	218	{HR,(,95,°,/,o,CI,),HR,(,95,°,/,o,CI,)}	{NULL}
journal.pmed.1001425.pdf	219	{No,GDM,",",GH,",",or,PEC,"23,108",(,2.5,),2.81,1,(,ref,),1,(,ref,),GH,alone,"1,085",(,3.9,),5.26,1.96,(,1.84,—,2.08,),1.95,(,1.83,—,2.07,),PEC,alone,"1,510",(,6.6,),6.47,2.25,(,2.14,—,2.37,),2.08,(,1.97,—,2.19,),GDM,alone,"8,082",(,26.2,),39.77,14.83,(,14.46,—,15.22,),12.77,(,12.44,—,13.10,),GDM+GH,681,(,32.4,),55.09,21.06,(,19.51,—,22.73,),18.49,(,17.12,—,19.96,),GDM+PEC,611,(,41.4,),55.02,19.80,(,18.27,—,21.45,),15.75,(,14.52,—,17.07,),aAdjusted,for,age,",",income,quintile,",",prior,hypertension,",",and,co,—,morbidity,using,John,Hopkins,collapsed,ambulatory,diagnostic,groups,(,CADG,),.}	{NULL}
journal.pmed.1001425.pdf	220	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	221	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	222	{tOO2}	{NULL}
journal.pmed.1001425.pdf	223	{Table,3,.}	{NULL}
journal.pmed.1001425.pdf	224	{Number,needed,to,follow,.}	{NULL}
journal.pmed.1001425.pdf	225	{F,°,"\\"",°,w_uP,Period,Number,Needed,to,Follow,",",n}	{NULL}
journal.pmed.1001425.pdf	226	{GH,PEC,GDM,GDM+GH,GDM+PEC}	{NULL}
journal.pmed.1001425.pdf	227	{2,y,"13,109","263 150 241",67,S,y,"4,511",123,68,105,31,8.5,y,(,median,),"2,332",83,44,66,21,16.5,(,maximum,),"1,152",60,29,41,15}	{NULL}
journal.pmed.1001425.pdf	228	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	229	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	230	{tOO3}	{NULL}
journal.pmed.1001425.pdf	231	{"1,000,000",women,followed,for,up,to,16.5,y,),.}	{NULL}
journal.pmed.1001425.pdf	232	{Our,study,also,examined,the,risk,of,diabetes,associated,with,both,GH,and,PEG,",",while,controlling,for,the,presence,of,GDM,",",and,examined,the,combined,impact,of,GDM,and,PEC/GH,together,.}	{NULL}
journal.pmed.1001425.pdf	233	{We,were,also,able,to,examine,the,severity,of,PEG,with,the,addition,of,preterm,delivery,.}	{NULL}
journal.pmed.1001425.pdf	234	{Some,limitations,of,this,study,include,our,inability,to,adjust,for,clinical,factors,",",in,particular,",",obesity,",",which,in,itself,is,associated,with,insulin,resistance,",",and,is,a,well-known,risk,factor,for,the,development,of,GDM,[,35,],and,PEG,[,36,],.}	{NULL}
journal.pmed.1001425.pdf	235	{Obesity,is,not,well,captured,in,our,inpatient,hospitalization,database,",",nor,is,it,well,coded,in,our,outpatient,database,",",which,is,based,on,physician,outpatient,billing,codes,.}	{NULL}
journal.pmed.1001425.pdf	236	{Furthermore,",",family,history,",",physical,activity,",",glucose,",",and,blood,pressure,measures,are,also,known,risk,factors,.}	{NULL}
journal.pmed.1001425.pdf	237	{We,were,",",however,",",able,to,adjust,for,several,other}	{NULL}
journal.pmed.1001425.pdf	238	{Hazard,Ratio}	{NULL}
journal.pmed.1001425.pdf	239	{Exposure,Groups,.}	{NULL}
journal.pmed.1001425.pdf	240	{_}	{NULL}
journal.pmed.1001425.pdf	241	{(,95,%,confidence,Interval,)}	{NULL}
journal.pmed.1001425.pdf	242	{No,gestational,diabetes,",",gestational,hypertension,",",preeclampsia}	{NULL}
journal.pmed.1001425.pdf	243	{100,Reference,1.51,(,1.38,to,1.66,)}	{NULL}
journal.pmed.1001425.pdf	244	{1.81,(,1.61,to,2.03,)}	{NULL}
journal.pmed.1001425.pdf	245	{Gestational,hypertension}	{NULL}
journal.pmed.1001425.pdf	246	{2.60,(,1.99,to,3.39,)}	{NULL}
journal.pmed.1001425.pdf	247	{1.82,(,1.43,to,2.31,)}	{NULL}
journal.pmed.1001425.pdf	248	{Pre,—,ec,|,ampsia}	{NULL}
journal.pmed.1001425.pdf	249	{2.23,(,1.77,to,2.82,)}	{NULL}
journal.pmed.1001425.pdf	250	{16.87,(,16.06,to,17.71,),20.68,(,18.65,to,22.92,)}	{NULL}
journal.pmed.1001425.pdf	251	{Gestational,diabetes}	{NULL}
journal.pmed.1001425.pdf	252	{24.61,(,21.77,to,27.82,),23.27,(,18.20,to,29.75,)}	{NULL}
journal.pmed.1001425.pdf	253	{Gestational,diabetes,",",gestational,hypertension}	{NULL}
journal.pmed.1001425.pdf	254	{18.82,(,14.11,to,25.10,),30.73,(,23.73,to,39.78,)}	{NULL}
journal.pmed.1001425.pdf	255	{Gestational,diabetes,",",preeclampsia,important,confounding,variables,including,maternal,age,",",prior,hypertension,",",income,quintile,",",parity,",",and,co-morbidity,.}	{1|8}
journal.pmed.1001425.pdf	256	{One,previous,study,was,able,to,adjust,for,obesity,and,physical,activity,",",and,the,risk,of,developing,diabetes,was,still,signiﬁcant,[,30,],.}	{NULL}
journal.pmed.1001425.pdf	257	{From,our,data,sources,we,could,not,differentiate,type,1,from,',ype,2,diabetes,;,however,",",given,the,mean,age,at,diagnosis,was,37.4,y,",",it,is,most,likely,that,the,majority,of,the,women,developed,',ype,2,diabetes,in,the,years,after,pregnancy,.}	{NULL}
journal.pmed.1001425.pdf	258	{Women,with,a,history,of,GDM,may,be,offered,routine,glucose,testing,postpartum,",",thus,leading,to,more,diagnoses,of,diabetes,compared,with,women,with,a,history,of,PEC,.}	{NULL}
journal.pmed.1001425.pdf	259	{This,situation,may,have,led,to,under-reporting,of,diabetes,in,women,with,a,history,of,PEG,;,therefore,the,rate,of,development,of,diabetes,in,these,women,may,even,be,higher,than,reported,.}	{NULL}
journal.pmed.1001425.pdf	260	{Follow-up,of,women,with,hypertensive,disease,in,pregnancy,may,lead,to,more,interactions,with,the,health,care,system,compared,to,women,without,hypertensive,diseases,in,pregnancy,",",thus,leading,to,more,diabetes,testing,and,diagnosis,and,a,possible,bias,towards,overestimating,the,risk,;,however,",",there,is,currently,no,standard,recommendation,to,screen,women,with,GH/PEC,for,diabetes,postpartum,.}	{NULL}
journal.pmed.1001425.pdf	261	{Our,capture,of,GH,and,PEG,may,have,been,incomplete,.}	{NULL}
journal.pmed.1001425.pdf	262	{In,a,study,looking,at,the,accuracy,of,hospital,data,in,the,perinatal,period,using,ICD-lo,codes,",",when,diagnosing,GH,and,PEG,",",sensitivity,was,reduced,(,58.6,%,and,50.0,%,",",respectively,),",",however,speciﬁcity,was,excellent,(,99,%,and,99.8,%,",",respectively,),[,37,],.}	{NULL}
journal.pmed.1001425.pdf	263	{Finally,",",the,algorithms,used,to,describe,a,number,of,the,variables,used,in,the,study,(,GDM,",",PEC,",",GH,),have,not,been,formally,validated,.}	{NULL}
journal.pmed.1001425.pdf	264	{I-O-I,oTenn,delivery}	{NULL}
journal.pmed.1001425.pdf	265	{Preterm,delivery}	{NULL}
journal.pmed.1001425.pdf	266	{I-O-I,Izozl}	{NULL}
journal.pmed.1001425.pdf	267	{I,.}	{NULL}
journal.pmed.1001425.pdf	268	{—,". . .",—,.}	{NULL}
journal.pmed.1001425.pdf	269	{I,n,—,<,»,u}	{NULL}
journal.pmed.1001425.pdf	270	{O,I,-,<,>,-,I}	{NULL}
journal.pmed.1001425.pdf	271	{I-O-I,|,é,),.}	{NULL}
journal.pmed.1001425.pdf	272	{—,.}	{NULL}
journal.pmed.1001425.pdf	273	{I}	{NULL}
journal.pmed.1001425.pdf	274	{|,:,.}	{NULL}
journal.pmed.1001425.pdf	275	{:,I}	{NULL}
journal.pmed.1001425.pdf	276	{I,.}	{NULL}
journal.pmed.1001425.pdf	277	{—,.}	{NULL}
journal.pmed.1001425.pdf	278	{(,),.}	{NULL}
journal.pmed.1001425.pdf	279	{—,.}	{NULL}
journal.pmed.1001425.pdf	280	{I}	{NULL}
journal.pmed.1001425.pdf	281	{Hazard,Ratio}	{NULL}
journal.pmed.1001425.pdf	282	{Figure,3,.}	{NULL}
journal.pmed.1001425.pdf	283	{Sub-analysis,modeling,the,relationship,among,preeclampsia,",",gestational,hypertension,",",gestational,diabetes,",",and,preterm,delivery,in,the,development,of,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	284	{Model,also,adjusts,for,age,",",income,quintile,",",prior,hypertension,",",and,co,—,morbidity,using,the,Johns,Hopkins,collapsed,ambulatory,diagnostic,group,(,CADG,),.}	{NULL}
journal.pmed.1001425.pdf	285	{The,bands,represent,95,%,conﬁdence,intervals,.}	{NULL}
journal.pmed.1001425.pdf	286	{doi,:,l0,.1371,/,journa,|,.}	{NULL}
journal.pmed.1001425.pdf	287	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	288	{g0O3}	{NULL}
journal.pmed.1001425.pdf	289	{April,2013,|,Volume,10,|,Issue,4,|,elOOl425}	{NULL}
journal.pmed.1001425.pdf	290	{In,summary,",",in,this,large,",",population-based,study,",",we,found,that,the,presence,of,either,PEC,or,GH,during,pregnancy,were,strong,predictors,for,the,development,of,diabetes,years,following,the,pregnancy,",",and,the,presence,of,PEC,or,GH,in,a,woman,with,a,history,of,GDM,increased,the,risk,of,diabetes,over,and,above,that,observed,with,GDM,alone,.}	{NULL}
journal.pmed.1001425.pdf	291	{These,ﬁndings,have,important,implications,for,maternal,health,",",especially,given,the,increase,in,obesity-related,diseases,.}	{NULL}
journal.pmed.1001425.pdf	292	{A,history,of,PEG,or,GH,during,pregnancy,should,alert,clinicians,to,the,need,for,preventative,counseling,and,more,vigilant,screening,for,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	293	{Supporting,Information}	{NULL}
journal.pmed.1001425.pdf	294	{Table,S1,Distribution,of,co-morbidity,categories,(,collapsed,ambulatory,diagnostic,groups,),*,among,women,stratified,by,gestational,diabetes,diagnosis,.}	{NULL}
journal.pmed.1001425.pdf	295	{*,Collapsed,ambulatory,diagnostic,groups,[,CADGs,],were,created,using,the,],ohns,Hopkins,Adjusted,Clinical,Groups,(,ACG,),System,.}	{NULL}
journal.pmed.1001425.pdf	296	{CADG,category,number,12,(,pregnancy,),was,not,included,in,the,analyses,.}	{NULL}
journal.pmed.1001425.pdf	297	{(,DOCX,)}	{NULL}
journal.pmed.1001425.pdf	298	{References}	{NULL}
journal.pmed.1001425.pdf	299	{1,.}	{NULL}
journal.pmed.1001425.pdf	300	{Zimmet,PZ,",",All,),erti,KG1,"\\\\",’,I1,"\\\\",’,I,(,2006,),Introduction,:,globalization,and,the,non4,communical,),le,disease,epidemic,.}	{NULL}
journal.pmed.1001425.pdf	301	{Obesity,14,:,143,.}	{NULL}
journal.pmed.1001425.pdf	302	{2,.}	{NULL}
journal.pmed.1001425.pdf	303	{Lipscombe,LL,",",Hux,],E,(,2007,),Trends,in,diabetes,prevalence,",",incidence,",",and,mortality,in,Ontario,",",Canada,199542005,:,a,population-based,study,.}	{NULL}
journal.pmed.1001425.pdf	304	{Lancet,369,:,7504756,.}	{NULL}
journal.pmed.1001425.pdf	305	{3,.}	{NULL}
journal.pmed.1001425.pdf	306	{Diabetes,Prevention,Program,Research,Group,(,2002,),N,Eng,],1,"\\\\",’,Ied,346,:,3934,403,.}	{NULL}
journal.pmed.1001425.pdf	307	{4,.}	{NULL}
journal.pmed.1001425.pdf	308	{Tuomilehto,],",",Lindstrom,],",",Eriksson,],G,",",Valle,TT,",",Hamalainen,H,",",et,al.,(,2001,),Prevention,of,type,2,diabetes,mellitus,by,changes,in,lifestyle,among,subjects,with,impaired,glucose,tolerance,.}	{NULL}
journal.pmed.1001425.pdf	309	{N,Eng,],Nled,344,:,134341350,.}	{NULL}
journal.pmed.1001425.pdf	310	{5,.}	{NULL}
journal.pmed.1001425.pdf	311	{Feig,DS,",",Zinman,B,",",VVang,X,",",Hux,],E,(,2008,),Risk,of,development,of,diabetes,mellitus,after,diagnosis,of,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	312	{CMA,],179,:,2294234,.}	{NULL}
journal.pmed.1001425.pdf	313	{6,.}	{NULL}
journal.pmed.1001425.pdf	314	{National,High,Blood,Pressure,Education,Program,"\\\\",/,Vorking,Group,(,2000,),Report,of,the,National,High,Blood,Pressure,Education,Program,VVorking,Group,on,high,blood,pressure,in,pregnancy,.}	{NULL}
journal.pmed.1001425.pdf	315	{Am,],Obstet,Gynecol,183,:,S14S22,.}	{NULL}
journal.pmed.1001425.pdf	316	{7,.}	{NULL}
journal.pmed.1001425.pdf	317	{Parretti,E,",",lapolla,A,",",Dalfra,1,"\\\\",’,IG,",",Pacini,G,",","1\\\\/Iari",A,",",et,al,(,2006,),Preeclampsia,in,lean,normotensive,normotolerant,pregnant,women,can,be,predicted,by,simple,insulin,sensitivity,indexes,.}	{NULL}
journal.pmed.1001425.pdf	318	{Hypertension,47,:,4494453,.}	{NULL}
journal.pmed.1001425.pdf	319	{8,.}	{NULL}
journal.pmed.1001425.pdf	320	{Sierra4Laguado,],",",Garcia,RG,",",Celedon,],",",Arenas-Nlantilla,IVI,",",Pradilla,LP,",",et,al,(,2007,),Determination,of,insulin,resistance,using,the,homeostatic,model,assessment,(,HOIVIA,),and,its,relation,with,the,risk,of,developing,pregnancy4,induced,hypertension,.}	{NULL}
journal.pmed.1001425.pdf	321	{Am,],Hypertens,20,:,4374442,.}	{NULL}
journal.pmed.1001425.pdf	322	{9,.}	{NULL}
journal.pmed.1001425.pdf	323	{Bryson,CL,",",Ioannou,GN,",",Rulyak,S,],",",Critchlow,C,(,2003,),Association,between,gestational,diabetes,and,gestational,hy,',pertension,.}	{NULL}
journal.pmed.1001425.pdf	324	{Am,],Epidemiol,158,:,11484,1153,.}	{NULL}
journal.pmed.1001425.pdf	325	{10,.}	{NULL}
journal.pmed.1001425.pdf	326	{Vambergue,A,",",Nuttens,MC,",",Goeusse,P,",",Biausque,S,",",Lepeut,M,",",et,al.,(,2002,),Pregnancy,induced,hypertension,in,women,with,gestational,carbohydrate,intolerance,:,the,diagest,study,.}	{NULL}
journal.pmed.1001425.pdf	327	{European,],Obs,Gyne,Repro,Bio,102,:,31435,.}	{NULL}
journal.pmed.1001425.pdf	328	{1,1,.}	{NULL}
journal.pmed.1001425.pdf	329	{Legro,RS,(,2009,),Insulin,resistance,in,women,’s,health,:,why,it,matters,and,how,to,identify,it,.}	{NULL}
journal.pmed.1001425.pdf	330	{Curr,Opin,Obstet,Gynecol,21,:,3014305,.}	{NULL}
journal.pmed.1001425.pdf	331	{12,.,]}	{NULL}
journal.pmed.1001425.pdf	332	{o1fe,GNI,",",Ester1itz,],R,",",Levine,R,],",",Clemens,],D,",",Ewell,RIG,",",et,al.,(,1998,),The,relationship,between,abnormal,glucose,tolerance,and,hypertensive,disorders,of,pregnancy,in,healthy,nulliparous,women,.}	{NULL}
journal.pmed.1001425.pdf	333	{Calcium,for,Preeclampsia,Prevention,(,CPEP,),Study,Group,.}	{NULL}
journal.pmed.1001425.pdf	334	{Am,],Obstet,Gynecol,179,:,103241037,.}	{NULL}
journal.pmed.1001425.pdf	335	{13,.}	{NULL}
journal.pmed.1001425.pdf	336	{Sermer,1,"\\\\",’,I,",",Naylor,CD,",",Gare,D,],(,1995,),Impact,of,increasing,carbohydrate,intolerance,on,maternal4fetal,outcomes,in,3637,women,without,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	337	{Am,],Obstet,Gynecol,173,:,1464156,.}	{NULL}
journal.pmed.1001425.pdf	338	{14,.}	{NULL}
journal.pmed.1001425.pdf	339	{Hux,],E,",",Ivis,F,",",Flintoft,V,",",Bica,A,(,2002,),Diabetes,in,Ontario,:,determination,of,prevalence,and,incidence,using,a,validated,administrative,data,algorithm,.}	{NULL}
journal.pmed.1001425.pdf	340	{Diabetes,Care,25,:,5124516,.}	{NULL}
journal.pmed.1001425.pdf	341	{15,.,]}	{NULL}
journal.pmed.1001425.pdf	342	{ohns,Hopkins,University,(,2011,),The,],ohns,Hopkins,ACG,®,Case-1,"\\\\",’,Iix,System,Applications,Guide,Version,10.0,December,2011,.}	{NULL}
journal.pmed.1001425.pdf	343	{Available,:,http://ywmnacg,.}	{NULL}
journal.pmed.1001425.pdf	344	{jhsph.org,.}	{NULL}
journal.pmed.1001425.pdf	345	{Accessed,31,],anuary,2013,.}	{NULL}
journal.pmed.1001425.pdf	346	{16,.}	{NULL}
journal.pmed.1001425.pdf	347	{Tu,K,",",Campbell,NR,",",Chen,Z,",",Cauch4Dudek,K,",",McA1ister,FA,(,2007,),Accuracy,of,administrative,databases,in,identifying,patients,with,hypertension,.}	{NULL}
journal.pmed.1001425.pdf	348	{Open,Nledicine,1,:,18426,.}	{NULL}
journal.pmed.1001425.pdf	349	{17,.}	{NULL}
journal.pmed.1001425.pdf	350	{Schoenfeld,D,(,1980,),Chi,~,squared,goodness-of,~,ﬁt,tests,for,the,proportional,hazards,regression,model,.}	{NULL}
journal.pmed.1001425.pdf	351	{Bometrika,67,:,1454153,.}	{NULL}
journal.pmed.1001425.pdf	352	{18,.}	{NULL}
journal.pmed.1001425.pdf	353	{Austin,PC,(,2010,),Absolute,risk,reductions,and,numbers,needed,to,treat,can,be,obtained,from,adjusted,survival,models,for,time-to,~,event,outcomes,.,]}	{NULL}
journal.pmed.1001425.pdf	354	{Clin,Epi,63,:,46455,.}	{NULL}
journal.pmed.1001425.pdf	355	{19,.}	{NULL}
journal.pmed.1001425.pdf	356	{Ryan,EA,",",Imes,S,",",Liu,D,",",NIc1,"\\\\",’,Ianus,R,",",Finegood,DT,",",et,al.,(,1995,),Defects,in,insulin,secretion,and,action,in,women,with,a,history,of,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	357	{Diabetes,44,:,5064512,.}	{NULL}
journal.pmed.1001425.pdf	358	{Table,S2,Number,of,women,at,risk,at,the,end,of,each,follow-up,year,in,Ontario,",",from,1994,to,201,1,.}	{NULL}
journal.pmed.1001425.pdf	359	{*,Year,o,indicates,the,beginning,of,the,follow-up,period,.}	{NULL}
journal.pmed.1001425.pdf	360	{(,DOCX,)}	{NULL}
journal.pmed.1001425.pdf	361	{Text,S1,(,DOCX,)}	{NULL}
journal.pmed.1001425.pdf	362	{Codes,for,variables,used,.}	{NULL}
journal.pmed.1001425.pdf	363	{Acknowledgments}	{NULL}
journal.pmed.1001425.pdf	364	{Wle,thank,Charles,Victor,for,his,invaluable,assistance,with,analysis,and,interpretation,of,data,.}	{NULL}
journal.pmed.1001425.pdf	365	{Author,Contributions}	{NULL}
journal.pmed.1001425.pdf	366	{Conceived,and,designed,the,experiments,:,DSF,BS,LL,],R,],L,GB,.}	{NULL}
journal.pmed.1001425.pdf	367	{Performed,the,experiments,:,FW,.}	{NULL}
journal.pmed.1001425.pdf	368	{Analyzed,the,data,:,DSF,BRS,LLL,F,"\\\\",V,],GR,],H,GLB,.}	{NULL}
journal.pmed.1001425.pdf	369	{Wrote,the,first,draft,of,the,manuscript,:,DSF,.}	{NULL}
journal.pmed.1001425.pdf	370	{Contributed,to,the,writing,of,the,manuscript,:,DSF,BRS,LLL,FW,',],GR,],L,],H,GLB,.}	{NULL}
journal.pmed.1001425.pdf	371	{"IC1\\\\/I",],E,criteria,for,authorship,read,and,met,:,DSF,BRS,LLL,FW,],GR,],L,],H,GLB,.}	{NULL}
journal.pmed.1001425.pdf	372	{Agree,with,manuscript,results,and,conclusions,:,DSF,BRS,LLL,FW,],GR,],L,],H,GLB,.}	{NULL}
journal.pmed.1001425.pdf	373	{20,.}	{NULL}
journal.pmed.1001425.pdf	374	{D’Anna,R,",",Baviera,G,",",Corrado,F,",",Giordano,D,",",De,Vivo,A,",",et,al.,(,2006,),Adiponectin,and,insulin,resistance,in,ear1y4,and,1ate4onset,preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	375	{B,],OG,113,:,126441269,.}	{NULL}
journal.pmed.1001425.pdf	376	{21,.}	{NULL}
journal.pmed.1001425.pdf	377	{Fuh,MMT,",",Yin,CS,",",Pei,D,",",Sheu,VVH,",",],eng,CY,",",et,al.,(,1995,),Resistance,to,insu1in4mediated,glucose,uptake,and,hyperinsulinemia,in,women,who,had,preeclampsia,during,pregnancy,.}	{NULL}
journal.pmed.1001425.pdf	378	{Am,],Hypertens,8,:,7684771,.}	{NULL}
journal.pmed.1001425.pdf	379	{22,.}	{NULL}
journal.pmed.1001425.pdf	380	{Soonthornpun,K,",",Soonthornpun,S,",",VVannaro,P,",",Setasuban,VV,",",Thamprasit,A,(,2009,),Insulin,resistance,in,women,with,a,history,of,severe,pre4ec1ampsia,.,]}	{NULL}
journal.pmed.1001425.pdf	381	{Obstet,Gynaecol,Res,35,:,55459,.}	{NULL}
journal.pmed.1001425.pdf	382	{23,.}	{NULL}
journal.pmed.1001425.pdf	383	{Ray,],G,(,2004,),Dysmetabolic,syndrome,",",placenta-mediated,disease,and,future,risk,of,cardiovascular,disease,.}	{NULL}
journal.pmed.1001425.pdf	384	{Fetal,and,Nlat,1,"\\\\",’,Ied,Rev,15,:,2314246,.}	{NULL}
journal.pmed.1001425.pdf	385	{24,.}	{NULL}
journal.pmed.1001425.pdf	386	{Sattar,N,",",Ramsay,],",",Crawford,L,",",Cheyne,H,",",Greer,IA,(,2003,),Classic,and,novel,risk,factor,parameters,in,women,with,a,history,of,preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	387	{Hypertension,12,:,12,.}	{NULL}
journal.pmed.1001425.pdf	388	{25,.}	{NULL}
journal.pmed.1001425.pdf	389	{Girouard,],",",Giguere,Y,",",Moutquin,],~,M,",",Forest,],-,C,(,2007,),Previous,hypertensive,disease,of,pregnancy,is,associated,with,alterations,of,markers,of,insulin,resistance,.}	{NULL}
journal.pmed.1001425.pdf	390	{Hypertension,49,:,105641062,.}	{NULL}
journal.pmed.1001425.pdf	391	{26,.}	{NULL}
journal.pmed.1001425.pdf	392	{Smith,GN,",",VVa1ker,IVIC,",",Liu,A,",",VVen,SVV,",",Swansburg,IVI,",",et,al.,(,2009,),A,history,of,preeclampsia,identifies,women,who,have,underlying,cardiovascular,risk,factors,.}	{NULL}
journal.pmed.1001425.pdf	393	{Am,],Obstet,Gynecol,200,:,58,.}	{NULL}
journal.pmed.1001425.pdf	394	{e1458,.}	{NULL}
journal.pmed.1001425.pdf	395	{e8,.}	{NULL}
journal.pmed.1001425.pdf	396	{27,.}	{NULL}
journal.pmed.1001425.pdf	397	{Agatisa,PK,",",Ness,RB,",",Roberts,],1,"\\\\",’,I,",",Costantino,],P,",",Kuller,LH,",",et,al.,(,2004,),Impairment,of,endothelial,function,in,women,with,a,history,of,preec1a_mpsia,:,an,indicator,of,cardiovascular,risk,.}	{NULL}
journal.pmed.1001425.pdf	398	{Am,],Phsiol,Circ,Physiol,286,:,H13894H1393,.}	{NULL}
journal.pmed.1001425.pdf	399	{28,.}	{NULL}
journal.pmed.1001425.pdf	400	{Kvehaugen,AS,",",Dechend,R,",",Ra_mstad,HB,",",Troisi,R,",",Fugelseth,D,",",et,al.,(,2011,),Endothelial,function,and,circulating,biomarkers,are,disturbed,in,women,and,children,after,preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	401	{Hypertension,58,:,63469,.}	{NULL}
journal.pmed.1001425.pdf	402	{29,.}	{NULL}
journal.pmed.1001425.pdf	403	{Hawﬁeld,A,",",Freedman,B1,(,2009,),Pre4ec1a,.}	{NULL}
journal.pmed.1001425.pdf	404	{mpsia,:,the,pivotal,role,of,the,placenta,in,its,pathophysiology,and,markers,for,early,detection,.}	{NULL}
journal.pmed.1001425.pdf	405	{Ther,Adv,Cardiovasc,Dis,3,:,65473,.}	{NULL}
journal.pmed.1001425.pdf	406	{.30,.}	{NULL}
journal.pmed.1001425.pdf	407	{Caballero,AE,(,2004,),Endothelial,dysfunction,",",inflammation,",",and,insulin,resistance,:,a,focus,on,subjects,at,risk,for,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	408	{Curr,Dial,),Rep,4,:,2374246,.}	{NULL}
journal.pmed.1001425.pdf	409	{31,.}	{NULL}
journal.pmed.1001425.pdf	410	{Kjos,SL,",",Peters,RK,",",Xiang,A,",",Henry,OA,",",1,"\\\\",’,Iontoro,1,"\\\\",’,I,",",et,al.,(,1995,),Predicting,future,diabetes,in,Latino,women,with,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	411	{Utility,of,early,postpartum,glucose,tolerance,testing,.}	{NULL}
journal.pmed.1001425.pdf	412	{Diabetes,44,:,5864591,.}	{NULL}
journal.pmed.1001425.pdf	413	{32,.}	{NULL}
journal.pmed.1001425.pdf	414	{Callaway,LK,",",Lawlor,DA,",",O’Ca11aghan,NI,",","\\\\",/,Villiams,GIVI,",",Najman,],1VI,",",et,al.,(,2007,),Diabetes,mellitus,in,the,21,years,after,a,pregnancy,that,was,complicated,by,hypertension,:,findings,from,a,prospective,cohort,study,.}	{23|24}
journal.pmed.1001425.pdf	415	{Am,],Obstet,Gynecol,197,:,492,.}	{NULL}
journal.pmed.1001425.pdf	416	{e14492,.}	{NULL}
journal.pmed.1001425.pdf	417	{e7,.}	{NULL}
journal.pmed.1001425.pdf	418	{33,.}	{NULL}
journal.pmed.1001425.pdf	419	{Lykke,],A,",",Langhoff-Roos,],",",Sibai,BN1,",",Funai,EF,",",Triche,EVV,",",et,al.,(,2009,),Hypertensive,pregnancy,disorders,and,subsequent,cardiovascular,morbidity,and,type,2,diabetes,mellitus,in,the,mother,.}	{NULL}
journal.pmed.1001425.pdf	420	{Hypertension,53,:,9444951,.}	{NULL}
journal.pmed.1001425.pdf	421	{34,.}	{NULL}
journal.pmed.1001425.pdf	422	{Engeland,A,",",Bjorge,T,",",Kjersti,Daltveit,AK,",",Skurtveit,S,",",Vangen,S,",",et,al.,(,201,1,),Risk,of,diabetes,after,gestational,diabetes,and,preelampsia,.}	{NULL}
journal.pmed.1001425.pdf	423	{A,registry-based,study,of230,",000",women,in,Norway,.}	{NULL}
journal.pmed.1001425.pdf	424	{Eur,],Epidemiol,26,:,1574163,.}	{NULL}
journal.pmed.1001425.pdf	425	{35,.}	{NULL}
journal.pmed.1001425.pdf	426	{Singh,],",",Huang,C-C,",",Driggers,RVV,",",Timofeev,],",",Amini,D,",",et,al.,(,2012,),The,impact,of,pre,~,pregnancy,body,mass,index,on,the,risk,of,gestational,diabetes,.,]}	{NULL}
journal.pmed.1001425.pdf	427	{1,"\\\\",’,Iaterna1,Fetal,Neonatal,1,"\\\\",’,Ied,25,:,5410,.}	{NULL}
journal.pmed.1001425.pdf	428	{36,.}	{NULL}
journal.pmed.1001425.pdf	429	{O’Brien,TE,",",Ray,],G,",",Chan,VV-S,(,2003,),1VIaterna1,body,mass,index,and,the,risk,of,preeclampsia,:,a,systematic,overview,.}	{NULL}
journal.pmed.1001425.pdf	430	{Epi,14,:,3684374,.}	{NULL}
journal.pmed.1001425.pdf	431	{37,.}	{NULL}
journal.pmed.1001425.pdf	432	{Taylor,LK,",",Travis,S,",",Pym,1,"\\\\",’,I,",",Olive,E,",",Henderson-Smart,D,],(,2005,),How,useful,are,hospital,morbidity,data,for,monitoring,conditions,occurring,in,the,perinatal,period,?}	{NULL}
journal.pmed.1001425.pdf	433	{Austr,NZ,],Obs,Gyn,45,:,36441,.}	{NULL}
journal.pmed.1001425.pdf	434	{Editors,’,Summary}	{NULL}
journal.pmed.1001425.pdf	435	{Background,.}	{NULL}
journal.pmed.1001425.pdf	436	{Diabetes,is,a,chronic,disease,that,occurs,either,when,the,pancreas,does,not,produce,enough,insulin,(,a,hormone,that,regulates,blood,sugar,),",",known,as,type,1,diabetes,",",or,when,the,body,can,not,effectively,use,the,insulin,it,produces,—,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	437	{Raised,blood,sugar,",",is,a,common,effect,of,uncontrolled,diabetes,and,over,time,leads,to,serious,complications,and,even,death,.}	{NULL}
journal.pmed.1001425.pdf	438	{Worryingly,",",the,global,burden,of,type,2,diabetes,is,increasing,worldwide,",",and,the,World,Health,Organization,estimates,that,90,%,of,the,347,million,people,with,diabetes,currently,have,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	439	{Previous,studies,have,shown,that,type,2,diabetes,can,be,prevented,or,delayed,in,high,risk,groups,by,a,range,of,lifestyle,and,treatment,interventions,and,so,it,is,important,to,identify,potential,high,risk,groups,to,screen,for,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	440	{Why,Was,This,Study,Done,?}	{NULL}
journal.pmed.1001425.pdf	441	{Gestational,diabetes,(,a,form,of,diabetes,that,is,related,to,pregnancy,),is,a,major,risk,factor,for,developing,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	442	{Therefore,",",diabetes,prevention,strategies,should,target,women,with,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	443	{Likewise,",",other,common,disorders,of,pregnancy,possibly,associated,with,insulin,resistance,",",such,as,preeclampsia,(,a,condition,in,which,affected,women,have,high,blood,pressure,",",fluid,retention,",",and,protein,in,their,urine,),and,gestational,hypertension,(,high,blood,pressure,associated,with,pregnancy,),",",may,lead,to,the,future,development,of,type,2,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	444	{50,women,with,these,conditions,may,also,benefit,from,diabetes,prevention,strategies,.}	{NULL}
journal.pmed.1001425.pdf	445	{Therefore,",",in,this,large,database,study,from,Ontario,",",Canada,",",the,researchers,examined,whether,pregnant,women,with,preeclampsia,or,gestational,hypertension,had,an,increased,risk,of,developing,diabetes,in,the,years,following,pregnancy,even,if,they,did,not,have,gestational,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	446	{What,Did,the,Researchers,Do,and,Find,?}	{NULL}
journal.pmed.1001425.pdf	447	{The,researchers,used,a,comprehensive,Canadian,health,database,to,identify,all,women,age,15,to,50,years,of,age,who,delivered,in,an,Ontario,hospital,between,April,1994,and,March,2008,.}	{NULL}
journal.pmed.1001425.pdf	448	{They,then,identified,women,who,had,preeclampsia,",",gestational,hypertension,",",or,gestational,diabetes,through,hospital,records,and,outpatient,information,.}	{NULL}
journal.pmed.1001425.pdf	449	{The,researchers,then,used,records,from,the,Ontario,Diabetes,Database,to,record,whether,these,women,went,on,to,develop,diabetes,in,the,period,from,180,days,after,delivery,until,March,2011,.}	{NULL}
journal.pmed.1001425.pdf	450	{Using,these,methods,",",the,researchers,identified,"1,010,068",pregnant,women,suitable,for,analysis,",",of,whom,"22,933",had,only,preeclampsia,",","27,605",had,only,gestational,hypertension,",",and,"30,852",had,only,gestational,diabetes,:,"2,100",women,had,both,gestational,diabetes,and,gestational,hypertension,and,"1,476",women,had,gestational,diabetes,and,preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	451	{Overall,",","35,077",women,developed,diabetes,(,3.5,%,),in,the,follow-up,period,(,median,of,8.5,years,),at,a,median,age,of,37,years,.}	{NULL}
journal.pmed.1001425.pdf	452	{In,a,modeling,analysis,",",the,researchers,found,that,women,with,gestational,diabetes,had,a,15-fold,increased,rate,of,developing,diabetes,compared,to,women,without,gestational,diabetes,",",gestational,hypertension,",",and,preeclampsia,",",while,women,with,gestational,diabetes,plus,either,preeclampsia,or,gestational,hypertension,had,a,20,-,to,21-fold,increased,rate,.}	{NULL}
journal.pmed.1001425.pdf	453	{These,results,were,slightly,reduced,after,adjusting,for,age,",",income,quintile,",",hypertension,prior,to,pregnancy,",",and,co-morbidity,",",giving,a,hazard,ratio,(,HR,),of,1.95,for,gestational,hypertension,alone,",",an,HR,of,2.08,for,preeclampsia,alone,",",an,HR,of,12.77,for,gestational,diabetes,alone,",",an,HR,of,18.49,for,gestational,diabetes,plus,gestational,hypertension,and,ﬁnally,",",an,HR,of,15.75,for,gestational,diabetes,plus,preeclampsia,.}	{NULL}
journal.pmed.1001425.pdf	454	{These,Findings,Mean,?}	{NULL}
journal.pmed.1001425.pdf	455	{These,findings,suggest,that,both,preeclampsia,and,gestational,hypertension,without,gestational,diabetes,are,associated,with,a,2-fold,increased,incidence,of,diabetes,in,the,years,following,pregnancy,after,controlling,for,several,important,variables,.}	{NULL}
journal.pmed.1001425.pdf	456	{When,combined,with,gestational,diabetes,",",these,conditions,were,associated,with,a,further,elevation,in,diabetes,incidence,additional,to,the,13-fold,increased,incidence,resulting,from,gestational,diabetes,alone,.}	{NULL}
journal.pmed.1001425.pdf	457	{A,limitation,of,this,study,was,the,lack,of,information,on,obesity,and,body,mass,index,",",factors,which,are,also,associated,with,increased,risk,of,developing,diabetes,.}	{NULL}
journal.pmed.1001425.pdf	458	{Nevertheless,",",these,ﬁndings,highlight,a,possible,new,risk,factor,for,diabetes,",",and,suggest,that,clinicians,should,be,aware,of,the,need,for,preventative,measures,and,vigilant,screening,for,diabetes,in,women,with,a,history,of,preeclampsia,or,gestational,hypertension,.}	{NULL}
journal.pmed.1001425.pdf	459	{Additional,Information,.}	{NULL}
journal.pmed.1001425.pdf	460	{Please,access,these,Web,sites,via,the,online,version,of,this,summary,at,http://dx.doi.org/10,.}	{NULL}
journal.pmed.1001425.pdf	461	{1371/journa,|,.}	{NULL}
journal.pmed.1001425.pdf	462	{pmed,.1001425,.}	{NULL}
journal.pmed.1001425.pdf	463	{o,NHS,Choices,has,information,about,preeclampsia,",",gestational,diabetes,",",and,gestational,hypertension,o,Living,with,diabetes,is,a,useful,resource,for,patients,with,diabetes}	{NULL}
journal.pmed.1001425.pdf	464	{o,The,Preeclampsia,Foundation,has,more,information,about,preeclampsia}	{2}
journal.pone.0049897.pdf	1	{OPEN,8,ACCESS,Freely,available,online}	{NULL}
journal.pone.0049897.pdf	2	{Ձ,|,ONE}	{NULL}
journal.pone.0049897.pdf	3	{Methamphetamine,Administration,Targets,Multiple,Immune,Subsets,and,Induces,Phenotypic,Alterations,Suggestive,of,lmmunosuppression}	{NULL}
journal.pone.0049897.pdf	4	{Robert,Harms1,*,",",Brenda,Morsey,’,",",Craig,W.,Boyer,‘,",",Howard,S.,Foxz,",",Nora,Sarvetnick,”}	{NULL}
journal.pone.0049897.pdf	5	{1Department,of,Surgery,.}	{NULL}
journal.pone.0049897.pdf	6	{—,.}	{NULL}
journal.pone.0049897.pdf	7	{Transp,|,ant,",",University,of,Nebraska,Medical,Center,",",Omaha,",",Nebraska,",",United,States,of,America,",",2Department,of,Pharmacology,and,Experimental,Neuroscience,",",University,of,Nebraska,Medical,Center,",",Omaha,",",Nebraska,",",United,States,of,America,",",3,Regenerative,Medicine,Project,",",University,of,Nebraska,Medical,Center,",",Omaha,",",Nebraska,",",United,States,of,America}	{NULL}
journal.pone.0049897.pdf	8	{Abstract}	{NULL}
journal.pone.0049897.pdf	9	{Methamphetamine,(,Meth,),is,a,widely,abused,stimulant,and,its,users,are,at,increased,risk,for,multiple,infectious,diseases,.}	{NULL}
journal.pone.0049897.pdf	10	{To,determine,the,impact,of,meth,on,the,immune,system,",",we,utilized,a,murine,model,that,simulates,the,process,of,meth,consumption,in,a,typical,addict,.}	{NULL}
journal.pone.0049897.pdf	11	{Our,phenotypic,analysis,of,leukocytes,from,this,dose,escalation,model,revealed,that,meth,affected,key,immune,subsets,.}	{NULL}
journal.pone.0049897.pdf	12	{Meth,administration,led,to,a,decrease,in,abundance,of,natural,killer,(,NK,),cells,and,the,remaining,NK,cells,possessed,a,phenotype,suggesting,reduced,responsiveness,.}	{NULL}
journal.pone.0049897.pdf	13	{Dendritic,cells,(,DCs,),and,Gr,—,1h,',9h,monocytes/macrophages,were,also,decreased,in,abundance,while,Gr,—,1,',°,"\\"","\\"",monocytes/macrophages,appear,to,show,signs,of,perturbation,.}	{NULL}
journal.pone.0049897.pdf	14	{CD4,and,CD8,T,cell,subsets,were,affected,by,methamphetamine,",",both,showing,a,reduction,in,antigenexperienced,subsets,.}	{NULL}
journal.pone.0049897.pdf	15	{CD4,T,cells,also,exhibited,signs,of,activation,",",with,increased,expression,of,CD150,on,CD226,—,expressing,cells,and,an,expansion,of,KLRG1,+,",",FoxP3,_,cells,.}	{NULL}
journal.pone.0049897.pdf	16	{These,results,exhibit,that,meth,has,the,ability,to,disrupt,immune,homeostasis,and,impact,key,subsets,of,leukocytes,which,may,leave,users,more,vulnerable,to,pathogens,.}	{NULL}
journal.pone.0049897.pdf	17	{Citation,:,Harms,R,",",Morsey,B,",",Boyer,CW,",",Fox,HS,",",Sarvetnick,N,(,2012,),Methamphetamine,Administration,Targets,Multiple,Immune,Subsets,and,Induces,Phenotypic,Alterations,Suggestive,of,lmmunosuppression,.}	{NULL}
journal.pone.0049897.pdf	18	{PLoS,ONE,7,(,12,),:,e49897,.}	{NULL}
journal.pone.0049897.pdf	19	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	20	{pone,.0049897,Editor,:,Wenzhe,Ho,",",Temple,University,School,of,Medicine,",",United,States,of,America,Received,July,23,",",2012,;,Accepted,October,17,",",2012,;,Published,December,5,",",2012,Copyright,:,©,2012,Harms,et,al.,.}	{NULL}
journal.pone.0049897.pdf	21	{This,is,an,open,~,access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pone.0049897.pdf	22	{Funding,:,This,work,was,funded,by,NIH,RO1,:345160,—,2058101,from,the,National,Institute,on,Drug,Abuse,.}	{NULL}
journal.pone.0049897.pdf	23	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pone.0049897.pdf	24	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pone.0049897.pdf	25	{*,E,—,mai,|,:,rharms@unmc.edu}	{NULL}
journal.pone.0049897.pdf	26	{Introduction}	{NULL}
journal.pone.0049897.pdf	27	{Methamphetamine,(,Meth,),is,a,highly,addictive,psychostimulant,and,neurotoxicant,of,increasing,popularity,among,drug-abusing,populations,worldwide,[,l,—,9,],.}	{NULL}
journal.pone.0049897.pdf	28	{This,rising,popularity,has,signiﬁcant,economic,consequences,",",as,in,the,US,alone,",",the,ﬁnancial,burden,of,meth,use,was,calculated,at,>,23,billion,dollars,annually,[,10,],.}	{NULL}
journal.pone.0049897.pdf	29	{Meth,is,typically,administered,nasally,",",intravenously,or,orally,",",and,meth,users,experience,feelings,of,euphoria,",",hyperactivity,",",reduced,appetite,",",sleeplessness,",",and,arousal,after,administration,[,1,1,],.}	{NULL}
journal.pone.0049897.pdf	30	{After,injection,",",meth,",",a,lipid-soluble,monamine,",",has,been,shown,to,disseminate,and,accumulate,widely,throughout,tissues,in,both,humans,and,rats,[,l2,",",l3,],",",and,there,is,an,extensive,body,of,data,that,describes,the,toxic,effects,of,meth,on,the,CNS,and,resulting,neurologic,damage,and,cognitive,impairment,[,"14,15",],.}	{NULL}
journal.pone.0049897.pdf	31	{Meth,users,are,prone,to,increased,rates,of,several,types,of,infections,",",including,human,immunodeﬁciency,virus,(,HIV,),",",hepatitis,A,",",B,",",and,C,",",and,methillicin-resistant,Stap/ylococcus,aureus,",",due,to,their,involvement,in,risky,sexual,practices,and,from,the,inherent,dangers,associated,with,intravenous,drug,use,[,l6,—,23,],.}	{NULL}
journal.pone.0049897.pdf	32	{In,addition,to,these,behaviors,putting,users,at,increased,risk,of,transmission,of,infectious,agents,",",meth,has,been,shown,to,promote,HIV,infection,of,human,macrophages,and,increase,hepatitis,C,replication,within,hepatocytes,[,"24,25",],.}	{NULL}
journal.pone.0049897.pdf	33	{Meth,itself,is,an,immunomodulatory,substance,with,a,wide,range,of,effects,that,have,been,observed,in,diverse,in,vitro,systems,as,well,as,murine,and,nonhuman,primate,models,.}	{NULL}
journal.pone.0049897.pdf	34	{Several,lines,of,evidence,support,the,notion,that,meth,suppresses,the,immune,system,.}	{NULL}
journal.pone.0049897.pdf	35	{Meth,has,been,associated,with,reduced,leukocyte,proliferation,[,26,—,28,],",",reduced,IL-2,production,[,28,—,30,],",",reduced,immunoglobulin,production,[,"30,3",l,],",",and,reduced,macrophage,and,dendritic,cell,(,DC,),function,[,32,—,34,],.}	{NULL}
journal.pone.0049897.pdf	36	{Meth,also,promotes,susceptibility,to,viral,and,fungal,pathogens,among,hosts,[,"27,34,35",],.}	{NULL}
journal.pone.0049897.pdf	37	{While,meth,appears,to,suppress,the,response,of,B,and,T,cells,",",macrophages,",",and,DCs,",",studies,have,shown,that,natural,killer,(,NK,),cells,exhibit,increased,levels,of,activation,after,meth,exposure,[,"29,30,35,36",],",",although,at,least,one,study,reported,reduced,NK,cell,function,[,37,],.}	{NULL}
journal.pone.0049897.pdf	38	{Meth,has,also,been,observed,to,alter,immune,function,in,the,brain,",",with,increased,microglia,activation,and,abundance,after,meth,exposure,[,38,],.}	{NULL}
journal.pone.0049897.pdf	39	{Finally,",",meth,has,been,reported,to,promote,apoptosis,in,the,thymus,and,spleen,[,39,],",",as,well,as,among,cultured,T,cells,[,28,],.}	{NULL}
journal.pone.0049897.pdf	40	{Taken,together,",",these,studies,reveal,that,meth,has,the,ability,to,profoundly,interfere,with,immunological,networks,",",affecting,diverse,leukocyte,subsets,and,thereby,leaving,the,user,vulnerable,to,pathogens,.}	{NULL}
journal.pone.0049897.pdf	41	{Although,several,studies,on,meth,have,employed,ﬂow,cytometry,to,evaluate,the,immune,response,",",this,has,not,been,performed,in,a,comprehensive,manner,to,elucidate,speciﬁc,cellular,alterations,induced,by,meth,.}	{NULL}
journal.pone.0049897.pdf	42	{Indeed,",",multiparameter,ﬂow,cytometry,can,be,used,to,generate,a,detailed,analysis,of,the,expression,level,of,multiple,proteins,at,the,single,cell,level,.}	{NULL}
journal.pone.0049897.pdf	43	{This,allows,the,investigator,to,generate,a,complex,",",yet,more,complete,",",picture,of,immunological,networks,in,states,of,health,",",disease,",",and,toxicant,exposure,",",and,ultimately,produce,a,wealth,of,observations,to,guide,further,investigations,.}	{NULL}
journal.pone.0049897.pdf	44	{As,previous,studies,suggested,profound,and,detrimental,impacts,of,meth,on,T,cell,",",NK,cell,",",and,macrophage,/,DC,responses,",",we,hypothesized,that,these,deﬁciencies,would,result,in,speciﬁc,phenotypic,alterations,of,these,cells,",",thereby,suggesting,altered,functionality,in,vivo,.}	{NULL}
journal.pone.0049897.pdf	45	{To,explore,this,hypothesis,",",we,treated,C5,7BL,/,6,mice,with,levels,of,methamphetamine,that,simulate,usage,patterns,observed,in,typical,human,addicts,(,following,methods,in,[,34,],),and,then,examined,multiple,leukocyte,subsets,to,observe,how,meth,changes,the,phenotypic,appearance,of,immune,cells,.}	{NULL}
journal.pone.0049897.pdf	46	{Our,results,reveal,that,meth,treatment,reduces,the,overall,abundance,of,activated,/,antigenexperienced,CD4,and,CD8,T,cells,while,promoting,activation,and,expansion,of,discrete,CD4,T,cell,subsets,.}	{NULL}
journal.pone.0049897.pdf	47	{We,also,observed,that,meth,impacts,splenic,myeloid,cells,",",reducing,the,number,of,DCs,and,Gr-lhigh,monocytes,/,macrophages,",",while,promoting,the,perturbation,of,Gr-11,"\\"",“,monocytes,/,macrophages,.}	{NULL}
journal.pone.0049897.pdf	48	{Finally,",",we,observed,that,meth,contributes,to,a,reduction,in,number,of,splenic,NK,cells,and,leaves,the,majority,of,remaining,NK,cells,with,a,phenotype,suggesting,reduced,responsiveness,and,functional,efﬁcacy,.}	{NULL}
journal.pone.0049897.pdf	49	{Methods}	{NULL}
journal.pone.0049897.pdf	50	{Mice,and,Meth,Treatment,Male,C5,7BL,/,6,mice,12,—,14,weeks,of,age,were,purchased,from,Jackson,Labs,",",housed,in,speciﬁc,pathogen,free,conditions,",",and,given,unlimited,access,to,food,and,water,.}	{NULL}
journal.pone.0049897.pdf	51	{We,purchased,(,+,),methamphetamine,hydrochloride,from,Sigma-Aldrich,and,employed,a,treatment,regimen,similar,to,that,described,in,[,34,],that,simulates,meth,usage,patterns,of,typical,human,addicts,.}	{NULL}
journal.pone.0049897.pdf	52	{Meth,was,administered,via,intraperitoneal,injections,in,a,ramped,dosing,schedule,on,days,1,—,4,with,2,",",4,",",6,",",and,8,mg,/,kg,given,per,day,.}	{NULL}
journal.pone.0049897.pdf	53	{On,days,5,—,l4,",",we,plateaued,the,dosage,to,10,mg,/,kg,/,day,.}	{NULL}
journal.pone.0049897.pdf	54	{Control,mice,were,given,saline,solution,(,vehicle,),over,this,same,time,period,.}	{NULL}
journal.pone.0049897.pdf	55	{On,day,14,",",within,3,hours,of,the,ﬁnal,injection,",",mice,were,anesthetized,with,isoﬂuorane,and,euthanized,via,cervical,dislocation,.}	{NULL}
journal.pone.0049897.pdf	56	{The,Institutional,Animal,Care,and,Use,Committee,of,the,University,of,Nebraska,Medical,Center,approved,all,procedures,.}	{NULL}
journal.pone.0049897.pdf	57	{Flow,Cytometry,Spleens,and,mesenteric,lymph,nodes,were,harvested,from,freshly,euthanized,mice,.}	{NULL}
journal.pone.0049897.pdf	58	{These,were,then,teased,apart,with,ﬁne,forceps,and,ran,through,nylon,mesh,screens,to,produce,single,cell,suspensions,.}	{NULL}
journal.pone.0049897.pdf	59	{Red,blood,cells,(,RBCs,),were,removed,from,splenocyte,preparations,by,utilizing,ammonium,chloride,RBC,lysis,buffer,.}	{NULL}
journal.pone.0049897.pdf	60	{Prior,to,labeling,cells,with,antibodies,",",we,stained,cells,with,Live/Dead,©,Fixable,.}	{NULL}
journal.pone.0049897.pdf	61	{Blue,Dead,Cell,Stain,(,Life,Technologies,),and,then,blocked,Fc,receptors,using,unlabeled,",",irrelevant,rat,IgG,.}	{NULL}
journal.pone.0049897.pdf	62	{We,used,mouse,monoclonal,antibodies,from,multiple,sources,in,our,ﬂow,Cytometry,panels,.}	{NULL}
journal.pone.0049897.pdf	63	{From,BD,Pharmingen,",",we,utilized,B220,(,RA36B2,),",",CD3e,(,500A2,),",",CD11c,(,HL3,),",",CD27,(,LG,.3,A10,),",",CD44,(,IM7,),",",CD80,(,16-10Al,),",",and,NKp46,(,29Al,.4,),.}	{NULL}
journal.pone.0049897.pdf	64	{From,eBiosciences,",",we,used,CD4,(,GK1,.5,),",",CD8,(,53-6,.7,),",",CD11b,(,M1/70,),",",CD25,(,PC61,.5,),",",CD62L,(,MEL-14,),",",CD94,(,18d3,),",",CD86,(,GL-1,),",",Gr-1,(,RB6-8C5,),",",NKG2D,(,CX5,),",",FoxP3,(,FjK-16s,),",",MHC,II,(,M5/114,.15.2,),",",Ly49H,(,3D,10,),and,Ly-49G2,(,eBio4D1,1,),.}	{NULL}
journal.pone.0049897.pdf	65	{Antibodies,against,CD3,(,17A2,),",",CD27,(,LG,.3,A10,),",",CD45RB,(,C363-16A,),",",KLRG1,(,2F1/KLRG1,),",",CD150,(,TC15-12F12,.2,),",",and,CD226,(,l0E5,),were,purchased,from,BioLegend,.}	{NULL}
journal.pone.0049897.pdf	66	{For,surface,staining,",",cells,were,suspended,in,staining,buffer,consisting,of,phosphate,buffered,saline,(,PBS,),containing,0.5,%,bovine,serum,albumin,(,BSA,),and,0.05,%,sodium,azide,(,NaN3,),.}	{NULL}
journal.pone.0049897.pdf	67	{Surface-stained,cells,were,ﬁxed,in,1.5,%,paraformaldehyde,(,PFA,),for,1,hour,",",then,washed,and,resuspended,in,staining,buffer,prior,to,analysis,.}	{NULL}
journal.pone.0049897.pdf	68	{For,FoxP3,staining,",",we,used,FoxP3,Fixation/Permeabilization,Concentrate,and,Diluent,from,eBiosciences,according,to,the,manufacturer,’s,recommendations,.}	{NULL}
journal.pone.0049897.pdf	69	{Cells,were,analyzed,with,an,LSR,II,(,BD,Biosciences,),within,24,hours,of,preparation,.}	{NULL}
journal.pone.0049897.pdf	70	{Analysis,and,Statistics,We,used,Flowjo,(,v.,8.8.6,",",TreeStar,",",Inc.,),to,analyze,ﬂow,cytometry,data,.}	{NULL}
journal.pone.0049897.pdf	71	{Values,from,Flowjo,were,transferred,into,GraphPad,Prism,(,v.,4.0,",",GraphPad,Software,),for,statistical,analysis,.}	{NULL}
journal.pone.0049897.pdf	72	{To,test,for,signiﬁcant,differences,between,meth-treated,and,control,animals,",",we,utilized,the,Mann-Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	73	{Results}	{NULL}
journal.pone.0049897.pdf	74	{Meth,Causes,a,Reduction,in,Absolute,Number,and,_,Proportion,of,Splenic,Natural,Killer,Cells,",",Gr,—,1,(,Ly,—,6C,),h,',9h,Monocytes/macrophages,",",and,DCs,To,determine,the,impact,of,meth,exposure,on,the,proportion,and,number,of,splenic,leukocyte,subsets,",",we,prepared,splenocyte,preparations,for,ﬂow,cytometric,analysis,with,antibodies,against,CD3,",",B220,",",Gr-1,",",CD1,lb,",",CD11c,",",MHC,II,",",and,NKp46,",",allowing,us,to,deﬁne,and,quantify,T,cells,",",B,cells,",",natural,killer,(,NK,),cells,",",neutrophils,",",eosinophils,",",dendritic,cells,(,DCs,),",",and,Grlhigh,and,Gr-11,””,monocytes,/,macrophages,(,see,gating,strategy,Fig,.}	{NULL}
journal.pone.0049897.pdf	75	{1,and,Table,1,),.}	{NULL}
journal.pone.0049897.pdf	76	{The,Gr-1,antibody,(,clone,RB6-8C5,),binds,to,epitopes,on,Ly-6G,and,Ly-6C,[,40,],",",and,can,be,used,to,label,neutrophils,(,SSC,"\\"",‘,"\\"",d,",",Gr-lbrigl,“,(,co-expressing,both,Ly6G,and,Ly6C,at,high,levels,),),and,divide,splenic,monocytes,/,macrophage,into,Gr-lhigh/l,"\\"",W,subsets,",",corresponding,to,high,or,low,levels,of,Ly-6C,expression,[,"41,42",],.}	{NULL}
journal.pone.0049897.pdf	77	{NKp46,is,an,activating,receptor,speciﬁcally,expressed,by,the,NK,cell,lineage,and,can,be,used,to,effectively,label,these,cells,[,43,],.}	{NULL}
journal.pone.0049897.pdf	78	{Our,results,indicated,that,although,absolute,counts,of,total,splenocytes,were,not,different,between,meth-treated,and,control,groups,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	79	{2A,),",",meth,treatment,caused,signiﬁcant,decreases,in,proportion,(,data,not,shown,),and,number,of,NK,cells,(,p,=,0.003,),",",Gr-l,(,Ly-6C,),high,monocytes/macrophages,(,p,=,0.0041,),",",and,DCs,(,p,=,0.0015,),in,meth-treated,mice,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	80	{2B,.}	{NULL}
journal.pone.0049897.pdf	81	{—,.}	{NULL}
journal.pone.0049897.pdf	82	{D,),.}	{NULL}
journal.pone.0049897.pdf	83	{T,cells,",",B,cells,",",neutrophils,",",eosinophils,",",and,Gr-l,(,Ly-6C,),l,‘“,"\\"",monocytes,/,macrophages,exhibited,no,signiﬁcant,difference,in,proportion,or,absolute,number,after,meth,treatment,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	84	{These,results,show,that,meth,has,the,ability,to,negatively,impact,the,abundance,of,innate,immune,subsets,.}	{NULL}
journal.pone.0049897.pdf	85	{Meth,Treatment,Causes,the,Perturbation,of,Gr,—,1,(,Ly,—,6C,),',°,‘”,Monocytes/macrophages,Meth,treatment,has,been,shown,to,upset,antigen,presentation,pathways,and,promote,apoptosis,",",thus,suggesting,an,alteration,of,antigen,presenting,cell,(,APC,),activation,with,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	86	{To,investigate,the,role,of,meth,treatment,on,APC,and,APC-precursor,activation,levels,",",we,labeled,splenic,DCs,and,monocytes,/,macrophages,with,antibodies,against,the,costimulatory,markers,CD80,and,CD86,[,44,],",",and,then,examined,surface,protein,expression,by,ﬂow,Cytometry,.}	{NULL}
journal.pone.0049897.pdf	87	{Interestingly,",",Gr-11,””,monocytes,/,macrophages,showed,statistically,signiﬁcant,upregulation,of,CD80,(,p,=,0.0057,;,measured,by,mean,ﬂuorescence,intensity,(,MFI,),),",",but,not,CD86,(,data,not,shown,),",",after,meth,exposure,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	88	{3A,&,B,),.}	{NULL}
journal.pone.0049897.pdf	89	{This,increase,in,CD80,expression,was,coupled,with,a,decrease,in,CDl1b,expression,by,Gr-11,””,monocytes,/,macrophages,(,p,=,0.0004,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	90	{3C,&,D,),.}	{NULL}
journal.pone.0049897.pdf	91	{There,was,no,change,in,CD80,or,CD86,expression,levels,by,Gr-lmgl,‘,monocytes,/,macrophages,and}	{NULL}
journal.pone.0049897.pdf	92	{_,|,.}	{NULL}
journal.pone.0049897.pdf	93	{O,m,_,.}	{NULL}
journal.pone.0049897.pdf	94	{ca,.}	{NULL}
journal.pone.0049897.pdf	95	{Livgl,Dead}	{NULL}
journal.pone.0049897.pdf	96	{D,50K,‘,EUOK,150K,200K,250K,o,50K,100K,150K,2lJl,',.}	{NULL}
journal.pone.0049897.pdf	97	{lK,250K,o,50K,100K,150K,20K,250K}	{NULL}
journal.pone.0049897.pdf	98	{FSC,FSC-H,FSC}	{NULL}
journal.pone.0049897.pdf	99	{o,50K,100K,150K,200K,250K,o,50K,100K,150K,200K,250K}	{NULL}
journal.pone.0049897.pdf	100	{FSC,FSC}	{NULL}
journal.pone.0049897.pdf	101	{o,50K,10m,(,150K,ZQOK,250K,o,50K,100K,150K,200K,250K}	{NULL}
journal.pone.0049897.pdf	102	{|,=,sc,FSC}	{NULL}
journal.pone.0049897.pdf	103	{Figure,1,.}	{NULL}
journal.pone.0049897.pdf	104	{Gating,strategy,for,defining,major,subsets,of,leukocytes,among,splenocytes,.}	{NULL}
journal.pone.0049897.pdf	105	{A.,Dead,cells,were,removed,from,the,analysis,using,Live/Dead,®,ﬁxable,dead,cell,stain,.}	{NULL}
journal.pone.0049897.pdf	106	{B.,Doublets,were,removed,from,living,cells,(,Live/Dead,’,),using,FSC,.}	{NULL}
journal.pone.0049897.pdf	107	{—,.}	{NULL}
journal.pone.0049897.pdf	108	{A,and,FSC-H,.}	{NULL}
journal.pone.0049897.pdf	109	{C.,Gr,—,1b,"\\"",9,“‘,splenocytes,were,gated,and,deﬁned,as,neutrophils,.}	{NULL}
journal.pone.0049897.pdf	110	{D.,NKp46,"\\"",events,were,gated,from,Gr,—,1,',°,‘”,”,splenocytes,and,defined,as,natural,killer,(,NK,),cells,.}	{NULL}
journal.pone.0049897.pdf	111	{E.,NKp46,’,",",Gr,—,1,',°,"\\"","\\"",”,splenocytes,were,divided,into,MHC,II,’,',and,MHC,II,’,populations,.}	{NULL}
journal.pone.0049897.pdf	112	{F.,MHC,II,"\\"",events,were,split,by,B220,and,CD11c,expression,.}	{NULL}
journal.pone.0049897.pdf	113	{MHC,II,"\\"",",",B220,"\\"",",",CD11c,’,events,were,defined,as,B,cells,.}	{NULL}
journal.pone.0049897.pdf	114	{MHC,II,"\\"",B220,’,",",CD11c,"\\"",events,were,defined,as,dendritic,cells,(,DCs,),.}	{NULL}
journal.pone.0049897.pdf	115	{G.,We,split,MHC,II,’,events,by,CD3,and,CD11b,expression,.}	{NULL}
journal.pone.0049897.pdf	116	{CD11b,‘,",",CD3,+,",",MHC,II,‘,events,were,labeled,as,T,cells,.}	{NULL}
journal.pone.0049897.pdf	117	{H.,CD11b,"\\"",",",CD3,’,",",MHC,II,‘,events,were,split,according,to,SSC,proﬁle,.}	{NULL}
journal.pone.0049897.pdf	118	{Events,with,higher,SSC,values,(,suggesting,greater,int_erna,|,granularity,),were,labeled,as,eosinophils,.}	{NULL}
journal.pone.0049897.pdf	119	{I.,Events,with,lower,SSC,values,were,divided,by,Gr,—,1,expression,",",giving,two,populations,:,Gr,—,1,(,Ly,—,6C,),h,',9h,monocytes/macrophages,and,Gr,—,1,(,Ly,—,6C,),',°,"\\"","\\"",monocytes/macrophages,(,mono/MID,),.}	{NULL}
journal.pone.0049897.pdf	120	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	121	{pone,.}	{NULL}
journal.pone.0049897.pdf	122	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	123	{gOO1}	{NULL}
journal.pone.0049897.pdf	124	{DCs,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	125	{An,upregulation,in,CD80,in,parallel,with,a,downregulation,of,CD1,lb,suggests,that,that,Gr-lbw,monocytes,/,macrophages,are,perturbed,after,meth,treatment,",",while,Gr-lhigh,monocytes,/,macrophages,appear,to,be,less,sensitive,to,methinduced,activation,.}	{NULL}
journal.pone.0049897.pdf	126	{A,Greater,Proportion,of,NK,Cells,Possess,a,Phenotype,Suggesting,Terminal,Differentiation,After,Meth,Exposure,Meth,treatment,has,been,shown,to,both,promote,and,inhibit,NK,cell,activation,.}	{NULL}
journal.pone.0049897.pdf	127	{To,address,if,NK,cells,exhibit,an,altered,phenotype,suggesting,changes,in,maturation,or,development,",",we,labeled,NK,cells,(,NKl,.}	{NULL}
journal.pone.0049897.pdf	128	{l,+,",",CD4,‘,",",CD8,‘,),with,KLRGI,",",CD27,",",Ly-49H,",",Ly,—,49G2,and,CD94,.}	{NULL}
journal.pone.0049897.pdf	129	{Among,rnurine,NK,cells,",",CD27}	{NULL}
journal.pone.0049897.pdf	130	{Table,1,.}	{NULL}
journal.pone.0049897.pdf	131	{Phenotype,of,splenic,leukocyte,subsets,analyzed,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	132	{Leukocyte,subset}	{NULL}
journal.pone.0049897.pdf	133	{Surface,expression,of,relevant,phenotypic,markers}	{NULL}
journal.pone.0049897.pdf	134	{T,cells,B,cells,Natural,killer,(,NK,),cells,Dendritic,cells,(,DCs,),Neutrophils,Eosinophils,Gr-1,(,Ly-6C,),"\\"",i9,"\\"",mono/MCI,),Gr-1,(,Ly-6C,),',°,‘”,monolM,(,I,)}	{NULL}
journal.pone.0049897.pdf	135	{cost,",",MHC,II,”,",",Gr-1,’,",",NKp46,’,",",CD11b,’,3220,*,",",MHC,II,*,",",CD3,”,",",Gr,»,1,',",",NKp46,’,",",cm,ic,’,NKp46,*,",",Gr-1,’,",",MHCII,’,",",CD3,”,cm,ict,",",MHC,Ir,",",CD11b,*,”,",",CD3,”,",",B220,’,",",NKp46,’,CD11b,*,",",Gr-1,‘,"\\"",‘,9,“‘,",",ssc,"\\"",‘,°,“,',",",CD3,”,",",3220,’,",",CD11c,',",",MHC,|,|,',",",NKp46,’,CD11b,*,",",Gr,—,1,',°,"\\"","\\"",",",ssc,"\\"",‘,9,"\\"",",",CD3,”,",",3220,’,",",CD11c,’,",",MHCII,’,",",NKp46,’,CD11b,*,",",Gr-1,*,",",MHCII,’,",",CD3,”,",",B220,’,",",CD11c,’,",",NKp46,’,CD11b,*,",",Gr,—,1,”,",",MHCII,”,",",CD3,’,",",B220,’,",",CD11c,',°,"\\"","\\"",”,",",NKp46,’}	{NULL}
journal.pone.0049897.pdf	136	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	137	{pone,.}	{NULL}
journal.pone.0049897.pdf	138	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	139	{tO01}	{NULL}
journal.pone.0049897.pdf	140	{expression,is,associated,with,naive,status,of,NK,cells,and,KLRGI,expression,is,associated,with,terminal,differentiation,[,"45,46",],.}	{NULL}
journal.pone.0049897.pdf	141	{"\\\\",/,Ve,noticed,a,signiﬁcant,decrease,in,proportion,of,KLRGI,_,",",CD27,’,NK,cells,(,p,=,o.,ooll,),concurrent,with,a,signiﬁcant,increase,in,KLRG1,+,",",CD27,_,NK,cells,(,p,=,0.0002,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	142	{4A,.}	{NULL}
journal.pone.0049897.pdf	143	{—,.}	{NULL}
journal.pone.0049897.pdf	144	{C,),.}	{NULL}
journal.pone.0049897.pdf	145	{While,a,greater,proportion,of,NK,cells,possessed,a,terminally,differentiated,phenotype,",",this,did,not,correspond,to,an,overall,increase,in}	{NULL}
journal.pone.0049897.pdf	146	{2.0,x10}	{NULL}
journal.pone.0049897.pdf	147	{1.0,x10}	{NULL}
journal.pone.0049897.pdf	148	{Total,Gr-1,(,Ly-6C,),high}	{NULL}
journal.pone.0049897.pdf	149	{Figure,2,.}	{NULL}
journal.pone.0049897.pdf	150	{Meth,causes,a,reduction,of,splenic,leukocyte,subsets,.}	{NULL}
journal.pone.0049897.pdf	151	{C57BL/6,mice,were,treated,with,vehicle,(,control,),or,ramped,dosage,of}	{NULL}
journal.pone.0049897.pdf	152	{T0t3l,DC5,Total,NK,cells,number,.}	{NULL}
journal.pone.0049897.pdf	153	{We,observed,that,total,KLRGl,+,",",CD27,_,NK,cells,were,relatively,similar,between,meth-treated,and,control,animals,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	154	{4E,),.}	{NULL}
journal.pone.0049897.pdf	155	{However,",",there,was,a,signiﬁcant,decrease,in,total,KLRGl,_,",",CD27,’,NK,cells,after,meth,treatment,compared,to,control,(,p,<,o.,oool,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	156	{4D,),.}	{NULL}
journal.pone.0049897.pdf	157	{These,results,suggest,that,meth,treatment,may,promote,the,terminal,differentiation,of,NK,cells,and,also,reduce,the,abundance,of,non-terminally,differentiated}	{NULL}
journal.pone.0049897.pdf	158	{Control,*,*,Meth,D,T}	{NULL}
journal.pone.0049897.pdf	159	{1.0,x10,‘}	{NULL}
journal.pone.0049897.pdf	160	{o,O,7.5,x105,'}	{NULL}
journal.pone.0049897.pdf	161	{I,I}	{NULL}
journal.pone.0049897.pdf	162	{5.0,x105,.}	{NULL}
journal.pone.0049897.pdf	163	{o,:3,:}	{NULL}
journal.pone.0049897.pdf	164	{2.5,x105,.}	{NULL}
journal.pone.0049897.pdf	165	{control,methamphetamine,(,meth,—,see,methods,),for,14,days,.}	{NULL}
journal.pone.0049897.pdf	166	{At,day,14,",",mice,were,sacrificed,and,splenic,leukocyte,subsets,were,analyzed,by,flow,cytometry,.}	{NULL}
journal.pone.0049897.pdf	167	{A.,Meth,treatment,did,not,alter,total,splenocyte,number,.}	{NULL}
journal.pone.0049897.pdf	168	{B.,Meth,causes,a,significant,reduction,in,total,natural,killer,(,NK,),cells,(,NKp46,*,",",CD3,’,",",B220,’,",",Gr,—,1,’,",",MHC,II,’,),.}	{NULL}
journal.pone.0049897.pdf	169	{C.,Gr,—,1hi9,"\\"",monocytes,(,CD11b,"\\"",",",Gr,—,1hi9,“,",",MHC,II,’,",",CD3,’,",",B220,’,),were,reduced,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	170	{D.,Meth,treatment,reduces,dendritic,cells,(,DCs,),defined,as,CD11c,+,",",MHC,II,"\\"",",",B220,’,",",Gr,—,1,’,events,.}	{NULL}
journal.pone.0049897.pdf	171	{Dead,cells,and,doublets,were,removed,prior,to,analysis,.}	{NULL}
journal.pone.0049897.pdf	172	{**,P,<,0.01,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	173	{—,.}	{NULL}
journal.pone.0049897.pdf	174	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	175	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	176	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	177	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	178	{pone,.}	{NULL}
journal.pone.0049897.pdf	179	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	180	{gOO2}	{NULL}
journal.pone.0049897.pdf	181	{A,I,Meth,I,Control,100}	{NULL}
journal.pone.0049897.pdf	182	{lsotype}	{NULL}
journal.pone.0049897.pdf	183	{03,O,G,"}",C,),M,"\\"",/,ahof,Max}	{NULL}
journal.pone.0049897.pdf	184	{MFI,CD80}	{NULL}
journal.pone.0049897.pdf	185	{105,ph,"}"}	{NULL}
journal.pone.0049897.pdf	186	{Bo,1,3000}	{NULL}
journal.pone.0049897.pdf	187	{E5,.9,12000,E,50,:,in,Q,1,1,ooo,°,u,‘,~,‘,34,°,—,10000,°,u.,20,E,9000}	{NULL}
journal.pone.0049897.pdf	188	{D,8000}	{NULL}
journal.pone.0049897.pdf	189	{o,"103 104 105",Control,Meth}	{NULL}
journal.pone.0049897.pdf	190	{CD1,1,b}	{NULL}
journal.pone.0049897.pdf	191	{Figure,3,.}	{NULL}
journal.pone.0049897.pdf	192	{Meth,perturbs,Gr-1,',°,‘”,monocytes/macrophages,.}	{NULL}
journal.pone.0049897.pdf	193	{Gr,—,1,',°,‘”,monocytes/macrophages,were,analyzed,for,signs,of,activation,after,meth,treatment,using,flow,cytometry,.}	{NULL}
journal.pone.0049897.pdf	194	{A.,Representative,histogram,showing,CD80,(,B7,—,1,),expression,by,Gr1,°,‘”}	{NULL}
journal.pone.0049897.pdf	195	{monocytes/macrophages,.}	{NULL}
journal.pone.0049897.pdf	196	{Red,represents,a,meth,—,treated,animal,",",black,represents,a,vehic,|,e,—,treated,animal,",",and,grey,is,the,isotype,control,.}	{NULL}
journal.pone.0049897.pdf	197	{B.,Meth,causes,increased,expression,of,CD80,by,Gr1,',°,‘”,",",quantified,by,mean,fluorescence,intensity,(,MFI,),.}	{NULL}
journal.pone.0049897.pdf	198	{C.,Representative,histogram,showing,CD11b,(,Mac,—,1,),expression,by,Gr,—,1,',°,‘”,monocytes,/,macrophages,with,colors,as,in,A,above,.}	{NULL}
journal.pone.0049897.pdf	199	{D.,Meth,causes,decreased,expression,of,CD11b,by,Gr,—,1,',°,‘”,monocytes,",",quantified,by,MFI,.}	{NULL}
journal.pone.0049897.pdf	200	{Dead,cells,and,doublets,were,removed,prior,to,analysis,.}	{NULL}
journal.pone.0049897.pdf	201	{**,p,<,0.01,",",***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	202	{—,.}	{NULL}
journal.pone.0049897.pdf	203	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	204	{Error,bars,represent,SEM,.}	{NULL}
journal.pone.0049897.pdf	205	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	206	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	207	{pone,.}	{NULL}
journal.pone.0049897.pdf	208	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	209	{gOO3}	{NULL}
journal.pone.0049897.pdf	210	{NK,cells,.}	{NULL}
journal.pone.0049897.pdf	211	{No,difference,in,Ly-49H,",",Ly-49G2,",",or,CD94,expression,was,noted,after,treatment,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	212	{CD4,T,Cells,Meth,treatxnent,results,in,decreased,proportions,of,activated,CD4,T,cells,in,spleen,and,lyrnph,node,.}	{NULL}
journal.pone.0049897.pdf	213	{Meth,has,been,associated,with,altered,T,cell,activation,and,proliferation,.}	{NULL}
journal.pone.0049897.pdf	214	{We,investigated,the,role,of,meth,on,CD4,and,CD8,T,cells,in,the,spleen,and,mesenteric,lymph,node,(,MLN,),to,determine,if,meth,inﬂuences,antigen-experienced,and,naive,subsets,of,T,cells,in,viva,.}	{NULL}
journal.pone.0049897.pdf	215	{Within,the,splenic,CD4,T,cell,compartment,",",we,observed,a,signiﬁcant,decrease,in,proportion,of,CD62Ll,"\\"",‘”,",",CD44high,antigen-experienced,cells,after,meth,treatment,(,p,<,o.,oool,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	216	{5A,&,B,),.}	{NULL}
journal.pone.0049897.pdf	217	{Futhermore,",",within,this,cD62L,“’,W,",",cD44hig,“,subset,we,observed,a,decreased,proportion,of,cells,expressing,high,levels,of,CD27,in,meth,—,treated,mice,compared,to,controls,(,p,=,0.0029,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	218	{5C,&,D,),.}	{NULL}
journal.pone.0049897.pdf	219	{Among,CD62L,+,CD4,T,cells,",",we,observed,a,signiﬁcant,increase,in,proportion,of,naive,CD45RB1,’,right,CD441,“,cells,(,p,<,o.,oool,),",",with,signiﬁcant,decreases,in,proportion,of,CD45RB1,"\\"",‘”,",",CD441,”,(,p,=,0.0003,),and,CD45RB,“,"\\"",”,",",cD44high,7}	{NULL}
journal.pone.0049897.pdf	220	{cells,(,p,=,o.,oool,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	221	{6A,.}	{NULL}
journal.pone.0049897.pdf	222	{—,.}	{NULL}
journal.pone.0049897.pdf	223	{D,),.}	{NULL}
journal.pone.0049897.pdf	224	{Combined,",",these,results,suggest,a,decrease,in,overall,actiVation,/,antigen,experience,by,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	225	{While,a,similar,decrease,in,CD62L,_,",",CD44high,proportion,was,noted,in,the,MLN,(,p,=,0.0052,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	226	{7A,&,B,),",",we,did,not,observe,differences,in,CD27,expression,within,this,subset,in,this,organ,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	227	{"\\\\",/,Ve,also,observed,no,differences,in,the,CD62L,+,population,of,MLN,CD4,T,cells,after,meth,treatment,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	228	{In,total,",",meth,appears,to,inhibit,CD4,T,cell,activation,in,secondary,lymphoid,tissue,.}	{NULL}
journal.pone.0049897.pdf	229	{Meth,causes,upregulation,of,CD150,(,SLAM,),on,CD226,+,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	230	{Members,of,the,signaling,lymphocytic,activation,(,SLAM,),family,are,associated,with,T,cell,activation,",",and,signaling,through,CD150,(,SLAM,),results,in,IFN-o,/,production,",",differentiation,",",and,proliferation,by,T,cells,[,47,],.}	{NULL}
journal.pone.0049897.pdf	231	{CD226,expression,has,been,associated,with,Thl,status,in,murine,T,cells,[,48,],.}	{NULL}
journal.pone.0049897.pdf	232	{"\\\\",Ne,hypothesized,that,meth,’s,negative,impact,on,T,cell,activation,should,correspond,to,a,decrease,in,CD150,expression,as,well,as,a,decreased,proportion,of,CD226-expressing,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	233	{To,test,this,hypothesis,",",we,compared,CD150,MFI,and,proportion,of,CD226,+,CD4,T,cells,from,meth,—,treated,and,control,mice,.}	{NULL}
journal.pone.0049897.pdf	234	{U,’,!}	{NULL}
journal.pone.0049897.pdf	235	{D,-,B,O,In}	{NULL}
journal.pone.0049897.pdf	236	{%,KLRG1,‘,",",0327,*}	{NULL}
journal.pone.0049897.pdf	237	{3,2,3,Total,KLRG1,"\\""}	{NULL}
journal.pone.0049897.pdf	238	{Control,Meth}	{NULL}
journal.pone.0049897.pdf	239	{C,*,*,1,-,_,E,30,',',Q,3,.}	{NULL}
journal.pone.0049897.pdf	240	{ox1o,°}	{NULL}
journal.pone.0049897.pdf	241	{‘,h,o,N,U,D,o,__,U,p,3,L,2.0,x105,+,"\\"",.}	{NULL}
journal.pone.0049897.pdf	242	{U,6,',3,S,m,40,4,:,o,3,1,.}	{NULL}
journal.pone.0049897.pdf	243	{ox1o,°,.}	{NULL}
journal.pone.0049897.pdf	244	{—,.}	{NULL}
journal.pone.0049897.pdf	245	{I,§,°,:2}	{NULL}
journal.pone.0049897.pdf	246	{2o,.2,o}	{NULL}
journal.pone.0049897.pdf	247	{Control,Control}	{NULL}
journal.pone.0049897.pdf	248	{Figure,4,.}	{NULL}
journal.pone.0049897.pdf	249	{Meth,alters,NK,cell,subsets,.}	{NULL}
journal.pone.0049897.pdf	250	{We,labeled,splenic,NK,cells,(,NK1,.1,"\\"",",",CD4,’,",",CD8,’,),with,antibodies,against,killer,cell,|,ectin,—,|,ike,receptor,G1,(,KLRG1,),and,CD27,to,determine,if,meth,treatment,alters,functionally,distinct,NK,cell,subsets,.}	{NULL}
journal.pone.0049897.pdf	251	{A.,Representative,gating,showing,KLRG1,and,CD27,on,gated,NK,cells,.}	{NULL}
journal.pone.0049897.pdf	252	{B,and,C.,Meth,treatment,results,in,a,decreased,proportion,of,KLRG1,’,",",CD27,*,NK,cells,with,an,increase,in,proportion,of,KLRG1,"\\"",",",CD27,’,NKs,.}	{NULL}
journal.pone.0049897.pdf	253	{D,and,E.,Although,proportionally,higher,",",KLRG1,*,",",CD27,’,NK,cells,are,not,increased,in,absolute,number,.}	{NULL}
journal.pone.0049897.pdf	254	{However,",",KLRG1,’,",",CD27,*,NK,cells,were,significantly,reduced,in,number,.}	{NULL}
journal.pone.0049897.pdf	255	{Dead,cells,and,doublets,were,removed,prior,to,analysis,.}	{NULL}
journal.pone.0049897.pdf	256	{***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	257	{—,.}	{NULL}
journal.pone.0049897.pdf	258	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	259	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	260	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	261	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	262	{pone,.}	{NULL}
journal.pone.0049897.pdf	263	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	264	{gOO4}	{NULL}
journal.pone.0049897.pdf	265	{Although,we,observed,no,differences,in,CD226,expression,after,meth,treatment,(,data,not,shown,),",",we,did,observe,signiﬁcantly,increased,expression,of,CD150,on,CD226,+,CD44,+,CD4,T,cells,(,p,<,o.,oool,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	266	{8A,&,B,),.}	{NULL}
journal.pone.0049897.pdf	267	{The,upregulation,of,this,costimulatory,molecule,suggests,that,meth,promotes,the,activation,of,speciﬁc,subsets,of,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	268	{Meth,causes,the,expansion,of,a,KLRGIT,CD4,T,cell,subset,that,is,not,FoxP3,+,.}	{NULL}
journal.pone.0049897.pdf	269	{Regulatory,T,cells,(,TREGS,),are,fundamental,in,maintaining,tolerance,[,49,],and,within,the,TREG,population,",",a,potent,regulatory,compartment,expressing,KLRG1,has,been,reported,in,healthy,mice,[,50,],.}	{NULL}
journal.pone.0049897.pdf	270	{To,determine,the,effect,of,meth,on,speciﬁc,subsets,of,TREGS,",",we,labeled,splenic,CD4,T,cells,with,FOXP3,",",CD25,(,IL-2Roc,),",",and,KLRG1,",",with,additional,markers,of,homing,and,differentiation,.}	{NULL}
journal.pone.0049897.pdf	271	{Although,we,observed,no,signiﬁcant,difference,in,KLRGW,‘,",",FoxP3,+,",",cD25,+,CD4,T,cells,after,meth,treatment,(,data,not,shown,),",",we,did,observe,a,signiﬁcant,expansion,of,KLRGl,+,FoxP3,_,CD4,T,cells,in,proportion,and,absolute,number,after,meth,treatment,(,p,<,o.,oool,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	272	{9A,&,B,),.}	{NULL}
journal.pone.0049897.pdf	273	{These,cells,were,cD44,',“,%,"\\"",",",CD45RB,“,"\\"",”,",",oD251,‘“,"\\"",oD62L,“’,W,",",and,NKGZD,‘,(,data,not,shown,),",",a,proﬁle,of,protein,expression,suggesting,u,103,10,‘,105,u,103,I,10,‘,105}	{NULL}
journal.pone.0049897.pdf	274	{CD62L}	{NULL}
journal.pone.0049897.pdf	275	{*,',k,*}	{NULL}
journal.pone.0049897.pdf	276	{%,cD44,*,"\\"",5,“,",",cD62I,.,'}	{NULL}
journal.pone.0049897.pdf	277	{°,"\\"","\\""}	{NULL}
journal.pone.0049897.pdf	278	{control}	{NULL}
journal.pone.0049897.pdf	279	{o,SDK,100K,150K,200K,250K,o,50K,100K,150K,ZDDK,250K}	{NULL}
journal.pone.0049897.pdf	280	{FSC}	{NULL}
journal.pone.0049897.pdf	281	{%,cD27,"\\"",‘,3,"\\""}	{NULL}
journal.pone.0049897.pdf	282	{Figure,5,.}	{NULL}
journal.pone.0049897.pdf	283	{Meth,reduces,proportions,of,CD62L,',°,"\\"","\\"",",",CD44,"\\"",‘,9,"\\"",splenic,CD4,T,cells,and,these,cells,exhibit,lower,CD27,expression,.}	{NULL}
journal.pone.0049897.pdf	284	{Splenic,CD4,T,cells,were,examined,after,meth,treatment,to,determine,if,meth,alters,surface,phenotypes,suggesting,activation/antigen,experience,and,effector,status,.}	{NULL}
journal.pone.0049897.pdf	285	{A.,Representative,gating,showing,CD62L,and,CD44,on,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	286	{B.,Meth,causes,a,reduction,in,proportion,of,CD44hi9h,",",CD62L,',°,‘”,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	287	{C.,CD27,expression,by,CD44,',“,9,“,",",CD62L,',°,‘”,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	288	{D.,CD44,“‘,9h,",",CD62L,',°,‘”,CD4,T,cells,from,meth,treated,animals,exhibit,a,lower,proportion,of,cells,expressing,CD27,at,a,high,level,.}	{NULL}
journal.pone.0049897.pdf	289	{**,p,<,0.01,",",***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	290	{—,.}	{NULL}
journal.pone.0049897.pdf	291	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	292	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	293	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	294	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	295	{pone,.}	{NULL}
journal.pone.0049897.pdf	296	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	297	{gOO5}	{NULL}
journal.pone.0049897.pdf	298	{activation,.}	{NULL}
journal.pone.0049897.pdf	299	{A,similar,KLRGl,+,expansion,was,observed,in,MLN,",",although,FoxP3,staining,was,not,performed,in,the,MLN,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	300	{These,data,from,spleen,and,MLN,demonstrate,that,meth,promotes,the,expansion,of,a,CD4,T,cell,subset,with,a,terminal,effector,phenotype,",",an,unexpected,ﬁnd,amidst,signs,of,suppression,.}	{NULL}
journal.pone.0049897.pdf	301	{CD8,T,Cells,Meth,treatxnent,results,in,decreased,proportions,of,activated,CD8,T,cells,in,spleen,and,lyxnph,node,.}	{NULL}
journal.pone.0049897.pdf	302	{Naive,CD8,T,cells,can,differentiate,into,cytotoxic,effectors,with,shortlived,status,or,long-term,memory,potential,.}	{NULL}
journal.pone.0049897.pdf	303	{Since,meth-induced,deﬁciencies,in,these,effector,subsets,may,leave,the,user,more,vulnerable,to,pathogens,",",we,investigated,meth,’s,ability,to,alter,CD8,T,cell,subpopulations,.}	{NULL}
journal.pone.0049897.pdf	304	{CD8,T,cells,can,be,divided,into,4,subsets,depending,on,levels,of,CD62L,and,CD44,expression,:,cD62L,“,ig,“,",",CD441,”,(,naive,CD8,T,cell,",",TN,),",",CD62Lh,‘,gh,",",cD44,‘“,i,%,‘“,",",(,central,memory,CD8,T,cell,",",TCM,),",",CD62L,“’,“’,",",CD44high,(,effector,memory,CD8,T,cells,",",TEM,),",",and,CD62Ll,"\\"",W,",",CD441,“,(,acute/activated,effector,CD8,T,cell,",",TAE,),[,"51,52",],.}	{NULL}
journal.pone.0049897.pdf	305	{Within,the,spleen,",",we,observed,a,signiﬁcant,increase,in,proportion,of,CD8,TN,cells,(,p,=,0.0185,),with,a,decrease,in,proportion,ofTEM,(,p,=,0.0021,),and,TAE,(,p,=,0.0021,),subsets,",",but,no,change,in,TQM,proportion,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	306	{loA,.}	{NULL}
journal.pone.0049897.pdf	307	{—,.}	{NULL}
journal.pone.0049897.pdf	308	{E,),.}	{NULL}
journal.pone.0049897.pdf	309	{Similar,alterations,were,observed,in,the,MLN,.}	{NULL}
journal.pone.0049897.pdf	310	{Mesenteric,lymph,node,CD8,T,cells,in,meth-treated,mice,showed,a,signiﬁcant,increase,in,proportion,of,CD8,TN,cells,(,p,<,o.,oool,),with,a,decrease,in,proportion,ofTEM,(,p,<,o.,oool,),",",TAE}	{NULL}
journal.pone.0049897.pdf	311	{(,o,=,o.,ooll,),",",and,TCM,subsets,(,p,=,0.0029,;,Fig,.}	{NULL}
journal.pone.0049897.pdf	312	{11,A,.}	{NULL}
journal.pone.0049897.pdf	313	{—,.}	{NULL}
journal.pone.0049897.pdf	314	{E,),.}	{NULL}
journal.pone.0049897.pdf	315	{From,these,results,",",it,appears,that,meth,also,negatively,impacts,the,accumulation,of,antigen-experienced,CD8,T,cells,",",similar,to,what,was,observed,in,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	316	{Meth,treatment,results,in,decreased,numbers,of,KLRGl,+,CD8,T,cells,in,the,MLN,.}	{4|5|10|11}
journal.pone.0049897.pdf	317	{KLRG1,is,expressed,by,effector,CD8,T,cells,[,53,],",",and,we,postulated,that,meth,’s,disruption,of,antigen,presenting,pathways,and,T,cell,activation,would,also,effect,the,proﬁle,of,this,marker,of,CD8,T,cell,activation,.}	{NULL}
journal.pone.0049897.pdf	318	{Interestingly,",",we,observed,a,signiﬁcant,decrease,in,KLRG1-expressing,CD8,T,cells,(,p,<,o.,oool,),in,the,MLN,(,Figure,12,A,),",",yet,we,observed,no,difference,in,KLRG1,expression,by,CD8,T,cells,in,the,spleen,(,data,not,shown,),.}	{NULL}
journal.pone.0049897.pdf	319	{This,reduction,in,the,MLN,adds,further,evidence,to,support,the,notion,that,meth,reduces,speciﬁc,effector,T,cells,and,may,promote,weakened,immunity,.}	{NULL}
journal.pone.0049897.pdf	320	{Discussion}	{NULL}
journal.pone.0049897.pdf	321	{Meth,Decreases,the,Abundance,of,Splenic,Innate,Leukocytes,Previous,studies,have,suggested,meth,has,the,potential,to,disrupt,immune,homeostasis,and,leave,the,user,more,susceptible,to,pathogenic,challenge,.}	{NULL}
journal.pone.0049897.pdf	322	{With,meth,impacting,the,function,of,NK,cells,and,antigen-presenting,cells,(,APCS,),",",a,basis,of,innate,immunity,becomes,weakened,",",and,consequent,and,appropriate,adaptive,responses,by,T,and,B,cells,are,less,likely,.}	{NULL}
journal.pone.0049897.pdf	323	{In,this,study,",",we,observed,an,overall,decrease,in,both,proportion,and,number,of,splenic,NK,cells,",",DCs,",",and,Gr-lhlgh,monocytes,/,macrophages,.}	{NULL}
journal.pone.0049897.pdf	324	{_,s,o,U1,cn4_5RB,_}	{NULL}
journal.pone.0049897.pdf	325	{Meth,0.53}	{NULL}
journal.pone.0049897.pdf	326	{c,L,","}	{NULL}
journal.pone.0049897.pdf	327	{E,»,E,Q.,70,—,q,_,E,<,Q,55,8,.}	{NULL}
journal.pone.0049897.pdf	328	{:,‘,3,"\\"",E,so,2,pg,m,I,:,D,:,In,55,',-,o,q,-,‘,:1,’,g,D,U,so,U,"\\\\",°,§,°,control,Meth,Control,Meth}	{NULL}
journal.pone.0049897.pdf	329	{_,-,=,D,|,E,’,10,3,9,e,s,2,‘,:,.}	{NULL}
journal.pone.0049897.pdf	330	{—,.}	{NULL}
journal.pone.0049897.pdf	331	{I,‘,o,fig,5,I,.}	{NULL}
journal.pone.0049897.pdf	332	{E,3,',§,2}	{NULL}
journal.pone.0049897.pdf	333	{Figure,6,.}	{NULL}
journal.pone.0049897.pdf	334	{Meth,causes,reduced,proportions,of,alternatively,spliced,CD4,T,cells,among,the,splenic,CD62L,"\\"",i9,"\\"",compartment,.}	{NULL}
journal.pone.0049897.pdf	335	{Meth,and,control,mice,were,analyzed,for,surface,expression,of,CD45RB,and,CD44,on,the,CD62L,“,',9h,subset,.}	{NULL}
journal.pone.0049897.pdf	336	{CD45RB,_,expression,is,downregulated,upon,antigen,experience,and,can,be,used,to,gauge,activation,levels,of,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	337	{A.,CD45RB,and,CD44,on,CD62Lh,',9h,splenic,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	338	{B,.}	{NULL}
journal.pone.0049897.pdf	339	{—,.}	{NULL}
journal.pone.0049897.pdf	340	{D.,Meth,—,treated,animals,had,a,higher,proportion,of,CD45RBhi9,"\\"",",",CD44,',°,‘”,CD4,T,cells,compared,to,controls,.}	{NULL}
journal.pone.0049897.pdf	341	{Meth,—,treated,animals,also,exhibited,lower,proportions,of,CD45RB,',°,‘”,",",CD44,',°,‘”,and,CD45RB,',°,‘”,",",CD44,',“,9,“,subsets,compared,to,controls,.}	{NULL}
journal.pone.0049897.pdf	342	{***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	343	{—,.}	{NULL}
journal.pone.0049897.pdf	344	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	345	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	346	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	347	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	348	{pone,.}	{NULL}
journal.pone.0049897.pdf	349	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	350	{gOO6}	{NULL}
journal.pone.0049897.pdf	351	{Meth-induced,leukopenia,had,been,previously,reported,by,Saito,et,al.,[,37,],",",who,noted,reduced,numbers,of,leukocytes,in,the,blood,of,male,Slc,:,ddY,mice,at,l,",",4,",",24,",",and,48,hours,after,meth,treatment,",",but,did,not,determine,which,subsets,were,impacted,by,meth,.}	{NULL}
journal.pone.0049897.pdf	352	{Furthermore,",",our,results,showing,no,difference,in,splenic,T,and,B,cell,proportion,after,meth,treatment,are,in,agreement,with,the,ﬁndings,of,Wey,et,al.,[,31,],",",who,analyzed,splenocytes,from,meth-treated,BALB,/,c,mice,for,proportion,of,B220,",",CD4,and,CD8-expressing,cells,.}	{NULL}
journal.pone.0049897.pdf	353	{While,the,effect,of,meth,of,promoting,apoptosis,[,"28,39",],may,explain,some,of,this,reduction,in,cell,number,",",it,would,also,raise,the,question,as,to,why,certain,subsets,remain,relatively,unchanged,after,meth,exposure,.}	{NULL}
journal.pone.0049897.pdf	354	{l}	{NULL}
journal.pone.0049897.pdf	355	{N,tall,o,O,O,O,oooo,O}	{NULL}
journal.pone.0049897.pdf	356	{%,cD44,“‘,3,“,",",cD62L,',°,"\\"","\\"",uu,N,01}	{NULL}
journal.pone.0049897.pdf	357	{CD62L,Control,Meth}	{NULL}
journal.pone.0049897.pdf	358	{Figure,7,.}	{NULL}
journal.pone.0049897.pdf	359	{Meth,treatment,causes,a,reduction,in,proportion,of,CD62L,',°,"\\"","\\"",",",CD44,"\\"",i9,"\\"",CD4,T,cells,in,the,mesenteric,lymph,node,(,MLN,),.}	{NULL}
journal.pone.0049897.pdf	360	{MLN,CD4,T,cells,were,labeled,with,CD62L,and,CD44,to,determine,proportions,of,antigen,—,e_xperienced,cells,.}	{NULL}
journal.pone.0049897.pdf	361	{A.,CD62L,and,CD44,on,MLN,CD4,T,cells,from,meth,and,vehicle,treated,animals,.}	{NULL}
journal.pone.0049897.pdf	362	{B.,Meth,causes,a,reduction,in,proportion,of,CD44h,',9,",",CD62L,',°,‘”,CD4,T,cells,in,the,MLN,.}	{NULL}
journal.pone.0049897.pdf	363	{**,p,<,0.01,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	364	{—,.}	{NULL}
journal.pone.0049897.pdf	365	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	366	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	367	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	368	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	369	{pone,.}	{NULL}
journal.pone.0049897.pdf	370	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	371	{gOO7}	{NULL}
journal.pone.0049897.pdf	372	{I,Meth,IControl,lsotype}	{NULL}
journal.pone.0049897.pdf	373	{Control,Meth}	{NULL}
journal.pone.0049897.pdf	374	{Figure,8,.}	{NULL}
journal.pone.0049897.pdf	375	{Increased,expression,of,CD150,on,CD226T,CD4,T,cells,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	376	{We,examined,the,expression,of,the,costimulatory,markers,CD150,and,CD226,by,splenic,CD4,T,cells,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	377	{A.,Representative,gating,and,histogram,showing,selection,of,CD226,"\\"",CD4,T,cells,and,increased,expression,of,CD1,50,by,meth,treated,animals,compared,to,control,.}	{NULL}
journal.pone.0049897.pdf	378	{Red,represents,a,meth,—,treated,animal,",",black,is,vehic,|,e,—,treated,animal,",",and,grey,is,the,isotype,control,.}	{NULL}
journal.pone.0049897.pdf	379	{B.,CD226T,CD4,T,cells,from,meth,treated,animals,express,higher,levels,of,CD150,than,those,from,control,animals,.}	{NULL}
journal.pone.0049897.pdf	380	{Protein,expression,was,calculated,using,mean,fluorescence,intensity,(,MFI,),.}	{NULL}
journal.pone.0049897.pdf	381	{***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	382	{—,.}	{NULL}
journal.pone.0049897.pdf	383	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	384	{Error,bars,represent,SEM,.}	{NULL}
journal.pone.0049897.pdf	385	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	386	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	387	{pone,.}	{NULL}
journal.pone.0049897.pdf	388	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	389	{gOO8}	{NULL}
journal.pone.0049897.pdf	390	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0049897.pdf	391	{p,|,osone.org,9,December,2012,|,Volume,7,|,Issue,12,|,e49897}	{NULL}
journal.pone.0049897.pdf	392	{Control,Meth}	{NULL}
journal.pone.0049897.pdf	393	{KLRG1}	{NULL}
journal.pone.0049897.pdf	394	{B,***,***}	{NULL}
journal.pone.0049897.pdf	395	{r,----,1,.}	{NULL}
journal.pone.0049897.pdf	396	{r,.}	{NULL}
journal.pone.0049897.pdf	397	{—,.}	{NULL}
journal.pone.0049897.pdf	398	{.}	{NULL}
journal.pone.0049897.pdf	399	{—,.}	{NULL}
journal.pone.0049897.pdf	400	{.}	{NULL}
journal.pone.0049897.pdf	401	{—,.}	{NULL}
journal.pone.0049897.pdf	402	{.}	{NULL}
journal.pone.0049897.pdf	403	{—,.}	{NULL}
journal.pone.0049897.pdf	404	{.}	{NULL}
journal.pone.0049897.pdf	405	{—,.}	{NULL}
journal.pone.0049897.pdf	406	{.}	{NULL}
journal.pone.0049897.pdf	407	{—,.}	{NULL}
journal.pone.0049897.pdf	408	{.}	{NULL}
journal.pone.0049897.pdf	409	{—,.}	{NULL}
journal.pone.0049897.pdf	410	{ﬁ}	{NULL}
journal.pone.0049897.pdf	411	{-,14,21,.}	{NULL}
journal.pone.0049897.pdf	412	{Ox105,"\\"",5,o,X,.}	{NULL}
journal.pone.0049897.pdf	413	{%,‘,2,E.,‘,w,<,.}	{NULL}
journal.pone.0049897.pdf	414	{+,I-7-5X10,.}	{NULL}
journal.pone.0049897.pdf	415	{H,L.,8,o,£,9,5.0,x10,3,as,6,°,5,3,“,C,in,4,I,“,2.5,x10,"\\"",o,',1,O}	{NULL}
journal.pone.0049897.pdf	416	{x,2,3,S}	{NULL}
journal.pone.0049897.pdf	417	{o,I2,o}	{NULL}
journal.pone.0049897.pdf	418	{Control,Meth,Control,Meth}	{NULL}
journal.pone.0049897.pdf	419	{Figure,9,.}	{NULL}
journal.pone.0049897.pdf	420	{Meth,promotes,the,expansion,of,splenic,KLRG1,+,",",FoxP3,’,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	421	{Meth,—,treated,animals,possessed,an,expansion,of,KLRG1,"\\"",CD4,T,cells,within,the,spleen,.}	{NULL}
journal.pone.0049897.pdf	422	{These,cells,were,CD44,',“,9h,and,negative/low,for,FoxP3,",",CD25,",",CD62L,",",NKG2D,",",and,CD45RB,.}	{NULL}
journal.pone.0049897.pdf	423	{A.,Representative,gating,showing,significant,expansion,of,splenic,KLRG1,+,",",FoxP3,’,CD4,T,cells,among,the,CD44,',“,9h,",",CD45RB,',°,"\\"","\\"",compartment,with,relatively,unchanged,proportions,of,FoxP3,—,expressing,subsets,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	424	{B,and,C.,Proportion,and,absolute,number,of,KLRG1,"\\"",",",FoxP3,’,CD4,cells,are,increased,with,meth,.}	{NULL}
journal.pone.0049897.pdf	425	{***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	426	{—,.}	{NULL}
journal.pone.0049897.pdf	427	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	428	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	429	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	430	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	431	{pone,.}	{NULL}
journal.pone.0049897.pdf	432	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	433	{gOO9}	{NULL}
journal.pone.0049897.pdf	434	{The,ﬁndings,of,Saito,et,al.,showing,leukocyte,deﬁciencies,in,stable,",",tissue,resident,and,endothelium-monitoring,population,blood,and,our,observed,reductions,of,myeloid,populations,within,capable,of,macrophage,and,DC,differentiation,",",while,Ly-6Chigh,the,spleen,may,suggest,a,sensitivity,to,meth,in,the,bone,marrow,",",monocytes,tend,to,home,to,areas,of,inﬂammation,and,mature,to,a,lipid-rich,environment,that,may,store,meth,and,have,inﬂammatory,DCs,and,macrophages,[,57,],.}	{NULL}
journal.pone.0049897.pdf	435	{Our,observation,of,detrimental,effects,on,bone,marrow-derived,leukocyte,subsets,.}	{NULL}
journal.pone.0049897.pdf	436	{It,reduced,splenic,Gr-l,(,Ly-6C,),high,monocytes,/,macrophages,ﬁts,well,is,known,that,meth,is,lipophilic,and,can,accumulate,in,solid,tissue,with,the,reduced,number,of,peritoneal,macrophages,after,meth,[,l2,",",l3,],",",and,it,has,been,reported,that,meth,can,persist,in,bone,exposure,reported,by,In,et,al.,[,32,],.}	{NULL}
journal.pone.0049897.pdf	437	{In,their,study,",",they,utilized,the,marrow,[,54,—,56,],.}	{NULL}
journal.pone.0049897.pdf	438	{Additionally,",",In,et,al.,[,30,],reported,reduced,intraperitoneal,thioglycolate,injection,model,of,inﬂammation,to,granulocyte-macrophage,colony,formation,in,GM-CSF-treated,promote,macrophage,accumulation,in,the,peritoneum,.}	{NULL}
journal.pone.0049897.pdf	439	{This,cultures,of,bone,marrow,harvested,from,meth-treated,CD-l,mice,.}	{NULL}
journal.pone.0049897.pdf	440	{model,has,been,shown,to,cause,the,migration,of,Ly-6C,"\\"",ig,"\\"",(,but,For,these,reasons,",",it,would,be,meaningful,to,perform,additional,not,Ly-6C1,"\\"",‘”,),monocytes,to,the,peritoneum,[,57,],",",where,they,investigations,on,the,effects,of,meth,on,haematopoesis,and,the,ultimately,mature,to,macrophage,.}	{NULL}
journal.pone.0049897.pdf	441	{The,noted,deﬁciencies,in,seeming,imperviousness,to,meth,by,B,cells,",",neutrophils,",",and,Gr,-,peritoneal,macrophages,correlates,with,our,observation,of,reduced,11,"\\"",“,monocytes/macrophages,compared,to,other,bone,marrow,-,numbers,of,splenic,precursors,to,this,population,.}	{NULL}
journal.pone.0049897.pdf	442	{Indeed,",",the,derived,subsets,.}	{NULL}
journal.pone.0049897.pdf	443	{spleen,has,been,shown,to,be,a,signiﬁcant,reservoir,of,mature,The,immunological,roles,of,Gr-l,(,Ly-6C,),l,‘“,"\\"",and,Gr-l,(,Ly,-,monocytes,and,upon,inﬂammatory,signaling,",",to,exhibit,substantial,6C,),high,monocytes,/,macrophages,are,not,completely,clear,",",but,it,decreases,in,monocyte,numbers,as,cells,emigrate,[,42,],.}	{NULL}
journal.pone.0049897.pdf	444	{has,been,shown,that,Ly-6C1,"\\"",W,monocytes,appear,to,be,a,more}	{NULL}
journal.pone.0049897.pdf	445	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0049897.pdf	446	{p,|,osone.org,10,December,2012,|,Volume,7,|,Issue,12,|,e49897}	{NULL}
journal.pone.0049897.pdf	447	{54_5,Co,|,',l’,[,l'ol}	{NULL}
journal.pone.0049897.pdf	448	{.2,.5,»,in,an,-,=,.}	{NULL}
journal.pone.0049897.pdf	449	{—,.}	{NULL}
journal.pone.0049897.pdf	450	{I,S-4,f5,],3,15,3,8,D,o,U,U,.}	{NULL}
journal.pone.0049897.pdf	451	{O,-,=,"\\\\",2,‘,~,70,.}	{NULL}
journal.pone.0049897.pdf	452	{8,'59,Eq,65,f,.}	{NULL}
journal.pone.0049897.pdf	453	{£,3,3,',o,.}	{NULL}
journal.pone.0049897.pdf	454	{I,§,',;,"\\\\",',§,3,control,Meth,Control,Meth,D,at,1,:,Ii,‘,o,','}	{NULL}
journal.pone.0049897.pdf	455	{D}	{NULL}
journal.pone.0049897.pdf	456	{%,co44,',°,‘,"\\"",",",cn52L,',°,“,'}	{NULL}
journal.pone.0049897.pdf	457	{2.21,It,...,“,.....,.}	{NULL}
journal.pone.0049897.pdf	458	{",",....,l,.}	{NULL}
journal.pone.0049897.pdf	459	{o,103,10,‘,ms}	{NULL}
journal.pone.0049897.pdf	460	{CD44}	{NULL}
journal.pone.0049897.pdf	461	{control}	{NULL}
journal.pone.0049897.pdf	462	{Figure,10,.}	{NULL}
journal.pone.0049897.pdf	463	{Meth-treated,animals,exhibit,a,greater,proportion,of,naive,phenotype,CD8,T,cells,and,reduced,proportions,of,antigenexperienced,subsets,within,the,spleen,.}	{NULL}
journal.pone.0049897.pdf	464	{Splenic,CD8,T,cells,were,labeled,with,CD62L,and,CD44,and,classified,into,4,groups,according,the,expression,of,these,two,proteins,:,CD62Lhi9h,",",CD44,',°,‘”,(,Naive,CD8,T,cell,",",TN,),",",CD62Lhi9h,",",CD44,',“,9h,",",(,central,memory,CD8,T,cell,",",TCM,),",",CD62L,',°,"\\"","\\"",",",CD44hi9,“,(,effector,memory,CD8,T,cells,",",TEM,),",",and,CD62L,',°,‘”,",",CD44,',°,‘”,(,acute,effector,CD8,T,cell,",",TAE,),.}	{NULL}
journal.pone.0049897.pdf	465	{A.,Gating,showing,CD44,and,CD62L,expression,by,splenic,CD8,T,cells,.}	{NULL}
journal.pone.0049897.pdf	466	{B,.}	{NULL}
journal.pone.0049897.pdf	467	{—,.}	{NULL}
journal.pone.0049897.pdf	468	{E.,After,meth,treatment,",",the,TN,compartment,is,increased,in,proportion,",",while,the,TAE,and,TEM,showed,a,decrease,in,proportion,and,TCM,appeared,unchanged,.}	{NULL}
journal.pone.0049897.pdf	469	{*,p,<,0.05,",",**,p,<,0.01,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	470	{—,.}	{NULL}
journal.pone.0049897.pdf	471	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	472	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	473	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	474	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	475	{pone,.}	{NULL}
journal.pone.0049897.pdf	476	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	477	{gO10}	{NULL}
journal.pone.0049897.pdf	478	{Perturbed,Gr,—,1,',°,W,Monocytes/macrophages,may,be,Responding,to,Meth,—,induced,Cytotoxicity,and,Exhibiting,a,Tolerogenic,Function,In,addition,to,alterations,in,splenic,abundance,",",our,results,indicate,that,the,Gr-1,(,Ly-6C,),"\\"",ig,"\\"",and,Gr-1,(,Ly-6C,),1,"\\"",“,',monocyte,/,macrophage,populations,are,unequally,affected,by,meth,in,terms,of,activation,.}	{NULL}
journal.pone.0049897.pdf	479	{While,we,observed,no,difference,in,CD86,and,CD80,expression,by,Gr-l,(,Ly6C,),high,monocytes,/,macrophages,",",we,did,observe,a,signiﬁcant,increase,in,CD80,expression,by,Grl,(,Ly6C,),1,"\\"",W,monocytes,/,macrophages,",",with,no,change,in,their,CD86,expression,.}	{NULL}
journal.pone.0049897.pdf	480	{In,addition,to,their,role,in,vascular,repair,and,monitoring,[,58,],",",Ly6Cl,"\\"",W,monocytes/macrophages,have,been,reported,to,operate,as,phagocytes,",",capable,of,engulﬁng,debris,from,dead,cells,and,ultimately,promoting,T,cell,proliferation,[,59,],or,self,tolerance,[,60,],.}	{NULL}
journal.pone.0049897.pdf	481	{If,meth,is,capable,of,inducing,increased,rates,of,apoptosis,as,suggested,by,Potula,et,al.,[,28,],and,Iwasa,et,al.,[,39,],",",perhaps,this,population,of,monocytes,/,macrophages,is,responding,to,an,accumulation,of,dead,material,and,maturing,to,promote,tolerance,.}	{NULL}
journal.pone.0049897.pdf	482	{Indeed,",",CD80,has,been,shown,to,bind,PDL-l,[,"61,62",],and,this,interaction,results,in,reduced,rates,of,proliferation,among,T,cells,[,6l,",63",],",",suggesting,a,tolerogenic,function,of,CD80,in,addition,to,it,’s,known,role,in,costimulation,[,64,],.}	{NULL}
journal.pone.0049897.pdf	483	{Although,CD80-CTLA-4,interactions,have,also,been,proposed,to,terminate,effector,T,cell,responses,in,the,periphery,[,44,],",",our,data,do,not,lend,themselves,to,this,interpretation,.}	{NULL}
journal.pone.0049897.pdf	484	{The,Ly-6Cl,"\\"",W,monocytes/macrophages,in,our,study,are,MHC,II,_,","}	{NULL}
journal.pone.0049897.pdf	485	{thus,they,are,not,presenting,antigen,in,this,manner,and,therefore,are,unlikely,to,be,involved,in,speciﬁc,TCR-MHC,II,interactions,.}	{NULL}
journal.pone.0049897.pdf	486	{Furthermore,",",the,only,expansion,of,T,cells,we,observed,was,within,the,CD4,compartment,",",suggesting,MHC,II,dependency,and,providing,little,evidence,for,cross,presentation,.}	{NULL}
journal.pone.0049897.pdf	487	{Accumulation,and,removal,of,apoptotic,cells,may,also,explain,our,observed,decrease,in,CD1,lb,expression,on,Ly-6Cl,"\\"",W,monocytes/macrophages,.}	{NULL}
journal.pone.0049897.pdf	488	{A,recent,report,by,Schif-Zuck,et,al.,[,65,],has,described,a,decrease,in,CD1,lb,expression,on,“,satiated,”,macrophages,resulting,from,iC3b,directed,internalization,of,apoptotic,cells,.}	{NULL}
journal.pone.0049897.pdf	489	{Although,work,by,Talloczy,et,al.,[,33,],and,Martinez,et,al.,[,34,],has,suggested,reduced,phagocytic,efficacy,due,to,the,basic,properties,of,meth,impacting,with,the,acidic,endosome,of,macrophages,",",ﬁndings,that,suggest,reduced,antigenpresentation,effectiveness,and,activation,",",their,results,did,not,suggest,eliminated,antigen,processing,and,internalization,capabilities,",",rather,",",attenuated,",",and,therefore,are,not,in,disagreement,with,our,ﬁndings,.}	{NULL}
journal.pone.0049897.pdf	490	{Meth,—,induced,Alterations,in,NK,Cell,Proportion,and,Number,Suggest,Functional,Deficiencies,The,fundamental,roles,performed,by,N,K,cells,in,viral,immunity,[,66,],",",tumor,surveillance,[,67,],",",and,guiding,the,adaptive,immune,response,have,been,revealed,[,68,],.}	{NULL}
journal.pone.0049897.pdf	491	{Consequently,",",a,deﬁciency,in,NK,cell,number,as,well,as,NK,cell,function,may,lead,to,weakened,immunity,.}	{NULL}
journal.pone.0049897.pdf	492	{Our,observation,of,an,increased,proportion,of,terminally,differentiated,NK,cells,corresponds,with,previous}	{NULL}
journal.pone.0049897.pdf	493	{A,we,69,23.9,;,C,;,.}	{NULL}
journal.pone.0049897.pdf	494	{—,.}	{NULL}
journal.pone.0049897.pdf	495	{:,30,—,l,3,25,8,—,l,—,£,320,:,4,:,£,3,15,',ca,.1,5,2,3,1,g,Pp,_,1,C,’,control,Meth,3,E,an,-,**}	{NULL}
journal.pone.0049897.pdf	496	{[,TI}	{NULL}
journal.pone.0049897.pdf	497	{6,U,s,:,4,T,3}	{NULL}
journal.pone.0049897.pdf	498	{%,cD44,"\\"",‘,3,"\\"",",",cD62L,',°,“,'}	{NULL}
journal.pone.0049897.pdf	499	{control,Meth}	{NULL}
journal.pone.0049897.pdf	500	{Figure,11,.}	{NULL}
journal.pone.0049897.pdf	501	{CD8,T,cells,from,the,mesenteric,lymph,node,(,MLN,),also,show,reductions,in,proportion,of,antigen-experienced,subsets,with,an,increase,in,the,naive,compartment,.}	{NULL}
journal.pone.0049897.pdf	502	{Mesenteric,lymph,node,CD8,T,cells,were,labeled,with,CD62L,and,CD44,and,classified,as,in,Fig,.}	{NULL}
journal.pone.0049897.pdf	503	{10,.}	{NULL}
journal.pone.0049897.pdf	504	{A.,Gating,showing,CD44,and,CD62L,expression,by,MLN,CD8,T,cells,.}	{NULL}
journal.pone.0049897.pdf	505	{B,.}	{NULL}
journal.pone.0049897.pdf	506	{—,.}	{NULL}
journal.pone.0049897.pdf	507	{E.,After,meth,treatment,",",the,TN,compartment,is,increased,in,proportion,",",while,the,TAE,",",TEM,",",and,TCM,compartments,all,revealed,a,decrease,in,proportion,.}	{NULL}
journal.pone.0049897.pdf	508	{**,p,<,0.01,",",***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	509	{—,.}	{NULL}
journal.pone.0049897.pdf	510	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	511	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	512	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	513	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	514	{pone,.}	{NULL}
journal.pone.0049897.pdf	515	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	516	{gO11}	{NULL}
journal.pone.0049897.pdf	517	{reports,suggesting,altered,activation,levels,of,NK,cells,after,meth,exposure,[,"30,35",],.}	{NULL}
journal.pone.0049897.pdf	518	{KLRG1,expression,by,NK,cells,is,almost,exclusively,restricted,to,the,CD1,lbhigh,",",CD271,”,subset,[,"45,46,69",],",",a,group,that,exhibits,lower,levels,of,homeostatic,proliferation,[,"45,69",],and,possesses,lower,levels,of,cytotoxicity,than,its,CD27high,counterpart,[,45,],.}	{NULL}
journal.pone.0049897.pdf	519	{KLRG1-expressing,NK,cells,have,also,been,shown,to,produce,lower,levels,of,IFN-y,than,KLRG1,*,',k,*}	{NULL}
journal.pone.0049897.pdf	520	{%,KLRG1,+,o.o}	{NULL}
journal.pone.0049897.pdf	521	{NK,cells,[,70,],.}	{NULL}
journal.pone.0049897.pdf	522	{Our,data,suggest,that,meth,causes,a,shift,in,the,NK,cell,compartment,",",with,a,marked,reduction,in,CD27high,",",KLRG1,_,NK,cells,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	523	{This,shift,leaves,the,majority,of,NK,cells,in,periphery,with,a,phenotype,suggesting,lower,responsiveness,and,effectiveness,",",a,dangerous,combination,considering,the,importance,of,NK,cells,during,viral,infections,and,the,increased,susceptibility,of,meth,users,to,several,viruses,.}	{NULL}
journal.pone.0049897.pdf	524	{TI}	{NULL}
journal.pone.0049897.pdf	525	{Meth,Meth}	{NULL}
journal.pone.0049897.pdf	526	{Figure,12,.}	{NULL}
journal.pone.0049897.pdf	527	{Meth,causes,a,reduced,proportion,and,number,of,KLGR1,*,CD8,T,cells,in,the,MLN,.}	{NULL}
journal.pone.0049897.pdf	528	{CD8,T,cells,were,labeled,with,KLRG1,to,investigate,whether,meth,impacts,subsets,of,antigen-experienced,CD8,T,cells,.}	{NULL}
journal.pone.0049897.pdf	529	{A.,The,proportion,and,number,of,CD8,T,cells,expressing,KLRG1,in,the,MLN,is,reduced,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	530	{*,p,<,0.01,",",***,p,<,0.001,calculated,by,Mann,.}	{NULL}
journal.pone.0049897.pdf	531	{—,.}	{NULL}
journal.pone.0049897.pdf	532	{Whitney,U,Test,.}	{NULL}
journal.pone.0049897.pdf	533	{Bars,represent,mean,.}	{NULL}
journal.pone.0049897.pdf	534	{Data,are,from,2,experiments,of,5,animals,per,treatment,group,per,experiment,.}	{NULL}
journal.pone.0049897.pdf	535	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	536	{pone,.}	{NULL}
journal.pone.0049897.pdf	537	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	538	{gO12}	{NULL}
journal.pone.0049897.pdf	539	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0049897.pdf	540	{p,|,osone.org,12,December,2012,|,Volume,7,|,Issue,12,|,e49897}	{NULL}
journal.pone.0049897.pdf	541	{-,Reduced,Gr,-,',l,"\\"",‘,9,"\\"",monocyteslmacrophage}	{NULL}
journal.pone.0049897.pdf	542	{-,Reduced,DCs}	{NULL}
journal.pone.0049897.pdf	543	{Gr-1,',“,9,"\\""}	{NULL}
journal.pone.0049897.pdf	544	{H,N,"\\\\"}	{NULL}
journal.pone.0049897.pdf	545	{‘,W,’}	{NULL}
journal.pone.0049897.pdf	546	{-,Reduced,NKs,-,Increased,proportion,of,terminally,differentiated,NKs}	{NULL}
journal.pone.0049897.pdf	547	{-,Reduced,antigen,experienced,subsets}	{NULL}
journal.pone.0049897.pdf	548	{Gr-1,',°,‘,"\\"",.}	{NULL}
journal.pone.0049897.pdf	549	{=}	{NULL}
journal.pone.0049897.pdf	550	{[,Activationof,Gr-1,',°,W}	{NULL}
journal.pone.0049897.pdf	551	{monocyteslmacrophage}	{NULL}
journal.pone.0049897.pdf	552	{/,Methamphetamine,"\\\\",‘}	{NULL}
journal.pone.0049897.pdf	553	{CD4}	{NULL}
journal.pone.0049897.pdf	554	{T,cell}	{NULL}
journal.pone.0049897.pdf	555	{-,Reduced,antigen,experienced,subsets,-,Expansion,of,KLRG1,*,subset}	{NULL}
journal.pone.0049897.pdf	556	{Figure,13,.}	{NULL}
journal.pone.0049897.pdf	557	{Methamphetamine,impacts,the,innate,and,adaptive,arms,of,immunity,.}	{NULL}
journal.pone.0049897.pdf	558	{Summary,of,the,effects,of,methamphetamine,on,immune,cell,subsets,based,upon,the,observations,in,this,report,.}	{NULL}
journal.pone.0049897.pdf	559	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0049897.pdf	560	{pone,.}	{NULL}
journal.pone.0049897.pdf	561	{OO49897,.}	{NULL}
journal.pone.0049897.pdf	562	{gO13}	{NULL}
journal.pone.0049897.pdf	563	{T,Cells,Exhibit,Signs,of,Suppression,as,well,as,Activation,After,Meth,Treatment,We,have,observed,that,meth,causes,a,reduction,of,activated,/,antigen-experienced,CD4,and,CD8,T,cells,.}	{NULL}
journal.pone.0049897.pdf	564	{We,noted,substantial,decreases,in,proportion,of,CD44high,",",CD62Ll,"\\"",W,CD4,T,cells,after,meth,treatment,and,within,this,population,",",we,observed,a,decrease,in,proportion,of,cells,expressing,CD27,.}	{NULL}
journal.pone.0049897.pdf	565	{Combined,",",these,results,suggest,a,decrease,in,CD4,T,cell,activation,perhaps,due,to,diminished,antigen,presentation,as,well,as,a,polarization,to,shortlived,status,",",as,CD27,expression,has,been,associated,with,longevity,in,T,cells,[,71,],.}	{NULL}
journal.pone.0049897.pdf	566	{Within,the,CD62L,+,subset,of,CD4,T,cells,",",we,observed,a,decrease,in,proportion,CD45RB1,"\\"",‘“,/,CD441,”,",",and,cD45RB1,"\\"",W,/,CD44hi,“,=,’,h,cells,",",with,an,increased,proportion,of,CD45RBhigh,/,CD441,”,cells,.}	{NULL}
journal.pone.0049897.pdf	567	{While,the,majority,of,naive,splenic,T,cells,express,CD45RB,",",after,antigen,experience,these,cells,will,undergo,alternate,exon,splicing,and,downregulate,CD45RB,[,72,],.}	{NULL}
journal.pone.0049897.pdf	568	{The,observed,deﬁciencies,in,CD45RB,downregulation,may,be,induced,by,reduced,APC,effectiveness,as,well,as,the,reduced,number,of,DCs,observed,in,our,experiment,.}	{NULL}
journal.pone.0049897.pdf	569	{Alternatively,",",meth,may,directly,obstruct,CD45,exon,splicing,in,some,fashion,.}	{NULL}
journal.pone.0049897.pdf	570	{An,additional,possibility,is,that,meth,promotes,increased,thymic,output,or,enhanced,proliferation,by,naive,subsets,within,the,spleen,.}	{NULL}
journal.pone.0049897.pdf	571	{However,",",our,data,do,not,reveal,an,increase,in,splenic,T,cell,number,",",nor,did,we,ﬁnd,an,altered,CD4,:,CD8,ratio,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	572	{Although,we,did,not,investigate,the,thymus,in,our,study,",",it,is,probable,that,meth,also,accumulates,within,thymic,tissue,and,may,impact,thymic,selection,and,output,.}	{NULL}
journal.pone.0049897.pdf	573	{Supporting,this,notion,",",Iwasa,et,al.,[,39,],observed,an,increased,proportion,of,apoptotic,cells,in,the,thymus,after,a,single,injection,of,meth,",",while,In,et,al.,[,30,],noted,an,increase,in,proportion,of,CD4,T,cells,in,the,thymus,with,decreases,in,proportion,CD8,and,double,positive,(,DP,),T,cells,accompanied,with,reduced,thymic,weight,after,meth,use,",",ﬁndings,which,justify,further,investigations,of,the,effects,of,meth,on,the,thymus,.}	{NULL}
journal.pone.0049897.pdf	574	{CD8,T,cell,activation,patterns,were,similarly,affected,as,those,of,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	575	{We,observed,reduced,proportions,of,effector,memory,(,TEM,),and,acute,effector,(,TAE,),CD8,T,cells,subsets,in,the,spleen,and,reduced,proportions,of,TEM,",",central,memory,(,TCM,),",",and,TAE,subsets,in,the,MLN,",",again,suggesting,either,decreased,antigen,presentation,and,/,or,increased,cell,death,among,these,reduced,populations,.}	{NULL}
journal.pone.0049897.pdf	576	{These,overall,decreases,in,CD4,and,CD8,T,cell,activation,may,be,highly,detrimental,during,the,host,’s,response,to,pathogenic,challenge,.}	{NULL}
journal.pone.0049897.pdf	577	{Considering,that,meth,users,are,at,increased,risk,for,HIV,and,other,viral,infections,",",suppression,of,the,immune,adaptive,response,would,be,expected,to,lead,to,exacerbated,infections,.}	{NULL}
journal.pone.0049897.pdf	578	{In,agreement,with,this,reasoning,",",meth,use,accompanying,HIV,has,been,associated,with,increased,viral,loads,in,human,subjects,[,73,],.}	{NULL}
journal.pone.0049897.pdf	579	{Although,our,investigations,revealed,signs,of,suppression,of,the,CD4,and,CD8,T,cell,response,",",we,did,observe,associations,suggesting,activation,",",namely,",",increased,CD150,expression,by}	{NULL}
journal.pone.0049897.pdf	580	{CD226,+,CD4,T,cells,and,an,expansion,of,KLRG1,+,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	581	{CD150,upregulation,by,T,cells,has,been,observed,after,concanavalin,A,[,47,],and,anti-CD3,[,74,],stimulation,",",and,CD150,costimulation,with,anti-CD3,antibodies,induced,increased,IFN-V,prodution,and,proliferation,compared,to,anti-CD3,antibody,treatment,alone,[,47,],.}	{NULL}
journal.pone.0049897.pdf	582	{In,our,analysis,of,the,splenic,CD4,T,cell,compartment,after,meth,treatment,",",we,noted,an,increase,in,CD150,expression,among,CD226,+,CD4,T,cells,that,are,also,CD44high,and,CD62Ll,"\\"",W.,This,is,an,interesting,ﬁnding,considering,that,overall,CD44high,",",CD62Ll,"\\"",W,numbers,were,decreased,with,meth,use,",",thus,suggesting,a,speciﬁc,subset,(,s,),of,unknown,TCR,speciﬁcity,is,somehow,activated,by,meth,",",while,others,are,diminished,.}	{25|26|50|69,7|8|17|48}
journal.pone.0049897.pdf	583	{Killer,cell,lectin-like,receptor,G1,(,KLRG1,),is,an,inhibitory,Ctype,lectin,receptor,that,binds,to,E,",",N,",",and,R,cadherins,[,"75,76",],and,we,observed,alterations,in,KLRG1,expression,by,NK,cells,and,CD4,and,CD8,T,cells,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	584	{Interestingly,",",we,noted,an,expansion,of,KLRG1,+,F,oxP3,_,CD4,T,cells,that,appears,surprising,in,the,midst,of,signs,of,several,signs,of,immune,suppression,.}	{NULL}
journal.pone.0049897.pdf	585	{Increased,KLRG1,+,CD4,T,cells,have,been,reported,after,Toxoplasma,gondii,infection,[,70,],and,A/Iycobacterium,tuberculosix,infection,[,77,],",",while,KLRG1,+,CD4,T,cells,were,found,to,be,unresponsive,to,TCR-induced,proliferation,[,50,],and,produced,high,levels,of,IFN-V,and,TNF-or,after,peptide,stimulation,[,77,],.}	{NULL}
journal.pone.0049897.pdf	586	{Beyersdorf,et,al.,[,50,],also,observed,that,a,portion,of,FoxP3,+,CD4,T,cells,coexpressed,KLRG1,and,CD152,",",were,CD252,"\\"",/,7,",",and,that,KLRG1,+,",",CD257,’,/,_,CD4,T,cells,were,capable,of,reducing,cellular,proliferation,of,anti-CD3,stimulated,naive,CD4,T,cells,in,the,presence,of,APC,",",as,well,as,limiting,H3,thymidine,uptake,by,TCR-stimulated,naive,CD4,T,cells,.}	{NULL}
journal.pone.0049897.pdf	587	{From,these,studies,",",we,can,conclude,that,there,are,at,least,two,main,populations,of,KLRG1,+,CD4,T,cells,in,mice,:,one,which,represents,a,terminally,differentiated,effector,",",and,another,which,is,a,potent,TREG,.}	{NULL}
journal.pone.0049897.pdf	588	{While,we,did,observe,KLRG1,+,expression,amongst,FoxP3,+,CD4,T,cells,and,these,cells,were,CD257,"\\"",/,7,",",we,did,not,ﬁnd,a,difference}	{NULL}
journal.pone.0049897.pdf	589	{References}	{NULL}
journal.pone.0049897.pdf	590	{1,.}	{NULL}
journal.pone.0049897.pdf	591	{Brouwer,KC,",",Case,P,",",Ramos,R,",",l,"\\\\",’,Iagis,~,Rodriguez,C,",",Bucardo,J,",",et,al.,(,2006,),Trends,in,production,",",trafficking,",",and,consumption,of,methamphetamine,and,cocaine,in,l,"\\\\",’,Iexico,.}	{NULL}
journal.pone.0049897.pdf	592	{Substance,Use,and,1,"\\\\",’,Iisuse,41,:,7074727,.}	{NULL}
journal.pone.0049897.pdf	593	{2,.}	{NULL}
journal.pone.0049897.pdf	594	{Cronkwright,Kirkos,VV,",",Carrique,T,",",Griffen,K,",",La,Barge,AP,(,2008,),The,York,region,methamphetamine,strategy,.}	{NULL}
journal.pone.0049897.pdf	595	{Canadian,lVIedical,Association,Journal,178,:,165541656,.}	{NULL}
journal.pone.0049897.pdf	596	{3,.}	{NULL}
journal.pone.0049897.pdf	597	{Degenhardt,L,",",Baker,A,",",lVIaher,L,(,2008,),Nlethamphetamine,:,Geographic,areas,and,populations,at,risk,",",and,emerging,evidence,for,effective,interventions,.}	{NULL}
journal.pone.0049897.pdf	598	{Drug,and,Alcohol,Review,27,:,2174219,.}	{NULL}
journal.pone.0049897.pdf	599	{4,.}	{NULL}
journal.pone.0049897.pdf	600	{NIcKetin,R,",",Kozel,N,",",DouglasJ,",",Ali,R,",",Vicknasingam,B,",",et,al.,(,2008,),The,rise,of,methamphetamine,in,southeast,and,east,Asia,.}	{NULL}
journal.pone.0049897.pdf	601	{Drug,and,Alcohol,Review,27,:,2204228,.}	{NULL}
journal.pone.0049897.pdf	602	{5,.}	{NULL}
journal.pone.0049897.pdf	603	{Nlau,IVIK,",",Asao,K,",",Efird,J,",",Saito,E,",",Ratner,R,",",et,al.,(,2009,),Risk,factors,associated,with,methamphetamine,use,and,heart,failure,among,native,Hawaiians,and,other,pacific,island,peoples,.}	{NULL}
journal.pone.0049897.pdf	604	{Journal,of,Vascular,Health,and,Risk,"1\\\\/Ianagement",5,:,45452,.}	{NULL}
journal.pone.0049897.pdf	605	{6,.}	{NULL}
journal.pone.0049897.pdf	606	{Sheridan,J,",",Butler,R,",","\\\\",/,Vheeler,A,(,2009,),Initiation,into,methamphetamine,use,:,qualitative,findings,from,an,exploration,of,first,time,use,among,a,group,of,New,Zealand,users,.}	{NULL}
journal.pone.0049897.pdf	607	{Journal,of,Psychoactive,Drugs,41,:,11417,.}	{NULL}
journal.pone.0049897.pdf	608	{7,.}	{NULL}
journal.pone.0049897.pdf	609	{Bonell,GP,",",Hickson,FC,",",VVeatherburn,P,",",Reid,DS,(,2010,),lVIethamphetamine,use,among,gay,men,across,the,UK,.}	{NULL}
journal.pone.0049897.pdf	610	{The,International,Journal,on,Drug,Policy,21,:,2444246,.}	{NULL}
journal.pone.0049897.pdf	611	{8,.}	{NULL}
journal.pone.0049897.pdf	612	{Gonzales,R,",",l,"\\\\",’,Iooney,L,",",Rawson,RA,(,2010,),The,methamphetamine,problem,in,the,United,States,.}	{NULL}
journal.pone.0049897.pdf	613	{Annual,Review,of,Public,Health,31,:,3854398,.}	{NULL}
journal.pone.0049897.pdf	614	{9,.}	{NULL}
journal.pone.0049897.pdf	615	{Peltzer,K,",",Ramlagan,S,",",Johnson,BD,",",Phaswana-Nlafuya,N,(,2010,),Illicit,drug,use,and,treatment,in,South,Africa,:,a,review,.}	{NULL}
journal.pone.0049897.pdf	616	{Substance,Use,and,1,"\\\\",’,Iisuse,45,:,22214,2243,.}	{NULL}
journal.pone.0049897.pdf	617	{10,.}	{NULL}
journal.pone.0049897.pdf	618	{Nicosia,N,",",Pacula,RL,",",Kilmer,B,",",Lundberg,R,",",ChiesaJ,(,2009,),The,economic,cost,of,methamphetamine,use,in,the,United,States,",",2005,.}	{NULL}
journal.pone.0049897.pdf	619	{Santa,Monica,",",CA,:,RAND,Corporation,.}	{NULL}
journal.pone.0049897.pdf	620	{Available,:,http://www.rand.org/pubs/monographs/,MG829,.}	{NULL}
journal.pone.0049897.pdf	621	{Accessed,2010,June,22,.}	{NULL}
journal.pone.0049897.pdf	622	{11,.}	{NULL}
journal.pone.0049897.pdf	623	{Cruickshank,CC,",",Dyer,KR,(,2009,),A,review,of,the,clinical,pharmacoloQ,',of,methamphetamine,.}	{NULL}
journal.pone.0049897.pdf	624	{Addiction,104,:,108541099,.}	{NULL}
journal.pone.0049897.pdf	625	{12,.}	{NULL}
journal.pone.0049897.pdf	626	{Riviere,GJ,",",Gentry,VVB,",",Owens,SIVI,(,2000,),Disposition,of,methamphetamine,and,its,metabolite,amphetamine,in,brain,and,other,tissues,in,rats,after,in,proportion,or,number,of,any,FoxP3-expressing,CD4,T,cell,subset,after,meth,treatment,.}	{NULL}
journal.pone.0049897.pdf	627	{Phenotypically,",",our,KLRG1,+,CD4,T,cell,subset,ﬁts,into,an,effector,/,memory,phenotype,",",being,oD62L,',",",oD45RB,“’,W,",",CD25,‘,",",FOXP3,_,and,onwigh,.}	{NULL}
journal.pone.0049897.pdf	628	{However,",",future,studies,must,be,conducted,to,determine,the,functional,attributes,of,this,population,and,to,determine,its,Th,status,.}	{NULL}
journal.pone.0049897.pdf	629	{15584,1565,.}	{NULL}
journal.pone.0049897.pdf	630	{Conclusions}	{NULL}
journal.pone.0049897.pdf	631	{Our,results,demonstrate,that,meth,impacts,several,leukocyte,populations,(,Fig,.}	{NULL}
journal.pone.0049897.pdf	632	{13,),.}	{NULL}
journal.pone.0049897.pdf	633	{Indeed,",",meth,’s,role,in,inducing,apoptosis,and,inhibiting,APC,function,may,have,tremendous,effects,on,T,cell,memory,populations,as,well,as,on,T,cell,activation,",",as,our,results,and,those,of,others,have,suggested,.}	{NULL}
journal.pone.0049897.pdf	634	{Furthermore,",",the,combined,effects,of,a,decrease,of,Gr-lhigh,monocytes,/,macrophages,",",DCs,",",and,NK,cell,numbers,",",with,a,proportional,increase,of,a,less-responsive,NK,cell,subset,may,leave,the,user,less,able,to,initiate,a,sufficient,immune,response,and,ultimately,reduce,the,effectiveness,of,the,adaptive,response,.}	{NULL}
journal.pone.0049897.pdf	635	{Although,our,data,reveal,speciﬁc,descriptive,alterations,induced,by,meth,and,suggest,a,reduced,ability,to,respond,efficiently,to,pathogens,",",additional,investigations,must,focus,on,how,the,innate,and,adaptive,arms,are,impacted,in,the,face,of,viral,and,bacterial,challenge,concurrent,with,meth,exposure,.}	{NULL}
journal.pone.0049897.pdf	636	{As,meth,addicts,are,at,risk,for,increased,rates,of,sexually,transmitted,diseases,(,STDs,),and,blood,borne,pathogens,due,to,behavioral,responses,and,drug,administration,routes,",",these,investigations,would,be,meaningful,in,revealing,which,mechanisms,promote,increased,susceptibility,to,infections,as,suggested,by,this,work,and,previous,studies,.}	{NULL}
journal.pone.0049897.pdf	637	{Author,Contributions}	{NULL}
journal.pone.0049897.pdf	638	{Conceived,and,designed,the,experiments,:,RH,HF,NS,.}	{NULL}
journal.pone.0049897.pdf	639	{Performed,the,experiments,:,RH,BlVI,C,"\\\\",VB,.}	{NULL}
journal.pone.0049897.pdf	640	{Analyzed,the,data,:,RH,.}	{NULL}
journal.pone.0049897.pdf	641	{Contributed,reagents,/,materia1s,/,analysis,tools,:,RH,HF,.}	{NULL}
journal.pone.0049897.pdf	642	{Wlrote,the,paper,:,RH,.}	{NULL}
journal.pone.0049897.pdf	643	{intravenous,administration,.}	{NULL}
journal.pone.0049897.pdf	644	{The,Journal,of,Pharmacology,and,Experimental,Therapeutics,292,:,104241047,.}	{NULL}
journal.pone.0049897.pdf	645	{13,.}	{NULL}
journal.pone.0049897.pdf	646	{Volkow,ND,",",Fowler,JS,",",VVang,GJ,",",Shumay,E,",",Telang,F,",",et,al.,(,2010,),Distribution,and,pharmacokinetics,of,methamphetamine,in,the,human,body,:,clinical,implications,.}	{NULL}
journal.pone.0049897.pdf	647	{PLoS,ONE,5,:,e15269,.}	{NULL}
journal.pone.0049897.pdf	648	{14,.}	{NULL}
journal.pone.0049897.pdf	649	{Nordahl,TE,",",Salo,R,",",Leamon,l,"\\\\",’,I,(,2003,),Neuropsychological,effects,of,chronic,methamphetamine,use,on,neurotransmitters,and,cognition,:,a,review,.}	{NULL}
journal.pone.0049897.pdf	650	{Journa_l,of,Neuropsychiatry,and,Clinical,Neuroscience,15,:,3174325,.}	{NULL}
journal.pone.0049897.pdf	651	{15,.}	{NULL}
journal.pone.0049897.pdf	652	{Krasnova,IN,",",Cadet,JL,(,2009,),Methamphetamine,toxicity,and,messengers,of,death,.}	{NULL}
journal.pone.0049897.pdf	653	{Brain,Research,Reviews,60,:,3794407,.}	{NULL}
journal.pone.0049897.pdf	654	{16,.}	{NULL}
journal.pone.0049897.pdf	655	{Hutin,YJF,",",Sabin,"K1\\\\/I",",",Hutwagner,LC,",",Schaben,L,",",Shipp,G1,"\\\\",’,I,",",et,al.,(,2000,),Nlultiple,modes,of,hepatitis,A,virus,transmission,among,methamphetamine,users,.}	{NULL}
journal.pone.0049897.pdf	656	{American,Journal,of,Epidemiology,152,:,1864192,.}	{NULL}
journal.pone.0049897.pdf	657	{17,.}	{NULL}
journal.pone.0049897.pdf	658	{Gonzales,RP,",","1\\\\/Iarinelli",~,Casey,P,",",Shoptaw,S,",",Ang,A,",",Rawson,RA,(,2006,),Hepatitis,C,virus,infection,among,methamphetamine-dependent,individuals,in,outpatient,treatment,.}	{NULL}
journal.pone.0049897.pdf	659	{Journal,of,Substance,Abuse,Treatment,31,:,1954202,.}	{NULL}
journal.pone.0049897.pdf	660	{18,.}	{NULL}
journal.pone.0049897.pdf	661	{Vogt,Tl,"\\\\",’,I,",",Perz,JF,",",Van,Houten,Jr,CK,",",Harrington,R,",",Hansuld,T,",",et,al.,(,2006,),An,outbreak,of,hepatitis,B,virus,among,methamphetamine,injectors,:,the,role,of,sharing,injection,drug,equipment,.}	{NULL}
journal.pone.0049897.pdf	662	{Addiction,101,:,7264730,.}	{NULL}
journal.pone.0049897.pdf	663	{19,.}	{NULL}
journal.pone.0049897.pdf	664	{Cohen,AL,",",Shuler,C,",",l,"\\\\",’,IcAllister,S,",",Fosheim,GE,",",Brown,1,"\\\\",’,IG,",",et,al.,(,2007,),Nlethamphetamine,use,and,methicillin-resistant,Sta,],;,/,2,ilomccux,aureus,skin,infections,.}	{NULL}
journal.pone.0049897.pdf	665	{Emerging,Infectious,Diseases,13,:,170741713,.}	{NULL}
journal.pone.0049897.pdf	666	{20,.}	{NULL}
journal.pone.0049897.pdf	667	{Corsi,KF,",",Booth,RE,(,2008,),HIV,sex,risk,behaviors,among,heterosexual,methamphetamine,users,:,literature,review,from,2000,to,present,.}	{NULL}
journal.pone.0049897.pdf	668	{Current,Drug,Abuse,Reviews,1,:,2924296,.}	{NULL}
journal.pone.0049897.pdf	669	{21,.}	{NULL}
journal.pone.0049897.pdf	670	{Forrest,DVV,",",lVIetsch,LR,",",LaLota,IVI,",",Cardenas,G,",",Beck,DVV,",",et,al.,(,2010,),Crystal,methamphetamine,use,and,sexual,risk,behaviors,among,HIV-positive,and,HIV,~,negative,men,who,have,sex,with,men,in,south,Florida,.}	{NULL}
journal.pone.0049897.pdf	671	{Journal,of,Urban,Health,:,Bulleting,of,the,New,York,Academy,of,1,"\\\\",’,Iedicine,87,:,4804485,.}	{NULL}
journal.pone.0049897.pdf	672	{22,.}	{NULL}
journal.pone.0049897.pdf	673	{Freeman,P,",","\\\\",/,Valker,BC,",",Harris,DR,",",Garofalo,R,",","\\\\",/,Villard,N,",",et,al.,(,2011,),Nlethamphetamine,use,and,risk,for,HIV,among,young,men,who,have,sex,with,men,in,8,US,cities,.}	{NULL}
journal.pone.0049897.pdf	674	{Archives,of,Pediatric,and,Adolescent,Medicine,165,:,7364,740,.}	{NULL}
journal.pone.0049897.pdf	675	{23,.}	{NULL}
journal.pone.0049897.pdf	676	{Nlarshall,BDL,",","\\\\",/,Vood,E,",",Shoveller,JA,",",Patterson,TL,",",l,"\\\\",’,Iontaner,JSG,",",et,al.,(,2011,),Pathways,to,HIV,’,risk,and,vulnerability,among,lesbian,",",gay,",",bisexual,",",and,transgendered,methamphetamine,users,:,A,mu1ti,~,cohort,gender-based,analysis,.}	{NULL}
journal.pone.0049897.pdf	677	{BMC,Public,Health,11,:,20,.}	{NULL}
journal.pone.0049897.pdf	678	{.}	{NULL}
journal.pone.0049897.pdf	679	{Liang,H,",",Wlang,X,",",Chen,H,",",Song,L,",",Ye,L,",",et,al.,(,2008,),1,"\\\\",’,Iethamphetamine,enhances,HIV,infection,of,macrophages,.}	{NULL}
journal.pone.0049897.pdf	680	{American,Journal,of,Pathology,172,:,161741624,.}	{NULL}
journal.pone.0049897.pdf	681	{.}	{NULL}
journal.pone.0049897.pdf	682	{Ye,L,",",Peng,JS,",",VVang,X,",",VVang,YJ,",",Luo,GX,",",et,al.,(,2008,),1,"\\\\",’,Iethamphetamine,enhances,hepatitis,C,virus,replication,in,human,hepatocytes,.}	{NULL}
journal.pone.0049897.pdf	683	{Journal,of,Viral,Hepatology,15,:,2614270,.}	{NULL}
journal.pone.0049897.pdf	684	{.}	{NULL}
journal.pone.0049897.pdf	685	{Gagnon,L,",",Lacroix,F,",",Chan,J,",",Buttar,HS,(,1992,),In,vitro,effects,of,‘,designer,’,amphetamines,on,human,peripheral,blood,mononuclear,leukocytes,proliferation,and,on,natural,killer,cell,activity,.}	{NULL}
journal.pone.0049897.pdf	686	{Toxicology,Letters,63,:,3134319,.}	{NULL}
journal.pone.0049897.pdf	687	{.}	{NULL}
journal.pone.0049897.pdf	688	{Yu,Q,Zhang,D,",",VValston,IVI,",",Zhang,J,",",Liu,Y,",",et,al.,(,2002,),Chronic,methamphetamine,exposure,alters,immune,function,in,normal,and,retrovirus,»,infected,mice,.}	{NULL}
journal.pone.0049897.pdf	689	{International,Immunopharmacology,2,:,9514962,.}	{NULL}
journal.pone.0049897.pdf	690	{Potula,R,",",Hawkins,BJ,",",Cenna,JNI,",",Fan,S,",",Dykstra,H,",",et,al.,(,2010,),1VIethamphetamine,causes,mitrochondrial,oxidative,damage,in,human,T,lymphocytes,leading,to,functional,impairment,.}	{NULL}
journal.pone.0049897.pdf	691	{Journal,of,Immunology,185,:,286742876,.}	{NULL}
journal.pone.0049897.pdf	692	{.}	{NULL}
journal.pone.0049897.pdf	693	{House,RV,",",Thomas,PT,(,1994,),Comparison,of,immune,functional,parameters,following,in,vitro,exposure,to,natural,and,synthetic,amphetamines,.}	{NULL}
journal.pone.0049897.pdf	694	{Immuno,~,pharmacology,and,Immunotoxicology,16,:,1421,.}	{NULL}
journal.pone.0049897.pdf	695	{In,S,",",Son,E,",",Rhee,D,",",Pyo,S,(,2005,),1,"\\\\",’,Iethamphetamine,administration,produces,immunomodulation,in,mice,.}	{NULL}
journal.pone.0049897.pdf	696	{Journal,of,Toxicology,and,Environmental,Health,",",Part,A,68,:,213342145,.}	{NULL}
journal.pone.0049897.pdf	697	{VVey,S,",",VVu,H,",",Chang,F,",",Jan,T,(,2008,),1,"\\\\",’,Iethamphetamine,and,diazepam,suppress,antigen-specific,cytokine,expression,and,antibody,production,in,ovalbumin-sensitized,BALB/c,mice,.}	{NULL}
journal.pone.0049897.pdf	698	{Toxicology,Letters,181,:,1574162,.}	{NULL}
journal.pone.0049897.pdf	699	{In,S,",",Son,E,",",Rhee,D,",",Pyo,S,(,2004,),1,"\\\\",’,Iodu1ation,of,murine,macrophage,function,by,methamphetamine,.}	{NULL}
journal.pone.0049897.pdf	700	{Journal,of,ToxicoloQ,',and,Environmental,Health,",",Part,A,67,:,192341937,.}	{NULL}
journal.pone.0049897.pdf	701	{Talloczy,Z,",",1,"\\\\",Iartinez,J,",",Joset,D,",",Ray,Y,",",Gacser,A,",",et,al.,(,2008,),Nlethamphetamine,inhibits,antigen,processing,",",presentation,",",and,phagocytosis,.}	{NULL}
journal.pone.0049897.pdf	702	{PLoS,Pathogens,4,:,e28,.}	{NULL}
journal.pone.0049897.pdf	703	{Nlartinez,LR,",",1VIihu,IVIR,",",Gacser,A,",",Santaml,),rogio,L,",",Nosanchuk,JD,(,2009,),Nlethamphetamine,enhances,histoplasmosis,by,immunosupression,of,the,host,.}	{NULL}
journal.pone.0049897.pdf	704	{The,Journal,of,Infectious,Diseases,200,:,1314141,.}	{NULL}
journal.pone.0049897.pdf	705	{.}	{NULL}
journal.pone.0049897.pdf	706	{"\\\\",Iarcondes,"1\\\\/ICG",",",Flynn,C,",","\\\\",/,Vatry,DD,",",Zandonatti,1,"\\\\",’,I,",",Fox,HS,(,2010,),Nlethamphetamine,increases,brain,viral,load,and,activates,natural,killer,cells,in,simian,immunodeficiency,virus-infected,monkeys,.}	{NULL}
journal.pone.0049897.pdf	707	{The,American,Journal,of,Pathology,177,:,3554361,.}	{NULL}
journal.pone.0049897.pdf	708	{Saito,IVI,",",Ya_maguchi,T,",",Kawata,T,",",Ito,H,",",Kanai,T,",",et,al.,(,2005,),Effects,of,methamphetamine,on,cortisone,concentration,",",NK,cell,activity,and,mitogen,response,of,T-lymphocytes,in,female,cynomolgus,monkeys,.}	{NULL}
journal.pone.0049897.pdf	709	{Experimental,Animals,55,:,4774481,.}	{NULL}
journal.pone.0049897.pdf	710	{Saito,NI,",",Terada,IVI,",",Kawata,T,",",Ito,H,",",Shigematsu,N,",",et,al.,(,2008,),Effects,of,single,or,repeated,administrations,of,methamphetamine,on,immune,response,in,mice,.}	{NULL}
journal.pone.0049897.pdf	711	{Experimental,Animals,.57,:,35443,.}	{NULL}
journal.pone.0049897.pdf	712	{Thomas,D1,"\\\\",’,I,",",VValker,PD,",",Benjamins,JA,",",Geddes,TJ,",",Kuhn,D.,"\\\\",I,(,2004,),Nlethamphetamine,neurotoxicity,in,dopamine,nerve,endings,of,the,striatum,is,associated,with,microglia,activation,.}	{NULL}
journal.pone.0049897.pdf	713	{The,Journal,of,Pharmacology,and,Experimental,Therapeutics,311,:,147,.}	{NULL}
journal.pone.0049897.pdf	714	{Iwasa,IVI,",",1VIaeno,Y,",",Inoue,H,",",Koyama,H,",",1VIatoba,R,(,1996,),Induction,of,apoptotic,cell,death,in,rat,thymus,and,spleen,after,bolus,injection,of,methamphetamine,.}	{NULL}
journal.pone.0049897.pdf	715	{InternationalJournal,of,Legal,1,"\\\\",’,Iedicine,109,:,23428,.}	{NULL}
journal.pone.0049897.pdf	716	{Daley,J1,"\\\\",’,I,",",Thomay,AA,",",Connolly,IVID,",",Reicl1nerJS,",",Albina,JE,(,2008,),Use,of,Ly6G,~,specific,monoclonal,antibody,to,deplete,neutrophils,in,mice,.}	{NULL}
journal.pone.0049897.pdf	717	{Journal,of,Leukocyte,Biology,83,:,64470,.}	{NULL}
journal.pone.0049897.pdf	718	{Strauss,~,Ayali,D,",",Conrad,SM,",",Mosser,DM,.}	{NULL}
journal.pone.0049897.pdf	719	{(,2007,),Monocyte,subpopulations,and,their,differentiation,patterns,during,infection,.}	{NULL}
journal.pone.0049897.pdf	720	{Journal,of,Leukocyte,Biology,82,:,2444252,.}	{NULL}
journal.pone.0049897.pdf	721	{Swirski,FK,",",Nahrendorf1VI,",",Etzrodt,NI,",",VVi1dgruber,IVI,",",Cortez-Retamozo,V,",",et,al.,(,2009,),Identification,of,splenic,reservoir,monocytes,and,their,deployment,to,inﬂammatory,sites,.}	{NULL}
journal.pone.0049897.pdf	722	{Science,325,:,6124616,.}	{NULL}
journal.pone.0049897.pdf	723	{VValzer,T,",",Blery,NI,",",Chaix,J,",",Fuseri,N,",",Chasson,L,",",et,al.,(,2007,),Identification,",",activation,",",and,selective,in,vivo,ablation,of,mouse,NK,cells,via,NKp46,.}	{NULL}
journal.pone.0049897.pdf	724	{Proceedings,of,the,National,Academy,of,Sciences,104,:,338443389,.}	{NULL}
journal.pone.0049897.pdf	725	{Sharpe,AH,",",Freeman,GJ,(,2002,),The,B7-CD28,superfa,.}	{NULL}
journal.pone.0049897.pdf	726	{mily,.}	{NULL}
journal.pone.0049897.pdf	727	{Nature,Reviews,Immunology,2,:,1164126,.}	{NULL}
journal.pone.0049897.pdf	728	{Hayal,<,awa,Y,",",Smyth,MJ,(,2006,),CD27,dissects,mature,N,K,cells,into,two,subsets,with,distinct,responsiveness,and,migratory,capacity,.}	{NULL}
journal.pone.0049897.pdf	729	{Journal,of,Immunology,176,:,151741524,.}	{NULL}
journal.pone.0049897.pdf	730	{Huntington,ND,",",Tabarias,H,",",Fairfax,K,",",BradyJ,",",Hayakawa,Y,",",et,al.,(,2007,),NK,cell,maturation,and,peripheral,homeostasis,is,associated,with,KLRG1,up,»,regulation,.}	{NULL}
journal.pone.0049897.pdf	731	{Journal,of,Immunology,178,:,476444770,.}	{NULL}
journal.pone.0049897.pdf	732	{Howie,D,",",Okamoto,S,",",Rietdijk,S,",",Clarke,K,",","\\\\",/,Vang,N,",",et,al.,(,2002,),The,role,of,SAP,in,murine,CD150,(,SLAIVI,),—,mediated,T,~,cel1,proliferation,and,interferon,7,production,.}	{NULL}
journal.pone.0049897.pdf	733	{Blood,"1002 289942907",.}	{NULL}
journal.pone.0049897.pdf	734	{Dardalhon,V,",",Schul,),art,AS,",",Reddy,J,",","1\\\\/Ieyers",JH,",",Nlonney,L,",",et,al.,(,2005,),CD226,is,specifically,expressed,on,the,surface,of,Thl,cells,and,regulates,their,expansion,and,effector,functions,.}	{NULL}
journal.pone.0049897.pdf	735	{Journal,of,Immunology,175,:,155841565,.}	{NULL}
journal.pone.0049897.pdf	736	{VVing,K,",",Sakaguchi,S,(,2010,),Regulatory,T,cells,exert,checks,and,balances,on,self,tolerance,and,autoimmunity,.}	{NULL}
journal.pone.0049897.pdf	737	{Nature,Immunology,11,:,7413,.}	{NULL}
journal.pone.0049897.pdf	738	{Beyersdorf,N,",",Ding,X,",",Tietze,JK,",",Hanke,T,(,2007,),Characterization,of,mouse,CD4,T,cell,subsets,defined,by,expression,of,KLRGI,.}	{NULL}
journal.pone.0049897.pdf	739	{European,Journal,of,Immunology,37,:,344543454,.}	{NULL}
journal.pone.0049897.pdf	740	{Tsujimura,K,",",Obata,Y,",",1VIatsudaira,Y,",",Nishida,K,",",Akatsuka,Y,",",et,al.,(,2006,),Characterization,of,murine,CD160,+,CD8,+,T,lymphocytes,.}	{NULL}
journal.pone.0049897.pdf	741	{Immunology,Letters,106,:,48456,.}	{NULL}
journal.pone.0049897.pdf	742	{VViede,F,",",Roomberg,A,",",Cretney,E,",",Lechner,A,",",Fromm,P,",",et,al.,(,2009,),Age,»,dependent,",",polyclonal,hyperactivation,of,T,cells,is,reduced,in,TNF-negative,gld/gld,mice,.}	{NULL}
journal.pone.0049897.pdf	743	{The,Journal,of,Leukocyte,Biology,85,:,1084116,.}	{NULL}
journal.pone.0049897.pdf	744	{Sarkar,S,",",Kalia,V,",",Haining,VVN,",",Konieczny,BT,",",Subramania_m,S,",",et,al.,(,2008,),Functional,and,genomic,profiling,of,effector,CD8,T,cell,subsets,with,distinct,memory,fates,.}	{NULL}
journal.pone.0049897.pdf	745	{The,Journal,of,Experimental,Nledicine,205,:,6254640,.}	{NULL}
journal.pone.0049897.pdf	746	{Kojima,T,",",Okamoto,I,",","1\\\\/Iiyazaki",T,",",Chikasue,F,",",Yashiki,IVI,",",et,al.,(,1986,),Detection,of,methamphetamine,and,amphetamine,in,a,skeletonized,body,buried,for,.5,years,.}	{NULL}
journal.pone.0049897.pdf	747	{Forensic,Science,International,31,:,934102,.}	{NULL}
journal.pone.0049897.pdf	748	{Nagata,T,",",Kimura,K,",",Hara,K,",",Kudo,K,(,1990,),1,"\\\\",Iethamphetamine,and,amphetamine,concentrations,in,postmortem,rabbit,tissues,.}	{NULL}
journal.pone.0049897.pdf	749	{Forensic,Science,International,48,:,39447,.}	{NULL}
journal.pone.0049897.pdf	750	{Sato,Y,",",Kondo,K,",",Takayasu,T,",",Ohshima,T,(,2000,),Detection,of,methamphetamine,in,a,severely,burned,cadaver,4,a,case,report,.}	{NULL}
journal.pone.0049897.pdf	751	{Nihon,Hoigaku,Zasshi,.54,:,4204424,.}	{NULL}
journal.pone.0049897.pdf	752	{Geissmann,F,",",Jung,S,",",Littman,DR,(,2003,),Blood,monocytes,consist,of,two,principal,subsets,with,distinct,migratory,properties,.}	{NULL}
journal.pone.0049897.pdf	753	{Immunity,19,:,71482,.}	{NULL}
journal.pone.0049897.pdf	754	{Nahrendorf,IVI,",",Swirski,FK,",",Aikawa,E,",",Stangenberg,L,",",VVurdinger,T,",",et,al.,(,2007,),The,healing,myocardium,sequentially,mobilizes,two,monocyte,subsets,with,divergent,and,complementary,functions,.}	{NULL}
journal.pone.0049897.pdf	755	{The,Journal,of,Experimental,.}	{NULL}
journal.pone.0049897.pdf	756	{"\\\\",Iedicine,204,:,303743047,.}	{NULL}
journal.pone.0049897.pdf	757	{Tacke,F,",",Ginhoux,F,",",Jakubzick,C,",",van,Rooijen,N,",",1VIerad,NI,",",et,al.,(,2006,),Immature,monocytes,acquire,antigens,from,other,cells,in,the,l,),one,marrow,and,present,them,to,T,cells,after,maturing,in,the,periphery,.}	{NULL}
journal.pone.0049897.pdf	758	{The,Journal,of,Experimental,1,"\\\\",’,Iedicine,203,:,5834597,.}	{NULL}
journal.pone.0049897.pdf	759	{Peng,Y,",",Latchman,Y,",",Elkon,KB,(,2009,),Ly6Clow,monocytes,differentiate,into,dendritic,cells,and,cross,~,to1erize,T,cells,through,PDL-l,.}	{NULL}
journal.pone.0049897.pdf	760	{Journal,of,Immunology,182,:,277742785,.}	{NULL}
journal.pone.0049897.pdf	761	{Butte,1,"\\\\",’,IJ,",",Keir,NIE,",",Phamduy,TB,",",Sharpe,AH,",",Freeman,GJ,(,2007,),Programmed,death-1,ligand,1,interacts,specifically,with,the,B741,costimulatory,molecule,to,inhibit,T,cell,responses,.}	{NULL}
journal.pone.0049897.pdf	762	{Immunity,27,:,1114122,.}	{NULL}
journal.pone.0049897.pdf	763	{Butte,1,"\\\\",’,IJ,",",Peﬁa,.}	{NULL}
journal.pone.0049897.pdf	764	{—,.}	{NULL}
journal.pone.0049897.pdf	765	{Cruz,V,",",Kim,IVIJ,",",Freeman,GJ,",",Sharpe,AH,(,2008,),Interaction,of,human,PD-L1,and,B741,.}	{NULL}
journal.pone.0049897.pdf	766	{1,"\\\\",Iolecular,Immunology,45,:,356743572,.}	{NULL}
journal.pone.0049897.pdf	767	{ParkJ,],",",Omiya,R,",",1,"\\\\",Iatsumura,Y,",",Sal,<,oda,Y,",",Kuramasu,A,",",et,al.,(,2010,),B7,~,Hl,/,CD80,interaction,is,required,for,the,induction,and,maintenance,of,peripheral,T,»,cell,tolerance,.}	{NULL}
journal.pone.0049897.pdf	768	{Blood,116,:,129141298,.}	{NULL}
journal.pone.0049897.pdf	769	{Bromley,SK,",",Iaboni,A,",",Davis,SJ,",",VVhitty,A,",",Green,JNI,",",et,al.,(,2001,),The,immunological,synapse,and,CD28-CD80,interactions,.}	{NULL}
journal.pone.0049897.pdf	770	{Nature,ImmunoloQ,',2,:,115941166,.}	{NULL}
journal.pone.0049897.pdf	771	{Schif,~,Zuck,S,",",Gross,N,",",Assi,S,",",Rostoker,R,",",Serhan,CN,",",et,al.,(,2011,),Saturatedefferocytosis,generates,pro-resolving,CD11blow,macrophages,:,modulation,by,resolvins,and,glucocorticoids,.}	{NULL}
journal.pone.0049897.pdf	772	{European,Journal,of,Immunology,41,:,3664379,.}	{NULL}
journal.pone.0049897.pdf	773	{Nlarcenaro,E,",",Carlomagno,S,",",Pesce,S,",",Della,Chiesa,NI,",",Parolini,S,",",et,al.,(,201,1,),NK,cells,and,their,receptors,during,viral,infections,.}	{NULL}
journal.pone.0049897.pdf	774	{Immunotherapy,3,:,10754,1086,.}	{NULL}
journal.pone.0049897.pdf	775	{VValdhauer,I,",",Steinle,A,(,2008,),NK,cells,and,cancer,immunosurveillance,.}	{NULL}
journal.pone.0049897.pdf	776	{Oncogene,27,:,293245943,.}	{NULL}
journal.pone.0049897.pdf	777	{VVaggoner,SN,",",Cornberg,1,"\\\\",’,I,",",Selin,LK,",",VVelsh,RNI,.}	{NULL}
journal.pone.0049897.pdf	778	{(,201,1,),Natural,killer,cells,act,as,rheostats,modulating,antiviral,T,cells,.}	{NULL}
journal.pone.0049897.pdf	779	{Nature,481,:,3944398,.}	{NULL}
journal.pone.0049897.pdf	780	{Chiossone,L,",",Chaix,J,",",Fuseri,N,",",Roth,C,",",Vivier,E,",",et,al.,(,2009,),1,"\\\\",’,Iaturation,of,mouse,NK,cells,is,a,4-stage,developmental,program,.}	{NULL}
journal.pone.0049897.pdf	781	{Blood,113,:,548845496,.}	{NULL}
journal.pone.0049897.pdf	782	{Robbins,SH,",",Nguyen,KB,",",Takahashi,N,",",Nlikayama,T,",",Biron,CA,",",et,al.,(,2002,),Cutting,edge,:,Inhibitory,functions,of,the,killer,cell,lectin-like,receptor,G1,molecule,during,the,activation,of,mouse,NK,ce11s,.}	{NULL}
journal.pone.0049897.pdf	783	{Journal,of,Immunology,168,:,258542589,.}	{NULL}
journal.pone.0049897.pdf	784	{Denoeud,J,",",1,"\\\\",’,Ioser,1,"\\\\",’,I,(,2011,),Role,of,CD27/CD70,pathway,of,activation,in,immunity,and,tolerance,.}	{NULL}
journal.pone.0049897.pdf	785	{Journal,of,Leukocyte,BioloQ,',89,:,1954203,.}	{NULL}
journal.pone.0049897.pdf	786	{Hermiston,1,"\\\\",’,IL,",",Xu,Z,",",VVeiss,A,(,2003,),CD45,:,A,critical,regulator,of,signaling,thresholds,in,immune,cells,.}	{NULL}
journal.pone.0049897.pdf	787	{Annual,Review,of,Immunology,21,:,1074137,.}	{NULL}
journal.pone.0049897.pdf	788	{Ellis,RJ,",",Childers,IVIE,",",Cherner,1,"\\\\",’,I,",",Lazzaretto,D,",",Letendre,S,",",et,al.,(,2003,),Increased,human,immunodeficiency,virus,loads,in,active,methamphetamine,users,are,explained,by,reduced,effectiveness,of,antiretroviral,therapy,.}	{NULL}
journal.pone.0049897.pdf	789	{The,Journal,of,Infectious,Diseases,188,:,182041826,.}	{NULL}
journal.pone.0049897.pdf	790	{Henning,G,",",Kraft,1,"\\\\",’,IS,",",Derfuss,T,",",Pirzer,R,",",de,Saint-Basile,G,",",at,al.,(,2001,),Signaling,lymphocyte,activation,molecule,(,SLANI,),regulates,T,cellular,cytotoxicity,.}	{NULL}
journal.pone.0049897.pdf	791	{European,Journal,of,ImmunoloQ,',31,:,274142750,.}	{NULL}
journal.pone.0049897.pdf	792	{Ito,IVI,",",1,"\\\\",’,Iaruyama,T,",",Saito,N,",",Koganei,S,",",Yamamoto,K,",",et,al.,(,2006,),Killer,cell,lectin-like,receptor,G1,binds,three,members,of,the,classical,cadherin,family,to,inhibit,NK,cell,cytotoxicity,.}	{NULL}
journal.pone.0049897.pdf	793	{The,Journal,of,Experimental,1VIedicine,203,:,2894,295,.}	{NULL}
journal.pone.0049897.pdf	794	{Li,Y,",",Hofmann,"1\\\\/I",",",VVang,Q,",",Teng,L,",",Chlewicki,LK,",",et,al.,(,2009,),Structure,of,natural,killer,cell,receptor,KLRG1,bound,to,E,~,cadherin,reveals,basis,for,1,"\\\\",IHCindependent,missing,self,recognition,.}	{NULL}
journal.pone.0049897.pdf	795	{Immunity,31,:,35446,.}	{NULL}
journal.pone.0049897.pdf	796	{Reiley,VVVV,",",Shafiani,S,",","\\\\",/,Vittmer,ST,",",Tucker-Heard,G,",",Nloon,JJ,",",et,al.,(,2010,),Distinct,functions,of,antigen-specific,CD4,T,cells,during,illycobacterium,Zu/Mrculoxir,infection,.}	{NULL}
journal.pone.0049897.pdf	797	{Proceedings,of,the,National,Academy,of,Sciences,107,:,19408419413,.}	{NULL}
journal.pone.0051251.pdf	1	{OPEN,8,ACCESS,Freely,available,online,',Ѕ,+,l,°,”,E}	{NULL}
journal.pone.0051251.pdf	2	{Sulforaphane,Induces,Cell,Cycle,Arrest,and,Apoptosis,in,Acute,Lymphoblastic,Leukemia,Cells}	{NULL}
journal.pone.0051251.pdf	3	{Koramit,Suppipat,‘,",",Chun,Shik,Parke,",",Ye,Shenz,",",Xiao,Zhu3,",",H.,Daniel,Lacorazza2,',4,*,1,Texas,Children,'s,Cancer,and,Hematology,Centers,",",Texas,Children,'s,Hospital,",",Houston,",",Texas,",",United,States,of,America,",",2,Department,of,Pathology,and,Immunology,",",Baylor,College,of,Medicine,",",Houston,",",Texas,",",United,States,of,America,",",3Summer,Medical,and,Research,Training,Program,",",Baylor,College,of,Medicine,",",Houston,",",Texas,",",United,States,of,America,",",4Department,of,Pediatrics,",",Baylor,College,of,Medicine,",",Houston,",",Texas,",",United,States,of,America}	{NULL}
journal.pone.0051251.pdf	4	{Abstract,Acute,Iymphoblastic,leukemia,(,ALL,),is,the,most,common,hematological,cancer,in,children,.}	{NULL}
journal.pone.0051251.pdf	5	{Although,risk,—,adaptive,therapy,",",CNS,—,directed,chemotherapy,",",and,supportive,care,have,improved,the,survival,of,ALL,patients,",",disease,relapse,is,still,the,leading,cause,of,cancer,—,related,death,in,children,.}	{NULL}
journal.pone.0051251.pdf	6	{Therefore,",",new,drugs,are,needed,as,frontline,treatments,in,high,—,risk,disease,and,as,salvage,agents,in,relapsed,ALL,.}	{NULL}
journal.pone.0051251.pdf	7	{In,this,study,",",we,report,that,purified,sulforaphane,",",a,natural,isothiocyanate,found,in,cruciferous,vegetables,",",has,anti,—,|,eukemic,properties,in,a,broad,range,of,ALL,cell,lines,and,primary,lymphoblasts,from,pediatric,T,.}	{NULL}
journal.pone.0051251.pdf	8	{—,.}	{NULL}
journal.pone.0051251.pdf	9	{ALL,and,pre,.}	{NULL}
journal.pone.0051251.pdf	10	{—,.}	{NULL}
journal.pone.0051251.pdf	11	{B,ALL,patients,.}	{NULL}
journal.pone.0051251.pdf	12	{The,treatment,of,ALL,leukemic,cells,with,sulforaphane,resulted,in,dosedependent,apoptosis,and,G2/M,cell,cycle,arrest,",",which,was,associated,with,the,activation,of,caspases,(,3,",",8,",",and,9,),",",inactivation,of,PARP,",",p53,—,independent,upregulation,of,p21e,',P,”,WAF,‘,",",and,inhibition,of,the,Cdc2/Cyclin,B1,complex,.}	{NULL}
journal.pone.0051251.pdf	13	{Interestingly,",",sulforaphane,also,inhibited,the,AKT,and,mTOR,survival,pathways,in,most,of,the,tested,cell,lines,by,lowering,the,levels,of,both,total,and,phosphorylated,proteins,.}	{NULL}
journal.pone.0051251.pdf	14	{Finally,",",the,administration,of,sulforaphane,to,the,ALL,xenograft,models,resulted,in,a,reduction,of,tumor,burden,",",particularly,following,oral,administration,",",suggesting,a,potential,role,as,an,adjunctive,agent,to,improve,the,therapeutic,response,in,high,—,risk,ALL,patients,with,activated,AKT,signaling,.}	{NULL}
journal.pone.0051251.pdf	15	{Citation,:,Suppipat,K,",",Park,CS,",",Shen,Y,",",Zhu,X,",",Lacorazza,HD,(,2012,),Sulforaphane,Induces,Cell,Cycle,Arrest,and,Apoptosis,in,Acute,Lymphoblastic,Leukemia,Cells,.}	{NULL}
journal.pone.0051251.pdf	16	{PLOS,ONE,7,(,12,),:,e51251,.}	{NULL}
journal.pone.0051251.pdf	17	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	18	{pone,.}	{NULL}
journal.pone.0051251.pdf	19	{O051251,Editor,:,Junji,Yodoi,",",Institute,for,Virus,Research,",",Laboratory,of,Infection,and,Prevention,",",Japan,Received,August,10,",",2012,;,Accepted,October,29,",",2012,;,Published,December,12,",",2012,Copyright,:,©,2012,Suppipat,et,al.,.}	{NULL}
journal.pone.0051251.pdf	20	{This,is,an,open,»,access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pone.0051251.pdf	21	{Funding,:,This,work,was,supported,by,Gabrie,|,|,e,’s,Angel,Foundation,for,Cancer,Research,and,Alkek,Foundation,.}	{NULL}
journal.pone.0051251.pdf	22	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pone.0051251.pdf	23	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pone.0051251.pdf	24	{*,E,—,mai,|,:,hd,|,@bcm.edu}	{NULL}
journal.pone.0051251.pdf	25	{|,nt,|,-,oduction,marrow,relapse,at,any,time,during,therapy,are,more,difficult,to,_,_,_,treat,and,therefore,exhibit,worse,outcomes,compared,to,relapsed,Acute,Wmphoblasue,leukemla,(,ALL,),15,the,most,Common,pre,.}	{NULL}
journal.pone.0051251.pdf	26	{—,.}	{NULL}
journal.pone.0051251.pdf	27	{B,ALL,patients,[,"5,6",],.}	{NULL}
journal.pone.0051251.pdf	28	{Thus,",",a,better,understanding,of,the,hematological,malignancy,in,children,.}	{NULL}
journal.pone.0051251.pdf	29	{The,incidence,of,the,two,pathogenesis,of,ALL,and,the,identiﬁcation,of,the,molecular,targets,ALL,subtypes,correlates,inversely,with,prognosis,;,appr9X1mate1Y,associated,with,more,aggressive,disease,can,aid,in,the,develop7OT80,/,o,of,ALL,eases,are,of,the,preeurser,B'eeh,hneage,(,pre'B,ment,of,new,therapeutic,strategies,for,children,with,high,—,risk,ALL,),’,Whereas,T'eeh,ALL,(,T'ALL,),Oeeurs,at,a,lower,frequehey,disease,.}	{NULL}
journal.pone.0051251.pdf	30	{The,enhanced,ability,of,leukemic,cells,to,proliferate,and,and,has,e,worse,prognosis,[,1,],',Although,risk,—,adaptive,therapy,has,survive,compared,to,normal,cells,is,an,important,factor,associated,improved,the,treatment,euteeme,of,ehhdheed,ALL,’,20,%,Of,these,with,disease,severity,[,7,],.}	{NULL}
journal.pone.0051251.pdf	31	{Leukemic,cells,deregulate,proliferation,patients,Shh,relapse,after,their,initial,treatment,[,2,],',A,peer,and,increase,survival,through,the,loss,of,key,cell,cycle,checkpoint,uhdereeﬁhehhg,of,‘,ELL,Pathobiology,has,prevented,th,:,_,d,:,Ye1e,"}",1,:,',controls,",",such,as,CDKN2A,/,B,misexpression,",",and,the,activation,of,(,+,+,,+,(,+,as,6,+,@,',+,p,+}	{NULL}
journal.pone.0051251.pdf	32	{.}	{NULL}
journal.pone.0051251.pdf	33	{.}	{NULL}
journal.pone.0051251.pdf	34	{.}	{NULL}
journal.pone.0051251.pdf	35	{"8,9,10",",",l1,",",l2,",13",.}	{NULL}
journal.pone.0051251.pdf	36	{Th,f,",",h,',l,d,h,bl}	{NULL}
journal.pone.0051251.pdf	37	{[,3,],.}	{NULL}
journal.pone.0051251.pdf	38	{Therefore,",",the,development,of,novel,agents,is,critical,to,P,+,d,H,1,],ere,er,:,+,Seglee,eempleen,ele,eeleeee,leee,enerate,frontline,thera,ies,for,hi,h-risk,atients,and,salva,e,In,uee,ee,eye,e,eeeeet,an,In,1,It,euevwe,elenee,Se,eemey,1n,g,p,g,p,g,leukemic,cells,both,in,vitro,and,in,preclinical,mouse,models,may,be,t,t,t,t,I,d,d,‘,". . . . ."}	{NULL}
journal.pone.0051251.pdf	39	{egen,e,o,Fee,re,epee,leeeee,",",.}	{NULL}
journal.pone.0051251.pdf	40	{the,next,line,of,chemodrugs,that,are,utilized,to,control,or,eradicate,Although,relapses,in,pre,.}	{NULL}
journal.pone.0051251.pdf	41	{—,.}	{NULL}
journal.pone.0051251.pdf	42	{B,ALL,are,frequently,associated,with,.}	{NULL}
journal.pone.0051251.pdf	43	{.}	{NULL}
journal.pone.0051251.pdf	44	{resistant,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	45	{high,—,risk,disease,(,i.e.,",",BCR-ABL,translocation,",",hyp0diP10idY,’,and,Many,standard,chemotherapeutic,agents,have,been,discovered,MLL,rearrangement,with,slow,early,response,and,induction,". . . . .",.}	{NULL}
journal.pone.0051251.pdf	46	{.}	{NULL}
journal.pone.0051251.pdf	47	{from,natural,sources,(,eg,",",daunorubicin,and,cytarabine,),.}	{NULL}
journal.pone.0051251.pdf	48	{Sulfofailure,),",",relapses,can,occur,within,all,currently,deﬁned,risk,groups,mphane,(,SF,),is,a,dietary,isothiocyanate,found,in,cruciferous,[,e,’,e,],',The,mejeney,of,eelepeee,eeeue,In,ehedeen,mleeey,eeelgeed,vegetables,and,is,endowed,with,both,preventive,and,therapeutic,to,the,standard,(,i.e.,",",age,l,—,9,y/o,and,white,blood,cells,<,"50,000",/,activities,in,solid,tumors,[,14,],Epidemiological,studies,conducted,ul,),or,high,—,risk,categories,(,i.e.,",",age,9,y/o,",",WBC,.}	{NULL}
journal.pone.0051251.pdf	49	{.}	{NULL}
journal.pone.0051251.pdf	50	{o,+,". . .",>,"50,000",/,ul,",",and,central,nervous,system,or,testicular,disease,at,In,the,Us,found,thee,‘,.}	{NULL}
journal.pone.0051251.pdf	51	{“,d,‘“,d,“,hS,Wee,eeeeumed,e,eeet,nee,m,cruciferous,vegetables,(,i.e.,",",broccoli,and,cabbage,),had,a,lower,','}	{NULL}
journal.pone.0051251.pdf	52	{.}	{NULL}
journal.pone.0051251.pdf	53	{Th,',1,f,',',h,l,-,B,eeeeeeelef,[,3,],e,Serve/e,eete,e,peeeme,We,re,epeed,pee,incidence,of,breast,",",lung,",",prostate,",",and,colon,cancer,ALL,ranges,from,20,to,50,%,",",depending,on,the,site,and,time,of,.}	{NULL}
journal.pone.0051251.pdf	54	{.}	{NULL}
journal.pone.0051251.pdf	55	{relapse,.}	{NULL}
journal.pone.0051251.pdf	56	{In,contrast,",",patients,with,T-cell,ALL,who,develop,bone,[,1e,’,1e,’,17,’,1e,’,19,],',Furthermore,’,the,eeneumpeen,of,raw,erueleee}	{NULL}
journal.pone.0051251.pdf	57	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0051251.pdf	58	{p,|,osone.org,1,December,2012,|,Volume,7,|,Issue,12,|,e51251}	{NULL}
journal.pone.0051251.pdf	59	{ous,vegetables,inversely,correlates,with,the,risk,of,bladder,cancer,[,20,],.}	{NULL}
journal.pone.0051251.pdf	60	{This,cancer,chemopreventive,property,has,been,largely,attributed,to,the,activity,of,isothiocyanates,derived,from,the,metabolism,of,glucosinolates,that,accumulate,in,cruciferous,vegetables,.}	{NULL}
journal.pone.0051251.pdf	61	{The,glucosinolate,glucoraphanin,is,converted,to,SF,by,myrosinases,that,are,present,in,cruciferous,vegetables,and,gut,bacteria,[,19,],.}	{NULL}
journal.pone.0051251.pdf	62	{SF,is,a,highly,reactive,and,hydrophobic,compound,that,can,alter,cellular,function,by,entering,cells,where,SF,is,either,conjugated,to,glutathione,and,secreted,via,the,mercapturic,pathway,or,it,forms,thionacyl,adducts,with,the,thiol,groups,of,not,yet,identiﬁed,proteins,in,cancer,cells,.}	{NULL}
journal.pone.0051251.pdf	63	{SF,induces,apoptosis,in,several,cancer,cell,lines,and,has,been,tested,in,animal,models,of,human,cancer,",",such,as,T-cell,leukemia,",",breast,",",colon,",",and,prostate,cancer,",",by,targeting,caspases,",",PARP,",",p2lCH,),1/WAF1,(,p21,),",",p53,and,Bax,[,2l,",22,23,24,25",],.}	{22}
journal.pone.0051251.pdf	64	{SF,also,causes,Gl/S,and,G2/M,cell,cycle,arrest,through,alterations,in,the,levels,of,cyclin,A,",",cyclin,B1,",",cyclin,D1,",",p2l,“,i,"\\"",1,/,“,M1,",",and,the,tumor,suppressor,KLF4,[,"23,26,27,28,29",],.}	{NULL}
journal.pone.0051251.pdf	65	{Moreover,",",a,recent,report,showed,that,SF,restricts,the,survival,of,cancer,cells,by,inhibiting,PI3K/AKT,signaling,in,the,PTEN-null,mouse,model,of,prostate,cancer,[,30,],.}	{NULL}
journal.pone.0051251.pdf	66	{In,this,study,",",we,describe,the,anti-leukemic,effect,of,SF,in,pre-B,ALL,and,T-ALL,cell,lines,and,primary,samples,from,pediatric,ALL,patients,.}	{NULL}
journal.pone.0051251.pdf	67	{SF,induced,apoptosis,",",G2,/,M,cell,cycle,arrest,",",higher,p2l,levels,",",cleavage,of,PARP,and,caspases,(,3,",",8,",",and,9,),",",and,the,inhibition,of,AKT/mTOR,signaling,in,ALL,cells,.}	{NULL}
journal.pone.0051251.pdf	68	{"\\\\",/,V,e,further,conﬁrmed,that,the,administration,of,SF,controlled,the,expansion,of,leukemic,cells,in,pre-clinical,xenograft,models,of,ALL,.}	{NULL}
journal.pone.0051251.pdf	69	{This,study,supports,further,testing,of,SF,as,an,adjunctive,agent,to,increase,remission,rates,in,high-risk,ALL,patients,and,to,treat,other,hematological,malignancies,with,activated,survival,pathways,.}	{NULL}
journal.pone.0051251.pdf	70	{Materials,and,Methods}	{NULL}
journal.pone.0051251.pdf	71	{Ethics,Statement,The,Baylor,College,of,Medicine,Institutional,Review,Board,approved,the,use,of,human,samples,for,this,study,.}	{NULL}
journal.pone.0051251.pdf	72	{Primary,clinical,specimens,were,obtained,from,the,tissue,repository,at,Texas,Children,’s,Hospital,that,collected,samples,following,written,informed,consent,.}	{NULL}
journal.pone.0051251.pdf	73	{We,received,archived,samples,upon,approval,by,the,Leukemia,Research,Interest,Group,at,Texas,Children,’s,Hospital,.}	{NULL}
journal.pone.0051251.pdf	74	{All,mice,were,maintained,in,speciﬁc,pathogen-free,conditions,at,the,Baylor,College,of,Medicine,(,Houston,",",TX,",",USA,),.}	{NULL}
journal.pone.0051251.pdf	75	{All,experiments,were,performed,with,the,approval,of,the,Institutional,Animal,Care,and,Usage,Committee,of,Baylor,College,of,Medicine,.}	{NULL}
journal.pone.0051251.pdf	76	{Chemicals,Synthetic,DL-Sulforaphane,(,SF,),was,purchased,from,SigmaAldrich,(,St.,Louis,",",MO,),and,LKT,Laboratories,(,St.,Paul,",",MN,),for,both,the,in,vitro,and,in,viva,studies,.}	{NULL}
journal.pone.0051251.pdf	77	{SF,was,dissolved,in,dimethyl,sulfoxide,(,DMSO,),to,generate,a,40,mM,stock,concentration,and,stored,at,—,20,°,C.,SF,was,diluted,to,the,speciﬁed,ﬁnal,concentration,in,RPMI-1640,medium,supplemented,with,lo,%,fetal,bovine,serum,(,FBS,),.}	{NULL}
journal.pone.0051251.pdf	78	{The,volume,of,DMSO,was,less,than,0.1,%,of,the,total,volume,",",and,the,identical,dilution,of,DMSO,in,culture,medium,was,used,as,the,vehicle,control,.}	{NULL}
journal.pone.0051251.pdf	79	{S,(,NMethylsulﬁnylbutylthiocarbamoyl,),-,glutathione,(,SF-glutathione,),",",S,(,NMethylsulﬁnylbutylthiocarbamoyl,),-,L-cysteine,(,SF-cysteine,),",",and,NAcetylS,(,N-Methylsulﬁnylbutylthiocarbamoyl,),-,L-cysteine,(,SF-NAC,),were,obtained,from,LKT,Laboratories,.}	{NULL}
journal.pone.0051251.pdf	80	{Cell,Lines,and,Cell,Culture,The,Nalm-6,",",REH,and,RS-4,cell,lines,were,obtained,from,Dr.,Karen,Rabin,(,Texas,Children,’s,Cancer,and,Hematology,Centers,",",Baylor,College,of,Medicine,),",",originally,from,the,American,Type,Tissue,Collection,(,REH,",",RS4,),and,the,DMSZ,German,Collection,of,Microorganisms,and,Cell,Culture,(,Nalm-6,),.}	{NULL}
journal.pone.0051251.pdf	81	{The,EBVtransformed,lymphoblastoid,cell,line,(,LCL,),was,provided,by,Dr.,Catherine,Bollard,(,Center,for,Cell,and,Gene,Therapy,",",Baylor,College,of,Medicine,),[,31,],.}	{NULL}
journal.pone.0051251.pdf	82	{The,RPMI,",",DND4l,and,KOPTKI,TALL,cell,lines,were,obtained,from,Dr.,Adolfo,F,errando,(,Columbia,University,",",New,York,),[,32,],and,jurkat,cells,from,the,American,Type,Tissue,Collection,.}	{NULL}
journal.pone.0051251.pdf	83	{All,of,the,cell,lines,were,maintained,in,RPMI-1640,medium,(,Lonza,),supplemented,with,10,%,FBS,",",2,mM,glutamine,",",1,mM,sodium,pyruvate,",",penicillin,(,10,U,/,ml,),",",and,streptomycin,(,10,ug,/,ml,),.}	{NULL}
journal.pone.0051251.pdf	84	{Patient,Samples,Bone,marrow,or,peripheral,blood,samples,from,pre-B,ALL,and,T-ALL,patients,collected,at,the,time,of,diagnosis,were,obtained,from,the,Texas,Children,’s,Cancer,Center,tissue,repository,(,>,800/0,blast,cells,),.}	{NULL}
journal.pone.0051251.pdf	85	{The,samples,were,collected,after,written,informed,consent,and,frozen,lymphoblasts,were,supplied,in,an,unspeciﬁed,manner,.}	{NULL}
journal.pone.0051251.pdf	86	{All,experiments,with,patient,samples,conformed,to,the,regulatory,standards,approved,by,the,Baylor,College,of,Medicine,Institutional,Review,Board,(,IRB,),.}	{NULL}
journal.pone.0051251.pdf	87	{Mononuclear,cells,from,healthy,donors,were,isolated,using,Ficoll,gradient,from,peripheral,blood,collected,according,institutional,review,board,protocols,.}	{NULL}
journal.pone.0051251.pdf	88	{In,vitro,Cell,Viability,Assay,The,cell,lines,were,cultured,overnight,in,96-well,plates,at,a,density,of,2x104,cells/well,.}	{NULL}
journal.pone.0051251.pdf	89	{The,next,day,",",SF,was,added,(,o,—,lo,uM,),",",and,the,cells,were,incubated,for,an,additional,24,—,48,hours,.}	{NULL}
journal.pone.0051251.pdf	90	{The,primary,patient,samples,were,cultured,for,4,hours,in,96-well,plates,at,a,density,of,at,least,2,X104,cells,/,well,followed,by,an,additional,24,~,48,hours,in,the,presence,of,SF,(,0,—,40,"ul\\\\/1",),.}	{NULL}
journal.pone.0051251.pdf	91	{Cell,viability,was,measured,using,the,CellTiter-Glo,Luminescent,Viability,assay,(,Promega,),",",an,ATP-based,method,",",and,the,number,of,viable,cells,was,estimated,as,relative,luminescent,units,.}	{NULL}
journal.pone.0051251.pdf	92	{The,half-maximal,inhibitory,concentration,(,IC50,),was,calculated,from,triplicates,of,each,dose,by,nonlinear,regression,analysis,using,GraphPad,software,.}	{NULL}
journal.pone.0051251.pdf	93	{Analysis,of,Apoptosis,and,DNA,Content,The,cell,lines,were,cultured,in,6-well,plates,at,a,ﬁnal,concentration,of,4,>,<,105,cells,/,ml,and,incubated,overnight,before,the,addition,of,SF,(,7.5,"ul\\\\/1",),.}	{NULL}
journal.pone.0051251.pdf	94	{The,cells,were,collected,48,hours,later,and,the,percentages,of,annexin-V,-,and,7-AAD-positive,cells,were,analyzed,by,ﬂow,cytometry,as,indicated,by,the,manufacturer,(,BD,Biosciences,),.}	{NULL}
journal.pone.0051251.pdf	95	{To,measure,DNA,content,",",the,cells,were,resuspended,in,PBS,containing,0.1,%,sodium,citrate,",",0.1,%,Triton-X,100,and,RNase,A,(,100,ug,/,ml,),",",and,the,nuclei,were,stained,with,propidium,iodide,(,50,ug,/,ml,),.}	{NULL}
journal.pone.0051251.pdf	96	{The,cell,cycle,distribution,was,analyzed,by,ﬂow,cytometry,(,FACScanto,),and,calculated,using,Flowjo,software,(,Tree,Star,Inc.,),.}	{NULL}
journal.pone.0051251.pdf	97	{lmmunoblots,The,leukemic,cells,were,harvested,after,24,hours,of,incubation,with,SF,(,7.5,uM,),or,the,vehicle,control,.}	{NULL}
journal.pone.0051251.pdf	98	{The,cells,were,lysed,with,a,1,%,Nonidet,P-40,(,NP-40,),solution,containing,5,mM,EDTA,",",150,mM,NaCl,",",50,mM,Tris-HCl,(,pH,8.0,),",",and,a,cocktail,of,phosphatase,and,protease,inhibitors,(,Roche,Molecular,Biochemicals,),.}	{NULL}
journal.pone.0051251.pdf	99	{The,samples,were,separated,by,SDS-PAGE,electrophoresis,and,transferred,to,PVDF,membranes,.}	{NULL}
journal.pone.0051251.pdf	100	{The,immunoblots,were,developed,using,the,following,antibodies,(,Cell,Signaling,),:,rabbit,polyclonal,anti-PARP,",",mouse,monoclonal,anti-caspase,3,",",mouse,monoclonal,anti-caspase,8,",",mouse,monoclonal,anti-caspase,9,",",mouse,monoclonal,anti-p21,",",mouse,monoclonal,anti-p53,",",rabbit,polyclonal,anti-AKT,",",rabbit,monoclonal,anti-phospho-AKT,(,Ser473,),",",rabbit,monoclonal,anti-mTOR,",",rabbit,monoclonal,anti-phospho-mTOR,",",rabbit,monoclonal,anti-cyclin,Bl,",",rabbit,anti-phospho-cdc2,(,Tyrl5,),",",rabbit,anti-cdc2,",",rabbit,antiphosphocdc25C,(,Ser2l6,),",",and,rabbit,anti-cdc25C,.}	{NULL}
journal.pone.0051251.pdf	101	{Mouse,anti-cyclin,Dl,antibody,was,obtained,from,Santa,Cruz,Biotechnology,.}	{NULL}
journal.pone.0051251.pdf	102	{Xenograft,Mouse,Models,The,Nalm-6,(,pre-B,ALL,),cells,were,transduced,with,retrovirus,generated,by,the,co-transfection,of,293T,cells,with,the,retroviral,construct,GFP-FFluc,and,the,psi-amphotropic,envelope,.}	{NULL}
journal.pone.0051251.pdf	103	{Transduced,tumor,cells,",",which,were,marked,by,GFP,expression,",",were,selected,by,ﬂuorescence-activated,cell,sorting,(,Nalm-6-FFLuc,),.}	{NULL}
journal.pone.0051251.pdf	104	{To,induce,leukemia,in,a,xenograft,mouse,model,of,systemic,disease,",",0.25,X,106,cells,were,injected,via,the,tail,veins,of,NOD,/,SCID,mice,(,Iackson,Lab,),.}	{NULL}
journal.pone.0051251.pdf	105	{Twenty-four,hours,later,",",the,mice,received,daily,intraperitoneal,injections,with,2,mg,SF,or,vehicle,and,were,monitored,for,leukemic,cell,expansion,by,bioluminescence,detection,each,week,.}	{NULL}
journal.pone.0051251.pdf	106	{To,induce,subcutaneous,tumors,",",5,>,<,1O6,Nalm-6-FFluc,cells,embedded,in,high,concentration,basement,membrane,matrix,(,BD,Bioscience,),were,injected,subcutaneously,into,the,ﬂanks,of,NOD/SCID,mice,.}	{NULL}
journal.pone.0051251.pdf	107	{Bioluminescent,imaging,was,performed,after,one,week,of,tumor,establishment,(,day,o,treatment,),and,after,4,and,7,days,of,SF,treatment,by,oral,gavage,(,2,mg,",",twice,daily,),.}	{NULL}
journal.pone.0051251.pdf	108	{For,bioluminescence,detection,",",the,images,were,acquired,in,anesthetized,mice,using,the,IVIS,Imaging,System,(,Xenogen,),10,minutes,after,intraperitoneal,injection,with,50,mg,/,kg,D-luciferin,.}	{NULL}
journal.pone.0051251.pdf	109	{All,mice,were,maintained,in,speciﬁc,pathogen-free,conditions,at,the,Baylor,College,of,Medicine,(,Houston,",",TX,",",USA,),.}	{NULL}
journal.pone.0051251.pdf	110	{All,experiments,were,performed,with,the,approval,of,the,Institutional,Animal,Care,and,Usage,Committee,of,Baylor,College,of,Medicine,.}	{NULL}
journal.pone.0051251.pdf	111	{Statistical,Analysis,Two-tailed,unpaired,Student,’s,t-tests,were,performed,using,GraphPad,software,.}	{NULL}
journal.pone.0051251.pdf	112	{Differences,were,considered,signiﬁcant,when,the,P,value,was,<,0.05,.}	{NULL}
journal.pone.0051251.pdf	113	{The,statistics,are,indicated,in,each,ﬁgure,legend,.}	{NULL}
journal.pone.0051251.pdf	114	{Results}	{NULL}
journal.pone.0051251.pdf	115	{Sulforaphane,Induces,Apoptosis,in,Pre,.}	{NULL}
journal.pone.0051251.pdf	116	{—,.}	{NULL}
journal.pone.0051251.pdf	117	{B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	118	{—,.}	{NULL}
journal.pone.0051251.pdf	119	{ALL,Cells,SF,is,a,natural,product,found,in,cruciferous,vegetables,and,has,shown,anti-cancer,properties,in,breast,",",prostate,",",and,colon,cancer,[,"33,34,35",],.}	{NULL}
journal.pone.0051251.pdf	120	{In,this,work,",",we,investigated,whether,puriﬁed,SF,is,also,effective,against,hematological,malignancies,by,testing,its,activity,in,ALL,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	121	{We,initially,observed,that,SF,(,10,uM,),signiﬁcantly,reduced,the,viability,of,the,Nalm-6,human,pre-B,ALL,cell,line,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	122	{IA,),.}	{NULL}
journal.pone.0051251.pdf	123	{We,next,examined,the,effects,of,different,concentrations,of,SF,(,o,—,lo,uM,),on,the,viability,of,the,cultured,pre-B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	124	{—,.}	{NULL}
journal.pone.0051251.pdf	125	{ALL,leukemic,cell,lines,compared,to,the,EBV-transformed,B-cell,lymphoblastoid,cell,line,(,LCL,),used,as,the,“,non-leukemic,”,control,.}	{NULL}
journal.pone.0051251.pdf	126	{SF,selectively,killed,the,Nalm-6,",",REH,",",and,RS-4,pre-B,ALL,cells,in,a,dose-dependent,manner,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	127	{1B,),.}	{NULL}
journal.pone.0051251.pdf	128	{In,contrast,",",the,incubation,of,non-leukemic,cells,with,the,highest,concentration,of,SF,resulted,in,a,20,%,reduction,in,cell,viability,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	129	{1B,),.}	{NULL}
journal.pone.0051251.pdf	130	{Similar,to,the,pre-B,ALL,cells,",",the,Jurkat,",",RPMI,",",DND4l,",",and,KOPTKI,T,.}	{NULL}
journal.pone.0051251.pdf	131	{—,.}	{NULL}
journal.pone.0051251.pdf	132	{ALL,cell,lines,were,susceptible,to,SF-mediated,cytotoxicity,",",and,nearly,no,viable,leukemic,cells,survived,after,incubation,with,10,uM,SF,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	133	{1B,),.}	{NULL}
journal.pone.0051251.pdf	134	{Consistent,with,the,inhibitory,concentrations,reported,for,other,cancer,cells,[,"29,36,37",],",",SF,exhibited,a,half-maximal,inhibitory,concentration,(,IC50,),in,the,1,—,7,uM,range,(,Table,1,),.}	{NULL}
journal.pone.0051251.pdf	135	{Because,patient-derived,cells,often,accumulate,additional,genetic,aberrations,during,the,establishment,of,a,cell,line,",",we,further,conﬁrmed,our,ﬁndings,using,primary,lymphoblasts,collected,at,diagnosis,from,the,pre-B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	136	{—,.}	{NULL}
journal.pone.0051251.pdf	137	{ALL,pediatric,patients,at,the,Texas,Children,’s,Cancer,and,Hematology,Centers,.}	{NULL}
journal.pone.0051251.pdf	138	{The,patient,lymphoblasts,showed,a,dose-dependent,cytotoxicity,with,an,IC50,(,48,h,),in,the,7,—,13,uM,range,",",and,only,one,of,six,pre-B,ALL,samples,displayed,a,poor,response,to,SF,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	139	{1C,",",Table,1,),.}	{NULL}
journal.pone.0051251.pdf	140	{Collectively,",",our,data,demonstrate,that,SF,signiﬁcantly,reduced,the,cell,viability,of,established,ALL,cell,lines,and,patient,samples,.}	{NULL}
journal.pone.0051251.pdf	141	{The,next,question,was,to,examine,the,toxicity,of,SF,on,normal,peripheral,blood,mononuclear,cells,(,PBMC,),.}	{NULL}
journal.pone.0051251.pdf	142	{We,cultured,PBMC,freshly,isolated,from,4,different,healthy,donors,in,the,presence,of,SF,(,O,—,4O,l.,"Ll\\\\/I",),for,24,hours,",",which,is,the,time,reported,for,complete,elimination,of,SF,from,blood,[,37,],.}	{NULL}
journal.pone.0051251.pdf	143	{In,contrast,to,lymphoblasts,from,ALL,patients,",",normal,PBMC,were,less,susceptible,to,SF,showing,lO,—,20,%,cytotoxicity,with,the,highest,concentration,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	144	{1D,),.}	{NULL}
journal.pone.0051251.pdf	145	{Even,though,longer,incubations,(,48,hours,),reduced,survival,of,normal,PBMC,due,to,their,limited,proliferative,and,survival,capacity,in,vitro,",",the,IC50,(,30.2:7.2,uM,",",n,=,4,),was,signiﬁcantly,higher,(,p,<,o.,ool,),than,primary,samples,from,pre-B,ALL,(,l3,.}	{NULL}
journal.pone.0051251.pdf	146	{li8,.}	{NULL}
journal.pone.0051251.pdf	147	{l,"}",",","lI\\\\/I",",",n,=,6,),and,T,.}	{NULL}
journal.pone.0051251.pdf	148	{—,.}	{NULL}
journal.pone.0051251.pdf	149	{ALL,(,l0,.}	{NULL}
journal.pone.0051251.pdf	150	{li2,.0,HM,",",n,=,7,),patients,.}	{NULL}
journal.pone.0051251.pdf	151	{Finally,",",we,investigated,whether,the,metabolism,of,SF,leads,to,abrogation,of,its,cytotoxic,properties,",",which,is,particularly,important,for,future,translation,into,the,clinic,.}	{NULL}
journal.pone.0051251.pdf	152	{In,contrast,to,SF,(,IC5O,4.7,uM,),",",the,survival,of,Nalm-6,cells,cultured,in,the,presence,of,different,doses,of,SF-glutathione,",",SF-cysteine,or,SF-N-acetyl-cysteine,was,significantly,improved,",",with,IC50s,9,LLM,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	153	{1E,),.}	{NULL}
journal.pone.0051251.pdf	154	{For,example,",",7.5,uM,of,SF-metabolites,induced,only,20,%,cytotoxicity,after,48,hours,of,incubation,compared,to,80,%,for,same,concentration,of,SF,.}	{NULL}
journal.pone.0051251.pdf	155	{Thus,",",future,clinical,trials,should,aim,at,maintaining,a,therapeutic,concentration,of,SF,(,active,form,),.}	{NULL}
journal.pone.0051251.pdf	156	{The,reduction,of,cell,viability,indicates,that,SF,induced,cell,death,in,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	157	{To,test,this,hypothesis,",",we,incubated,ALL,and,LCL,cells,with,7.5,uM,SF,for,48,hours,and,then,stained,the,cells,with,annexin-V,and,7-AAD,for,ﬂow,cytometric,analysis,.}	{NULL}
journal.pone.0051251.pdf	158	{In,contrast,to,the,LCL,cells,",",SF,induced,apoptosis,in,the,Nalm-6,",",Jurkat,and,KOPTKI,cells,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	159	{2A,",",B,),.}	{NULL}
journal.pone.0051251.pdf	160	{Selectivity,for,leukemic,cells,is,a,desired,property,of,chemotherapeutic,agents,.}	{NULL}
journal.pone.0051251.pdf	161	{Next,",",we,analyzed,the,effect,of,SF,on,the,cleavage,of,caspases,to,elucidate,the,mechanism,of,SF-induced,cell,death,in,ALL,cells,.}	{NULL}
journal.pone.0051251.pdf	162	{Proapoptotic,signals,activate,caspases,8,and,9,",",which,lead,to,the,activation,of,the,effector,caspase,3,.}	{NULL}
journal.pone.0051251.pdf	163	{No,signiﬁcant,cleavage,of,caspases,was,observed,in,LCL,cells,treated,with,SF,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	164	{2C,),.}	{NULL}
journal.pone.0051251.pdf	165	{In,contrast,",",the,pre-B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	166	{—,.}	{NULL}
journal.pone.0051251.pdf	167	{ALL,cell,lines,showed,cleavage,of,caspases,3,",",8,",",and,9,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	168	{2C,),.}	{NULL}
journal.pone.0051251.pdf	169	{The,inactivating,cleavage,of,the,DNA,repair,enzyme,PARP,was,also,observed,only,in,ALL,cells,treated,with,SF,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	170	{2C,),.}	{NULL}
journal.pone.0051251.pdf	171	{Sulforaphane,Induces,G2/M,Ce,|,|,.}	{NULL}
journal.pone.0051251.pdf	172	{—,.}	{NULL}
journal.pone.0051251.pdf	173	{cyc,|,e,Arrest,and,Inhibits,AKT,—,mediated,Survival,Signals,in,ALL,Cells,Chemical,compounds,can,induce,cytotoxicity,by,causing,aberrations,in,the,cell,cycle,checkpoints,",",thus,forcing,cells,to,undergo,division,and,cell,death,.}	{NULL}
journal.pone.0051251.pdf	174	{To,study,the,effect,of,SF,on,the,cell,cycle,",",we,examined,the,DNA,content,of,LCL,",",Nalm-6,",",],urkat,and,KOPTKI,cells,incubated,with,7.5,uM,SF,by,ﬂow,cytometry,.}	{NULL}
journal.pone.0051251.pdf	175	{Interestingly,",",SF,-,treated,ALL,cells,accumulated,in,the,G2,/,M,and,sub-Gl,phases,of,the,cell,cycle,",",while,LCL,cells,showed,lower,percentages,in,S,phase,and,a,slight,increase,in,apoptosis,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	176	{3A,),.}	{NULL}
journal.pone.0051251.pdf	177	{The,aggregate,analysis,clearly,demonstrates,that,the,leukemic,cells}	{NULL}
journal.pone.0051251.pdf	178	{A}	{NULL}
journal.pone.0051251.pdf	179	{B,-,o,-,Nalm-6,-,Ar,RS-4,-,o,-,Jurkat,-,Ar,DND41,100,*,REH,-,V,-,LCL,A100,+,RPMI,+,KOPTK1}	{NULL}
journal.pone.0051251.pdf	180	{E,”,"\\"",---,V.,.}	{NULL}
journal.pone.0051251.pdf	181	{-,5,3,"\\"","\\"",°,““,"\\"",9,3,E,50,E,50,>,3,E,E,U,U}	{NULL}
journal.pone.0051251.pdf	182	{o,O,O,2,4,6,8,10,o,2,4,6,8,10}	{NULL}
journal.pone.0051251.pdf	183	{5Flt,~,tM,),SF,(,uMl,C,.}	{NULL}
journal.pone.0051251.pdf	184	{100,T,.}	{NULL}
journal.pone.0051251.pdf	185	{—,.}	{NULL}
journal.pone.0051251.pdf	186	{ALL,patients}	{NULL}
journal.pone.0051251.pdf	187	{Cell,viability,(,%,)}	{NULL}
journal.pone.0051251.pdf	188	{U}	{NULL}
journal.pone.0051251.pdf	189	{rn}	{NULL}
journal.pone.0051251.pdf	190	{E,.32,‘,E,50,-,o,-,SF,>,>,-,o,-,SF-NAC,ﬁ,-,o,-,Healthy,PBMC,ﬁ,_,U,_,.}	{NULL}
journal.pone.0051251.pdf	191	{_,pre_B,ALL,U,-,o,-,SF-glutathlone}	{NULL}
journal.pone.0051251.pdf	192	{-,o,-,SF-Cysteine}	{NULL}
journal.pone.0051251.pdf	193	{-13,-,T,.}	{NULL}
journal.pone.0051251.pdf	194	{—,.}	{NULL}
journal.pone.0051251.pdf	195	{ALL}	{NULL}
journal.pone.0051251.pdf	196	{SF,(,uM,),SF,(,1.1,M,)}	{NULL}
journal.pone.0051251.pdf	197	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0051251.pdf	198	{p,|,osone.org,4,December,2012,|,Volume,7,|,Issue,12,|,e51251}	{NULL}
journal.pone.0051251.pdf	199	{Figure,1,.}	{NULL}
journal.pone.0051251.pdf	200	{Inhibition,of,acute,lymphoblastic,leukemic,cell,survival,by,the,SF,isothiocyanate,.}	{NULL}
journal.pone.0051251.pdf	201	{(,A,),Phase,contrast,images,of,Nalm-6,cells,after,culture,with,10,uM,SF,for,24,hours,.}	{NULL}
journal.pone.0051251.pdf	202	{The,chemical,structure,of,sulforaphane,is,shown,.}	{NULL}
journal.pone.0051251.pdf	203	{(,B,),Pre,.}	{NULL}
journal.pone.0051251.pdf	204	{—,.}	{NULL}
journal.pone.0051251.pdf	205	{B,ALL,cells,(,Nalm-6,",",REH,and,RS,—,4,),",",non,—,|,eukemic,LCL,cells,",",and,T,.}	{NULL}
journal.pone.0051251.pdf	206	{—,.}	{NULL}
journal.pone.0051251.pdf	207	{ALL,cells,(,Jurkat,",",RPMI,",",DND41,",",and,KOPTK1,),were,incubated,with,SF,or,vehicle,for,48,hours,(,n,=,3,),.}	{NULL}
journal.pone.0051251.pdf	208	{Cytotoxicity,was,measured,using,an,ATP,—,based,cell,viability,assay,and,expressed,as,a,percentage,of,the,vehicle,control,.}	{NULL}
journal.pone.0051251.pdf	209	{The,data,are,representative,of,three,independent,experiments,(,mean,and,standard,deviation,),.}	{NULL}
journal.pone.0051251.pdf	210	{(,C,),Samples,from,pediatric,patients,diagnosed,with,pre,.}	{NULL}
journal.pone.0051251.pdf	211	{—,.}	{NULL}
journal.pone.0051251.pdf	212	{B,ALL,(,n,=,8,),and,T,.}	{NULL}
journal.pone.0051251.pdf	213	{—,.}	{NULL}
journal.pone.0051251.pdf	214	{ALL,(,n,=,7,),were,incubated,with,the,specified,SF,concentrations,for,48,hours,.}	{NULL}
journal.pone.0051251.pdf	215	{Each,patient,sample,was,processed,in,triplicate,(,mean,and,standard,deviation,),.}	{NULL}
journal.pone.0051251.pdf	216	{(,D,),The,effect,of,SF,(,24,h,),on,PBMC,freshly,isolated,from,healthy,donors,(,n,=,4,",",each,measured,in,triplicates,),was,compared,to,cell,viability,in,the,pre,.}	{NULL}
journal.pone.0051251.pdf	217	{—,.}	{NULL}
journal.pone.0051251.pdf	218	{B,and,T,.}	{NULL}
journal.pone.0051251.pdf	219	{—,.}	{NULL}
journal.pone.0051251.pdf	220	{ALL,patient,samples,(,mean,:,S.D.,),.}	{NULL}
journal.pone.0051251.pdf	221	{(,E,),Nalm-6,cells,were,cultured,in,the,presence,of,SF,—,g,|,utathione,",",SF,.}	{NULL}
journal.pone.0051251.pdf	222	{—,.}	{NULL}
journal.pone.0051251.pdf	223	{NAC,",",SF,—,cysteine,",",or,SF,for,48,hours,.}	{NULL}
journal.pone.0051251.pdf	224	{Cell,viability,is,shown,as,mean,and,S.D.,(,n,=,3,),.}	{NULL}
journal.pone.0051251.pdf	225	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	226	{pone,.}	{NULL}
journal.pone.0051251.pdf	227	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	228	{gOO1}	{NULL}
journal.pone.0051251.pdf	229	{treated,with,SF,accumulated,in,the,G2,/,M,and,sub-Gl,phases,with,a,concurrent,reduction,in,the,G0/G1,and,S,phases,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	230	{3B,),.}	{NULL}
journal.pone.0051251.pdf	231	{To,gain,further,insight,into,the,mechanism,of,SF,",",we,determined,the,expression,of,cell,cycle,regulators,and,pro-survival,signals,.}	{NULL}
journal.pone.0051251.pdf	232	{Cell,lysates,from,pre,.}	{NULL}
journal.pone.0051251.pdf	233	{—,.}	{NULL}
journal.pone.0051251.pdf	234	{B,ALL,cells,(,Nalm-6,",",REH,",",RS-4,),",",T,.}	{NULL}
journal.pone.0051251.pdf	235	{—,.}	{NULL}
journal.pone.0051251.pdf	236	{ALL,cells,(,Iurkat,",",RPMI,",",DND41,and,KOPTK1,),",",and,control,LCL,cells,were,incubated,for,24,hours,in,the,presence,of,7.5,uM,SF,or,vehicle,control,and,then,analyzed,by,immunoblotting,.}	{NULL}
journal.pone.0051251.pdf	237	{"\\\\",/,V,e,measured,the,expression,of,the,tumor,suppressor,KLF4,and,the,cell,cycle,inhibitor,p21,because,SF,was,shown,to,induce,the,expression,of,both,proteins,in,Caco-2,cells,[,29,],.}	{NULL}
journal.pone.0051251.pdf	238	{Consistent,with,a,previous,report,[,38,],",",SF,increased,the,levels,of,p21,independently,of,p53,in,most,ALL,cells,",",except,the,Jurkat,and,KOPTK1,cells,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	239	{4A,),.}	{NULL}
journal.pone.0051251.pdf	240	{In,LCL,cells,",",p21,expression,was,associated,with,the,inhibition,of,proliferation,rather,than,the,induction,of,cell,death,(,Figs,.}	{NULL}
journal.pone.0051251.pdf	241	{3,",",4,),.}	{NULL}
journal.pone.0051251.pdf	242	{The,low,levels,of,KLF4,expression,observed,in,ALL,cells,",",regardless,of,SF,incubation,",",suggests,that,the,upregulation,of,p21,was,independent,of,KLF4,activity,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	243	{4A,),.}	{NULL}
journal.pone.0051251.pdf	244	{Epigenetic,silencing,of,the,KLF,4,gene,",",an,alternate,mechanism,that,may,be}	{NULL}
journal.pone.0051251.pdf	245	{Table,1,.}	{NULL}
journal.pone.0051251.pdf	246	{ICSO,values,in,leukemic,cell,lines,",",primary,Iymphoblast,cells,from,pre,.}	{NULL}
journal.pone.0051251.pdf	247	{—,.}	{NULL}
journal.pone.0051251.pdf	248	{B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	249	{—,.}	{NULL}
journal.pone.0051251.pdf	250	{ALL,patients,.}	{NULL}
journal.pone.0051251.pdf	251	{Cells,IC50,(,HM,),(,24,h,),IC50,(,|,.}	{NULL}
journal.pone.0051251.pdf	252	{LM,),(,48,h,)}	{NULL}
journal.pone.0051251.pdf	253	{LCL,80.81,(,26.80,—,243.60,),30.83,(,17.67-53,.80,),Nalm-6,8.91,(,7.43,—,10.83,),4.58,4.37-4,.79,)}	{NULL}
journal.pone.0051251.pdf	254	{REH,10.26,(,9.40-11,.20,),4.38,4.10-4,.67,)}	{NULL}
journal.pone.0051251.pdf	255	{RS-4,9.86,(,9.35,—,10.41,),3.85,3.69-4,.01,)}	{NULL}
journal.pone.0051251.pdf	256	{Jurkat,4.72,(,4.19,—,5.25,),2.39,1.44-3,.34,)}	{NULL}
journal.pone.0051251.pdf	257	{RPMI,7.87,(,6.40,—,9.34,),5.72,4.12-7,.32,)}	{NULL}
journal.pone.0051251.pdf	258	{DND41,13.49,(,12.84,—,14.15,7.14,6.27-8,.01,)}	{NULL}
journal.pone.0051251.pdf	259	{KOPTK1,3.04,(,2.16,—,3.92,),1.24,0.84-1,.66,)}	{NULL}
journal.pone.0051251.pdf	260	{preB,—,1,22.02,(,19.39,—,25.00,5.46,4.91-6,.07,),preB,—,2,59.53,(,45.00,—,78.73,10.09,(,9.02-11,.29,),preB,—,3,36.30,(,32.19,—,40-94,),10.98,(,9.94-12,.13,),preB,—,4,21.00,(,18.13,—,24.32,6.21,5.17-7,.45,),preB,—,5,51.29,(,39.81,—,66.09,25.36,(,22.43-28,.68,),preB,—,6,331.2,(,211,—,519.5,),20.81,(,22.59,),T,—,1,51.52,(,38.04,—,69.77,11.64,(,10.87-12,.47,)}	{NULL}
journal.pone.0051251.pdf	261	{T-2,20.28,(,18.48,—,22.24,9.55,(,8.31-11,.0,)}	{NULL}
journal.pone.0051251.pdf	262	{T,—,3,50.39,(,37.33,—,68.04,13.02,(,9.11-18,.63,)}	{NULL}
journal.pone.0051251.pdf	263	{T-4,22.46,(,19.72,—,25.58,11.36,(,10.32-12,.49,)}	{NULL}
journal.pone.0051251.pdf	264	{T,—,5,9.12,(,7.97-10,.45,),10.42,(,9.31-11,.67,)}	{NULL}
journal.pone.0051251.pdf	265	{T-6,16.95,(,15.50,—,18.54,7.12,(,6.11-8,.32,)}	{NULL}
journal.pone.0051251.pdf	266	{T,—,7,21.32,(,19.52,—,23.28,8.01,(,6.92-9,.24,)}	{NULL}
journal.pone.0051251.pdf	267	{*,The,|,C5O,values,were,obtained,by,triplicate,from,each,sample,(,pre,.}	{NULL}
journal.pone.0051251.pdf	268	{—,.}	{NULL}
journal.pone.0051251.pdf	269	{B,and,TALL,),.}	{NULL}
journal.pone.0051251.pdf	270	{The,values,in,parentheses,represent,the,95,%,conﬁdence,interval,.}	{NULL}
journal.pone.0051251.pdf	271	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	272	{pone,.}	{NULL}
journal.pone.0051251.pdf	273	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	274	{tO01}	{NULL}
journal.pone.0051251.pdf	275	{responsible,for,the,low,expression,of,KLF4,in,ALL,cells,",",was,supported,by,the,8-fold,(,KOPTK1,),",",13-fold,(,RMPI,),",",6-fold,(,DND41,),",",and,5-fold,(,Iurkat,),increases,of,KLF4,expression,upon,culture,of,the,leukemic,cells,in,the,presence,of,5-azacytidine,(,not,shown,),.}	{NULL}
journal.pone.0051251.pdf	276	{In,accordance,with,our,ﬁndings,",",KLF4,gene,was,found,hypermethylated,in,adult,T,.}	{NULL}
journal.pone.0051251.pdf	277	{—,.}	{NULL}
journal.pone.0051251.pdf	278	{ALL,[,39,],.}	{NULL}
journal.pone.0051251.pdf	279	{"\\\\",Ne,also,measured,Cyclin,D1,levels,because,SF,can,induce,Gl,cell,cycle,arrest,by,inhibiting,expression,of,Cyclin,D1,in,human,colon,carcinoma,HT-29,cells,[,38,],.}	{NULL}
journal.pone.0051251.pdf	280	{No,signiﬁcant,differences,were,observed,upon,SF,treatment,",",only,pre,.}	{NULL}
journal.pone.0051251.pdf	281	{—,.}	{NULL}
journal.pone.0051251.pdf	282	{B,ALL,cells,showed,a,modest,reduction,in,Cyclin,D1,expression,likely,due,to,the,G2,/,M,arrest,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	283	{4A,),.}	{NULL}
journal.pone.0051251.pdf	284	{To,further,study,the,mechanism,of,cell,cycle,arrest,",",we,first,analyzed,the,levels,of,Cyclin,B1,in,SF-treated,ALL,cell,lines,because,the,Cdc2-Cyclin,Bl,complex,controls,the,G2,/,M,transition,.}	{NULL}
journal.pone.0051251.pdf	285	{It,has,been,reported,that,SF,induces,G2,/,M,arrest,by,altering,the,levels,of,Cyclin,B1,in,PC-3,and,LnCap,prostate,cancer,cell,lines,[,"28,40",],.}	{NULL}
journal.pone.0051251.pdf	286	{In,acute,lymphoblastic,leukemia,",",SF,increased,the,expression,of,Cyclin,B1,in,the,REH,",",RS-4,and,T,.}	{NULL}
journal.pone.0051251.pdf	287	{—,.}	{NULL}
journal.pone.0051251.pdf	288	{ALL,cell,lines,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	289	{4A,),.}	{NULL}
journal.pone.0051251.pdf	290	{Immunoblots,revealed,increased,levels,of,phosphoCdc2,(,Tyr-15,),in,ALL,cells,treated,with,SF,",",suggesting,that,SF,inhibits,the,Cdc2/Cyclin,Bl,complex,by,increasing,phosphorylation,of,Cdc2,(,inactive,),despite,elevated,levels,of,Cyclin,Bl,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	291	{4A,),.}	{NULL}
journal.pone.0051251.pdf	292	{Cdc25C,activates,Cdc2/Cyclin,Bl,complex,by,dephosphorylating,Cdc2,and,it,is,inactivated,by,phosphorylation,at,Ser,216,in,response,to,DNA,damage,[,"41,42",],.}	{NULL}
journal.pone.0051251.pdf	293	{Since,we,did,not,detect,signiﬁcant,changes,in,total,and,phosphorylated,Cdc25C,",",we,concluded,that,SF,likely,activates,the,Weel,or,Mytl,kinases,that,phosphorylate,Cdc2,[,"43,44",],",",in,addition,to,the,inhibitory,role,of,p21,in,the,G2/M,transition,.}	{NULL}
journal.pone.0051251.pdf	294	{To,investigate,whether,SF,causes,DNA,damage,",",we,determined,by,ﬂow,cytometry,nuclear,expression,of,phospho-H2AX,",",a,sensitive,marker,of,doublestranded,DNA,breaks,",",using,etoposide,(,topoisomerase,inhibitor,),as,a,positive,control,.}	{NULL}
journal.pone.0051251.pdf	295	{Nalm-6,cells,treated,with,7.5,uM,SF,showed,considerably,lower,phospho-H2AX,content,compared,to,Nalm-6,cells,treated,with,etoposide,",",while,almost,no,positive,cells,were,detected,in,Jurkat,cells,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	296	{4B,),.}	{NULL}
journal.pone.0051251.pdf	297	{Collectively,",",our,data,indicate,that,SF,induces,G2,/,M,arrest,by,inactivating,Cdc2,and,elevating,p21,levels,without,inducing,signiﬁcant,DNA,damage,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	298	{4C,),.}	{NULL}
journal.pone.0051251.pdf	299	{Finally,",",we,were,interested,to,study,the,effect,of,SF,on,survival,signals,",",as,many,patients,with,T,.}	{NULL}
journal.pone.0051251.pdf	300	{—,.}	{NULL}
journal.pone.0051251.pdf	301	{ALL,exhibit,activation,of,the,AKT,pathway,.}	{NULL}
journal.pone.0051251.pdf	302	{Interestingly,",",SF,inhibited,the,AKT,and,mTOR,pathways,by,lowering,the,protein,levels,of,both,total,and,phosphorylated,AKT,and,mTOR,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	303	{5,),.}	{NULL}
journal.pone.0051251.pdf	304	{In,contrast,to,the,pre,.}	{NULL}
journal.pone.0051251.pdf	305	{—,.}	{NULL}
journal.pone.0051251.pdf	306	{B,and,T,.}	{NULL}
journal.pone.0051251.pdf	307	{—,.}	{NULL}
journal.pone.0051251.pdf	308	{ALL,cell,lines,",",the,LCL,cells,showed,a,slight,activation,of,AKT,signaling,in,response,to,SF,treatment,.}	{NULL}
journal.pone.0051251.pdf	309	{Collectively,",",these,ﬁndings,indicate,that,SF,can,inhibit,AKT,/,mTOR-mediated,survival,signals,in,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	310	{Pre,—,c,|,inica,|,Testing,of,SF,Using,Xenograft,Leukemia,Models,First,",",we,tested,the,efficacy,of,SF,in,controlling,the,expansion,of,Nalm-6,cells,injected,in,NOD/SCID,mice,to,model,systemic,disease,.}	{NULL}
journal.pone.0051251.pdf	311	{The,leukemic,cells,were,detected,by,bioluminescence,in,the,ﬁrst,week,whereas,in,the,peripheral,blood,were,detected,by}	{NULL}
journal.pone.0051251.pdf	312	{A,LCL,KOPTK1}	{NULL}
journal.pone.0051251.pdf	313	{=,l,=,**,=,l,¢,=,l,=,*,>,lUl,=,=,l,=}	{NULL}
journal.pone.0051251.pdf	314	{E,60,.9,U,),3,40,C,),.}	{NULL}
journal.pone.0051251.pdf	315	{O,D.,<,1,20}	{NULL}
journal.pone.0051251.pdf	316	{o}	{NULL}
journal.pone.0051251.pdf	317	{—,+,—,+,—,+,—,+,LCL,Nalm-6,Jurkat,KOPTK1}	{NULL}
journal.pone.0051251.pdf	318	{C,LCL,Nalm-6,REH,RS-4,Jurkat,RPMI,DND41KOPTK1}	{NULL}
journal.pone.0051251.pdf	319	{SF,.}	{NULL}
journal.pone.0051251.pdf	320	{—,.}	{NULL}
journal.pone.0051251.pdf	321	{+,.}	{NULL}
journal.pone.0051251.pdf	322	{—,.}	{NULL}
journal.pone.0051251.pdf	323	{+,.}	{NULL}
journal.pone.0051251.pdf	324	{—,.}	{NULL}
journal.pone.0051251.pdf	325	{+,.}	{NULL}
journal.pone.0051251.pdf	326	{—,.}	{NULL}
journal.pone.0051251.pdf	327	{+,__,",",___,",",___,",",__,+,caspase,9,&,/,x,",",.}	{NULL}
journal.pone.0051251.pdf	328	{.}	{NULL}
journal.pone.0051251.pdf	329	{61-1,-,:,-9,Caspase8,CC-9,4lC,"\\"","\\"",-1,___,",",x}	{NULL}
journal.pone.0051251.pdf	330	{Caspase,3}	{NULL}
journal.pone.0051251.pdf	331	{Figure,2,.}	{NULL}
journal.pone.0051251.pdf	332	{SF,induces,apoptosis,selectively,in,ALL,cell,lines,.}	{NULL}
journal.pone.0051251.pdf	333	{(,A,),Apoptosis,was,evaluated,by,annexin,.}	{NULL}
journal.pone.0051251.pdf	334	{—,.}	{NULL}
journal.pone.0051251.pdf	335	{V,and,7,.}	{NULL}
journal.pone.0051251.pdf	336	{—,.}	{NULL}
journal.pone.0051251.pdf	337	{AAD,staining,of,LCL,",",Nalm-6,",",Jurkat,and,KOPTK1,cells,cultured,in,the,absence,or,presence,of,7.5,uM,SF,.}	{NULL}
journal.pone.0051251.pdf	338	{The,data,are,representative,of,three,independent,experiments,.}	{NULL}
journal.pone.0051251.pdf	339	{(,B,),The,percentages,of,annexin,.}	{NULL}
journal.pone.0051251.pdf	340	{—,.}	{NULL}
journal.pone.0051251.pdf	341	{V,.}	{NULL}
journal.pone.0051251.pdf	342	{—,.}	{NULL}
journal.pone.0051251.pdf	343	{positive,cells,were,determined,for,each,cell,line,cultured,in,the,presence,or,absence,of,SF,.}	{NULL}
journal.pone.0051251.pdf	344	{(,C,),SF,activates,the,proteolytic,cascade,of,caspases,and,PARP,in,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	345	{LCL,cells,(,control,),",",pre,.}	{NULL}
journal.pone.0051251.pdf	346	{—,.}	{NULL}
journal.pone.0051251.pdf	347	{B,ALL,cells,(,Nalm-6,",",REH,",",and,RS,—,4,),",",and,T,.}	{NULL}
journal.pone.0051251.pdf	348	{—,.}	{NULL}
journal.pone.0051251.pdf	349	{ALL,cells,(,Jurkat,",",RPMI,",",DND41,",",and,KOPTK1,),were,incubated,with,7.5,uM,SF,for,24,hours,and,analyzed,by,immunoblotting,.}	{NULL}
journal.pone.0051251.pdf	350	{The,arrows,indicate,the,cleaved,forms,of,the,caspases,and,PARP,.}	{NULL}
journal.pone.0051251.pdf	351	{B,—,actin,was,used,as,a,loading,control,.}	{NULL}
journal.pone.0051251.pdf	352	{The,data,represent,the,mean,and,standard,deviation,(,n,=,3,),.}	{NULL}
journal.pone.0051251.pdf	353	{***,P,<,0.001,(,two,—,tailed,Student,'s,t,—,test,),.}	{NULL}
journal.pone.0051251.pdf	354	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	355	{pone,.}	{NULL}
journal.pone.0051251.pdf	356	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	357	{gOO2}	{NULL}
journal.pone.0051251.pdf	358	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0051251.pdf	359	{p,|,osone.org,6,December,2012,|,Volume,7,|,Issue,12,|,e51251}	{NULL}
journal.pone.0051251.pdf	360	{A,LCL,Na,|,m,—,6,Jurkat,KOPTK1}	{NULL}
journal.pone.0051251.pdf	361	{G0/G1}	{NULL}
journal.pone.0051251.pdf	362	{Control,5}	{NULL}
journal.pone.0051251.pdf	363	{/,G2/M}	{NULL}
journal.pone.0051251.pdf	364	{SF}	{NULL}
journal.pone.0051251.pdf	365	{(,7.5,uM,)}	{NULL}
journal.pone.0051251.pdf	366	{E,E,SubG1}	{NULL}
journal.pone.0051251.pdf	367	{DNA,content}	{NULL}
journal.pone.0051251.pdf	368	{B}	{NULL}
journal.pone.0051251.pdf	369	{so,LCL}	{NULL}
journal.pone.0051251.pdf	370	{9:130,I,SF,(,7.5,uM,),E,El,DMSO,g,40,:12,*,8,20,Q.,‘,-,I,=}	{NULL}
journal.pone.0051251.pdf	371	{Sub,G1,G0/G1,S,G2/M,Sub,"61 60/61",S,G2/M}	{NULL}
journal.pone.0051251.pdf	372	{30,Jurkat,30,KO,PTK-1,'}	{NULL}
journal.pone.0051251.pdf	373	{3,',5,%,60,***,-,Eyso,***,>,l,=,*,=,l,<,*,E,=,r,:,=,:,=,=,r,=,E,*,:40,**,$,40,>,>,>,l,°,E,E,—,8,20,8,20,CL,o.}	{NULL}
journal.pone.0051251.pdf	374	{Sub,G1,G0/G1,S,G2/M,Sub,G1,G0/G1,S,G2/M}	{NULL}
journal.pone.0051251.pdf	375	{Figure,3,.}	{NULL}
journal.pone.0051251.pdf	376	{SF,causes,G2/M,cell,cycle,arrest,in,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	377	{(,A,),The,DNA,content,of,LCL,",",Na,|,m,—,6,",",Jurkat,and,KOPTK1,cells,incubated,with,7.5,uM,SF,or,vehicle,for,24,hours,was,analyzed,by,propidium,iodide,staining,of,nuclei,and,flow,cytometry,.}	{NULL}
journal.pone.0051251.pdf	378	{A,representative,profile,is,shown,.}	{NULL}
journal.pone.0051251.pdf	379	{(,B,),The,cell,cycle,distribution,was,calculated,as,described,in,the,Methods,.}	{NULL}
journal.pone.0051251.pdf	380	{The,data,represent,the,mean,and,standard,deviation,(,n,=,3,),.}	{NULL}
journal.pone.0051251.pdf	381	{*,P,<,0.05,",",**,P,<,0.01,",",***,P,<,0.001,(,two,—,tailed,Student,'s,t,—,test,),.}	{NULL}
journal.pone.0051251.pdf	382	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	383	{pone,.}	{NULL}
journal.pone.0051251.pdf	384	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	385	{g003}	{NULL}
journal.pone.0051251.pdf	386	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0051251.pdf	387	{p,|,osone.org,7,December,2012,|,Volume,7,|,Issue,12,|,e51251}	{NULL}
journal.pone.0051251.pdf	388	{Pre,.}	{NULL}
journal.pone.0051251.pdf	389	{—,.}	{NULL}
journal.pone.0051251.pdf	390	{B,ALL}	{NULL}
journal.pone.0051251.pdf	391	{LCL,Na,|,m,—,6,REH,RS,—,4,Jurkat}	{NULL}
journal.pone.0051251.pdf	392	{SF,KLF4,p21,«,-,o.,1,:,1,1}	{NULL}
journal.pone.0051251.pdf	393	{RPMI}	{NULL}
journal.pone.0051251.pdf	394	{.}	{NULL}
journal.pone.0051251.pdf	395	{—,.}	{NULL}
journal.pone.0051251.pdf	396	{+,.}	{NULL}
journal.pone.0051251.pdf	397	{—,.}	{NULL}
journal.pone.0051251.pdf	398	{+,.}	{NULL}
journal.pone.0051251.pdf	399	{—,.}	{NULL}
journal.pone.0051251.pdf	400	{+,.}	{NULL}
journal.pone.0051251.pdf	401	{—,.}	{NULL}
journal.pone.0051251.pdf	402	{+,.}	{NULL}
journal.pone.0051251.pdf	403	{—,.}	{NULL}
journal.pone.0051251.pdf	404	{+,.}	{NULL}
journal.pone.0051251.pdf	405	{—,.}	{NULL}
journal.pone.0051251.pdf	406	{+,.}	{NULL}
journal.pone.0051251.pdf	407	{—,.}	{NULL}
journal.pone.0051251.pdf	408	{+,.}	{NULL}
journal.pone.0051251.pdf	409	{—,.}	{NULL}
journal.pone.0051251.pdf	410	{+,---,Elli,.}	{NULL}
journal.pone.0051251.pdf	411	{_,IniT-ALL}	{NULL}
journal.pone.0051251.pdf	412	{DN,D41,KOPTK1}	{NULL}
journal.pone.0051251.pdf	413	{-,O-O,I,-,.,'}	{NULL}
journal.pone.0051251.pdf	414	{22,?}	{NULL}
journal.pone.0051251.pdf	415	{’,r,‘,:,COO-5,"\\""}	{NULL}
journal.pone.0051251.pdf	416	{p-cdc2,‘,*,',-,zj-j,—,"\\"",jjmTCdcz}	{NULL}
journal.pone.0051251.pdf	417	{-,I,-,--,«,-1,-11,-1,1GI1iI,—,111}	{NULL}
journal.pone.0051251.pdf	418	{p-cdc25C}	{NULL}
journal.pone.0051251.pdf	419	{—,-2,.}	{NULL}
journal.pone.0051251.pdf	420	{’,!!!}	{NULL}
journal.pone.0051251.pdf	421	{CdC35C,13,;,1-333,-,-,',',-,Qgj,Cyc,|,inD1,4,¢,_,>,9,a.,`,31,!}	{NULL}
journal.pone.0051251.pdf	422	{pit,B-woos-5999,-,so-coo}	{NULL}
journal.pone.0051251.pdf	423	{Control}	{NULL}
journal.pone.0051251.pdf	424	{%,(,15pM,)}	{NULL}
journal.pone.0051251.pdf	425	{ETO,(,7.5,pM,)}	{NULL}
journal.pone.0051251.pdf	426	{Jurkat}	{NULL}
journal.pone.0051251.pdf	427	{SSC,pH2AX}	{NULL}
journal.pone.0051251.pdf	428	{C,lp21}	{NULL}
journal.pone.0051251.pdf	429	{DNA,damage,l,cdc25C,(,p,—,cdc2,(,inactive,)}	{NULL}
journal.pone.0051251.pdf	430	{p53,1}	{NULL}
journal.pone.0051251.pdf	431	{Figure,4,.}	{NULL}
journal.pone.0051251.pdf	432	{Effect,of,SF,on,the,levels,of,total,and,phosphorylated,proteins,involved,in,the,G2/M,cell,cycle,arrest,.}	{NULL}
journal.pone.0051251.pdf	433	{(,A,),The,protein,levels,of,KLF4,",",p21,",",p53,",",cyclin,B1,",",cyclin,D1,",",cdc2,",",and,cdc25C,and,phosphorylation,of,cdc2,(,Tyr,15,),and,cdc25C,(,Ser,216,),were,evaluated,by,immunoblots,in,LCL,",",pre,.}	{NULL}
journal.pone.0051251.pdf	434	{—,.}	{NULL}
journal.pone.0051251.pdf	435	{B,ALL,",",and,T,.}	{NULL}
journal.pone.0051251.pdf	436	{—,.}	{NULL}
journal.pone.0051251.pdf	437	{ALL,cell,lines,incubated,with,7.5,uM,SF,or,vehicle,for,24,hours,.}	{NULL}
journal.pone.0051251.pdf	438	{B,—,actin,was,used,as,a,loading,control,.}	{NULL}
journal.pone.0051251.pdf	439	{The,data,are,representative,of,three,independent,experiments,.}	{NULL}
journal.pone.0051251.pdf	440	{(,B,),Detection,of,phospho,.}	{NULL}
journal.pone.0051251.pdf	441	{—,.}	{NULL}
journal.pone.0051251.pdf	442	{H2AX,(,pH2AX,),in,nuclei,by,flow,cytometry,in,Na,|,m,—,6,and,Jurkat,cells,treated,with,7.5,uM,of,SF,or,Etoposide,(,ETO,),for,24,hours,.}	{NULL}
journal.pone.0051251.pdf	443	{The,data,are,representative,of,three,independent,experiments,.}	{NULL}
journal.pone.0051251.pdf	444	{(,C,),Diagram,depicting,the,role,of,SF,in,the,G2/M,cell,cycle,arrest,of,ALL,cells,.}	{NULL}
journal.pone.0051251.pdf	445	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	446	{pone,.}	{NULL}
journal.pone.0051251.pdf	447	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	448	{gOO4}	{NULL}
journal.pone.0051251.pdf	449	{ﬂow,cytometry,at,a,later,stage,",",when,mice,showed,signs,of,disease,(,weight,loss,and,hind-limb,paralysis,),.}	{NULL}
journal.pone.0051251.pdf	450	{The,NOD/SCID,mice,injected,with,Nalm-6-FFluc,cells,were,randomized,to,two,groups,:,the,experimental,group,received,daily,administration,of,SF,(,2,mg,",",ip,),",",and,the,control,group,received,vehicle,starting,24,hours,after,injection,of,the,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	451	{Bioluminescent,imaging,of,the,tumor-bearing,mice,showed,that,treatment,with,SF,reduced,disease,progression,in,the,ﬁrst,2,weeks,",",although,we,did,not,observe,signiﬁcant,differences,in,survival,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	452	{6A,),.}	{NULL}
journal.pone.0051251.pdf	453	{The,partial,response,may,be,due,to,the,low,SF,concentration,in,tissues,",",such,as,the,bone,and,spine,",",where,leukemic,cells,initially,reside,and,expand,during,the,ﬁrst,few,weeks,.}	{NULL}
journal.pone.0051251.pdf	454	{Therefore,",",we,next,tested,the,oral,administration,of,SF,in,pre-established,subcutaneous,xenograft}	{NULL}
journal.pone.0051251.pdf	455	{tumors,.}	{NULL}
journal.pone.0051251.pdf	456	{Mice,that,received,the,vehicle,showed,a,4-6-fold,increase,in,tumor,burden,compared,to,the,tumor,size,before,treatment,(,day,o,),.}	{NULL}
journal.pone.0051251.pdf	457	{In,contrast,",",the,mice,treated,with,SF,showed,a,signiﬁcant,reduction,in,tumor,growth,after,4,days,of,treatment,(,Fig,.}	{NULL}
journal.pone.0051251.pdf	458	{6B,),.}	{NULL}
journal.pone.0051251.pdf	459	{Our,ﬁndings,demonstrate,the,effectiveness,of,SF,in,controlling,the,expansion,of,human,leukemic,cells,in,vivo,.}	{NULL}
journal.pone.0051251.pdf	460	{The,low,toxicity,associated,with,the,administration,of,extracts,enriched,in,SF,in,human,clinical,trials,supports,further,studies,on,the,role,of,SF,in,hematological,malignancies,.}	{NULL}
journal.pone.0051251.pdf	461	{Discussion}	{NULL}
journal.pone.0051251.pdf	462	{There,is,emerging,evidence,that,SF,has,anti-carcinogenic,properties,in,addition,to,the,chemopreventive,effect,of,broccoli}	{NULL}
journal.pone.0051251.pdf	463	{Pre-BALL,LCL,Nalm-6,REH,RS-4}	{NULL}
journal.pone.0051251.pdf	464	{SF,—,+,—,+,—,+,—,+}	{NULL}
journal.pone.0051251.pdf	465	{AKTT,Pmsll-6065}	{NULL}
journal.pone.0051251.pdf	466	{mToR,"\\"",II-I-O,--,uni,p-mTOR,_,",",-,.}	{NULL}
journal.pone.0051251.pdf	467	{",",-,.}	{NULL}
journal.pone.0051251.pdf	468	{.}	{NULL}
journal.pone.0051251.pdf	469	{I3-Actin,$,I$,$,t,:,¢,¢,$}	{NULL}
journal.pone.0051251.pdf	470	{T,.}	{NULL}
journal.pone.0051251.pdf	471	{—,.}	{NULL}
journal.pone.0051251.pdf	472	{ALL,RPMI,DND41,KOPTKI}	{NULL}
journal.pone.0051251.pdf	473	{—,+,—,+,—,+,—,+,AKTW}	{NULL}
journal.pone.0051251.pdf	474	{DAKT,-,j,Jurkat,mTOR.-ip,¢,«,u,¢,-,véﬂ}	{NULL}
journal.pone.0051251.pdf	475	{p,'m,-,I-OR,-,"\\"",',I,I,:,1,I,WWCCCCOUCC}	{NULL}
journal.pone.0051251.pdf	476	{Figure,5,.}	{NULL}
journal.pone.0051251.pdf	477	{SF,inhibits,the,AKT/mTOR,survival,pathway,in,leukemic,cells,.}	{NULL}
journal.pone.0051251.pdf	478	{The,protein,levels,of,phosphorylated,and,total,AKT,and,mTOR,were,examined,by,immunoblotting,.}	{NULL}
journal.pone.0051251.pdf	479	{LCL,",",pre,.}	{NULL}
journal.pone.0051251.pdf	480	{—,.}	{NULL}
journal.pone.0051251.pdf	481	{B,ALL,",",and,TALL,cell,lines,were,incubated,with,7.5,uM,SF,or,vehicle,for,24,hours,.}	{NULL}
journal.pone.0051251.pdf	482	{[,3actin,was,used,as,a,loading,control,.}	{NULL}
journal.pone.0051251.pdf	483	{The,data,are,representative,of,three,independent,experiments,.}	{NULL}
journal.pone.0051251.pdf	484	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	485	{pone,.}	{NULL}
journal.pone.0051251.pdf	486	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	487	{gOO5}	{NULL}
journal.pone.0051251.pdf	488	{extracts,that,have,been,extensively,investigated,in,solid,tumors,.}	{NULL}
journal.pone.0051251.pdf	489	{The,main,goal,of,this,study,was,to,test,the,anti-leukemic,properties,of,SF,in,the,most,prevalent,hematological,cancer,in,children,because,the,development,of,new,chemodrugs,for,pediatric,patients,has,lagged,behind,the,development,of,new,therapies,for,adult,leukemia,.}	{NULL}
journal.pone.0051251.pdf	490	{In,this,work,",",we,found,that,synthesized,DLSulforaphane,induced,a,dose-dependent,cytotoxicity,in,ALL,cell,lines,and,primary,lymphoblasts,from,pediatric,patients,diagnosed,with,preB,ALL,or,T,.}	{NULL}
journal.pone.0051251.pdf	491	{—,.}	{NULL}
journal.pone.0051251.pdf	492	{ALL,.}	{NULL}
journal.pone.0051251.pdf	493	{Most,importantly,",",normal,peripheral,blood,mononuclear,cells,were,more,resistant,than,patient,lymphoblasts,to,SF,mediated,cytotoxicity,.}	{NULL}
journal.pone.0051251.pdf	494	{Based,on,previous,reports,indicating,that,SF-mediated,cytotoxicity,in,Caco-2,cells,was,associated,with,the,increased,expression,of,the,tumor,suppressor,KLF4,and,the,cyclin-dependent,kinase,inhibitor,p21,",",we,initially,hypothesized,that,SF,would,also,induce,KLF4,expression,in,ALL,cells,[,29,],.}	{NULL}
journal.pone.0051251.pdf	495	{However,",",the,low,levels,of,KLF4,observed,in,ALL,cell,lines,suggested,an,epigenetic,silencing,that,could,not,be,reversed,by,SF,;,in,support,of,this,hypothesis,",",we,observed,increased,KLF4,expression,in,T,.}	{NULL}
journal.pone.0051251.pdf	496	{—,.}	{NULL}
journal.pone.0051251.pdf	497	{ALL,cell,lines,cultured,with,a,demethylating,agent,.}	{NULL}
journal.pone.0051251.pdf	498	{Despite,the,low,expression,levels,of,KLF4,and,p53,",",we,observed,a,signiﬁcant,upregulation,of,p21,in,pre,.}	{NULL}
journal.pone.0051251.pdf	499	{—,.}	{NULL}
journal.pone.0051251.pdf	500	{B,ALL,and,T,.}	{NULL}
journal.pone.0051251.pdf	501	{—,.}	{NULL}
journal.pone.0051251.pdf	502	{ALL,cells,following,SF,treatment,.}	{NULL}
journal.pone.0051251.pdf	503	{Because,the,anti-tumor,activity,of,many,conventional,chemotherapeutic,agents}	{NULL}
journal.pone.0051251.pdf	504	{(,e.g.,",",doxorubicin,",",cisplatin,",",and,etoposide,),is,mediated,by,p53,[,"45,46",],",",the,p53-independent,activation,of,p21,that,was,observed,upon,SF,treatment,could,represent,an,alternative,therapeutic,approach,for,ALL,patients,that,fail,to,respond,to,conventional,agents,targeting,p53,.}	{NULL}
journal.pone.0051251.pdf	505	{In,addition,to,p21,upregulation,",",SF,inactivated,the,Cyclin,B1,and,Cdc2,complex,by,promoting,phosphorylation,of,Cdc2,in,spite,of,increased,levels,of,Cyclin,Bl,.}	{NULL}
journal.pone.0051251.pdf	506	{Our,ﬁndings,are,consistent,with,previous,reports,showing,that,SF,induces,G1,or,G2,/,M,cell,cycle,arrest,by,regulating,cell,cycle,proteins,[,"26,27,28,29,47",],.}	{NULL}
journal.pone.0051251.pdf	507	{Several,reports,have,shown,activation,of,the,mitochondrial,or,death,receptor,pathways,in,cancer,cells,cultured,with,SF,[,2l,",22,23,28,48",],.}	{NULL}
journal.pone.0051251.pdf	508	{In,this,work,",",we,showed,that,SF,induced,apoptosis,in,pre,.}	{NULL}
journal.pone.0051251.pdf	509	{—,.}	{NULL}
journal.pone.0051251.pdf	510	{B,ALL,(,Nalm-6,",",REH,",",and,RS-4,),and,T,.}	{NULL}
journal.pone.0051251.pdf	511	{—,.}	{NULL}
journal.pone.0051251.pdf	512	{ALL,(,Iurkat,",",RPMI,",",DND4l,",",and,KOPTKI,),cell,lines,by,activating,caspases,3,",",8,",",and,9,and,inactivating,PARP,.}	{NULL}
journal.pone.0051251.pdf	513	{Interestingly,",",SFmediated,cytotoxicity,appeared,speciﬁc,to,leukemic,cells,",",as,no,signiﬁcant,activation,of,the,caspase,proteolytic,cascade,was,observed,in,the,non-leukemic,control,cells,.}	{NULL}
journal.pone.0051251.pdf	514	{In,addition,to,cell,cycle,arrest,and,apoptosis,",",SF,inhibited,the,AKT/mTOR,pathway,in,ALL,cells,by,lowering,the,expression,of,both,the,total,and,phosphorylated,forms,of,AKT,and,mTOR,.}	{NULL}
journal.pone.0051251.pdf	515	{This,result,was,of,interest,because,the,AKT/mTOR,survival,pathway,is,the,target,of,choice,in,the,development,of,alternative,ALL,therapies,since,approximately,30,%,of,pre,.}	{NULL}
journal.pone.0051251.pdf	516	{—,.}	{NULL}
journal.pone.0051251.pdf	517	{B,ALL,patients,display,mutations,in,the,signaling,molecules,that,activate,AKT,",",including,RAS,",",PTPN,ll,and,FLT3,[,"49,50,51,52",],.}	{NULL}
journal.pone.0051251.pdf	518	{In,addition,",",a,gene,expression,study,showed,that,AKT,activation,was,associated,with,resistance,to,glucocorticoids,in,pre,.}	{NULL}
journal.pone.0051251.pdf	519	{—,.}	{NULL}
journal.pone.0051251.pdf	520	{B,ALL,[,10,],.}	{NULL}
journal.pone.0051251.pdf	521	{Inactivation,of,PTEN,by,deletion,",",mutation,",",epigenetic,silencing,",",or,post-translational,inactivation,has,been,reported,in,T,.}	{NULL}
journal.pone.0051251.pdf	522	{—,.}	{NULL}
journal.pone.0051251.pdf	523	{ALL,patients,",",suggesting,that,activation,of,the,AKT,pathway,also,contributes,to,the,development,of,T,.}	{NULL}
journal.pone.0051251.pdf	524	{—,.}	{NULL}
journal.pone.0051251.pdf	525	{ALL,[,"13,53",],[,54,],.}	{NULL}
journal.pone.0051251.pdf	526	{Taken,together,",",our,data,indicate,that,SF,may,be,effective,in,the,treatment,of,ALL,patients,with,activated,AKT,pathways,.}	{NULL}
journal.pone.0051251.pdf	527	{Several,therapeutic,compounds,that,target,the,cell,cycle,and,the,PI3K/AKT/mTOR,pathway,are,being,tested,as,ALL,therapies,.}	{NULL}
journal.pone.0051251.pdf	528	{For,example,",",clofarabine,and,nelarabine,are,cell-cycle,dependent,CDK,inhibitors,that,have,been,recently,approved,to,treat,pediatric,ALL,[,55,],.}	{NULL}
journal.pone.0051251.pdf	529	{Alternatively,",",several,PI3K,inhibitors,with,distinct,spectra,of,activity,are,in,clinical,development,as,combination,therapies,to,eliminate,drug-resistant,ALL,",",such,as,the,dual,PI3K/mTOR,inhibitor,NVP-BEZ235,and,the,PI3K,/,PDK-l,inhibitor,BAG956,[,"56,57",],.}	{NULL}
journal.pone.0051251.pdf	530	{The,PI3K-AKT,inhibitor,Ly294002,has,also,shown,marked,activity,in,leukemia,cells,[,58,],.}	{NULL}
journal.pone.0051251.pdf	531	{Our,study,showed,that,",",in,addition,to,perturbing,the,cell,cycle,",",SF,also,inhibited,the,AKT,survival,pathway,by,lowering,protein,levels,of,total,and,phosphorylated,AKT,and,mTOR,.}	{NULL}
journal.pone.0051251.pdf	532	{There,are,several,advantages,to,using,natural,food,products,for,cancer,treatment,such,as,correct,chirality,to,bind,biomolecules,",",safety,",",and,the,record,of,the,natural,products,tested,in,clinical,trials,.}	{NULL}
journal.pone.0051251.pdf	533	{SF,also,induced,phase,2,metabolic,enzymes,(,detoxiﬁcation,),in,addition,to,its,anti-carcinogenic,properties,[,"19,59",],.}	{NULL}
journal.pone.0051251.pdf	534	{Therefore,",",SF,may,perform,dual,activities,as,a,chemotherapeutic,agent,by,inducing,cell,death,in,cancer,cells,and,reducing,toxicity,in,multi-drug,intensiﬁed,treatments,.}	{NULL}
journal.pone.0051251.pdf	535	{The,pharmacokinetics,of,SF,have,been,extensively,studied,in,humans,.}	{NULL}
journal.pone.0051251.pdf	536	{After,oral,intake,of,broccoli,",",SF,reaches,a,transient,plasma,concentration,of,approximately,2,|,J.,"I\\\\/I",[,"60,61",],.}	{NULL}
journal.pone.0051251.pdf	537	{The,bioavailability,of,SF,depends,on,food,processing,",",as,cooked,broccoli,demonstrated,lower,serum,concentrations,compared,to,raw,broccoli,[,62,],.}	{NULL}
journal.pone.0051251.pdf	538	{Inhibitory,concentrations,in,the,micromolar,range,(,l,—,7,LLIVI,in,ALL,cell,lines,and,5,—,20,|,J.,"I\\\\/I",in,primary,lymphoblastic,cells,),indicate,that,a,therapeutic,concentration,of,SF}	{NULL}
journal.pone.0051251.pdf	539	{Day7}	{NULL}
journal.pone.0051251.pdf	540	{Day14,Day21}	{NULL}
journal.pone.0051251.pdf	541	{2,U,',%,3,>}	{NULL}
journal.pone.0051251.pdf	542	{4,-,"\\"",3,5,%,E,‘,--,.}	{NULL}
journal.pone.0051251.pdf	543	{“,DD,‘,DE,gm,.}	{NULL}
journal.pone.0051251.pdf	544	{_,.}	{NULL}
journal.pone.0051251.pdf	545	{_,d.,W,:}	{NULL}
journal.pone.0051251.pdf	546	{B}	{NULL}
journal.pone.0051251.pdf	547	{DayO,Day4,Day7}	{NULL}
journal.pone.0051251.pdf	548	{6,«,E,600,u}	{NULL}
journal.pone.0051251.pdf	549	{3,EU}	{NULL}
journal.pone.0051251.pdf	550	{_,",",_,",",',c5,200,COJ,we,E5,nu,‘,-,.}	{NULL}
journal.pone.0051251.pdf	551	{.}	{NULL}
journal.pone.0051251.pdf	552	{o,9,””,o,HE,l.,|,.}	{NULL}
journal.pone.0051251.pdf	553	{f,"\\"",~,J,“,oh,.9,’,","}	{NULL}
journal.pone.0051251.pdf	554	{",",C,t,I,High,510,El,on,ro}	{NULL}
journal.pone.0051251.pdf	555	{ISF,treated}	{NULL}
journal.pone.0051251.pdf	556	{4x10}	{NULL}
journal.pone.0051251.pdf	557	{E,2:10,g,III,:,-,...,8000,_,p,=,0.08,El,6000,4000}	{NULL}
journal.pone.0051251.pdf	558	{I-OW,7,14,21}	{NULL}
journal.pone.0051251.pdf	559	{Treatment,(,days,)}	{NULL}
journal.pone.0051251.pdf	560	{-,o,-,Control,-9,-,SF,treated,p,=,0.04}	{NULL}
journal.pone.0051251.pdf	561	{Treatment,(,days,)}	{NULL}
journal.pone.0051251.pdf	562	{Figure,6,.}	{NULL}
journal.pone.0051251.pdf	563	{In,vivo,anti-leukemic,effect,of,SF,in,ALL,xenograft,models,.}	{NULL}
journal.pone.0051251.pdf	564	{(,A,),Nalm-6,cells,were,transduced,with,the,FF,|,uc,retrovirus,and,injected,intravenously,into,NOD/SCID,mice,.}	{NULL}
journal.pone.0051251.pdf	565	{Twenty,—,four,hours,later,",",the,mice,were,treated,with,SF,or,vehicle,(,2,mg,i.p.,daily,),and,monitored,weekly,for,the,distribution,of,leukemic,cells,by,bioluminescence,imaging,(,BLI,),.}	{NULL}
journal.pone.0051251.pdf	566	{(,B,),The,Na,|,m,.}	{NULL}
journal.pone.0051251.pdf	567	{—,.}	{NULL}
journal.pone.0051251.pdf	568	{6,.}	{NULL}
journal.pone.0051251.pdf	569	{—,.}	{NULL}
journal.pone.0051251.pdf	570	{FF,|,uc,cells,were,mixed,with,a,high,—,protein,matrigel,and,injected,into,the,flank,of,NOD/SCID,mice,.}	{NULL}
journal.pone.0051251.pdf	571	{One,week,later,",",tumor,establishment,was,conﬁrmed,by,BLI,;,then,",",the,mice,were,treated,by,oral,gavage,(,2,mg/gave,",",twice,daily,),for,7,days,.}	{NULL}
journal.pone.0051251.pdf	572	{The,total,counts,were,determined,for,the,control,—,and,SF,—,treated,mice,.}	{NULL}
journal.pone.0051251.pdf	573	{The,data,are,representative,of,three,independent,experiments,.}	{NULL}
journal.pone.0051251.pdf	574	{The,statistical,significance,was,calculated,using,the,two,—,tailed,Student,'s,t,—,test,.}	{NULL}
journal.pone.0051251.pdf	575	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0051251.pdf	576	{pone,.}	{NULL}
journal.pone.0051251.pdf	577	{OO51251,.}	{NULL}
journal.pone.0051251.pdf	578	{gOO6}	{NULL}
journal.pone.0051251.pdf	579	{can,not,be,reached,through,the,dietary,consumption,of,cruciferous,vegetables,.}	{NULL}
journal.pone.0051251.pdf	580	{We,tested,the,efficacy,of,SF,in,two,pre-clinical,xenograft,models,of,ALL,as,a,proof-of-principle,that,SF,can,inhibit,the,expansion,of,leukemic,cells,in,viva,.}	{NULL}
journal.pone.0051251.pdf	581	{Intraperitoneal,administration,of,SF,to,NOD/SCID,mice,injected,with,Nalm-6,reduced,the,expansion,of,leukemic,cells,in,the,first,two,weeks,.}	{NULL}
journal.pone.0051251.pdf	582	{The,inability,to,efficiently,eliminate,or,control,the,expansion,of,leukemic,cells,in,viva,was,likely,due,to,the,low,concentrations,achieved,in,leukemic,cell,niches,such,as,the,bone,marrow,.}	{NULL}
journal.pone.0051251.pdf	583	{However,",",oral,administration,of,SF,led,to,a,signiﬁcant,reduction,in,the,expansion,of,leukemic,cells,in,a,model,for,pre-established,lymphoma,tumors,.}	{NULL}
journal.pone.0051251.pdf	584	{Collectively,",",our,pre-clinical,studies,showed,that,SF,can,inhibit,the,expansion,of,leukemic,cells,in,viva,",",which,supports,future,clinical,trials,as,adjunctive,agent,.}	{NULL}
journal.pone.0051251.pdf	585	{In,summary,",",the,results,presented,in,this,study,demonstrate,the,anti-leukemic,properties,of,SF,in,acute,lymphoblastic,leukemia,by,inducing,cell,cycle,arrest,and,apoptosis,.}	{16|18}
journal.pone.0051251.pdf	586	{Furthermore,",",we,showed,that,SF,inhibits,the,AKT/mTOR,survival,pathway,.}	{NULL}
journal.pone.0051251.pdf	587	{This,is,the,first,report,on,the,anti-leukemic,property,of,SF,in,hematological,malignancies,",",supporting,its,use,as,an,adjunctive,chemotherapy,in,ALL,.}	{NULL}
journal.pone.0051251.pdf	588	{Acknowledgments}	{NULL}
journal.pone.0051251.pdf	589	{Wle,thank,Karen,Rabin,a11d,Catherine,Bollard,for,providing,us,with,the,pre-B,ALL,aI1d,lymphoblastoid,cell,lines,",",Sharon,Lam,for,preparation,of,PB1VIC,",",Adolfo,Ferrando,for,providing,us,with,the,T-ALL,cell,lines,",",and,Kare11,Prince,for,preparation,of,ﬁgures,.}	{NULL}
journal.pone.0051251.pdf	590	{References}	{NULL}
journal.pone.0051251.pdf	591	{1,.,]}	{NULL}
journal.pone.0051251.pdf	592	{emal,A,",",Siegel,R,",","\\\\",/,Vard,E,",",Hao,Y,",",Xu,],",",et,al.,(,2008,),lancer,statistics,",",2008,.}	{NULL}
journal.pone.0051251.pdf	593	{CA,Cancer,],Clin,58,:,71496,.}	{NULL}
journal.pone.0051251.pdf	594	{Chessells,],l,"\\\\",’,I,",",Veys,P,",",Kempski,H,",",Henley,P,",",Leiper,A,",",et,al.,(,2003,),Long,~,term,follow-up,of,relapsed,childhood,acute,lymphoblastic,leukaemia,.}	{NULL}
journal.pone.0051251.pdf	595	{Br,],Haematol,123,:,3964405,.}	{NULL}
journal.pone.0051251.pdf	596	{Pui,CH,",",],eha,S,(,2007,),New,therapeutic,strategies,for,the,treatment,of,acute,lymphoblastic,leukaemia,.}	{NULL}
journal.pone.0051251.pdf	597	{Nat,Rev,Drug,Discov,6,:,1494165,.}	{NULL}
journal.pone.0051251.pdf	598	{Pui,CH,",",Evans,VVE,(,2006,),Treatment,of,acute,lymphoblastic,leukemia,.}	{NULL}
journal.pone.0051251.pdf	599	{N,Engl,],lVIed,354,:,1664178,.}	{NULL}
journal.pone.0051251.pdf	600	{Einsiedel,HG,",",von,Stackelberg,A,",",Hartmann,R,",",Fengler,R,",",Schrappe,NI,",",et,al.,(,2005,),Long,~,term,outcome,in,children,with,relapsed,ALL,l,),y,risk,~,strati1led,salvage,therapy,:,results,of,trial,acute,lymphoblastic,leukemia-relapse,study,of,the,Berlin,~,Frankﬁ1rt-l,"\\\\",’,Iunster,Group,87,.,]}	{NULL}
journal.pone.0051251.pdf	601	{Clin,Oncol,23,:,794247950,.}	{NULL}
journal.pone.0051251.pdf	602	{Nguyen,K,",",Devidas,NI,",",Cheng,SC,",",La,.}	{NULL}
journal.pone.0051251.pdf	603	{"\\\\",I,",",Raetz,EA,",",et,al.,(,2008,),Factors,inﬂuencing,survival,after,relapse,from,acute,lymphol,),lastic,leukemia,:,a,Children,’s,Oncology,Group,study,.}	{NULL}
journal.pone.0051251.pdf	604	{Leukemia,22,:,214242150,.}	{0}
journal.pone.0051251.pdf	605	{Bourquin,],P,",",lzraeli,S,(,2010,),"\\\\",Vhere,can,biology,of,childhood,ALL,be,attacked,by,new,compounds,?}	{NULL}
journal.pone.0051251.pdf	606	{Cancer,Treat,Rev,36,:,2984306,.}	{NULL}
journal.pone.0051251.pdf	607	{.}	{NULL}
journal.pone.0051251.pdf	608	{"\\\\",Iullighan,CG,",",Goorha,S,",",Radtke,I,",",NIiller,CB,",",Coustan-Smith,E,",",et,al.,(,2007,),Genome-wide,analysis,of,genetic,alterations,in,acute,lymphoblastic,leukaemia,.}	{NULL}
journal.pone.0051251.pdf	609	{Nature,446,:,7584764,.}	{NULL}
journal.pone.0051251.pdf	610	{NIullighan,CG,",",V,"\\\\",’,illiams,RT,",",Downing,],R,",",Sherr,C,],(,2008,),Failure,of,CDKN2A,/,B,(,INK4A/B,.}	{NULL}
journal.pone.0051251.pdf	611	{—,.}	{NULL}
journal.pone.0051251.pdf	612	{ARF,),~,mediated,tumor,suppression,and,resistance,to,targeted,therapy,in,acute,lymphoblastic,leukemia,induced,by,BCR-ABL,.}	{NULL}
journal.pone.0051251.pdf	613	{Genes,Dev,22,:,141141415,.}	{NULL}
journal.pone.0051251.pdf	614	{VVei,G,",",Twomey,D,",",Lamb,],",",Schlis,K,",",Agarwal,],",",et,al.,(,2006,),Gene,expressionbased,chemical,genomics,identiﬁes,rapamycin,as,a,modulator,of,"l\\\\/ICL1",and,glucocorticoid,resistance,.}	{NULL}
journal.pone.0051251.pdf	615	{Cancer,Cell,10,:,3314342,.}	{NULL}
journal.pone.0051251.pdf	616	{Gutierrez,A,",",Look,AT,(,2007,),NOTCH,and,Pl3K-AKT,pathways,intertwined,.}	{NULL}
journal.pone.0051251.pdf	617	{Cancer,Cell,12,:,4114413,.}	{NULL}
journal.pone.0051251.pdf	618	{Bornhauser,BC,",",Bonapace,L,",",Lindholm,D,",",l,"\\\\",’,Iartinez,R,",",Cario,G,",",et,al.,(,2007,),Low,~,dose,arsenic,trioxide,sensitizes,glucocorticoid-resistant,acute,lymphoblastic,leukemia,cells,to,dexamethasone,via,an,Akt-dependent,pathway,.}	{NULL}
journal.pone.0051251.pdf	619	{Blood,110,:,208442091,.}	{NULL}
journal.pone.0051251.pdf	620	{Palomero,T,",",Dominguez,lVI,",",Ferrando,AA,(,2008,),The,role,of,the,PTEN/AKT,Pathway,in,NOTCH1,~,induced,leukemia,.}	{NULL}
journal.pone.0051251.pdf	621	{Cell,Cycle,7,:,9654970,.}	{NULL}
journal.pone.0051251.pdf	622	{Fimognari,C,",",Hrelia,P,(,2007,),Sulforaphane,as,a,promising,molecule,for,fighting,cancer,.}	{NULL}
journal.pone.0051251.pdf	623	{l,"\\\\",’,Iutat,Res,635,:,904104,.}	{NULL}
journal.pone.0051251.pdf	624	{Ambrosone,CB,",",l,"\\\\",’,IcCann,SE,",",Freudenheim,],L,",",lVIarshall,],R,",",Zhang,Y,",",et,al.,(,2004,),Breast,cancer,risk,in,premenopausal,women,is,inversely,associated,with,consumption,of,broccoli,",",a,source,ofisothiocyanates,",",but,is,not,modiﬁed,by,GST,genotype,.,]}	{NULL}
journal.pone.0051251.pdf	625	{Nutr,134,:,113441138,.}	{NULL}
journal.pone.0051251.pdf	626	{16,.,]}	{NULL}
journal.pone.0051251.pdf	627	{oseph,lVIA,",",1,"\\\\",Ioysich,KB,",",Freudenheim,],L,",",Shields,PG,",",Bowman,ED,",",et,al.,.}	{NULL}
journal.pone.0051251.pdf	628	{(,2004,),Cruciferous,vegetables,",",genetic,polymorphisms,in,glutathione,Stransferases,lVI1,and,T1,",",and,prostate,cancer,risk,.}	{NULL}
journal.pone.0051251.pdf	629	{Nutr,Cancer,50,:,2064213,.}	{NULL}
journal.pone.0051251.pdf	630	{Probst,~,Hensch,NNI,",",Tannenbaum,SR,",",Chan,KK,",",Coetzee,GA,",",Ross,RK,",",et,al.,(,1998,),Absence,of,the,glutathione,S,~,transferase,NI1,gene,increases,cytochrome,P4501A2,activity,among,frequent,consumers,of,cruciferous,vegetables,in,a,Caucasian,population,.}	{NULL}
journal.pone.0051251.pdf	631	{Cancer,Epidemiol,Biomarkers,Prev,7,:,6354638,.}	{NULL}
journal.pone.0051251.pdf	632	{Spitz,lVIR,",",Duphorne,C1,"\\\\",I,",",Detry,KIA,",",Pillow,PC,",",Amos,CI,",",et,al.,(,2000,),Dietary,intake,ofisothiocyanates,:,evidence,of,a,joint,effect,with,glutathione,S,~,transferase,polymorphisms,in,lung,cancer,risk,.}	{NULL}
journal.pone.0051251.pdf	633	{Cancer,Epidemiol,Biomarkers,Prev,9,:,10174,1020,.}	{NULL}
journal.pone.0051251.pdf	634	{Traka,lVI,",",Gasper,AV,",",1,"\\\\",Ielchini,A,",",Bacon,],R,",",Needs,PVV,",",et,al.,(,2008,),Broccoli,consumption,interacts,with,GST1,"\\\\",’,I1,to,perturb,oncogenic,signalling,pathways,in,the,prostate,.}	{NULL}
journal.pone.0051251.pdf	635	{PLoS,One,3,:,e2568,.}	{NULL}
journal.pone.0051251.pdf	636	{.}	{NULL}
journal.pone.0051251.pdf	637	{Tang,L,",",Zirpoli,GR,",",Guru,K,",",NIoysich,KB,",",Zhang,Y,",",et,al.,(,2008,),Consumption,of,raw,cruciferous,vegetables,is,inversely,associated,with,bladder,cancer,risk,.}	{NULL}
journal.pone.0051251.pdf	638	{Cancer,Epidemiol,Biomarkers,Prev,17,:,9384944,.}	{NULL}
journal.pone.0051251.pdf	639	{.}	{NULL}
journal.pone.0051251.pdf	640	{Fimognari,C,",",Nusse,1,"\\\\",I,",",Cesari,R,",",Iori,R,",",Cantelli-Forti,G,",",et,al.,(,2002,),Growth,inhibition,",",cell,~,cycle,arrest,and,apoptosis,in,human,T,~,cell,leukemia,by,the,isothiocyanate,sulforaphane,.}	{NULL}
journal.pone.0051251.pdf	641	{Carcinogenesis,23,:,5814586,.}	{NULL}
journal.pone.0051251.pdf	642	{.}	{NULL}
journal.pone.0051251.pdf	643	{Parnaud,G,",",Li,P,",",Cassar,G,",",Rouimi,P,",",Tulliez,],",",et,al.,(,2004,),NIechanism,of,sulforaphane-induced,cell,cycle,arrest,and,apoptosis,in,human,colon,cancer,cells,.}	{NULL}
journal.pone.0051251.pdf	644	{Nutr,Cancer,48,:,1984206,.}	{NULL}
journal.pone.0051251.pdf	645	{.}	{NULL}
journal.pone.0051251.pdf	646	{ackson,S,",",Sin,letarr,KVV,2004,Sulfora,hane,inhibits,human,NICF-7}	{NULL}
journal.pone.0051251.pdf	647	{g,),P}	{NULL}
journal.pone.0051251.pdf	648	{mammary,cancer,cell,mitotic,progression,and,tubulin,polymerization,.,]}	{NULL}
journal.pone.0051251.pdf	649	{Nutr,134,:,222942236,.}	{NULL}
journal.pone.0051251.pdf	650	{Singh,AV,",",Xiao,D,",",Lew,KL,",",Dhir,R,",",Singh,SV,(,2004,),Sulforaphane,induces,caspase-mediated,apoptosis,in,cultured,PC-3,human,prostate,cancer,cells,and,retards,growth,of,PC-3,xenografts,in,vivo,.}	{NULL}
journal.pone.0051251.pdf	651	{Carcinogenesis,25,:,83490,.}	{NULL}
journal.pone.0051251.pdf	652	{.}	{NULL}
journal.pone.0051251.pdf	653	{NIyzak,1,"\\\\",’,IC,",",Dashwood,VVl,"\\\\",’,I,",",Orner,GA,",",Ho,E,",",Dashwood,RH,(,2006,),Sulforaphane,inhibits,histone,deacetylase,in,vivo,and,suppresses,tumorigenesis,in,Apc-minus,mice,.}	{NULL}
journal.pone.0051251.pdf	654	{FASEB,],20,:,5064508,.}	{NULL}
journal.pone.0051251.pdf	655	{Author,Contributions}	{NULL}
journal.pone.0051251.pdf	656	{Performed,the,experiments,:,KS,CSP,XZ,YS,.}	{NULL}
journal.pone.0051251.pdf	657	{Analyzed,the,data,:,KS,HDL,CSP,.}	{NULL}
journal.pone.0051251.pdf	658	{"\\\\",Vrote,the,paper,:,KS,CSP,HDL,.}	{NULL}
journal.pone.0051251.pdf	659	{39,.}	{NULL}
journal.pone.0051251.pdf	660	{.}	{NULL}
journal.pone.0051251.pdf	661	{Pham,NA,",",],acobberger,],"\\\\",/,V,",",Schimmer,AD,",",Cao,P,",",Gronda,lVI,",",et,al.,(,2004,),The,dietary,isothiocyanate,sulforaphane,targets,pathways,of,apoptosis,",",cell,cycle,arrest,",",and,oxidative,stress,in,human,pancreatic,cancer,cells,and,inhibits,tumor,growth,in,severe,combined,immunodeﬁcient,mice,.}	{NULL}
journal.pone.0051251.pdf	662	{lVIol,Cancer,Ther,3,:,12394,1248,.}	{NULL}
journal.pone.0051251.pdf	663	{.}	{NULL}
journal.pone.0051251.pdf	664	{Gamet-Payrastre,L,",",Li,P,",",Lumeau,S,",",Cassar,G,",",Dupont,1,"\\\\",IA,",",et,al.,(,2000,),Sulforaphane,",",a,naturally,occurring,isothiocyanate,",",induces,cell,cycle,arrest,and,apoptosis,in,HT29,human,colon,cancer,cells,.}	{NULL}
journal.pone.0051251.pdf	665	{Cancer,Res,60,:,142641433,.}	{NULL}
journal.pone.0051251.pdf	666	{Singh,SV,",",Herman-Antosiewicz,A,",",Singh,AV,",",Lew,KL,",",Srivastava,SK,",",et,al.,(,2004,),Sulforaphane-induced,G2/l,"\\\\",’,I,phase,cell,cycle,arrest,involves,checkpoint,kinase,2-mediated,phosphorylation,of,cell,division,cycle,25C,.,]}	{NULL}
journal.pone.0051251.pdf	667	{Biol,Chem,279,:,25813425822,.}	{NULL}
journal.pone.0051251.pdf	668	{.}	{NULL}
journal.pone.0051251.pdf	669	{Traka,lVI,",",Gasper,AV,",",Smith,],A,",",Hawkey,C,],",",Bao,Y,",",et,al.,(,2005,),Transcriptome,analysis,of,human,colon,Caco-2,cells,exposed,to,su1foraphane,.,]}	{NULL}
journal.pone.0051251.pdf	670	{Nutr,135,:,186541872,.}	{NULL}
journal.pone.0051251.pdf	671	{Traka,NIH,",",Spinks,CA,",",Doleman,],F,",",l,"\\\\",’,Ielchini,A,",",Ball,RY,",",et,al.,(,2010,),The,dietary,isothiocyanate,sulforaphane,modulates,gene,expression,and,alternative,gene,splicing,in,a,PTEN,"null",preclinical,murine,model,of,prostate,cancer,.}	{NULL}
journal.pone.0051251.pdf	672	{lVIol,Cancer,9,:,189,.}	{NULL}
journal.pone.0051251.pdf	673	{Rooney,C1,"\\\\",I,",",Bollard,C,",",Huls,1,"\\\\",IH,",",Gahn,B,",",Gottschalk,S,",",et,al.,(,2002,),lmmunotherapy,for,Hodgkin,’s,disease,.}	{NULL}
journal.pone.0051251.pdf	674	{Ann,Hematol,81,Suppl,2,:,S39442,.}	{NULL}
journal.pone.0051251.pdf	675	{VVeng,AP,",",Ferrando,AA,",",Lee,VV,",",NIorris,],Pt,",",Silverman,LB,",",et,al.,(,2004,),Activating,mutations,of,N,OTCH1,in,human,T,cell,acute,lymphoblastic,leukemia,.}	{NULL}
journal.pone.0051251.pdf	676	{Science,306,:,2694271,.}	{NULL}
journal.pone.0051251.pdf	677	{Sakao,K,",",Singh,SV,(,2012,),"D,L-sulforaphane-induced",apoptosis,in,human,breast,cancer,cells,is,regulated,by,the,adapter,protein,p66Shc,.,]}	{NULL}
journal.pone.0051251.pdf	678	{Cell,Biochem,113,:,5994610,.}	{NULL}
journal.pone.0051251.pdf	679	{Li,Y,",",Zhang,T,",",Korkaya,H,",",Liu,S,",",Lee,HF,",",et,al.,(,2010,),Sulforaphane,",",a,dietary,component,of,broccoli,/,broccoli,sprouts,",",inhibits,breast,cancer,stem,cells,.}	{NULL}
journal.pone.0051251.pdf	680	{Clin,Cancer,Res,16,:,258042590,.}	{NULL}
journal.pone.0051251.pdf	681	{Keum,YS,",",Khor,TO,",",Lin,VV,",",Shen,G,",",Kwon,KH,",",et,al.,(,2009,),Pharmacokinetics,and,pharmacodynamics,ofbroccoli,sprouts,on,the,suppression,ofprostate,cancer,in,transgenic,adenocarcinoma,of,mouse,prostate,(,TRAl,"\\\\",’,IP,),mice,:,implication,of,induction,of,Nrf2,",",HO-1,and,apoptosis,and,the,suppression,of,Akt,~,dependent,kinase,pathway,.}	{NULL}
journal.pone.0051251.pdf	682	{Pharm,Res,26,:,232442331,.}	{NULL}
journal.pone.0051251.pdf	683	{Singh,SV,",",VVarin,R,",",Xiao,D,",",Powolny,AA,",",Stan,SD,",",et,al.,(,2009,),Sulforaphane,inhibits,prostate,carcinogenesis,and,pulmonary,metastasis,in,TRA1,"\\\\",IP,mice,in,association,with,increased,cytotoxicity,of,natural,killer,cells,.}	{NULL}
journal.pone.0051251.pdf	684	{Cancer,Res,69,:,211742125,.}	{NULL}
journal.pone.0051251.pdf	685	{Cornblatt,BS,",",Ye,L,",",Dinkova,~,Kostova,AT,",",Erb,l,"\\\\",’,I,",",Fahey,],V,"\\\\",l,",",et,al.,(,2007,),Preclinical,and,clinical,evaluation,of,sulforaphane,for,chemoprevention,in,the,breast,.}	{NULL}
journal.pone.0051251.pdf	686	{Carcinogenesis,28,:,148541490,.}	{NULL}
journal.pone.0051251.pdf	687	{Shen,G,",",Xu,C,",",Chen,C,",",Hebbar,V,",",Kong,AN,(,2006,),p53-independent,G1,cell,cycle,arrest,of,human,colon,carcinoma,cells,HT,~,29,by,sulforaphane,is,associated,with,induction,of,p21ClP1,and,inhibition,of,expression,ofcyclin,D1,.}	{NULL}
journal.pone.0051251.pdf	688	{Cancer,Chemother,Pharmacol,57,:,3174327,.}	{NULL}
journal.pone.0051251.pdf	689	{Yasunaga,],",",Taniguchi,Y,",",Nosaka,K,",",Yoshida,1,"\\\\",I,",",Satou,Y,",",et,al.,(,2004,),Identiﬁcation,of,aberrantly,methylated,genes,in,association,with,adult,T,~,cell,leukemia,.}	{NULL}
journal.pone.0051251.pdf	690	{Cancer,Res,64,:,600246009,.}	{NULL}
journal.pone.0051251.pdf	691	{Herman-Antosiewicz,A,",",Xiao,H,",",Lew,KL,",",Singh,SV,(,2007,),Induction,of,p21,protein,protects,against,sulforaphane-induced,mitotic,arrest,in,LNCaP,human,prostate,cancer,cell,line,.}	{NULL}
journal.pone.0051251.pdf	692	{l,"\\\\",’,Iol,Cancer,Ther,6,:,167341681,.}	{NULL}
journal.pone.0051251.pdf	693	{Pines,],(,1999,),Four-dimensional,control,of,the,cell,cycle,.}	{NULL}
journal.pone.0051251.pdf	694	{Nat,Cell,Biol,1,:,E734,79,.}	{NULL}
journal.pone.0051251.pdf	695	{Bulavin,DV,",",Higashimoto,Y,",",Demidenko,ZN,",",1,"\\\\",Ieek,S,",",Graves,P,",",et,al.,(,2003,),Dual,phosphorylation,controls,Cdc25,phosphatases,and,mitotic,entry,.}	{NULL}
journal.pone.0051251.pdf	696	{Nat,Cell,Biol,5,:,5454551,.}	{NULL}
journal.pone.0051251.pdf	697	{NIcGowan,CH,",",Russell,P,(,1993,),Human,V,"\\\\",lee1,kinase,inhibits,cell,division,by,phosphorylating,p34cdc2,exclusively,on,Tyr15,.}	{NULL}
journal.pone.0051251.pdf	698	{ENIBO,],12,:,75485,.}	{NULL}
journal.pone.0051251.pdf	699	{VVells,N,],",",VVatanabe,N,",",Tokusumi,T,",",],iang,VV,",",Verdecia,KIA,",",et,al.,(,1999,),The,C-terminal,domain,of,the,Cdc2,inhibitory,kinase,l,"\\\\",’,Iyt1,interacts,with,Cdc2,complexes,and,is,required,for,inhibition,of,G,(,2,),/,NI,progression,.,]}	{NULL}
journal.pone.0051251.pdf	700	{Cell,Sci,112,(,Pt,19,),:,336143371,.}	{NULL}
journal.pone.0051251.pdf	701	{VVang,LH,",",Okaichi,K,",",lhara,NI,",",Okumura,Y,(,1998,),Sensitivity,of,anticancer,drugs,in,Saos-2,cells,transfected,with,mutant,p53,varied,with,mutation,point,.}	{NULL}
journal.pone.0051251.pdf	702	{Anticancer,Res,18,:,3214325,.}	{NULL}
journal.pone.0051251.pdf	703	{Lowe,SVV,",",Ruley,HE,",",],acks,T,",",Housman,DE,(,1993,),p53-dependent,apoptosis,modulates,the,cytotoxicity,of,anticancer,agents,.}	{NULL}
journal.pone.0051251.pdf	704	{Cell,74,:,9574967,.}	{NULL}
journal.pone.0051251.pdf	705	{.,]}	{NULL}
journal.pone.0051251.pdf	706	{ackson,S,],",",Singletary,KVV,(,2004,),Sulforaphane,:,a,naturally,occurring,mammary,carcinoma,mitotic,inhibitor,",",which,disrupts,tubulin,polymerization,.}	{NULL}
journal.pone.0051251.pdf	707	{Carcinogenesis,25,:,2194227,.}	{NULL}
journal.pone.0051251.pdf	708	{.}	{NULL}
journal.pone.0051251.pdf	709	{"\\\\",Iyzak,lVIC,",",Hardin,K,",",VVang,R,",",Dashwood,RH,",",Ho,E,(,2006,),Sulforaphane,inhibits,histone,deacetylase,activity,in,BPH-1,",",LnCaP,and,PC-3,prostate,epithelial,cells,.}	{NULL}
journal.pone.0051251.pdf	710	{Carcinogenesis,27,:,8114819,.}	{NULL}
journal.pone.0051251.pdf	711	{Tartaglia,l,"\\\\",’,I,",",l,"\\\\",’,Iartinelli,S,",",Cazzaniga,G,",",Cordeddu,V,",",Iavarone,I,",",et,al.,(,2004,),Genetic,evidence,for,lineage-related,and,differentiation,stage-related,contribu,~,tion,of,somatic,PTPN,ll,mutations,to,leukemogenesis,in,childhood,acute,leukemia,.}	{NULL}
journal.pone.0051251.pdf	712	{Blood,l04,:,3074313,.}	{NULL}
journal.pone.0051251.pdf	713	{Cao,L,",",Yu,Y,",",Darko,I,",",Currier,D,",",l,"\\\\",’,Iayeenuddin,LH,",",et,al.,(,2008,),Addiction,to,elevated,insulin-like,growth,factor,I,receptor,and,initial,modulation,of,the,AKT,pathway,define,the,responsiveness,of,rhabdomyosarcoma,to,the,targeting,antibody,.}	{NULL}
journal.pone.0051251.pdf	714	{Cancer,Res,68,:,8039,—,8048,.}	{NULL}
journal.pone.0051251.pdf	715	{Case,NI,",",l,"\\\\",’,Iatheson,E,",",l,"\\\\",’,Iinto,L,",",Hassan,R,",",Harrison,C,],",",et,al.,(,2008,),l,"\\\\",’,Iutation,of,genes,affecting,the,RAS,pathway,is,common,in,childhood,acute,lymphoblastic,leukemia,.}	{NULL}
journal.pone.0051251.pdf	716	{Cancer,Res,68,:,6803,—,6809,.}	{NULL}
journal.pone.0051251.pdf	717	{Paulsson,K,",",Horvat,A,",",Strombeck,B,",",Nilsson,F,",",Heldrup,J,",",et,al.,(,2008,),Nlutations,of,FLT3,",",NRAS,",",KRAS,",",and,PTPNII,are,frequent,and,possibly,mutually,exclusive,in,high,hyperdiploid,childhood,acute,lymphoblastic,leukemia,.}	{NULL}
journal.pone.0051251.pdf	718	{Genes,Chromosomes,Cancer,47,:,26453,.}	{NULL}
journal.pone.0051251.pdf	719	{Silva,A,",",Yunes,JA,",",Cardoso,BA,",",l,"\\\\",’,Iartins,LR,",",Jotta,PY,",",et,al.,(,2008,),PTEN,posttranslationa_l,inactivation,and,hyperactivation,of,the,PI3K/Akt,pathway,sustain,primary,T,cell,leukemia,viability,.}	{NULL}
journal.pone.0051251.pdf	720	{J,Clin,Invest,ll8,:,376243774,.}	{NULL}
journal.pone.0051251.pdf	721	{Palomero,T,",",Sulis,NIL,",",Cortina,NI,",",Real,P,],",",Barnes,K,",",et,al.,(,2007,),lVIutational,loss,of,PTEN,induces,resistance,to,NOTCHI,inhibition,in,T-cell,leukemia,.}	{NULL}
journal.pone.0051251.pdf	722	{Nat,Med,13,:,1203,—,l2l0,.}	{NULL}
journal.pone.0051251.pdf	723	{Larson,RA,(,2007,),Three,new,drugs,for,acute,lymphol,),lastic,leukemia,:,nelarabine,",",clofarabine,",",and,forodesine,.}	{NULL}
journal.pone.0051251.pdf	724	{Semin,Oncol,34,:,Sl3,—,20,.}	{NULL}
journal.pone.0051251.pdf	725	{Eichhorn,P,],",",Gili,IVI,",",Scaltriti,IVI,",",Serra,V,’,",",Guzman,l,"\\\\",’,I,",",et,al.,(,2008,),Phosphatidylinositol,3,—,kinase,hyperactivation,results,in,lapatinil,),resistance,that,is,reversed,by,the,mTOR/phosphatidylinositol,3-kinase,inhibitor,NV,P-BEZ235,.}	{NULL}
journal.pone.0051251.pdf	726	{Cancer,Res,68,:,922l,—,9230,.}	{NULL}
journal.pone.0051251.pdf	727	{VVeisberg,E,",",Banerji,L,",","\\\\",/,Vright,RD,",",Barrett,R,",",Ray,A,",",et,al.,(,2008,),Potentiation,of,antileukemic,therapies,by,the,dual,PI3K/PDK,~,l,inhibitor,",",BAG956,:,effects,on,BCR,~,ABL,~,and,mutant,FLT3-expressing,cells,.}	{NULL}
journal.pone.0051251.pdf	728	{Blood,lll,:,3723,—,3734,.}	{NULL}
journal.pone.0051251.pdf	729	{Uddin,S,",",Hussain,A,",",Al-Hussein,K,",",Platanias,LC,",",Bhatia,KG,(,2004,),Inhibition,of,phosphatidylinositol,3,',~,kinase,induces,preferentially,killing,of,PTEN,»,"null",T,leukemias,through,AKT,pathway,.}	{NULL}
journal.pone.0051251.pdf	730	{Biochem,Biophys,Res,Commun,320,:,932,*,938,.}	{NULL}
journal.pone.0051251.pdf	731	{Nlaheo,K,",",Nlorel,F,",",Langouet,S,",",Kramer,H,",",Le,Ferrec,E,",",et,al.,(,1997,),Inhil,),ition,of,cytochromes,F-450,and,induction,of,glutathione,S-transferases,by,sulforaphane,in,primary,human,and,rat,hepatocytes,.}	{NULL}
journal.pone.0051251.pdf	732	{Cancer,Res,57,:,3649,—,3652,.}	{NULL}
journal.pone.0051251.pdf	733	{Ye,L,",",Dinkova-Kostova,AT,",",VVade,KL,",",Zhang,Y,",",Shapiro,TA,",",et,al.,(,2002,),Q_uantitative,determination,of,dithiocarbamates,in,human,plasma,",",serum,",",erythrocytes,and,urine,:,pharmacokinetics,of,broccoli,sprout,isothiocyanates,in,humans,.}	{NULL}
journal.pone.0051251.pdf	734	{Clin,Chim,Acta,316,:,43,—,53,.}	{NULL}
journal.pone.0051251.pdf	735	{Gasper,AV,",",Al-Janobi,A,",",Smith,JA,",",Bacon,JR,",",Fortun,P,",",et,al.,(,2005,),Glutathione,S-transferase,XII,polymorphism,and,metabolism,of,sulforaphane,from,standard,and,high,~,glucosinolate,broccoli,.}	{NULL}
journal.pone.0051251.pdf	736	{Am,],Clin,Nutr,82,:,l283,—,l29l,.}	{NULL}
journal.pone.0051251.pdf	737	{Vermeulen,l,"\\\\",’,I,",",Klopping,.}	{NULL}
journal.pone.0051251.pdf	738	{—,.}	{NULL}
journal.pone.0051251.pdf	739	{Ketelaars,IVV,",",Van,den,Berg,R,",",Vaes,VVH,(,2008,),Bioavailability,and,kinetics,of,sulforaphane,in,humans,after,consumption,of,cooked,versus,raw,broccoli,],Agric,Food,Chem,.56,:,10505,—,10509,.}	{NULL}
journal.pone.0052370.pdf	1	{OPEN,8,ACCESS,Freely,available,online,',P,*,"\\"",*,i,°,”,E}	{NULL}
journal.pone.0052370.pdf	2	{Liver,Gene,Transfer,of,lnterkeukin-15,Constructs,That}	{NULL}
journal.pone.0052370.pdf	3	{Become,Part,of,Circulating,High,Density,Lipoproteins,for,Immunotherapy}	{NULL}
journal.pone.0052370.pdf	4	{Maria,C.,Ochoa,‘,",",Jessica,Fioravanti,‘,",",Erwin,H.,Duitmanz,",",Jose,Medina,.}	{NULL}
journal.pone.0052370.pdf	5	{—,.}	{NULL}
journal.pone.0052370.pdf	6	{Echeverz,‘,",",Asis,Palazon,‘,",",Ainhoa,Arina3,",",Juan,Dubrot,',",",Carlos,Alfaro,‘,",",Aizea,Morales-Kastresana,‘,",",Oihana,Murillo,“,",",Sandra,Hervas-Stubbs,',",",Jesus,Prieto,',",",Pedro,Berraondo,‘,*,“’,",",Ignacio,Me,|,ero,‘,*,"\\"",1,Center,for,Applied,Medical,Research,",",University,of,Navarra,",",Pamplona,",",Spain,",",2,Department,of,Immunology,and,Cell,Biology,",",Research,Center,Borstel,",",Borstel,",",Germany,",",3,Department,of,Pathology,",",University,of,Chicago,",",Chicago,",",Illinois,",",United,States,of,America,",",4Department,of,Otolawngology,",",Stanford,Cancer,Center,and,Institute,for,Stem,Cell,Biology,and,Regenerative,Medicine,",",Stanford,University,",",Stanford,",",California,",",United,States,of,America}	{NULL}
journal.pone.0052370.pdf	7	{Abstract}	{NULL}
journal.pone.0052370.pdf	8	{Apolipoprotein,A-I,(,Apo,A-I,),is,a,major,component,of,high,density,lipoproteins,(,HDL,),that,transport,cholesterol,in,circulation,.}	{NULL}
journal.pone.0052370.pdf	9	{We,have,constructed,an,expression,plasmid,encoding,a,chimeric,molecule,encompassing,interleukin-15,(,IL-15,),and,Apo,A-I,(,pApo-hIL15,),that,was,tested,by,hydrodynamic,injections,into,mice,and,was,co,—,administered,with,a,plasmid,encoding,the,sushi,domain,of,|,L-15Ror,(,pSushi,),in,order,to,enhance,IL-15,trans,—,presentation,and,thereby,bioactivity,.}	{NULL}
journal.pone.0052370.pdf	10	{The,pharmacokinetics,of,the,Apo,A-I,chimeric,protein,were,much,longer,than,non-stabilized,IL-15,and,its,bioactivity,was,enhanced,in,combination,with,IL-15Ror,Sushi,.}	{NULL}
journal.pone.0052370.pdf	11	{Importantly,",",the,APO-IL-15,fusion,protein,was,incorporated,in,part,into,circulating,HDL,.}	{NULL}
journal.pone.0052370.pdf	12	{Liver,gene,transfer,of,these,constructs,increased,NK,and,memory-phenotype,CD8,lymphocyte,numbers,in,peripheral,blood,",",spleen,and,liver,as,a,result,of,proliferation,documented,by,CFSE,dilution,and,BrdU,incorporation,.}	{NULL}
journal.pone.0052370.pdf	13	{Moreover,",",the,gene,transfer,procedure,partly,rescued,the,NK,and,memory,T-cell,deficiency,observed,in,IL-15Ror,"\\"",‘,mice,.}	{NULL}
journal.pone.0052370.pdf	14	{pApo-h,|,L15,+,pSushi,gene,transfer,to,the,liver,showed,a,modest,therapeutic,activity,against,subcutaneously,transplanted,MC38,colon,carcinoma,tumors,",",that,was,more,evident,when,tumors,were,set,up,as,liver,metastases,.}	{NULL}
journal.pone.0052370.pdf	15	{The,improved,pharmacokinetic,profile,and,the,strong,biological,activity,of,APO-IL-15,fusion,protein,holds,promise,for,further,development,in,combination,with,other,immunotherapies,.}	{NULL}
journal.pone.0052370.pdf	16	{Citation,:,Ochoa,MC,",",Fioravanti,J,",",Duitman,EH,",",Medina,.}	{NULL}
journal.pone.0052370.pdf	17	{—,.}	{NULL}
journal.pone.0052370.pdf	18	{Echeverz,J,",",Palazon,A,",",et,al.,(,2012,),Liver,Gene,Transfer,of,Interkeukin-15,Constructs,That,Become,Part,of,Circulating,High,Density,Lipoproteins,for,Immunotherapy,.}	{NULL}
journal.pone.0052370.pdf	19	{PLoS,ONE,7,(,12,),:,e52370,.}	{NULL}
journal.pone.0052370.pdf	20	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	21	{pone,.0052370,Editor,:,Ali,A.,Ashkar,",",McMaster,University,",",Canada,Received,May,22,",",2012,;,Accepted,November,13,",",2012,;,Published,December,21,",",2012,Copyright,:,©,2012,Ochoa,et,al.,.}	{NULL}
journal.pone.0052370.pdf	22	{This,is,an,open,—,access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pone.0052370.pdf	23	{Funding,:,MCO,receives,a,Sara,Borrell,contract,from,Ministerio,de,Ciencia,e,Innovacion,.}	{NULL}
journal.pone.0052370.pdf	24	{CA,is,supported,by,Fundacion,Cientiﬁca,of,AECC,.}	{NULL}
journal.pone.0052370.pdf	25	{SH,.}	{NULL}
journal.pone.0052370.pdf	26	{—,.}	{NULL}
journal.pone.0052370.pdf	27	{S,receives,a,Ramon,y,Cajal,contract,from,Ministerio,de,Educacion,y,Ciencia,",",and,AM-K,a,scholarship,from,Ministerio,de,Ciencia,e,Innovacion,.}	{NULL}
journal.pone.0052370.pdf	28	{PB,a,Miguel,Servet,contract,from,Fondo,de,Investigacion,Sanitaria,(,FIS,),;,AP,",",JF,and,JM,a,scholarship,from,FIS,.}	{NULL}
journal.pone.0052370.pdf	29	{Financial,support,was,from,MEC/El,Ministerio,de,Ciencia,e,Innovacion,(,SAF2005-03131,and,SAF2008,.}	{NULL}
journal.pone.0052370.pdf	30	{—,.}	{NULL}
journal.pone.0052370.pdf	31	{O3294,),",",RETIC,(,RDO6/0020/0065,),",",(,PIO60932,and,FIS,P110/00264,),",",European,commission,7th,famework,program,and,SUDOE,.}	{NULL}
journal.pone.0052370.pdf	32	{—,.}	{NULL}
journal.pone.0052370.pdf	33	{IMMUNONET,",",Fundacion,Mutua,Madrileﬁa,",",and,”,UTE,for,project,FIMA,”,.}	{NULL}
journal.pone.0052370.pdf	34	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pone.0052370.pdf	35	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pone.0052370.pdf	36	{*,E,—,mai,|,:,ime,|,ero@unav.es,(,IM,),;,pberraondo,|,@unav,.}	{NULL}
journal.pone.0052370.pdf	37	{es,(,PB,),5,These,authors,contributed,equally,to,this,work,.}	{NULL}
journal.pone.0052370.pdf	38	{|,nt,|,-,oduction,Indeed,",",IL-15,coupled,to,the,sushi,domain,has,been,engineered,to,increase,bioactivity,[,15,],.}	{NULL}
journal.pone.0052370.pdf	39	{For,cancer,immunotherapy,",",IL-15,has,created,great,expectations,based,on,mouse,data,from,injections,of,the,soluble,cytokine,[,1,],or,gene,transfer,[,l6,",",l7,",",l8,],.}	{NULL}
journal.pone.0052370.pdf	40	{However,",",the,most,striking,effects}	{NULL}
journal.pone.0052370.pdf	41	{There,is,much,interest,in,the,development,of,interleukin-15,for,immunotherapy,[,"1,2",],.}	{NULL}
journal.pone.0052370.pdf	42	{This,is,because,it,inhibits,activation,induced,T,cell,death,[,3,],",",homeostaticaly,increases,lymphocyte,numbers,[,"4,5",],",",and,up-regulates,the,function,of,NK,cells,[,"6,7,8,9",j,of,IL-15,are,observed,in,combinatorial,immunotherapeutic,and,IKDC,(,interferon-producing,killer,dendritic,cells,),[,10,],.}	{NULL}
journal.pone.0052370.pdf	43	{IL-15,Strategies,Such,as,those,with,adoptive,T,Cell,transfer,[,19,],or,is,more,a,costimulatory,molecule,than,a,soluble,cytokine,in,the,Vaccines,[,20,21,],.}	{NULL}
journal.pone.0052370.pdf	44	{sense,that,it,is,physiologically,trans-presented,[,l,1,],as,a,cell,surface,complex,which,is,non-covalently,attached,with,high,affinity,to,ILl5ROL,[,"8,9",",",ll,",",l2,],.}	{NULL}
journal.pone.0052370.pdf	45	{The,region,of,IL-l5ROL,involved,in,transpresentation,of,IL-15,has,been,identiﬁed,as,the,sushi,domain,(,so,named,because,of,structural,resemblance,with,the,roll,shape,of,a,popular,Japanese,dish,),[,l3,",",l4,",",l5,],.}	{NULL}
journal.pone.0052370.pdf	46	{The,binding,of,IL-15,to,the,sushi,domain,of,ILl5ROL,is,believed,to,orient,the,molecule,and,improves,the,interaction,with,the,IL-2R,|,3/IL,-2,Ry,signaling,receptors,[,"13,15",],.}	{NULL}
journal.pone.0052370.pdf	47	{The,pharmacokinetic,proﬁle,of,IL-15,as,a,soluble,molecule,is,not,favourable,since,such,a,small,protein,undergoes,rapid,renal,clearance,.}	{NULL}
journal.pone.0052370.pdf	48	{To,stabilize,the,molecule,and,provide,trans,—,presentation,",",IL-15Roi-Fc,chimeric,proteins,are,conjugated,ex,vivo,to,IL-15,.}	{NULL}
journal.pone.0052370.pdf	49	{The,resulting,complexes,are,much,more,bioactive,and,exert,more,potent,immunotherapeutic,effects,[,"22,23,24",],.}	{NULL}
journal.pone.0052370.pdf	50	{GMP-grade,IL-15,has,been,tested,in,non-human,primates,mainly,showing,expanding,effects,on,CD8,memory,T,cells,and}	{NULL}
journal.pone.0052370.pdf	51	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0052370.pdf	52	{p,|,osone.org,1,December,2012,|,Volume,7,|,Issue,12,|,e52370}	{NULL}
journal.pone.0052370.pdf	53	{NK,cells,[,"25,26",],.}	{NULL}
journal.pone.0052370.pdf	54	{Most,effects,are,transient,and,cease,following,cytokine,withdrawal,[,26,],thus,offering,a,promising,overall,safety,proﬁle,.}	{NULL}
journal.pone.0052370.pdf	55	{Accordingly,",",phase,I,trials,have,begun,(,NCTOl02l059,),.}	{NULL}
journal.pone.0052370.pdf	56	{In,mice,",",the,immunotherapeutic,effects,of,IL-15,against,tumors,are,dependent,on,NK,and,CD8,T,cells,[,"2,9,27",],.}	{NULL}
journal.pone.0052370.pdf	57	{Importantly,",",the,effects,of,IL-15,are,very,different,from,those,of,IL-2,",",although,both,cytokines,share,similar,receptors,and,attain,similar,effects,on,lymphocyte,cultures,[,2,],.}	{NULL}
journal.pone.0052370.pdf	58	{For,instance,",",IL-15,inhibits,activationinduced,cell,death,in,viva,",",whilst,IL-2,induces,the,contrary,[,2,],.}	{NULL}
journal.pone.0052370.pdf	59	{Furthermore,",",the,phenotypes,of,IL-15,"\\"",’,[,28,],and,1L,—,15Ror,',/,',mice,[,29,],show,that,IL-15,is,absolutely,required,for,NK,and,NKT,cell,ontogeny,as,well,as,for,homeostatic,maintenance,of,CD8,memory,T,cells,.}	{NULL}
journal.pone.0052370.pdf	60	{On,the,contrary,",",IL-2,_,’,_,mice,show,a,totally,unrelated,phenotype,with,autoimmune,inﬂammatory,bowel,disease,[,30,],.}	{NULL}
journal.pone.0052370.pdf	61	{Lipids,are,transported,in,plasma,wrapped,in,apolipoproteins,that,coalesce,forming,lipoparticles,.}	{NULL}
journal.pone.0052370.pdf	62	{Apo,A-I,is,a,major,constituent,of,high,density,lipoproteins,(,HDL,),",",whose,main,function,is,to,gather,cholesterol,from,the,tissues,and,take,it,back,to,the,liver,[,31,],.}	{NULL}
journal.pone.0052370.pdf	63	{High,plasma,concentrations,of,HDL,are,linked,to,lower,risk,of,cardiovascular,events,[,31,],.}	{NULL}
journal.pone.0052370.pdf	64	{Apo,A-I,protein,is,an,HDL,constituent,synthesized,and,secreted,by,hepatocytes,and,interacts,with,the,surface,scavenger,receptor,BI,(,SR-BI,),broadly,distributed,in,the,organism,[,32,],.}	{NULL}
journal.pone.0052370.pdf	65	{Because,of,these,features,",",Apo,A-I,has,been,used,to,stabilize,interferon,or,to,achieve,sustained,levels,of,the,cytokine,with,a,safer,proﬁle,[,33,],.}	{NULL}
journal.pone.0052370.pdf	66	{In,these,constructions,",",the,cytokine,is,supposed,to,be,facing,the,hydrophilic,side,",",popping,from,the,hydrophobic,core,of,the,lipoprotein,.}	{NULL}
journal.pone.0052370.pdf	67	{In,this,study,",",IL-15,was,fused,to,Apo,A-I,and,gene-transferred,to,the,liver,by,hydrodynamic,injections,as,previously,performed,with,several,cytokine,genes,[,34,],including,IL-15,[,35,],.}	{NULL}
journal.pone.0052370.pdf	68	{We,show,that,this,chimeric,gene,encompassing,IL-15,leads,to,more,sustained,serum,concentrations,than,the,concentrations,achieved,with,non-fused,IL-15,.}	{NULL}
journal.pone.0052370.pdf	69	{Furthermore,",",we,co-transferred,to,the,hepatocytes,the,sushi,domain,of,IL-15Roi,and,the,resulting,complex,showed,enhanced,bioactivity,and,as,a,monotherapy,shows,partial,efficacy,against,colon,carcinomas,derived,from,the,MC38,cell,line,.}	{NULL}
journal.pone.0052370.pdf	70	{Materials,and,Methods}	{NULL}
journal.pone.0052370.pdf	71	{Mice,and,Cell,Lines,C57BL,/,6,and,(,6,—,lO,weeks,old,),were,purchased,from,Harlan,Laboratories,(,Barcelona,",",Spain,),.}	{NULL}
journal.pone.0052370.pdf	72	{IL-15ROL,_,/,_,mice,in,C57BL,/,6,background,[,29,],were,kindly,provided,by,Dr.,Hans,Schreiber,(,University,of,Chicago,),.}	{NULL}
journal.pone.0052370.pdf	73	{IL-l5Roc,_,’,_,mice,in,background,B6129S2,and,their,syngenic,wild-type,controls,were,purchased,from,Jackson,Laboratories,(,Bar,Harbor,",",Maine,",",US,),.}	{NULL}
journal.pone.0052370.pdf	74	{MC38,is,a,colon,adenocarcinoma,cell,line,of,C5,7BL,/,6,origin,whose,identity,has,been,veriﬁed,by,Idexx,Radil,(,Columbia,",",MO,",",USA,.}	{NULL}
journal.pone.0052370.pdf	75	{Case,6592-2012,),and,was,provided,to,us,by,Dr.,Karl,E.,Hellstrom,(,Seattle,",",WA,),[,36,],.}	{NULL}
journal.pone.0052370.pdf	76	{YAC-1,cells,were,obtained,from,American,Type,Culture,Collection,(,Manassas,",",VA,",",USA,),[,35,],.}	{NULL}
journal.pone.0052370.pdf	77	{CTLL-2,is,a,stable,subclone,of,cytotoxic,T-lymphocytes,originally,isolated,from,a,C57BL,/,6,mouse,kindly,provided,to,us,by,Dr.,Juan,J,Lasarte,(,CIMA,.}	{NULL}
journal.pone.0052370.pdf	78	{Pamplona,.}	{NULL}
journal.pone.0052370.pdf	79	{Spain,),[,37,],.}	{NULL}
journal.pone.0052370.pdf	80	{Ethics,Statement,All,animal,procedures,were,conducted,under,Navarra,Government,recommendations,and,the,protocol,was,approved,by,the,Committee,on,the,Ethics,of,Animal,Research,of,the,University,of,Navarra,(,study,approval,number,060,/,10,),.}	{NULL}
journal.pone.0052370.pdf	81	{All,surgery,was,performed,under,anesthesia,",",and,all,efforts,were,made,to,minimize,suffering,.}	{NULL}
journal.pone.0052370.pdf	82	{Plasmids,The,human,interleukin-15,expression,plasmid,(,pVkL/ILl5IRESneo,),",",which,carries,a,modiﬁed,cDNA,encoding,for,hILl5,protein,was,produced,and,puriﬁed,as,described,[,"35,38",],and,will,be,called,phILl5,.}	{NULL}
journal.pone.0052370.pdf	83	{For,sushi,domain,construction,",",complete,mIL15Rcx,was,cloned,into,the,BamHI,and,NotI,sites,of,the,vector,pcDNATM3,.1,(,Invitrogen,",",Carfsbed,",",CA,),(,pIL15Rcx,),.}	{NULL}
journal.pone.0052370.pdf	84	{The,C-terminal,part,was,removed,by,PCR,(,Uprim,.}	{NULL}
journal.pone.0052370.pdf	85	{TAA,AGA,GGG,CCC,TAT,TCT,ATA,GTG,and,Lprim,.}	{NULL}
journal.pone.0052370.pdf	86	{GGG,GTC,TCT,GAT,GCA,CTT,GAG,),and,subsequent,ligation,of,the,product,.}	{NULL}
journal.pone.0052370.pdf	87	{The,transgene,in,the,expression,plasmid,was,veriﬁed,by,sequencing,.}	{NULL}
journal.pone.0052370.pdf	88	{We,will,refer,to,this,as,pSushi,.}	{NULL}
journal.pone.0052370.pdf	89	{Apolipoprotein,A-I,plasmid,(,apoal,",",GeneID,:,l,1806,),was,produced,and,puriﬁed,as,described,[,33,],and,will,be,called,pApo,.}	{NULL}
journal.pone.0052370.pdf	90	{Apolipoprotein,A-I,and,Interleukin,15,Gene,Fusion,Designs,PCR,ampliﬁcation,was,carried,out,using,the,sense,primer,FwATGmApoA1,(,5,’,-,ATGAAAGCTGTGGTGCTGGC-3,’,),on,pApo,as,a,template,",",and,the,antisense,primer,RvAscImApoA1,(,5,’,GGCGCGCCCTGGGCAG-TCAGAGTCTCGC-3,’,),",",introducing,the,restriction,site,for,the,AscI,enzyme,(,GGCGCGCCC,),in,the,3,’,end,of,apolipoprotein,A-I,gene,",",eliminating,the,stop,codon,and,including,a,GAP,peptide,as,linker,of,the,two,coded,proteins,.}	{NULL}
journal.pone.0052370.pdf	91	{mApoA-I-AscI,puriﬁed,CDNA,was,cloned,in,the,expression,vector,pcDNATM3,.1,/,V5-His,ToPo,®,TA,(,Invitrogen,",",Carfsbed,",",CA,),",",which,we,will,call,pCMV-mApoAl-AscI,.}	{NULL}
journal.pone.0052370.pdf	92	{Human,interleukin,15,sequence,was,cloned,in,the,expression,vector,pTrcHis2,TOPO,®,TA,(,Invitrogen,",",Carfsbed,",",CA,),using,5,’,AATAATGGCGCGCCGAACTGGATAG-ATG-3,’,(,FwAscIhIL-l5,),and,3,’,GCGGCCGCTCAGGACGTGTTGATGAAC,5,’,(,RvNotIhIL-15,),primers,that,introduced,a,restriction,site,for,AscI,enzyme,in,3,’,and,NotI,in,5,’,.}	{NULL}
journal.pone.0052370.pdf	93	{pTrcHis2-hIL-15,was,digested,with,AscI,and,NotI,and,the,AscI-hIL-15-NotI,DNA,fragment,(,345,nt,),was,obtained,.}	{NULL}
journal.pone.0052370.pdf	94	{To,carry,out,the,gene,fusion,",",plasmid,pCMV-mApoA1-AscI,was,digested,with,the,AscI/NotI,enzymes,(,New,England,Biolabs,),.}	{NULL}
journal.pone.0052370.pdf	95	{The,ligation,was,performed,with,the,open,plasmid,pCMVmApoA1-AscI,and,the,AscI-hIL15-NotI,insert,in,a,1:3,(,vector,:,insert,),ratio,using,T4,DNA,ligase,High,Concentration,and,2X,Rapid,Ligation,Buffer,(,Promega,",",Wl,),.}	{NULL}
journal.pone.0052370.pdf	96	{The,resulting,6669nucleotide,plasmid,will,hereinafter,be,called,pApo-hIL15,.}	{NULL}
journal.pone.0052370.pdf	97	{All,plasmids,were,conﬁrmed,by,sequencing,the,cloned,genes,.}	{NULL}
journal.pone.0052370.pdf	98	{For,the,fusion,of,mouse,albumin,with,hILl5,",",the,plasmid,pApohIL15,was,digested,with,AscI/XhoI,and,the,insert,containing,the,hIL15,was,cloned,into,a,the,plasmid,pALF,[,39,],after,removal,of,the,sequence,of,IFN,by,AscI/XhoI,digestion,.}	{NULL}
journal.pone.0052370.pdf	99	{Hydrodynamic,Injections,and,ELISA,C57BL/6,or,IL-15Roc,_,’,_,mice,received,an,intravenous,injection,(,tail,vein,),of,10,pg,of,plasmid,in,a,volume,of,100,ml,kg_1,using,a,27-G,needle,at,a,rate,of,0.4,ml,s_1,",",as,described,[,40,],.}	{NULL}
journal.pone.0052370.pdf	100	{The,hIL-l5,serum,concentrations,were,assessed,by,ELISA,(,OptEIA,BD,Biosciences,",",San,Jose,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	101	{Concentration,of,mouse,Apolipoprotein,A-I,were,measured,with,an,ELISA,kit,(,Cusabio,",",Hubei,",",P.,R.,China,),.}	{NULL}
journal.pone.0052370.pdf	102	{RT,.}	{NULL}
journal.pone.0052370.pdf	103	{—,.}	{NULL}
journal.pone.0052370.pdf	104	{PCR,and,Analysis,of,h,|,L15,and,mSushi,Expresion,Total,RNA,from,mice,livers,was,isolated,from,samples,using,TRI,reagent,(,Sigma,",",Dorset,",",UK,),.}	{NULL}
journal.pone.0052370.pdf	105	{The,concentration,and,purity,of,samples,were,determined,by,absorbance,at,260,and,280,nm,with,background,correction,at,320,nm,in,a,spectrophotometer,.}	{NULL}
journal.pone.0052370.pdf	106	{RNA,was,treated,with,DNase,I,and,retrotranscribed,to,cDNA,with,MMLV,RT,in,the,presence,of,RNase,OUT,(,all,the,reagents,Invitrogen,",",Carlsbad,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	107	{The,reaction,was,incubated,for,1,hour,at,37,°,C,",",denatured,for,1,minute,at,95,°,C,and,taken,to,4,°,C.,The,samples,were,used,immediately,for,PCR,or,stored,at,—,20,°,C.,Murine,actin,was,used,to,standardize,gene,expression,.}	{NULL}
journal.pone.0052370.pdf	108	{The,mRNA,values,were,represented,by,the,formula,QAC,‘,",",where,ACt,indicates,the,difference,in,the,threshold,cycle,between,mActin,and,the,target,genes,(,all,reagents,from,BioRad,",",Hercules,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	109	{Primers,for,quantitative,real,time,RT,.}	{NULL}
journal.pone.0052370.pdf	110	{—,.}	{NULL}
journal.pone.0052370.pdf	111	{PCR,for,hIL15,were,:,(,Fw,hIL15,),5,’,-,TGGGTGAATGTAATAAGTGATTTGAAA-3,’,and,(,Rv,hIL15,),5,’,-,TTTCCTCCAG,TTCCTCACATTCTT-3,’,",",for,actin,:,(,FwmActin,),5,’,-,(,CGCGTCCACCCGCGAG-3,’,and,(,RvmActin,),5,',-,CCTGGTGCCTAGGGCG-3,’,",",and,primers,for,quantitative,real,time,RT,.}	{NULL}
journal.pone.0052370.pdf	112	{—,.}	{NULL}
journal.pone.0052370.pdf	113	{PCR,for,the,sushi,domain,were,:,(,Fw,Sushi,),5,’,-,AGACAGACACCCTGCTGCTC-3,’,and,(,Rw,Sushi,),5,’,-,CCACGTTGGTGTTCTTGTTG-3,',.}	{NULL}
journal.pone.0052370.pdf	114	{Isolation,of,HDLs,by,differential,ultracentrifugation,in,sodium,bromide,gradient,.}	{NULL}
journal.pone.0052370.pdf	115	{24,hours,after,hydrodynamic,delivery,of,pApo,",",pApo-hIL15,or,pApo-hIL15,+,pSushi,plasmids,",",HDLs,were,isolated,from,plasma,samples,as,described,by,Rodriguez-Sureda,et,al,[,41,],.}	{NULL}
journal.pone.0052370.pdf	116	{Electrophoresis,and,immunoblotting,against,Apo,A-I,were,performed,as,described,[,33,],.}	{NULL}
journal.pone.0052370.pdf	117	{IL-15,Bioactivity,Assay,CTLL-2,cells,were,plated,in,a,96-well,plate,at,104,cells,/,well,and,1:10,diluted,serum,obtained,24,h,after,hydrodynamic,injections,was,added,.}	{NULL}
journal.pone.0052370.pdf	118	{Each,serum,sample,was,serially,diluted,1:2,twelve,times,.}	{NULL}
journal.pone.0052370.pdf	119	{The,plates,were,incubated,for,2,days,and,subsequently,the,CTLL-2,cells,were,pulsed,with,1,uCi,of,tritiated,thymidine,(,[,3H,],TdR,),8,h,before,[,31-I,],TdR,incorporation,was,measured,using,a,Topcount,liquid,scintillation,counter,(,Packard,),.}	{NULL}
journal.pone.0052370.pdf	120	{Electrophoresis,and,Apo,A-I,lmmunoblotting,HDL,+,fraction,samples,were,separated,in,4,—,20,%,Trishepes,PAGE,LongLife,iGels,(,Nusep,",",Lane,Cove,",",Australia,),gradient,gels,",",and,transferred,to,nitrocellulose,membrane,(,1/Vhatman,",",Kent,",",UK,),.}	{NULL}
journal.pone.0052370.pdf	121	{Apo,A-I,and,hIL-15,were,detected,with,Goat,polyclonal,anti-bodies,(,Santa,Cruz,Biotechnology,",",Santa,Cruz,",",CA,",",USA,),and,a,1:200,dilution,Anti-goat,IgG,(,whole,molecule,),-,HRP,conjugated,(,Sigma-Aldrich,",",St,Louis,",",MO,",",USA,),as,secondary,antibody,[,33,],.}	{NULL}
journal.pone.0052370.pdf	122	{Isolation,of,Mononuclear,Cells,from,Spleen,and,Livers,Spleens,and,livers,were,incubated,in,collagenase,and,DNase,(,Roche,),for,15,min,at,37,°,C,",",mechanically,disrupted,and,passed,through,a,70,um,nylon,mesh,ﬁlter,(,BD,Falcon,",",BD,Biosciences,),.}	{NULL}
journal.pone.0052370.pdf	123	{Dissociated,cells,from,livers,were,centrifuged,with,Percoll,©,(,GE,Healthcare,",",Chalfont,St,Giles,",",UK,),at,35,%,(,500,g,",",10,min,",",200C,),making,a,gradient,in,order,to,eliminate,parenchymal,cells,.}	{NULL}
journal.pone.0052370.pdf	124	{Erythrocytes,were,lysed,with,ACK,buffer,.}	{NULL}
journal.pone.0052370.pdf	125	{For,the,study,of,CD8,T,and,NK,cell,proliferation,",",splenocytes,were,enriched,in,DX5,+,or,CD8,’,cells,using,immunomagnetic,beads,according,to,the,manufacturer,’s,protocol,(,Miltenyi,Biotec,",",Bergisch,Gladbach,",",Germany,),.}	{NULL}
journal.pone.0052370.pdf	126	{Antibodies,and,Flow,Cytometry,Cells,isolated,from,livers,and,spleens,were,pretreated,with,FcBlock,(,anti-CDl6,/,32,",",eBioscience,",",San,Diego,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	127	{Monoclonal,antibodies,to,the,following,mouse,antigens,were,conjugated,to,ﬂuorescein,isothiocyanate,",",phycoerythrin,",",phycoerythrin-cyanine7,",",allophycocyanin,or,biotin,:,CD3,(,145-2C11,),",",NKl,.}	{NULL}
journal.pone.0052370.pdf	128	{l,(,PK-136,),",",CD8,(,53-6,.7,),and,CD44,(,IIM7,),and,BdrU,(,BD,Biosciences,",",San,Diego,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	129	{Intracellular,stainings,were,performed,with,Cytoﬁx,/,Cytoperm,©,buffer,(,(,BD,Biosciences,",",San,Diego,",",CA,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	130	{Biotinylated,antibodies,were,visualized,with,streptavidin-APC-Cy7,.}	{NULL}
journal.pone.0052370.pdf	131	{FACSCanto,and,FACSCalibur,cytometers,were,used,for,cell,acquisition,",",and,data,analysis,was,performed,using,FACS,DiVa,(,BD,Biosciences,),and,Flowjo,7.2.1,(,Tree,Star,Inc.,",",Ashland,",",OR,",",USA,),.}	{NULL}
journal.pone.0052370.pdf	132	{CFSE,Labeling,of,Cells,",",Adoptive,Transfer,and,BrdU,Assessment,of,Proliferation,in,vivo,Enriched,DX5,+,or,CD8,+,cells,were,washed,twice,with,phosphate-buffered,saline,and,resuspended,at,107,cells,m1_1,in,5,uM,CFSE,(,Sigma-Aldrich,),for,15,min,at,room,temperature,.}	{NULL}
journal.pone.0052370.pdf	133	{3,>,<,105,~,5,>,<,105,stained,cells,were,transferred,to,mice,by,the,retro,orbital,sinus,.}	{NULL}
journal.pone.0052370.pdf	134	{The,proliferation,of,adoptively,transferred,NK,and,CD8,T,lymphocytes,was,analyzed,72,h,after,the,transfer,by,CFSE,dilution,using,a,FACSCalibur,cytometer,.}	{NULL}
journal.pone.0052370.pdf	135	{For,BrdU,incorporation,in,vivo,and,detection,by,ﬂow,Cytometry,",",we,used,the,FITC,BrdU,ﬂow,kit,(,BD,Biosciences,),according,to,manufacturer,instructions,.}	{NULL}
journal.pone.0052370.pdf	136	{Intraperitoneal,injections,of,BrdU,were,provided,three,times,every,24,h,with,doses,of,1.5,mg,.}	{NULL}
journal.pone.0052370.pdf	137	{In,vivo,Tumor,Growth,For,the,subcutaneous,models,",",C57Bl/6,mice,received,a,s.c.,injection,of,MC38,cells,(,5,X105,per,mouse,),.}	{NULL}
journal.pone.0052370.pdf	138	{On,the,indicated,days,",",mice,were,treated,with,a,hydrodynamic,injection,with,the,plasmids,.}	{NULL}
journal.pone.0052370.pdf	139	{Tumor,diameters,were,measured,using,an,electronic,caliper,every,2,to,4,days,",",and,tumor,size,was,determined,by,multiplying,perpendicular,diameters,.}	{NULL}
journal.pone.0052370.pdf	140	{For,the,intrasplenic,tumor,model,",",C57BL,/,6,mice,were,anesthetized,and,a,small,incision,in,peritoneum,was,performed,to,access,the,spleen,.}	{NULL}
journal.pone.0052370.pdf	141	{MC38,cells,were,injected,in,the,spleen,(,5,X105,per,mouse,),in,50,ill,.}	{NULL}
journal.pone.0052370.pdf	142	{of,PBS,.}	{NULL}
journal.pone.0052370.pdf	143	{On,day,1,",",mice,were,treated,with,the,corresponding,plasmids,by,hydrodynamic,injection,.}	{NULL}
journal.pone.0052370.pdf	144	{Mice,were,observed,daily,and,were,sacriﬁced,when,one,of,the,mice,presented,impaired,mobility,.}	{NULL}
journal.pone.0052370.pdf	145	{Following,sacriﬁce,",",tumor,nodules,in,spleen,and,liver,metastases,were,counted,and,measured,.}	{NULL}
journal.pone.0052370.pdf	146	{Mice,were,weighed,as,well,as,various,excised,organs,upon,necropsy,.}	{NULL}
journal.pone.0052370.pdf	147	{Results}	{NULL}
journal.pone.0052370.pdf	148	{Fusion,Proteins,Encompassing,IL-15,and,Apo,A-I,are,more,Stable,in,Plasma,and,Partly,become,Complexed,with,HDL,IL-15,renal,clearance,is,rapid,due,to,the,small,molecular,size,of,the,protein,.}	{NULL}
journal.pone.0052370.pdf	149	{In,order,to,stabilize,IL-15,in,circulation,",",constructions,that,encompassed,Apo,A-I,lipoprotein,and,human,IL-15,were,prepared,.}	{NULL}
journal.pone.0052370.pdf	150	{Figure,S1,represents,the,expression,plasmids,in,which,the,indicated,genes,are,placed,under,the,transcriptional,control,of,the,CMV,promoter,.}	{NULL}
journal.pone.0052370.pdf	151	{The,sushi,domain,of,IL-l5Roc,was,also,cloned,in,a,similar,expression,cassette,.}	{NULL}
journal.pone.0052370.pdf	152	{C57BL,/,6,mice,were,injected,by,hydrodynamic,infusions,with,the,expression,plasmids,as,single,agents,or,in,combinations,to,achieve,expression,of,the,encoded,proteins,in,the,liver,[,35,],.}	{NULL}
journal.pone.0052370.pdf	153	{Since,Apo,A-I,is,naturally,biosynthesized,in,the,liver,",",local,production,of,the,secretable,transgene,products,was,expected,to,reach,circulation,.}	{NULL}
journal.pone.0052370.pdf	154	{IL-15Rcx,sushi,domain,has,been,reported,to,conjugate,with,IL-15,non-covalently,during,protein,processing,[,"13,42",],.}	{NULL}
journal.pone.0052370.pdf	155	{Figure,1A,shows,the,time,courses,of,the,serum,concentrations,of,human,IL-15,following,hydrodynamic,injections,of,the,plasmids,.}	{NULL}
journal.pone.0052370.pdf	156	{As,can,be,seen,",",conjugation,to,Apo,A-I,dramatically,extends,the,pharmacokinetic,proﬁle,and,reaches,much,higher,concentrations,of,the,transgene,product,than,non-fused,IL-15,.}	{NULL}
journal.pone.0052370.pdf	157	{Liver,mRNA,from,the,expression,plasmids,was,quantiﬁed,by,RT-PCR,and,found,to,correlate,with,peak,protein,expression,(,ﬁgure,1B,),.}	{NULL}
journal.pone.0052370.pdf	158	{In,addition,",",pSushi,RNA,was,also,detected,by,RT-PCR,in,similar,samples,",",when,pSushi,was,co-administered,(,ﬁgure,S2,),.}	{NULL}
journal.pone.0052370.pdf	159	{Differential,centrifugation,of,the,plasma,of,the,mice,to,separate,the,lipid,fractions,indicated,that,immunoreactive,IL-15,by,ELISA}	{NULL}
journal.pone.0052370.pdf	160	{was,observed,both,in,high,density,lipoproteins,(,HDL,),and,in,lipidfree,plasma,upon,liver,gene,co-transfer,of,APO-IL-15,and,IL15Roc,sushi,domain,",",or,upon,a,single,hydrodynamic,injection,of,the,APO-IL-15-encoding,plasmid,(,ﬁgure,1C,),.}	{NULL}
journal.pone.0052370.pdf	161	{This,indicates,that,the,chimeric,protein,circulates,in,serum,both,free,and,complexed,to,HDL,.}	{NULL}
journal.pone.0052370.pdf	162	{The,absence,of,HDL,in,the,lipid,free,plasma,fractions,was,checked,by,ELISA,quantiﬁcation,of,Apo,A-I,(,inset,to,ﬁgure,1C,),.}	{NULL}
journal.pone.0052370.pdf	163	{These,data,were,conﬁrmed,using,HDL,fraction,and,lipid-free,plasma,to,test,IL-15,bioactivity,on,CTLL2,cells,.}	{NULL}
journal.pone.0052370.pdf	164	{As,can,be,seen,in,ﬁgure,1D,both,fractions,contained,bioactivity,",",but,a,comparison,on,nmol/mL,basis,indicates,that,the,HDL,complexed,fraction,is,slightly,more,bioactive,.}	{NULL}
journal.pone.0052370.pdf	165	{C,1n,+,=,;,:,:,:,:,:,l,H,E,PAW}	{NULL}
journal.pone.0052370.pdf	166	{3,10,",",",",§,0,.}	{NULL}
journal.pone.0052370.pdf	167	{2n,+,i,:1,pApo-hIL15}	{NULL}
journal.pone.0052370.pdf	168	{A,Q,5,A,—,pApo-h,|,L15,+,pSushi}	{NULL}
journal.pone.0052370.pdf	169	{4,:,3,won,_,.}	{NULL}
journal.pone.0052370.pdf	170	{5,<}	{NULL}
journal.pone.0052370.pdf	171	{54,-,I,-,pApo-hIL15,+,pSushi,3,’,3,‘,E,pApo-h,|,L15,ﬂ,75,-,ﬁ,-,ph,|,L15,+,pSushi,o}	{NULL}
journal.pone.0052370.pdf	172	{E,50,',ﬁ,~,ph,|,L15,"\\\\",‘,"\\\\",_,g,"\\\\",V9,»,“,ox,.}	{NULL}
journal.pone.0052370.pdf	173	{adéoo,2,’,-,o,-,pApo,D,_,‘,¢,5,.}	{NULL}
journal.pone.0052370.pdf	174	{t3e,‘,<,In,.}	{NULL}
journal.pone.0052370.pdf	175	{‘,.9,g,25,+,Saline,mm,"\\""}	{NULL}
journal.pone.0052370.pdf	176	{10.0,75,40000,-,I,-,pApo-hIL15,+,pSushi,(,HDL,),i,E,-,o,-,pApo-hlL15,+,pSushi,(,Lipid,free,),5.0,32-5,20000}	{NULL}
journal.pone.0052370.pdf	177	{Ho,5,1,.}	{NULL}
journal.pone.0052370.pdf	178	{u,~,<,10,”,1,.}	{NULL}
journal.pone.0052370.pdf	179	{o,~,10,“,I.,ox1o,*,"\\""}	{NULL}
journal.pone.0052370.pdf	180	{B,W,E,nma,|,.}	{NULL}
journal.pone.0052370.pdf	181	{lrnL}	{NULL}
journal.pone.0052370.pdf	182	{—,pApo}	{NULL}
journal.pone.0052370.pdf	183	{C,10,"\\"",_,g,$,phlL,‘,l5,g,19-2,B,pApo_h,”,_,15,',9,',hIL15rec,:,9,;,we,‘,I,pApo-h,|,L15,+,pSushi,5,E,-,B,pApo-h,|,L15,104,"\\"",2,W,‘,E,10,‘,5,E,II,10,*,10-1,swﬂsywwaﬂyws,Tisﬂiﬂe,s,f,2,=,=,',“,"\\"","\\"",»‘,*,‘,$,"\\"",',°,“’,°,',»‘,“,°,$,"\\"",°,““,"\\"",»,°,‘,°,v,»‘,=,"\\"",”,°,1n,+,p,1n,+,E,p,1n,+,E,r,1n,+,`,n,1n,+,x,2n,+,f,1n,+,b,1n,+,8,1n,+}	{NULL}
journal.pone.0052370.pdf	184	{Figure,1,.}	{NULL}
journal.pone.0052370.pdf	185	{Liver,gene,transfer,of,APO-IL-15,and,IL-15Ra,sushi,domain,results,in,extended,half-life,and,enhanced,bioactivity,.}	{NULL}
journal.pone.0052370.pdf	186	{(,A,),Mice,(,n,=,3,per,group,),were,hydrodynamically,injected,with,the,indicated,expression,plasmids,and,serum,concentrations,of,human,IL-15,were,sequentially,monitored,by,ELISA,.}	{NULL}
journal.pone.0052370.pdf	187	{Mean,:,SEM,from,one,representative,experiment,out,of,three,similarly,performed,.}	{NULL}
journal.pone.0052370.pdf	188	{(,B,),IL-15,and,Apo,A-I,mRNA,expression,quantified,by,real-time,RT-PCR,referred,to,B,actin,at,the,given,time-points,following,hydrodynamic,injection,of,the,indicated,plasmids,as,in,A.,(,C,),Plasma,samples,of,mice,hydrodynamically,treated,with,the,indicated,plasmids,were,fractioned,by,centrifugation,into,the,different,Iipoprotein,particles,and,lipid-depleted,plasma,.}	{NULL}
journal.pone.0052370.pdf	189	{IL-15,content,in,each,fraction,was,monitored,by,ELISA,.}	{NULL}
journal.pone.0052370.pdf	190	{Results,are,from,two,pooled,experiments,performed,with,4,and,6,mice,per,group,.}	{NULL}
journal.pone.0052370.pdf	191	{The,inset,represents,the,Apo,A-I,concentration,in,the,indicated,fractions,.}	{NULL}
journal.pone.0052370.pdf	192	{(,D,),IL-15,bioactivity,measured,on,CTLL2,cells,by,3HThy,incorporation,when,testing,the,indicated,dilutions,of,the,serum,and,the,HDL,concentrated,fractions,from,equivalent,volumes,of,serum,.}	{NULL}
journal.pone.0052370.pdf	193	{Concentration,were,adjusted,to,nmol/mL,using,IL-15,concentration,as,assessed,by,ELISA,.}	{NULL}
journal.pone.0052370.pdf	194	{(,E,),CTLL-2,proliferation,in,response,to,sequentially,diluted,plasma,samples,in,which,IL-15,content,had,been,measured,by,ELISA,as,in,D.,When,indicated,",",mice,had,been,hydrodynamically,given,pApo,—,h,|,L15,with,or,without,combination,with,a,plasmid,encoding,the,IL-15Roc,sushi,domain,.}	{NULL}
journal.pone.0052370.pdf	195	{Data,represent,mean,:,SEM,of,four,—,replicated,samples,.}	{NULL}
journal.pone.0052370.pdf	196	{The,experiment,was,repeated,at,least,three,times,with,comparable,results,.}	{NULL}
journal.pone.0052370.pdf	197	{Commercial,human,r,|,L,—,15,is,included,as,a,positive,control,and,the,discontinuous,line,represents,thymidine,incorporation,to,CTLL2,exposed,to,the,serum,of,a,mouse,treated,with,pApo,as,a,negative,control,.}	{NULL}
journal.pone.0052370.pdf	198	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	199	{pone,.}	{NULL}
journal.pone.0052370.pdf	200	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	201	{gOO1}	{NULL}
journal.pone.0052370.pdf	202	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0052370.pdf	203	{p,|,osone.org,4,December,2012,|,Volume,7,|,Issue,12,|,e52370}	{NULL}
journal.pone.0052370.pdf	204	{Gene,Co,—,transfer,of,the,Sushi,Domain,of,IL,—,15Rot,Increases,APO-IL-15,Bioactivity,and,thereby,Increases,Numbers,of,NK,and,CD8,T,Cells,in,the,Spleen,and,in,the,Liver,Bioactivity,of,the,IL-15,molecules,was,characterized,on,a,molar,basis,in,functional,tests,on,the,proliferation,of,CTLL-2,cells,(,ﬁgure,1E,),.}	{NULL}
journal.pone.0052370.pdf	205	{A,one,log,difference,was,observed,when,we,compared,the,IL-15,bioactivity,from,serum,samples,drawn,from,mice,transferred,with,APO-IL-15,as,a,simple,plasmid,or,co-transferred,with,the,sushi,domain,of,IL-15RoL,.}	{NULL}
journal.pone.0052370.pdf	206	{This,ﬁnding,is,in,line,with,the,literature,showing,the,enhanced,effect,of,IL-15,in,combination,with,the,sushi,domain,[,"2,10,18,42",],.}	{NULL}
journal.pone.0052370.pdf	207	{Of,note,",",Apo,A-I,or,other,HDLs,components,do,not,hinder,the,IL-15,/,Sushi,domain,interaction,",",allowing,the,enhancement,of,bioactivity,.}	{NULL}
journal.pone.0052370.pdf	208	{Given,the,fact,that,IL-15,is,detected,both,in,the,HDL,and,the,lipid,free,plasma,fractions,(,ﬁgure,1C,and,D,),",",we,performed,experiments,to,see,if,IL-15,were,released,from,HDL,upon,overnight,incubation,at,37,°,C,in,PBS,.}	{NULL}
journal.pone.0052370.pdf	209	{We,found,that,almost,none,of,the,HDL-complexed,IL-15,was,released,into,the,buffer,(,data,not,shown,),.}	{NULL}
journal.pone.0052370.pdf	210	{In,ﬁgure,2A,",",an,immunoblot,of,the,HDL,fractions,of,the,mice,was,probed,with,an,anti-Apo,A-I,polyclonal,Ab,that,showed,a,shift,in,molecular,weight,from,the,abundant,non-complexed,Apo,A-I,when,the,APO-IL-15,sequences,had,been,transferred,by,hydrodynamic,injection,.}	{NULL}
journal.pone.0052370.pdf	211	{This,ﬁnding,further,indicates,that,APO-IL-15,was,incorporated,in,part,into,circulating,HDL,.}	{NULL}
journal.pone.0052370.pdf	212	{Furthermore,",",we,developed,similar,blots,with,an,anti-IL15,antibody,that,also,showed,a,compatible,molecular,weight,for,the,fusion,form,of,IL-15,in,the,corresponding,HDL,fractions,from,mice,in,which,pApo-hILl5,plasmids,had,been,hydrodynamically,injected,(,ﬁgure,2B,),.}	{NULL}
journal.pone.0052370.pdf	213	{In,summary,",",IL-15,in,covalent,conjugation,with,Apo,A-I,complexes,with,HDL,and,extends,its,half-life,.}	{NULL}
journal.pone.0052370.pdf	214	{In,addition,",",gene,transfer,of,the,sushi,domain,of,IL-15ROL,enhances,the,bioactivity,of,the,cytokine,.}	{NULL}
journal.pone.0052370.pdf	215	{One,of,the,intended,functions,of,Apo,A-I,is,to,increase,molecular,weight,(,ﬁgure,2A,and,B,),is,such,a,way,that,it,surpasses,the,renal,ﬁltration,threshold,and,hence,extends,half-life,.}	{NULL}
journal.pone.0052370.pdf	216	{This,can}	{NULL}
journal.pone.0052370.pdf	217	{E}	{NULL}
journal.pone.0052370.pdf	218	{Q.,"\\"",),1,;,3,-,I,_,=,:1,§,o,E,-5,:,‘,°,',3,n.,E,9,.}	{NULL}
journal.pone.0052370.pdf	219	{"90,9",kD,—}	{NULL}
journal.pone.0052370.pdf	220	{A,lL15,sow,T,"\\"",‘,',°,°,',40kD,—}	{NULL}
journal.pone.0052370.pdf	221	{3lJkD,—}	{NULL}
journal.pone.0052370.pdf	222	{"38,6",kD,_}	{NULL}
journal.pone.0052370.pdf	223	{"32,2",kD,—,",",_,Apo,M}	{NULL}
journal.pone.0052370.pdf	224	{20kD,—}	{NULL}
journal.pone.0052370.pdf	225	{"17,4",kD,—}	{NULL}
journal.pone.0052370.pdf	226	{be,achieved,to,a,similar,extent,with,other,fusion,patners,",",such,as,albumin,(,ﬁgure,S3,),",",even,though,the,biodistribution,of,the,lipidcomplexed,IL-15,could,be,different,.}	{NULL}
journal.pone.0052370.pdf	227	{Another,important,question,was,if,HDL,from,mice,receiving,plasmids,encoding,Apo-hIL15,preserved,their,anti-inﬂammatory,and,cholesterol,transporting,functions,.}	{NULL}
journal.pone.0052370.pdf	228	{As,can,be,seen,in,ﬁgure,S4,",",such,HDL,fractions,preserved,their,ability,to,counteract,TN,For,induction,of,VCAM,on,mouse,endothelial,cells,and,promote,the,efflux,of,cholesterol,from,3T3,cells,.}	{NULL}
journal.pone.0052370.pdf	229	{Importantly,",",mice,which,received,pApo-hILl5,+,pSushi,showed,a,marked,increase,of,CD8,|,3,+,T,cells,",",CD44high,CD8,+,memory,T,cells,and,NK,cells,in,the,spleen,if,analyzed,ﬁve,days,following,gene,transfer,.}	{NULL}
journal.pone.0052370.pdf	230	{This,ﬁnding,as,shown,in,ﬁgure,3A,indicates,that,cotransfer,with,the,sushi,domain,increases,in,viva,bioactivity,.}	{NULL}
journal.pone.0052370.pdf	231	{A,time,course,(,ﬁgure,S5A,),of,an,independent,series,of,experiments,indicates,that,the,peak,of,the,effects,on,immune,system,cells,takes,place,around,four,days,after,the,hydrodynamic,injection,of,the,plasmids,.}	{NULL}
journal.pone.0052370.pdf	232	{As,previously,reported,[,42,],",",the,IL-l5Roc,sushi,domain,also,enhances,the,activity,of,IL-15,without,Apo,A-I,.}	{NULL}
journal.pone.0052370.pdf	233	{Of,note,",",pSushi,transference,lacked,by,itself,any,kind,of,detectable,effects,(,data,not,shown,),.}	{NULL}
journal.pone.0052370.pdf	234	{Liver,lymphocytes,followed,a,similar,trend,with,a,dramatic,accumulation,of,memory,CD8,T,lymphocytes,and,NK,cells,",",as,shown,in,ﬁgure,313,.}	{NULL}
journal.pone.0052370.pdf	235	{Indeed,",",the,time,course,was,similar,with,a,peak,around,day,4,after,plasmid,injection,(,ﬁgure,S5B,),.}	{NULL}
journal.pone.0052370.pdf	236	{Sequential,follow-up,of,peripheral,blood,mononuclear,lymphocytes,in,treated,groups,of,mice,showed,also,these,changes,(,ﬁgure,S5C,),.}	{NULL}
journal.pone.0052370.pdf	237	{When,testing,the,natural,killer,cytotoxic,activity,of,spleen,cells,harvested,three,days,following,treatment,with,the,pApo-hILl5,+,pSushi,in,comparison,to,that,of,mice,treated,with,pApo,A-I,",",a,clear,increase,in,activity,against,YAC-1,target,cells,was,observed,(,ﬁgure,S6,),.}	{NULL}
journal.pone.0052370.pdf	238	{Gene,Co,—,transfer,of,APO-IL-15,and,IL-1,SRo,:,Sushi,Domain,Induces,the,Proliferation,of,CD8,+,and,NK,Lymphocytes,Accumulation,of,CD8,memory,T,cells,and,NK,cells,could,be,the,result,of,enhanced,proliferation,.}	{NULL}
journal.pone.0052370.pdf	239	{To,study,this,possibility,",",CFSE-labeled,NK,and,CD8,T,cells,were,infused,into,mice,one}	{NULL}
journal.pone.0052370.pdf	240	{MW}	{NULL}
journal.pone.0052370.pdf	241	{pApo-hl,|,L15,.}	{NULL}
journal.pone.0052370.pdf	242	{_,pApo-hlL15,+,pSushi}	{NULL}
journal.pone.0052370.pdf	243	{CI,1,:,.}	{NULL}
journal.pone.0052370.pdf	244	{<,o.}	{NULL}
journal.pone.0052370.pdf	245	{Figure,2,.}	{NULL}
journal.pone.0052370.pdf	246	{Western,blot,analysis,of,the,circulating,APO-IL-15,fusion,protein,.}	{NULL}
journal.pone.0052370.pdf	247	{(,A,),Plasma,HDL,fractions,from,figure,1C,were,immunoblotted,with,an,anti-Apo,A-I,polyclonal,Ab,.}	{NULL}
journal.pone.0052370.pdf	248	{A,shift,in,molecular,weight,indicated,the,chimeric,proteins,and,the,electrophoretic,migration,molecular,weight,standards,are,indicated,.}	{NULL}
journal.pone.0052370.pdf	249	{(,B,),Samples,as,in,A,were,immunoblotted,with,an,anti,—,|,L15,polyclonal,antibody,and,lanes,with,prestained,molecular,weight,markers,were,run,in,parallel,",",indicating,a,fusion,protein,with,a,relative,molecular,weight,between,40,and,50,kD,.}	{NULL}
journal.pone.0052370.pdf	250	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	251	{pone,.}	{NULL}
journal.pone.0052370.pdf	252	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	253	{gOO2}	{NULL}
journal.pone.0052370.pdf	254	{kw,nu,:}	{NULL}
journal.pone.0052370.pdf	255	{IL-15,Fused,to,Apolipoprotein,A-1,an}	{NULL}
journal.pone.0052370.pdf	256	{50,us,-,"\\"",40,9,.}	{NULL}
journal.pone.0052370.pdf	257	{-,.}	{NULL}
journal.pone.0052370.pdf	258	{.25,.}	{NULL}
journal.pone.0052370.pdf	259	{E,‘,m,g,30,',5,30,E}	{NULL}
journal.pone.0052370.pdf	260	{ii,.5,20,20,E,E,U,10,U,10,g,o,_,o,Q3,»,"\\\\",V,.}	{NULL}
journal.pone.0052370.pdf	261	{". . .",.}	{NULL}
journal.pone.0052370.pdf	262	{",2",”,.}	{NULL}
journal.pone.0052370.pdf	263	{",",$,3,‘,"\\\\",«,$,7,V90,‘,Qo,’,Q,Q,’}	{NULL}
journal.pone.0052370.pdf	264	{T,**,i-ii}	{NULL}
journal.pone.0052370.pdf	265	{—,-,2,.}	{NULL}
journal.pone.0052370.pdf	266	{n,:72,F,2.0,.5,.}	{NULL}
journal.pone.0052370.pdf	267	{S,3,1.5,1,‘,.}	{NULL}
journal.pone.0052370.pdf	268	{E,g,1.5}	{NULL}
journal.pone.0052370.pdf	269	{O,=,Li,.9,:,1.0,:3,e,*,10,o,E,(,:3,0.5,z.,'15,3,8,‘,-,’,o,no}	{NULL}
journal.pone.0052370.pdf	270	{5,‘,I,9,*,"\\"",9,°,’,¢,°,‘‘,Qv,Y9,“}	{NULL}
journal.pone.0052370.pdf	271	{Figure,3,.}	{NULL}
journal.pone.0052370.pdf	272	{Gene,transfer,of,APO-IL-15,and,IL-15Ra,sushi,domain,increase,memory-phenotype,CD8,+,T,cells,and,NK,cells,.}	{NULL}
journal.pone.0052370.pdf	273	{(,A,),Absolute,numbers,ofthe,indicated,lymphocyte,subsets,in,the,spleen,of,mice,treated,with,the,indicated,plasmids,5,days,before,splenectomy,.}	{NULL}
journal.pone.0052370.pdf	274	{Each,point,shows,an,individual,mouse,.}	{NULL}
journal.pone.0052370.pdf	275	{This,experiment,was,repeated,twice,with,comparable,results,.}	{NULL}
journal.pone.0052370.pdf	276	{(,***,indicates,p,<,0.0001,in,a,one-way,ANOVA,test,followed,by,Bonferroni,corrections,),.}	{NULL}
journal.pone.0052370.pdf	277	{Figure,55,shows,a,time,course,analysis,of,these,parameters,(,B,),Experiments,as,in,A,measuring,numbers,of,intrahepatic,mononuclear,leukocytes,with,the,indicated,surface,phenotypes,.}	{NULL}
journal.pone.0052370.pdf	278	{Each,point,represents,an,individual,mouse,(,***,indicates,p,<,0.0001,in,a,one-way,ANOVA,test,followed,by,Bonferroni,corrections,),.}	{NULL}
journal.pone.0052370.pdf	279	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	280	{pone,.}	{NULL}
journal.pone.0052370.pdf	281	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	282	{gOO3}	{NULL}
journal.pone.0052370.pdf	283	{day,following,hydrodynamic,injection,of,control,plasmids,or,the,pApo-hIL-15,+,pSushi,combination,.}	{NULL}
journal.pone.0052370.pdf	284	{As,is,shown,in,ﬁgure,4,",",most,adoptively,transferred,cells,undergo,at,least,one,cycle,of,proliferation,in,response,to,gene,transfer,of,pApo-hILl5,+,pSushi,.}	{NULL}
journal.pone.0052370.pdf	285	{Therefore,",",proliferation,contributes,at,least,in,part,to,accumulation,of,such,lymphocytes,.}	{NULL}
journal.pone.0052370.pdf	286	{To,evaluate,the,induction,proliferation,on,endogenous,CD8,+,T,cells,and,NK,cells,",",we,performed,experiments,in,which,the,mice,were,treated,with,BrdU,and,splenocytes,stained,for,incorporation,of,this,compound,into,the,DNA,of,each,gated,lymphocyte,subset,.}	{NULL}
journal.pone.0052370.pdf	287	{As,it,can,be,seen,in,ﬁgure,S7,",",there,was,a,clear,stimulation,of,a,proliferative,response,in,both,endogenous,lymphocyte,subpopulations,upon,treatment,with,pApo-hILl5,+,pSushi,.}	{NULL}
journal.pone.0052370.pdf	288	{Gene,Co,—,transfer,of,APO,—,|,L,—,15,and,|,L,—,15Roc,Sushi,Domain,Partially,Rescues,the,NK,and,CD8,Phenotype,of,|,L,—,15Roc,"\\"",’,‘,Mice,IL-15,‘,/,',and,1L,—,15Rcx,',/,',mice,are,virtually,devoid,of,NK,and,NKT,cells,and,experience,a,drastic,reduction,in,CD8,memory,T,cells,[,"28,29",],.}	{NULL}
journal.pone.0052370.pdf	289	{We,intended,to,see,if,pApo-hIL-15,+,pSushi,liver,gene,transfer,could,modify,the,phenotype,of,ILl5ROl,_,/,_,mice,.}	{NULL}
journal.pone.0052370.pdf	290	{Figure,5,shows,the,normal,proportions,of,NK,and,CD8,cells,in,the,liver,of,WT,C57Bl/6,mice,.}	{NULL}
journal.pone.0052370.pdf	291	{IL-l5ROl,_,/,_,mice,",",even,if,transduced,with,pApo,control,plasmid,four,days,before,",",showed,negligible,levels,of,NK,(,CD3,_,NK1,.}	{NULL}
journal.pone.0052370.pdf	292	{l,*,),and,NKT,(,CD3,+,NKl,.}	{NULL}
journal.pone.0052370.pdf	293	{l,+,),cells,.}	{NULL}
journal.pone.0052370.pdf	294	{Transfer,of,phIL-15,and,pApo-hILl5,only,marginally,increased,these,numbers,.}	{NULL}
journal.pone.0052370.pdf	295	{However,",",the,combination,of,pApo-hIL1,5,+,pSushi,enhanced,the,number,of,N,K,cells,",",but,not,as,much,as,NKT,cells,.}	{NULL}
journal.pone.0052370.pdf	296	{These,results,were,reproducible,in,the,spleen,of,three,individual,mice,per,group,as,shown,in,ﬁgure,5B,.}	{NULL}
journal.pone.0052370.pdf	297	{Moreover,",",we,have,extended,these,results,to,IL-l5ROL,—,/,—,mice,in,B6129S2,background,using,ﬁve,mice,per,group,as,shown,in,ﬁgure,S8A,and,B.,In,this,background,",",the,recovery,of,CD8,T,cells,with,a,memory,phenotype,was,remarkable,and,NK,cells,",",at,least,partially,recovered,in,most,cases,",",were,identiﬁed,as,NKP46,+,DX5,+,CD3,_,.}	{NULL}
journal.pone.0052370.pdf	298	{We,performed,these,experiments,also,with,a,plasmid,encoding,a,full,length,pIL-15Roc,instead,of,only,the,sushi,domain,.}	{NULL}
journal.pone.0052370.pdf	299	{As,can,be,seen,in,ﬁgure,S8C,",",pSushi,was,superior,to,pIL-l5Rcx,indicating,that,a,sequence,upstream,the,sushi,domain,somehow,interferes,with,trans-presentation,as,suggested,by,previous,reports,[,"14,42",],.}	{NULL}
journal.pone.0052370.pdf	300	{Therapeutic,Effects,of,Liver,Gene,Co,—,transfer,with,APO,|,L,—,15,and,|,L,—,15Roc,Sushi,Domain,on,Subcutaneously,and,lntrasplenically,Injected,MC38,Colon,Cancer,Cells,Based,on,the,observation,of,biological,activity,",",we,performed,a,series,of,experiments,in,mice,grafted,for,six,days,with,subcutaneous,MC38-derived,colon,carcinomas,.}	{NULL}
journal.pone.0052370.pdf	301	{As,can,be,seen,in,ﬁgure,6,",",a,combination,of,pApo-hILl5,+,pSushi,resulted,in,7,out,of,26,complete,rejections,with,an,overall,delay,in,tumor,growth,when,compared,to,control,groups,.}	{NULL}
journal.pone.0052370.pdf	302	{pApo-hILl5,cured,3,out,of,14,animals,while,phILl5,+,pSushi,only,1,in,10,.}	{NULL}
journal.pone.0052370.pdf	303	{In,the,case,ofpApo,Ain,“}	{NULL}
journal.pone.0052370.pdf	304	{m,‘,pApO,—,h,|,L,—,1,5,+,pSushi,mpApo,"\\"",:,h,|,LA,‘,f,%,+,pwéushi,“}	{NULL}
journal.pone.0052370.pdf	305	{w,"\\""}	{NULL}
journal.pone.0052370.pdf	306	{/,9,CD8,+,CD45,.1,',CFSE,',°,‘,"\\"",',cells,m,’,to,‘,m,‘}	{NULL}
journal.pone.0052370.pdf	307	{50,“,la,NK1,.1,+,CD3,',CD45,.1,',CFSE,',°,‘,"\\"",cells}	{NULL}
journal.pone.0052370.pdf	308	{Figure,4,.}	{NULL}
journal.pone.0052370.pdf	309	{APO-IL-15,and,IL-1,5Ra,sushi,domain,gene,co-transfer,induces,proliferation,of,adoptively,transferred,CD8,and,NK,lymphocytes,.}	{NULL}
journal.pone.0052370.pdf	310	{Mice,were,gene,—,transferred,by,hydrodynamic,injections,of,the,indicated,plasmids,which,were,24,h,later,intravenously,injected,with,CD8,+,T,cells,or,NK1,.1,*,NK,cells,preloaded,with,CFSE,.}	{NULL}
journal.pone.0052370.pdf	311	{Proliferation,was,monitored,by,CFSE,dilution,of,the,indicated,electronically,gated,lymphocyte,subsets,(,dot,plots,A,and,C,),.}	{NULL}
journal.pone.0052370.pdf	312	{Results,pooled,from,two,independent,experiments,included,two,mice,per,experimental,group,(,B,and,D,),.}	{NULL}
journal.pone.0052370.pdf	313	{Figure,57,shows,proliferative,effects,on,endogenous,lymphocytes,studied,by,BrdU,intake,.}	{NULL}
journal.pone.0052370.pdf	314	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	315	{pone,.}	{NULL}
journal.pone.0052370.pdf	316	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	317	{gOO4}	{NULL}
journal.pone.0052370.pdf	318	{I,",",one,mouse,rejected,a,tumor,that,could,be,related,to,the,recently,described,non,immune,anti-tumor,actions,of,Apo,A-I,[,43,],.}	{NULL}
journal.pone.0052370.pdf	319	{Therapeutic,effects,resulted,in,extended,survival,as,shown,in,ﬁgure,6B,.}	{NULL}
journal.pone.0052370.pdf	320	{Since,our,gene,transfers,are,phenomena,conﬁned,to,some,extent,to,the,liver,",",it,was,conceivable,that,if,MC38,were,injected,into,the,spleen,to,metastize,to,the,liver,via,the,portal,vein,",",a,more,prominent,therapeutic,effect,could,then,appear,.}	{NULL}
journal.pone.0052370.pdf	321	{Indeed,",",if,mice,that,had,been,gene,transferred,on,day,l,were,euthanized,on,day,19,after,tumor,cell,inoculation,",",the,number,of,observable,liver,metastases,was,drastically,reduced,by,all,the,plasmids,encoding,ILl5,",",but,not,by,the,pApo,A-I,expression,plasmid,.}	{NULL}
journal.pone.0052370.pdf	322	{In,the,case,of,pApo-hILl5,+,pSushi,",",5,out,of,6,mice,were,free,of,metastatic,lesions,on,the,liver,surface,(,ﬁgure,7,),.}	{NULL}
journal.pone.0052370.pdf	323	{Moreover,",",observations,of,the,spleen,tumors,(,measured,as,spleen,weight,/,mouse,weight,),indicated,that,pApo-hILl5,+,pSushi,also,markedly,retarded,the,tumor,at,the,primary,site,of,malignant,cell,inoculation,(,ﬁgure,7B,with,inset,photographs,of,representative,spleen,tumors,),.}	{NULL}
journal.pone.0052370.pdf	324	{The,pApo-hIL15,(,without,pSushi,),and,phIL15,+,pSushi,(,without,fusion,to,Apo,A-I,),showed,a,more,partial,effect,on,the,splenic,tumors,as,well,.}	{NULL}
journal.pone.0052370.pdf	325	{The,role,of,the,cellular,immune,system,in,these,antitumor,effects,was,conﬁrmed,because,selective,depletions,with,antibodies,against,CD85,",",CD4,or,NK,cells,hampered,the,therapeutic,effects,on,the,liver,metastases,(,data,not,shown,),.}	{NULL}
journal.pone.0052370.pdf	326	{As,a,whole,",",these,APO-IL-15,chimeric,constructions,transiently,expressed,by,the,liver,give,rise,to,therapeutic,effects,",",which,become,candidates,for,improvement,by,means,of,combinatorial,strategies,[,44,],.}	{NULL}
journal.pone.0052370.pdf	327	{Discussion}	{NULL}
journal.pone.0052370.pdf	328	{This,study,intended,to,generate,more,stable,and,bioactive,forms,of,IL-15,by,incorporation,into,lipoproteins,.}	{NULL}
journal.pone.0052370.pdf	329	{Hydrodynamic,injections,offer,a,versatile,technical,opportunity,to,test,these,new,agents,without,the,need,for,cumbersome,protein,bio-production,and,puriﬁcation,procedures,[,"45,46",],.}	{NULL}
journal.pone.0052370.pdf	330	{In,our,case,",",the,advantage,was,obvious,because,we,are,able,to,achieve,the,synthesis,of,our,protein,in,the,actual,organ,which,produces,HDL,.}	{NULL}
journal.pone.0052370.pdf	331	{Even,though,liver,gene,transfer,faces,obstacles,for,clinical,translation,",",it,is,certainly,a,clinical,alternative,to,be,considered,since,it,might,be,feasible,and,cost,/,effective,[,"18,46",],.}	{NULL}
journal.pone.0052370.pdf	332	{The,idea,of,using,Apo,A-I,fusions,was,originally,used,by,our,group,to,stabilize,interferon,cx,[,33,],.}	{NULL}
journal.pone.0052370.pdf	333	{In,the,case,of,IL-15,",",this,idea,is,pApo,lL-15Ra,"\\"",'}	{NULL}
journal.pone.0052370.pdf	334	{pApo,—,h,|,L15,ph,|,L15,+,psushi,pApo,—,hlL15,+,psushi}	{NULL}
journal.pone.0052370.pdf	335	{NK,‘,l.,1}	{NULL}
journal.pone.0052370.pdf	336	{CD3}	{NULL}
journal.pone.0052370.pdf	337	{D,3,“,4,9,-,:,M,E,E,3,2,3,%,E,:,:,L,",",.}	{NULL}
journal.pone.0052370.pdf	338	{_,.}	{NULL}
journal.pone.0052370.pdf	339	{‘,=,_,5,>,2,2,2,E,*,1,‘,**,8,g,I,o,1,2,1,E,32,**,i,',iii,iii,‘,:3,u,o,9,3,',3,5,o,"\\"",3,.}	{NULL}
journal.pone.0052370.pdf	340	{"{","\\\\","\\\\",.}	{NULL}
journal.pone.0052370.pdf	341	{°,"\\\\",ab,Q,°,',5,’,1,*,‘,‘,£,5,¢,;,>,‘,°,QV9,"\\\\",$,>,.}	{NULL}
journal.pone.0052370.pdf	342	{.}	{NULL}
journal.pone.0052370.pdf	343	{—,.}	{NULL}
journal.pone.0052370.pdf	344	{",",",",o,"\\"","9,9",”,(,«,*,2,<,2,"\\"",.}	{NULL}
journal.pone.0052370.pdf	345	{*,>,‘,"\\\\",',9,°,?}	{NULL}
journal.pone.0052370.pdf	346	{9,°,‘,:,056,v,&,°,’,*,9,‘,Q,~,39,‘,V90,~,=,:,"\\"",Q,cfq,'}	{NULL}
journal.pone.0052370.pdf	347	{o,‘,a,Q,-,.}	{NULL}
journal.pone.0052370.pdf	348	{N,Q,Qo,’,Q,V90,9,*,9}	{NULL}
journal.pone.0052370.pdf	349	{Figure,5,.}	{NULL}
journal.pone.0052370.pdf	350	{Partial,rescue,of,the,phenotype,of,IL-1,5Ra,"\\"",',15Ro,(,”}	{NULL}
journal.pone.0052370.pdf	351	{mice,in,NK,cells,and,memory-phenotype,CD8,cells,.}	{NULL}
journal.pone.0052370.pdf	352	{WT,C57B,|,/,6,mice,(,WT,),or,ILsyngenic,mice,(,|,L,—,15Rot,”’,),were,injected,with,the,indicated,plasmids,by,hydrodynamic,injection,.}	{NULL}
journal.pone.0052370.pdf	353	{Four,days,later,splenocytes,were,immunostained,.}	{NULL}
journal.pone.0052370.pdf	354	{(,A,),CD3,+,CD8,+,dot,plots,with,the,percentage,of,events,in,the,gated,rectangles,.}	{NULL}
journal.pone.0052370.pdf	355	{Results,reflect,the,percentage,referred,to,total,spenocytes,(,B,),Histograms,showing,CD44,specific,immunofluorescence,on,the,cells,gated,in,A,to,assess,the,percentage,of,CD44,“‘,9,"\\"",CD8,+,memoryphenotype,T,cells,.}	{NULL}
journal.pone.0052370.pdf	356	{(,C,),CD3,NK1,.1,double,staining,showing,the,percentage,of,events,in,each,dot,plot,quadrant,.}	{NULL}
journal.pone.0052370.pdf	357	{Histograms,and,dot,plots,were,taken,from,a,representative,individual,mouse,.}	{NULL}
journal.pone.0052370.pdf	358	{(,D,),Grouped,sets,of,data,from,other,individuals,.}	{NULL}
journal.pone.0052370.pdf	359	{Confirmatory,results,in,a,series,of,mice,in,B6129,background,are,presented,in,figure,58,.}	{NULL}
journal.pone.0052370.pdf	360	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	361	{pone,.}	{NULL}
journal.pone.0052370.pdf	362	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	363	{gOO5}	{NULL}
journal.pone.0052370.pdf	364	{likely,to,be,more,suitable,since,IL-15,is,trans-presented,[,"12,22",],.}	{NULL}
journal.pone.0052370.pdf	365	{In,essence,",",trans-presentation,can,be,conceived,to,involve,cell,surface,lipid,bilayers,and,IL-l5RoL,[,1,"1,4247",],.}	{NULL}
journal.pone.0052370.pdf	366	{Both,conditions,could,be,mimicked,to,some,extent,by,the,surface,of,an,HDL,lipoparticle,",",if,IL-l5Rcx,is,complexed,there,to,IL-15,.}	{NULL}
journal.pone.0052370.pdf	367	{Therefore,",",IL-15,could,not,only,be,stabilized,but,also,become,more,bioactive,",",taking,advantage,in,this,way,of,its,physiological,mechanisms,of,action,that,depend,on,trans-presentation,.}	{NULL}
journal.pone.0052370.pdf	368	{It,is,of,note,that,APO-IL-15}	{NULL}
journal.pone.0052370.pdf	369	{complexes,only,in,part,to,HDL,",",so,the,free,protein,and,the,particle,absorbed,forms,coexist,in,circulation,",",and,maybe,in,equilibrium,",",although,once,complexed,APO-IL-15,tends,to,remain,attached,to,HDL,at,body,temperature,.}	{NULL}
journal.pone.0052370.pdf	370	{A,series,of,studies,had,reported,that,the,sushi,domain,region,of,IL-l5ROL,was,required,for,trans-presentation,and,that,the,isolated,sushi,domain,performs,even,more,actively,than,the,whole,ILl5Roc,protein,for,this,cooperative,function,[,1,3,",",14,",",15,],",",hence}	{NULL}
journal.pone.0052370.pdf	371	{A,pApo,pApo-hIL15,3,.}	{NULL}
journal.pone.0052370.pdf	372	{’14,(,21.4,%,)}	{NULL}
journal.pone.0052370.pdf	373	{sea,500}	{NULL}
journal.pone.0052370.pdf	374	{N,300,E,E,200}	{NULL}
journal.pone.0052370.pdf	375	{mo}	{NULL}
journal.pone.0052370.pdf	376	{o,o,40,so}	{NULL}
journal.pone.0052370.pdf	377	{Days}	{NULL}
journal.pone.0052370.pdf	378	{Ph,"\\"",-15,+,P3UShi,pApo-h,|,L-15,+,psushi,"\\""}	{NULL}
journal.pone.0052370.pdf	379	{10,(,10,%,),mo,7/25,(,26.9,%,)}	{NULL}
journal.pone.0052370.pdf	380	{sou}	{NULL}
journal.pone.0052370.pdf	381	{N,3,N,E,E,200,E,200}	{NULL}
journal.pone.0052370.pdf	382	{me,100}	{NULL}
journal.pone.0052370.pdf	383	{o,a,',g,+,o,20,40,so,o,20,40,so,so}	{NULL}
journal.pone.0052370.pdf	384	{D3,???}	{NULL}
journal.pone.0052370.pdf	385	{Days}	{NULL}
journal.pone.0052370.pdf	386	{_,so,-,I,-,pApo-h,|,L15,+,pSushi,(,n,=,26,),g,-3,-,pApo-h,|,],_,15,(,n,=,14,),E,so,+,phlL15,+,pSu5hi,(,n,=,10,),‘,E,-,o,-,pApo,(,n,=,21,),g,4D,o,n.}	{NULL}
journal.pone.0052370.pdf	387	{El,o,20,40,ED,80}	{NULL}
journal.pone.0052370.pdf	388	{Days}	{NULL}
journal.pone.0052370.pdf	389	{Figure,6,.}	{NULL}
journal.pone.0052370.pdf	390	{Immunotherapeutic,activity,of,liver,gene,transfer,with,the,APO-IL-15,constructions,for,established,subcutaneous,MC38,tumors,.}	{NULL}
journal.pone.0052370.pdf	391	{MC38,bearing,mice,were,treated,on,day,six,after,tumor,cell,inoculation,with,10,ug,ofthe,indicated,plasmids,by,hydrodynamic,injection,.}	{NULL}
journal.pone.0052370.pdf	392	{(,A,),Individual,follow,—,up,of,tumor,sizes,upon,treatment,with,each,plasmid,.}	{NULL}
journal.pone.0052370.pdf	393	{Graphics,represent,pooled,data,from,3,independent,experiments,.}	{NULL}
journal.pone.0052370.pdf	394	{Fraction,of,surviving,mice,is,indicated,for,each,experimental,group,.}	{NULL}
journal.pone.0052370.pdf	395	{Differences,in,tumor,growth,between,the,pApo,—,h,|,L15,+,pSushi,and,the,pApo,group,were,found,(,p,<,0.001,),in,a,nonlinear,mixed,effect,model,calculated,with,Monolix,software,.}	{NULL}
journal.pone.0052370.pdf	396	{(,B,),Survival,curves,of,the,experimental,groups,from,panel,A,(,*,indicates,p,<,0.05,between,pApo,—,h,|,L15,+,pSushi,and,pApo,in,a,Gehan,.}	{NULL}
journal.pone.0052370.pdf	397	{—,.}	{NULL}
journal.pone.0052370.pdf	398	{Bres,|,ow,.}	{NULL}
journal.pone.0052370.pdf	399	{—,.}	{NULL}
journal.pone.0052370.pdf	400	{Wi,|,coxon,Survival,Test,),.}	{NULL}
journal.pone.0052370.pdf	401	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	402	{pone,.}	{NULL}
journal.pone.0052370.pdf	403	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	404	{gOO6}	{NULL}
journal.pone.0052370.pdf	405	{giving,a,reason,for,our,choice,of,this,protein,domain,.}	{NULL}
journal.pone.0052370.pdf	406	{Our,results,indicate,that,the,complex,pApo-hILl5,:,pSushi,domain,is,stable,and,bioactive,on,NK,and,T,cells,in,vivo,.}	{NULL}
journal.pone.0052370.pdf	407	{The,effects,of,gene,transfer,were,able,to,correct,in,part,the,immune,phenotype,of,IL-l5ROL,_,/,_,mice,which,have,reduced,CD8,+,memory-phenotype,T,lymphocytes,and,virtually,no,NK,or,NKT,cells,.}	{NULL}
journal.pone.0052370.pdf	408	{These,ﬁndings,underscore,the,biological,potency,of,the,constructions,.}	{NULL}
journal.pone.0052370.pdf	409	{Our,strategy,has,readily,observed,biological,effects,.}	{NULL}
journal.pone.0052370.pdf	410	{However,",",direct,side,by,side,comparisons,to,other,complexes,of,IL-15,such,as,the,IL-l5Roc-Fc,conjugates,[,"19,21",],or,other,previously,reported,constructs,linking,IL-15,to,IL-l5ROL,[,42,],need,to,be,carried,out,both,in,terms,of,pharmacokinetics,and,pharmacodynamics,experiments,.}	{NULL}
journal.pone.0052370.pdf	411	{Indeed,",",our,data,with,pAlbumin-hILl5,suggest,that,this,fusion,partner,stabilizes,IL-15,pharmacokinetics,to,a,comparable,extent,",",albeit,the,biodistribution,and,biological,propierties,may,be,quiet,different,.}	{NULL}
journal.pone.0052370.pdf	412	{Future,research,is,required,to,optimize,liver,gene,transfer,and,comparisons,with,the,corresponding,recombinant,proteins,are,a,must,to,ascertain,the,translational,potential,of,these,strategies,.}	{NULL}
journal.pone.0052370.pdf	413	{Using,gene,therapy,and,the,liver,to,create,a,factory,of,proteins,that,complex,into,HDL,has,the,advantage,of,using,the,natural,routes,of,biosynthesis,.}	{NULL}
journal.pone.0052370.pdf	414	{However,",",the,alternative,of,exogenously,provided,recombinant,proteins,is,deemed,more,feasible,for,translation,.}	{NULL}
journal.pone.0052370.pdf	415	{In,any,case,hydrodynamic,gene,transfers,",",although,so,far,not,translatable,to,humans,",",have,provided,important,information,on,the,pharmacokinetics,and,bioactivity,of,these,new,constructions,.}	{NULL}
journal.pone.0052370.pdf	416	{Indeed,",",although,recombinant,fusion,proteins,are,our,preferred,approach,to,be,translated,into,the,clinic,",",we,are,further,exploring,the,potential,of,liver,gene,transfer,with,gutless,adenoviral,vectors,.}	{NULL}
journal.pone.0052370.pdf	417	{Interestingly,",",Apo,A-I,fusion,cytokines,incorporated,to,HDL,do,not,impair,the,anti-inﬂammatory,an,cholesterol,transporting,functions,of,the,HDL,fractions,",",at,least,at,the,relative,quantities,generated,in,our,studies,.}	{NULL}
journal.pone.0052370.pdf	418	{This,has,important,implications,for,the,kid,:}	{NULL}
journal.pone.0052370.pdf	419	{E}	{NULL}
journal.pone.0052370.pdf	420	{_,;,UI,Metastasis,number,3}	{NULL}
journal.pone.0052370.pdf	421	{Figure,7,.}	{NULL}
journal.pone.0052370.pdf	422	{Antitumor,effects,following,the,transfer,of,IL-15,constructions,against,MC38,tumors,metastatic,to,the,liver,.}	{NULL}
journal.pone.0052370.pdf	423	{Mice,injected,intraesplenically,with,5x105,MC38,cells,upon,Iaparotomy,were,treated,by,hydrodynamic,injections,of,the,indicated,plasmids,one,day,later,.}	{NULL}
journal.pone.0052370.pdf	424	{On,day,19,mice,were,euthanized,and,(,A,),liver,surface,was,inspected,to,count,macroscopic,metastases,observed,in,the,surface,of,the,liver,under,magnifying,lens,and,data,are,represented,on,individual,basis,(,***,indicates,p,<,0.0001,between,pApo,—,h,|,L15,+,pSushi,and,the,rest,of,the,groups,in,Bonferroni,test,following,one-way,ANOVA,test,),.}	{NULL}
journal.pone.0052370.pdf	425	{(,B,),The,weights,of,the,spleens,that,also,grafted,tumors,were,recorded,.}	{NULL}
journal.pone.0052370.pdf	426	{Representative,images,of,spleen,tumors,in,the,indicated,groups,are,provided,.}	{NULL}
journal.pone.0052370.pdf	427	{The,experiment,shown,is,representative,of,two,similarly,performed,(,*,indicates,p,<,0.05,between,pApo,—,h,|,L15,+,pSushi,and,pApo,groups,in,a,t,—,student,test,),.}	{NULL}
journal.pone.0052370.pdf	428	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0052370.pdf	429	{pone,.}	{NULL}
journal.pone.0052370.pdf	430	{OO52370,.}	{NULL}
journal.pone.0052370.pdf	431	{gOO7}	{NULL}
journal.pone.0052370.pdf	432	{overall,strategy,since,as,a,result,these,agents,are,unlikely,to,result,in,increased,cardiovascular,risk,.}	{NULL}
journal.pone.0052370.pdf	433	{IL-15,is,being,tested,in,patients,as,a,monotherapy,for,melanoma,and,renal,cell,carcinoma,in,a,dose,escalating,clinical,trial,(,NCT0lO2lO59,),.}	{NULL}
journal.pone.0052370.pdf	434	{However,the,use,of,IL-15,is,more,attractive,when,combined,to,adoptive,T,cell,therapy,[,19,],",",vaccines,[,"20,21",],or,immunostimulatory,mAb,[,48,],.}	{NULL}
journal.pone.0052370.pdf	435	{"\\\\",/,V,e,are,currently,testing,various,combinatorial,approaches,that,include,our,APO-IL-I5,constructs,.}	{NULL}
journal.pone.0052370.pdf	436	{In,a,sense,",",the,antitumor,effects,observed,under,our,conditions,of,treatment,are,less,efficacious,than,what,we,had,predicted,based,on,the,intense,proliferative,effects,on,NK,and,T,cells,.}	{NULL}
journal.pone.0052370.pdf	437	{However,",",MC38,is,a,difficult-to-treat,tumor,model,[,49,],and,therefore,",",reaching,more,than,25,%,curative,efficacy,in,monotherapy,against,6-day,established,MC38,tumors,is,a,remarkable,achievement,",",which,would,be,",",for,instance,",",comparable,to,what,agonist,antiCD137,mAb,attain,in,the,same,context,[,50,],.}	{NULL}
journal.pone.0052370.pdf	438	{The,experiments,in,mice,bearing,liver,MC38,tumors,are,illustrative,of,the,local,potency,of,the,approach,against,metastatic,disease,and,are,conceivably,associated,to,the,fact,of,in,situ,activation,of,intrahepatic,lymphocytes,.}	{NULL}
journal.pone.0052370.pdf	439	{However,we,have,observed,that,these,numeric,increases,of,lymphocytes,at,such,organ,do,not,correlate,with,brighter,expression,of,effector,or,activation-denoting,molecules,(,data,not,shown,),.}	{NULL}
journal.pone.0052370.pdf	440	{Therefore,",",the,provision,in,combinatorial,immunotherapies,of,therapeutic,tools,to,enhance,tumoricidal,activity,on,cell,per,cell,basis,is,guiding,our,next,steps,(,MC,Ochoa,et,al.,unpublished,results,),.}	{NULL}
journal.pone.0052370.pdf	441	{In,any,case,",",it,is,of,note,that,unresectable,liver,metastases,of,colon,cancer,constitute,a,major,unmet,therapeutic,need,and,that,our,results,show,evidence,for,therapeutic,efficacy,in,difficult,to,treat,mouse,models,.}	{NULL}
journal.pone.0052370.pdf	442	{All,in,all,",",we,have,constructed,chimeric,IL-15,variants,that,are,incorporated,at,least,in,part,into,HDL,.}	{NULL}
journal.pone.0052370.pdf	443	{In,our,experiments,",",we,took,advantage,of,IL-15,trans-presentation,by,the,sushi,domain,of,IL-l5Rcx,to,attain,stronger,bioactivity,.}	{NULL}
journal.pone.0052370.pdf	444	{Partial,antitumor,efficacy,as,a,monotherapy,strongly,advocates,for,further,development,with,combinatorial,approaches,",",both,in,terms,of,adding,other,immunotherapeutic,agents,and,in,terms,of,further,engineering,the,cytokine,transgene,products,to,be,built,into,HDL,.}	{NULL}
journal.pone.0052370.pdf	445	{Supporting,Information}	{NULL}
journal.pone.0052370.pdf	446	{Figure,S1,Schematic,representation,of,the,plasniids,used,for,hydrodynamic,injections,.}	{NULL}
journal.pone.0052370.pdf	447	{pcDNA3.l-based,expression,plasmids,were,engineered,to,encode,for,cassettes,of,expression,encompassing,Apo,A-I,lipoprotein,",",Apo,A-I,fused,to,human,IL-15,and,the,sushi,domain,of,IL-l5RoL,.}	{NULL}
journal.pone.0052370.pdf	448	{Human,IL-15,was,cloned,in,a,pIRESlneo,-,based,plasmid,(,TIF,)}	{NULL}
journal.pone.0052370.pdf	449	{Figure,S2,Expression,of,Sushi,mRNA,in,the,liver,of,mice,receiving,hydrodynaxnic,injections,with,pApo-hILl5,and,the,pla,.}	{NULL}
journal.pone.0052370.pdf	450	{mid,encoding,the,IL-l5Ra,sushi,domain,.}	{NULL}
journal.pone.0052370.pdf	451	{Mice,received,lo,ug,of,pApo-hILl5,or,pApo-hILl5,+,pSushi,by,hydrodynamic,injection,and,12,h,following,treatment,",",livers,were,harvested,and,expression,of,Sushi,mRNA,was,studied,by,quantitative,RT-PCR,normalized,to,B-actin,.}	{NULL}
journal.pone.0052370.pdf	452	{Data,from,2,mice,per,group,are,presented,.}	{NULL}
journal.pone.0052370.pdf	453	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	454	{Figure,S3,Similar,kinetics,of,hIL-15,serunm,concentrations,in,mice,hydrodynaniically,gene-transferred,with,pAlbumin-hILl5,and,pApo-hILl5,.}	{NULL}
journal.pone.0052370.pdf	455	{C56Bl,/,6,mice,received,a,hydrodynamic,injection,with,10,ug,of,a,construction,coding,for,a,protein,encompassing,albumin,and,hIL-I5,or,pApo-hILl5,.}	{NULL}
journal.pone.0052370.pdf	456	{Sera,were,obtained,at,the,indicated,times,and,hIL-15,concentrations,were,measured,by,ELISA,.}	{NULL}
journal.pone.0052370.pdf	457	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	458	{Figure,S4,HDL-fractions,from,pApo-hILl5,injected,niice,preserve,their,normal,physiological,functions,.}	{NULL}
journal.pone.0052370.pdf	459	{(,A,),The,endothelial,Py4-l,cell,line,was,cultured,in,presence,or,absence,of,TNF-or,for,4,h,and,later,incubated,or,not,overnight,with,HDL,from,mice,injected,with,pApo,or,pApo-hILl5,.}	{NULL}
journal.pone.0052370.pdf	460	{Expression,of,VCAM,was,examined,by,ﬂow,eytometry,.}	{NULL}
journal.pone.0052370.pdf	461	{(,B,),3T3,Ll,cells,were,loaded,by,incubation,with,3H-cholesterol,and,then,HDLs,from,mice,treated,with,pApo,",",pApo-hILl5,or,pApohILl5,+,pSushi,were,added,to,the,culture,.}	{NULL}
journal.pone.0052370.pdf	462	{Cholesterol,eﬂlux,was,measured,as,3H,cpms,in,the,culture,supernatans,.}	{NULL}
journal.pone.0052370.pdf	463	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	464	{Figure,S5,Percentage,of,CD8,and,NK,cells,in,spleen,",",liver,and,blood,increases,in,response,to,liver,gene,cotransfer,of,Apo-IL-l5,and,IL-l5Ra,sushi,domain,.}	{NULL}
journal.pone.0052370.pdf	465	{Time,course,analyses,of,cell,suspensions,from,spleen,(,A,),",",liver,(,B,),and,blood,(,C,),deﬁning,the,percentages,of,lymphocyte,subsets,at,the,indicated,time,points,(,*,indicates,p,<,0.05,and,**,p,<,o.,ol,between,pApo-hILl5,+,pSushi,and,phIL15,+,pSushi,group,in,a,Bonferroni,test,following,two-way,ANOVA,test,with,p,<,o.,oool,),.}	{NULL}
journal.pone.0052370.pdf	466	{This,experiment,is,representative,of,two,performed,with,2,—,3,mice,for,each,time,point,.}	{NULL}
journal.pone.0052370.pdf	467	{In,(,B,),mice,were,sequentially,followed,.}	{NULL}
journal.pone.0052370.pdf	468	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	469	{Figure,S6,Apo-IL-15,and,IL-l5Ra,sushi,domain,gene,transfer,to,the,liver,increases,NK,activity,in,the,spleen,.}	{NULL}
journal.pone.0052370.pdf	470	{Natural,cytotoxicity,of,spleen,cells,against,the,classical,NK,target,Yac-l,at,the,indicated,E,:,T,ratios,.}	{NULL}
journal.pone.0052370.pdf	471	{Effector,cells,were,obtained,from,mice,treated,3,days,earlier,with,the,indicated,plasmids,or,plamid,combination,.}	{NULL}
journal.pone.0052370.pdf	472	{Data,are,from,one,representative,experiment,out,of,two,performed,.}	{NULL}
journal.pone.0052370.pdf	473	{Each,experiment,was,performed,with,two,mice,per,group,and,rendered,similar,results,.}	{NULL}
journal.pone.0052370.pdf	474	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	475	{Figure,S7,Apo-IL-15,and,IL-l5Ra,sushi,domain,gene,transfer,to,the,liver,induces,the,proliferation,CD8,and,NK,lymphocytes,measured,by,BrdU,incorporation,.}	{NULL}
journal.pone.0052370.pdf	476	{Mice}	{NULL}
journal.pone.0052370.pdf	477	{References}	{NULL}
journal.pone.0052370.pdf	478	{1,.}	{NULL}
journal.pone.0052370.pdf	479	{Cheever,l,"\\\\",’,IA,",",Allison,JP,",",Ferris,AS,",",Finn,OJ,",",Hastings,BN1,",",et,al.,(,2009,),The,prioritization,of,cancer,antigens,:,a,national,cancer,institute,pilot,project,for,the,acceleration,of,translational,research,.}	{NULL}
journal.pone.0052370.pdf	480	{Clin,Cancer,Res,15,:,5323,+5337,.}	{NULL}
journal.pone.0052370.pdf	481	{2,.}	{NULL}
journal.pone.0052370.pdf	482	{"\\\\",/,Valdmann,TA,(,2006,),The,biology,of,interleukin-2,and,interleukin-15,:,implications,for,cancer,therapy,and,vaccine,design,.}	{NULL}
journal.pone.0052370.pdf	483	{Nat,Rev,Immunol,6,:,595,—,601,.}	{NULL}
journal.pone.0052370.pdf	484	{3,.}	{NULL}
journal.pone.0052370.pdf	485	{Oh,S,",",Perera,LP,",",Terabe,IVI,",",Ni,L,",",VValdmann,TA,",",et,al.,(,2008,),IL-15,as,a,mediator,of,CD4,+,help,for,CD8,+,T,cell,longevity,and,avoidance,of,TRAILmediated,apoptosis,.}	{NULL}
journal.pone.0052370.pdf	486	{Proc,Natl,Acad,Sci,U,S,A,105,:,5201,+5206,.}	{NULL}
journal.pone.0052370.pdf	487	{4,.}	{NULL}
journal.pone.0052370.pdf	488	{Goldrath,AVV,",",Sivakumar,PV,",",Glaccum,l,"\\\\",’,I,",",Kennedy,IVIK,",",Bevan,NIJ,",",et,al.,(,2002,),Cytokine,requirements,for,acute,and,Basal,homeostatic,proliferation,of,naive,and,memory,CD8,+,T,cells,.}	{NULL}
journal.pone.0052370.pdf	489	{J,Exp,l,"\\\\",’,Ied,195,:,1515,+1522,.}	{NULL}
journal.pone.0052370.pdf	490	{5,.}	{NULL}
journal.pone.0052370.pdf	491	{Fehniger,TA,",",Suzuki,K,",",Ponnappan,A,",",V'anDeusen,JB,",",Cooper,IVIA,",",et,al.,(,2001,),Fatal,leukemia,in,interleukin,15,transgenic,mice,follows,early,expansions,in,natural,killer,and,memory,phenotype,CD8,+,T,cells,.}	{NULL}
journal.pone.0052370.pdf	492	{J,Exp,Nled,193,:,219,+,231,.}	{NULL}
journal.pone.0052370.pdf	493	{6,.}	{NULL}
journal.pone.0052370.pdf	494	{Carson,VVE,",",Giri,JG,",",Lindemann,IVIJ,",",Linett,l,"\\\\",’,IL,",",Ahdieh,l,"\\\\",’,I,",",et,al.,(,1994,),Interleukin,(,IL,),15,is,a,novel,cytokine,that,activates,human,natural,killer,cells,via,components,of,the,IL-2,receptor,.}	{NULL}
journal.pone.0052370.pdf	495	{J,Exp,Med,180,:,13954403,.}	{NULL}
journal.pone.0052370.pdf	496	{7,.}	{NULL}
journal.pone.0052370.pdf	497	{VValdmann,TA,",",Tagaya,Y,(,1999,),The,multifaceted,regulation,of,interleukin-15,expression,and,the,role,of,this,cytokine,in,NK,cell,differentiation,and,host,response,to,intracellular,pathogens,.}	{NULL}
journal.pone.0052370.pdf	498	{Annu,Rev,Immunol,17,:,19,+49,.}	{NULL}
journal.pone.0052370.pdf	499	{8,.}	{NULL}
journal.pone.0052370.pdf	500	{Huntington,ND,",",Legrand,N,",",Alves,NL,",",Jaron,B,",",VVeijer,K,",",et,al.,(,2009,),IL-15,trans-presentation,promotes,human,NK,cell,development,and,differentiation,in,vivo,.}	{NULL}
journal.pone.0052370.pdf	501	{J,Exp,l,"\\\\",’,Ied,206,:,25,+34,.}	{NULL}
journal.pone.0052370.pdf	502	{9,.}	{NULL}
journal.pone.0052370.pdf	503	{Kobayashi,H,",",Dubois,S,",",Sato,N,",",Sabzevari,H,",",Sakai,Y,",",et,al.,(,2005,),Role,of,trans-cellular,IL-15,presentation,in,the,activation,of,NK,cell-mediated,killing,",",which,leads,to,enhanced,tumor,immunosurveillance,.}	{NULL}
journal.pone.0052370.pdf	504	{Blood,105,:,721,—,727,.}	{NULL}
journal.pone.0052370.pdf	505	{Nlignot,G,",",Ullrich,E,",",Bonmort,l,"\\\\",’,I,",",l,"\\\\",’,Ienard,C,",",Apetoh,L,",",et,al.,(,2008,),The,critical,role,of,IL-15,in,the,antitumor,effects,mediated,by,the,combination,therapy,imatinib,and,IL-2,.}	{NULL}
journal.pone.0052370.pdf	506	{J,Immunol,180,:,6477,—,6483,.}	{NULL}
journal.pone.0052370.pdf	507	{11,.}	{NULL}
journal.pone.0052370.pdf	508	{Dubois,S,",","l\\\\/Iariner",J,",",VValdmann,TA,",",Tagaya,Y,(,2002,),IL-15Ralpha,recycles,and,presents,IL-15,In,trans,to,neighboring,cells,.}	{NULL}
journal.pone.0052370.pdf	509	{Immunity,17,:,537,+547,.}	{NULL}
journal.pone.0052370.pdf	510	{were,gene-transferred,by,hydrodynamic,injections,of,the,indicated,plasmids,.}	{NULL}
journal.pone.0052370.pdf	511	{Subsequently,three,daily,ip,doses,of,BrdU,were,provided,.}	{NULL}
journal.pone.0052370.pdf	512	{Incorporation,of,BrdU,to,DNA,was,measured,at,72,h,since,the,gene,transference,by,immunostaining,and,ﬂowcytometry,.}	{NULL}
journal.pone.0052370.pdf	513	{Gating,strategy,(,A,and,C,),and,data,of,an,experiment,with,two,mice,per,group,(,B,and,D,),are,showed,.}	{NULL}
journal.pone.0052370.pdf	514	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	515	{Figure,S8,NK,and,CD8,memory-phenotype,T,cells,augment,in,IL15Ra,—,/,-,mice,on,a,B6l29S,background,upon,combined,liver,gene,transfer,of,pApo-IL-15,and,pSushi,.}	{NULL}
journal.pone.0052370.pdf	516	{(,A,and,B,),B6l29S,VVT,and,syngenic,IL15Roc,.}	{NULL}
journal.pone.0052370.pdf	517	{—,.}	{NULL}
journal.pone.0052370.pdf	518	{/,mice,were,treated,by,hydrodynamic,injections,of,the,indicated,plasmids,3,times,every,7,days,.}	{NULL}
journal.pone.0052370.pdf	519	{At,day,25,mononuclear,leukocytes,from,the,spleen,were,immunostained,.}	{NULL}
journal.pone.0052370.pdf	520	{Dots,represent,individual,data,from,a,single,experiment,with,ﬁve,mice,per,group,.}	{NULL}
journal.pone.0052370.pdf	521	{(,C,),Represents,a,separate,experiment,as,in,A,/,B,that,compares,pSushi,with,a,full,length,ILl5Rcx,version,upon,coinjection,with,pApo-hIL15,to,rescue,the,NK,and,CD8,phenotype,of,IL-l5ROL,.}	{NULL}
journal.pone.0052370.pdf	522	{—,.}	{NULL}
journal.pone.0052370.pdf	523	{/,mice,.}	{NULL}
journal.pone.0052370.pdf	524	{(,TIF,)}	{NULL}
journal.pone.0052370.pdf	525	{Acknowledgments}	{NULL}
journal.pone.0052370.pdf	526	{W76,are,grateful,to,Elena,Ciordia,and,Eneko,Elizalde,for,excellent,animal,facility,management,",",to,Paul,"l\\\\/Iiller",for,editing,and,to,Nuria,Ardaiz,for,technical,assistance,.}	{NULL}
journal.pone.0052370.pdf	527	{Dr.,Bulfone-Paus,(,Borstel,),is,acknowledged,for,providing,the,pSushi-encoding,plasmid,and,for,scientiﬁc,discussion,.}	{NULL}
journal.pone.0052370.pdf	528	{"\\\\",47e,are,also,grateful,to,Dr.,Hans,Schreiber,(,University,of,Chicago,),for,hosting,IVICO,iI1,his,laboratory,and,providing,IL-l5RCL,—,/,—,mice,.}	{NULL}
journal.pone.0052370.pdf	529	{Author,Contributions}	{NULL}
journal.pone.0052370.pdf	530	{Conceived,and,designed,the,experiments,:,MCO,PB,IM,.}	{NULL}
journal.pone.0052370.pdf	531	{Performed,the,experiments,:,MCO,JF,ED,JME,AA,JD,CA,AP,"Al\\\\/I-K","Ol\\\\/I",SH-S,.}	{NULL}
journal.pone.0052370.pdf	532	{Analyzed,the,data,:,IM,PB,MCO,JP,SH-S,AA,JD,"Ol\\\\/I",.}	{NULL}
journal.pone.0052370.pdf	533	{Contributed,reageI1ts,/,materials,/,analysis,tools,:,ED,PB,.}	{NULL}
journal.pone.0052370.pdf	534	{Wlrote,the,paper,:,IVICO,PB,IIVI,.}	{NULL}
journal.pone.0052370.pdf	535	{Obtained,funding,:,IIVI,JP,PB,.}	{NULL}
journal.pone.0052370.pdf	536	{12,.}	{NULL}
journal.pone.0052370.pdf	537	{Sandau,IVIIVI,",",Schluns,KS,",",Lefrancois,L,",",Jameson,SC,(,2004,),Cutting,edge,:,transpresentation,of,IL-15,by,bone,marrow-derived,cells,necessitates,expression,of,IL-15,and,IL-15R,alpha,by,the,same,cells,.}	{NULL}
journal.pone.0052370.pdf	538	{J,Immunol,173,:,6537,—,6541,.}	{NULL}
journal.pone.0052370.pdf	539	{Lorenzen,I,",",Dingley,AJ,",",Jacques,Y,",",GrotzingerJ,(,2006,),The,structure,of,the,interleukin-15,alpha,receptor,and,its,implications,for,ligand,binding,.}	{NULL}
journal.pone.0052370.pdf	540	{J,Biol,Chem,281,:,664243647,.}	{NULL}
journal.pone.0052370.pdf	541	{VVei,X,",",Orchardson,NI,",",Gracie,JA,",",Leung,BP,",",Gao,B,",",et,al.,(,2001,),The,Sushi,domain,of,soluble,IL-15,receptor,alpha,is,essential,for,binding,IL-15,and,inhibiting,inflammatory,and,allogenic,responses,in,vitro,and,in,vivo,.}	{NULL}
journal.pone.0052370.pdf	542	{J,Immunol,167,:,277,—,282,.}	{NULL}
journal.pone.0052370.pdf	543	{Duitman,EH,",",Orinska,Z,",",Bulanova,E,",",Paus,R,",",Bulfone-Paus,S,(,2008,),How,a,cytokine,is,chaperoned,through,the,secretory,pathway,by,complexing,with,its,own,receptor,:,lessons,from,interleukin-15,(,IL-15,),/,IL-15,receptor,alpha,.}	{NULL}
journal.pone.0052370.pdf	544	{l,"\\\\",Iolecular,and,cellular,biology,28,:,4851,—,4861,.}	{NULL}
journal.pone.0052370.pdf	545	{Croce,l,"\\\\",’,I,",",l,"\\\\",’,Ieazza,R,",",Orengo,Al,"\\\\",’,I,",",Radic,L,",",De,Giovanni,B,",",et,al.,(,2005,),Sequential,immunogene,therapy,with,interleukin-12,-,and,interleukin15engineered,neuroblastoma,cells,cures,metastatic,disease,in,syngeneic,mice,.}	{NULL}
journal.pone.0052370.pdf	546	{Clin,Cancer,Res,11,:,735,—,742,.}	{NULL}
journal.pone.0052370.pdf	547	{Vera,IVI,",",Razquin,N,",",Prieto,J,",",Nlelero,I,",",Fortes,P,",",et,al.,(,2005,),Intratumoral,injection,of,dendritic,cells,transduced,by,an,SV40,—,based,vector,expressing,interleukin-15,induces,curative,immunity,mediated,by,CD8,+,T,lymphocytes,and,NK,cells,.}	{NULL}
journal.pone.0052370.pdf	548	{Mol,Ther,12,:,950,+959,.}	{NULL}
journal.pone.0052370.pdf	549	{Chang,Cl,"\\\\",’,I,",",Lo,CH,",",Shih,Yl,"\\\\",’,I,",",Chen,Y,",","\\\\",Vu,PY,",",et,al.,(,2010,),Treatment,of,hepatocellular,carcinoma,with,adeno-associated,virus,encoding,interleukin-15,superagonist,.}	{29|30}
journal.pone.0052370.pdf	550	{Hum,Gene,Ther,21,:,611,—,621,.}	{NULL}
journal.pone.0052370.pdf	551	{Klebanoff,CA,",",Finkelstein,SE,",",Surman,DR,",",Lichtman,l,"\\\\",’,IK,",",Gattinoni,L,",",et,al.,(,2004,),IL-15,enhances,the,in,vivo,antitumor,activity,of,tumor-reactive,CD8,+,T,cells,.}	{NULL}
journal.pone.0052370.pdf	552	{Proc,Natl,Acad,Sci,U,S,A,101,:,1969,—,1974,.}	{NULL}
journal.pone.0052370.pdf	553	{.}	{NULL}
journal.pone.0052370.pdf	554	{Oh,S,",",Berzofsky,JA,",",Burke,DS,",",VValdmann,TA,",",Perera,LP,(,2003,),Coadministration,of,HIV,vaccine,vectors,with,vaccinia,viruses,expressing,IL15,but,not,IL-2,induces,long-lasting,cellular,immunity,.}	{NULL}
journal.pone.0052370.pdf	555	{Proc,Natl,Acad,Sci,U,S,A,100,:,3392,—,3397,.}	{NULL}
journal.pone.0052370.pdf	556	{.}	{NULL}
journal.pone.0052370.pdf	557	{SteelJC,",",Ramlogan,CA,",",Yu,P,",",Sakai,Y,",",Forni,G,",",et,al.,(,2010,),Interleukin-15,and,its,receptor,augment,dendritic,cell,vaccination,against,the,neu,oncogene,through,the,induction,of,antil,),odies,partially,independent,of,CD4,help,.}	{NULL}
journal.pone.0052370.pdf	558	{Cancer,Res,70,:,1072,—,l081,.}	{NULL}
journal.pone.0052370.pdf	559	{.}	{NULL}
journal.pone.0052370.pdf	560	{Dubois,S,",",Patel,HJ,",",Zhang,1,%,",",V,"\\\\",laldmann,TA,",",NIullerJR,(,2008,),Preassociation,of,IL,~,l5,with,IL-15R,alpha,~,IgG1-Fc,enhances,its,activity,on,proliferation,ofNK,and,CD8,+,/,CD44high,T,cells,and,its,antitumor,action,.}	{NULL}
journal.pone.0052370.pdf	561	{J,Immunol,180,:,2099,*,2106,.}	{NULL}
journal.pone.0052370.pdf	562	{.}	{NULL}
journal.pone.0052370.pdf	563	{Rubinstein,NIP,",",Kovar,NI,",",Purton,JF,",",Cho,JH,",",Boyman,O,",",et,al.,(,2006,),Converting,IL,~,15,to,a,superagonist,by,binding,to,soluble,IL-l5R,"{",alpha,"}",.}	{NULL}
journal.pone.0052370.pdf	564	{Proc,Natl,Acad,Sci,U,S,A,103,:,9166,—,9171,.}	{NULL}
journal.pone.0052370.pdf	565	{Stoklasek,TA,",",Schluns,KS,",",Lefrancois,L,(,2006,),Combined,IL-15,/,IL-l5Ralpha,immunotherapy,maximizes,IL-15,activity,in,vivo,.}	{NULL}
journal.pone.0052370.pdf	566	{J,Immunol,177,:,6072,*,6080,.}	{NULL}
journal.pone.0052370.pdf	567	{.}	{NULL}
journal.pone.0052370.pdf	568	{Berger,C,",",Berger,NI,",",Hackman,RC,",",Gough,1,%,",",Elliott,C,",",et,al.,(,2009,),Safety,and,immunologic,effects,of,IL-15,administration,in,nonhuman,primates,.}	{NULL}
journal.pone.0052370.pdf	569	{Blood,114,:,241,7,—,2426,.}	{NULL}
journal.pone.0052370.pdf	570	{.}	{NULL}
journal.pone.0052370.pdf	571	{Lugli,E,",",Goldman,CK,",",Perera,LP,",",SmedleyJ,",",Pung,R,",",et,al.,(,2010,),Transient,and,persistent,effects,of,IL-15,on,lymphocyte,homeostasis,in,nonhuman,primates,.}	{NULL}
journal.pone.0052370.pdf	572	{Blood,116,:,3238,—,3248,.}	{NULL}
journal.pone.0052370.pdf	573	{.}	{NULL}
journal.pone.0052370.pdf	574	{Nlunger,VV,",",DeJoy,0,"}",7O,*,Jeyaseelan,R,",",Sr.,",",Torley,LVV,",",Grabstein,KH,",",et,al.,(,1995,),Studies,evaluating,the,antitumor,activity,and,toxicity,of,interleukin-15,",",a,new,T,cell,growth,factor,:,comparison,with,interleukin-2,.}	{NULL}
journal.pone.0052370.pdf	575	{Cell,Immunol,165,:,289,—,293,.}	{NULL}
journal.pone.0052370.pdf	576	{.}	{NULL}
journal.pone.0052370.pdf	577	{Kennedy,NIK,",",Glaccum,l,"\\\\",’,I,",",Brown,SN,",",Butz,EA,",",Viney,JL,",",et,al.,(,2000,),Reversible,defects,in,natural,killer,and,memory,CD8,T,cell,lineages,in,interleukin,15-deficient,mice,.}	{NULL}
journal.pone.0052370.pdf	578	{J,Exp,l,"\\\\",’,Ied,191,:,77l,*,780,.}	{NULL}
journal.pone.0052370.pdf	579	{.}	{NULL}
journal.pone.0052370.pdf	580	{Lodolce,JP,",",Boone,DL,",",Chai,S,",",Swain,RE,",",Dassopoulos,T,",",et,al.,(,1998,),IL,~,l.,5,receptor,maintains,lymphoid,homeostasis,by,supporting,lymphocyte,homing,and,proliferation,.}	{NULL}
journal.pone.0052370.pdf	581	{Immunity,9,:,669,—,676,.}	{NULL}
journal.pone.0052370.pdf	582	{Sadlack,B,",",l,"\\\\",’,Ierz,H,",",Schorle,H,",",Schimpl,A,",",Feller,AC,",",et,al.,(,1993,),Ulcerative,colitis-like,disease,in,mice,with,a,disrupted,interleukin-2,gene,.}	{NULL}
journal.pone.0052370.pdf	583	{Cell,75,:,253,—,261,.}	{NULL}
journal.pone.0052370.pdf	584	{Francis,GA,(,2010,),The,complexity,of,HDL,.}	{NULL}
journal.pone.0052370.pdf	585	{Biochim,Biophys,Acta,1801,:,l286,—,1293,.}	{NULL}
journal.pone.0052370.pdf	586	{Lund-Katz,S,",",Phillips,MC,(,2010,),High,density,lipoprotein,structure-function,and,role,in,reverse,cholesterol,transport,.}	{NULL}
journal.pone.0052370.pdf	587	{Subcell,Biochem,51,:,183,—,227,.}	{NULL}
journal.pone.0052370.pdf	588	{FioravantiJ,",",Gonzalez,1,",",Nledina-Echeverz,J,",",Larrea,E,",",Ardaiz,N,",",et,al.,(,2011,),Anchoring,interferon,alpha,to,apolipoprotein,A-I,reduces,hematological,toxicity,while,enhancing,immunostimulatory,properties,.}	{NULL}
journal.pone.0052370.pdf	589	{Hepatologn,Zabala,l,"\\\\",’,I,",",Lasarte,J,],",",Perret,C,",",SolaJ,",",Berraondo,P,",",et,al.,(,2007,),Induction,of,immunosuppressive,molecules,and,regulatory,T,cells,counteracts,the,antitumor,effect,of,interleukin-12-based,gene,therapy,in,a,transgenic,mouse,model,of,liver,cancer,.}	{NULL}
journal.pone.0052370.pdf	590	{J,Hepatol,47,:,807,*,8l5,.}	{NULL}
journal.pone.0052370.pdf	591	{Arina,A,",",l,"\\\\",’,Iurillo,O,",",DubrotJ,",",Azpilikueta,A,",",Gabari,I,",",et,al.,(,2008,),Interleukin15,liver,gene,transfer,increases,the,number,and,function,of,IKDCs,and,NK,cells,.}	{NULL}
journal.pone.0052370.pdf	592	{Gene,Ther,15,:,473,—,483,.}	{NULL}
journal.pone.0052370.pdf	593	{Nlelero,I,",",Duarte,1V1,",",Ruiz,J,",",Sangro,B,",",Galofre,J,",",et,al.,(,1999,),Intratumoral,injection,of,bone-marrow,derived,dendritic,cells,engineered,to,produce,interleukin-12,induces,complete,regression,of,established,murine,transplantable,colon,adenocarcinomas,.}	{NULL}
journal.pone.0052370.pdf	594	{Gene,Ther,6,:,l779,—,l784,.}	{NULL}
journal.pone.0052370.pdf	595	{Soman,G,",",Yang,X,",",Jiang,H,",",Giardina,S,",",Vyas,V,",",et,al.,(,2009,),l,"\\\\",’,ITS,dye,based,colorimetric,CTLL-2,cell,proliferation,assay,for,product,release,and,stability,monitoring,of,interleukin-15,:,assay,qualification,",",standardization,and,statistical,analysis,.}	{NULL}
journal.pone.0052370.pdf	596	{J,Immunol,lVIethods,348,:,83,*,94,.}	{NULL}
journal.pone.0052370.pdf	597	{Nleazza,R,",",Lollini,PL,",",Nanni,P,",",De,Giovanni,C,",",Gaggero,A,",",et,al.,(,2000,),Gene,transfer,of,a,secretal,),le,form,of,IL-15,in,murine,adenocarcinoma,cells,:,effects,on,tumorigenicity,",",metastatic,potential,and,immune,response,.}	{NULL}
journal.pone.0052370.pdf	598	{IntJ,Cancer,87,:,574,—,58l,.}	{NULL}
journal.pone.0052370.pdf	599	{FioravantiJ,",",Gonzalez,1,",",Nledina-Echeverz,J,",",Larrea,E,",",Ardaiz,N,",",et,al.,(,2011,),Anchoring,interferon,alpha,to,apolipoprotein,A-I,reduces,hematological,toxicity,while,enhancing,immunostimulatory,properties,.}	{NULL}
journal.pone.0052370.pdf	600	{Hepatology,53,:,l864,—,l873,.}	{NULL}
journal.pone.0052370.pdf	601	{He,Y,",",Pimenov,AA,",",NayakJV,",",P1oweyJ,",",Falo,LD,",",Jr.,",",et,al.,(,2000,),Intravenous,injection,of,naked,DNA,encoding,secreted,ﬂt3,ligand,dramatically,increases,the,number,of,dendritic,cells,and,natural,killer,cells,in,vivo,.}	{NULL}
journal.pone.0052370.pdf	602	{Hum,Gene,Ther,11,:,547,—,554,.}	{NULL}
journal.pone.0052370.pdf	603	{.}	{NULL}
journal.pone.0052370.pdf	604	{Rodriguez-Sureda,V,",",Julve,J,",",Llol,),era,l,"\\\\",’,I,",",Peinado,~,Onsurbe,J,(,2002,),Ultracentrifugation,micromethod,for,preparation,of,small,experimental,animal,lipoproteins,.}	{NULL}
journal.pone.0052370.pdf	605	{Anal,Biochem,303,:,73,*,77,.}	{NULL}
journal.pone.0052370.pdf	606	{Nlortier,E,",",Quemener,A,",",Vusio,P,",",Lorenzen,I,",",Boublik,Y,",",et,al.,(,2006,),Soluble,interleukin-15,receptor,alpha,(,IL-15R,alpha,),~,sushi,as,a,selective,and,potent,agonist,of,IL-15,action,through,IL-15R,beta,/,gamma,.}	{NULL}
journal.pone.0052370.pdf	607	{Hyperagonist,IL-15,>,<,IL15R,alpha,fusion,proteins,.}	{NULL}
journal.pone.0052370.pdf	608	{J,Biol,Chem,281,:,l6l2,—,l6l9,.}	{NULL}
journal.pone.0052370.pdf	609	{Yu,P,",",Steel,JC,",",Zhang,l,"\\\\",’,I,",",.}	{NULL}
journal.pone.0052370.pdf	610	{"\\\\",Iorris,JC,",",VValdmann,TA,(,2010,),Simultaneous,blockade,of,multiple,immune,system,inhibitory,checkpoints,enhances,antitumor,activity,mediated,by,interleukin-15,in,a,murine,metastatic,colon,carcinoma,model,.}	{NULL}
journal.pone.0052370.pdf	611	{Clin,Cancer,Res,16,:,6019,—,6028,.}	{NULL}
journal.pone.0052370.pdf	612	{Tirapu,I,",",Arina,A,",",Nlazzolini,G,",",Duarte,l,"\\\\",’,I,",",Alfaro,C,",",et,al.,(,2004,),Improving,efficacy,of,interleukin,»,12-transfected,dendritic,cells,injected,into,murine,colon,cancer,with,anti-CD137,monoclonal,antibodies,and,alloantigens,.}	{NULL}
journal.pone.0052370.pdf	613	{International,journal,of,cancerJournal,international,du,cancer,110,:,5l,*,60,.}	{NULL}
journal.pone.0052370.pdf	614	{DubrotJ,",",Portero,A,",",Orive,G,",",Hernandez,Rl,"\\\\",’,I,",",Palazon,A,",",et,al.,(,2010,),Delivery,of,immunostimulatory,monoclonal,antibodies,by,encapsulated,hybridoma,cells,.}	{NULL}
journal.pone.0052370.pdf	615	{Cancer,Immunol,Immunother,59,:,l621,—,l63l,.}	{NULL}
journal.pone.0072418.pdf	1	{‘,Eo,?}	{NULL}
journal.pone.0072418.pdf	2	{-,PLOS,1,K}	{NULL}
journal.pone.0072418.pdf	3	{OPEN,8,ACCESS,Freely,available,online}	{NULL}
journal.pone.0072418.pdf	4	{Integrative,Analysis,of,Porcine,microRNAome,during,Skeletal,Muscle,Development}	{NULL}
journal.pone.0072418.pdf	5	{Lijun,Qin,",",Yaosheng,Chen,",",Xiaohong,Liu,",",Sanxing,Ye,",",Kaifan,Yu,",",Zheng,Huang,",",Jingwei,Yu,",",Xingyu,Zhou,",",Hu,Chen,",",Delin,Mo,‘}	{NULL}
journal.pone.0072418.pdf	6	{State,Key,Laboratory,of,Biocontrol,",",School,of,Life,Sciences,",",Sun,Yat-Sen,University,",",Guangzhou,",",P.,R.,China}	{NULL}
journal.pone.0072418.pdf	7	{Abstract}	{NULL}
journal.pone.0072418.pdf	8	{Pig,is,an,important,agricultural,animal,for,meat,production,and,provides,a,valuable,model,for,many,human,diseases,.}	{NULL}
journal.pone.0072418.pdf	9	{Functional,studies,have,demonstrated,that,microRNAs,(,miRNAs,),play,critical,roles,in,almost,all,aspects,of,skeletal,muscle,development,and,disease,pathogenesis,.}	{NULL}
journal.pone.0072418.pdf	10	{To,investigate,the,miRNAs,involved,in,regulating,different,periods,of,skeletal,muscle,development,",",we,herein,performed,a,comprehensive,research,for,porcine,microRNAome,(,miRNAome,),during,10,skeletal,muscle,developmental,stages,including,35,",",49,",",63,",",77,",",91,dpc,(,days,post,coitum,),and,2,",",28,",",90,",",120,",",180,dpn,(,days,postnatal,),using,Solexa,sequencing,technology,.}	{NULL}
journal.pone.0072418.pdf	11	{Our,results,extend,the,repertoire,of,pig,miRNAome,to,247,known,miRNAs,processed,from,210,pre,—,miRNAs,and,297,candidate,novel,miRNAs,through,comparison,with,known,miRNAs,in,the,miRBase,.}	{NULL}
journal.pone.0072418.pdf	12	{Expression,analysis,of,the,15,most,abundant,miRNAs,in,every,library,indicated,that,functional,miRNAome,may,be,smaller,and,tend,to,be,highly,expressed,.}	{NULL}
journal.pone.0072418.pdf	13	{A,series,of,musclerelated,miRNAs,summarized,in,our,study,present,different,patterns,between,myofibers,formation,phase,and,muscle,maturation,phase,",",providing,valuable,reference,for,investigation,of,functional,miRNAs,during,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	14	{Analysis,of,temporal,profiles,of,miRNA,expression,identifies,18,novel,candidate,myogenic,miRNAs,in,pig,",",which,might,provide,new,insight,into,regulation,mechanism,mediated,by,miRNAs,underlying,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	15	{Citation,:,Qin,L,",",Chen,Y,",",Liu,X,",",Ye,8,",",Yu,K,",",et,al.,(,2013,),Integrative,Analysis,of,Porcine,microRNAome,during,Skeletal,Muscle,Development,.}	{NULL}
journal.pone.0072418.pdf	16	{PLoS,ONE,8,(,9,),:,e72418,.}	{NULL}
journal.pone.0072418.pdf	17	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	18	{pone,.0072418,Editor,:,Atsushi,Asakura,",",University,of,Minnesota,Medical,School,",",United,States,of,America,Received,April,9,",",2013,;,Accepted,July,9,",",2013,;,Published,September,11,",",2013,Copyright,:,©,2013,Qin,et,al.,.}	{NULL}
journal.pone.0072418.pdf	19	{This,is,an,open-access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pone.0072418.pdf	20	{Funding,:,This,research,was,supported,by,the,National,Natural,Science,Foundation,of,China,(,U1201213,",",31272417,),and,the,China,Agriculture,Research,System,(,CARS-36,),.}	{NULL}
journal.pone.0072418.pdf	21	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pone.0072418.pdf	22	{Competing,interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pone.0072418.pdf	23	{*,E-mail,:,mode,|,in@mai,|,.}	{NULL}
journal.pone.0072418.pdf	24	{sysu.edu,.}	{NULL}
journal.pone.0072418.pdf	25	{cn}	{NULL}
journal.pone.0072418.pdf	26	{Introduction}	{NULL}
journal.pone.0072418.pdf	27	{Pork,is,an,important,source,of,protein,for,human,consumption,",",particularly,in,China,where,it,tops,the,list,of,meat,consumed,.}	{NULL}
journal.pone.0072418.pdf	28	{In,addition,",",the,pig,can,be,considered,as,a,suitable,model,for,human,diseases,because,it,is,similar,with,human,in,size,",",physiology,",",pathology,and,genomics,[,1,],.}	{NULL}
journal.pone.0072418.pdf	29	{Muscle,development,is,a,complex,process,",",including,not,only,embryonic,myogenesis,but,adult,myofiber,maturation,.}	{NULL}
journal.pone.0072418.pdf	30	{Most,research,suggested,that,porcine,primary,myoﬁbers,mainly,formed,at,35,to,64,dpc,and,secondary,myofibers,at,54,to,90,dpc,[,2,],.}	{NULL}
journal.pone.0072418.pdf	31	{However,",",Swatland,et,al.,pointed,out,that,fetal,myoﬁber,hyperplasia,ceased,at,slightly,later,at,70,days,gestation,and,the,increase,in,number,of,myofibers,seen,in,a,transverse,section,was,caused,by,growth,in,length,of,myofibers,[,3,],.}	{NULL}
journal.pone.0072418.pdf	32	{Similarly,",",Zhao,et,al.,discovered,that,myogenesis,was,almost,completed,before,77,dpc,[,4,],",",suggesting,that,the,muscle,fiber,formed,at,35,to,77,dpc,.}	{NULL}
journal.pone.0072418.pdf	33	{Other,research,described,that,there,existed,a,third,generation,of,fibers,around,birth,in,pigs,and,might,be,part,of,mechanisms,leading,to,the,larger,muscle,mass}	{NULL}
journal.pone.0072418.pdf	34	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0072418.pdf	35	{p,|,osone.org}	{NULL}
journal.pone.0072418.pdf	36	{[,"5,6",],.}	{NULL}
journal.pone.0072418.pdf	37	{The,total,fiber,number,(,TFN,),does,not,increase,after,birth,and,is,fixed,at,the,number,formed,during,embryonic,life,.}	{NULL}
journal.pone.0072418.pdf	38	{Myofibers,were,classiﬁed,according,to,their,contractile,and,metabolic,properties,as,type,1,",",type,2,(,2A,and,2B,),and,an,intermediate,type,2X,.}	{NULL}
journal.pone.0072418.pdf	39	{From,late,gestation,through,the,first,four,postnatal,weeks,",",myofibers,underwent,a,process,of,maturation,from,type,1,to,type,2,[,"4,6",],.}	{NULL}
journal.pone.0072418.pdf	40	{Hypertrophy,is,another,process,of,skeletal,muscle,maturation,",",involving,an,increase,in,muscle,mass,and,in,the,size,",",associated,with,increased,myofibrillar,protein,content,.}	{0|6}
journal.pone.0072418.pdf	41	{Signaling,pathways,such,as,insulin-like,growth,factor,I,(,IGF-I,),and,Ca,”,/,calmodulin-dependent,transcriptional,pathways,have,been,demonstrated,to,govern,skeletal,muscle,hypertrophy,and,atrophy,[,7,],.}	{24|25}
journal.pone.0072418.pdf	42	{Understanding,the,complex,mechanism,underlying,porcine,muscle,development,might,contribute,to,swine,industry,as,well,as,human,muscular,growth,and,diseases,.}	{NULL}
journal.pone.0072418.pdf	43	{Increasing,evidence,suggests,that,miRNAs,serve,as,biological,regulators,by,mediating,gene,expression,.}	{NULL}
journal.pone.0072418.pdf	44	{It,was,increasingly,clear,that,miRNAs,involve,almost,all,aspects,of,skeletal,muscle,development,",",including,cell,migration,","}	{NULL}
journal.pone.0072418.pdf	45	{proliferation,",",differentiation,and,apoptosis,[,"8,9",],.}	{NULL}
journal.pone.0072418.pdf	46	{Despite,the,significant,role,of,miRNAs,in,the,regulation,of,myogenesis,",",the,miRBase,(,release,18.0,),lists,only,257,distinct,mature,miRNA,sequences,in,pigs,",",significantly,fewer,than,that,in,human,.}	{NULL}
journal.pone.0072418.pdf	47	{lt,’s,worth,noting,that,many,miRNAs,are,expressed,in,a,tissuespecific,or,stage-specific,manner,[,10,],",",and,the,bestcharacterized,muscle-specific,miRNAs,(,myomiRs,[,11,],),are,miR-1,",",miR-206,and,miR-133,families,which,specifically,expressed,in,cardiac,and,skeletal,muscles,.}	{NULL}
journal.pone.0072418.pdf	48	{Dicer,was,known,to,be,essential,for,miRNA,biogenesis,",",whose,elimination,in,the,skeletal,muscles,could,lead,to,prenatal,death,",",muscle,mass,reduction,or,myofiber,malformation,[,12,],",",an,outcome,highlights,the,significance,of,miRNAs,in,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	49	{Currently,",",scientists,tend,to,study,the,molecular,mechanism,of,swine,skeletal,muscle,development,through,analysis,of,miRNA,transcriptome,proﬁles,[,"13,14",],",",discovering,and,identifying,more,miRNAs,based,on,bioinformatics,analysis,.}	{NULL}
journal.pone.0072418.pdf	50	{However,",",it,is,still,not,enough,for,investigation,in,mapping,a,nearly,complete,porcine,miRNAome,during,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	51	{The,Landrace,",",one,of,the,most,popular,pig,breeds,in,most,countries,in,Europe,",",North,America,and,Asia,",",was,employed,in,this,investigation,.}	{NULL}
journal.pone.0072418.pdf	52	{Its,miRNAome,during,skeletal,muscle,development,at,ten,developmental,stages,including,five,prenatal,stages,(,35,",",49,",",63,",",77,",",91,dpc,",",simpliﬁed,as,LR,1,",",2,",",3,",",4,",",5,),and,ﬁve,postnatal,stages,(,2,",",28,",",90,",",120,",",180,dpn,",",simplified,as,LR,6,",",7,",",8,",",9,",",10,),using,Solexa,sequencing,.}	{NULL}
journal.pone.0072418.pdf	53	{The,time,points,cover,almost,all,morphological,and,physiological,changes,of,porcine,skeletal,muscle,growth,and,development,[,4,],.}	{NULL}
journal.pone.0072418.pdf	54	{Thus,",",this,study,will,provide,a,thorough,investigation,of,miRNAome,in,porcine,skeletal,muscle,to,facilitate,a,better,understanding,of,their,involvement,in,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	55	{Materials,and,Methods}	{NULL}
journal.pone.0072418.pdf	56	{Ethics,statement,All,animal,procedures,were,performed,according,to,guidelines,developed,by,the,China,Council,on,Animal,Care,and,protocols,were,approved,by,the,Animal,Care,and,Use,Committee,of,Guangdong,Province,",",China,.}	{NULL}
journal.pone.0072418.pdf	57	{The,approval,ID,or,permit,numbers,are,SCXK,(,Guangdong,),2004-0011,and,SYXK,(,Guangdong,),2007-0081,.}	{NULL}
journal.pone.0072418.pdf	58	{Sample,preparation,Fifteen,Landrace,(,LR,),purebred,sows,with,the,same,genetic,background,were,artificially,inseminated,with,semen,from,the,same,purebred,boars,.}	{NULL}
journal.pone.0072418.pdf	59	{The,pregnant,sows,were,slaughtered,at,five,prenatal,stages,(,35,",",49,",",63,",",77,",",91,dpc,",",days,post,coitum,),while,the,piglets,and,adult,pigs,were,slaughtered,at,five,postnatal,stages,(,2,",",28,",",90,",",120,",",180,dpn,",",days,postnatal,),.}	{NULL}
journal.pone.0072418.pdf	60	{The,longissimus,dorsi,muscle,tissues,collected,per,time,point,were,used,as,the,experimental,samples,for,sequencing,.}	{NULL}
journal.pone.0072418.pdf	61	{These,samples,were,snap-frozen,in,liquid,nitrogen,and,stored,at,-80,°,C.}	{NULL}
journal.pone.0072418.pdf	62	{Small,RNA,library,construction,and,Solexa,sequencing,Total,RNA,was,extracted,using,miRNeasy,Mini,Kit,(,Cat,#,217004,",",QIAGEN,",",GmBH,",",Germany,),according,to,the,manufacturer,’s,protocol,.}	{NULL}
journal.pone.0072418.pdf	63	{For,each,developmental,stage,",",equal,quantities,of,total,RNA,isolated,from,three,individual,pigs,were,pooled,.}	{NULL}
journal.pone.0072418.pdf	64	{Total,RNA,integrity,was,measured,on,an,Agilent,2100,Bioanalyzer,system,(,Agilent,),for,quality,contro,|,.16,-35,nt,RNA,fragments,were,excised,",",purified,from,a,PAGE,gel,",",and,ligated,with,5,',and,3,’,adaptors,using,T4,RNA,ligase,.}	{NULL}
journal.pone.0072418.pdf	65	{Reverse,transcription,followed,by,PCR,was,used,to,create,cDNA,constructs,based,on,the,small,RNA,ligated,with,3,’,and,5,',adapters,.}	{NULL}
journal.pone.0072418.pdf	66	{Subsequently,",",the,amplified,cDNA,constructs,were,purified,from,agarose,gel,",",in,preparation,for,sequencing,analysis,using,the,lllumina,Genome,Analyzer,(,lllumina,",",CA,",",USA,),according,to,the,manufacturer,'s,instructions,.}	{NULL}
journal.pone.0072418.pdf	67	{Data,analysis,The,raw,data,were,processed,using,lllumina,1G,Genome,Analyzer,Pipeline,software,and,then,submitted,to,data,filtration,.}	{NULL}
journal.pone.0072418.pdf	68	{Clean,reads,were,obtained,after,filtering,low-quality,reads,and,trimming,the,adaptor,sequences,.}	{NULL}
journal.pone.0072418.pdf	69	{All,of,the,clean,reads,were,initially,searched,against,miRBase,(,version,18,;,http,:,/,/,www.mirbase.org,/,),to,identify,known,porcine,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	70	{Unmappable,reads,subsequently,were,annotated,and,classified,by,reference,to,non-coding,RNAs,in,the,Ensemble,(,ftp,:,/,/,ftp.ensembl.org/pub/release-69/fasta/sus_scrofa/ncrna/,),",",piRNA,(,http://pirnabank.ibab.ac.in/,),and,Rfam,(,version,10,;,http://rfam.sanger.ac.uk/,),databases,.}	{NULL}
journal.pone.0072418.pdf	71	{The,mappable,sequences,were,achieved,and,used,for,further,analysis,.}	{NULL}
journal.pone.0072418.pdf	72	{Meantime,",",many,unannotated,sequences,that,can,not,match,any,above,databases,were,analyzed,by,miRDeep,[,15,],(,http,:,/,/,deepbase.sysu.edu,.}	{NULL}
journal.pone.0072418.pdf	73	{cn/miRDeep,.}	{NULL}
journal.pone.0072418.pdf	74	{php,),to,predict,novel,miRNA,candidates,.}	{NULL}
journal.pone.0072418.pdf	75	{Their,hairpin,structures,were,then,analyzed,using,RNAfo,|,d,software,(,http://rna.tbi.univie.ac.at/cgi-bin/,RNAfo,|,d.,cgi,),.}	{NULL}
journal.pone.0072418.pdf	76	{Only,with,tipical,stem-loop,hairpins,and,the,free,energy,lower,than,-20,kcal/mol,could,the,sequences,be,considered,to,be,potential,novel,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	77	{After,all,annotation,steps,",",the,sequencing,libraries,were,used,for,size,distribution,and,saturation,analysis,.}	{NULL}
journal.pone.0072418.pdf	78	{All,the,sequence,data,have,been,submitted,to,the,NCBI,Sequence,Read,Archive,(,http,:,/,/,www.ncbi.nlm.nih.gov/Traces/sra/,),under,accession,No.,SRA073195,.}	{NULL}
journal.pone.0072418.pdf	79	{STEM,Clustering,STEM,(,Short,Time-series,Expression,Miner,v,1.1,),herein,was,used,for,clustering,and,visualizing,possible,profiles,of,differentially,expressed,(,DE,),miRNAs,’,change,in,expression,over,time,(,less,than,8,time,points,),.}	{NULL}
journal.pone.0072418.pdf	80	{The,Maximum,Unit,Change,in,Model,Profiles,between,Time,Points,was,adjusted,to,1,and,the,Maximum,Number,of,Model,Profiles,to,50,.}	{NULL}
journal.pone.0072418.pdf	81	{MiRNA,expression,profiles,were,clustered,according,to,the,correlation,coefficient,.}	{NULL}
journal.pone.0072418.pdf	82	{The,statistical,significance,of,the,number,of,genes,assigned,to,each,profile,versus,the,number,expected,was,computed,by,algorithm,suggested,by,Ernstet,et,al.,[,16,],and,the,default,P-value,was,1E-5,.}	{NULL}
journal.pone.0072418.pdf	83	{Statistically,significant,model,profiles,which,are,similar,to,each,other,can,be,grouped,together,to,form,clusters,of,profiles,.}	{NULL}
journal.pone.0072418.pdf	84	{Target,Prediction,and,KEGG,Orthology,Analysis,Based,on,the,sequences,of,the,miRNAs,",",the,targets,of,DE,miRNAs,were,predicted,using,the,online,database,miRecords,[,17,],(,http://mirecords.bio,|,ead.org,/,),and,chosen,when,they,were,predicted,in,at,least,databases,integrated,in,miRecords,.}	{NULL}
journal.pone.0072418.pdf	85	{The,predicted,target,genes,were,subsequently,submitted,to,KOBAS,[,18,],for,KEGG,Orthology,analysis,(,http://kobas.cbi.pku.edu.cn/,home,.}	{NULL}
journal.pone.0072418.pdf	86	{do,),using,KEGG,database,.}	{NULL}
journal.pone.0072418.pdf	87	{Given,the,P,values,in,KOBAS,",",pathways,with,statistically,significant,values,(,P,<,0.05,),were,chosen,.}	{NULL}
journal.pone.0072418.pdf	88	{In,addition,",",SPSS,was,used,to,divide,the,pathways,into,categories,by,using,the,fuzzy,theories,to,Kmeans,algorithm,.}	{NULL}
journal.pone.0072418.pdf	89	{Stem-loop,RT-PCR,To,validate,the,sequencing,results,",",nine,miRNAs,with,different,expression,levels,were,selected,and,Stem,—,loop,RTPCR,was,performed,using,the,Lightcycler480,(,Roche,),with,SYBR-Green,detection,(,SYBR,PrimeScript,RT-PCR,Kit,",",TaKaRa,Biotechnology,Co.,.}	{NULL}
journal.pone.0072418.pdf	90	{Ltd.,),according,to,the,manufacturer,‘,s,instructions,.}	{NULL}
journal.pone.0072418.pdf	91	{The,reverse,transcriptase,reaction,was,performed,using,Reverse,Transcription,System,Kit,(,Promega,),with,the,stem-loop,primers,listed,in,Table,S7,.}	{NULL}
journal.pone.0072418.pdf	92	{Each,real-time,PCR,system,contained,5,pl,2,>,<,SYBR,Premix,DimerEraserT,“,"\\"",(,TaKaRa,),",",0.3,ul,forward,and,reverse,primers,respectively,",",1,ul,template,cDNA,",",and,dH2O,up,to,the,final,volume,of,10,pl,.}	{NULL}
journal.pone.0072418.pdf	93	{The,reactions,were,incubated,at,95,°,C,for,30,s,",",followed,by,40,cycles,of,95,°,C,for,10,s,",",60,°,C,for,20,s,and,72,°,C,for,10,s.,Mir-17-5p,was,chosen,as,internal,control,and,all,reactions,were,run,in,triplicate,.}	{NULL}
journal.pone.0072418.pdf	94	{The,experimental,data,were,analyzed,using,the,244,”,method,.}	{NULL}
journal.pone.0072418.pdf	95	{Results}	{NULL}
journal.pone.0072418.pdf	96	{Overview,of,sequencing,data,After,trimming,of,adaptor,sequences,and,removal,of,low,quality,reads,",","181,224,007",total,clean,reads,were,obtained,from,ten,libraries,",",of,which,almost,96,%,matched,small,RNA,databases,mentioned,in,the,Materials,and,Methods,",",namely,annotated,reads,(,Table,S1,),.}	{NULL}
journal.pone.0072418.pdf	97	{Saturation,plots,of,ten,libraries,were,created,to,assess,the,efﬁciency,and,accuracy,of,deep,sequencing,for,miRNA,detection,(,Figure,S1,),.}	{NULL}
journal.pone.0072418.pdf	98	{Taking,the,LR1,library,as,an,example,",",the,deeper,were,sequenced,",",the,more,unique,small,RNAs,were,found,.}	{NULL}
journal.pone.0072418.pdf	99	{However,",",the,most,of,unique,small,RNAs,were,unknown,",",for,the,number,of,annotated,small,RNAs,accounted,for,less,than,20,%,.}	{NULL}
journal.pone.0072418.pdf	100	{Furthermore,",",the,number,of,new,sequences,observed,for,known,small,RNAs,and,porcine,miRNAs,(,miRBase,found,),reached,a,plateau,when,the,number,of,sequenced,reads,was,"9,500,000",",",suggesting,that,the,library,capacity,approached,saturation,.}	{NULL}
journal.pone.0072418.pdf	101	{Similar,plots,of,the,other,nine,libraries,were,shown,in,Figure,S1,.}	{NULL}
journal.pone.0072418.pdf	102	{Therefore,",",the,results,demonstrated,that,the,deep,sequencing,data,were,able,to,accurately,represent,the,miRNA,transcriptome,profiles,of,porcine,skeletal,muscle,.}	{NULL}
journal.pone.0072418.pdf	103	{Of,the,annotated,sequences,",",the,most,abundant,size,class,in,the,small,RNA,sequences,distribution,was,22,nt,",",followed,by,21,and,23nt,(,Figure,1A,and,B,),",",consistent,with,the,known,21-23,nt,range,for,mature,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	104	{In,addition,",",the,annotated,sequences,were,analyzed,referencing,the,data,from,miRBase}	{NULL}
journal.pone.0072418.pdf	105	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0072418.pdf	106	{p,|,osone.org}	{NULL}
journal.pone.0072418.pdf	107	{(,release,18.0,",",containing,228,precursors,and,257,mature,miRNAs,),",",resulting,247,(,96,%,),mature,miRNAs,and,210,(,92,%,),precursor,were,identified,.}	{NULL}
journal.pone.0072418.pdf	108	{Next,",",the,rest,annotated,sequences,were,subjected,to,piwi-interacting,RNA,(,piRNA,),database,",",Rfam,(,version,10,),and,non-coding,RNA,in,Ensemble,and,the,results,were,summarized,in,Table,S1,.}	{NULL}
journal.pone.0072418.pdf	109	{Most,annotated,small,RNAs,were,porcine,miRNAs,(,ssc-miRNAs,),",",accounting,for,76.7,%,of,the,total,sequence,reads,but,a,less,proportion,(,8.7,%,),of,the,unique,sequence,reads,in,ten,small,RNA,libraries,(,Figure,1C,),.}	{NULL}
journal.pone.0072418.pdf	110	{The,results,indicated,that,the,majority,of,small,RNAs,were,annotated,miRNAs,while,other,classes,added,diversity,.}	{NULL}
journal.pone.0072418.pdf	111	{Together,",",all,of,the,above,results,provide,confidence,that,the,deep,sequencing,data,were,highly,enriched,for,known,miRNA,sequences,",",suggesting,that,the,data,are,reliable,for,analyzing,miRNA,expression,profiles,as,well,as,for,predicting,novel,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	112	{Identification,of,potential,novel,miRNAs,Deep,sequencing,is,a,robust,approach,for,discovering,novel,miRNAs,that,are,expressed,at,low,levels,.}	{NULL}
journal.pone.0072418.pdf	113	{To,find,more,potential,miRNAs,",",unannotated,sequences,longer,than,18,nt,were,searched,against,porcine,genome,and,analyzed,by,miDeep,.}	{NULL}
journal.pone.0072418.pdf	114	{According,to,criteria,for,novel,miRNAs,identification,",",297,candidate,novel,miRNAs,were,predicted,and,named,sscmiR-new-N,(,N,=,1,~,297,),.}	{NULL}
journal.pone.0072418.pdf	115	{These,novel,miRNAs,ranged,from,20,to,23,nt,in,length,",",among,which,22,nt,sequences,accounted,for,the,most,(,40,%,),followed,by23,nt,(,25,%,),",",21,nt,(,22,%,),and,20nt,(,13,%,),",",consistent,with,typical,length,distribution,of,mature,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	116	{Total,reads,of,these,novel,miRNAs,counted,up,from,ten,libraries,were,at,a,relatively,low,level,:,267,putative,novel,miRNAs,were,sequenced,below,100,times,",",27,were,below,1000,times,(,of,which,3,were,above,500,times,),",",2,were,above,1000,times,and,only,1,were,above,10000,times,(,Table,S2,),.}	{NULL}
journal.pone.0072418.pdf	117	{Hairpin,structures,of,the,putative,novel,miRNAs,were,then,analyzed,using,RNAfold,.}	{NULL}
journal.pone.0072418.pdf	118	{Characterization,of,miRNAome,in,different,stages,of,skeletal,muscle,As,presented,in,Table,S3,",",247,identiﬁed,mature,porcine,miRNAs,have,been,substituted,as,257,mature,porcine,miRNAs,(,If,the,normalized,expression,of,a,given,miRNA,is,zero,",",its,expression,value,will,be,modified,to,0.01,),that,expressed,at,different,levels,",",ranging,from,single,reads,for,the,least,abundant,to,millions,of,reads,for,the,most,abundant,.}	{NULL}
journal.pone.0072418.pdf	119	{Previous,study,has,demonstrated,that,over,60,%,of,miRNAs,detected,by,deep,sequencing,had,no,discernible,activity,",",all,of,which,expressed,below,100-1,",000",reads,per,million,(,RPM,),[,19,],.}	{NULL}
journal.pone.0072418.pdf	120	{Thus,",",the,distribution,of,numbers,for,normalized,miRNAs,was,summarized,in,Table,S3,",",from,which,we,could,ﬁnd,that,the,number,of,miRNAs,with,mean,expression,value,below,1000,is,197,(,123,and,74,",",respectively,),",",almost,accounts,for,77,%,of,the,total,number,of,miRNAs,(,48,%,and,29,%,",",respectively,),in,the,ten,libraries,.}	{NULL}
journal.pone.0072418.pdf	121	{However,",",the,number,of,miRNAs,expressed,on,average,over,1000,RPM,is,60,(,23,%,),",",among,which,15,miRNAs,(,6,%,),expressed,over,10000,RPM,.}	{NULL}
journal.pone.0072418.pdf	122	{Moreover,",",we,counted,the,top,most,abundant,15,miRNAs,in,each,library,",",accounting,for,85,%,of,the,total,counts,of,all,unique,miRNAs,on,average,(,Figure,S2,),",",from,which,we,obtained,a,common,27,miRNAs}	{NULL}
journal.pone.0072418.pdf	123	{1e,+7}	{NULL}
journal.pone.0072418.pdf	124	{LR1}	{NULL}
journal.pone.0072418.pdf	125	{1e,+7,—}	{NULL}
journal.pone.0072418.pdf	126	{8e,+6,6e,+6}	{NULL}
journal.pone.0072418.pdf	127	{—}	{NULL}
journal.pone.0072418.pdf	128	{4e,+6,—,Length,distribution,of,miRNA,in,10,libraries}	{NULL}
journal.pone.0072418.pdf	129	{oo,Q}	{NULL}
journal.pone.0072418.pdf	130	{W,fl,),.9,8,.}	{NULL}
journal.pone.0072418.pdf	131	{E,+7,—,E,HsnRNA,3,7,.}	{NULL}
journal.pone.0072418.pdf	132	{E,+7,',I-lsnoRNA,‘,UFRNA,E,5-517,’,Iretrotransposed,E,lpseudogene,=,5-E,*,7,’,Iprotein_coding,g,iMt_tRNA,w,4-5,”,‘,iMt_rRNA,°,lmisc_RNA,.5,3,',5,"\\"",’,ImiRNA,§,2,.}	{NULL}
journal.pone.0072418.pdf	133	{E,+7,—,%,1,E,+7,*,5,.}	{NULL}
journal.pone.0072418.pdf	134	{§,o,E+O,_,l,.}	{NULL}
journal.pone.0072418.pdf	135	{Length,(,nt,)}	{NULL}
journal.pone.0072418.pdf	136	{3,ssc,—,miRNA}	{NULL}
journal.pone.0072418.pdf	137	{I,piRNA}	{NULL}
journal.pone.0072418.pdf	138	{F,non,—,coding,RNA}	{NULL}
journal.pone.0072418.pdf	139	{3,Rfam}	{NULL}
journal.pone.0072418.pdf	140	{I,Unknown}	{NULL}
journal.pone.0072418.pdf	141	{Figure,1,.}	{NULL}
journal.pone.0072418.pdf	142	{Basic,analysis,of,Sequencing,data,.}	{NULL}
journal.pone.0072418.pdf	143	{A,.}	{NULL}
journal.pone.0072418.pdf	144	{—,.}	{NULL}
journal.pone.0072418.pdf	145	{B.,Sequence,length,distribution,of,known,miRNAs,(,A,),and,small,RNAs,(,B,),;,C.,Count,number,distribution,of,Total,Reads,(,left,),and,Unique,Small,RANs,(,right,),.}	{NULL}
journal.pone.0072418.pdf	146	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	147	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	148	{g001}	{NULL}
journal.pone.0072418.pdf	149	{with,the,highest,expression,level,in,ten,libraries,(,Table,1,",",details,see,Table,84,),",",suggesting,that,the,majority,of,abundant,miRNAs,are,from,fewer,miRNAs,[,20,],.}	{NULL}
journal.pone.0072418.pdf	150	{Previous,studies,have,announced,that,there,were,more,miRNAs,with,reported,myogenic,function,in,muscle,besides,well-known,myomiRs,(,Table,2,),.}	{NULL}
journal.pone.0072418.pdf	151	{Among,the,27,miRNAs,",",we,found,11,(,40,%,),miRNAs,have,a,relationship,with,muscle,development,validated,by,experiments,.}	{NULL}
journal.pone.0072418.pdf	152	{Almost,all,known,myomiRs,were,identiﬁed,with,the,most,abundance,.}	{NULL}
journal.pone.0072418.pdf	153	{The,most,abundant,miRNA,was,sscmiR-1,",",which,presented,by,more,than,"2,100,000",RPM,in,ten,libraries,.}	{NULL}
journal.pone.0072418.pdf	154	{The,predominance,of,miR-1,is,consistent,with,its,well,established,function,during,skeletal,muscle,development,[,21,],and,reported,role,during,porcine,myogenesis,[,22,],.}	{NULL}
journal.pone.0072418.pdf	155	{Similarly,",",two,other,myomiRs,",",miR-133,[,21,],and,miR-206,[,23,],",",were,highly,expressed,and,ranked,the,4,”‘,and,6,”‘,respectively,",",while,two,other,miRNAs,(,miR-378,[,"24,25",],and,miR-143,[,25,],),ranked,the,2,”“,and,3,',“,have,been,identiﬁed,to,participate,in,the,proliferation,and,differentiation,of,muscle,cells,.}	{NULL}
journal.pone.0072418.pdf	156	{Identification,of,differentially,expressed,miRNAs,between,different,developmental,stages,Besides,high,abundant,miRNAs,",",differentially,expressed,miRNAs,may,play,important,roles,in,biological,processes,.}	{NULL}
journal.pone.0072418.pdf	157	{To,determine,miRNAs,involved,in,porcine,myogenesis,",",differentially,expressed,(,DE,),miRNAs,between,two,libraries,were,identified,by,comparing,the,normalized,expression,data,of,the,257,mature,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	158	{In,total,",",183,DE,miRNAs,(,|,fo,|,dchange,(,logz,),|,21,;,P-value,<,0.01,),were,identified,during,muscle,development,(,Table,3,),.}	{NULL}
journal.pone.0072418.pdf	159	{Based,on,previous,studies,on,porcine,myogenesis,",",we,speculated,that,muscle,fiber,formed,at,35,to,77,dpc,(,LR1-4,),",",underwent,myofiber,transformation,at,77,dpc,to,28,dpn,(,LR4-7,),and,further,matured,at,28,to,180,dpn,(,LR7-10,),[,2,—,"4,6",],",",from,which,DE,miRNAs,were,obtained,and,compared,.}	{NULL}
journal.pone.0072418.pdf	160	{Figure,2,showed,that,the,number,of,DE,miRNAs,during,myoﬁber,formation,was,the,least,but,still,accounted,for,almost,50,%,of,total,DE,miRNAs,",",from,which,all,of,porcine,myomiRs,(,ssc-miR-1,",",-206,",",-133,a-3p,/,a-5p,/,b,),were,identified,.}	{NULL}
journal.pone.0072418.pdf	161	{Notably,",",there,were,53,",",57,and,97,DE,miRNAs,identified,from,every,two,data,sets,",",among,which,41,DE,miRNAs,(,22,%,of,183}	{NULL}
journal.pone.0072418.pdf	162	{Table,1,.}	{NULL}
journal.pone.0072418.pdf	163	{The,top,most,abundant,15,miRNAs,in,each,library,.}	{NULL}
journal.pone.0072418.pdf	164	{Total}	{NULL}
journal.pone.0072418.pdf	165	{Mature,normaIizedexpression35,dpc,49,dpc,63,dpc,Rank,miRNA,(,RPM,),(,LR1,),(,LR2,),(,LR3,),1,ssc-miR-1,2103431.74,14168.38,79554.80,117686.25,2,ssc-miR-378,1625963.19,19043.59,104583.43,93292.67,3,556,-,1176846.35,85966.88,97786.87,101871.98}	{NULL}
journal.pone.0072418.pdf	166	{miR-143-3p,sscmiR-133a-3p}	{NULL}
journal.pone.0072418.pdf	167	{sscmiR-30a-5p}	{NULL}
journal.pone.0072418.pdf	168	{ssc-miR-206,486805.67,14430.69,58818.28,70883.78,ssc-let-7f,317168.48,14823.77,51717.88,51980.72,8,556,-,253477.02,48633.91,62835.68,30149.73}	{NULL}
journal.pone.0072418.pdf	169	{miR-148a}	{NULL}
journal.pone.0072418.pdf	170	{9,ssc-miR-10b,234732.07,55274.96,42326.43,30113.66,10,ssc-miR-127,214267.02,11872.22,62283.84,56300.94,11,586,-,187553.50,163247.38,4841.03,4036.55}	{NULL}
journal.pone.0072418.pdf	171	{miR-140,*}	{NULL}
journal.pone.0072418.pdf	172	{12,ssc-miR-30d,172056.17,31767.19,29605.00,30624.26,13,556,-,155142.75,20257.32,32769.39,36970.07}	{NULL}
journal.pone.0072418.pdf	173	{miR-542-3p}	{NULL}
journal.pone.0072418.pdf	174	{14,ssc-miR-21,131742.03,32846.54,22577.72,16102.99,15,ssc-let-7a,121288.75,12151.08,18169.62,17302.43,16,59:6,‘,87618.91,20876.82,14889.87,15178.98}	{NULL}
journal.pone.0072418.pdf	175	{miR-30e-5p}	{NULL}
journal.pone.0072418.pdf	176	{17,ssc-miR-101,75739.16,10927.72,10465.49,11372.56,18,ssc-miR-10a,73489.75,54439.05,6034.88,3408.41,19,ssc-miR-26a,70050.82,4336.72,5112.43,5343.07,20,ssc-miR-103,64540.89,24347.45,11077.11,6324.15,21,ssc-miR-30c,58032.92,6600.70,4842.93,5957.25,22,556,-,57966.15,1095.91,3365.47,4991.24}	{NULL}
journal.pone.0072418.pdf	177	{miR-133b}	{NULL}
journal.pone.0072418.pdf	178	{23,ssc-miR-411,35786.91,625.66,3329.22,5246.32,24,SS,?}	{NULL}
journal.pone.0072418.pdf	179	{35683.28,591,1.43,5695.56,3643.81}	{NULL}
journal.pone.0072418.pdf	180	{miR-30e-3p}	{NULL}
journal.pone.0072418.pdf	181	{25,ssc-miR-9-2,28464.42,27754.31,103.78,63.66,26,ssc-miR-9-1,28464.22,27754.31,103.40,63.33,27,59:6,‘,28196.90,1534.35,1614.82,2019.87}	{NULL}
journal.pone.0072418.pdf	182	{miR-30b-5p}	{NULL}
journal.pone.0072418.pdf	183	{77,dpc,91,dpc,28,dpn,90,dpn,120,dpn,180,dpn,(,LR4,),(,LR5,),2,dpn,(,LR6,),(,LR7,),(,LR8,),(,LR9,),(,LR10,),126702.52,119640.12,142618.55,218084.74,310634.60,402667.63,571674.13,101497.98,121417.03,283735.95,329605.58,377885.10,79332.57,115569.27}	{NULL}
journal.pone.0072418.pdf	184	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	185	{pone,.00724181001}	{NULL}
journal.pone.0072418.pdf	186	{DE,miRNAs,),were,common,",",including,the,above,mentioned,ssc-miR-133,family,.}	{NULL}
journal.pone.0072418.pdf	187	{The,variations,in,abundance,might,aid,understanding,of,functional,miRNAs,being,involved,in,myogenesis,[,"21,26",],.}	{NULL}
journal.pone.0072418.pdf	188	{In,addition,to,the,best-studied,myomiRs,(,miR-1,",",-206,and,miR-133,families,),",",11,other,DE,muscle-related,miRNAs,(,miR-378,[,24,],",",miR-148a,[,27,],",",miR-26a,[,"28,29",],",",miR-27a,/,b,[,"30,31",],.}	{NULL}
journal.pone.0072418.pdf	189	{miR-23a,[,"32,33",],",",miR-125b,[,34,],",",miR-24,[,35,],",",miR-128,[,36,],",",miR-199a,[,37,],and,miR-424,[,38,],),with,high,abundance,(,average,RPM,>,"1,000",),and,another,14,(,miR-181a,/,b/c/d,-5,p,[,26,],",",miR-499-5p,[,11,],",",miR-503,[,38,],",",miR-486,[,39,],",",miR-214,[,40,],",",miR-29a,/,b/c,[,41,—,43,],",",miR-221,/,222,[,44,],and,miR-208,[,11,]}	{NULL}
journal.pone.0072418.pdf	190	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0072418.pdf	191	{p,|,osone.org,with,low,abundance,(,average,RPM,<,"1,000",),were,detected,in,myogenesis,of,pig,.}	{NULL}
journal.pone.0072418.pdf	192	{MicroRNA,target,predictions,and,KEGG,Orthology,analysis,To,gain,further,insight,into,the,biological,functions,of,the,identified,miRNAs,",",miRecords,[,17,],was,applied,to,predict,target,mRNAs,and,KOBAS,[,18,],was,used,for,KEGG,Orthology,analysis,.}	{NULL}
journal.pone.0072418.pdf	193	{To,identify,whether,highly,expressed,miRNAs,play,key,roles,in,skeletal,muscle,development,",",the,target,genes,of,25,miRNAs,with,the,most,abundance,(,not,including,let-7,family,for,their,ubiquitous,expression,),in,ten,libraries,(,Table,1,),were}	{NULL}
journal.pone.0072418.pdf	194	{Table,2,.}	{NULL}
journal.pone.0072418.pdf	195	{Information,of,miRNAs,known,to,function,in,muscle,development,(,musc,|,e,—,related,miRNAs,),.}	{NULL}
journal.pone.0072418.pdf	196	{Transcription,Factors,(,TF,),&,TF,-,miR,MiR,-,targets,Signaling,pathways,microRNA,(,miR,),Relationship,Targets,(,including,Potential,Targets,),Relationship,Tissues,&,CeIls,MyoD,[,62,—,64,],",",MEF2,HDAC4,[,21,],",",Cx43,[,"69,70",],",",G6PD,[,71,],",",[,"62,65",—,67,],",",SRF,[,62,],",",Sox6,[,72,],",",Hand2,[,62,],",",KCNJ2,[,69,],",",C2C12,",",skeletal,muscle,",",cardiac,Myogenin,[,63,],",",Myf5,[,63,],",",miR-1,up-regulation,HSP60,[,73,],",",HSP70,[,73,],",",caspase-9,down-regulation,muscle,",",smooth,muscle,",",MRF4,[,63,],",",Twist,[,65,],",",[,73,],",",c-Met,[,74,],",",Pax7,[,75,],",",Pax3,[,64,],",",Rhabdomyosarcoma,mTOR,[,68,],",",SREBP,[,66,],IGF-1R,[,76,],",",KLF4,[,77,],HMOX1,[,78,],",",Notch3,[,67,],down-regulation,Notch3,[,67,],down-regulation}	{NULL}
journal.pone.0072418.pdf	197	{SRF,[,"21,79",],",",KLF15,[,79,],",",nPTB,[,80,],","}	{NULL}
journal.pone.0072418.pdf	198	{M,',63,",",M,D63,",",UCP281,",",RhA82,",",Cd4282,",",_,yogemn,[,1,yo,[,1,_,_,[,1,O,[,1,C,[,1,_,C2C12,",",skeletal,muscle,",",cardiac,MEF2,[,66,],",",Myf5,[,63,],",",MRF4,miR-133,up-regulation,Nelf-A/WHSC2,[,82,],",",CTGF,[,83,],",",down-regulation,muscle,",",Rhabdomyosarcoma}	{NULL}
journal.pone.0072418.pdf	199	{[,63,],",",SREBP,[,66,],HSP60,[,73,],",",HSP70,[,73,],",",caspase-9,[,73,],",",Runx2,[,84,],",",dynamin,2,[,85,]}	{NULL}
journal.pone.0072418.pdf	200	{HMOX1,[,78,],down-regulation,down-regulation}	{NULL}
journal.pone.0072418.pdf	201	{Cx43,[,70,],",",HDAC4,[,87,],",",DNA}	{NULL}
journal.pone.0072418.pdf	202	{Myogenin,[,63,],",",MyoD,polymerase,[,88,],",",Fstl1,[,86,],",",Utrn,[,86,],",",C2C12,",",skeletal,muscle,",",[,"63,64,86",],",",Myf5,[,63,],",",MRF4,miR-206,up-regulation,c-Met,[,74,],",",Pax7,[,89,],",",Pax3,[,64,],",",down-regulation,Rhabdomyosarcoma,",",laryngeal,[,63,],",",MEF2C,[,67,],Hmgb3,[,90,],",",Otx2,[,91,],",",TlMP3,#,[,92,],",",squamous,cell,carcinoma,(,LSCC,)}	{NULL}
journal.pone.0072418.pdf	203	{VEGF,#,[,93,]}	{NULL}
journal.pone.0072418.pdf	204	{TGF,-,[,3,[,87,],",",BMP2,[,94,],",",_,_,down-regulation,Notch3,[,67,],down-regulation}	{NULL}
journal.pone.0072418.pdf	205	{HMOX1,[,78,],",",Notch3,[,67,],MyoD,[,24,],miR-378,up-regulation,MyoR,[,24,],",",BMP2,*,[,53,],",",MAPK1,*,[,53,],down-regulation,C2C12,",",skeletal,muscle,*,IGF1,[,95,],down-regulation,lGF1R,[,95,],down-regulation,cardiac,muscle}	{NULL}
journal.pone.0072418.pdf	206	{_,",",_,skeletal,muscle,*,",",vascular,smoothmiR-155,MEF2A,[,96,],",",OLFML3,[,97,],down-regulation,muscle}	{NULL}
journal.pone.0072418.pdf	207	{KDM2B,(,Ndy1/FBXL10,/,_,_,_}	{NULL}
journal.pone.0072418.pdf	208	{let-7,/,miR-101,down-regulation,EZH2,[,98,],down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	209	{JHDM1B,),[,98,]}	{NULL}
journal.pone.0072418.pdf	210	{let-7b,GHR,[,99,],down-regulation}	{NULL}
journal.pone.0072418.pdf	211	{STAT3,[,100,],miR-124a,up-regulation,embryonic,stem,cell,(,ESC,)}	{NULL}
journal.pone.0072418.pdf	212	{_,_,_,skeletal,muscle,",",smooth,muscle,","}	{NULL}
journal.pone.0072418.pdf	213	{mTOR,[,34,],miR-125,down-regulation,IGF-ll,[,34,],",",Cbx7,[,101,],",",SP7,[,102,],down-regulation,ESC}	{NULL}
journal.pone.0072418.pdf	214	{miR-126,Spred-1,[,58,],",",VCAM-1,[,58,],",",IRS-1,[,57,],down-regulation,cardiac,muscle,",",ESC,miR-128a,PPARV,[,36,],",",Runx1,[,36,],",",Pax3,[,36,],down-regulation,skeletal,muscle,miR-130a,GAX,[,103,],",",HOXA5,[,103,],down-regulation,vascular,endothelial,cells,(,ECs,),miR-135,Smad5,[,84,],",",JAK2,#,[,104,],down-regulation,C2C12,",",Hodgkin,lymphoma}	{NULL}
journal.pone.0072418.pdf	215	{SRF,[,105,],",",myocardin,[,105,],miR-143,/,145,up-regulation,SRF,[,25,],",",myocardin,[,25,],",",Nkx2-5,[,25,],down-regulation,smooth,muscle,miR-144,IRS1,[,106,],down-regulation,Type,II,diabetes,mellitus,miR-148a,ROCK1,[,27,],down-regulation,skeletal,muscle,miR-15a,DLK1,[,107,],down-regulation,3T3-L1,preadipocytes,miR-15a,/,16,cyclin,D1,[,108,],down-regulation,skeletal,muscle,miR-181,Hox-A11,[,26,],",",Cbx7,[,101,],down-regulation,skeletal,muscle,",",ESC,miR-199a,Hif-1o,[,37,],",",Sirt1,[,37,],down-regulation,cardiac,muscle,miR-204,Runx2,[,109,],down-regulation,smooth,muscle,miR-208a,Thrap1,[,110,],",",myostatin,[,110,],down-regulation,cardiac,muscle}	{NULL}
journal.pone.0072418.pdf	216	{S,611,",",P,"11,S311,HP-1"}	{NULL}
journal.pone.0072418.pdf	217	{miR-208b,/,499,Hi,:,[,1,mg,I,1,p,I,1,B,down-regulation,muscle}	{NULL}
journal.pone.0072418.pdf	218	{TGF,-,[,3/BMPs,signaling,_}	{NULL}
journal.pone.0072418.pdf	219	{_,_,_,skeletal,muscle,",",cardiac,muscle,","}	{NULL}
journal.pone.0072418.pdf	220	{[,111,],",",p38,[,112,],",",MKP-1,miR-21,up-regulation,PTEN,[,113,],",",PDCD4,[,111,],down-regulation,smooth,muscle}	{NULL}
journal.pone.0072418.pdf	221	{[,112,],Hif1,a,[,114,],miR-210,up-regulation,cardiac,muscle,Myogenin,[,115,],",",MyoD,[,115,],miR-214,up-regulation,Ezh2,[,115,],",",N-Ras,[,40,],down-regulation,C2C12,",",skeletal,muscle,",",ESC,Ras-MAPK,pathway,[,44,],miR-221,up-regulation,p27,[,44,],",",Mdm2,[,116,],down-regulation,skeletal,muscle,",",mesenchymal,cells,Ras-MAPK,pathway,[,44,],miR-222,up-regulation,p27,[,44,],",",[,31-syntrophin,[,117,],down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	222	{_,MAFbx/atrogin,-1,[,33,],",",MuRF1,_}	{NULL}
journal.pone.0072418.pdf	223	{NFATc3,[,118,],miR-23a,down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	224	{[,"33,118",],",",Myh1/2/4,[,32,]}	{NULL}
journal.pone.0072418.pdf	225	{September,2013,[,Volume,8,|,Issue,9,|,e72418}	{NULL}
journal.pone.0072418.pdf	226	{Table,2,(,continued,),.}	{NULL}
journal.pone.0072418.pdf	227	{Transcription,Factors,(,TF,),&,TF,-,miR,MiR,-,targets,Signaling,pathways,microRNA,(,miR,),Relationship,Targets,(,including,Potential,Targets,),Relationship,Tissues,&,CeIls,TGF,-,[,3,[,35,],miR-24,down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	228	{_,_,GSK-313,[,119,],",",Ezh2,[,29,],",",Smad1,[,28,],",",_}	{NULL}
journal.pone.0072418.pdf	229	{C/EBPor,[,119,],miR-26a,up-regulation,down-regulation,skeletal,muscle,",",smooth,muscle}	{NULL}
journal.pone.0072418.pdf	230	{Smad4,[,28,]}	{NULL}
journal.pone.0072418.pdf	231	{Pitx2,[,31,],miR-27a,/,b,down-regulation,MSTN,[,30,],",",Pax3,[,31,],",",myostatin,[,30,],down-regulation,skeletal,muscle,NF-kappa-B-YY1,[,"41,43",],",",HDAC4,[,87,],",",YY1,[,"41,42",],",",Smad3,[,87,],",",_,_,_,_,C2C12,",",skeletal,muscle,",",cardiac}	{NULL}
journal.pone.0072418.pdf	232	{CKD,[,42,],",",TGF-beta-Smad3,miR-29,down-regulation,Smad4,[,121,],",",MMP-2,[,43,],",",COL1A1,down-regulation,_,_,muscle,",",Aneurysm,signaling,[,120,],[,122,],",",ELN,[,122,],",",Rybp,[,123,]}	{NULL}
journal.pone.0072418.pdf	233	{miR-30,CTGF,[,83,],down-regulation,cardiac,muscle}	{NULL}
journal.pone.0072418.pdf	234	{_,skeletal,muscle,",",Duchenne,miR-31,Myf5,[,124,],down-regulation,muscular,dystrophy,miR-320,PFKm,[,125,],down-regulation,muscle,miR-322,/,424,Cdc25A,[,38,],down-regulation,skeletal,muscle,miR-351,E2f3,[,126,],down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	235	{SRF,[,39,],",",MRTF-A,[,39,],",",_,_,_}	{NULL}
journal.pone.0072418.pdf	236	{miR-486,up-regulation,PTEN,[,39,],",",Foxo1,[,39,],",",Pax7,[,89,],down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	237	{MyoD,[,39,]}	{NULL}
journal.pone.0072418.pdf	238	{miR-489,Dek,[,127,],down-regulation,skeletal,muscle,miR-494,mtTFA,[,128,],",",Foxj3,[,128,],down-regulation,skeletal,muscle,miR-503,Cdc25A,[,"38,129",],",",CCNE1,[,129,],down-regulation,skeletal,muscle,miR-546,Mybbp1,a,[,130,],down-regulation,skeletal,muscle,miR-669a,/,669q,MyoD,[,131,],down-regulation,skeletal,muscle,miR-696,PGC-1or,[,132,],down-regulation,skeletal,muscle}	{NULL}
journal.pone.0072418.pdf	239	{STAT3,[,100,],miR-9,up-regulation,ESCs,miR-92a,up-regulation,integrin,or5,[,133,],down-regulation,muscle,",",Ecs}	{NULL}
journal.pone.0072418.pdf	240	{*,.}	{NULL}
journal.pone.0072418.pdf	241	{Identiﬁed,in,pig,#,.}	{NULL}
journal.pone.0072418.pdf	242	{Potential,target,doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	243	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	244	{t002}	{NULL}
journal.pone.0072418.pdf	245	{predicted,and,total,2325,target,genes,were,found,.}	{NULL}
journal.pone.0072418.pdf	246	{The,predictions,were,then,applied,to,analyze,the,KEGG,Orthology,using,the,KEGG,database,.}	{NULL}
journal.pone.0072418.pdf	247	{Thirty,one,significantly,enriched,pathways,(,P-value,<,0.01,),were,picked,out,(,Figure,3A,),.}	{NULL}
journal.pone.0072418.pdf	248	{Particularly,",",the,highly-expressed,miRNAs,involved,in,Wnt,[,45,],",",MAPK,[,46,],",",ErbB,[,47,],",",TGF-beta,[,48,],signaling,pathways,and,Focal,adhesion,[,49,],",",which,are,known,to,be,closely,involved,in,the,regulation,of,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	249	{Furthermore,",",some,pathways,concerned,with,diseases,such,as,Melanoma,",",cancers,and,Hypertrophic,cardiomyopathy,(,HCM,),were,actively,regulated,by,miRNAs,in,muscle,tissues,[,50,],.}	{NULL}
journal.pone.0072418.pdf	250	{To,identify,whether,different,biological,processes,responding,to,different,stages,of,muscle,development,",",KEGG,Orthology,analyses,were,performed,using,predicted,targets,of,DE,miRNAs,at,35,to,77,dpc,(,LR,1-4,),",",77,dpc,to,28,dpn,(,LR4-7,),and,28,to,180,dpn,(,LR7-10,),.}	{NULL}
journal.pone.0072418.pdf	251	{Figure,3B,illustrated,that,most,pathways,with,reported,function,in,regulating,myogenesis,were,significantly,enriched,(,P,<,0.01,),in,the,above,three,developmental,stages,",",including,Wnt,",",MAPK,",",Neurotrophin,",",TGF-beta,",",ErbB,",",Insulin,",",Calcium,",",GnRH,",",T,cell,receptor,signaling,pathways,and,Focal,adhesion,as,well,as,Adherens,junction,.}	{NULL}
journal.pone.0072418.pdf	252	{In,particular,",",two,well-known,signaling,pathways,that,Wnt,and,MAPK,were,both,highly,enriched,in,all,of,the,three,stages,.}	{NULL}
journal.pone.0072418.pdf	253	{Comparing,these,pathways,among,the,three,stages,",",Wnt,",",the,most,differently,expressed,signaling,pathway,",",was,significantly,enriched,throughout,the,muscle,development,",",with}	{NULL}
journal.pone.0072418.pdf	254	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0072418.pdf	255	{p,|,osone.org}	{NULL}
journal.pone.0072418.pdf	256	{Table,3,.}	{NULL}
journal.pone.0072418.pdf	257	{The,numbers,of,differentially,expressed,miRNAs,between,libraries,.}	{NULL}
journal.pone.0072418.pdf	258	{Numbers,of,differentially,expressed,miRNAs}	{NULL}
journal.pone.0072418.pdf	259	{The,comparison,between,adjacent,Total,DE,miRNAs,-,Total,DE,miRNAslibraries,Total,DE,miRNAs,up,down,LR2,/,1,75,38,37,LR3/2,9,2,7,LR4/3,15,4,1,1,LR5/4,20,15,5,LR6/5,61,7,54,LR7/6,74,5,69,LR8/7,47,8,39,LR9/8,1,18,1,16,2,LR1,0/9,1,05,1,104,LR,",",Landrace,;,DE,",",differentially,expressed,(,P,<,0.01,|,log2fold-change,|,>,2,),;,up,",",up,regulation,;,down,",",down,regulation,doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	260	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	261	{t003}	{NULL}
journal.pone.0072418.pdf	262	{the,highest,expression,at,28,to,180,dpn,",",the,second,at,77dpc,to,28,dpn,",",and,the,least,at,35,to,77,dpc,.}	{NULL}
journal.pone.0072418.pdf	263	{However,",",MAPK,signaling,pathway,expressed,at,the,same,level,in,all,stages,.}	{NULL}
journal.pone.0072418.pdf	264	{Other,pathways,such,as,TGF-beta,and,Calcium,signaling}	{NULL}
journal.pone.0072418.pdf	265	{September,2013,[,Volume,8,|,Issue,9,|,e72418}	{NULL}
journal.pone.0072418.pdf	266	{LR,1-4,(,86,)}	{NULL}
journal.pone.0072418.pdf	267	{LR,4-7,(,120,)}	{NULL}
journal.pone.0072418.pdf	268	{Figure,2,.}	{NULL}
journal.pone.0072418.pdf	269	{overlapping,areas,shows,the,common,DE,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	270	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	271	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	272	{g002}	{NULL}
journal.pone.0072418.pdf	273	{pathways,showed,more,differences,in,different,stages,",",and,Insulin,",",GnRH,and,ErbB,signaling,pathways,were,just,the,opposite,.}	{NULL}
journal.pone.0072418.pdf	274	{Notably,",",almost,all,pathways,showed,s,similar,expression,pattern,in,two,waves,of,myofiber,maturation,:,myofiber,transformation,and,hypertrophy,",",suggesting,their,closer,relationship,in,terms,of,myogenic,regulation,.}	{NULL}
journal.pone.0072418.pdf	275	{Furthermore,",",we,refined,a,more,detailed,KEGG,Orthology,analysis,using,predicted,targets,of,DE,miRNAs,in,Table,3,between,two,time,points,contributing,to,describing,the,different,developmental,phases,of,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	276	{The,significant,pathways,(,P,<,0.05,),related,to,muscle,development,were,listed,in,Table,4,",",most,of,which,have,been,identified,according,to,the,most,abundant,miRNAs,(,Figure,3A,),.}	{NULL}
journal.pone.0072418.pdf	277	{Further,analysis,of,these,pathways,suggested,three,clusters,of,enrichment,by,using,SPSS,",",setting,values,for,statistic,significance,(,’,P,<,0.05,and,"\\"",‘,P,<,0.01,were,assigned,1,and,1.5,",",respectively,",",using,o,where,no,significance,was,detected,),2,A,),with,universal,enrichment,",",including,Adherens,junction,",",Focal,adhesion,",",Adipocytokine,",",GnRH,",",Insulin,",",Notch,",",p53,",",Phosphatidylinositol,",",TGF-beta,",",VEGF,and,Wnt,signaling,pathways,;,B,),with,more,enrichment,during,prenatal,myogenesis,",",including,Axon,guidance,",",Gap,junction,",",Melanogenesis,and,Neurotrophin,signaling,pathways,;,C,),with,more,enrichment,during,postnatal,myogenesis,","}	{NULL}
journal.pone.0072418.pdf	278	{Comparison,of,differentially,expressed,(,DE,),miRNAs,among,three,data,sets,.}	{NULL}
journal.pone.0072418.pdf	279	{LR,7-10,(,143,)}	{NULL}
journal.pone.0072418.pdf	280	{The,number,marked,in,the,including,Calcium,",",Chemokine,",",ErbB,",",Hedgehog,",",mTOR,",",T,cell,receptor,and,MAPK,signaling,pathways,(,Table,4,),.}	{NULL}
journal.pone.0072418.pdf	281	{Clustering,miRNA,expression,We,used,the,Short,Time-series,Expression,Miner,(,v,1.1,",",STEM,),[,51,],to,cluster,temporal,proﬁles,of,miRNA,expression,during,muscle,ﬁber,formation,at,35,to,77,doc,(,LR1-4,),as,well,as,fiber,further,maturation,at,77,dpc,to,180,dpn,(,LR4-10,),.}	{NULL}
journal.pone.0072418.pdf	282	{After,that,a,total,of,57,out,of,87,DE,miRNAs,(,65.5,%,of,87,DE,miRNAs,;,Table,85,),observed,at,35,to,77,dpc,were,significantly,clustered,into,three,kinds,of,expression,patterns,(,11.5,%,of,26,clusters,;,Figure,4A,),",",while,112,out,of,166,DE,miRNAs,(,67.5,%,of,166,DE,miRNAs,;,Table,85,),observed,at,77,dpc,to,180,dpn,were,significantly,clustered,into,two,kinds,of,expression,patterns,(,4,%,of,50,clusters,;,Figure,4B,",",the,default,P-value,was,1E-5,),.}	{NULL}
journal.pone.0072418.pdf	283	{Figure,4C,showed,miRNA,expression,profiles,for,the,five,clusters,found,to,be,significant,out,of,76,possible,clusters,successively,.}	{NULL}
journal.pone.0072418.pdf	284	{The,cardinality,of,each,cluster,was,ranged,from,7,DE,miRNAs,in,cluster,3,to,80,in,cluster,4,(,Table,86,),.}	{NULL}
journal.pone.0072418.pdf	285	{Visual,examination,of,these,clusters,suggested,that,down-regulated,DE,miRNAs,were,distributed,both,Cluster,1,and,3,while,Cluster,2,included,DE,miRNAs,that,showed,more,gradual,increase,",",which,peaked,at,63,to,77,dpc,during,myofiber,formation,.}	{NULL}
journal.pone.0072418.pdf	286	{STEM}	{NULL}
journal.pone.0072418.pdf	287	{Neurotrophin,signaling,pathway,Wnt,signaling,pathway,Pathways,in,cancer,Axon,guidance,Oocyte,meiosis,Chronic,myeloid,leukemia,Long-term,potentiation,Melanogenesis,Melanoma,Endocrine,and,other,factor-regulated,calcium,reabsorption,Ubiquitin,mediated,proteolysis,Renal,cell,carcinoma,Bacterial,invasion,of,epithelial,cells,MAPK,signaling,pathway,Dopaminergic,synapse,Focal,adhesion,Dilated,cardiomyopathy,Cholinergic,synapse,Transcriptional,misregulation,in,cancer,Gap,junction,Glioma,Regulation,of,actln,cytoskeleton,ErbB,signaling,pathway,Retrograde,endocannabinoid,signaling,Arrhythmogenic,right,ventricular,cardiomyopathy,(,ARVC,),TGF-beta,signaling,pathway,Aldosterone-regulated,sodium,reabsorption,Basal,cell,carcinoma,Dorso-ventral,axis,formation,Hypertrophic,cardlomyopathy,(,HCM,),Prostate,cancer}	{NULL}
journal.pone.0072418.pdf	288	{KEGG,Pathways}	{NULL}
journal.pone.0072418.pdf	289	{2,Top,25,miRNAs}	{NULL}
journal.pone.0072418.pdf	290	{-,|,g,(,P-value,)}	{NULL}
journal.pone.0072418.pdf	291	{B,Axon,guidance,Pathways,in,cancer,Wnt,signaling,pathway,MAPK,signaling,pathway,Neurotrophin,signaling,pathway,Chronic,myeloid,leukemia,Focal,adhesion,ErbB,signaling,pathway,Glioma,Prostate,cancer,Adherens,junction,Regulation,of,actin,cytoskeleton,Acute,myeloid,leukemia,Melanogenesis,TGF-beta,signaling,pathway,T,cell,receptor,signaling,pathway,Melanoma,insulin,signaling,pathway,Arrhythmogenic,right,ventricular,cardiomyopathy,(,ARVC,),Gapjunction,Glycosaminoglycan,biosynthesis,-,keratan,sulfate,Calcium,signaling,pathway,GABAergic,synapse,GnRH,signaling,pathway,Endocrine,and,other,factor-regulated,calcium,reabsorption,Oocyte,meiosis,Protein,processing,in,endoplasmic,reticulum,Dilated,cardiomyopathy,Type,II,diabetes,mellitus,mRNA,surveillance,pathway,Tightjunction}	{NULL}
journal.pone.0072418.pdf	292	{KEGG,Pathways}	{NULL}
journal.pone.0072418.pdf	293	{-,lg,(,P-value,)}	{NULL}
journal.pone.0072418.pdf	294	{Figure,3,.}	{NULL}
journal.pone.0072418.pdf	295	{KEGG,Orthology,analysis,of,the,most,abundant,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	296	{A.,31,significantly,enriched,KEGG,pathways,were,achieved,using,the,target,genes,of,the,most,abundant,25,miRNAs,(,not,including,let-7,family,),in,ten,libraries,;,B.,comparison,of,KEGG,pathways,significantly,enriched,during,skeletal,muscle,development,at,35,to,77dpc,(,LR,1-4,),",",77dpc,to,28,dpn,(,LR,4-7,),and,28,to,180,dpn,(,LR,7-10,),.}	{NULL}
journal.pone.0072418.pdf	297	{P-value,<,0.01,.}	{NULL}
journal.pone.0072418.pdf	298	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	299	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	300	{g003}	{NULL}
journal.pone.0072418.pdf	301	{also,clustered,biphasic,responding,DE,miRNAs,in,Cluster,4,and,down-regulated,DE,miRNAs,in,Cluster,5,during,myofiber,further,maturation,from,77,dpc,to,180,dpn,.}	{NULL}
journal.pone.0072418.pdf	302	{Similar,expression,pattern,could,be,associated,with,functional,correlation,to,a,certain,extent,.}	{NULL}
journal.pone.0072418.pdf	303	{Notably,",",in,addition,to,porcine,myomiRs,(,miR-1,",",-206,",",-133,a-3p,/,a-5p,/,b,),",",three,other,miRNAs,(,miR-128,",",-208,b,and,-378,),reported,to,be,related,to,muscle,development,in,other,mammals,were,also,included,in,up-regulation,Cluster,2,",",suggesting,their,roles,in,the,regulation,of,porcine,embryonic,myogenesis,at,35,to,77,dpc,.}	{NULL}
journal.pone.0072418.pdf	304	{However,",",Cluster,5,illustrated,that,ssc-miR-206,and,other,four,musclerelated,miRNAs,(,ssc-miR-126,",",-148,a/b,and,-15,b,),continued,to,decline,while,ssc-miR-133b,and,eleven,other,muscle-related,miRNAs,(,ssc-miR-125b,",",-128,",",-181,a/b,",",-199,a,",",-214,",",-23,a,",",-24,",",-424,",",-503,and,-7,),in,Cluster,4,presented,a,down,and,then,up,trend,from,77,dpc,to,180,dpn,",",suggesting,their,different,roles,played,in,adult,fiber,maturation,.}	{NULL}
journal.pone.0072418.pdf	305	{Moreover,",",parts,of,these,miRNA,expression,proﬁles,during,10,developmental,stages,were,illustrated,in,Figure,5,",",providing,the,possibility,for,further,research,into,miRNAs,that,had,similar,expression,profiles,with,muscle-related,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	306	{Validation,of,the,Sequencing,data,Stem-loop,quantitative,RT-PCR,was,applied,to,validate,the,sequencing,data,.}	{NULL}
journal.pone.0072418.pdf	307	{Choosing,an,appropriate,set,of,endogenous,control,(,EC,),miRNA,genes,is,crucial,",",for,EC,genes,are,widely,used,to,normalize,the,miRNA,q-PCR,data,",",which,are,expected,to,express,constantly,at,all,stages,of,development,of,one,or,more,tissues,.}	{NULL}
journal.pone.0072418.pdf	308	{Although,U6,snRNA,is,one,of,the,most,widely,used,internal,control,",",Gu,et,al.,demonstrated,that,the,U6,gene,was,the,least,stable,gene,compared,with,other,candidate,EC,genes,in,all,tissues,(,including,muscle,tissues,),comparing,with,miR,—,17,",",-103,",",-107,and,-23,a,[,52,],.}	{NULL}
journal.pone.0072418.pdf	309	{Hence,",",the,optimal,EC,gene,from,above,candidates,was,studied,by,calculating,the,standard,deviation,(,Stdev,.,)}	{NULL}
journal.pone.0072418.pdf	310	{of,four,genes,in,all,samples,when,the,fifth,was,supposed,to,be,an,EC,gene,(,Figure,83,),.}	{NULL}
journal.pone.0072418.pdf	311	{As,a,consequence,",",miR-17-5p,was,actually,the,most,stable,gene,(,Stdev,.}	{NULL}
journal.pone.0072418.pdf	312	{=,0.1,),",",while,the,U6,gene,was,the,least,stable,gene,(,Stdev,.}	{NULL}
journal.pone.0072418.pdf	313	{=,4.9,),",",consistent,with,the,previous,study,[,52,],.}	{NULL}
journal.pone.0072418.pdf	314	{Stemloop,quantitative,RT-PCR,was,then,performed,on,9,random,miRNAs,with,different,expression,levels,(,miR-1,",",-206,",",-133,a-3p,",",-133,a-5p,",",-133,b,",",-378,",",-214,",",-744,and,let-7f,),to,validate,the,sequencing,data,(,Figure,6,),.}	{NULL}
journal.pone.0072418.pdf	315	{Stem-loop,RT-PCR,primers,were,presented,in,Table,S7,.}	{NULL}
journal.pone.0072418.pdf	316	{The,Pearson,correlation,coefficient,of,the,Real-time,PCR,and,the,Solexa,sequencing,was,calculated,and,the,r,values,ranged,from,0.84,to,0.95,",",indicating,that,there,was,a,high,consistency,between,the,two,methods,.}	{NULL}
journal.pone.0072418.pdf	317	{Discussion}	{NULL}
journal.pone.0072418.pdf	318	{Since,pigs,are,important,farm,animals,and,are,suitable,models,for,studying,human,diseases,",",we,herein,presented,the,systematical,porcine,miRNAome,at,ten,important,developmental,stages,of,skeletal,muscle,using,Solexa,sequencing,.}	{NULL}
journal.pone.0072418.pdf	319	{A,total,of,247,known,and,297,potential,novel}	{NULL}
journal.pone.0072418.pdf	320	{Table,4,.}	{NULL}
journal.pone.0072418.pdf	321	{KEGG,Orthology,enriched,for,target,genes,of,DE,miRNAs,between,different,libraries,.}	{NULL}
journal.pone.0072418.pdf	322	{Pathway,LR2I1,LR3I2,LR4I3,LR5I4,LR6I5,LR7I6,LR8I7,LR9l8,LR10l9,up,down,up,down,up,down,up,down,up,down,up,down,up,down,up,down,up,down,Adherens,junction,*,**,*,*,*,*,**,*,**,**,Adipocytokine,signaling,pathway,*,*,*,*,**,*,Axon,guidance,*,H,*,H,.}	{NULL}
journal.pone.0072418.pdf	323	{H,.}	{NULL}
journal.pone.0072418.pdf	324	{H,.}	{NULL}
journal.pone.0072418.pdf	325	{H,H,H,H,H,H,Calcium,signaling,pathway,*,**,*,**,*,**,**,Chemokine,signaling,pathway,*,*,*,ErbB,signaling,pathway,**,**,*,**,**,*,**,**,**,Focal,adhesion,H,H,.}	{NULL}
journal.pone.0072418.pdf	326	{H,.}	{NULL}
journal.pone.0072418.pdf	327	{H,H,H,H,H,H,H,H,Gan,junction,H,H,H,.}	{NULL}
journal.pone.0072418.pdf	328	{H,H,.}	{NULL}
journal.pone.0072418.pdf	329	{H,H,*,GnRH,signaling,pathway,H,H,". . .",H,.}	{NULL}
journal.pone.0072418.pdf	330	{.}	{NULL}
journal.pone.0072418.pdf	331	{H,H,H,H,Hedgehog,signaling,pathway,*,*,*,*,*,Insulin,signaling,pathway,**,**,**,**,**,**,**,**,**,MAPK,signaling,pathway,**,**,*,**,**,**,**,**,Melanogenesis,H,H,H,H,.}	{NULL}
journal.pone.0072418.pdf	332	{H,H,H,H,H,H,.}	{NULL}
journal.pone.0072418.pdf	333	{H,H,H,mTOR,signaling,pathway,*,**,*,*,*,Neurotropnin,Signaling,pathway,H,H,H,.}	{NULL}
journal.pone.0072418.pdf	334	{H,H,.}	{NULL}
journal.pone.0072418.pdf	335	{H,H,H,H,H,H,Notch,signaling,pathway,**,p53,signaling,pathway,*,*,*,*,*,*,Phosphatidylinositol,signaling,system,*,*,**,**,*,*,T,cell,receptor,signaling,pathway,**,*,**,**,**,TGF-beta,signaling,pathway,**,*,**,*,*,**,**,**,**,**,**,VEGF,signaling,pathway,*,Wnt,signaling,pathway,H,H,H,.}	{NULL}
journal.pone.0072418.pdf	336	{H,.}	{NULL}
journal.pone.0072418.pdf	337	{H,.}	{NULL}
journal.pone.0072418.pdf	338	{H,H,H,H,H,Asterisk,indicated,the,signiﬁcant,enrichment,of,KEGG,pathways,(,*,p,valued,<,0.05,;,**,p,value,<,0.01,),doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	339	{pone,.00724181004}	{NULL}
journal.pone.0072418.pdf	340	{miRNAs,were,identified,.}	{NULL}
journal.pone.0072418.pdf	341	{247,known,porcine,miRNAs,were,substituted,as,257,mature,porcine,miRNAs,in,miRBase,18.0,for,further,analysis,.}	{NULL}
journal.pone.0072418.pdf	342	{Similar,to,the,work,of,McDane,|,d,et,al.,[,14,],",",this,study,aimed,at,studying,the,mechanism,of,skeletal,muscle,development,in,swine,through,analysis,of,miRNA,transcriptome,profiles,at,designed,different,developmental,stages,.}	{NULL}
journal.pone.0072418.pdf	343	{In,addition,",",we,both,focused,on,the,changes,in,abundance,of,myomiRs,(,miR-1,",",-206,and,-133,),during,swine,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	344	{Contrarily,",",different,developmental,stages,were,used,to,study,muscle,development,in,the,two,investigations,.}	{NULL}
journal.pone.0072418.pdf	345	{Moreover,",",the,proliferating,satellite,cells,were,employed,in,the,previous,work,",",which,might,be,complement,each,other,and,contribute,to,revealing,the,expression,profiles,and,biological,function,of,miRNA,during,swine,skeletal,muscle,development,more,comprehensively,.}	{NULL}
journal.pone.0072418.pdf	346	{Unlike,the,previous,work,",",the,present,study,paid,more,attention,to,the,most,abundant,miRNAs,",",but,not,limited,to,the,well-studied,myomiRs,",",which,have,been,proven,to,play,important,roles,during,swine,skeletal,muscle,development,",",consistent,with,the,conclusion,that,functional,miRNAs,tend,to,be,highly,expressed,[,19,],.}	{NULL}
journal.pone.0072418.pdf	347	{The,sequencing,data,was,then,verified,by,stem,—,|,oop,quantitative,RT-PCR,.}	{NULL}
journal.pone.0072418.pdf	348	{Moreover,",",the,abundance,of,the,top,15,miRNAs,were,found,to,be,the,majority,of,total,reads,in,each,library,(,Figure,S2,),.}	{NULL}
journal.pone.0072418.pdf	349	{KEGG,Orthology,analysis,of,the,most,abundant,25,common,miRNAs,(,excluding,let-7,family,),from,10,libraries,indicated,that,their,involvement,in,the,regulation,of,canonical,myogenesis-related,pathways,and,diseases,(,Figure,5,),.}	{NULL}
journal.pone.0072418.pdf	350	{lntriguingly,",",11,of,the,25,common,miRNAs,were,reported,to,function,as,muscle-related,miRNAs,including,the,well-known,myomiRs,(,miR-1,",",-206,and,-133,family,),.}	{NULL}
journal.pone.0072418.pdf	351	{Therefore,",",it,is,reasonable,to,hypothesize,that,the,functional,miRNA,",",in,terms,of,mediating,target,suppression,to,regulate,myogenesis,and,muscle,diseases,",",tended,to,express,abundantly,.}	{NULL}
journal.pone.0072418.pdf	352	{Currently,",",differently,expressed,(,DE,),miRNAs,were,thought,to,be,closely,related,to,almost,all,aspects,of,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	353	{In,this,study,",",a,total,of,183,DE,miRNAs,between,different,libraries,were,identified,.}	{NULL}
journal.pone.0072418.pdf	354	{Ssc-miR-1,was,the,most,abundant,miRNA,in,ten,libraries,",",consistent,with,the,wellestablished,function,of,miR-1,during,skeletal,muscle,development,[,21,],.}	{NULL}
journal.pone.0072418.pdf	355	{Interestingly,",",the,second,abundant,DE,miRNA,was,miR-378,",",a,new,candidate,miRNA,for,myogenesis,in,pigs,by,down-regulating,porcine,BMP2,or,MAPK1,[,53,],.}	{NULL}
journal.pone.0072418.pdf	356	{Another,DE,miRNA,(,miR-148a,),",",whose,average,abundance,before,birth,was,eight,times,higher,than,that,in,postnatal,",",might,be,a,part,of,mechanism,implicated,in,differences,between,embryonic,myogenesis,and,adult,myofiber,maturation,.}	{NULL}
journal.pone.0072418.pdf	357	{Exceptions,were,some,previously,reported,muscle-related,miRNAs,such,as,miR-181c,/,d-5p,",",miR-29b,/,c,",",miR-221,/,222,and,miR-208,",",all,of,which,expressed,at,a,very,low,level,(,average,RPM,<,100,),.}	{NULL}
journal.pone.0072418.pdf	358	{In,addition,to,highly,expressed,myomiRs,",",the,expression,of,muscle-related,miRNAs,was,varied,in,pigs,",",suggesting,that,highly,expressed,muscle-related,miRNAs,that,have,been,validated,in,other,species,should,be,the,first,priority,in,studying,porcine,skeletal,muscle,development,",",followed,by,the,muscle-related,miRNAs,expressed,at,lower,levels,.}	{NULL}
journal.pone.0072418.pdf	359	{A,Prairies,ordered,based,on,the,irvalue,signlfrcanoe,or,numberof,genes,assigned,versus,expected}	{NULL}
journal.pone.0072418.pdf	360	{4,PBQ,m,1,%,o,24,—,3,C,¥,a,—,2e,.}	{NULL}
journal.pone.0072418.pdf	361	{.}	{NULL}
journal.pone.0072418.pdf	362	{—,.}	{NULL}
journal.pone.0072418.pdf	363	{7,M,Be-3,J,0.2,0.3,%}	{NULL}
journal.pone.0072418.pdf	364	{16,9,15,o,17,1/o,"\\\\",/,0.4,0.5,0.6,0.6,M,0.7,0.9,12,1/p,"\\\\",11,7,25,10,22,:17,—,r,1,o,1,o,1,o,1,T,1,U,k,1,U,2,V,2,5,e,13,14,C,O,"\\\\",/,5,"\\\\",/,"\\\\",1,%,1.0,1,.}	{NULL}
journal.pone.0072418.pdf	365	{1,.}	{NULL}
journal.pone.0072418.pdf	366	{1.0,1.0,E,L,O,‘,IL,o.,»,.}	{NULL}
journal.pone.0072418.pdf	367	{o,U,:,o,E}	{NULL}
journal.pone.0072418.pdf	368	{Promes,ordered,based,on,the,pvalue,significance,or,number,of,genes,assigned,versus,expected,4,5,may,:1,/,"\\\\",_,/,"\\\\",43,2,"\\\\",1,/,.}	{NULL}
journal.pone.0072418.pdf	369	{—,.}	{NULL}
journal.pone.0072418.pdf	370	{/,"\\\\",7,26,23,$,2e2,3e2,1,0.1,L,m,04,06}	{NULL}
journal.pone.0072418.pdf	371	{9,.9,9,U,9,p,m,1,o,M,",",","}	{NULL}
journal.pone.0072418.pdf	372	{W,"}",K,/,"\\\\",/,28,1,o,1,D}	{NULL}
journal.pone.0072418.pdf	373	{‘”,>,“,fT,%,:,‘,?}	{NULL}
journal.pone.0072418.pdf	374	{f,§}	{NULL}
journal.pone.0072418.pdf	375	{er,s,20,15,i,"\\\\","\\\\",/,15,14,4,10,I1,10,1,"\\\\",(,J,"\\\\",7,I,10,5,"30,1",10,27,A,1,13,W,19,6,1,(,1,),:,10,V,m,10,1.0,10,W,10,',18,11,48,:,M}	{NULL}
journal.pone.0072418.pdf	376	{Myoﬁber,maturation,(,LR,4-10,)}	{NULL}
journal.pone.0072418.pdf	377	{Log2,expression,change,ration,to,control,Log2,expression,change,ration,to,control,Log2,expression,change,ration,to,control}	{NULL}
journal.pone.0072418.pdf	378	{12,_,T3,Cluster,2:24,DE,miRNAs}	{NULL}
journal.pone.0072418.pdf	379	{6,1,E,2,E,1,‘,e,o,P,!}	{NULL}
journal.pone.0072418.pdf	380	{D,m,é,’,o,p,m,‘,Q,35,dpc,49,dpc,63,dpc,77,dpc}	{NULL}
journal.pone.0072418.pdf	381	{",9",.5,—,l,E,-2,E,‘,G,)}	{NULL}
journal.pone.0072418.pdf	382	{-12,%,i,),‘,4,","}	{NULL}
journal.pone.0072418.pdf	383	{3,Library,5,_,Cluster,3:7,DE,miRNAs}	{NULL}
journal.pone.0072418.pdf	384	{O,l}	{NULL}
journal.pone.0072418.pdf	385	{35,dp,63,dpc,77,dpc,.5,—,C,7,‘,‘,*,‘}	{NULL}
journal.pone.0072418.pdf	386	{Library}	{NULL}
journal.pone.0072418.pdf	387	{Cluster,4,:,80,DE,miRNAs,2,Cluster,5,:,32,DE,miRNAs}	{NULL}
journal.pone.0072418.pdf	388	{Log2,expression,change,ration,to,control}	{NULL}
journal.pone.0072418.pdf	389	{Library,Library}	{NULL}
journal.pone.0072418.pdf	390	{Figure,4,.}	{NULL}
journal.pone.0072418.pdf	391	{Clustering,of,miRNA,expression,profiles,.}	{NULL}
journal.pone.0072418.pdf	392	{A,.}	{NULL}
journal.pone.0072418.pdf	393	{—,.}	{NULL}
journal.pone.0072418.pdf	394	{B.,Each,box,corresponded,to,a,model,expression,profile,and,only,colored,profiles,reached,statistical,significance,.}	{NULL}
journal.pone.0072418.pdf	395	{The,upper-left,number,in,the,box,gave,information,about,the,order,of,profile,(,upper,left,),and,the,p-value,significance,(,bottom,left,),.}	{NULL}
journal.pone.0072418.pdf	396	{A.,26,clusters,of,87,DE,miRNAs,during,myofiber,formation,",",the,first,three,of,which,showed,statistically,significant,;,B.,50,clusters,of,166,DE,miRNAs,during,myofiber,maturation,",",the,ﬁrst,two,of,which,showed,statistically,significant,.}	{NULL}
journal.pone.0072418.pdf	397	{C.,Five,signiﬁcant,clusters,of,miRNA,proﬁles,during,myofiber,formation,(,cluster,1-3,),and,myofiber,maturation,(,cluster,4-5,),were,displayed,as,time,course,plots,of,log,2miRNA,expression,ratios,to,controls,.}	{NULL}
journal.pone.0072418.pdf	398	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	399	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	400	{g004}	{NULL}
journal.pone.0072418.pdf	401	{Next,",",target,prediction,and,KEGG,Orthology,analysis,of,stage-specific,DE,miRNAs,might,suggest,that,myofiber,formation,and,maturation,were,controlled,by,multiple,signal,pathways,in,different,ways,",",suggesting,that,different,molecular,regulation,mechanism,underlined,different,biological,processes,.}	{NULL}
journal.pone.0072418.pdf	402	{In,particular,",",the,two,waves,of,myofiber,maturation,:,myofiber,transformation,and,hypertrophy,showed,a,closer,relationship,in,myogenic,regulation,",",providing,a,possibility,to,undergo,subsequent,STEM,clustering,by,combining,them,.}	{NULL}
journal.pone.0072418.pdf	403	{Furthermore,",",a,more,detailed,KEGG,Orthology,analysis,of,DE,miRNAs,between,two,time,points,identified,a,list,of,pathways,participating,in,the,regulation,of,myogenesis,and,related,diseases,",",suggesting,that,DE,miRNAs,were,tightly,related,with,biological,processes,at,different,stages,of,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	404	{For,example,",",Wnt,signaling,pathway,involved,in,embryonic,myogenesis,and,in,regulating,the,homeostasis,of,adult,muscle}	{NULL}
journal.pone.0072418.pdf	405	{PLOS,ONE,|,www,.}	{NULL}
journal.pone.0072418.pdf	406	{p,|,osone.org}	{NULL}
journal.pone.0072418.pdf	407	{[,45,],",",resulting,its,universal,enrichment,from,embryonic,to,adult,myofiber,maturation,.}	{NULL}
journal.pone.0072418.pdf	408	{Calcium,signaling,",",though,with,less,attention,",",was,considered,potential,mediators,of,postnatal,muscle,development,and,hypertrophy,[,54,],",",giving,some,indication,for,more,enrichment,during,postnatal,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	409	{An,exception,was,Notch,signaling,pathway,",",though,it,was,classified,to,the,category,with,universal,enrichment,",",only,expressed,highly,during,late,embryogenesis,.}	{NULL}
journal.pone.0072418.pdf	410	{However,",",previous,studies,have,showed,its,crucial,role,not,only,for,embryogenesis,but,for,muscle,maintenance,and,repair,in,the,adult,[,55,],.}	{NULL}
journal.pone.0072418.pdf	411	{One,reason,might,explain,the,difference,is,that,there,is,still,plenty,of,unknown,information,about,miRNA,",",resulting,insufﬁciency,of,its,functional,annotation,.}	{NULL}
journal.pone.0072418.pdf	412	{In,general,",",integrated,analysis,of,sequencing,results,and,biological,pathway,information,might,add,insight,into,the,vital,roles,played,by,miRNA,during,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	413	{However,","}	{NULL}
journal.pone.0072418.pdf	414	{a,:,m,+,£,7,!}	{NULL}
journal.pone.0072418.pdf	415	{-,ssc-rrrir-1,-,ssc-rnir,»,133a-3p,-,ssc-rnir,»,378}	{NULL}
journal.pone.0072418.pdf	416	{<,11,m,+,Ln,A,m,+,or,m,m,«,m,M,m,+,£,7,!}	{NULL}
journal.pone.0072418.pdf	417	{Normalized,expression,(,RPM,),$,5,‘,+,+,on,4,:,.}	{NULL}
journal.pone.0072418.pdf	418	{Normalized,expression,(,RPM,)}	{NULL}
journal.pone.0072418.pdf	419	{__,uuIiuJ,Jlllllllll,.}	{NULL}
journal.pone.0072418.pdf	420	{N,m,+,on,ll}	{NULL}
journal.pone.0072418.pdf	421	{<,3,‘,+,s}	{NULL}
journal.pone.0072418.pdf	422	{X,ssc,~,mir,~,133b,Z,ssc,»,mrr-411,Z,ssc-mir-128,.}	{NULL}
journal.pone.0072418.pdf	423	{iI,.}	{NULL}
journal.pone.0072418.pdf	424	{l,“,lI,.}	{NULL}
journal.pone.0072418.pdf	425	{LI,.}	{NULL}
journal.pone.0072418.pdf	426	{Jllllllllll}	{NULL}
journal.pone.0072418.pdf	427	{Z,ssc-mlr-206,Z,ssc-mlr-127}	{NULL}
journal.pone.0072418.pdf	428	{$,+,s,to,m,+,(,.3,on,m,+,on}	{NULL}
journal.pone.0072418.pdf	429	{4e,+3}	{NULL}
journal.pone.0072418.pdf	430	{Ze,+2,‘,',~,1e,+2,o,Normalized,expression,(,RPM,),I,"\\\\",),m,+,«,.3,C,)}	{NULL}
journal.pone.0072418.pdf	431	{LR1,LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9,LR10,LR1}	{NULL}
journal.pone.0072418.pdf	432	{Libraries}	{NULL}
journal.pone.0072418.pdf	433	{LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9,LR10}	{NULL}
journal.pone.0072418.pdf	434	{Libraries,l.,Rl,LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9,LR10}	{NULL}
journal.pone.0072418.pdf	435	{Libraries}	{NULL}
journal.pone.0072418.pdf	436	{1e,+5}	{NULL}
journal.pone.0072418.pdf	437	{2e,+5,I,ssrrmir-10a,-,sso-mir-140,‘}	{NULL}
journal.pone.0072418.pdf	438	{“,*,5,-,ssrrmir-9-2,A,1e,+5,g,-,ssrrrnir-9-1,E,u,_,1e,+5,-,ssr,:,.}	{NULL}
journal.pone.0072418.pdf	439	{—,.}	{NULL}
journal.pone.0072418.pdf	440	{mir-23b,1,3544,E,",",Z,ssc,—,mIr,—,27b,‘’,E,1e,+5,8,k,BM,3,6e,+4,2,2,%,59,*,‘,3,;,4e,+4,3,4e,+4,E,.8,N,E,=,2e,+4,E,2e,+4,E,‘,5,1,.}	{NULL}
journal.pone.0072418.pdf	441	{zsen,I,_,.}	{NULL}
journal.pone.0072418.pdf	442	{.}	{NULL}
journal.pone.0072418.pdf	443	{u,-.1,-,.}	{NULL}
journal.pone.0072418.pdf	444	{.}	{NULL}
journal.pone.0072418.pdf	445	{-,I.,_,L.,.}	{NULL}
journal.pone.0072418.pdf	446	{n.,_,....,_,l,-,.}	{NULL}
journal.pone.0072418.pdf	447	{-,__,219,”,5,&,2,o,.}	{NULL}
journal.pone.0072418.pdf	448	{o}	{NULL}
journal.pone.0072418.pdf	449	{LR,],LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9,LR10}	{NULL}
journal.pone.0072418.pdf	450	{Libraries}	{NULL}
journal.pone.0072418.pdf	451	{Figure,5,.}	{NULL}
journal.pone.0072418.pdf	452	{l,lllJ1,.}	{NULL}
journal.pone.0072418.pdf	453	{i.,.}	{NULL}
journal.pone.0072418.pdf	454	{J.,...,Jlllllllllllll,LR1,LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9,LR10}	{NULL}
journal.pone.0072418.pdf	455	{Libraries}	{NULL}
journal.pone.0072418.pdf	456	{Expression,profiles,of,candidate,myogenic,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	457	{to,‘,E,A}	{NULL}
journal.pone.0072418.pdf	458	{1,ssc-mir-148a,Z,ssc-mir-148b,Z,ssc,~,mir,~,542-3p,Z,ssc,»,|,eI-7a,Z,ssc,»,mir-30a-5p,Z,ssc-mir-30e-5p,I,ssc-mrr-30d,Z,ssc-mir-126,Z,ssc-mir-103,1,ssc-mir-107}	{NULL}
journal.pone.0072418.pdf	459	{N,‘,E,.}	{NULL}
journal.pone.0072418.pdf	460	{.}	{NULL}
journal.pone.0072418.pdf	461	{Ix,),m,+,s,Normalized,expression,(,RPM,),N,U.,A,‘,E,‘,E,',3,iv,14,),s,5,‘,+,N}	{NULL}
journal.pone.0072418.pdf	462	{‘,I,|,|,N,I,_,I}	{NULL}
journal.pone.0072418.pdf	463	{LR,],LR2,LR3,LR4,LR5,LR6,LR7,LR8,LR9}	{NULL}
journal.pone.0072418.pdf	464	{Libraries}	{NULL}
journal.pone.0072418.pdf	465	{Based,on,STEM,results,",",DE,miRNAs,that,had,similar,expression,profiles,with,muscle-related,miRNAs,were,selected,and,clustered,into,six,distinctive,types,of,expression,patterns,during,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	466	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	467	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	468	{g005}	{NULL}
journal.pone.0072418.pdf	469	{comprehensive,information,about,miRNA,is,still,lacking,",",such,as,insufficiency,of,functional,analysis,",",which,requires,more,research,focusing,on,combination,of,bioinformatic,analysis,of,miRNAome,and,subsequently,experimental,validation,.}	{NULL}
journal.pone.0072418.pdf	470	{We,hypothesized,that,miRNAs,with,similar,expression,patterns,might,be,function-related,.}	{NULL}
journal.pone.0072418.pdf	471	{STEM,clustering,results,suggested,that,ssc-miR-378,functioned,as,a,new,candidate,miRNA,for,porcine,myogenesis,because,of,its,expression,profile,similar,to,ssc-miR-1,and,-133,a-3p,(,Figure,5A,),.}	{NULL}
journal.pone.0072418.pdf	472	{Interestingly,",",recently,studies,have,validated,that,ssc-miR-378,regulated,myogenesis,by,directly,targeting,the,BMP2,or,MAPK1,in,pig,",",suggesting,that,the,STEM,clustering,was,reliable,for,analyzing,miRNA,expression,profiles,as,well,as,for,predicting,of,candidate,myogenic,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	473	{We,focused,on,either,highly,expressed,DE,miRNAs,or,muscle-related,miRNAs,to,ensure,the,accuracy,of,prediction,.}	{NULL}
journal.pone.0072418.pdf	474	{Consequently,",",18,candidate,miRNAs,were,selected,",",including,ssc-miR-378,",",-127,",",-128,",",-411,",",23b,",",-27,b,",",-10,a,",",-140,*,",",-9,-1,/,-2,",",-148,a/b,",",-126,",",542-3p,",",30a-5p,/,d/e,-5,p,and,miR-103,(,Figure,5,),.}	{NULL}
journal.pone.0072418.pdf	475	{MiR-127,",",which,is,located,within,a,CpG,island,with,little,research,on,myogenesis,",",showed,similar,expression,pattern,to,sscmiR-206,",",up,regulated,at,35,to,77,dpc,and,down,regulated,at,77,dpc,to,180,dpn,(,Figure,5B,),",",providing,the,possibility,for,further,investigation,concerning,the,function,of,ssc-miR-127,during,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	476	{miR-128,was,reported,to,participate,in,the,regulation,of,adipogenesis,",",osteogenesis,and,myogenesis,[,36,],and,herein,",",together,with,ssc-miR-411,",",up,regulated,at,35,to,77,dpc,and,fluctuated,at,77,dpc,to,180,dpn,(,Figure,5C,),",",might,behave,in,a,similar,manner,as,sscmiR-133b,during,porcine,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	477	{MiR-23b,was,found,to,interact,with,TGF,bata,signaling,by,down-regulating,Smads,in,fetal,hepatocytes,[,56,],",",while,miR-27b,was,involved,in,myogenic,differentiation,[,31,],as,well,as,fast-speciﬁc,and,glucocorticoid-dependent,myostatin,expression,[,30,],",",both,of,which,were,highly,expressed,at,35,dpc,and,down-regulated,thereafter,(,Figure,5D,),",",suggesting,their,roles,played,in,porcine,embryonic,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	478	{Like,ssc-miR-23b,and,27b,",",it,is,reasonable,to,hypothesize,that,ssc-miR-10a,",",-140,*,and,-9,-1,/,-2,might,act,on,earlier,embryonic,myogenesis,",",for,they,highly,expressed,at,35,dpc,then,decline,dramatically,.}	{NULL}
journal.pone.0072418.pdf	479	{MiR-148a,has,been,identified,as,a,novel,myogenic,miRNA,that,mediated,myogenic,differentiation,via,targeting,ROCK1,[,27,],",",while,miR-126,attenuated,insulin,signaling,[,57,],and,governed,vascular,integrity,and,angiogenesis,[,58,],",",suggesting,their,interactions,with,signaling,pathways,were,required,for,muscle,normal,development,and,maintenance,.}	{NULL}
journal.pone.0072418.pdf	480	{Similarly,",",sscmiR-148b,",",-542,-3,p,and,-30,family,(,a-5p,/,d/e,-5,p,),showed,similar,expression,patterns,with,ssc-miR-148a,and,-126,",",highly,expressed,and,down-regulated,at,77,dpc,to,180,dpn,(,Figure,5E,),",",making,it,possible,that,they,belong,to,the,candidate,ssc-mir-1,(,r,value,0.95,)}	{NULL}
journal.pone.0072418.pdf	481	{ssc-mir-133a,-,3p,(,r,value,ssc-mir-133a,-,5p,(,r,value,0.85,)}	{NULL}
journal.pone.0072418.pdf	482	{45,70,0.90,),14,o,",",;,‘,g,',Q'PCR,G,",",60,IQ-PCR,G,",",12,IQ-PCR,g30,I,Solexa,9,50,I,Solexa,910,I,Solexa,.}	{NULL}
journal.pone.0072418.pdf	483	{E,25,2,4o,2,8,O,20,o,30,o,5,"\\"",g,15,E,',_,q,LL,10,IE,20,Le,4,5,1o,2,OqI‘Q,3/q9qP,‘,Q5,',-,’,<,=,oo,0,"\\\\",‘,1,«,"\\"",‘,.}	{NULL}
journal.pone.0072418.pdf	484	{>,bn,°,JQ,:,’,"\\\\",‘,b,<,‘,bQ,"\\\\",’,V,"\\\\",',VV,"\\"",V,"\\\\","\\"",’,$,‘,"\\\\",‘,3,‘,$,‘,$,‘,"\\\\",9,‘,"\\\\",9,‘,"\\\\",9,‘,"\\\\",‘,3,‘,"\\\\",9,‘,"\\\\",$,‘,"\\\\",<,",25",‘,"\\\\",9,‘,"\\\\",9,‘,"\\\\",9,‘,"\\\\",‘,3,‘,"\\\\",9,‘,"\\\\",3,‘,"\\\\",3,‘,$,‘,$,‘,"\\\\",<,",25",‘,ss,°,'m,"\\"",',133b,(,r,"\\"",awe,0,',88,),ssc-mir-206,(,r,value,0.84,),ssc-mir-378,(,r,value,0.88,)}	{NULL}
journal.pone.0072418.pdf	485	{L,:,9,25,gm,',Q,‘,|,PCR,w,3,IQ-PCR,‘,D,20,IQ,.}	{NULL}
journal.pone.0072418.pdf	486	{—,.}	{NULL}
journal.pone.0072418.pdf	487	{PCR,E,10,'30,exa,96,ISo,|,exa,E,’,ISo,|,exa,_,:,as,(,U,15,O,8,.}	{NULL}
journal.pone.0072418.pdf	488	{C,5,.}	{NULL}
journal.pone.0072418.pdf	489	{C,2,6,o,4,010,O,4,%,3,%,L,"\\"",2,u.,2,U.,5}	{NULL}
journal.pone.0072418.pdf	490	{0,<,25,‘,Q3,’,~,2,',3,’,Q,~,"\\"",‘,Q3,°,Qg,’,<,2,’,~,"\\\\",Q3,’,Q3,"\\"","\\\\",°,Ox,',bb1,<,9,*,b,’,"\\\\",‘,bCbQ,O,',"\\\\",',1,",","\\"",bbn,’,"\\\\",<,b,<,bQ,VVVVVVVVV3,‘,»‘,3,‘,$,3,',3,‘,"\\\\",3,‘,3,‘,"\\\\",‘,3,‘,"\\\\",‘,3,‘,"\\\\",‘,3,‘,"\\\\",3,‘,V,<,25,‘,"\\\\",9,‘,$,‘»,‘,3,‘,"\\\\",‘,3,‘,"\\\\",‘,3,‘,"\\\\",9,‘,"\\\\",3,‘,3,‘,"\\\\",3,‘,"\\\\",g5,‘}	{NULL}
journal.pone.0072418.pdf	491	{ssc-let-7f,(,r,value,0.88,),ssc-mir-214,(,r,value,0.88,),ssc-mir-744,(,r,value,0.94,)}	{NULL}
journal.pone.0072418.pdf	492	{6,1.4,1.2,Q,),5,-,Q_pCR,‘,D12,IQ-PCR,o,1,IQ-PCR,g4,Isolexa,g,1,ISolexa,gm,ISolexa,‘“,‘“,o.,8,‘“,.}	{NULL}
journal.pone.0072418.pdf	493	{C,.}	{NULL}
journal.pone.0072418.pdf	494	{C,.}	{NULL}
journal.pone.0072418.pdf	495	{C,o,3,00.6,00.6,%,2,%,o.,4,go-4,"\\"",',"\\"",1,“,'02,"\\"","\\"",02,o,o,o}	{NULL}
journal.pone.0072418.pdf	496	{co,1,‘,L,>,<,:,>,e,«,~,',»,rbvv,;,e,>,',"\\\\",co,°,&,‘,&,§,&,&,&,&,¢,<,w,<,*,2e,°,&,&,&,&,&,&,&,&,&,§}	{NULL}
journal.pone.0072418.pdf	497	{Figure,6,.}	{NULL}
journal.pone.0072418.pdf	498	{Validation,of,the,sequencing,data,using,Real-time,PCR,method,.}	{NULL}
journal.pone.0072418.pdf	499	{The,fold,changes,in,abundance,of,night,random,miRNAs,in,10,libraries,were,normalized,by,comparing,with,the,LR1,.}	{NULL}
journal.pone.0072418.pdf	500	{The,r,value,indicates,the,Pearson,Correlation,Coefficient,between,the,two,methods,.}	{NULL}
journal.pone.0072418.pdf	501	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	502	{pone,.0072418,.}	{NULL}
journal.pone.0072418.pdf	503	{g006}	{NULL}
journal.pone.0072418.pdf	504	{myogenic,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	505	{MiR-103,/,107,family,was,validated,to,attenuate,miRNA,biosynthesis,by,targeting,Dicer,[,59,],",",regulate,insulin,sensitivity,through,down-regulating,caveolin-1,[,60,],and,affect,cellular,migration,by,modulating,CDK5R1,expression,[,61,],",",allowing,us,to,hypothesize,that,these,miRNA-mediated,mechanism,may,affect,myogenesis,when,the,microRNA,family,",",especially,ssc-miR-103,",",down-regulated,during,both,myoﬁber,formation,(,at,35,to,77,dpc,),and,maturation,(,at,77,dpc,to,180,dpn,),(,Figure,5F,),.}	{NULL}
journal.pone.0072418.pdf	506	{In,summary,",",STEM,clustering,of,miRNA,temporal,expression,contributed,to,determining,candidate,myogenic,miRNAs,in,an,effective,way,.}	{NULL}
journal.pone.0072418.pdf	507	{In,this,study,",",297,novel,miRNAs,were,identified,.}	{NULL}
journal.pone.0072418.pdf	508	{Analysis,of,the,evolutionary,conservation,of,these,novel,miRNAs,revealed,that,none,is,conserved,in,mammals,.}	{NULL}
journal.pone.0072418.pdf	509	{Therefore,",",it,is,reasonable,to,hypothesize,that,pig-specific,miRNAs,may,exist,.}	{NULL}
journal.pone.0072418.pdf	510	{However,",",it,is,the,ﬁrst,time,that,more,than,200,novel,miRNAs,were,detected,from,miRNAome,of,porcine,skeletal,muscle,attributing,to,high-throughput,deep,sequencing,technology,.}	{NULL}
journal.pone.0072418.pdf	511	{Although,few,of,these,novel,miRNAs,might,play,any,roles,in,establishing,and,maintaining,phenotype,of,muscle,tissue,during,individual,development,for,their,extremely,low,expression,",",there,are,still,several,highly,expressed,novel,miRNAs,that,need,further,validation,.}	{NULL}
journal.pone.0072418.pdf	512	{In,particular,",",a,functional,validation,of,novel,and,species-specific,miRNAs,is,a,challenge,for,understanding,the,critical,roles,played,by,miRNAs,during,muscle,development,and,for,providing,the,valuable,information,for,pig,meat,quality,improvement,.}	{NULL}
journal.pone.0072418.pdf	513	{Supporting,Information}	{NULL}
journal.pone.0072418.pdf	514	{Figure,S1,.}	{NULL}
journal.pone.0072418.pdf	515	{Saturation,plots,of,ten,libraries,.}	{NULL}
journal.pone.0072418.pdf	516	{(,TIF,)}	{NULL}
journal.pone.0072418.pdf	517	{Figure,S2,.}	{NULL}
journal.pone.0072418.pdf	518	{Counts,characteristics,of,the,unique,miRNAs,in,each,library,.}	{NULL}
journal.pone.0072418.pdf	519	{Starting,from,the,miRNA,with,the,highest,counts,(,x-axis,),",",the,black,bar,represents,the,accumulative,proportion,of,miRNAs,in,total,counts,of,each,library,.}	{NULL}
journal.pone.0072418.pdf	520	{The,red,horizontal,line,represents,the,proportion,of,individual,miRNA,versus,the,total,257,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	521	{(,TIF,)}	{NULL}
journal.pone.0072418.pdf	522	{Figure,S3,.}	{NULL}
journal.pone.0072418.pdf	523	{Determination,of,the,optimal,endogenous,control,(,EC,),pig,genes,for,normalization,.}	{NULL}
journal.pone.0072418.pdf	524	{Based,on,standard,deviation,",",the,stability,of,5,candidate,EC,genes,was,measured,.}	{NULL}
journal.pone.0072418.pdf	525	{The,pairwise,difference,between,all,tested,genes,was,compared,using,t-test,",",and,the,significance,was,labeled,with,asterisk,(,“,p,value,<,0.001,),.}	{NULL}
journal.pone.0072418.pdf	526	{(,TIF,)}	{NULL}
journal.pone.0072418.pdf	527	{Table,S1,.}	{NULL}
journal.pone.0072418.pdf	528	{Annotations,of,sequenced,small,RNAs,.}	{NULL}
journal.pone.0072418.pdf	529	{Table,S1-1,Number,of,small,RNA,reads,.}	{NULL}
journal.pone.0072418.pdf	530	{Table,S1-2,Summary,of,reads,matching,noncoding,RNA,.}	{NULL}
journal.pone.0072418.pdf	531	{Table,S1-3,Summary,of,small,RNA,matching,noncoding,RNA,databases,.}	{NULL}
journal.pone.0072418.pdf	532	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	533	{Table,S2,.}	{NULL}
journal.pone.0072418.pdf	534	{Summary,of,predicted,novel,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	535	{Table,S2-1,Predicted,chromosomal,positions,and,counts,of,novel,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	536	{Table,S2-1,Predicted,chromosomal,positions,and,counts,of,novel,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	537	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	538	{Table,S3,.}	{NULL}
journal.pone.0072418.pdf	539	{Summary,of,reads,distribution,of,257,known,porcine,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	540	{Table,S3-1,Expression,profiles,of,257,miRNAs,in,ten,libraries,.}	{NULL}
journal.pone.0072418.pdf	541	{Table,S3-2,Raw,reads,distribution,.}	{NULL}
journal.pone.0072418.pdf	542	{Table,S3-3,The,distribution,of,numbers,for,normalized,miRNAs,.}	{NULL}
journal.pone.0072418.pdf	543	{References}	{NULL}
journal.pone.0072418.pdf	544	{1,.}	{NULL}
journal.pone.0072418.pdf	545	{Rocha,D,",",Plastow,G,(,2006,),Commercial,pigs,:,an,untapped,resource,for,human,obesity,research,?}	{NULL}
journal.pone.0072418.pdf	546	{Drug,Discov,Today,11:475,-477,.}	{NULL}
journal.pone.0072418.pdf	547	{doi,:10.1016,/,j.,drudis,.2006.04.009,.}	{NULL}
journal.pone.0072418.pdf	548	{PubMed,:,16713897,.}	{NULL}
journal.pone.0072418.pdf	549	{2,.}	{NULL}
journal.pone.0072418.pdf	550	{Wigmore,PM,",",Strickland,NC,(,1983,),DNA,",",RNA,and,protein,in,skeletal,muscle,of,large,and,small,pig,fetuses,.}	{NULL}
journal.pone.0072418.pdf	551	{Growth,47,:,67-76,.}	{NULL}
journal.pone.0072418.pdf	552	{PubMed,:,6190708,.}	{NULL}
journal.pone.0072418.pdf	553	{3,.}	{NULL}
journal.pone.0072418.pdf	554	{Swatland,HJ,(,1973,),Muscle,growth,in,the,fetal,and,neonatal,pig,.}	{NULL}
journal.pone.0072418.pdf	555	{J,Anim,Sci,37,:,536-545,.}	{NULL}
journal.pone.0072418.pdf	556	{PubMed,:,4748487,.}	{NULL}
journal.pone.0072418.pdf	557	{4,.}	{NULL}
journal.pone.0072418.pdf	558	{Zhao,X,",",Mo,DL,",",Li,AN,",",Gong,W,",",Xiao,SQ,et,al.,(,2011,),Comparative,Analyses,by,Sequencing,of,Transcriptomes,during,Skeletal,Muscle,Development,between,Pig,Breeds,Differing,in,Muscle,Growth,Rate,and,Fatness,.}	{NULL}
journal.pone.0072418.pdf	559	{PLOS,ONE,6,:,e19774,.}	{NULL}
journal.pone.0072418.pdf	560	{PubMed,:,21637832,.}	{NULL}
journal.pone.0072418.pdf	561	{5,.}	{NULL}
journal.pone.0072418.pdf	562	{Mascarello,F,",",Stecchini,ML,",",Rowlerson,A,",",Ballocchi,E,(,1992,),Tertiary,myotubes,in,postnatal,growing,pig,muscle,detected,by,their,myosin,isoform,composition,.}	{NULL}
journal.pone.0072418.pdf	563	{J,Anim,Sci,70,:,1806-1813,.}	{NULL}
journal.pone.0072418.pdf	564	{PubMed,:,1386067,.}	{NULL}
journal.pone.0072418.pdf	565	{6,.}	{NULL}
journal.pone.0072418.pdf	566	{Picard,B,",",Lefaucheur,L,",",Berri,C,",",Duclos,MJ,(,2002,),Muscle,ﬁbre,ontogenesis,in,farm,animal,species,.}	{NULL}
journal.pone.0072418.pdf	567	{Reprod,Nutr,Dev,42,:,415-431,.}	{NULL}
journal.pone.0072418.pdf	568	{doi,:,10.1051,/,rnd,:2002035,.}	{NULL}
journal.pone.0072418.pdf	569	{PubMed,:,12537254,.}	{NULL}
journal.pone.0072418.pdf	570	{7,.}	{NULL}
journal.pone.0072418.pdf	571	{Glass,DJ,(,2005,),Skeletal,muscle,hypertrophy,and,atrophy,signaling,pathways,.}	{NULL}
journal.pone.0072418.pdf	572	{Int,J,Biochem,Cell,Biol,37,:,1974-1984,.}	{NULL}
journal.pone.0072418.pdf	573	{doi,:10.1016,/,j.,bioce,|,.}	{NULL}
journal.pone.0072418.pdf	574	{2005.04.018,.}	{NULL}
journal.pone.0072418.pdf	575	{PubMed,:,16087388,.}	{NULL}
journal.pone.0072418.pdf	576	{8,.}	{NULL}
journal.pone.0072418.pdf	577	{Brennecke,J,",",Hipfner,DR,",",Stark,A,",",Russell,RB,",",Cohen,SM,(,2003,),bantam,encodes,a,developmentally,regulated,microRNA,that,controls,cell,proliferation,and,regulates,the,proapoptotic,gene,hid,in,Drosophila,.}	{NULL}
journal.pone.0072418.pdf	578	{Cell,113,:,25-36,.}	{NULL}
journal.pone.0072418.pdf	579	{doi,:10.1016,/,S0092-8674,(,03,),00231-9,.}	{NULL}
journal.pone.0072418.pdf	580	{PubMed,:,12679032,.}	{NULL}
journal.pone.0072418.pdf	581	{9,.}	{NULL}
journal.pone.0072418.pdf	582	{Ambros,V,",",Bartel,B,",",Bartel,DP,",",Burge,CB,",",Carrington,JC,et,al.,(,2003,),A,uniform,system,for,microRNA,annotation,.}	{NULL}
journal.pone.0072418.pdf	583	{RNA,9,:,277-279,.}	{NULL}
journal.pone.0072418.pdf	584	{doi,:,10.1261,/,rna,.2183803,.}	{NULL}
journal.pone.0072418.pdf	585	{PubMed,:,12592000,.}	{NULL}
journal.pone.0072418.pdf	586	{Lagos-Quintana,M,",",Rauhut,R,",",Yalcin,A,",",Meyer,J,",",Lendeckel,W,et,al.,(,2002,),Identiﬁcation,of,tissue-speciﬁc,microRNAs,from,mouse,.}	{NULL}
journal.pone.0072418.pdf	587	{Curr,Biol,12,:,735-739,.}	{NULL}
journal.pone.0072418.pdf	588	{doi,:10.1016,/,S0960-9822,(,02,),00809-6,.}	{NULL}
journal.pone.0072418.pdf	589	{PubMed,:,12007417,.}	{NULL}
journal.pone.0072418.pdf	590	{van,Rooij,E,",",Quiat,D,",",Johnson,BA,",",Sutherland,LB,",",Qi,X,et,al.,(,2009,),A,family,of,microRNAs,encoded,by,myosin,genes,governs,myosin}	{NULL}
journal.pone.0072418.pdf	591	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	592	{Table,S4,.}	{NULL}
journal.pone.0072418.pdf	593	{Summary,of,top,15,most,abundant,miRNAs,in,10,libraries,.}	{NULL}
journal.pone.0072418.pdf	594	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	595	{Table,S5,.}	{NULL}
journal.pone.0072418.pdf	596	{Expression,profiles,of,DE,miRNAs,during,LR,1-4,and,LR,4-10,.}	{NULL}
journal.pone.0072418.pdf	597	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	598	{Table,S6,.}	{NULL}
journal.pone.0072418.pdf	599	{Information,about,five,significant,clusters,.}	{NULL}
journal.pone.0072418.pdf	600	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	601	{Table,S7,.}	{NULL}
journal.pone.0072418.pdf	602	{Primers,for,miRNA,RT-qPCR,.}	{NULL}
journal.pone.0072418.pdf	603	{(,XLS,)}	{NULL}
journal.pone.0072418.pdf	604	{Acknowledgements}	{NULL}
journal.pone.0072418.pdf	605	{We,thank,the,Shanghai,Biotechnology,Corporation,(,SBC,),and,Gene,Denovo,for,providing,us,with,technical,assistance,in,Solexa,sequencing,and,bioinformatics,analysis,.}	{NULL}
journal.pone.0072418.pdf	606	{Author,Contributions}	{NULL}
journal.pone.0072418.pdf	607	{Conceived,and,designed,the,experiments,:,LQ,YC,DM,.}	{NULL}
journal.pone.0072418.pdf	608	{Performed,the,experiments,:,LQ,ZH,KY,XZ,HC,.}	{NULL}
journal.pone.0072418.pdf	609	{Analyzed,the,data,:,LQ,SY,JY,DM,.}	{NULL}
journal.pone.0072418.pdf	610	{Contributed,reagents/materials/analysis,tools,:,YC,DM,XL,.}	{NULL}
journal.pone.0072418.pdf	611	{Wrote,the,manuscript,:,LQ,DM,.}	{NULL}
journal.pone.0072418.pdf	612	{Acquired,funding,:,YC,DM,.}	{NULL}
journal.pone.0072418.pdf	613	{expression,and,muscle,performance,.}	{NULL}
journal.pone.0072418.pdf	614	{Dev,Cell,17,:,662-673,.}	{NULL}
journal.pone.0072418.pdf	615	{doi,:,10.1016,/,j.,devcel,.2009.10.013,.}	{NULL}
journal.pone.0072418.pdf	616	{PubMed,:,19922871,.}	{NULL}
journal.pone.0072418.pdf	617	{O'Rourke,JR,",",Georges,SA,",",Seay,HR,",",Tapscott,SJ,",",McManus,MT,et,al.,(,2007,),Essential,role,for,Dicer,during,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	618	{Dev,Biol,311,:,359-368,.}	{NULL}
journal.pone.0072418.pdf	619	{doi,:10.1016,/,j.,ydbio,.2007.08.032,.}	{NULL}
journal.pone.0072418.pdf	620	{PubMed,:,17936265,.}	{NULL}
journal.pone.0072418.pdf	621	{Huang,TH,",",Zhu,MJ,",",Li,XY,",",Zhao,SH,(,2008,),Discovery,of,Porcine,microRNAs,and,Proﬁling,from,Skeletal,Muscle,Tissues,during,Development,.}	{NULL}
journal.pone.0072418.pdf	622	{PLOS,ONE,3,:,e3225,.}	{NULL}
journal.pone.0072418.pdf	623	{PubMed,:,18795099,.}	{NULL}
journal.pone.0072418.pdf	624	{McDane,|,d,TG,",",Smith,TPL,",",Doumit,ME,",",Miles,JR,",",Coutinho,LL,et,al.,(,2009,),MicroRNA,transcriptome,profiles,during,swine,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	625	{BMC,Genomics,10,:,77,-,.}	{NULL}
journal.pone.0072418.pdf	626	{PubMed,:,19208255,.}	{NULL}
journal.pone.0072418.pdf	627	{Friedlénder,MR,",",Chen,W,",",Adamidi,C,",",Maaskola,J,",",Einspanier,R,et,al.,(,2008,),Discovering,microRNAs,from,deep,sequencing,data,using,miRDeep,.}	{NULL}
journal.pone.0072418.pdf	628	{Nat,Biotechnol,26,:,407-415,.}	{NULL}
journal.pone.0072418.pdf	629	{doi,:10.1038,/,nbt1394,.}	{NULL}
journal.pone.0072418.pdf	630	{PubMed,:,18392026,.}	{NULL}
journal.pone.0072418.pdf	631	{Ernst,J,",",Nau,GJ,",",Bar-Joseph,Z,(,2005,),Clustering,short,time,series,gene,expression,data,.}	{NULL}
journal.pone.0072418.pdf	632	{Bioinformatics,21,Suppl,1,:,I159-I168,.}	{NULL}
journal.pone.0072418.pdf	633	{doi,:10.1093,/,bioinformatics/bti1022,.}	{NULL}
journal.pone.0072418.pdf	634	{PubMed,:,15961453,.}	{NULL}
journal.pone.0072418.pdf	635	{Xiao,F,",",Zuo,2,",",Cal,G,",",Kang,S,",",Gao,X,et,al.,(,2009,),miRecords,:,an,integrated,resource,for,microRNA-target,interactions,.}	{NULL}
journal.pone.0072418.pdf	636	{Nucleic,Acids,Res,37,:,D105-D110,.}	{NULL}
journal.pone.0072418.pdf	637	{doi,:10.1093,/,nar/gkn851,.}	{NULL}
journal.pone.0072418.pdf	638	{PubMed,:,18996891,.}	{NULL}
journal.pone.0072418.pdf	639	{Xie,C,",",Mao,X,",",Huang,J,",",Ding,Y,",",Wu,J,et,al.,(,2011,),.}	{NULL}
journal.pone.0072418.pdf	640	{KOBAS,2.0,:,a,web,server,for,annotation,and,identification,of,enriched,pathways,and,diseases,.}	{NULL}
journal.pone.0072418.pdf	641	{Nucleic,Acids,Res,39,:,W316-322,.}	{NULL}
journal.pone.0072418.pdf	642	{Mullokandov,G,",",Baccarini,A,",",Ruzo,A,",",Jayaprakash,AD,",",Tung,N,et,al.,(,2012,),High-throughput,assessment,of,microRNA,activity,and,function,using,microRNA,sensor,and,decoy,libraries,.}	{NULL}
journal.pone.0072418.pdf	643	{Nat,Methods,",",9,:,840-6,.}	{NULL}
journal.pone.0072418.pdf	644	{PubMed,:,22751203,.}	{NULL}
journal.pone.0072418.pdf	645	{Li,GX,",",Li,YJ,",",Li,XJ,",",Ning,XM,",",Li,MH,et,al.,(,2011,),MicroRNA,Identity,and,Abundance,in,Developing,Swine,Adipose,Tissue,as,Determined,by,Solexa,Sequencing,.}	{NULL}
journal.pone.0072418.pdf	646	{J,Cell,Biochem,112,:,1318-1328,.}	{NULL}
journal.pone.0072418.pdf	647	{doi,:10.1002,/,jcb,.}	{NULL}
journal.pone.0072418.pdf	648	{23045,.}	{NULL}
journal.pone.0072418.pdf	649	{PubMed,:,21312241,.}	{NULL}
journal.pone.0072418.pdf	650	{Chen,JF,",",Mandel,EM,",",Thomson,JM,",",Wu,Q,",",Callis,TE,et,al.,(,2006,),The,role,of,microRNA-1,and,microRNA-133,in,skeletal,muscle,proliferation,and,differentiation,.}	{NULL}
journal.pone.0072418.pdf	651	{PubMed,:,16380711,.}	{NULL}
journal.pone.0072418.pdf	652	{Nielsen,M,",",Hansen,JH,",",Hedegaard,J,",",Nielsen,RO,",",Panitz,F,et,al.,(,2010,),MicroRNA,identity,and,abundance,in,porcine,skeletal,muscles,determined,by,deep,sequencing,.}	{NULL}
journal.pone.0072418.pdf	653	{Anim,Genet,41,:,159-168,.}	{NULL}
journal.pone.0072418.pdf	654	{doi,:,10.1111,/,j.1365-2052,.2010.02127,.}	{NULL}
journal.pone.0072418.pdf	655	{x.,PubMed,:,19917043,.}	{NULL}
journal.pone.0072418.pdf	656	{Townley-Tilson,WH,",",Callis,TE,",",Wang,D,(,2010,),.}	{NULL}
journal.pone.0072418.pdf	657	{MicroRNAs,1,",",133,",",and,206,:,critical,factors,of,skeletal,and,cardiac,muscle,development,",",function,",",and,disease,.}	{NULL}
journal.pone.0072418.pdf	658	{Int,J,Biochem,Cell,Biol,42,:,1252-1255,.}	{NULL}
journal.pone.0072418.pdf	659	{Gagan,J,",",Dey,BK,",",Layer,R,",",Yan,Z,",",Dutta,A,(,2011,),MicroRNA-378,Targets,the,Myogenic,Repressor,MyoR,during,Myoblast,Differentiation,.}	{NULL}
journal.pone.0072418.pdf	660	{J,Biol,Chem,286,:,19431-19438,.}	{NULL}
journal.pone.0072418.pdf	661	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	662	{M111,.219006,.}	{NULL}
journal.pone.0072418.pdf	663	{PubMed,:,21471220,.}	{NULL}
journal.pone.0072418.pdf	664	{Cordes,KR,",",Sheehy,NT,",",White,MP,",",Berry,EC,",",Morton,SU,et,al.,(,2009,),miR-145,and,miR-143,regulate,smooth,muscle,cell,fate,and,plasticity,.}	{NULL}
journal.pone.0072418.pdf	665	{Nature,460,:,705-U780,.}	{NULL}
journal.pone.0072418.pdf	666	{PubMed,:,19578358,.}	{NULL}
journal.pone.0072418.pdf	667	{Naguibneva,I,",",Ameyar-Zazoua,M,",",Polesskaya,A,",",Ait-Si-Ali,S,",",Groisman,R,",",et,al.,(,2006,),The,microRNA,miR-181,targets,the,homeobox,protein,Hox-A11,during,mammalian,myoblast,differentiation,.}	{NULL}
journal.pone.0072418.pdf	668	{Nat,Cell,Biol,8,:,278-284,.}	{NULL}
journal.pone.0072418.pdf	669	{doi,:10.1038,/,ncb1373,.}	{NULL}
journal.pone.0072418.pdf	670	{PubMed,:,16489342,.}	{NULL}
journal.pone.0072418.pdf	671	{Zhang,J,",",Ying,ZZ,",",Tang,ZL,",",Long,LQ,",",Li,K,(,2012,),MicroRNA-148a,Promotes,Myogenic,Differentiation,by,Targeting,the,ROCK1,Gene,.}	{NULL}
journal.pone.0072418.pdf	672	{J,Biol,Chem,287,:,21093-21101,.}	{NULL}
journal.pone.0072418.pdf	673	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	674	{M111,.330381,.}	{NULL}
journal.pone.0072418.pdf	675	{PubMed,:,22547064,.}	{NULL}
journal.pone.0072418.pdf	676	{Dey,BK,",",Gagan,J,",",Yan,Z,",",Dutta,A,(,2012,),miR-26a,is,required,for,skeletal,muscle,differentiation,and,regeneration,in,mice,.}	{NULL}
journal.pone.0072418.pdf	677	{Genes,Dev,26,:,2180-2191,.}	{NULL}
journal.pone.0072418.pdf	678	{doi,:10.1101,/,gad,.198085.112,.}	{NULL}
journal.pone.0072418.pdf	679	{PubMed,:,23028144,.}	{NULL}
journal.pone.0072418.pdf	680	{Wong,CF,",",Tellam,RL,(,2008,),MicroRNA-26a,targets,the,histone,methyltransferase,Enhancer,of,Zeste,homolog,2,during,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	681	{J,Biol,Chem,283,:,9836-9843,.}	{NULL}
journal.pone.0072418.pdf	682	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	683	{M709614200,.}	{NULL}
journal.pone.0072418.pdf	684	{PubMed,:,18281287,.}	{NULL}
journal.pone.0072418.pdf	685	{Allen,DL,",",Loh,AS,(,2011,),Posttranscriptional,mechanisms,involving,microRNA-27a,and,b,contribute,to,fast-speciﬁc,and,gIucocorticoidmediated,myostatin,expression,in,skeletal,muscle,.}	{NULL}
journal.pone.0072418.pdf	686	{Am,J,Physiol,Cell,Physiol,300,:,C124-C137,.}	{NULL}
journal.pone.0072418.pdf	687	{doi,:10.1152,/,ajpceII,.00142.2010,.}	{NULL}
journal.pone.0072418.pdf	688	{PubMed,:,20980549,.}	{NULL}
journal.pone.0072418.pdf	689	{Nat,Genet,38,:,228-233,.}	{NULL}
journal.pone.0072418.pdf	690	{doi,:10.1038,/,ng1725,.}	{NULL}
journal.pone.0072418.pdf	691	{.}	{NULL}
journal.pone.0072418.pdf	692	{Lozano-Velasco,E,",",Contreras,A,",",Crist,C,",",Hernandez-Torres,F,",",Franco,D,et,al.,(,2011,),Pitx2c,modulates,Pax3,+,/,Pax7,+,cell,populations,and,regulates,Pax3,expression,by,repressing,miR27,expression,during,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	693	{Dev,Biol,357,:,165-178,.}	{NULL}
journal.pone.0072418.pdf	694	{doi,:10.1016,/,j.,ydbio,.2011.06.039,.}	{NULL}
journal.pone.0072418.pdf	695	{PubMed,:,21749861,.}	{NULL}
journal.pone.0072418.pdf	696	{Wang,L,",",Chen,X,",",Zheng,YY,",",Li,F,",",Lu,Z,et,al.,(,2012,),MiR-23a,inhibits,myogenic,differentiation,through,down,regulation,of,fast,myosin,heavy,chain,isoforms,.}	{NULL}
journal.pone.0072418.pdf	697	{Exp,Cell,Res,318,:,2324-2334,.}	{NULL}
journal.pone.0072418.pdf	698	{doi,:10.1016,/,j.,yexcr,.}	{NULL}
journal.pone.0072418.pdf	699	{2012.06.018,.}	{NULL}
journal.pone.0072418.pdf	700	{PubMed,:,22771720,.}	{NULL}
journal.pone.0072418.pdf	701	{Wada,S,",",Kato,Y,",",Okutsu,M,",",Miyaki,S,",",Suzuki,K,et,al.,(,2011,),Translational,Suppression,of,Atrophic,Regulators,by,MicroRNA-23a,Integrates,Resistance,to,Skeletal,Muscle,Atrophy,.}	{NULL}
journal.pone.0072418.pdf	702	{J,Biol,Chem,286,:,38456-38465,.}	{NULL}
journal.pone.0072418.pdf	703	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	704	{M111,.271270,.}	{NULL}
journal.pone.0072418.pdf	705	{PubMed,:,21926429,.}	{NULL}
journal.pone.0072418.pdf	706	{Ge,YJ,",",Sun,YT,",",Chen,J,(,2011,),IGF-II,is,regulated,by,microRNA-125b,in,skeletal,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	707	{J,Cell,Biol,192,:,69-81,.}	{NULL}
journal.pone.0072418.pdf	708	{doi,:10.1083,/,jcb,.}	{NULL}
journal.pone.0072418.pdf	709	{201007165,.}	{NULL}
journal.pone.0072418.pdf	710	{PubMed,:,21200031,.}	{NULL}
journal.pone.0072418.pdf	711	{Sun,Q,",",Zhang,Y,",",Yang,G,",",Chen,XP,",",Zhang,YG,et,al.,(,2008,),Transforming,growth,factor-beta-regulated,miR-24,promotes,skeletal,muscle,differentiation,.}	{NULL}
journal.pone.0072418.pdf	712	{Nucleic,Acids,Res,36,:,2690-2699,.}	{NULL}
journal.pone.0072418.pdf	713	{doi,:,10.1093,/,nar/gkn032,.}	{NULL}
journal.pone.0072418.pdf	714	{PubMed,:,18353861,.}	{NULL}
journal.pone.0072418.pdf	715	{Motohashi,N,",",Alexander,MS,",",Casar,JC,",",Kunkel,LM,(,2012,),Identification,of,a,Novel,microRNA,That,Regulates,the,Proliferation,and,Differentiation,in,Muscle,Side,Population,Cells,.}	{NULL}
journal.pone.0072418.pdf	716	{Stem,Cells,Dev,21,:,3031-3043,.}	{NULL}
journal.pone.0072418.pdf	717	{doi,:10.1089,/,scd,.2011.0721,.}	{NULL}
journal.pone.0072418.pdf	718	{PubMed,:,22541023,.}	{NULL}
journal.pone.0072418.pdf	719	{Rane,S,",",He,MZ,",",Sayed,D,",",Vashistha,H,",",Malhotra,A,et,al.,(,2009,),Downregulation,of,MiR-199a,Derepresses,Hypoxia-Inducible,Factor-1,alpha,and,Sirtuin,1,and,Recapitulates,Hypoxia,Preconditioning,in,Cardiac,Myocytes,.}	{NULL}
journal.pone.0072418.pdf	720	{Circ,Res,104,:,879-886,.}	{NULL}
journal.pone.0072418.pdf	721	{doi,:10.1161,/,CIRCRESAHA,.}	{NULL}
journal.pone.0072418.pdf	722	{108.193102,.}	{NULL}
journal.pone.0072418.pdf	723	{PubMed,:,19265035,.}	{NULL}
journal.pone.0072418.pdf	724	{Sarkar,S,",",Dey,BK,",",Dutta,A,(,2010,),MiR-322,/,424,and-503,Are,Induced,during,Muscle,Differentiation,and,Promote,Cell,Cycle,Quiescence,and,Differentiation,by,Down-Regulation,of,Cdc25A,.}	{NULL}
journal.pone.0072418.pdf	725	{Mol,Biol,Cell,21,:,2138-2149,.}	{NULL}
journal.pone.0072418.pdf	726	{doi,:10.1091,/,mbc.E10-01-0062,.}	{NULL}
journal.pone.0072418.pdf	727	{PubMed,:,20462953,.}	{NULL}
journal.pone.0072418.pdf	728	{Small,EM,",",O’Rourke,JR,",",Moresi,V,",",Sutherland,LB,",",McAna,|,|,y,J,et,al.,(,2010,),Regulation,of,PI3-kinase/Akt,signaling,by,muscle-enriched,microRNA-486,.}	{NULL}
journal.pone.0072418.pdf	729	{Proc,Natl,Acad,Sci,U,S,A,107,:,4218-4223,.}	{NULL}
journal.pone.0072418.pdf	730	{doi,:10.1073,/,pnas,.1000300107,.}	{NULL}
journal.pone.0072418.pdf	731	{PubMed,:,20142475,.}	{NULL}
journal.pone.0072418.pdf	732	{Liu,J,",",Luo,XJ,",",Xiong,AW,",",Zhang,ZD,",",Yue,S,et,al.,(,2010,),MicroRNA-214,Promotes,Myogenic,Differentiation,by,Facilitating,Exit,from,Mitosis,via,Down-regulation,of,Proto-oncogene,N-ras,.}	{NULL}
journal.pone.0072418.pdf	733	{J,Biol,Chem,285,:,26599-26607,.}	{NULL}
journal.pone.0072418.pdf	734	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	735	{M110,.115824,.}	{NULL}
journal.pone.0072418.pdf	736	{PubMed,:,20534588,.}	{NULL}
journal.pone.0072418.pdf	737	{Wang,H,",",Garzon,R,",",Sun,H,",",Ladner,KJ,",",Singh,R,et,al.,(,2008,),NFkappaB-YY1-miR-29,Regulatory,Circuitry,in,Skeletal,Myogenesis,and}	{NULL}
journal.pone.0072418.pdf	738	{Rhabdomyosarcoma,.}	{NULL}
journal.pone.0072418.pdf	739	{Cancer,Cell,14,:,369-381,.}	{NULL}
journal.pone.0072418.pdf	740	{doi,:10.1016,/,j.,ccr,.}	{NULL}
journal.pone.0072418.pdf	741	{2008.10.006,.}	{NULL}
journal.pone.0072418.pdf	742	{PubMed,:,18977326,.}	{NULL}
journal.pone.0072418.pdf	743	{Wang,XNH,",",Hu,ZY,",",Klein,JD,",",Zhang,LP,",",Fang,FD,et,al.,(,2011,),Decreased,miR-29,Suppresses,Myogenesis,in,CKD,.}	{NULL}
journal.pone.0072418.pdf	744	{J,Am,Soc,Nephrol,22,:,2068-2076,.}	{NULL}
journal.pone.0072418.pdf	745	{doi,:10.1681,/,ASN,.2010121278,.}	{NULL}
journal.pone.0072418.pdf	746	{PubMed,:,21965375,.}	{NULL}
journal.pone.0072418.pdf	747	{Merk,DR,",",Chin,JT,",",Dake,BA,",",Maegdefessel,L,",",Miller,MO,et,al.,(,2012,),miR-29b,Participates,in,Early,Aneurysm,Development,in,Marfan,Syndrome,.}	{NULL}
journal.pone.0072418.pdf	748	{Circ,Res,110,:,312,—,324,+,doi,:10.1161,/,CIRCRESAHA,.}	{NULL}
journal.pone.0072418.pdf	749	{111.253740,.}	{NULL}
journal.pone.0072418.pdf	750	{PubMed,:,22116819,.}	{NULL}
journal.pone.0072418.pdf	751	{Cardinali,B,",",Castellani,L,",",Fasanaro,P,",",Basso,A,",",Alema,S,et,al.,(,2009,),Microrna-221,and,Microrna-222,Modulate,Differentiation,and,Maturation,of,Skeletal,Muscle,Cells,.}	{NULL}
journal.pone.0072418.pdf	752	{PLOS,ONE,4,:,e7607,.}	{NULL}
journal.pone.0072418.pdf	753	{PubMed,:,19859555,.}	{NULL}
journal.pone.0072418.pdf	754	{von,Maltzahn,J,",",Chang,NC,",",Bentzinger,CF,",",Rudnicki,MA,(,2012,),Wnt,signaling,in,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	755	{Trends,Cell,Biol,22,:,602-609,.}	{NULL}
journal.pone.0072418.pdf	756	{doi,:10.1016,/,j.,tcb,.2012.07.008,.}	{NULL}
journal.pone.0072418.pdf	757	{PubMed,:,22944199,.}	{NULL}
journal.pone.0072418.pdf	758	{Zetser,A,",",Gredinger,E,",",Bengal,E,(,1999,),p38,mitogen-activated,protein,kinase,pathway,promotes,skeletal,muscle,differentiation,-,Participation,of,the,MEF2C,transcription,factor,.}	{NULL}
journal.pone.0072418.pdf	759	{J,Biol,Chem,274,:,5193-5200,.}	{NULL}
journal.pone.0072418.pdf	760	{doi,:,10.1074,/,jbc,.274.8.5193,.}	{NULL}
journal.pone.0072418.pdf	761	{PubMed,:,9988769,.}	{NULL}
journal.pone.0072418.pdf	762	{Lebrasseur,NK,",",Cote,GM,",",Miller,TA,",",Fielding,RA,",",Sawyer,DB,(,2003,),Regulation,of,neuregulin/ErbB,signaling,by,contractile,activity,in,skeletal,muscle,.}	{NULL}
journal.pone.0072418.pdf	763	{Am,J,Physiol,Cell,Physiol,284,:,C1149-C1155,.}	{NULL}
journal.pone.0072418.pdf	764	{doi,:,10.1152,/,ajpceII,.00487.2002,.}	{NULL}
journal.pone.0072418.pdf	765	{PubMed,:,12519750,.}	{NULL}
journal.pone.0072418.pdf	766	{Pirskanen,A,",",Kiefer,JC,",",Hauschka,SD,(,2000,),IGFs,",",insulin,",",Shh,",",bFGF,",",and,TGF-beta1,interact,synergistically,to,promote,somite,myogenesis,in,vitro,.}	{NULL}
journal.pone.0072418.pdf	767	{Dev,Biol,224,:,189-203,.}	{NULL}
journal.pone.0072418.pdf	768	{doi,:10.1006,/,dbio,.2000.9784,.}	{NULL}
journal.pone.0072418.pdf	769	{PubMed,:,10926759,.}	{NULL}
journal.pone.0072418.pdf	770	{Kumar,A,",",Murphy,R,",",Robinson,P,",",Wei,L,",",Boriek,AM,(,2004,),Cyclic,mechanical,strain,inhibits,skeletal,myogenesis,through,activation,of,focal,adhesion,kinase,",",Rac-1,GTPase,",",and,NF-kappaB,transcription,factor,.}	{NULL}
journal.pone.0072418.pdf	771	{FASEB,J,18,:,1524-1535,.}	{NULL}
journal.pone.0072418.pdf	772	{doi,:10.1096,/,fj.04-2414com,.}	{NULL}
journal.pone.0072418.pdf	773	{PubMed,:,15466361,.}	{NULL}
journal.pone.0072418.pdf	774	{van,Rooij,E,",",Sutherland,LB,",",Qi,XX,",",Richardson,JA,",",Hill,J,et,al.,(,2007,),Control,of,stress-dependent,cardiac,growth,and,gene,expression,by,a,microRNA,.}	{NULL}
journal.pone.0072418.pdf	775	{Science,316,:,575-579,.}	{NULL}
journal.pone.0072418.pdf	776	{doi,:10.1126,/,science,.1139089,.}	{NULL}
journal.pone.0072418.pdf	777	{PubMed,:,17379774,.}	{NULL}
journal.pone.0072418.pdf	778	{.}	{NULL}
journal.pone.0072418.pdf	779	{Anand,A,",",Suganthan,PN,",",Deb,K,(,2007,),A,novel,fuzzy,and,multiobjective,evolutionary,algorithm,based,gene,assignment,for,clustering,short,time,series,expression,data,.}	{NULL}
journal.pone.0072418.pdf	780	{2007,Ieee,Congress,on,Evolutionary,Computation,",",Vols,1-10,",",Proceedings,:,297-304,.}	{NULL}
journal.pone.0072418.pdf	781	{Gu,YR,",",Li,MZ,",",Zhang,K,",",Chen,L,",",Jiang,AA,et,al.,(,2011,),Identiﬁcation,of,suitable,endogenous,control,microRNA,genes,in,normal,pig,tissues,.}	{NULL}
journal.pone.0072418.pdf	782	{Anim,Sci,J,82,:,722-728,.}	{NULL}
journal.pone.0072418.pdf	783	{doi,:10.1111,/,j.1740-0929,.2011.00908,.}	{NULL}
journal.pone.0072418.pdf	784	{x.,PubMed,:,22111626,.}	{NULL}
journal.pone.0072418.pdf	785	{Hou,X,",",Tang,2,",",Liu,H,",",Wang,N,",",Ju,H,et,al.,(,2012,),Discovery,of,MicroRNAs,associated,with,myogenesis,by,deep,sequencing,of,serial,developmental,skeletal,muscles,in,pigs,.}	{NULL}
journal.pone.0072418.pdf	786	{PLOS,ONE,7,:,e52123,.}	{NULL}
journal.pone.0072418.pdf	787	{doi,:,10.1371,/,journa,|,.}	{NULL}
journal.pone.0072418.pdf	788	{pone,.0052123,.}	{NULL}
journal.pone.0072418.pdf	789	{PubMed,:,23284895,.}	{NULL}
journal.pone.0072418.pdf	790	{AI-Shanti,N,",",Stewart,CE,(,2009,),Ca2,+,/,calmodulin-dependent,transcriptional,pathways,:,potential,mediators,of,skeletal,muscle,growth,and,development,.}	{NULL}
journal.pone.0072418.pdf	791	{Biol,Rev,Camb,Philos,Soc,84,:,637-652,.}	{NULL}
journal.pone.0072418.pdf	792	{doi,:,10.1111,/,j.1469-185X,.2009.00090,.}	{NULL}
journal.pone.0072418.pdf	793	{x.,PubMed,:,19725819,.}	{NULL}
journal.pone.0072418.pdf	794	{Mayeuf,A,",",Relaix,F,(,2011,),Notch,pathway,:,from,development,to,regeneration,of,skeletal,muscle,.}	{NULL}
journal.pone.0072418.pdf	795	{M,S,Med,Sci,27,:,521-526,.}	{NULL}
journal.pone.0072418.pdf	796	{Rogler,CE,",",LeVoci,L,",",Ader,T,",",Massimi,A,",",Tchaikovskaya,T,et,al.,(,2009,),MicroRNA-23b,Cluster,MicroRNAs,Regulate,Transforming,Growth,Factor-Beta/Bone,Morphogenetic,Protein,Signaling,and,Liver,Stem,Cell,Differentiation,by,Targeting,Smads,.}	{NULL}
journal.pone.0072418.pdf	797	{Hepatology,50,:,575-584,.}	{NULL}
journal.pone.0072418.pdf	798	{doi,:,10.1002,/,hep,.22982,.}	{NULL}
journal.pone.0072418.pdf	799	{PubMed,:,19582816,.}	{NULL}
journal.pone.0072418.pdf	800	{Ryu,HS,",",Park,SY,",",Ma,DA,",",Zhang,J,",",Lee,W,(,2011,),The,Induction,of,MicroRNA,Targeting,IRS-1,Is,Involved,in,the,Development,of,Insulin,Resistance,under,Conditions,of,Mitochondrial,Dysfunction,in,Hepatocytes,.}	{NULL}
journal.pone.0072418.pdf	801	{PLOS,ONE,6,:,e17343,.}	{NULL}
journal.pone.0072418.pdf	802	{PubMed,:,21464990,.}	{NULL}
journal.pone.0072418.pdf	803	{Wang,SS,",",Aurora,AB,",",Johnson,BA,",",Qi,XX,",",McAna,|,|,y,J,et,al.,(,2008,),The,endothelial-specific,microRNA,miR-126,governs,vascular,integrity,and,angiogenesis,.}	{NULL}
journal.pone.0072418.pdf	804	{Dev,Cell,15,:,261-271,.}	{NULL}
journal.pone.0072418.pdf	805	{doi,:10.1016,/,j.,devceI,.2008.07.002,.}	{NULL}
journal.pone.0072418.pdf	806	{PubMed,:,18694565,.}	{NULL}
journal.pone.0072418.pdf	807	{Martello,G,",",Rosato,A,",",Ferrari,F,",",Manfrin,A,",",Cordenonsi,M,et,al.,(,2010,),A,MicroRNA,Targeting,Dicer,for,Metastasis,Control,.}	{NULL}
journal.pone.0072418.pdf	808	{Cell,141,:,1195U1176,.}	{NULL}
journal.pone.0072418.pdf	809	{doi,:10.1016,/,j.,ceII,.2010.05.017,.}	{NULL}
journal.pone.0072418.pdf	810	{PubMed,:,20603000,.}	{NULL}
journal.pone.0072418.pdf	811	{Trajkovski,M,",",Hausser,J,",",Soutschek,J,",",Bhat,B,",",Akin,A,et,al.,(,2011,),MicroRNAs,103,and,107,regulate,insulin,sensitivity,.}	{NULL}
journal.pone.0072418.pdf	812	{Nature,474,:,649U127,.}	{NULL}
journal.pone.0072418.pdf	813	{doi,:10.1038,/,nature10112,.}	{NULL}
journal.pone.0072418.pdf	814	{PubMed,:,21654750,.}	{NULL}
journal.pone.0072418.pdf	815	{.}	{NULL}
journal.pone.0072418.pdf	816	{Moncini,S,",",Salvi,A,",",Zuccotti,P,",",Viero,G,",",Quattrone,A,et,al.,(,2011,),Role,of,miR-103,and,miR-107,in,Regulation,of,CDK5R1,Expression,and,in,Cellular,Migration,.}	{NULL}
journal.pone.0072418.pdf	817	{PLOS,ONE,6,.}	{NULL}
journal.pone.0072418.pdf	818	{80,.}	{NULL}
journal.pone.0072418.pdf	819	{Zhao,Y,",",Samal,E,",",Srivastava,D,(,2005,),Serum,response,factor,regulates,a,muscle-specific,microRNA,that,targets,.}	{NULL}
journal.pone.0072418.pdf	820	{Hand,2,during,cardiogenesis,.}	{NULL}
journal.pone.0072418.pdf	821	{Nature,436,:,214-220,.}	{NULL}
journal.pone.0072418.pdf	822	{.}	{NULL}
journal.pone.0072418.pdf	823	{Sweetman,D,",",Goljanek,K,",",Rathjen,T,",",Oustanina,8,",",Braun,T,et,al.,(,2008,),Specific,requirements,of,MRFs,for,the,expression,of,muscle,specific,microRNAs,",",miR-1,",",miR-206,and,miR-133,.}	{NULL}
journal.pone.0072418.pdf	824	{Dev,Biol,321,:,491-499,.}	{NULL}
journal.pone.0072418.pdf	825	{doi,:10.1016,/,j.,ydbio,.2008.06.019,.}	{NULL}
journal.pone.0072418.pdf	826	{PubMed,:,18619954,.}	{NULL}
journal.pone.0072418.pdf	827	{.}	{NULL}
journal.pone.0072418.pdf	828	{Hirai,H,",",Verma,M,",",Watanabe,S,",",Tastad,C,",",Asakura,Y,et,al.,(,2010,),MyoD,regulates,apoptosis,of,myoblasts,through,microRNA-mediated,down-regulation,of,Pax3,.}	{NULL}
journal.pone.0072418.pdf	829	{J,Cell,Biol,191,:,347-365,.}	{NULL}
journal.pone.0072418.pdf	830	{doi,:10.1083,/,jcb,.}	{NULL}
journal.pone.0072418.pdf	831	{201006025,.}	{NULL}
journal.pone.0072418.pdf	832	{PubMed,:,20956382,.}	{NULL}
journal.pone.0072418.pdf	833	{.}	{NULL}
journal.pone.0072418.pdf	834	{Sokol,NS,",",Ambros,V,(,2005,),Mesodermally,expressed,Drosophila,microRNA-1,is,regulated,by,Twist,and,is,required,in,muscles,during,larval,growth,.}	{NULL}
journal.pone.0072418.pdf	835	{Genes,Dev,19,:,2343-2354,.}	{NULL}
journal.pone.0072418.pdf	836	{doi,:10.1101,/,gad,.1356105,.}	{NULL}
journal.pone.0072418.pdf	837	{PubMed,:,16166373,.}	{NULL}
journal.pone.0072418.pdf	838	{.}	{NULL}
journal.pone.0072418.pdf	839	{Granjon,A,",",Gustin,MP,",",Rieusset,J,",",Lefai,E,",",Meugnier,E,et,al.,(,2009,),The,microRNA,signature,in,response,to,insulin,reveals,its,implication,in,the,transcriptional,action,of,insulin,in,human,skeletal,muscle,and,the,role,of,a,sterol,regulatory,element-binding,protein-1c,/,myocyte,enhancer,factor,2C,pathway,.}	{NULL}
journal.pone.0072418.pdf	840	{Diabetes,58,:,2555-2564,.}	{NULL}
journal.pone.0072418.pdf	841	{doi,:10.2337,/,db09-0165,.}	{NULL}
journal.pone.0072418.pdf	842	{PubMed,:,19720801,.}	{NULL}
journal.pone.0072418.pdf	843	{.}	{NULL}
journal.pone.0072418.pdf	844	{Gagan,J,",",Dey,BK,",",Layer,R,",",Yan,Z,",",Dutta,A,(,2012,),Notch3,and,Mef2c,proteins,are,mutually,antagonistic,via,Mkp1,protein,and,miR-1,/,206,microRNAs,in,differentiating,myoblasts,.}	{NULL}
journal.pone.0072418.pdf	845	{J,Biol,Chem,287,:,40360-40370,.}	{NULL}
journal.pone.0072418.pdf	846	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	847	{M112,.378414,.}	{NULL}
journal.pone.0072418.pdf	848	{PubMed,:,23055528,.}	{NULL}
journal.pone.0072418.pdf	849	{.}	{NULL}
journal.pone.0072418.pdf	850	{Sun,YT,",",Ge,YJ,",",Dmevich,J,",",Zhao,Y,",",Band,M,et,al.,(,2010,),Mammalian,target,of,rapamycin,regulates,miRNA-1,and,follistatin,in,skeletal,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	851	{J,Cell,Biol,189,:,1157-1169,.}	{NULL}
journal.pone.0072418.pdf	852	{doi,:10.1083,/,jcb,.200912093,.}	{NULL}
journal.pone.0072418.pdf	853	{PubMed,:,20566686,.}	{NULL}
journal.pone.0072418.pdf	854	{.}	{NULL}
journal.pone.0072418.pdf	855	{Yang,BF,",",Lin,HX,",",Xiao,JN,",",Lu,YJ,",",Luo,XB,et,al.,(,2007,),The,musclespecific,microRNA,miR-1,regulates,cardiac,arrhythmogenic,potential,by,targeting,GJA1,and,KCNJ2,.}	{NULL}
journal.pone.0072418.pdf	856	{Nat,Med,13,:,486-491,.}	{NULL}
journal.pone.0072418.pdf	857	{doi,:10.1038,/,nm1569,.}	{NULL}
journal.pone.0072418.pdf	858	{PubMed,:,17401374,.}	{NULL}
journal.pone.0072418.pdf	859	{.}	{NULL}
journal.pone.0072418.pdf	860	{Anderson,C,",",Catoe,H,",",Werner,R,(,2006,),MIR-206,regulates,connexin43,expression,during,skeletal,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	861	{Nucleic,Acids,Res,34,:,5863-5871,.}	{NULL}
journal.pone.0072418.pdf	862	{doi,:10.1093,/,nar/gkl743,.}	{NULL}
journal.pone.0072418.pdf	863	{PubMed,:,17062625,.}	{NULL}
journal.pone.0072418.pdf	864	{.}	{NULL}
journal.pone.0072418.pdf	865	{Cacchiarelli,D,",",Martone,J,",",Girardi,E,",",Cesana,M,",",lncitti,T,et,al.,(,2010,),MicroRNAs,Involved,in,Molecular,Circuitries,Relevant,for,the,Duchenne,Muscular,Dystrophy,Pathogenesis,Are,Controlled,by,the,Dystrophinl,nNOS,Pathway,.}	{NULL}
journal.pone.0072418.pdf	866	{Cell,Metab,12,:,341-351,.}	{NULL}
journal.pone.0072418.pdf	867	{doi,:10.1016,/,j.,cmet,.}	{NULL}
journal.pone.0072418.pdf	868	{2010.07.008,.}	{NULL}
journal.pone.0072418.pdf	869	{PubMed,:,20727829,.}	{NULL}
journal.pone.0072418.pdf	870	{.}	{NULL}
journal.pone.0072418.pdf	871	{Sluijter,JPG,",",van,Mil,A,",",van,Vliet,P,",",Metz,CHG,",",Liu,J,et,al.,(,2010,),MicroRNA-1,and,-499,Regulate,Differentiation,and,Proliferation,in,Human-Derived,Cardiomyocyte,Progenitor,Cells,.}	{NULL}
journal.pone.0072418.pdf	872	{Arterioscler,Thromb,Vasc,Biol,30,:,859-U591,.}	{NULL}
journal.pone.0072418.pdf	873	{doi,:10.1161,/,ATVBAHA,.109.197434,.}	{NULL}
journal.pone.0072418.pdf	874	{PubMed,:,20081117,.}	{NULL}
journal.pone.0072418.pdf	875	{.}	{NULL}
journal.pone.0072418.pdf	876	{Xu,CQ,",",Lu,YJ,",",Pan,ZW,",",Chu,WF,",",Luo,XB,et,al.,(,2007,),The,musclespecific,microRNAs,miR-1,and,miR-133,produce,opposing,effects,on,apoptosis,by,targeting,HSP60,",",HSP70,and,caspase-9,in,cardiomyocytes,(,Retracted,Article,;,see,vol,.}	{NULL}
journal.pone.0072418.pdf	877	{124,.}	{NULL}
journal.pone.0072418.pdf	878	{p.,3187,(,2011,),),.}	{NULL}
journal.pone.0072418.pdf	879	{Journal,of,Cell,Science,120,:,3045-3052,.}	{NULL}
journal.pone.0072418.pdf	880	{Yan,D,",",Dong,XD,",",Chen,XY,",",Wang,LH,",",Lu,CJ,et,al.,(,2009,),MicroRNA-1,/,206,Targets,c-Met,and,Inhibits,Rhabdomyosarcoma,Development,.}	{NULL}
journal.pone.0072418.pdf	881	{J,Biol,Chem,284,:,29596-29604,.}	{NULL}
journal.pone.0072418.pdf	882	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	883	{M109,.020511,.}	{NULL}
journal.pone.0072418.pdf	884	{PubMed,:,19710019,.}	{NULL}
journal.pone.0072418.pdf	885	{.}	{NULL}
journal.pone.0072418.pdf	886	{Chen,JF,",",Tao,Y,",",Li,J,",",Deng,Z,",",Yan,Z,et,al.,(,2010,),microRNA-1,and,microRNA-206,regulate,skeletal,muscle,satellite,cell,proliferation,and,differentiation,by,repressing,Pax7,.}	{NULL}
journal.pone.0072418.pdf	887	{J,Cell,Biol,190,:,867-879,.}	{NULL}
journal.pone.0072418.pdf	888	{doi,:,10.1083,/,jcb,.200911036,.}	{NULL}
journal.pone.0072418.pdf	889	{PubMed,:,20819939,.}	{NULL}
journal.pone.0072418.pdf	890	{.}	{NULL}
journal.pone.0072418.pdf	891	{Elia,L,",",Contu,R,",",Quintavalle,M,",",Varrone,F,",",Chimenti,C,et,al.,(,2009,),Reciprocal,regulation,of,microRNA-1,and,insulin-like,growth,factor-1,signal,transduction,cascade,in,cardiac,and,skeletal,muscle,in,physiological,and,pathological,conditions,.}	{NULL}
journal.pone.0072418.pdf	892	{Circulation,120,:,2377-2385,.}	{NULL}
journal.pone.0072418.pdf	893	{doi,:10.1161,/,ClRCULATlONAHA,.109.879429,.}	{NULL}
journal.pone.0072418.pdf	894	{PubMed,:,19933931,.}	{NULL}
journal.pone.0072418.pdf	895	{.}	{NULL}
journal.pone.0072418.pdf	896	{Xie,CQ,",",Huang,HR,",",Sun,XA,",",Guo,YH,",",Hamblin,M,et,al.,(,2011,),MicroRNA-1,Regulates,Smooth,Muscle,Cell,Differentiation,by,Repressing,Kriippel-Like,Factor,4,.}	{NULL}
journal.pone.0072418.pdf	897	{Stem,Cells,Dev,20,:,205-210,.}	{NULL}
journal.pone.0072418.pdf	898	{doi,:,10.1089,/,scd,.2010.0283,.}	{NULL}
journal.pone.0072418.pdf	899	{PubMed,:,20799856,.}	{NULL}
journal.pone.0072418.pdf	900	{.}	{NULL}
journal.pone.0072418.pdf	901	{Kozakowska,M,",",Ciesla,M,",",Stefanska,A,",",Skrzypek,K,",",Was,H,et,al.,(,2012,),Heme,Oxygenase-1,Inhibits,Myoblast,Differentiation,by,Targeting,Myomirs,.}	{NULL}
journal.pone.0072418.pdf	902	{Antioxid,Redox,Signal,16,:,113-127,.}	{NULL}
journal.pone.0072418.pdf	903	{doi,:10.1089,/,ars,.2011.3964,.}	{NULL}
journal.pone.0072418.pdf	904	{PubMed,:,21827279,.}	{NULL}
journal.pone.0072418.pdf	905	{.}	{NULL}
journal.pone.0072418.pdf	906	{Takahiro,H,",",Ono,K,",",Warraga,Y,",",Nishi,H,",",Nagao,K,et,al.,(,2007,),MicroRNA-133,regulates,the,expression,of,CPT-1b,and,GLUT4,by,targeting,SRF,and,KLF15,and,is,involved,in,metabolic,control,in,cardiac,myocytes,.}	{NULL}
journal.pone.0072418.pdf	907	{Circulation,116,:,163-163,.}	{NULL}
journal.pone.0072418.pdf	908	{doi,:10.1161,/,CIRCULATIONAHA,.}	{NULL}
journal.pone.0072418.pdf	909	{106.684381,.}	{NULL}
journal.pone.0072418.pdf	910	{PubMed,:,17592079,.}	{NULL}
journal.pone.0072418.pdf	911	{.}	{NULL}
journal.pone.0072418.pdf	912	{Boutz,PL,",",Chawla,G,",",Stoilov,P,",",Black,DL,(,2007,),MicroRNAs,regulate,the,expression,of,the,alternative,splicing,factor,nPTB,during,muscle,development,.}	{NULL}
journal.pone.0072418.pdf	913	{Genes,Dev,21,:,71-84,.}	{NULL}
journal.pone.0072418.pdf	914	{doi,:10.1101,/,gad,.1500707,.}	{NULL}
journal.pone.0072418.pdf	915	{PubMed,:,17210790,.}	{NULL}
journal.pone.0072418.pdf	916	{.}	{NULL}
journal.pone.0072418.pdf	917	{Chen,X,",",Wang,KH,",",Chen,JN,",",Guo,JG,",",Yin,Y,et,al.,(,2009,),In,Vitro,Evidence,Suggests,That,miR-133a-mediated,Regulation,of,Uncoupling,Protein,2,(,UCP2,),Is,an,Indispensable,Step,in,Myogenic,Differentiation,.}	{NULL}
journal.pone.0072418.pdf	918	{J,Biol,Chem,284,:,5362-5369,.}	{NULL}
journal.pone.0072418.pdf	919	{PubMed,:,19073597,.}	{NULL}
journal.pone.0072418.pdf	920	{Care,A,",",Catalucci,D,",",Felicetti,F,",",Bonci,D,",",Addario,A,et,al.,(,2007,),MicroRNA-133,controls,cardiac,hypertrophy,.}	{NULL}
journal.pone.0072418.pdf	921	{Nat,Med,13,:,613-618,.}	{NULL}
journal.pone.0072418.pdf	922	{doi,:,10.1038,/,nm1582,.}	{NULL}
journal.pone.0072418.pdf	923	{PubMed,:,17468766,.}	{NULL}
journal.pone.0072418.pdf	924	{Duisters,RF,",",Tijsen,AJ,",",Schroen,B,",",Leenders,JJ,",",Lentink,V,et,al.,(,2009,),miR-133,and,miR-30,Regulate,Connective,Tissue,Growth,Factor,Implications,for,a,Role,of,MicroRNAs,in,Myocardial,Matrix,Remodeling,.}	{NULL}
journal.pone.0072418.pdf	925	{Circ,Res,104,:,170-U161,.}	{NULL}
journal.pone.0072418.pdf	926	{doi,:10.1161,/,ClRCRESAHA,.108.182535,.}	{NULL}
journal.pone.0072418.pdf	927	{PubMed,:,19096030,.}	{NULL}
journal.pone.0072418.pdf	928	{Li,Z,",",Hassan,MQ,",",Volinia,S,",",van,Wijnen,AJ,",",Stein,JL,et,al.,(,2008,),A,microRNA,signature,for,a,BMP2-induced,osteoblast,lineage,commitment,program,.}	{NULL}
journal.pone.0072418.pdf	929	{Proc,Natl,Acad,Sci,U,S,A,105,:,13906-13911,.}	{NULL}
journal.pone.0072418.pdf	930	{doi,:10.1073,/,pnas,.0804438105,.}	{NULL}
journal.pone.0072418.pdf	931	{PubMed,:,18784367,.}	{NULL}
journal.pone.0072418.pdf	932	{Liu,N,",",Bezprozvannaya,S,",",Shelton,JM,",",Frisard,MI,",",Hulver,MW,et,al.,(,2011,),Mice,lacking,microRNA,133a,develop,dynamin,2-dependent,centronuclear,myopathy,.}	{NULL}
journal.pone.0072418.pdf	933	{J,Clin,Invest,121,:,3258-3268,.}	{NULL}
journal.pone.0072418.pdf	934	{doi,:10.1172,/,JCI46267,.}	{NULL}
journal.pone.0072418.pdf	935	{PubMed,:,21737882,.}	{NULL}
journal.pone.0072418.pdf	936	{Rosenberg,Ml,",",Georges,SA,",",Asawachaicharn,A,",",Analau,E,",",Tapscott,SJ,(,2006,),MyoD,inhibits,Fst,|,1,and,Utrn,expression,by,inducing,transcription,of,miR-206,.}	{NULL}
journal.pone.0072418.pdf	937	{J,Cell,Biol,175,:,77-85,.}	{NULL}
journal.pone.0072418.pdf	938	{doi,:10.1083,/,jcb,.}	{NULL}
journal.pone.0072418.pdf	939	{200603039,.}	{NULL}
journal.pone.0072418.pdf	940	{PubMed,:,17030984,.}	{NULL}
journal.pone.0072418.pdf	941	{Winbanks,CE,",",Wang,B,",",Beyer,C,",",Koh,P,",",White,L,et,al.,(,2011,),TGFbeta,Regulates,miR-206,and,miR-29,to,Control,Myogenic,Differentiation,through,Regulation,of,HDAC4,.}	{NULL}
journal.pone.0072418.pdf	942	{J,Biol,Chem,286,:,13805-13814,.}	{NULL}
journal.pone.0072418.pdf	943	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	944	{M110,.192625,.}	{NULL}
journal.pone.0072418.pdf	945	{PubMed,:,21324893,.}	{NULL}
journal.pone.0072418.pdf	946	{Kim,HK,",",Lee,YS,",",Sivaprasad,U,",",Malhotra,A,",",Dutta,A,(,2006,),Musclespeciﬁc,microRNA,miR-206,promotes,muscle,differentiation,.}	{NULL}
journal.pone.0072418.pdf	947	{J,Cell,Biol,174,:,677-687,.}	{NULL}
journal.pone.0072418.pdf	948	{doi,:10.1083,/,jcb,.200603008,.}	{NULL}
journal.pone.0072418.pdf	949	{PubMed,:,16923828,.}	{NULL}
journal.pone.0072418.pdf	950	{Dey,BK,",",Gagan,J,",",Dutta,A,(,2011,),miR-206,and,-486,Induce,Myoblast,Differentiation,by,Downregulating,Pax7,.}	{NULL}
journal.pone.0072418.pdf	951	{Mol,Cell,Biol,31,:,203-214,.}	{NULL}
journal.pone.0072418.pdf	952	{doi,:,10.1128,/,MCB.01009-10,.}	{NULL}
journal.pone.0072418.pdf	953	{PubMed,:,21041476,.}	{NULL}
journal.pone.0072418.pdf	954	{Maciotta,S,",",Meregalli,M,",",Cassinelli,L,",",Parolini,D,",",Farini,A,et,al.,(,2012,),Hmgb3,Is,Regulated,by,MicroRNA-206,during,Muscle,Regeneration,.}	{NULL}
journal.pone.0072418.pdf	955	{PLOS,ONE,7,:,e43464,.}	{NULL}
journal.pone.0072418.pdf	956	{PubMed,:,22912879,.}	{NULL}
journal.pone.0072418.pdf	957	{.}	{NULL}
journal.pone.0072418.pdf	958	{Wang,R,",",Hu,Y,",",Song,G,",",Hao,CJ,",",Cui,Y,et,al.,(,2012,),MiR-206,Regulates,Neural,Cells,Proliferation,and,Apoptosis,via,Otx2,.}	{NULL}
journal.pone.0072418.pdf	959	{Cell,Physiol,Biochem,29,:,381-390,.}	{NULL}
journal.pone.0072418.pdf	960	{doi,:10.1159,/,000338493,.}	{NULL}
journal.pone.0072418.pdf	961	{PubMed,:,22508046,.}	{NULL}
journal.pone.0072418.pdf	962	{Liu,HJ,",",Chen,SE,",",Jin,BW,",",Carson,JA,",",Niu,AR,et,al.,(,2010,),TIMP3,:,a,physiological,regulator,of,adult,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	963	{J,Cell,Sci,123,:,2914-2921,.}	{NULL}
journal.pone.0072418.pdf	964	{doi,:10.1242,/,jcs,.057620,.}	{NULL}
journal.pone.0072418.pdf	965	{PubMed,:,20682640,.}	{NULL}
journal.pone.0072418.pdf	966	{Zhang,TH,",",Liu,M,",",Wang,CR,",",Lin,C,",",Sun,YA,et,al.,(,2011,),Downregulation,of,MiR-206,Promotes,Proliferation,and,Invasion,of,Laryngeal,Cancer,by,Regulating,VEGF,Expression,.}	{NULL}
journal.pone.0072418.pdf	967	{Anticancer,Res,31,:,3859-3863,.}	{NULL}
journal.pone.0072418.pdf	968	{PubMed,:,22110210,.}	{NULL}
journal.pone.0072418.pdf	969	{Sato,MM,",",Nashimoto,M,",",Katagiri,T,",",Yawaka,Y,",",Tamura,M,(,2009,),Bone,morphogenetic,protein-2,down-regulates,miR-206,expression,by,blocking,its,maturation,process,.}	{NULL}
journal.pone.0072418.pdf	970	{Biochem,Biophys,Res,Commun,383,:,125-129,.}	{NULL}
journal.pone.0072418.pdf	971	{doi,:10.1016,/,j.,bbrc,.2009.03.142,.}	{NULL}
journal.pone.0072418.pdf	972	{PubMed,:,19341710,.}	{NULL}
journal.pone.0072418.pdf	973	{Knezevic,I,",",Patel,A,",",Sundaresan,NR,",",Gupta,MP,",",Solaro,RJ,et,al.,(,2012,),A,Novel,Cardiomyocyte-enriched,MicroRNA,",",miR-378,",",Targets,Insulinlike,Growth,Factor,1,Receptor,implications,in,postnatal,cardiac,remodeling,and,cell,survival,.}	{NULL}
journal.pone.0072418.pdf	974	{J,Biol,Chem,287,:,12913-12926,.}	{NULL}
journal.pone.0072418.pdf	975	{doi,:,10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	976	{M111,.331751,.}	{NULL}
journal.pone.0072418.pdf	977	{PubMed,:,22367207,.}	{NULL}
journal.pone.0072418.pdf	978	{Seok,HY,",",Tatsuguchi,M,",",Callis,TE,",",He,A,",",Pu,WT,et,al.,(,2011,),miR-155,inhibits,expression,of,the,MEF2A,protein,to,repress,skeletal,muscle,differentiation,.}	{NULL}
journal.pone.0072418.pdf	979	{J,Biol,Chem,286,:,35339-35346,.}	{NULL}
journal.pone.0072418.pdf	980	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	981	{M111,.273276,.}	{NULL}
journal.pone.0072418.pdf	982	{PubMed,:,21868385,.}	{NULL}
journal.pone.0072418.pdf	983	{Zhao,SP,",",Zhang,J,",",Hou,XH,",",Zan,LS,",",Wang,N,et,al.,(,2012,),OLFML3,Expression,is,Decreased,during,Prenatal,Muscle,Development,and,Regulated,by,MicroRNA-155,in,Pigs,.}	{NULL}
journal.pone.0072418.pdf	984	{Int,J,Biol,Sciences,8,:,459-469,.}	{NULL}
journal.pone.0072418.pdf	985	{PubMed,:,22419891,.}	{NULL}
journal.pone.0072418.pdf	986	{Tzatsos,A,",",Paskaleva,P,",",Lymperi,S,",",Contino,G,",",Stoykova,S,et,al.,(,2011,),Lysine-speciﬁc,Demethylase,2B,(,KDM2B,),-,let-7-Enhancer,of,Zester,Homolog,2,(,EZH2,),Pathway,Regulates,Cell,Cycle,Progression,and,Senescence,in,Primary,Cells,.}	{NULL}
journal.pone.0072418.pdf	987	{J,Biol,Chem,286,:,33061-33069,.}	{NULL}
journal.pone.0072418.pdf	988	{doi,:,10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	989	{M111,.257667,.}	{NULL}
journal.pone.0072418.pdf	990	{PubMed,:,21757686,.}	{NULL}
journal.pone.0072418.pdf	991	{Lin,SM,",",Li,HM,",",Mu,HP,",",Luo,W,",",Li,Y,et,al.,(,2012,),Let-7b,regulates,the,expression,of,the,growth,hormone,receptor,gene,in,deletion-type,dwarf,chickens,.}	{NULL}
journal.pone.0072418.pdf	992	{BMC,Genomics,13,:,306,-,.}	{NULL}
journal.pone.0072418.pdf	993	{PubMed,:,22781587,.}	{NULL}
journal.pone.0072418.pdf	994	{Krichevsky,AM,",",Sonntag,KC,",",lsacson,O,",",Kosik,KS,(,2006,),Specific,microRNAs,modulate,embryonic,stem,cell-derived,neurogenesis,.}	{NULL}
journal.pone.0072418.pdf	995	{Stem,Cells,24,:,857-864,.}	{NULL}
journal.pone.0072418.pdf	996	{doi,:10.1634,/,stemcells.2005-0441,.}	{NULL}
journal.pone.0072418.pdf	997	{PubMed,:,16357340,.}	{NULL}
journal.pone.0072418.pdf	998	{O’Loghlen,A,",",Muﬁoz-Cabello,AM,",",Gaspar-Maia,A,",",Wu,HA,",",Banito,A,et,al.,(,2012,),MicroRNA,Regulation,of,Cbx7,Mediates,a,Switch,of,Polycomb,Orthologs,during,ESC,Differentiation,.}	{NULL}
journal.pone.0072418.pdf	999	{Cell,Stem,Cell,10,:,33-46,.}	{NULL}
journal.pone.0072418.pdf	1000	{doi,:10.1016,/,j.,stem,.2011.12.004,.}	{NULL}
journal.pone.0072418.pdf	1001	{PubMed,:,22226354,.}	{NULL}
journal.pone.0072418.pdf	1002	{Goettsch,C,",",Rauner,M,",",Pacyna,N,",",Hempel,U,",",Bornstein,SR,et,al.,(,2011,),miR-125b,Regulates,Calcification,of,Vascular,Smooth,Muscle,Cells,.}	{NULL}
journal.pone.0072418.pdf	1003	{Am,J,Pathol,179,:,1594-1600,.}	{NULL}
journal.pone.0072418.pdf	1004	{doi,:10.1016,/,j.,ajpath,.2011.06.016,.}	{NULL}
journal.pone.0072418.pdf	1005	{PubMed,:,21806957,.}	{NULL}
journal.pone.0072418.pdf	1006	{Chen,Y,",",Gorski,DH,(,2008,),Regulation,of,angiogenesis,through,a,microRNA,(,miR-130a,),that,down-regulates,antiangiogenic,homeobox,genes,GAX,and,HOXA5,.}	{NULL}
journal.pone.0072418.pdf	1007	{Blood,111,:,1217-1226,.}	{NULL}
journal.pone.0072418.pdf	1008	{PubMed,:,17957028,.}	{NULL}
journal.pone.0072418.pdf	1009	{Navarro,A,",",Diaz,T,",",Martinez,A,",",Gaya,A,",",Pons,A,et,al.,(,2009,),Regulation,of,JAK2,by,miR-135a,:,prognostic,impact,in,classic,Hodgkin,lymphoma,.}	{NULL}
journal.pone.0072418.pdf	1010	{Blood,114,:,2945-2951,.}	{NULL}
journal.pone.0072418.pdf	1011	{doi,:10.1182,/,blood-2009-02-204842,.}	{NULL}
journal.pone.0072418.pdf	1012	{PubMed,:,19666866,.}	{NULL}
journal.pone.0072418.pdf	1013	{Xin,M,",",Small,EM,",",Sutherland,LB,",",Qi,XX,",",McAna,|,|,y,J,et,al.,(,2009,),MicroRNAs,miR-143,and,miR-145,modulate,cytoskeletal,dynamics,and,responsiveness,of,smooth,muscle,cells,to,injury,.}	{NULL}
journal.pone.0072418.pdf	1014	{Genes,Dev,23,:,2166-2178,.}	{NULL}
journal.pone.0072418.pdf	1015	{doi,:10.1101,/,gad,.1842409,.}	{NULL}
journal.pone.0072418.pdf	1016	{PubMed,:,19720868,.}	{NULL}
journal.pone.0072418.pdf	1017	{Karolina,DS,",",Armugam,A,",",Tavintharan,S,",",Wong,MTK,",",Lim,SC,et,al.,(,2011,),MicroRNA,144,Impairs,Insulin,Signaling,by,Inhibiting,the,Expression,of,Insulin,Receptor,Substrate,1,in,Type,2,Diabetes,Mellitus,.}	{NULL}
journal.pone.0072418.pdf	1018	{PLOS,ONE,6,:,e22839,.}	{NULL}
journal.pone.0072418.pdf	1019	{PubMed,:,21829658,.}	{NULL}
journal.pone.0072418.pdf	1020	{Andersen,DC,",",Jensen,CH,",",Schneider,M,",",Nossent,AY,",",Eskildsen,T,et,al.,(,2010,),MicroRNA-15a,fine-tunes,the,level,of,Delta-like,1,homolog,(,DLK1,),in,proliferating,3T3-L1,preadipocytes,.}	{NULL}
journal.pone.0072418.pdf	1021	{Exp,Cell,Res,316,:,1681-1691,.}	{NULL}
journal.pone.0072418.pdf	1022	{doi,:10.1016,/,j.,yexcr,.2010.04.002,.}	{NULL}
journal.pone.0072418.pdf	1023	{PubMed,:,20385127,.}	{NULL}
journal.pone.0072418.pdf	1024	{Biggar,KK,",",Storey,KB,(,2012,),Evidence,for,cell,cycle,suppression,and,microRNA,regulation,of,cyclin,D1,during,anoxia,exposure,in,turtles,.}	{NULL}
journal.pone.0072418.pdf	1025	{Cell,Cycle,11,:,1705-1713,.}	{NULL}
journal.pone.0072418.pdf	1026	{doi,:10.4161,/,cc,.19790,.}	{NULL}
journal.pone.0072418.pdf	1027	{PubMed,:,22510561,.}	{NULL}
journal.pone.0072418.pdf	1028	{Cui,RR,",",Li,SJ,",",Liu,LJ,",",Yi,L,",",Liang,QH,et,al.,(,2012,),MicroRNA-204,regulates,vascular,smooth,muscle,cell,calciﬁcation,in,vitro,and,in,vivo,.}	{NULL}
journal.pone.0072418.pdf	1029	{Cardiovasc,Res,96,:,320-329,.}	{NULL}
journal.pone.0072418.pdf	1030	{doi,:10.1093,/,cvr/cvs258,.}	{NULL}
journal.pone.0072418.pdf	1031	{PubMed,:,22871591,.}	{NULL}
journal.pone.0072418.pdf	1032	{Callis,TE,",",Pandya,K,",",Seok,HY,",",Tang,RH,",",Tatsuguchi,M,et,al.,(,2009,),MicroRNA-208a,is,a,regulator,of,cardiac,hypertrophy,and,conduction,in,mice,.}	{NULL}
journal.pone.0072418.pdf	1033	{J,Clin,Invest,119,:,2772-2786,.}	{NULL}
journal.pone.0072418.pdf	1034	{doi,:10.1172,/,JCl36154,.}	{NULL}
journal.pone.0072418.pdf	1035	{PubMed,:,19726871,.}	{NULL}
journal.pone.0072418.pdf	1036	{Davis,BN,",",Hilyard,AC,",",Lagna,G,",",Hata,A,(,2008,),SMAD,proteins,control,DROSHA-mediated,microRNA,maturation,.}	{NULL}
journal.pone.0072418.pdf	1037	{Nature,454,:,56-U52,.}	{NULL}
journal.pone.0072418.pdf	1038	{doi,:,10.1038,/,nature07086,.}	{NULL}
journal.pone.0072418.pdf	1039	{PubMed,:,18548003,.}	{NULL}
journal.pone.0072418.pdf	1040	{Perdiguero,E,",",Sousa-Victor,P,",",Ruiz-Bonilla,V,",",Jardi,M,",",Caelles,C,et,al.,(,2011,),p38/MKP,-1,-,regulated,AKT,coordinates,macrophage,transitions,and,resolution,of,inflammation,during,tissue,repair,.}	{NULL}
journal.pone.0072418.pdf	1041	{J,Cell,Biol,195,:,307-322,.}	{NULL}
journal.pone.0072418.pdf	1042	{doi,:10.1083,/,jcb,.201104053,.}	{NULL}
journal.pone.0072418.pdf	1043	{PubMed,:,21987635,.}	{NULL}
journal.pone.0072418.pdf	1044	{Roy,S,",",Khanna,S,",",Hussain,SRA,",",Biswas,S,",",Azad,A,et,al.,(,2009,),MicroRNA,expression,in,response,to,murine,myocardial,infarction,:,miR-21,regulates,fibroblast,metalloprotease-2,via,phosphatase,and,tensin,homologue,.}	{NULL}
journal.pone.0072418.pdf	1045	{Cardiovasc,Res,82,:,21-29,.}	{NULL}
journal.pone.0072418.pdf	1046	{doi,:10.1093,/,cvr/cvp015,.}	{NULL}
journal.pone.0072418.pdf	1047	{PubMed,:,19147652,.}	{NULL}
journal.pone.0072418.pdf	1048	{Cicchillitti,L,",",Di,Stefano,V,",",Isaia,E,",",Crimaldi,L,",",Fasanaro,P,et,al.,(,2012,),Hypoxia-inducible,Factor,1-alpha,Induces,miR-210,in,Normoxic,Differentiating,Myoblasts,.}	{NULL}
journal.pone.0072418.pdf	1049	{J,Biol,Chem,287,:,44761-44771,.}	{NULL}
journal.pone.0072418.pdf	1050	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	1051	{M112,.421255,.}	{NULL}
journal.pone.0072418.pdf	1052	{PubMed,:,23148210,.}	{NULL}
journal.pone.0072418.pdf	1053	{Juan,AH,",",Kumar,RM,",",Marx,JG,",",Young,RA,",",Sartorelli,V,(,2009,),Mir214Dependent,Regulation,of,the,Polycomb,Protein,Ezh2,in,Skeletal,Muscle,and,Embryonic,Stem,Cells,.}	{NULL}
journal.pone.0072418.pdf	1054	{Mol,Cell,36,:,61-74,.}	{NULL}
journal.pone.0072418.pdf	1055	{doi,:10.1016,/,j.,molcel,.2009.08.008,.}	{NULL}
journal.pone.0072418.pdf	1056	{PubMed,:,19818710,.}	{NULL}
journal.pone.0072418.pdf	1057	{Kim,D,",",Song,J,",",Jin,EJ,(,2010,),MicroRNA-221,Regulates,Chondrogenic,Differentiation,through,Promoting,Proteosomal,Degradation,of,Slug,by,Targeting,Mdm2,.}	{NULL}
journal.pone.0072418.pdf	1058	{J,Biol,Chem,285,:,26900-26907,.}	{NULL}
journal.pone.0072418.pdf	1059	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	1060	{M110,.115105,.}	{NULL}
journal.pone.0072418.pdf	1061	{PubMed,:,20576614,.}	{NULL}
journal.pone.0072418.pdf	1062	{De,Arcangelis,V,",",Serra,F,",",Cogoni,C,",",Vivarelli,E,",",Monaco,L,et,al.,(,2010,),beta,1-Syntrophin,Modulation,by,miR-222,in,mdx,Mice,.}	{NULL}
journal.pone.0072418.pdf	1063	{PLOS,ONE,5,.}	{NULL}
journal.pone.0072418.pdf	1064	{Lin,ZQ,",",Murtaza,I,",",Wang,K,",",Jiao,JQ,",",Gao,J,et,al.,(,2009,),miR-23a,functions,downstream,of,NFATc3,to,regulate,cardiac,hypertrophy,.}	{NULL}
journal.pone.0072418.pdf	1065	{Proc}	{NULL}
journal.pone.0072418.pdf	1066	{Natl,Acad,Sci,U,S,A,106,:,12103-12108,.}	{NULL}
journal.pone.0072418.pdf	1067	{doi,:10.1073,/,pnas,.0811371106,.}	{NULL}
journal.pone.0072418.pdf	1068	{PubMed,:,19574461,.}	{NULL}
journal.pone.0072418.pdf	1069	{Mohamed,JS,",",Lopez,MA,",",Boriek,AM,(,2010,),Mechanical,Stretch,Upregulates,MicroRNA-26a,and,Induces,Human,Aiwvay,Smooth,Muscle,Hypertrophy,by,Suppressing,Glycogen,Synthase,Kinase-3,beta,.}	{NULL}
journal.pone.0072418.pdf	1070	{J,Biol,Chem,285,:,29336-29347,.}	{NULL}
journal.pone.0072418.pdf	1071	{doi,:10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	1072	{M110,.101147,.}	{NULL}
journal.pone.0072418.pdf	1073	{PubMed,:,20525681,.}	{NULL}
journal.pone.0072418.pdf	1074	{Zhou,L,",",Wang,LJ,",",Lu,LN,",",Jiang,PY,",",Sun,H,et,al.,(,2012,),Inhibition,of,miR-29,by,TGF-beta-Smad3,Signaling,through,Dual,Mechanisms,Promotes,Transdifferentiation,of,Mouse,Myoblasts,into,Myofibroblasts,.}	{NULL}
journal.pone.0072418.pdf	1075	{PLOS,ONE,7,:,e33766,.}	{NULL}
journal.pone.0072418.pdf	1076	{PubMed,:,22438993,.}	{NULL}
journal.pone.0072418.pdf	1077	{Raychaudhuri,S,(,2012,),MicroRNAs,Overexpressed,in,GrowthRestricted,Rat,Skeletal,Muscles,Regulate,the,Glucose,Transport,in,Cell,Culture,Targeting,Central,TGF-beta,Factor,SMAD4,.}	{NULL}
journal.pone.0072418.pdf	1078	{PLOS,ONE,7,.}	{NULL}
journal.pone.0072418.pdf	1079	{van,Rooij,E,",",Sutherland,LB,",",Thatcher,JE,",",DiMaio,JM,",",Naseem,RH,et,al.,(,2008,),Dysregulation,of,microRNAs,after,myocardial,infarction,reveals,a,role,of,miR-29,in,cardiac,fibrosis,.}	{NULL}
journal.pone.0072418.pdf	1080	{Proc,Natl,Acad,Sci,U,S,A,105,:,13027-13032,.}	{NULL}
journal.pone.0072418.pdf	1081	{doi,:10.1073,/,pnas,.0805038105,.}	{NULL}
journal.pone.0072418.pdf	1082	{PubMed,:,18723672,.}	{NULL}
journal.pone.0072418.pdf	1083	{Zhou,L,",",Wang,LJ,",",Lu,LN,",",Jiang,PY,",",Sun,H,et,al.,(,2012,),A,Novel,Target,of,MicroRNA-29,",",Ring1,and,YY1-binding,Protein,(,Rybp,),",",Negatively,Regulates,Skeletal,Myogenesis,.}	{NULL}
journal.pone.0072418.pdf	1084	{J,Biol,Chem,287,:,25255-25265,.}	{NULL}
journal.pone.0072418.pdf	1085	{doi,:,10.1074,/,jbc,.}	{NULL}
journal.pone.0072418.pdf	1086	{M112,.357053,.}	{NULL}
journal.pone.0072418.pdf	1087	{PubMed,:,22661705,.}	{NULL}
journal.pone.0072418.pdf	1088	{Crist,CG,",",Montarras,D,",",Buckingham,M,(,2012,),Muscle,Satellite,Cells,Are,Primed,for,Myogenesis,but,Maintain,Quiescence,with,Sequestration,of,Myf5,mRNA,Targeted,by,microRNA-31,in,mRNP,Granules,.}	{NULL}
journal.pone.0072418.pdf	1089	{Cell,Stem,Cell,11,:,118-126,.}	{NULL}
journal.pone.0072418.pdf	1090	{doi,:10.1016,/,j.,stem,.2012.03.011,.}	{NULL}
journal.pone.0072418.pdf	1091	{PubMed,:,22770245,.}	{NULL}
journal.pone.0072418.pdf	1092	{Tang,HB,",",Lee,M,",",Sharpe,O,",",Salamone,L,",",Noonan,EJ,et,al.,(,2012,),Oxidative,stress-responsive,microRNA-320,regulates,glycolysis,in,diverse,biological,systems,.}	{NULL}
journal.pone.0072418.pdf	1093	{FASEB,J,26,:,4710-4721,.}	{NULL}
journal.pone.0072418.pdf	1094	{d0iZ10,.1096,/,f,],.}	{NULL}
journal.pone.0072418.pdf	1095	{11-197467,.}	{NULL}
journal.pone.0072418.pdf	1096	{PubMed,:,22767230,.}	{NULL}
journal.pone.0072418.pdf	1097	{Chen,YX,",",Melton,DW,",",Gelfond,JAL,",",McManus,LM,",",Shireman,PK,(,2012,),MiR-351,transiently,increases,during,muscle,regeneration,and,promotes,progenitor,cell,proliferation,and,survival,upon,differentiation,.}	{NULL}
journal.pone.0072418.pdf	1098	{Physiol,Genomics,44,:,1042-1051,.}	{NULL}
journal.pone.0072418.pdf	1099	{doi,:10.1152,/,physiolgenomics,.}	{NULL}
journal.pone.0072418.pdf	1100	{00052.2012,.}	{NULL}
journal.pone.0072418.pdf	1101	{PubMed,:,22968638,.}	{NULL}
journal.pone.0072418.pdf	1102	{Cheung,TH,",",Quach,NL,",",Charville,GW,",",Liu,L,",",Park,L,et,al.,(,2012,),Maintenance,of,muscle,stem-cell,quiescence,by,microRNA-489,.}	{NULL}
journal.pone.0072418.pdf	1103	{Nature,482,:,524-U247,.}	{NULL}
journal.pone.0072418.pdf	1104	{doi,:10.1038,/,nature10834,.}	{NULL}
journal.pone.0072418.pdf	1105	{PubMed,:,22358842,.}	{NULL}
journal.pone.0072418.pdf	1106	{Yamamoto,H,",",Morino,K,",",Nishio,Y,",",Ugi,S,",",Yoshizaki,T,et,al.,(,2012,),MicroRNA-494,regulates,mitochondrial,biogenesis,in,skeletal,muscle,through,mitochondrial,transcription,factor,A,and,Forkhead,box,j3,.}	{NULL}
journal.pone.0072418.pdf	1107	{Am,J,Physiol,Endocrinol,Metab,303,:,E1419-E1427,.}	{NULL}
journal.pone.0072418.pdf	1108	{doi,:10.1152,/,ajpendo,.}	{NULL}
journal.pone.0072418.pdf	1109	{00097.2012,.}	{NULL}
journal.pone.0072418.pdf	1110	{PubMed,:,23047984,.}	{NULL}
journal.pone.0072418.pdf	1111	{Caporali,A,",",Meloni,M,",",Vollenkle,C,",",Bonci,D,",",Sala-Newby,GB,et,al.,(,2011,),Deregulation,of,microRNA-503,Contributes,to,Diabetes,MellitusInduced,Impairment,of,Endothelial,Function,and,Reparative,Angiogenesis,Afler,Limb,Ischemia,.}	{NULL}
journal.pone.0072418.pdf	1112	{Circulation,123,:,282-U117,.}	{NULL}
journal.pone.0072418.pdf	1113	{doi,:,10.1161,/,ClRCULATlONAHA,.110.952325,.}	{NULL}
journal.pone.0072418.pdf	1114	{PubMed,:,21220732,.}	{NULL}
journal.pone.0072418.pdf	1115	{Yang,CC,",",Liu,H,",",Chen,SL,",",Wang,TH,",",Hsieh,CL,et,al.,(,2012,),Epigenetic,silencing,of,myogenic,gene,program,by,Myb-binding,protein,1a,suppresses,myogenesis,.}	{NULL}
journal.pone.0072418.pdf	1116	{EMBO,J,31,:,1739-1751,.}	{NULL}
journal.pone.0072418.pdf	1117	{doi,:10.1038,/,emboj,.}	{NULL}
journal.pone.0072418.pdf	1118	{2012.24,.}	{NULL}
journal.pone.0072418.pdf	1119	{PubMed,:,22333916,.}	{NULL}
journal.pone.0072418.pdf	1120	{Crippa,S,",",Cassano,M,",",Messina,G,",",Galli,D,",",Galvez,BG,et,al.,(,2011,),miR669a,and,miR669q,prevent,skeletal,muscle,differentiation,in,postnatal,cardiac,progenitors,.}	{NULL}
journal.pone.0072418.pdf	1121	{J,Cell,Biol,193,:,1197-1212,.}	{NULL}
journal.pone.0072418.pdf	1122	{doi,:10.1083,/,jcb,.201011099,.}	{NULL}
journal.pone.0072418.pdf	1123	{PubMed,:,21708977,.}	{NULL}
journal.pone.0072418.pdf	1124	{Aoi,W,",",Naito,Y,",",Mizushima,K,",",Takanami,Y,",",Kawai,Y,et,al.,(,2010,),The,microRNA,miR-696,regulates,PGC-1,alpha,in,mouse,skeletal,muscle,in,response,to,physical,activity,.}	{NULL}
journal.pone.0072418.pdf	1125	{Am,J,Physiol,Endocrinol,Metab,298,:,E799-E806,.}	{NULL}
journal.pone.0072418.pdf	1126	{doi,:10.1152,/,ajpendo,.00448.2009,.}	{NULL}
journal.pone.0072418.pdf	1127	{PubMed,:,20086200,.}	{NULL}
journal.pone.0072418.pdf	1128	{Bonauer,A,",",Carmona,G,",",Iwasaki,M,",",Mione,M,",",Koyanagi,M,et,al.,(,2009,),MicroRNA-92a,Controls,Angiogenesis,and,Functional,Recovery,of,lschemic,Tissues,in,Mice,.}	{NULL}
journal.pone.0072418.pdf	1129	{Science,324,:,1710-1713,.}	{NULL}
journal.pone.0072418.pdf	1130	{doi,:10.1126,/,science,.1174381,.}	{NULL}
journal.pone.0072418.pdf	1131	{PubMed,:,19460962,.}	{NULL}
journal.pone.0099155.pdf	1	{o,|,ONE}	{NULL}
journal.pone.0099155.pdf	2	{OPEN,8,ACCESS,Freely,available,online}	{NULL}
journal.pone.0099155.pdf	3	{The,Characterization,of,Obese,Polycystic,Ovary,Syndrome,Rat,Model,Suitable,for,Exercise,Intervention}	{NULL}
journal.pone.0099155.pdf	4	{C,!,)}	{NULL}
journal.pone.0099155.pdf	5	{CrossMark,Llldlanlpdalas}	{NULL}
journal.pone.0099155.pdf	6	{Chuyan,Wu,”,",",Feng,Lin,”,",",Shuwei,Qiu,",",Zhongli,Jiang,*,Department,of,Rehabilitation,Medicine,",",The,First,Afﬁliated,Hospital,of,Nanjing,Medical,University,",",Nanjing,",",China}	{NULL}
journal.pone.0099155.pdf	7	{Abstract}	{NULL}
journal.pone.0099155.pdf	8	{Objective,:,To,develop,a,new,polycystic,ovary,syndrome,(,PCOS,),rat,model,suitable,for,exercise,intervention,.}	{NULL}
journal.pone.0099155.pdf	9	{Method,:,Thirty,six,rats,were,randomly,divided,into,three,experimental,groups,:,PCOS,rats,with,high,—,fat,diet,(,PF,",",n,=,24,),",",PCOS,rats,with,ordinary,diet,(,PO,",",n,=,6,),",",and,control,rats,with,ordinary,diet,(,CO,",",n,:6,),.}	{NULL}
journal.pone.0099155.pdf	10	{Two,kinds,of,PCOS,rat,model,were,made,by,adjustment,diet,structure,and,testosterone,injection,for,28,days,.}	{NULL}
journal.pone.0099155.pdf	11	{After,a,successful,animal,model,",",PF,model,rats,were,randomly,assigned,to,three,groups,:,exercise,with,a,continuation,of,high,—,fat,diet,(,PF,.}	{NULL}
journal.pone.0099155.pdf	12	{—,.}	{NULL}
journal.pone.0099155.pdf	13	{EF,",",n,=,6,),",",sedentary,with,a,continuation,of,high,—,fat,diet,(,PF,.}	{NULL}
journal.pone.0099155.pdf	14	{—,.}	{NULL}
journal.pone.0099155.pdf	15	{SF,",",n,=,6,),",",exercise,with,an,ordinary,diet,(,PF,.}	{NULL}
journal.pone.0099155.pdf	16	{—,.}	{NULL}
journal.pone.0099155.pdf	17	{EO,",",n,=,6,),.}	{NULL}
journal.pone.0099155.pdf	18	{Fasting,blood,glucose,(,FBG,),and,insulin,(,FINS,),",",estrogen,(,E2,),",",progesterone,(,P,),",",and,testosterone,(,1,',),in,serum,were,determined,by,RIA,",",and,ovarian,morphology,was,evaluated,by,|,mage,.}	{NULL}
journal.pone.0099155.pdf	19	{—,.}	{NULL}
journal.pone.0099155.pdf	20	{Pro,plus,6.0,.}	{NULL}
journal.pone.0099155.pdf	21	{Results,:,Body,weight,",",Lee,index,",",FINS,increased,significantly,in,PF,rat,model,.}	{NULL}
journal.pone.0099155.pdf	22	{Serum,levels,of,E2,and,T,were,signiﬁcantly,higher,in,PF,and,PO,than,in,CO.,.}	{NULL}
journal.pone.0099155.pdf	23	{Ovary,organ,index,and,ovarian,areas,were,significant,lower,in,PF,than,in,CO.,.}	{NULL}
journal.pone.0099155.pdf	24	{After,intervention,for,2,weeks,",",the,levels,of,1,h,postprandial,blood,glucose,(,PBG1,),",",2,h,postprandial,blood,glucose,(,PBG2,),",",FINS,and,the,serum,levels,ofT,decreased,signiﬁcantly,in,PF,.}	{NULL}
journal.pone.0099155.pdf	25	{—,.}	{NULL}
journal.pone.0099155.pdf	26	{EF,rats,and,PF,.}	{NULL}
journal.pone.0099155.pdf	27	{—,.}	{NULL}
journal.pone.0099155.pdf	28	{EO,rats,.}	{NULL}
journal.pone.0099155.pdf	29	{The,ratio,of,FBG/FINS,was,significant,higher,in,PF,.}	{NULL}
journal.pone.0099155.pdf	30	{—,.}	{NULL}
journal.pone.0099155.pdf	31	{EO,rats,than,in,PF,.}	{NULL}
journal.pone.0099155.pdf	32	{—,.}	{NULL}
journal.pone.0099155.pdf	33	{SF,rats,.}	{NULL}
journal.pone.0099155.pdf	34	{Ovarian,morphology,showed,that,the,numbers,of,preantral,follicles,and,atretic,follicles,decreased,significantly,",",and,the,numbers,of,antral,follicles,and,corpora,lutea,increased,significantly,in,the,rats,of,PF,.}	{NULL}
journal.pone.0099155.pdf	35	{—,.}	{NULL}
journal.pone.0099155.pdf	36	{EF,and,PF,.}	{NULL}
journal.pone.0099155.pdf	37	{—,.}	{NULL}
journal.pone.0099155.pdf	38	{EO,.}	{NULL}
journal.pone.0099155.pdf	39	{Conclusion,:,By,combination,of,high,—,fat,diet,and,testosterone,injection,",",the,obese,PCOS,rat,model,is,conformable,with,the,lifestyle,habits,of,fatty,foods,and,insufficient,exercise,",",and,has,metabolic,and,reproductive,characteristics,of,human,PCOS,.}	{NULL}
journal.pone.0099155.pdf	40	{This,model,can,be,applied,to,study,exercise,intervention,.}	{NULL}
journal.pone.0099155.pdf	41	{Citation,:,Wu,C,",",Lin,F,",",Qiu,S,",",Jiang,Z,(,2014,),The,Characterization,of,Obese,Polycystic,Ovary,Syndrome,Rat,Model,Suitable,for,Exercise,Intervention,.}	{NULL}
journal.pone.0099155.pdf	42	{PLoS,ONE,9,(,6,),:,e99155,.}	{NULL}
journal.pone.0099155.pdf	43	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	44	{pone,.0,O99155,Editor,:,Harpal,Singh,Randeva,",",University,of,Warwick,—,Medical,School,",",United,Kingdom,Received,September,30,",",2013,;,Accepted,May,12,",",2014,;,Published,June,6,",",2014,Copyright,:,©,2014,Wu,et,al.,.}	{NULL}
journal.pone.0099155.pdf	45	{This,is,an,open,—,access,article,distributed,under,the,terms,of,the,Creative,Commons,Attribution,License,",",which,permits,unrestricted,use,",",distribution,",",and,reproduction,in,any,medium,",",provided,the,original,author,and,source,are,credited,.}	{NULL}
journal.pone.0099155.pdf	46	{Funding,:,This,study,was,supported,by,National,Nature,Science,Foundation,of,China,(,81101452,),.}	{NULL}
journal.pone.0099155.pdf	47	{The,support,from,the,Priority,Academic,Program,Development,(,PAPD,),of,Jiangsu,Higher,Education,Institutions,is,also,appreciated,.}	{NULL}
journal.pone.0099155.pdf	48	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.pone.0099155.pdf	49	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.pone.0099155.pdf	50	{*,E,—,mai,|,:,jiangzh3721@I63.com,5,These,authors,contributed,equally,to,this,work,.}	{NULL}
journal.pone.0099155.pdf	51	{starting,before,puberty,results,in,a,PCOS,model,with,reproductive,and,metabolic,features,of,the,syndrome,[,8,],.}	{NULL}
journal.pone.0099155.pdf	52	{The,letrozole,model,targets,the,study,of,aromotase,deﬁciency,—,induced,classic,PCOS,[,3,],and,can,used,for,studying,the,mechanism,for,the,complex,pathogenesis,of,PCOS,[,8,],.}	{NULL}
journal.pone.0099155.pdf	53	{Continuous,exposure,to,dihydrotestosterone,(,DHT,),can,develop,an,obese,PCOS,rat,model,which,has,typical,hormonal,disorders,and,ovarian,morphological,changes,[,9,],.}	{NULL}
journal.pone.0099155.pdf	54	{The,DHT,model,may,be,suitable,for,studies,of,both,ovarian,and,metabolic,features,of,the,syndrome,.}	{NULL}
journal.pone.0099155.pdf	55	{The,insulin,sensitivity,and}	{NULL}
journal.pone.0099155.pdf	56	{Introduction}	{NULL}
journal.pone.0099155.pdf	57	{Polycystic,ovary,syndrome,(,PCOS,),is,a,heterogeneous,syndrome,that,is,characterized,by,anovulation,",",clinical,and,/,or,biochemical,signs,of,hyperanclrogenism,",",and,abnormal,ovarian,morphology,[,1,],.}	{NULL}
journal.pone.0099155.pdf	58	{It,is,the,most,common,endocrine,disorder,in,women,of,reproductive,age,",",affecting,5,—,l0,%,of,women,in,this,age,group,[,2,],.}	{NULL}
journal.pone.0099155.pdf	59	{Various,methods,have,been,used,to,induce,PCOS,in,rodents,",",including,exposure,to,androgens,",",estrogens,",",aromatase,inhibitors,",",antiprogesterone,agents,",",constant,light,and,genetic,modiﬁcations,[,3,],.}	{NULL}
journal.pone.0099155.pdf	60	{Estradiol,valerateis,often,used,to,make,a,PCOS,rat,model,",",which,has,several,characteristics,of,acyclicity,and,polycystic,ovarian,changes,without,the,typical,metabolic,disturbances,of,human,PCOS,[,4,~,7,],.}	{NULL}
journal.pone.0099155.pdf	61	{Letrozole,",",a,nonsteroidal,aromatase,inhibitor,",",blocks,the,conversion,of,testosterone,to,estradiol,and,also,induces,PCOS,in,6-week-old,female,rats,.}	{NULL}
journal.pone.0099155.pdf	62	{Continuous,administration,of,letrozole,",",200,mg/d,",",to,female,rats,for,90day,estrus,cyclicity,in,DHT,induced,PCOS,rat,model,can,be,improved,by,running,wheel,exercise,[,10,],",",although,circulating,sex,hormones,were,not,measured,.}	{NULL}
journal.pone.0099155.pdf	63	{The,model,by,administration,of,testosterone,to,immature,female,rats,seeks,to,incorporate,both,the,morphological,changes,as,well,as,the,hormonal,disorders,seen,in,PCOS,.}	{NULL}
journal.pone.0099155.pdf	64	{It,was,demonstrated,that,testosterone,administration,blocked,the,ovulatory,process,in,the,model,of,immature,rats,.}	{NULL}
journal.pone.0099155.pdf	65	{After,injection,of,testosterone,propionate,for,up,to,28,days,",",typical,high,insulin,blood,levels,and,the,fasting,glucose,/,insulin,ratio,was,dramatically,reduced,in,the,animals,.}	{NULL}
journal.pone.0099155.pdf	66	{Nevertheless,",",because,a,large,pool,of,primordial,follicles,was,still,well,preserved,as,well,as,a,small,fraction,of,preantral,and,antral,follicles,were,still,remained,",",this,model,can,lend,itself,for,the,therapy,of,PCOS,phenotype,[,1,1,],.}	{NULL}
journal.pone.0099155.pdf	67	{In,our,previous,study,",",swimming,training,for,2,weeks,improved,signiﬁcantly,body,weight,index,",",insulin,resistance,and,the,androgen,level,in,PCOS,rat,model,induced,by,testosterone,injection,[,12,],.}	{NULL}
journal.pone.0099155.pdf	68	{The,pathogenesis,of,PCOS,is,poorly,understood,until,now,.}	{NULL}
journal.pone.0099155.pdf	69	{Starting,from,early,life,and,extending,through,lifecycle,",",environmental,insults,may,affect,susceptible,women,who,ﬁnally,demonstrate,the,clinical,phenotype,of,PCOS,.}	{NULL}
journal.pone.0099155.pdf	70	{High-fat,diet,and,sedentary,lifestyle,emerge,as,the,major,environmental,determinant,of,PCOS,[,13,],.}	{NULL}
journal.pone.0099155.pdf	71	{Many,studies,have,reported,that,the,rats,fed,with,high-fat,diet,develop,insulin,resistance,which,is,one,of,the,important,features,of,PCOS,[,14,—,16,],.}	{NULL}
journal.pone.0099155.pdf	72	{Many,researchers,have,demonstrated,that,the,improvement,of,insulin,sensitivity,decreased,androgen,concentration,[,17,—,19,],.}	{NULL}
journal.pone.0099155.pdf	73	{Exercise,training,can,signiﬁcantly,improve,insulin,resistance,",",thus,reducing,serum,levels,of,androstenedione,and,dehydroepiandrosterone,[,20,],.}	{NULL}
journal.pone.0099155.pdf	74	{However,",",several,studies,have,demonstrated,that,simple,dietary,intervention,did,not,improve,insulin,resistance,.}	{NULL}
journal.pone.0099155.pdf	75	{A,European,randomized,dietary,intervention,study,for,12,weeks,had,conﬁrmed,that,overall,reduction,of,dietary,SFA,had,no,effect,on,insulin,sensitivity,in,weight-stable,obese,subjects,[,21,],.}	{NULL}
journal.pone.0099155.pdf	76	{Rajaie,et,al,also,found,that,compared,a,calorierestricted,moderately,restricted,carbohydrate,and,high,fat,diet,(,430/o,—,47,°,/,o,of,total,calories,as,carbohydrate,and,36,°,/,o,—,40,%,as,dietary,fats,),with,a,calorie-restricted,high-carbohydrate,and,low,fat,diet,(,60,%,.}	{NULL}
journal.pone.0099155.pdf	77	{—,.}	{NULL}
journal.pone.0099155.pdf	78	{65,%,of,energy,from,carbohydrates,and,20,%,.}	{NULL}
journal.pone.0099155.pdf	79	{—,.}	{NULL}
journal.pone.0099155.pdf	80	{25,%,from,fats,),",",there,was,not,statistically,different,changes,in,fasting,plasma,glucose,and,insulin,[,22,],.}	{NULL}
journal.pone.0099155.pdf	81	{Therefore,",",in,the,lifestyle,interventions,",",exercise,is,used,as,an,important,measure,and,diet,is,considered,as,a,supporting,factor,.}	{NULL}
journal.pone.0099155.pdf	82	{According,to,unhealthy,lifestyle,such,as,highfat,diet,and,lack,of,exercise,existing,in,human,PCOS,",",the,purpose,of,the,present,study,is,to,develop,new,animal,model,to,ﬁt,exercise,intervention,.}	{NULL}
journal.pone.0099155.pdf	83	{In,this,present,study,",",obese,PCOS,rat,model,manifesting,hyperinsulinemia,",",hyperandrogenemia,and,morphological,feature,of,polycystic,ovaries,was,successfully,created,by,the,combination,of,high-fat,diet,and,testosterone,propionate,injection,",",and,then,intervened,by,exercise,training,with,diet,structure,adjustment,.}	{NULL}
journal.pone.0099155.pdf	84	{The,results,indicated,that,exercise,intervention,can,effectively,improve,the,reproductive,endocrine,environment,of,the,obese,PCOS,model,rats,.}	{NULL}
journal.pone.0099155.pdf	85	{Materials,and,Methods}	{NULL}
journal.pone.0099155.pdf	86	{Ethics,Statement,Thirty-six,Wistar,female,rats,(,50,—,70,g,",",21,days,old,),were,purchased,from,Shanghai,SLC,Co.,(,Shanghai,",",China,),",",kept,in,temperature-controlled,rooms,(,22,°,C,),",",with,light,from,08:00,to,20:00,h,and,dark,from,20:00,to,08:00,h,and,free,access,to,water,.}	{NULL}
journal.pone.0099155.pdf	87	{The,experimental,protocols,were,approved,and,strictly,followed,by,the,Institutional,Animal,Care,and,Use,Committees,of,Nanjing,Medical,University,(,permit,number,:,NJMU,/,IACUC_20120210_01,),in,strict,accordance,with,the,Guidelines,for,the,Care,and,Use,of,Laboratory,Animals,(,National,Research,Council,of,People,’s,Republic,of,China,",",2010,),.}	{NULL}
journal.pone.0099155.pdf	88	{Study,procedure,All,rats,were,randomly,divided,into,three,experimental,groups,(,Fig,.}	{NULL}
journal.pone.0099155.pdf	89	{1,),:,PCOS,model,with,high-fat,diet,(,PF,",",n,=,24,),",",PCOS,model,with,ordinary,diet,(,PO,",",n,=,6,),",",and,control,group,with,ordinary,diet,(,CO,",",n,=,6,),.}	{NULL}
journal.pone.0099155.pdf	90	{PF,rats,were,fed,with,high-fat,diet,for,28,days,.}	{NULL}
journal.pone.0099155.pdf	91	{CO,rats,were,fed,with,ordinary,diet,.}	{NULL}
journal.pone.0099155.pdf	92	{High-fat,diet,composed,of}	{NULL}
journal.pone.0099155.pdf	93	{22,%,fat,",",48,%,carbohydrate,",",and,20,°,/,oprotein,with,total,caloriﬁc,value,44.3,Kj,/,Kg,[,23,],and,ordinary,diet,composed,of,5,%,fat,",",53,%,carbohydrate,",",23,%,protein,",",with,total,caloriﬁc,value,25KJ,/,Kg,were,ordered,in,Shanghai,SLC,Co.,(,Shanghai,",",China,),.}	{NULL}
journal.pone.0099155.pdf	94	{At,the,same,time,",",these,rats,in,PF,and,PO,were,subcutaneously,injected,daily,at,8:00,for,28,days,with,testosterone,propionate,of,1,mg,/,100,g,body,weight,dissolved,in,tea,oil,[,11,],.}	{NULL}
journal.pone.0099155.pdf	95	{The,rats,in,CO,were,injected,daily,with,the,same,volume,of,tea,oil,alone,.}	{NULL}
journal.pone.0099155.pdf	96	{At,the,day,after,the,end,of,28,days,of,injection,",",total,18,rats,from,PF,",",PO,and,CO,with,6,rats,in,each,group,were,sacriﬁced,by,cervical,dislocation,.}	{NULL}
journal.pone.0099155.pdf	97	{Then,",",the,remaining,18,rats,in,PF,were,randomly,assigned,to,three,groups,(,Fig,.}	{NULL}
journal.pone.0099155.pdf	98	{1,),:,exercise,with,high-fat,diet,(,PF-EF,",",n,=,6,),",",exercise,with,ordinary,diet,(,PF-EO,",",n,=,6,),",",sedentary,with,high-fat,diet,(,PF-SF,",",n,=,6,),.}	{NULL}
journal.pone.0099155.pdf	99	{The,rats,in,PF-EF,and,PF,-,SF,continued,feeding,with,high-fat,diet,",",and,the,rats,in,PF-EO,were,fed,with,ordinary,diet,for,two,weeks,.}	{NULL}
journal.pone.0099155.pdf	100	{The,exercise,rats,in,PF,-,EF,and,PFEO,were,forced,to,swim,simultaneously,without,a,load,at,with,120,min,/,d,and,6,d/week,for,two,weeks,in,a,barrel,ﬁlled,with,water,maintained,at,33,—,35,°,C,to,a,depth,of,40,—,50,cm,",",in,which,the,area,for,every,rat,is,enough,to,swim,freely,.}	{NULL}
journal.pone.0099155.pdf	101	{The,non-exercise,rats,in,PF,-,FS,were,placed,in,shallow,water,at,33,—,35,°,C,",",120,min,",",6,day,/,week,for,two,weeks,of,housing,[,12,],.}	{NULL}
journal.pone.0099155.pdf	102	{All,the,rats,were,sacriﬁced,by,cervical,dislocation,between,08:00,and,1,1:00,AM,under,fasting,condition,at24,h,after,the,end,of,the,last,training,session,with,3,%,pentobarbital,abdominal,anesthesia,.}	{NULL}
journal.pone.0099155.pdf	103	{Blood,and,ovary,samples,were,collected,from,all,animals,.}	{NULL}
journal.pone.0099155.pdf	104	{Measurements,of,body,weight,",",body,length,and,ovary,weight,Body,weight,and,length,of,rats,were,measured,weekly,from,21days,of,age,.}	{NULL}
journal.pone.0099155.pdf	105	{Body,length,was,deﬁned,as,the,distance,from,nose,to,anus,of,rats,.}	{NULL}
journal.pone.0099155.pdf	106	{Lee,index,reﬂects,the,body,fat,as,a,parameter,[,LI,=,body,weight,(,g,),1/3,>,<,1000/body,length,(,cm,),],[,11,],.}	{NULL}
journal.pone.0099155.pdf	107	{Bilateral,ovaries,of,one,rat,were,weighed,",",in,which,the,mean,values,were,regarded,as,the,ovary,weight,.}	{NULL}
journal.pone.0099155.pdf	108	{Ovarian,organ,index,=,ovary,weight/body,weight,X10,”,[,12,],.}	{NULL}
journal.pone.0099155.pdf	109	{Wistar,female,rats}	{NULL}
journal.pone.0099155.pdf	110	{(,n,=,36,)}	{NULL}
journal.pone.0099155.pdf	111	{(,F6,),(,F6,),(,F24,),<,2,!}	{NULL}
journal.pone.0099155.pdf	112	{Model,groups}	{NULL}
journal.pone.0099155.pdf	113	{I,','}	{NULL}
journal.pone.0099155.pdf	114	{i13,&,e,"\\"",m,?}	{NULL}
journal.pone.0099155.pdf	115	{g,',"\\"",;,IL,for,28,days,1}	{NULL}
journal.pone.0099155.pdf	116	{-,PF-SF,PF-EF,PF-Eo,Intervention,groups,(,F6,),(,F6,),(,F6,),",",.}	{NULL}
journal.pone.0099155.pdf	117	{_,_,_,_,_,_,_,_,_,_,__,.,'}	{NULL}
journal.pone.0099155.pdf	118	{L-lléilflliiiﬁi,__,EF,>,5,.,'}	{NULL}
journal.pone.0099155.pdf	119	{.55,E,',.,'}	{NULL}
journal.pone.0099155.pdf	120	{l,=,"\\"",E,',*,',F,"\\"",=}	{NULL}
journal.pone.0099155.pdf	121	{Figure,1,.}	{NULL}
journal.pone.0099155.pdf	122	{The,experiment,protocol,.}	{NULL}
journal.pone.0099155.pdf	123	{o,:,ordinary,diet,;,F,:,high,fat,diet,;,T,:,testosterone,propionate,;,CO,:,control,group,with,ordinary,diet,;,PO,:,PCOS,model,with,ordinary,diet,;,PF,:,PCOS,model,with,high-fat,diet,;,S,:,no,exercise,;,E,:,exercise,;,PF-SF,:,sedentary,with,high-fat,diet,in,PF,rats,;,PF-EF,:,exercise,with,high-fat,diet,in,PF,rats,;,PF,.}	{NULL}
journal.pone.0099155.pdf	124	{—,.}	{NULL}
journal.pone.0099155.pdf	125	{EO,:,exercise,with,ordinary,diet,in,PF,rats,.}	{NULL}
journal.pone.0099155.pdf	126	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	127	{pone,.}	{NULL}
journal.pone.0099155.pdf	128	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	129	{gOO1}	{NULL}
journal.pone.0099155.pdf	130	{Vaginal,smears,Vaginal,smears,were,monitored,daily,to,determine,the,stage,of,cyclicity,from,42,days,of,age,to,the,end,of,experiment,.}	{NULL}
journal.pone.0099155.pdf	131	{In,this,procedure,",",smears,obtained,by,vaginal,washing,were,dyed,with,methylthioninium,chloride,and,then,analyzed,under,a,microscope,for,the,predominant,cell,type,in,vaginal,smears,.}	{NULL}
journal.pone.0099155.pdf	132	{The,estrus,cycle,experiences,four,stages,of,proestrus,",",estrus,",",metoestrus,",",and,diestrus,.}	{NULL}
journal.pone.0099155.pdf	133	{Cycles,with,duration,of,4,—,5,days,were,considered,as,regular,[,3,],.}	{NULL}
journal.pone.0099155.pdf	134	{At,the,beginning,of,experiment,",",all,rats,showed,regular,cycles,.}	{NULL}
journal.pone.0099155.pdf	135	{Oral,glucose,tolerance,test,(,OG,',|,‘,|,',),Before,sacriﬁced,",",all,rats,were,fasted,overnight,and,infused,intragastrically,with,2,g,glucose,per,kilogram,of,body,weight,.}	{NULL}
journal.pone.0099155.pdf	136	{Blood,samples,were,collected,at,o,min,",",60,min,and,120,min,after,oral,glucose,used,to,evaluate,fasting,blood,glucose,(,FBG,),",",l,h,postprandial,blood,glucose,(,PBG1,),and,2,h,postprandial,blood,glucose,(,PBG2,),",",respectively,[,23,],.}	{NULL}
journal.pone.0099155.pdf	137	{Serum,analysis,Blood,samples,obtained,from,all,rats,fasting,for,12,h,were,centrifuged,at,2500,g,for,10,min,and,stored,at,—,80,°,C.,Fasting,serum,levels,for,insulin,(,FIN,S,),",",estrogen,(,E2,),",",progesterone,(,P,),",",and,testosterone,(,T,),were,determined,using,correspondent,commercial,RIA,kits,(,Northern,biological,technical,institute,",",Beijing,",",P.,R.,China,),.}	{NULL}
journal.pone.0099155.pdf	138	{Fasting,blood,glucose,(,FBG,),was,analyzed,by,GOD-PAP,.}	{NULL}
journal.pone.0099155.pdf	139	{Insulin,resistance,index,is,deﬁned,as,the,ratio,of,FBG/FINS,[,1,1,],.}	{NULL}
journal.pone.0099155.pdf	140	{Ovarian,morphology,analysis,When,rats,were,sacriﬁced,",",the,ovaries,were,dissected,from,connective,tissue,",",ﬁxed,in,10,%,formalin,for,24,h,",",dehydrated,in,increasing,concentrations,of,ethanol,",",followed,by,immersion,in,xylene,",",and,embedded,in,parafﬁn,.}	{NULL}
journal.pone.0099155.pdf	141	{The,ovaries,were,longitudinally,and,serially,sectioned,at,4,pm,from,the,center,.}	{NULL}
journal.pone.0099155.pdf	142	{Serial,sections,were,mounted,on,3,slides,",",deparafﬁnized,with,xylene,",",hydrated,with,successive,decreasing,concentrations,of,ethanolin,water,",",and,then,stained,with,hematoxylin,and,eosin,@,The,section,with,the,largest,area,was,chosen,for,analysis,to,count,the,numbers,of,preantral,",",antral,and,atretic,follicles,",",and,corporalutea,[,24,],.}	{NULL}
journal.pone.0099155.pdf	143	{Atretic,follicles,were,conﬁrmed,when,one,of,the,following,characteristics,was,observed,",",such,as,the,presence,of,pyknosis,in,the,granulose,cell,",",granulosa,cells,present,in,the,follicular,ﬂuid,",",or,theca,cell,hypertrophy,.}	{NULL}
journal.pone.0099155.pdf	144	{Sections,were,photographed,with,a,camera,(,Olympus,BX51,",",Japan,),at,>,<,40,",",X,100,",",and,>,<,200,magniﬁcations,.}	{NULL}
journal.pone.0099155.pdf	145	{The,area,of,the,ovary,was,determined,with,a,calibrated,scale,tool,in,the,virtual,microscope,.}	{NULL}
journal.pone.0099155.pdf	146	{Then,",",the,areas,of,the,largest,section,(,at,>,<,40,magniﬁcation,),",",all,corporalutea,(,at,X,100,magniﬁcation,),",",and,thickness,of,theca,cell,layer,and,granulosa,cell,layer,(,from,3,visual,ﬁelds,of,follicles,at,>,<,200,magniﬁcation,),were,measured,with,Image-Pro,plus,6.0,.}	{NULL}
journal.pone.0099155.pdf	147	{Statistical,analyses,Data,were,expressed,as,means,iSD,.}	{NULL}
journal.pone.0099155.pdf	148	{Statistical,evaluations,were,performed,with,SPSS,software,(,version,16.0,",",SPSS,",",Chicago,",",IL,",",USA,),.}	{NULL}
journal.pone.0099155.pdf	149	{All,the,data,were,analyzed,by,one-way,AN,OVA,",",and,p,<,0.05,was,considered,signiﬁcant,.}	{NULL}
journal.pone.0099155.pdf	150	{V/V,hen,the,AN,OVA,revealed,signiﬁcant,differences,among,three,experimental,groups,",",post,hoc,analysis,was,performed,by,using,Bonferroni,’s,method,of,multiple,comparisons,(,3,repeated,tests,;,p,<,0.0167,was,considered,signiﬁcant,for,each,test,),.}	{NULL}
journal.pone.0099155.pdf	151	{Results}	{NULL}
journal.pone.0099155.pdf	152	{Vaginal,smears,The,vaginal,smears,were,monitored,during,whole,experiment,.}	{NULL}
journal.pone.0099155.pdf	153	{The,vaginas,in,all,rats,mostly,opened,at,40,days,old,.}	{NULL}
journal.pone.0099155.pdf	154	{The,regular,estrous,cycle,of,4,~,5,days,was,observed,in,control,(,Fig,.}	{NULL}
journal.pone.0099155.pdf	155	{2,),.}	{NULL}
journal.pone.0099155.pdf	156	{However,",",there,were,many,white,cells,",",less,epithelial,cell,",",and,keratinocytein,vaginal,smears,of,PO,and,PF,rats,",",indicating,these,rats,persisted,in,diestrus,and,no,ovulation,happened,.}	{NULL}
journal.pone.0099155.pdf	157	{After,2,weeks,",",the,rats,in,PF-EF,and,PF-EO,restored,to,normal,estrous,cycles,",",while,the,rats,in,PF-SF,still,showed,persistent,diestrus,.}	{NULL}
journal.pone.0099155.pdf	158	{Changes,of,metabolic,and,endocrine,variables,in,PCOS,model,induced,by,high,—,fat,diet,and,testosterone,propionate,The,metabolic,and,endocrine,variables,were,measured,on,the,28th,day,of,experiment,in,three,groups,of,CO,",",PO,and,PF,.}	{NULL}
journal.pone.0099155.pdf	159	{Body,weight,and,Lee,index,in,PF,signiﬁcantly,increased,in,comparison,with,CO,and,PO,.}	{NULL}
journal.pone.0099155.pdf	160	{The,levels,of,F,BG,were,signiﬁcantly,lower,in,PF,than,in,CO.,.}	{NULL}
journal.pone.0099155.pdf	161	{The,levels,of,FINS,were,signiﬁcantly,higher,in,PF,than,in,PO,and,CO,",",while,ratios,of,FBG,/,F,INS,in,PF,signiﬁcantly,decreased,in,comparison,with,other,two,groups,.}	{NULL}
journal.pone.0099155.pdf	162	{Serum,levels,of,E2,and,T,were,signiﬁcantly,higher,in,PF,and,PO,than,in,CO,(,Table,1,),.}	{NULL}
journal.pone.0099155.pdf	163	{Changes,of,ovarian,morphological,parameters,in,PCOS,model,induced,by,high,—,fat,diet,and,testosterone,propionate,Ovarian,morphological,parameters,were,measured,on,the,28th,day,of,experiment,in,three,groups,of,CO,",",PO,and,PF,(,Fig,.}	{NULL}
journal.pone.0099155.pdf	164	{3,),.}	{NULL}
journal.pone.0099155.pdf	165	{Ovary,organ,index,and,ovarian,areas,were,signiﬁcant,lower,in,PF,than,in,CO.,.}	{NULL}
journal.pone.0099155.pdf	166	{Corpora,lutea,in,PF,and,PO,were,not,observed,.}	{NULL}
journal.pone.0099155.pdf	167	{In,comparison,with,CO,group,",",thickness,of,theca,layer,",",numbers,of,preantral,follicle,",",numbers,of,atretic,follicle,",",total,numbers,of,follicle,and,ratios,of,numbers,of,atretic,follicle,to,total,numbers,of,follicles,signiﬁcantly,increased,in,PF,and,PO,",",while,thickness,of,granular,layer,signiﬁcantly,decreased,in,PF,and,PO,(,Table,2,),.}	{NULL}
journal.pone.0099155.pdf	168	{N,»,o,"\\\\",.}	{NULL}
journal.pone.0099155.pdf	169	{",",1,»,.}	{NULL}
journal.pone.0099155.pdf	170	{.}	{NULL}
journal.pone.0099155.pdf	171	{-,.}	{NULL}
journal.pone.0099155.pdf	172	{HI,-,95,°,"\\"","\\"","\\"",°,°,‘,F661,’,.}	{NULL}
journal.pone.0099155.pdf	173	{V,-,_,.}	{NULL}
journal.pone.0099155.pdf	174	{o,.}	{NULL}
journal.pone.0099155.pdf	175	{a,"\\\\",-,.}	{NULL}
journal.pone.0099155.pdf	176	{‘,V,",",3,o,.....,",","\\\\",?}	{NULL}
journal.pone.0099155.pdf	177	{_,°,C,’,D,1,o,‘,$,6,;,',_,.}	{NULL}
journal.pone.0099155.pdf	178	{.}	{NULL}
journal.pone.0099155.pdf	179	{3,°,.}	{NULL}
journal.pone.0099155.pdf	180	{:9,a,T}	{NULL}
journal.pone.0099155.pdf	181	{‘,_,.}	{NULL}
journal.pone.0099155.pdf	182	{_,J,",",.}	{NULL}
journal.pone.0099155.pdf	183	{Q.,‘‘,.}	{NULL}
journal.pone.0099155.pdf	184	{.}	{NULL}
journal.pone.0099155.pdf	185	{L,O,.01,Q,o,c,o,',»,e}	{NULL}
journal.pone.0099155.pdf	186	{.}	{NULL}
journal.pone.0099155.pdf	187	{4,’,‘,n,v,;,.}	{NULL}
journal.pone.0099155.pdf	188	{",",QP,PW,®,',°,ol,"\\"",‘,cg,so,",",",",.}	{NULL}
journal.pone.0099155.pdf	189	{.}	{NULL}
journal.pone.0099155.pdf	190	{Figure,2,.}	{NULL}
journal.pone.0099155.pdf	191	{Figures,and,cell,types,of,vaginal,smears,.}	{NULL}
journal.pone.0099155.pdf	192	{A,:,preoestrus,",",loaded,mainly,with,epithelial,cell,;,B,:,estrus,",",loaded,mainly,with,keratinocytes,;,C,:,metoestrus,",",disp,|,aying,epithelial,cell,",",keratinocytes,",",and,leukocytes,;,Dzdiestrus,",",displaying,full,of,leukocytes,(,magnification,>,<,100,),.}	{NULL}
journal.pone.0099155.pdf	193	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	194	{pone,.}	{NULL}
journal.pone.0099155.pdf	195	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	196	{gOO2}	{NULL}
journal.pone.0099155.pdf	197	{Table,1,.}	{NULL}
journal.pone.0099155.pdf	198	{Changes,of,metabolic,and,endocrine,variables,in,obese,PCOS,model,induced,by,high,—,fat,diet,.}	{NULL}
journal.pone.0099155.pdf	199	{co,PO,pr}	{NULL}
journal.pone.0099155.pdf	200	{Body,weight,(,g,),13e,.33:1,o.,s1,149.33.110.07,172.33:11,.}	{NULL}
journal.pone.0099155.pdf	201	{s2,*,#,Body,|,ength,(,cm,),17.22,i0,.64,',l7,.96,iO,.64,l7,.65,tO,.75,Lee,Index,3oo,.3,s,:3.61,29s,.75:3.9,o,31s,.35:8.39,*,1,?}	{NULL}
journal.pone.0099155.pdf	202	{‘,FBG,(,mmol/I,),5.38,i0,.55,4.88,i0,.46,4.38,‘,£,0.60,*,PBG1,(,mmol/I,),9.1,s,:,o.,s3,s.,72:1.3,s,9.43,:,o.,32,PBG2,(,mmol/I,),6.95,i0,.6,l,6.43,i0,.7,l,7.53,il,.56,FINS,(,LIIU/ml,),21,.}	{NULL}
journal.pone.0099155.pdf	203	{e3,:4,.}	{NULL}
journal.pone.0099155.pdf	204	{o2,23.9,o,:4,.}	{NULL}
journal.pone.0099155.pdf	205	{o3,50.58,-:6.86,*,#,FBG/FINS,0.26,i0,.05,0.23,i0,.09,0.1,Oi0,.03,*,#,122,(,ng/ml,),1,.}	{NULL}
journal.pone.0099155.pdf	206	{eo,:,o.,31,2.41,:,o.,s6,*,2.61,i0,.28,*,P,(,ng/ml,),0.39,i0,.22,0.31,‘,£,0.16,O.,25i0,.06,T,(,ng/ml,),o.,17,:,o.,oe,28.32,i7,.24,*,31.92:5.31,*}	{NULL}
journal.pone.0099155.pdf	207	{Values,are,means,:,SD,.}	{NULL}
journal.pone.0099155.pdf	208	{*,p,<,0.0167,versus,CO,by,Bonferoni,post,—,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	209	{#p,<,0.0167,versus,PO,by,Bonferoni,post,—,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	210	{doizl0,.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	211	{pone,.}	{NULL}
journal.pone.0099155.pdf	212	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	213	{tO01}	{NULL}
journal.pone.0099155.pdf	214	{Effects,of,exercise,and,diet,on,metabolic,and,endocrine,variables,in,PF,rats,The,metabolic,and,endocrine,variables,were,measured,at,the,end,of,experiment,in,PF-SF,",",PF-EF,and,PF-EO,.}	{NULL}
journal.pone.0099155.pdf	215	{Body,weight,was,signiﬁcantly,lower,in,PF,-,EF,and,PF-EO,than,in,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	216	{The,levels,of,FBG,were,signiﬁcant,higher,in,PF-EO,than,in,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	217	{The,levels,of,PBG1,",",PBG2,and,FINS,were,signiﬁcantly,lower,in,PF-EF,and,PF,-,EO,than,in,PF-SF,",",while,the,levels,of,PBG2,were,signiﬁcantly,lower,in,PF-EO,than,in,PF-EF,.}	{NULL}
journal.pone.0099155.pdf	218	{In,comparison,with,PF-SF,",",the,ratio,of,FBG/FINS,increased,signiﬁcantly,in,PF-EO,.}	{NULL}
journal.pone.0099155.pdf	219	{Serum,levels,of,T,were,signiﬁcantly,lower,in,PF-EF,and,PF-EO,than,in,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	220	{There,were,no,statistical,differences,in,serum,levels,of,E2,and,P,in,the,three,groups,of,PF-SF,",",PF-EF,and,PF-EO,(,Table,3,),.}	{NULL}
journal.pone.0099155.pdf	221	{Effects,of,exercise,and,diet,on,ovarian,morphologic,parameters,in,PF,rats,Ovarian,morphological,parameters,were,measured,on,the,end,of,experiment,in,PF-SF,",",PF-EF,and,PF-EO,.}	{NULL}
journal.pone.0099155.pdf	222	{In,comparison,with,PF-SF,",",ovary,organ,index,",",ovarian,areas,",",numbers,of,antral,follicle,",",and,numbers,of,corpora,lutea,signiﬁcantly,increased,",",while,thickness,of,theca,layer,",",numbers,of,preantral,follicle,",",numbers,of,atretic,follicle,",",total,numbers,of,follicle,",",and,ratio,of,numbers,of,atretic,follicle,to,total,numbers,of,follicle,signiﬁcantly,decreased,in,PF-EF,and,PF-EO,.}	{NULL}
journal.pone.0099155.pdf	223	{The,ratios,of,numbers,of,corpora,lutea,to,total,numbers,of,follicles,were,signiﬁcantly,higher,in,PF-EF,and,PF-EO,than,in,PF-SF,",",and,were,signiﬁcantly,lower,in,PF-EF,than,in,PFEO,.}	{NULL}
journal.pone.0099155.pdf	224	{Other,parameters,in,corpora,lutea,areas,and,thickness,of,theca,layer,were,signiﬁcantly,higher,in,PF-EO,than,in,PF-SF,(,Table,4,),.}	{NULL}
journal.pone.0099155.pdf	225	{Figure,3,.}	{NULL}
journal.pone.0099155.pdf	226	{Ovarian,morphology,of,rats,from,three,groups,(,>,<,100,),.}	{NULL}
journal.pone.0099155.pdf	227	{A,:,PF,.}	{NULL}
journal.pone.0099155.pdf	228	{A,lot,of,preantral,follicles,(,P,),and,atretic,follicles,(,AF,),with,enlargement,of,stroma,(,arrow,),and,cystic,follicles,(,C,),are,shown,in,the,section,.}	{NULL}
journal.pone.0099155.pdf	229	{B,:,PO,.}	{NULL}
journal.pone.0099155.pdf	230	{A,lot,of,preantral,follicles,(,P,),",",atretic,follicles,(,AF,),and,cystic,fo,|,|,ic,|,es,(,C,),are,shown,in,the,section,.}	{NULL}
journal.pone.0099155.pdf	231	{C,:,CO.,.}	{NULL}
journal.pone.0099155.pdf	232	{Various,stages,of,development,follicles,and,some,corpora,lutea,(,CL,),are,shown,.}	{NULL}
journal.pone.0099155.pdf	233	{D,:,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	234	{A,lot,of,preantral,follicles,(,P,),and,atretic,follicles,(,AF,),",",and,cystic,fo,|,|,ic,|,es,(,C,),are,shown,in,the,section,.}	{NULL}
journal.pone.0099155.pdf	235	{E,:,PF-EF,.}	{NULL}
journal.pone.0099155.pdf	236	{A,lot,of,antral,follicles,(,A,),and,a,bit,of,corpora,lutea,(,CL,),are,shown,in,the,section,.}	{NULL}
journal.pone.0099155.pdf	237	{F,:,PF-EO,.}	{NULL}
journal.pone.0099155.pdf	238	{A,lot,of,antral,follicles,(,A,),and,a,bit,of,corpora,lutea,(,CL,),are,shown,in,the,section,.}	{NULL}
journal.pone.0099155.pdf	239	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	240	{pone,.}	{NULL}
journal.pone.0099155.pdf	241	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	242	{gOO3}	{NULL}
journal.pone.0099155.pdf	243	{Table,2,.}	{NULL}
journal.pone.0099155.pdf	244	{Changes,of,ovarian,morphological,parameters,in,PF,.}	{NULL}
journal.pone.0099155.pdf	245	{CO,PO,PF}	{NULL}
journal.pone.0099155.pdf	246	{Ovary,weight,(,mg,),18.55,i3,.41,16.09:2.37,15.80,i1,.79,Ovarian,organ,index,(,>,<,10,’,3,),O.,14i0,.03,O.,12:0.02,0.09,i0,.02,*,Ovarian,area,(,mm2,),2.79:0.49,1.77:0.88,1.07:0.18,*,Corpora,lutea,area,(,mm2,),1.04,i0,.48,o.,oo,:,o.,oo,*,o.,ooio,.}	{NULL}
journal.pone.0099155.pdf	247	{oo,*,Thickness,of,granular,|,ayer,(,um,),35.05:4.63,24.36:5.14,*,24.03:4.91,*,Thickness,of,theca,|,ayer,(,um,),14.56,i1,.28,19.04:2.39,*,19.63:1.94,*,Numbers,of,preantral,follicle,3.67:1.63,7.67:1.86,*,10.20:1.30,*,Numbers,of,antral,follicle,2.83,i2,.40,2.83:1.47,1.80:0.84,Numbers,of,atretic,follicle,1.17:1.17,7.00:1.90,*,9.00:3.67,*,Total,numbers,of,follicle,7.67,i3,.67,17.50:3.94,*,21.00,i2,.65,*,Numbers,of,corpora,lutea,4.00:1.26,o.,oo,:,o.,oo,*,o.,oo,:,o.,oo,*,Ratio,of,corpora,lutea,area,to,ovarian,area,0.37:0.16,o.,oo,:,o.,oo,*,o.,oo,:,o.,oo,*,Ratio,of,numbers,of,corpora,lutea,to,total,numbers,of,follicle,0.62:0.34,o.,oo,:,o.,oo,*,o.,oo,:,o.,oo,*,Ratio,of,numbers,of,atretic,follicle,to,total,numbers,of,follicle,0.13,i0,.12,O.,40:0.08,*,0.42,i0,.12,*}	{NULL}
journal.pone.0099155.pdf	248	{Values,are,means,:,SD,.}	{NULL}
journal.pone.0099155.pdf	249	{*,p,<,0.0167,versus,CO,by,Bonferoni,post,—,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	250	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	251	{pone,.}	{NULL}
journal.pone.0099155.pdf	252	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	253	{tO02}	{NULL}
journal.pone.0099155.pdf	254	{Microscopic,observation,of,ovarian,section,F,ollicles,in,various,stages,of,development,and,atretic,follicle,in,small,amounts,were,observed,on,sections,from,PF-EF,",",PF,-,EO,and,CO.,.}	{NULL}
journal.pone.0099155.pdf	255	{A,large,number,of,preantral,and,atretic,follicles,and,some,cystic,follicles,were,observed,in,PO,",",PF,and,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	256	{The,pathological,characteristics,such,as,thickened,ovarian,adventitial,coat,",",obvious,demixing,between,theca,interna,and,theca,externa,",",inspissated,theca,cell,layer,",",and,apparent,proliferation,of,ovarian,stroma,were,observed,in,Po,",",PF,and,PF-SF,(,Fig,.}	{NULL}
journal.pone.0099155.pdf	257	{3,),.}	{NULL}
journal.pone.0099155.pdf	258	{Discussion}	{NULL}
journal.pone.0099155.pdf	259	{In,this,study,",",the,obese,PCOS,rats,were,successfully,induced,by,using,high-fat,diet,and,testosterone,injection,at,the,same,time,.}	{NULL}
journal.pone.0099155.pdf	260	{The,PF,rats,had,endocrine,and,reproductive,characteristics,such,as,hyperandrogenemia,",",hyperinsulinemia,",",anovulation,",",and,enlarged,ovaries,with,follicular,atresia,and,multiple,cysts,in,the,periphery,",",which,is,consistent,with,human,PCOS,[,25,],.}	{NULL}
journal.pone.0099155.pdf	261	{A,difference,of,approximately,24,%,in,body,weight,was,observed,between,PF,rats,and,CO,rats,.}	{NULL}
journal.pone.0099155.pdf	262	{This,body,weight,difference,has,been,assumed,in,the,literature,as,inferring,obesity,[,26,],.}	{NULL}
journal.pone.0099155.pdf	263	{Except,for,body,weight,",",the,Lee,Index,in,PF,rats,displayed,a,statistically,significant,difference,compared,with,rats,of,CO,and,PO,.}	{NULL}
journal.pone.0099155.pdf	264	{Therefore,",",PF,rats,were,considered,as,an,obese,PCOS,model,.}	{NULL}
journal.pone.0099155.pdf	265	{Diet,",",as,the,major,environmental,determinant,",",plays,an,important,role,during,early,stages,of,human,development,from,prenatal,life,to,puberty,[,l3,],.}	{NULL}
journal.pone.0099155.pdf	266	{The,dietary,intake,of,advanced,glycated,end,products,(,AGEs,),such,as,lipid,and,protein-rich,foods,is,increasingly,recognized,as,a,determinant,of,metabolic,and,cardiovascular,morbidity,[,"27,28",],.}	{NULL}
journal.pone.0099155.pdf	267	{Diamanti-Kandarakis,et,al.,found,that,the,rats,with,high-fat,feeding,manifested,concurrent,increase,of,testosterone,",",suggesting,an,impact,of,dietary,AGES,on}	{NULL}
journal.pone.0099155.pdf	268	{Table,3,.}	{NULL}
journal.pone.0099155.pdf	269	{Effects,of,exercise,and,diet,on,metabolic,and,endocrine,variables,in,PF,rats,.}	{NULL}
journal.pone.0099155.pdf	270	{PF-SF,PF-EF,PF-EO}	{NULL}
journal.pone.0099155.pdf	271	{Body,weight,(,g,),213.00:9.86,188.50,i7,.77,*,174.33,i11,.81,*,Body,|,ength,(,cm,),19.31,:0.61,19.24,i0,.49,18.69,i0,.57,Lee,Index,309.21,:5.85,298.03,i8,.95,299.01,‘,£,9.08,FBG,(,mmo,|,/,I,),4.00:0.32,4.20,i0,.42,4.75,i0,.31,*,PBG1,(,mmol/I,),9.11,:,O.,33,7.70,i0,.49,*,7.01,i0,.64,*,PBG2,(,mmol/I,),9.20:1.42,7.40,i0,.94,*,5.67,i0,.43,*,#,F,|,NS,(,u,|,U/ml,),21.75:0.73,17.63,i1,.66,*,16.89,i1,.20,*,FBG/FINS,O.,18:0.02,0.24,i0,.04,0.29,i0,.05,*,E2,(,ng/ml,),1.72,:,O.,31,1.36,i0,.51,1.30,i0,.28,P,(,ng/ml,),O.,44,:,O.,10,0.54,i0,.08,0.59,i0,.18,T,(,ng/ml,),0.18:0.02,0.08,i0,.04,*,0.07,i0,.03,*}	{NULL}
journal.pone.0099155.pdf	272	{Values,are,means,:,SD,.}	{NULL}
journal.pone.0099155.pdf	273	{*,p,<,0.0167,versus,PF-SF,by,Bonferoni,post,—,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	274	{#p,<,0.0167,versus,PF-EF,by,Bonferoni,post,~,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	275	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	276	{pone,.}	{NULL}
journal.pone.0099155.pdf	277	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	278	{tO03}	{NULL}
journal.pone.0099155.pdf	279	{Table,4,.}	{NULL}
journal.pone.0099155.pdf	280	{Effects,of,exercise,and,diet,on,ovarian,morphological,parameters,in,obese,PCOS,rats,.}	{NULL}
journal.pone.0099155.pdf	281	{PF-SF,PF-EF,PF-Eo}	{NULL}
journal.pone.0099155.pdf	282	{Ovarian,weight,(,mg,),13.92,i1,.06,16.02:1.62,16.11:1.57,Ovarian,organ,index,(,>,<,10,’,3,),0.07,i0,.00,0.09:0.01,*,0.09,i0,.01,*,Ovarian,area,(,mm2,),4.74:0.65,5.73:0.45,*,6.17:0.47,*,Corpora,Iutea,area,(,mm2,),1.18,i0,.43,1.52,:,O.,52,2.03:0.42,*,Thickness,of,granular,|,ayer,(,pm,),22.59:3.53,26.04:5.03,29.28:3.35,*,Thickness,of,theca,|,ayer,(,um,),16.76,i1,.78,13.96:1.61,*,13.37,i1,.53,*,Numbers,of,preantral,follicle,9.83:2.79,5.67:1.75,*,3.67:1.21,*,Numbers,of,antral,follicle,2.33,i1,.37,6.17:1.47,*,7.17,i1,.17,*}	{NULL}
journal.pone.0099155.pdf	283	{Numbers,of,atretic,follicle,5.33:2.16,2.00:0.89,*,1.33:1.03,*}	{NULL}
journal.pone.0099155.pdf	284	{Total,numbers,of,follicle,17.50,i2,.07,13.83:2.23,*,12.16:1.47,*}	{NULL}
journal.pone.0099155.pdf	285	{Numbers,of,corpora,lutea,3.00:1.10,5.67:0.82,*,8.33:2.58,*,Ratio,of,corpora,lutea,area,to,ovarian,area,0.25:0.11,O.,26:0.08,0.33:0.08,Ratio,of,numbers,of,corpora,lutea,to,total,numbers,of,follicle,0.17:0.06,0.42:0.08,*,0.68:0.17,*,#,Ratio,of,numbers,of,atretic,follicle,to,total,numbers,of,follicle,0.31,i0,.13,0.14:0.05,*,0.11,i0,.09,*}	{NULL}
journal.pone.0099155.pdf	286	{Values,are,means,:,SD,.}	{NULL}
journal.pone.0099155.pdf	287	{*,p,<,0.0167,versus,PF-SF,by,Bonferoni,post,—,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	288	{#p,<,0.0167,versus,PF-EF,by,Bonferoni,post,~,hoc,test,.}	{NULL}
journal.pone.0099155.pdf	289	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.pone.0099155.pdf	290	{pone,.}	{NULL}
journal.pone.0099155.pdf	291	{OO99155,.}	{NULL}
journal.pone.0099155.pdf	292	{tO04}	{NULL}
journal.pone.0099155.pdf	293	{ovarian,tissue,[,29,],.}	{NULL}
journal.pone.0099155.pdf	294	{Androgen,excess,plays,an,important,role,in,the,pathophysiology,of,PCOS,and,has,been,hypothesized,to,be,the,ﬁnal,common,pathway,for,the,development,of,the,signs,and,symptoms,of,this,disorder,.}	{NULL}
journal.pone.0099155.pdf	295	{The,majority,(,80,%,),of,adults,with,PCOS,have,hyperandrogenemia,[,30,],.}	{NULL}
journal.pone.0099155.pdf	296	{Long-term,administration,of,androgens,can,induce,visceral,obesity,and,consecutive,insulin,resistance,.}	{NULL}
journal.pone.0099155.pdf	297	{Abdominal,adiposity,",",insulin,resistance,and,compensatory,hyperinsulinemia,could,trigger,androgenization,in,women,[,31,],.}	{NULL}
journal.pone.0099155.pdf	298	{The,predominate,increase,of,TP,and,E2,in,PO,and,PF,was,considered,to,be,mostly,due,to,persistent,TP,injection,in,this,present,study,.}	{NULL}
journal.pone.0099155.pdf	299	{Frankset,al.,reported,that,the,characteristic,feature,of,polycystic,ovaries,is,an,apparent,failure,to,select,a,dominant,follicle,and,the,accumulation,of,antral,follicles,2,—,8,mm,in,size,.}	{NULL}
journal.pone.0099155.pdf	300	{It,was,assumed,that,this,appearance,reﬂects,an,androgen-induced,arrest,in,antral,follicle,development,[,32,],.}	{NULL}
journal.pone.0099155.pdf	301	{Several,studies,on,rats,have,demonstrated,that,continuous,exposure,of,post,pubertal,animals,to,steroid,hormones,",",either,via,regular,s.c.,dosing,or,continuous,release,pellet,implant,",",produces,an,anovulatory,phenotype,in,these,animals,[,33,],.}	{NULL}
journal.pone.0099155.pdf	302	{In,this,present,study,",",ovarian,morphological,parameters,in,both,PF,and,PO,rats,manifested,large,",",atretic,antral,follicles,",",follicular,cysts,with,a,thickened,theca,interna,cell,layer,",",a,diminished,granulosa,cell,compartment,",",and,few,fresh,corpora,lutea,",",consistent,with,the,research,by,Beloosesky,et,al,[,1,l,],.}	{NULL}
journal.pone.0099155.pdf	303	{Ovarian,organ,index,and,ovarian,area,were,signiﬁcantly,less,in,PF,rats,than,in,CO,rats,.}	{NULL}
journal.pone.0099155.pdf	304	{These,results,suggest,that,a,high-fat,diet,is,more,likely,to,form,typical,PCOS,morphological,changes,in,comparison,with,ordinary,diet,.}	{NULL}
journal.pone.0099155.pdf	305	{Sedentary,behavior,",",as,assessed,by,sitting,time,",",is,increased,in,human,PCOS,and,is,being,increasingly,recognized,as,a,contributor,both,to,elevated,adiposity,and,to,obesity-associated,[,34,],.}	{NULL}
journal.pone.0099155.pdf	306	{In,this,present,study,",",the,obese,PCOS,rat,model,induced,by,high-fat,diet,and,testosterone,injection,imitated,successfully,the,unhealthy,lifestyle,habits,such,as,high,lipid,diet,and,insufficient,exercise,of,human,PCOS,.}	{NULL}
journal.pone.0099155.pdf	307	{Testosterone,administration,induces,insulin,resistance,",",attributed,to,effects,on,glucose,transport,.}	{NULL}
journal.pone.0099155.pdf	308	{Another,ﬁnding,was,reduced,capillary,density,in,the,muscle,despite,increased,muscle,weight,[,9,],.}	{NULL}
journal.pone.0099155.pdf	309	{Previous,studies,showed,that,high,fat,diet,of,obese,mice,and,humans,could,lead,to,increased}	{NULL}
journal.pone.0099155.pdf	310	{FFA,inﬂux,through,the,portal,vein,into,the,liver,",",which,could,result,in,a,state,of,IR,[,14,],.}	{NULL}
journal.pone.0099155.pdf	311	{These,PF,rats,manifested,signiﬁcant,metabolic,characteristics,of,insulin,resistance,(,increase,of,FINS,and,decrease,of,FBG,/,FIN,S,),and,overweight,or,obesity,(,increase,of,Lee,Index,),in,comparison,with,Po,rats,.}	{NULL}
journal.pone.0099155.pdf	312	{Insulin,resistance,has,been,recognized,to,contribute,not,only,to,metabolic,but,also,to,reproductive,aspects,of,the,syndrome,[,"13,35",],.}	{NULL}
journal.pone.0099155.pdf	313	{Numerous,studies,also,have,shown,that,a,high-fat,diet,can,cause,insulin,resistance,in,muscles,at,rest,[,15,],.}	{11|12}
journal.pone.0099155.pdf	314	{Although,insulin,resistance,is,not,enough,to,become,the,diagnosis,of,PCOS,",",it,is,present,in,up,to,50,%,women,with,PCOS,[,36,],.}	{NULL}
journal.pone.0099155.pdf	315	{Overweight,or,obesity,is,a,common,feature,of,PCOS,women,[,"37,38",],.}	{NULL}
journal.pone.0099155.pdf	316	{The,link,between,PCOS,and,overweight,or,obesity,also,has,been,conﬁrmed,in,adolescent,PCOS,patients,[,39,],.}	{NULL}
journal.pone.0099155.pdf	317	{Exercise,based,lifestyle,modiﬁcations,are,successfully,employed,to,treat,obese,and,overweight,women,with,PCOS,[,2,],.}	{NULL}
journal.pone.0099155.pdf	318	{Morifuji,et,al.,reported,that,intake,of,dietary,soya,protein,and,exercise,training,by,swimming,for,2,weeks,had,an,additive,effect,on,decreases,of,insulin,resistant,and,body,fat,in,rats,[,40,],.}	{NULL}
journal.pone.0099155.pdf	319	{Our,previous,study,has,shown,that,exercise,for,2,weeks,increased,insulin,sensitivity,",",decreased,serum,androgen,levels,",",and,recovered,normal,ovarian,morphology,in,PCOS,rats,without,high-fat,diet,[,12,],.}	{NULL}
journal.pone.0099155.pdf	320	{In,this,present,study,",",swimming,training,for,2,weeks,",",with,or,without,a,high-fat,diet,",",signiﬁcantly,decreased,PBG1,",",PBG2,",",FINS,and,the,lever,of,testosterone,",",and,improved,ovarian,morphology,indexes,in,PF,rats,.}	{NULL}
journal.pone.0099155.pdf	321	{Lungeret,et,al.,suggested,the,use,of,FIN,S,as,a,simple,screening,test,for,assessment,of,insulin,resistance,in,women,with,PCOS,[,36,],.}	{NULL}
journal.pone.0099155.pdf	322	{In,this,present,study,",",the,decrease,of,FINS,after,swimming,training,indicated,the,improvement,of,insulin,resistance,to,be,associated,with,exercise,rather,than,diet,.}	{NULL}
journal.pone.0099155.pdf	323	{Overweight,and,obesity,impact,the,clinical,reproductive,and,metabolic,features,of,the,syndrome,.}	{NULL}
journal.pone.0099155.pdf	324	{Long-term,complications,of,obesity,such,as,cardiovascular,risk,and,diabetes,",",as,well,as,those,over,the,short,term,in,reproductive,function,",",are,signiﬁcantly,improved,by,lifestyle,modiﬁcation,.}	{NULL}
journal.pone.0099155.pdf	325	{Weight,loss,decreases,signiﬁcantly,hyperinsulinemia,and,hyperandrogenism,in,women,with,PCOS,[,42,],.}	{NULL}
journal.pone.0099155.pdf	326	{High-ﬁber,diet,and,low-fat,diets,enriched,with,monounsaturated,fats,may,help,to,reduce,body,weight,[,43,],.}	{NULL}
journal.pone.0099155.pdf	327	{Several,studies,have,paid,close,attention,to,impacting,of,low,carbohydrate,and,standard,dietary,intervention,regimens,on,both,amount,of,weight,lost,as,well,as,speciﬁc,metabolic,and,endocrine,features,of,human,PCOS,[,44,],.}	{NULL}
journal.pone.0099155.pdf	328	{In,a,short-term,crossover,trial,of,human,PCOS,within,16,days,",",fasting,insulin,was,lower,following,a,low,carbohydrate,(,43,%,),diet,relative,to,a,standard,carbohydrate,diet,(,56,%,carbohydrate,",",31,%,fat,",",16,%,protein,),.}	{NULL}
journal.pone.0099155.pdf	329	{Fasting,glucose,",",insulin,sensitivity,",",and,the,circulating,concentrations,of,reproductive,hormones,were,not,signiﬁcantly,affected,by,the,intervention,[,45,],.}	{NULL}
journal.pone.0099155.pdf	330	{In,our,present,study,",",the,ratio,of,fasting,glucose,to,fasting,insulin,in,PF-EO,rats,was,signiﬁcantly,higher,than,that,in,PF-SF,rats,",",and,the,levels,of,PBG2,were,signiﬁcantly,lower,in,PF-EO,rats,than,in,PF-EF,rats,.}	{NULL}
journal.pone.0099155.pdf	331	{These,results,suggested,that,dietary,constitutes,had,a,certain,inﬂuence,on,blood,glucose,.}	{NULL}
journal.pone.0099155.pdf	332	{The,appearance,of,corpora,lutea,is,considered,as,occurrence,of,ovulation,.}	{NULL}
journal.pone.0099155.pdf	333	{In,this,present,study,",",only,a,few,corpora,lutea,were,observed,in,PF-SF,.}	{NULL}
journal.pone.0099155.pdf	334	{Four,rats,in,PF-SF,showed,persistent,diestrus,and,the,other,two,PF-SF,rats,showed,irregular,cycles,.}	{NULL}
journal.pone.0099155.pdf	335	{Manneras,et,al.,also,reported,that,the,PCOS,rat,model,induced,by,DHT,had,irregular,cycles,Ш,V,Their,ovaries,had,large,",",atretic,antral,follicles,",",follicular,cysts,with,a,thickened,theca,interna,cell,layer,",",and,few,fresh,corpora,lutea,",",similar,to,our,present,results,.}	{NULL}
journal.pone.0099155.pdf	336	{In,this,present,study,",",swimming,training,for,2,weeks,",",with,or,without,high-fat,diet,",",increased,signiﬁcantly,the,numbers,of,corpora,lutea,",",the,ratio,of,numbers,of,corpora,lutea,to,total,numbers,of,follicle,and,numbers,of,antral,follicle,",",and,decreased,signiﬁcantly,numbers,of,preantral,follicle,and,atretic,follicle,",",according,with,Manni,’s,research,[,7,],.}	{NULL}
journal.pone.0099155.pdf	337	{These,results,suggest,that,exercise,is,conducive,to,promoting,follicular,maturation,and,ovulation,.}	{NULL}
journal.pone.0099155.pdf	338	{The,possible,explanation,for,the,improvement,of,cyclicity,is,that,decreased,sympathetic,activity,will,have,a,direct,impact,on,the,ovaries,and,affect,the,sex,steroid,synthesis,pathways,.}	{NULL}
journal.pone.0099155.pdf	339	{It,has,been,shown,that,physical,exercise,can,decrease,sympathetic,nerve,activity,",",improve,menstrual,frequency,",",and,decrease,the,levels,of,several,sex,steroids,in,women,with,PCOS,[,10,],.}	{NULL}
journal.pone.0099155.pdf	340	{In,addition,",",signiﬁcant,increases,in,thickness,of,granular,layer,and,corpora,lutea,area,were,found,in,PF-EO,rats,but,not,in,PF-EF,rats,.}	{NULL}
journal.pone.0099155.pdf	341	{The,ratio,of,numbers,of,corpora,lutea,to,total,numbers,of,follicle,was,also,signiﬁcantly,higher,in,PFReferences}	{NULL}
journal.pone.0099155.pdf	342	{1,.}	{NULL}
journal.pone.0099155.pdf	343	{Norman,R,],",",Dewailly,D,",",Legro,RS,",",Hickey,TE,(,2007,),Polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	344	{Lancet,370,:,685,—,697,.}	{NULL}
journal.pone.0099155.pdf	345	{2,.}	{NULL}
journal.pone.0099155.pdf	346	{Norman,R,],",",VVu,R,",",Stankiewicz,NIT,(,2004,),Polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	347	{Med,],Aust,180,:,132,—,137,.}	{NULL}
journal.pone.0099155.pdf	348	{3,.}	{NULL}
journal.pone.0099155.pdf	349	{Shi,D,",",Vine,DF,(,2012,),Animal,models,of,polycystic,ovary,syndrome,:,a,focused,review,of,rodent,models,in,relationship,to,clinical,phenotypes,and,cardiometabolic,risk,.}	{NULL}
journal.pone.0099155.pdf	350	{Fertil,Steril,98,:,l85,—,l93,.}	{NULL}
journal.pone.0099155.pdf	351	{4,.}	{NULL}
journal.pone.0099155.pdf	352	{Lara,HE,",",Ferruz,],L,",",Luza,S,",",Bustamante,DA,",",Borges,Y,",",et,al.,(,1993,),Activation,of,ovarian,sympathetic,nerves,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	353	{EndocrinoloQ,',133,:,2690,—,2695,.}	{NULL}
journal.pone.0099155.pdf	354	{5,.}	{NULL}
journal.pone.0099155.pdf	355	{Stener-Victorin,E,",",Lundel,),erg,T,",",VValdenstrom,U,",","l\\\\/Ianni",L,",",Aloe,L,",",et,al.,(,2000,),Effects,of,electro-acupuncture,on,nerve,growth,factor,and,ovarian,morphology,in,rats,with,experimentally,induced,polycystic,ovaries,.}	{NULL}
journal.pone.0099155.pdf	356	{Biol,Reprod,63,:,l497,—,1503,.}	{NULL}
journal.pone.0099155.pdf	357	{6,.}	{NULL}
journal.pone.0099155.pdf	358	{Stener-Victorin,E,",",Lindholm,C,(,2004,),Immunity,and,beta,~,endorphin,concen,»,trations,in,hypothalamus,and,plasma,in,rats,with,steroid-induced,polycystic,ovaries,:,effect,of,low-frequency,electroacupuncture,.}	{NULL}
journal.pone.0099155.pdf	359	{Biol,Reprod,70,:,329,—,333,.}	{NULL}
journal.pone.0099155.pdf	360	{7,.}	{NULL}
journal.pone.0099155.pdf	361	{Nfanni,L,",",Cajander,S,",",Lundeberg,T,",",Naylor,AS,",",Aloe,L,",",et,al.,(,2005,),Effect,of,exercise,on,ovarian,morphology,and,expression,of,nerve,growth,factor,and,alpha,(,1,),-,and,beta,(,2,),~,adrenergic,receptors,in,rats,with,steroid-induced,polycystic,ovaries,.}	{NULL}
journal.pone.0099155.pdf	362	{J,Neuroendocrinol,17,:,846,—,858,.}	{NULL}
journal.pone.0099155.pdf	363	{8,.}	{NULL}
journal.pone.0099155.pdf	364	{Nfaliqueo,l,"\\\\",’,I,",",Sun,lVI,",",JohanssonJ,",",Benrick,A,",",Labrie,F,",",et,al.,(,2013,),Continuous,administration,of,a,P450,aromatase,inhibitor,induces,polycystic,ovary,syndrome,with,a,metabolic,and,endocrine,phenotype,in,female,rats,at,adult,age,.}	{NULL}
journal.pone.0099155.pdf	365	{Endocrinology,154,:,434,~,445,.}	{NULL}
journal.pone.0099155.pdf	366	{9,.}	{NULL}
journal.pone.0099155.pdf	367	{Nfanneras,L,",",Cajander,S,",",Holmang,A,",",Seleskovic,Z,",",Lystig,T,",",et,al.,(,2007,),A,new,rat,model,exhibiting,l,),oth,ovarian,and,metabolic,characteristics,of,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	368	{Endocrinology,148,:,378143791,.}	{NULL}
journal.pone.0099155.pdf	369	{10,.}	{NULL}
journal.pone.0099155.pdf	370	{Benrick,A,",",lVIa_liqueo,IVI,",",l,"\\\\",Iiao,S,",",Villanueva,JA,",",Feng,Y,",",et,al.,(,2013,),Resveratrol,is,not,as,effective,as,physical,exercise,for,improving,reproductive}	{NULL}
journal.pone.0099155.pdf	371	{EO,rats,than,in,PF-EF,rats,",",suggesting,that,dietary,adjustments,had,an,additional,role,on,promotion,of,ovulation,.}	{NULL}
journal.pone.0099155.pdf	372	{Lifestyle,intervention,of,human,PCOS,has,been,widely,accepted,.}	{NULL}
journal.pone.0099155.pdf	373	{From,our,research,results,",",exercise,training,may,play,a,more,important,role,on,reproductive,/,endocrine,outcomes,.}	{NULL}
journal.pone.0099155.pdf	374	{Different,mechanisms,of,reproductive,function,improved,by,exercise,may,be,involved,to,explain,their,beneﬁcial,effects,on,glucose,/,insulin,homeostasis,.}	{NULL}
journal.pone.0099155.pdf	375	{Insulin,sensitivity,improvement,itself,is,the,pivotal,factor,involved,in,the,restoration,of,ovarian,function,.}	{NULL}
journal.pone.0099155.pdf	376	{Several,reports,have,demonstrated,that,loss,of,body,weight,is,related,to,increase,of,insulin,sensitivity,[,"46,47",],.}	{NULL}
journal.pone.0099155.pdf	377	{Exercise,could,ameliorate,insulin,sensitivity,not,only,by,a,large,reduction,of,body,weight,and,visceral,fat,[,48,],but,also,by,cellular,muscle,metabolism,enhancement,.}	{NULL}
journal.pone.0099155.pdf	378	{Skeletal,muscle,is,the,main,site,of,glucose,deposition,implicated,in,insulin,resistance,",",and,it,is,well,known,that,physical,exercise,inﬂuences,the,expression,and,/,or,activity,of,proteins,involved,in,insulin,signal,transduction,in,skeletal,muscle,[,49,],such,as,the,translocation,of,GLUT-4,glucose,transporters,to,the,plasma,membrane,and,transverse,tubules,[,41,],.}	{NULL}
journal.pone.0099155.pdf	379	{Previous,studies,demonstrated,improvement,of,insulin,resistant,induced,by,exercise,was,accompanied,with,the,concurrent,decrease,of,hyperandrogenism,[,"12,20",],.}	{NULL}
journal.pone.0099155.pdf	380	{It,is,speculated,that,androgen,may,be,involved,in,some,sections,of,glucose,metabolism,",",which,needs,to,be,conﬁrmed,by,further,studies,.}	{NULL}
journal.pone.0099155.pdf	381	{Conclusively,",",our,present,study,demonstrated,that,obese,PCOS,rat,model,created,successfully,by,a,combination,of,high-fat,diet,and,testosterone,injection,was,conformable,with,metabolic,and,reproductive,characteristics,of,human,PCOS,and,can,be,used,for,mechanism,study,of,exercise,intervention,on,reproductive,/,endocrine,outcomes,of,PCOS,.}	{NULL}
journal.pone.0099155.pdf	382	{Author,Contributions}	{NULL}
journal.pone.0099155.pdf	383	{Conceived,and,designed,the,experiments,:,FL,ZL,],.}	{NULL}
journal.pone.0099155.pdf	384	{Performed,the,experiments,:,CYW7,SVVQ,",",Analyzed,the,data,:,CYW,',FL,SVVCQ,.}	{NULL}
journal.pone.0099155.pdf	385	{Contributed,reagents/materials/analysis,tools,:,CYW,FL,S,"\\\\",VQ,.}	{NULL}
journal.pone.0099155.pdf	386	{W'rote,the,paper,:,CYW,FL,ZL,],.}	{NULL}
journal.pone.0099155.pdf	387	{and,metabolic,functions,in,rats,with,dihydrotestosterone,~,induced,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	388	{Evid,Based,Complement,Alternat,lVIed,2013,:,964070,.}	{NULL}
journal.pone.0099155.pdf	389	{11,.}	{NULL}
journal.pone.0099155.pdf	390	{Beloosesky,R,",",Gold,R,",",Almog,B,",",Sasson,R,",",Dames,A,",",et,al.,(,2004,),Induction,of,polycystic,ovary,l,),y,testosterone,in,immature,female,rats,:,lVIodulation,of,apoptosis,and,attenuation,of,glucose/insulin,ratio,.}	{NULL}
journal.pone.0099155.pdf	391	{Int,],lVIol,l,"\\\\",’,Ied,14,:,207,—,2l5,.}	{NULL}
journal.pone.0099155.pdf	392	{12,.}	{NULL}
journal.pone.0099155.pdf	393	{Q_iu,S,",","\\\\",/,Vu,C,",",Lin,F,",",Chen,L,",",Huang,Z,",",et,al.,(,2009,),Exercise,training,improved,insulin,sensitivity,and,ovarian,morphology,in,rats,with,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	394	{Horm,"l\\\\/Ietab",Res,41,:,880,—,885,.}	{NULL}
journal.pone.0099155.pdf	395	{13,.}	{NULL}
journal.pone.0099155.pdf	396	{Diamanti-Kandarakis,E,",",Christakou,C,",",lVIarinakis,E,(,2012,),Phenotypes,and,enviromental,factors,:,their,inﬂuence,in,PCOS,.}	{NULL}
journal.pone.0099155.pdf	397	{Curr,Pharm,Des,18,:,270,—,282,.}	{NULL}
journal.pone.0099155.pdf	398	{14,.}	{NULL}
journal.pone.0099155.pdf	399	{Zhao,S,",",Chu,Y,",",Zhang,C,",",Lin,Y,",",Xu,K,",",et,al.,(,2008,),Diet-induced,central,obesity,and,insulin,resistance,in,rabbits,.}	{NULL}
journal.pone.0099155.pdf	400	{J,Anim,Physiol,Anim,Nutr,(,Berl,),92,:,105,—,111,.}	{NULL}
journal.pone.0099155.pdf	401	{15,.}	{NULL}
journal.pone.0099155.pdf	402	{Tanaka,S,",",Hayashi,T,",",Toyoda,T,",",Hamada,T,",",Shimizu,Y,",",et,al.,(,2007,),High,~,fat,diet,impairs,the,effects,of,a,single,l,),out,of,endurance,exercise,on,glucose,transport,and,insulin,sensitivity,in,rat,skeletal,muscle,.}	{NULL}
journal.pone.0099155.pdf	403	{lVIetabolism,56,:,l7l9,—,1728,.}	{NULL}
journal.pone.0099155.pdf	404	{16,.}	{NULL}
journal.pone.0099155.pdf	405	{Flanagan,"Al\\\\/I",",",Brown,],L,",",Santiago,CA,",",Aad,PY,",",Spicer,L,],",",et,al.,(,2008,),High,~,fat,diets,promote,insulin,resistance,through,cytokine,gene,expression,in,growing,female,rats,.}	{NULL}
journal.pone.0099155.pdf	406	{J,Nutr,Biochem,19,:,505,—,5l3,.}	{NULL}
journal.pone.0099155.pdf	407	{17,.}	{NULL}
journal.pone.0099155.pdf	408	{Cataldo,NA,",",Al,),l,),asi,F,",",l,"\\\\",’,IcLaughlin,TL,",",Basina,NI,",",Fechner,PY,",",et,al.,(,2006,),Nfetabolic,and,ovarian,effects,of,rosiglitazone,treatment,for,12,weeks,in,insulin,»,resistant,women,with,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	409	{Hum,Reprod,21,:,1094120,.}	{NULL}
journal.pone.0099155.pdf	410	{18,.}	{NULL}
journal.pone.0099155.pdf	411	{Khorram,O,",",HelliwellJP,",",Katz,S,",",Bonpane,ClVI,",",Jaramillo,L,(,2006,),Two,weeks,of,metformin,improves,clomiphene,citrate,~,induced,ovulation,and,metabolic,profiles,in,women,with,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	412	{Fertil,Steril,85,:,1448,—,145l,.}	{NULL}
journal.pone.0099155.pdf	413	{19,.}	{NULL}
journal.pone.0099155.pdf	414	{Guzick,DS,(,2007,),Ovulation,induction,management,of,PCOS,.}	{NULL}
journal.pone.0099155.pdf	415	{Clin,Obstet}	{NULL}
journal.pone.0099155.pdf	416	{Gynecol,50,:,255,—,267,.}	{NULL}
journal.pone.0099155.pdf	417	{20,.}	{NULL}
journal.pone.0099155.pdf	418	{Palomba,S,",",Giallauria,F,",",Fa_ll,),o,A,",",Russo,T,",",Oppedisano,R,",",et,al.,(,2008,),Structured,exercise,training,programme,versus,hypocaloric,hyperproteic,diet,in,obese,polycystic,ovary,syndrome,patients,with,anovulatory,infertility,:,a,24-week,pilot,study,.}	{NULL}
journal.pone.0099155.pdf	419	{Hum,Reprod,23,:,642,—,650,.}	{NULL}
journal.pone.0099155.pdf	420	{Tierney,AC,",",McMonagleJ,",",Shaw,DI,",",Gulseth,HL,",",Helal,O,",",et,al.,(,2011,),Effects,of,dietary,fat,modiﬁcation,on,insulin,sensitivity,and,on,other,risk,factors,of,the,metabolic,syndrome,.}	{NULL}
journal.pone.0099155.pdf	421	{—,.}	{NULL}
journal.pone.0099155.pdf	422	{LIPGENE,:,a,European,randomized,dietary,intervention,study,.}	{NULL}
journal.pone.0099155.pdf	423	{Int,],Obes,(,Lond,),35,:,800,—,809,.}	{NULL}
journal.pone.0099155.pdf	424	{Rajaie,S,",",Azadba_kht,L,",",Khazaei,M,",",Sherbafchi,M,",",Esmaillzadeh,A,(,2014,),Moderate,replacement,of,carbohydrates,by,dietary,fats,affects,features,of,metabolic,syndrome,:,A,randomized,crossover,clinical,trial,.}	{NULL}
journal.pone.0099155.pdf	425	{Nutrition,30,:,6l,—,68,.}	{NULL}
journal.pone.0099155.pdf	426	{Zhang,M,",",Lv,XY,",",Li,],",",Xu,ZG,",",Chen,L,(,2008,),The,characterization,of,high-fat,diet,and,multiple,low,—,dose,streptozotocin,induced,type,2,diabetes,rat,model,.}	{NULL}
journal.pone.0099155.pdf	427	{Exp,Diabetes,Res,2008,:,704045,.}	{NULL}
journal.pone.0099155.pdf	428	{Liu,G,",",Shi,F,",",Blas-Machado,U,",",Duong,Q,",",Davis,VL,",",et,al.,(,2005,),Ovarian,effects,of,a,high,lactose,diet,in,the,female,rat,.}	{NULL}
journal.pone.0099155.pdf	429	{Reprod,Nutr,Dev,45,:,185,—,l92,.}	{NULL}
journal.pone.0099155.pdf	430	{Hickey,M,",",Doherty,DA,",",Atkinson,H,",",Sloboda,DM,",",Franks,S,",",et,al.,(,2011,),Clinical,",",ultrasound,and,biochemical,features,of,polycystic,ovary,syndrome,in,adolescents,:,implications,for,diagnosis,.}	{NULL}
journal.pone.0099155.pdf	431	{Hum,Reprod,26,:,l469,—,1477,.}	{NULL}
journal.pone.0099155.pdf	432	{Cavagni,],",",V4/agner,TP,",",Gaio,E,],",",Rego,RO,",",Torres,IL,",",et,al.,(,2013,),Obesity,may,increase,the,occurrence,of,spontaneous,periodontal,disease,in,V4/istar,rats,.}	{NULL}
journal.pone.0099155.pdf	433	{Arch,Oral,Biol,58,:,1034,~,1039,.}	{NULL}
journal.pone.0099155.pdf	434	{Cai,VV,",",Gao,QD,",",Zhu,L,",",Peppa,M,",",He,C,",",et,al.,(,2002,),Oxidative,stress-inducing,carbonyl,compounds,from,common,foods,:,novel,mediators,of,cellular,dysfunction,.}	{NULL}
journal.pone.0099155.pdf	435	{Mol,Med,8,:,337,—,346,.}	{NULL}
journal.pone.0099155.pdf	436	{Goldberg,T,",",Cai,VV,",",Peppa,M,",",Dardaine,V,",",Baliga,BS,",",et,al.,(,2004,),Advanced,glycoxidation,end,products,in,commonly,consumed,foods,.}	{NULL}
journal.pone.0099155.pdf	437	{J,Am,Diet,Assoc,104,:,1287,—,1291,.}	{NULL}
journal.pone.0099155.pdf	438	{Dia_manti-Kandara_kis,E,",",Piperi,C,",",Korkolopoulou,P,",",Kandaraki,E,",",Levidou,G,",",et,al.,(,2007,),Accumulation,of,dietary,glycotoxins,in,the,reproductive,system,of,normal,female,rats,.}	{NULL}
journal.pone.0099155.pdf	439	{J,Mol,Med,(,Berl,),85,:,1413,—,l420,.}	{NULL}
journal.pone.0099155.pdf	440	{Azziz,R,",",Carmina,E,",",Dewailly,D,",",Diamanti-Kandarakis,E,",",Escobar-Morreale,HF,",",et,al.,(,2006,),Positions,statement,:,criteria,for,deﬁning,polycystic,ovary,syndrome,as,a,predominantly,hyperandrogenic,syndrome,:,an,Androgen,Excess,Society,guideline,.,]}	{NULL}
journal.pone.0099155.pdf	441	{Clin,Endocrinol,Metab,91,:,423741245,.}	{NULL}
journal.pone.0099155.pdf	442	{Schuring,AN,",",Schulte,N,",",Sonntag,B,",",Kiesel,L,(,2008,),Androgens,and,insulin,—,two,key,players,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	443	{Recent,concepts,in,the,pathophysiology,and,genetics,of,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	444	{Gynakol,Geburtshilﬂiche,Rundsch,48,:,9,—,15,.}	{NULL}
journal.pone.0099155.pdf	445	{Franks,S,",",Stark,J,",",Hardy,K,(,2008,),Follicle,dyna_mics,and,anovulation,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	446	{Hum,Reprod,Update,14,:,367,—,378,.}	{NULL}
journal.pone.0099155.pdf	447	{Tyndall,V,",",Broyde,M,",",Sharpe,R,",",VVelsh,M,",",Drake,AJ,",",et,al.,(,2012,),Effect,of,androgen,treatment,during,foetal,and,/,or,neonatal,life,on,ovarian,function,in,prepubertal,and,adult,rats,.}	{NULL}
journal.pone.0099155.pdf	448	{Reproduction,143,:,21,—,33,.}	{NULL}
journal.pone.0099155.pdf	449	{Moran,L,],",",Ranasinha,S,",",Zoungas,S,",",McNaughton,SA,",",Brown,V4/J,",",et,al.,(,2013,),The,contribution,of,diet,",",physical,activity,and,sedentary,behaviour,to,body,mass,index,in,women,with,and,without,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	450	{Hum,Reprod,28,:,2276,—,2283,.}	{NULL}
journal.pone.0099155.pdf	451	{Dunaif,A,(,1997,),Insulin,resistance,and,the,polycystic,ovary,syndrome,:,mechanism,and,implications,for,pathogenesis,.}	{NULL}
journal.pone.0099155.pdf	452	{Endocr,Rev,18,:,774,—,800,.}	{NULL}
journal.pone.0099155.pdf	453	{Lunger,F,",",Wildt,L,",",Seeber,B,(,2013,),Accurate,screening,for,insulin,resistance,in,PCOS,women,using,fasting,insulin,concentrations,.}	{NULL}
journal.pone.0099155.pdf	454	{Gynecol,Endocrinol,29,:,541,*,544,.}	{NULL}
journal.pone.0099155.pdf	455	{Norman,R,],",",Davies,M,],",",Lord,J,",",Moran,L,],(,2002,),The,role,of,lifestyle,modiﬁcation,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	456	{Trends,Endocrinol,Metab,13,:,25,l,—,257,.}	{NULL}
journal.pone.0099155.pdf	457	{Yildiz,BO,",",Knochenhauer,ES,",",Azziz,R,(,2008,),Impact,of,obesity,on,the,risk,for,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	458	{J,Clin,Endocrinol,Metab,93,:,l62,—,l68,.}	{NULL}
journal.pone.0099155.pdf	459	{Coviello,AD,",",Legro,RS,",",Dunaif,A,(,2006,),Adolescent,girls,with,polycystic,ovary,syndrome,have,an,increased,risk,of,the,metabolic,syndrome,associated,with,increasing,androgen,levels,independent,of,obesity,and,insulin,resistance,.}	{NULL}
journal.pone.0099155.pdf	460	{J,Clin,Endocrinol,Metab,91,:,492,~,497,.}	{NULL}
journal.pone.0099155.pdf	461	{Morifuji,M,",",Sanbongi,C,",",Sugiura,K,(,2006,),Dietary,soya,protein,intake,and,exercise,training,have,an,additive,effect,on,skeletal,muscle,fatty,acid,oxidation,enzyme,activities,and,mRNA,levels,in,rats,.}	{NULL}
journal.pone.0099155.pdf	462	{Br,],Nutr,96,:,469,—,475,.}	{NULL}
journal.pone.0099155.pdf	463	{.}	{NULL}
journal.pone.0099155.pdf	464	{Hayashi,T,",","\\\\",/,Vojtaszewski,",",],F,",",Goodyear,L,],(,1997,),Exercise,regulation,of,glucose,transport,in,skeletal,muscle,.}	{NULL}
journal.pone.0099155.pdf	465	{Amj,Physiol,273,:,E1039,—,l05l,.}	{NULL}
journal.pone.0099155.pdf	466	{Al,.}	{NULL}
journal.pone.0099155.pdf	467	{—,.}	{NULL}
journal.pone.0099155.pdf	468	{Nozha,O,",",Habib,F,",",Mojaddidi,M,",",El-Bab,MF,(,2013,),Body,weight,reduction,and,metformin,:,Roles,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	469	{Pathophysiology,20,:,l3l,—,137,.}	{NULL}
journal.pone.0099155.pdf	470	{Vignesh,JP,",",Mohan,V,(,2007,),Polycystic,ovary,syndrome,:,a,component,of,metabolic,syndrome,?}	{NULL}
journal.pone.0099155.pdf	471	{J,Postgrad,Med,53,:,l28,—,l34,.}	{NULL}
journal.pone.0099155.pdf	472	{Hoeger,KM,(,2007,),Obesity,and,lifestyle,management,in,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	473	{Clin,Obstet,Gynecol,50,:,277/294,.}	{NULL}
journal.pone.0099155.pdf	474	{Douglas,CC,",",Gower,BA,",",Darnell,BE,",",Ovalle,F,",",Oster,RA,",",et,al.,(,2006,),Role,of,diet,in,the,treatment,of,polycystic,ovary,syndrome,.}	{NULL}
journal.pone.0099155.pdf	475	{Fertil,Steril,85,:,679,—,688,.}	{NULL}
journal.pone.0099155.pdf	476	{(,2004,),National,Institute,for,Clinical,Excellence,.}	{NULL}
journal.pone.0099155.pdf	477	{Fertility,assessment,and,treatment,for,people,with,fertility,problems,.}	{NULL}
journal.pone.0099155.pdf	478	{A,clinical,guideline,.}	{NULL}
journal.pone.0099155.pdf	479	{London,:,RCOG,Press,.}	{NULL}
journal.pone.0099155.pdf	480	{Ha_milton-Fairley,D,",",Kiddy,D,",",Anyaoku,V,",",Koistinen,R,",",Seppala,M,",",et,al.,(,1993,),Response,of,sex,hormone,binding,globulin,and,insulin,—,like,growth,factor,binding,protein,—,l,to,an,oral,glucose,tolerance,test,in,obese,women,with,polycystic,ovary,syndrome,before,and,aﬁer,calorie,restriction,.}	{NULL}
journal.pone.0099155.pdf	481	{Clin,Endocrinol,(,Oxf,),39,:,363,—,367,.}	{NULL}
journal.pone.0099155.pdf	482	{Lord,_,],M,",",Norman,R,(,2006,),Obesity,",",polycystic,ovary,syndrome,",",infertility,treatment,:,lifestyle,modiﬁcation,is,paramount,.}	{NULL}
journal.pone.0099155.pdf	483	{BMJ,332,:,609,.}	{NULL}
journal.pone.0099155.pdf	484	{49,.}	{NULL}
journal.pone.0099155.pdf	485	{HawleyJA,(,2004,),Exercise,as,a,therapeutic,intervention,for,the,prevention,and,treatment,of,insulin,resistance,.}	{NULL}
journal.pone.0099155.pdf	486	{Diabetes,Metab,Res,Rev,20,:,383,—,393,.}	{NULL}
journal.ppat.1003470.pdf	1	{OPEN,8,ACCESS,Freely,available,online,]}	{NULL}
journal.ppat.1003470.pdf	2	{PATHOGENS}	{NULL}
journal.ppat.1003470.pdf	3	{Endothelial,Cell,Permeability,during,Hantavirus,Infection,Involves,Factor,XII-Dependent,Increased,Activation,of,the,Kallikrein-Kinin,System}	{NULL}
journal.ppat.1003470.pdf	4	{Shannon,L.,Taylor,‘,",",Victoria,Wahl-Jensenz,",",Anna,Maria,Copeland,‘,",",Peter,B.,Jahrling,’,",",Connie,S.,Schma,|,john,',*}	{NULL}
journal.ppat.1003470.pdf	5	{1,United,States,Army,Medical,Research,Institute,of,Infectious,Diseases,",",Fort,Detrick,",",Maryland,",",United,States,of,America,",",2,Integrated,Research,Facility,at,Fort,Detrick,",",National,Institute,of,Allergy,and,Infectious,Diseases,",",National,Institutes,of,Health,",",Fort,Detrick,",",Maryland,",",United,States,of,America}	{NULL}
journal.ppat.1003470.pdf	6	{Abstract}	{NULL}
journal.ppat.1003470.pdf	7	{Hemorrhagic,fever,with,renal,syndrome,(,HFRS,),and,hantavirus,pulmonary,syndrome,(,HPS,),are,diseases,caused,by,hantavirus,infections,and,are,characterized,by,vascular,leakage,due,to,alterations,of,the,endothelial,barrier,.}	{NULL}
journal.ppat.1003470.pdf	8	{Hantavirusinfected,endothelial,cells,(,EC,),display,no,overt,cytopathology,;,consequently,",",pathogenesis,models,have,focused,either,on,the,influx,of,immune,cells,and,release,of,cytokines,or,on,increased,degradation,of,the,adherens,junction,protein,",",vascular,endothelial,(,VE,),.}	{NULL}
journal.ppat.1003470.pdf	9	{—,.}	{NULL}
journal.ppat.1003470.pdf	10	{cadherin,",",due,to,hantavirus,—,mediated,hypersensitization,of,EC,to,vascular,endothelial,growth,factor,(,VEGF,),.}	{NULL}
journal.ppat.1003470.pdf	11	{To,examine,endothelial,leakage,in,a,relevant,in,vitro,system,",",we,co,—,cu,|,tured,endothelial,and,vascular,smooth,muscle,cells,(,vSMC,),to,generate,capillary,blood,vesse,|,.}	{NULL}
journal.ppat.1003470.pdf	12	{—,.}	{NULL}
journal.ppat.1003470.pdf	13	{|,ike,structures,.}	{NULL}
journal.ppat.1003470.pdf	14	{In,contrast,to,results,obtained,in,monolayers,of,cultured,EC,",",we,found,that,despite,viral,replication,in,both,cell,types,as,well,as,the,presence,of,VEGF,",",infected,in,vitro,vessels,neither,lost,integrity,nor,displayed,evidence,of,VE,—,cadherin,degradation,.}	{NULL}
journal.ppat.1003470.pdf	15	{Here,",",we,present,evidence,for,a,novel,mechanism,of,hantavirus,—,induced,vascular,leakage,involving,activation,of,the,plasma,ka,|,|,ikrein,—,kinin,system,(,KKS,),.}	{NULL}
journal.ppat.1003470.pdf	16	{We,show,that,incubation,of,factor,XII,(,FXII,),",",prekallikrein,(,PK,),",",and,high,molecular,weight,kininogen,(,HK,),plasma,proteins,with,hantavirusinfected,EC,results,in,increased,cleavage,of,HK,",",higher,enzymatic,activities,of,FX,|,|,a/kallikrein,(,KAL,),and,increased,liberation,of,bradykinin,(,BK,),.}	{NULL}
journal.ppat.1003470.pdf	17	{Measuring,cell,permeability,in,real,—,time,using,electric,ce,|,|,.}	{NULL}
journal.ppat.1003470.pdf	18	{—,.}	{NULL}
journal.ppat.1003470.pdf	19	{substrate,impedance,sensing,(,ECIS,),",",we,identiﬁed,dramatic,increases,in,endothelial,cell,permeability,after,KKS,activation,and,liberation,of,BK,.}	{NULL}
journal.ppat.1003470.pdf	20	{Furthermore,",",the,alterations,in,permeability,could,be,prevented,using,inhibitors,that,directly,block,BK,binding,",",the,activity,of,FX,|,|,a,",",or,the,activity,of,KAL,.}	{NULL}
journal.ppat.1003470.pdf	21	{Lastly,",",FXII,binding,and,autoactivation,is,increased,on,the,surface,of,hantavirus,—,infected,EC,.}	{NULL}
journal.ppat.1003470.pdf	22	{These,data,are,the,first,to,demonstrate,KKS,activation,during,hantavirus,infection,and,could,have,profound,implications,for,treatment,of,hantavirus,infections,.}	{NULL}
journal.ppat.1003470.pdf	23	{Citation,:,Taylor,SL,",",Wah,|,.}	{NULL}
journal.ppat.1003470.pdf	24	{—,.}	{NULL}
journal.ppat.1003470.pdf	25	{Jensen,V,",",Copeland,AM,",",Jahrling,PB,",",Schmaljohn,CS,(,2013,),Endothelial,Cell,Permeability,during,Hantavirus,Infection,Involves,Factor,XIIDependent,Increased,Activation,of,the,Ka,|,|,ikrein,.}	{NULL}
journal.ppat.1003470.pdf	26	{—,.}	{NULL}
journal.ppat.1003470.pdf	27	{Kinin,System,.}	{NULL}
journal.ppat.1003470.pdf	28	{PLoS,Pathog,9,(,7,),:,e1003470,.}	{NULL}
journal.ppat.1003470.pdf	29	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	30	{ppat,.1003470,Editor,:,Andrew,Pekosz,",",Johns,Hopkins,University,»,Bloomberg,School,of,Public,Health,",",United,States,of,America,Received,February,1,",",2013,;,Accepted,May,16,",",2013,;,Published,July,18,",",2013,This,is,an,open,»,access,article,",",free,of,all,copyright,",",and,may,be,freely,reproduced,",",distributed,",",transmitted,",",modified,",",built,upon,",",or,otherwise,used,by,anyone,for,any,lawful,purpose,.}	{NULL}
journal.ppat.1003470.pdf	31	{The,work,is,made,available,under,the,Creative,Commons,CCO,public,domain,dedication,.}	{NULL}
journal.ppat.1003470.pdf	32	{Funding,:,This,work,was,sponsored,by,an,Independent,Laboratory,In-House,Research,(,ILIR,),grant,",",project,number,1591244,.}	{NULL}
journal.ppat.1003470.pdf	33	{The,funders,had,no,role,in,study,design,",",data,collection,and,analysis,",",decision,to,publish,",",or,preparation,of,the,manuscript,.}	{NULL}
journal.ppat.1003470.pdf	34	{Competing,Interests,:,The,authors,have,declared,that,no,competing,interests,exist,.}	{NULL}
journal.ppat.1003470.pdf	35	{*,E,—,mai,|,:,Connie,.}	{NULL}
journal.ppat.1003470.pdf	36	{Schma,|,john@us.army.mi,|}	{NULL}
journal.ppat.1003470.pdf	37	{zxitro,studies,have,identiﬁed,EC,as,a,primary,site,of,viral,replication,",",although,hantaviruses,can,infect,epithelial,and,vascular,smooth,muscle,cells,(,VSMC,),as,well,[,"4,5",],.}	{NULL}
journal.ppat.1003470.pdf	38	{Importantly,",",despite,high,levels,of,viral,antigens,",",the,capillary,endothelium,displays,no,obvious,cytopathology,[,"5,6",],.}	{NULL}
journal.ppat.1003470.pdf	39	{The,mechanism,by,which,hantaviruses,cause,pronounced,vascular,leakage,when,the,lining,of,the,endothelium,is,still,intact,has,remained,elusive,.}	{NULL}
journal.ppat.1003470.pdf	40	{It,has,been,assumed,that,during}	{NULL}
journal.ppat.1003470.pdf	41	{Introduction}	{NULL}
journal.ppat.1003470.pdf	42	{The,Buryxazxiridae,family,encompasses,viruses,that,cause,numerous,hemorrhagic,fever,diseases,in,humans,.}	{9}
journal.ppat.1003470.pdf	43	{The,genus,Hantavirus,includes,Old,World,and,New,World,viral,lineages,.}	{NULL}
journal.ppat.1003470.pdf	44	{Old,World,hantaviruses,are,widespread,throughout,Asia,and,Europe,and,are,associated,with,the,clinical,syndrome,",",hemorrhagic,fever,with,renal,syndrome,(,HFRS,),.}	{NULL}
journal.ppat.1003470.pdf	45	{The,prototype,hantavirus,",",Hantaan,virus,(,HTNV,),",",can,cause,severe,HFRS,with,a,case,fatality,rate,as,high,as,15,%,[,"1,2",],.}	{NULL}
journal.ppat.1003470.pdf	46	{The,New,"\\\\",/,Vorld,hantaviruses,are,the,causative,agents,of,hantavirus,pulmonary,syndrome,(,HPS,),and,are,found,in,the,Americas,[,"1,2",],.}	{NULL}
journal.ppat.1003470.pdf	47	{The,case,fatality,rate,for,HPS,is,greater,than,that,of,HFRS,and,has,been,reported,to,be,as,high,as,50,%,for,Andes,virus,(,ANDV,),[,1,],.}	{NULL}
journal.ppat.1003470.pdf	48	{While,HFRS,and,HPS,differ,in,the,organs,exhibiting,pathogenic,consequences,;,i.e.,",",kidneys,for,HFRS,and,lungs,for,HPS,",",both,diseases,primarily,affect,blood,vessels,and,cause,systemic,vascular,leakage,that,can,lead,to,hypotension,and,shock,[,l,—,3,],.}	{NULL}
journal.ppat.1003470.pdf	49	{In,vivo,and,in,viral,infection,",",since,EC,are,not,damaged,",",there,must,be,some,alteration,to,the,infected,cells,directly,or,indirectly,through,immune,mediated,processes,that,result,in,vascular,leakage,.}	{NULL}
journal.ppat.1003470.pdf	50	{One,hypothesis,implicates,the,indirect,effects,of,cytokines,released,from,immune,cells,such,as,monocytes,or,T,cells,.}	{NULL}
journal.ppat.1003470.pdf	51	{Support,for,this,hypothesis,stems,from,several,clinical,studies,showing,that,hantavirus,—,infected,patients,develop,high,levels,of,T,cells,and,cytokine-producing,cells,",",which,have,been,correlated,with,disease,severity,(,reviewed,in,[,7,],),.}	{NULL}
journal.ppat.1003470.pdf	52	{However,",",in,laboratory,studies,",",depletion,of,T,cells,was,found,to,have,no,effect,on,the,outcome,of,disease,in,a,hamster,model,that,accurately,reﬂects,HPS,[,8,],.}	{NULL}
journal.ppat.1003470.pdf	53	{Author,Summary}	{NULL}
journal.ppat.1003470.pdf	54	{Primary,manifestations,of,disease,due,to,hantavirus,infections,include,systemic,vascular,leakage,and,hypotension,for,which,the,underlying,mechanism,is,not,known,.}	{NULL}
journal.ppat.1003470.pdf	55	{A,particularly,perplexing,ﬁnding,is,that,the,vascular,endothelium,remains,intact,during,hantavirus,infection,and,with,no,apparent,cytopathic,effects,to,explain,leakage,and,edema,.}	{NULL}
journal.ppat.1003470.pdf	56	{Our,studies,show,for,the,first,time,that,hantavirusinfected,EC,have,increased,KKS,activation,resulting,in,liberation,of,the,inflammatory,peptide,",",BK,.}	{NULL}
journal.ppat.1003470.pdf	57	{BK,is,a,potent,inducer,of,vascular,permeability,",",edema,formation,",",and,hypotension,;,thus,",",our,results,provide,a,novel,mechanism,for,hantavirus,—,induced,vascular,abnormalities,.}	{NULL}
journal.ppat.1003470.pdf	58	{Additionally,",",we,describe,the,use,of,an,in,vitro,capillary,blood,vessel,model,to,examine,responses,occurring,locally,in,blood,vessels,during,infection,.}	{NULL}
journal.ppat.1003470.pdf	59	{This,model,could,be,used,in,future,studies,by,others,for,assessing,further,aspects,of,hantavirus,pathogenesis,or,that,of,other,vascular,tropic,viruses,.}	{NULL}
journal.ppat.1003470.pdf	60	{A,second,hypothesis,centers,around,observations,that,vascular,endothelial,growth,factor,(,V,EGF,),levels,are,elevated,in,HPS,and,HFRS,patients,",",and,that,VEGF,could,affect,vascular,permeability,by,increasing,the,degradation,of,VE-cadherin,[,9,—,12,],.}	{NULL}
journal.ppat.1003470.pdf	61	{VEcadherin,is,an,endothelial,speciﬁc,adhesion,molecule,that,is,critical,for,maintaining,cell,contact,integrity,and,for,regulating,vascular,permeability,[,13,],.}	{NULL}
journal.ppat.1003470.pdf	62	{However,",",in,the,lethal,hamster,model,of,HPS,",",an,upregulation,of,VEGF,was,not,observed,in,plasma,of,ANDV-infected,hamsters,[,14,],.}	{NULL}
journal.ppat.1003470.pdf	63	{In,the,studies,we,report,here,",",we,developed,and,tested,an,alternative,hypothesis,;,ie,",",that,permeability,changes,in,hantavirus-infected,EC,are,due,to,increased,kallikrein-kinin,system,(,KKS,),activation,and,the,liberation,of,bradykinin,2I,+,The,KKS,consists,of,serine,proteinases,;,factor,XII,(,FXII,),and,prekallikrein,(,PK,),",",and,the,cofactor,",",high,molecular,weight,kininogen,2I,+,[,15,],.}	{NULL}
journal.ppat.1003470.pdf	64	{Initiation,of,this,pathway,can,occur,via,two,mechanisms,.}	{NULL}
journal.ppat.1003470.pdf	65	{The,first,is,dependent,upon,autoactivation,of,FXII,.}	{NULL}
journal.ppat.1003470.pdf	66	{FXII,can,bind,to,artiﬁcial,and,biological,surfaces,to,induce,a,conformational,change,and,activation,to,FXIIa,.}	{NULL}
journal.ppat.1003470.pdf	67	{FXIIa,mediates,the,proteolytic,cleavage,and,activation,of,PK,to,kallikrein,(,KAL,),and,subsequent,cleavage,of,HK,.}	{NULL}
journal.ppat.1003470.pdf	68	{Alternatively,",",activation,of,this,cascade,can,occur,independently,of,FXII,.}	{NULL}
journal.ppat.1003470.pdf	69	{Polycarboxylpeptidase,(,PRCP,),and,heat,shock,protein,90,(,HSP90,),have,been,shown,to,be,activators,of,PK,and,mediate,conversion,of,PK,to,KAL,and,cleavage,of,HK,[,"16,17",],.}	{NULL}
journal.ppat.1003470.pdf	70	{However,",",if,FXII,is,present,after,initial,KAL,formation,",",both,enzymes,can,reciprocally,activate,causing,an,ampliﬁcation,of,the,cascade,.}	{NULL}
journal.ppat.1003470.pdf	71	{In,both,circumstances,the,outcome,is,cleavage,of,HK,resulting,in,release,of,a,9,amino,acid,peptide,",",BK,[,18,],.}	{NULL}
journal.ppat.1003470.pdf	72	{BK,is,an,extremely,potent,inﬂammatory,peptide,that,exerts,numerous,effects,on,the,vasculature,including,vasodilation,and,increased,vascular,permeability,[,19,],.}	{NULL}
journal.ppat.1003470.pdf	73	{BK,binds,to,the,bradykinin,B2,receptor,(,BKB2R,),and,triggers,an,increase,in,intracellular,Ca2,+,",",endothelium-derived,hyperpolarizing,factor,(,EDHF,),",",prostacyclin,(,PGI2,),",",and,nitric,oxide,(,NO,),production,",",eliciting,relaxation,of,vSMC,and,a,drop,in,blood,pressure,[,20,],.}	{NULL}
journal.ppat.1003470.pdf	74	{Vascular,permeability,is,also,increased,allowing,protein,and,ﬂuid,extravasation,across,the,endothelium,via,endothelial,gaps,or,transendothelial,transport,[,21,],.}	{NULL}
journal.ppat.1003470.pdf	75	{BK,has,been,implicated,in,the,pathogenesis,of,numerous,diseases,and,disorders,including,sepsis,",",pancreatitis,",",asthma,",",and,most,notably,the,genetic,disorder,",",hereditary,angioedema,(,HAE,),[,22,—,25,],.}	{27}
journal.ppat.1003470.pdf	76	{HAE,patients,are,deﬁcient,in,C1,esterase,inhibitor,(,Cl-INH,),",",an,important,regulator,of,activated,FXII,",",which,leads,to,excessive,BK,generation,resulting,in,edema,.}	{NULL}
journal.ppat.1003470.pdf	77	{Several,therapeutics,that,block,BK,formation,and,BK,binding,have,been,developed,and,approved,for,human,use,to,treat,this,disorder,.}	{NULL}
journal.ppat.1003470.pdf	78	{The,similar,disease,parameters,seen,in,HAE,",",HFRS,",",and,HPS,led,us,to,examine,the,importance,of,BK,in,the,pathogenesis,of,hantavirus,infections,.}	{NULL}
journal.ppat.1003470.pdf	79	{Taken,together,",",our,in,vitro,ﬁndings,of,increased,KKS,activation,",",clinical,data,demonstrating,activation,of,PK,",",and,the,reported,successful,treatment,of,patient,with,severe,HFRS,due,to,Puumala,virus,infection,with,a,BK,antagonist,[,26,],implicates,BK,in,the,vascular,leakage,associated,with,pathogenic,HFRS,hantavirus,infections,.}	{NULL}
journal.ppat.1003470.pdf	80	{Results}	{NULL}
journal.ppat.1003470.pdf	81	{Formation,of,in,vitro,human,capillary,blood,vessels,In,vitro,organotypic,blood,vessel,systems,are,becoming,more,common,for,studying,the,processes,associated,with,angiogenesis,.}	{NULL}
journal.ppat.1003470.pdf	82	{Work,by,Evenson,et,:1,],.}	{NULL}
journal.ppat.1003470.pdf	83	{resulted,in,such,a,system,in,which,coculture,of,human,umbilical,vein,EC,(,HUVEC,),with,human,mesenchymal,stem,cells,(,hMSC,),or,human,pulmonary,artery,SMC,(,PaSMC,),produced,spontaneous,formation,of,capillary-like,blood,vessels,[,27,],.}	{NULL}
journal.ppat.1003470.pdf	84	{The,capillary-like,blood,vessels,underwent,phenotypic,changes,that,are,commonly,observed,in,viva,such,as,stabilization,of,endothelial,capillary,tubes,by,PaSMC,or,hMSCdifferentiated,cells,",",formation,of,adherens,junctions,",",and,the,presence,of,basement,membrane,like,structures,[,27,],.}	{NULL}
journal.ppat.1003470.pdf	85	{We,adapted,this,system,as,a,platform,for,studying,hantavirus,pathogenesis,.}	{NULL}
journal.ppat.1003470.pdf	86	{To,generate,and,then,verify,the,formation,of,blood,vessel-like,structures,in,vitro,",",we,co-cultured,HUVEC,with,PaSMC,or,hMSC,on,silicon,chips,and,processed,them,for,scanning,electron,microscopy,.}	{NULL}
journal.ppat.1003470.pdf	87	{Upon,ultrastructural,examination,",",long,and,branched,EC,tubes,were,visualized,throughout,the,samples,(,Figure,1A,and,B,),.}	{NULL}
journal.ppat.1003470.pdf	88	{Tubes,varied,in,size,with,the,largest,tubes,measuring,approximately,12,pm,in,diameter,(,Figure,1A,and,B,),.}	{NULL}
journal.ppat.1003470.pdf	89	{The,tubes,were,presumably,stabilized,and,wrapped,by,additional,cells,that,consisted,of,PaSMC,or,hMSC-differentiated,cells,.}	{NULL}
journal.ppat.1003470.pdf	90	{A,matrix,morphologically,consistent,with,collagen,was,observed,supporting,the,capillaries,.}	{NULL}
journal.ppat.1003470.pdf	91	{To,more,specifically,identify,cell,types,",",we,fixed,and,immunostained,HUVEC,and,PaSMC,or,hMSC,co-cultures,with,antibodies,speciﬁc,for,von,"\\\\",Nillebrand,’s,factor,(,vWF,),or,smooth,muscle,actin,(,SMA,),to,identify,EC,or,SMC,and,collagen,XVIII,",",a,vascular,basement,membrane,protein,that,is,normally,localized,to,the,peri-endothelial,cell,region,and,is,indicative,of,vessel,maturity,(,Figure,1C,and,D,),.}	{NULL}
journal.ppat.1003470.pdf	92	{Numerous,EC,capillary,tubes,could,be,observed,in,both,co-culture,samples,(,Figure,1C,and,D,),.}	{NULL}
journal.ppat.1003470.pdf	93	{Taken,together,these,data,demonstrate,that,we,were,able,to,generate,an,in,vitro,capillary,system,that,could,be,used,as,a,novel,model,for,studying,multicellular,involvement,during,hantavirus,pathogenesis,.}	{NULL}
journal.ppat.1003470.pdf	94	{Hantaviruses,infect,in,vitro,capillary,blood,vessels,Most,in,vitro,studies,of,hantavirus,pathogenesis,have,been,performed,by,infecting,EC,alone,",",and,although,hantaviruses,do,predominantly,infect,this,cell,type,",",there,are,also,reports,of,viral,antigen,within,the,perivascular,SMC,of,infected,patients,[,"4,5",],.}	{NULL}
journal.ppat.1003470.pdf	95	{The,in,vitro,capillary,blood,vessel,model,contains,EC,and,SMC,and,recapitulates,the,natural,site,of,infection,during,hantavirus,diseases,",",so,we,sought,to,determine,if,pathogenic,hantaviruses,infect,both,cell,types,in,this,model,.}	{NULL}
journal.ppat.1003470.pdf	96	{We,found,that,after,infection,with,HTNV,or,ANDV,",",we,could,detect,viral,nucleocapsid,proteins,(,N,),in,the,EC,capillary,tubes,(,Figure,2A,",",arrows,),.}	{NULL}
journal.ppat.1003470.pdf	97	{Surprisingly,",",we,discovered,that,HTNV,and,AN,DV,antigens,were,detected,in,cells,not,expressing,vWF,",",suggesting,that,they,were}	{NULL}
journal.ppat.1003470.pdf	98	{Figure,1,.}	{NULL}
journal.ppat.1003470.pdf	99	{Formation,of,capillary-like,vessels,in,vitro,.}	{NULL}
journal.ppat.1003470.pdf	100	{HUVEC,and,PaSMC,(,A,&,C,),or,HUVEC,and,hMSC,(,B,&,D,),were,plated,and,co-cultured,for,5,days,to,form,in,vitro,capillaries,.}	{NULL}
journal.ppat.1003470.pdf	101	{Cells,were,fixed,and,processed,for,scanning,electron,microscopy,.}	{NULL}
journal.ppat.1003470.pdf	102	{(,A,),Capillary,tubes,were,long,and,branched,.}	{NULL}
journal.ppat.1003470.pdf	103	{Size,bar,:,10,pm,.}	{NULL}
journal.ppat.1003470.pdf	104	{(,B,),EC,tubes,(,arrow,),were,stabilized,and,wrapped,by,additional,cells,that,were,presumably,hMSC,—,differentiated,cells,(,asterick,),.}	{NULL}
journal.ppat.1003470.pdf	105	{Size,bar,:,10,pm,.}	{NULL}
journal.ppat.1003470.pdf	106	{(,C,),Cells,were,ﬁxed,and,stained,with,antibodies,specific,for,SMA,(,brown,),and,COL18A1,(,blue,),or,(,D,),vWF,(,red,),and,COL18A1,(,green,),.}	{NULL}
journal.ppat.1003470.pdf	107	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	108	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	109	{g001}	{NULL}
journal.ppat.1003470.pdf	110	{also,able,to,infect,PaSMC,in,the,capillary,blood,vessel,system,(,Figure,2A,",",arrowheads,),.}	{NULL}
journal.ppat.1003470.pdf	111	{Similarly,",",hantavirus,N,staining,patterns,were,also,observed,in,HUVEC,and,hMSC,co-cultures,(,data,not,shown,),.}	{NULL}
journal.ppat.1003470.pdf	112	{For,subsequent,experiments,",",which,compared,individual,cell,types,and,co-cultures,",",we,used,only,capillaries,formed,with,HUVEC,and,PaSMC,because,PaSMC,do,not,require,differentiation,.}	{NULL}
journal.ppat.1003470.pdf	113	{To,determine,if,VSMC,infection,was,unique,to,the,capillary,blood,vessel,system,or,if,the,VSMC,alone,could,be,infected,",",PaSMC,were,infected,with,HTNV,or,ANDV,",",fixed,",",and,stained,with,antibodies,speciﬁc,for,SMA,and,hantavirus,N.,Both,HTNV,and,ANDV,N,were,detected,within,PaSMC,(,Figure,2B,),indicating,that,a,co-culture,system,is,not,required,for,infection,of,VSMC,.}	{NULL}
journal.ppat.1003470.pdf	114	{To,determine,if,viral,replication,was,occurring,",",we,also,performed,a,time,course,infection,experiment,over,4,days,.}	{NULL}
journal.ppat.1003470.pdf	115	{PaSMC,were,mock-infected,or,infected,with,HTNV,or,ANDV,and,whole,cell,lysates,were,harvested,on,1,",",2,",",3,",",and,4,days,post-infection,and,western,blots,performed,to,measure,the,viral,N,proteins,.}	{NULL}
journal.ppat.1003470.pdf	116	{Increases,in,N,were,apparent,for,both,hantaviruses,over,the,4,days,",",demonstrating,that,viral,infection,and,replication,in,PaSMC,were,occurring,(,Figure,2C,),.}	{NULL}
journal.ppat.1003470.pdf	117	{Pathogenic,hantavirus,infections,do,not,cause,degradation,of,VE,—,cadherin,in,in,vitro,capillary,blood,vessels,VEGF,potently,mediates,vascular,permeability,through,a,complex,signaling,process,in,which,binding,to,the,receptor}	{NULL}
journal.ppat.1003470.pdf	118	{VEGF-R2,results,in,loss,of,the,endothelial,barrier,due,to,internalization,and,degradation,of,VE,—,cadherin,[,13,],.}	{NULL}
journal.ppat.1003470.pdf	119	{VEGF,has,been,proposed,to,mediate,hantavirus,pathogenesis,",",as,inferred,from,studies,in,which,adding,VEGF,to,hantavirus-infected,HUVEC,resulted,in,hyperphosphorylation,of,VEGF-R2,and,internalization,and,degradation,of,VE,—,cadherin,[,10,],.}	{NULL}
journal.ppat.1003470.pdf	120	{Another,study,",",however,",",showed,that,infection,of,primary,human,pulmonary,microvascular,EC,(,HMVEC-L,),with,ANDV,alone,can,direct,degradation,of,VE,—,cadherin,[,12,],.}	{NULL}
journal.ppat.1003470.pdf	121	{To,further,explore,this,possible,mechanism,of,hantavirus,pathogenesis,",",we,tested,the,effects,of,HTNV,and,ANDV,infections,on,VE,—,cadherin,degradation,in,the,in,vitro,capillary,blood,vessel,model,.}	{NULL}
journal.ppat.1003470.pdf	122	{This,model,should,more,faithfully,represent,in,vivo,conditions,than,EC,alone,because,it,contains,both,cell,types,normally,present,in,human,blood,vessels,and,secretes,VEGF,[,27,],.}	{NULL}
journal.ppat.1003470.pdf	123	{HUVEC,and,PaSMC,were,co-cultured,to,form,in,vitro,capillary,blood,vessels,and,mockinfected,or,infected,with,HTNV,or,ANDV,for,3,days,without,VEGF-containing,media,.}	{NULL}
journal.ppat.1003470.pdf	124	{Whole,cell,lysates,of,HTNV,-,or,ANDVinfected,samples,were,examined,for,the,presence,of,VE,—,cadherin,by,western,blotting,.}	{NULL}
journal.ppat.1003470.pdf	125	{There,was,no,noticeable,degradation,of,VEcadherin,in,the,virus-infected,samples,(,Figure,3A,),",",despite,the,presence,of,HTNV,and,ANDV,antigens,in,both,HUVEC,and,PaSMC,as,determined,by,IFA,.}	{NULL}
journal.ppat.1003470.pdf	126	{VEGF,was,detected,in,all,supernatants,at,3,days,post-infection,with,no,statistically,signiﬁcant,levels,in,hantavirus,samples,when,compared,to,mock,(,Figure,3B,),.}	{NULL}
journal.ppat.1003470.pdf	127	{In,addition,",",we,did,not,observe,abnormalities,in,vessel,structures,",",which,we,would,expect,if,VE,—,cadherin,levels,were,reduced,as,VEvWF}	{NULL}
journal.ppat.1003470.pdf	128	{Nucleocapsid,Merged}	{NULL}
journal.ppat.1003470.pdf	129	{C,MOCK,HTNV,ANDV}	{NULL}
journal.ppat.1003470.pdf	130	{1,2,3,4,1,2,3,4,1,2,3,4,Day,PI}	{NULL}
journal.ppat.1003470.pdf	131	{Nucleocapsid}	{NULL}
journal.ppat.1003470.pdf	132	{‘,GAPDH}	{NULL}
journal.ppat.1003470.pdf	133	{Figure,2,.}	{NULL}
journal.ppat.1003470.pdf	134	{Hantavirus,infection,of,in,vitro,capillaries,.}	{NULL}
journal.ppat.1003470.pdf	135	{HUVEC,and,PaSMC,were,plated,and,co,—,cu,|,tured,for,3,days,to,form,in,vitro,capillaries,.}	{NULL}
journal.ppat.1003470.pdf	136	{Samples,were,then,mock,—,infected,or,infected,with,HTNV,or,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	137	{(,A,),Cells,were,fixed,and,stained,with,antibodies,specific,for,vWF,(,red,),",",hantavirus,N,(,green,),",",and,nuclei,(,DAPI,),.}	{NULL}
journal.ppat.1003470.pdf	138	{Arrows,indicate,hantavirus,—,infected,HUVEC,and,arrowheads,indicate,hantavirus,—,infected,PaSMC,(,10,>,<,),.}	{NULL}
journal.ppat.1003470.pdf	139	{(,B,),PaSMC,were,mock,—,infected,or,infected,with,HTNV,or,ANDV,for,3,days,.}	{NULL}
journal.ppat.1003470.pdf	140	{Cells,were,fixed,and,stained,with,antibodies,to,SMA,(,red,),",",hantavirus,N,(,green,),",",and,nuclei}	{NULL}
journal.ppat.1003470.pdf	141	{PLOS,Pathogens,|,www,.}	{NULL}
journal.ppat.1003470.pdf	142	{p,|,ospathogens.org,4,July,2013,|,Volume,9,|,Issue,7,|,e1003470}	{NULL}
journal.ppat.1003470.pdf	143	{(,DAPI,),(,20,>,<,),.}	{NULL}
journal.ppat.1003470.pdf	144	{(,C,),PaSMC,were,mock,—,infected,or,infected,with,HTNV,and,ANDV,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	145	{Whole,cell,lysates,were,harvested,on,days,1,",",2,",",3,",",and,4,and,prepared,for,immunoblotting,.}	{NULL}
journal.ppat.1003470.pdf	146	{Separated,proteins,were,transferred,to,PVDF,membranes,and,probed,with,antibodies,to,detect,hantavirus,N,or,GAPDH,.}	{NULL}
journal.ppat.1003470.pdf	147	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	148	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	149	{g002}	{NULL}
journal.ppat.1003470.pdf	150	{cadherin,is,also,recognized,to,be,essential,for,maintaining,the,structural,integrity,of,newly,formed,blood,vessels,[,28,],.}	{NULL}
journal.ppat.1003470.pdf	151	{These,results,demonstrate,that,infection,with,pathogenic,hantaviruses,in,a,blood,vessel,model,that,secretes,VEGF,does,not,cause,loss,of,vascular,integrity,.}	{NULL}
journal.ppat.1003470.pdf	152	{The,liberation,of,bradykinin,is,increased,on,hantavirusinfected,in,vitro,capillaries,",",vascular,smooth,muscle,cells,",",and,endothelial,cells,Hantavirus-infected,EC,would,likely,be,exposed,to,blood,plasma,proteins,in,viva,",",providing,an,opportunity,for,their,participation,in,dysregulating,endothelial,cell,barrier,functions,through,the,release,of,BK,",",which,in,turn,would,immediately,affect,vascular,permeability,.}	{NULL}
journal.ppat.1003470.pdf	153	{To,test,whether,the,KKS,can,result,in,altered,levels,of,BK,",",HUVEC,and,PaSMC,were,plated,and,cocultured,to,form,in,vitro,capillaries,and,then,were,mock,—,infected,or,infected,with,HTNV,or,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	154	{The,plasma,factors,FXII,",",PK,",",and,HK,were,added,to,cultures,and,BK,in,the,supernatants,was,measured,using,an,enzyme,immunoassay,.}	{NULL}
journal.ppat.1003470.pdf	155	{Signiﬁcantly,higher}	{NULL}
journal.ppat.1003470.pdf	156	{B}	{NULL}
journal.ppat.1003470.pdf	157	{A}	{NULL}
journal.ppat.1003470.pdf	158	{Mock,HTNV,AN,DV}	{NULL}
journal.ppat.1003470.pdf	159	{VEGF,(,pg/ml,)}	{NULL}
journal.ppat.1003470.pdf	160	{Mock,HTNV,ANDV}	{NULL}
journal.ppat.1003470.pdf	161	{Figure,3,.}	{NULL}
journal.ppat.1003470.pdf	162	{Hantavirus,infection,of,in,vitro,capillaries,does,not,alter,VE-cadherin,or,VEGF,levels,.}	{NULL}
journal.ppat.1003470.pdf	163	{HUVEC,and,PaSMC,were,plated,and,co,—,cu,|,tured,for,3,days,to,form,in,vitro,capillaries,then,mockinfected,or,infected,with,HTNV,or,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	164	{(,A,),Cells,were,lysed,and,prepared,for,immunoblotting,.}	{NULL}
journal.ppat.1003470.pdf	165	{Separated,proteins,were,transferred,to,a,PVDF,membrane,and,probed,with,antibodies,that,detect,VE,—,cadherin,",",hantavirus,N,",",or,GAPDH,.}	{NULL}
journal.ppat.1003470.pdf	166	{(,B,),Supernatants,were,collected,and,analyzed,by,ELISA,to,measure,concentrations,of,VEGF,.}	{NULL}
journal.ppat.1003470.pdf	167	{Data,are,represented,as,mean,+,/,SEM,",",n,=,4,.}	{NULL}
journal.ppat.1003470.pdf	168	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	169	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	170	{g003}	{NULL}
journal.ppat.1003470.pdf	171	{levels,of,BK,(,pSo,.}	{NULL}
journal.ppat.1003470.pdf	172	{oool,),were,identiﬁed,in,supernatants,from,both,HTNV,-,and,ANDV-infected,capillaries,as,compared,to,the,mockinfected,samples,(,Figure,4,),.}	{NULL}
journal.ppat.1003470.pdf	173	{To,determine,if,BK,elevations,occur,in,individual,cell,types,",",PaSMC,and,HUVEC,were,also,cultured,separately,and,mockinfected,or,infected,with,HTNV,or,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	174	{Plasma,components,FXII,",",PK,",",and,HK,were,added,to,the,cultures,",",and,BK,levels,in,cell,supernatants,were,measured,.}	{NULL}
journal.ppat.1003470.pdf	175	{We,detected,signiﬁcantly,higher,levels,of,BK,in,the,supernatants,of,HTNV,-,(,3.5-fold,),and,ANDVinfected,(,3-fold,),HUVEC,as,compared,to,mock,—,infected,samples,",",and,a,modest,increase,in,PaSMC,(,pSo,.}	{NULL}
journal.ppat.1003470.pdf	176	{ool,),(,Figure,4,),.}	{NULL}
journal.ppat.1003470.pdf	177	{Increased,cleavage,of,kininogen,on,the,surface,of,hantavirus,—,infected,endothelial,cells,While,KKS,activation,can,occur,on,the,surface,of,normal,uninfected,HUVEC,",",the,increased,levels,of,BK,that,we,observed,in,the,supernatants,of,hantavirus,—,infected,capillaries,or,individual,cultures,of,PaSMC,or,HUVEC,suggested,an,increase,in,cleavage,of,HK,was,occurring,.}	{NULL}
journal.ppat.1003470.pdf	178	{FXII,can,amplify,the,KKS,through,reciprocal,activation,with,PK,and,cleavage,of,HK,yielding,BK,;,however,",",in,the,absence,of,FXII,",",other,proteins,such,as,PRCP,and,HSP90,can,mediate,the,activation,of,PK,and,subsequent,cleavage,of,HK,.}	{NULL}
journal.ppat.1003470.pdf	179	{To,determine,if,FXII,was,required,for,increased,HK,cleavage,in,hantavirus,—,infected,EC,",",we,mock,—,infected,or,infected,HUVEC,with,HTNV,or,ANDV,and,incubated,with,FXII,",",PK,",",and,HK,or,only,PK,and,HK,.}	{NULL}
journal.ppat.1003470.pdf	180	{"\\\\",/,Vhen,FXH,was,present,",",we,observed,a,signiﬁcant,decrease,of,full,length,HK,in,HTNV,-,and,ANDV-infected,samples,as,compared,to,the,mock,and,evident,by,densitometry,(,Figure,5A,),.}	{NULL}
journal.ppat.1003470.pdf	181	{"\\\\",/,Ve,also,observed,the,appearance,of,cleavage}	{NULL}
journal.ppat.1003470.pdf	182	{Bradykinin,(,ng/ml,)}	{NULL}
journal.ppat.1003470.pdf	183	{"\\\\",~,l,~,~,L,~,~,"{",~,A,A,~,"{",~,A,A,~,t,~,A,A,"{",P,Q,Q,‘,QOOVQQ,®,Oo,?}	{NULL}
journal.ppat.1003470.pdf	184	{§,Q,Qoové,)}	{NULL}
journal.ppat.1003470.pdf	185	{Capillaries,PaSMC,HUVEC}	{NULL}
journal.ppat.1003470.pdf	186	{Figure,4,.}	{NULL}
journal.ppat.1003470.pdf	187	{Liberation,of,bradykinin,on,hantavirus,—,infected,in,vitro,capillaries,",",PaSMC,",",and,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	188	{Capillaries,",",PaSMC,",",and,HUVEC,were,plated,separately,and,mock,—,infected,or,infected,with,HTNV,or,ANDV,for,3,days,.}	{NULL}
journal.ppat.1003470.pdf	189	{Cells,were,treated,with,1,uM,HOE,140,and,5,uM,Trandolapril,and,incubated,with,50,nM,of,FXII,",",PK,",",and,HK,in,buffer,for,1,h,at,37,°,C.,Supernatants,were,collected,and,analyzed,using,a,bradykinin,enzyme,immunoassay,.}	{NULL}
journal.ppat.1003470.pdf	190	{As,controls,",",FXII,",",PK,",",and,HK,were,also,tested,individually,for,non,—,specific,binding,in,the,immunoassay,.}	{NULL}
journal.ppat.1003470.pdf	191	{Data,are,represented,as,mean,+,/,SEM,",",n,=,6,.}	{NULL}
journal.ppat.1003470.pdf	192	{***,pSo,.}	{NULL}
journal.ppat.1003470.pdf	193	{ool,",",****,pSo,.}	{NULL}
journal.ppat.1003470.pdf	194	{oool,.}	{NULL}
journal.ppat.1003470.pdf	195	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	196	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	197	{g004}	{NULL}
journal.ppat.1003470.pdf	198	{products,",",a,heavy,chain,(,62,KDa,),and,two,light,chain,products,(,56,KDa,and,46,KDa,),[,29,],(,Figure,5A,),.}	{NULL}
journal.ppat.1003470.pdf	199	{Moreover,",",treatment,of,the,mock,—,or,hantavirus-infected,HUVEC,with,the,FXIIa,inhibitor,",",corn,trypsin,inhibitor,(,CTI,),",",resulted,in,increased,full,length,HK,in,all,samples,",",indicating,that,FXII,was,important,for,this,process,(,Figure,5A,),.}	{NULL}
journal.ppat.1003470.pdf	200	{In,contrast,",",when,exogenous,FXII,was,not,present,",",similar,amounts,of,full,length,HK,and,cleavage,products,were,detected,in,mock,—,",",HTNV,-,",",and,ANDV-infected,samples,(,Figure,5B,),.}	{NULL}
journal.ppat.1003470.pdf	201	{Treatment,with,the,KAL,inhibitor,",",PKSI-527,",",but,not,CTI,was,able,to,inhibit,cleavage,of,full,length,kininogen,indicating,that,KAL,was,present,in,our,samples,(,data,not,shown,),.}	{NULL}
journal.ppat.1003470.pdf	202	{Additionally,",",when}	{NULL}
journal.ppat.1003470.pdf	203	{A,FX,|,|,+,PK+HK,Untreated,CTI}	{NULL}
journal.ppat.1003470.pdf	204	{2,I,<,:,E,I,<,2,:}	{NULL}
journal.ppat.1003470.pdf	205	{62kDa,56kDa,46kDa}	{NULL}
journal.ppat.1003470.pdf	206	{Nucleocapsid}	{NULL}
journal.ppat.1003470.pdf	207	{B,PK+HK,C}	{NULL}
journal.ppat.1003470.pdf	208	{Mock,HTNV,AN,DV}	{NULL}
journal.ppat.1003470.pdf	209	{Full,length,HK}	{NULL}
journal.ppat.1003470.pdf	210	{62kDa,56kDa,46kDa}	{NULL}
journal.ppat.1003470.pdf	211	{Nucleocapsid}	{NULL}
journal.ppat.1003470.pdf	212	{GAPDH}	{NULL}
journal.ppat.1003470.pdf	213	{Full,length,HK}	{NULL}
journal.ppat.1003470.pdf	214	{only,HK,was,added,",",we,did,not,observe,a,signiﬁcant,difference,in,the,levels,of,HK,on,the,surface,of,mock,—,and,hantavirusinfected,HUVEC,by,western,blotting,",",indicating,that,hantavirus,infection,by,itself,does,not,increase,HK,binding,(,data,not,shown,),.}	{NULL}
journal.ppat.1003470.pdf	215	{Although,it,has,not,been,clearly,established,how,PRCP,or,HSP90,activates,PK,",",we,considered,whether,viral,infection,might,increase,the,levels,of,these,proteins,and,lead,to,increased,PK,activation,.}	{NULL}
journal.ppat.1003470.pdf	216	{To,eliminate,a,role,for,these,proteins,in,increased,PK,activation,",",we,tested,levels,of,PRCP,and,HSP90,in,mock,—,",",HTNV,-,",",and,AN,DV,-,infected,HUVEC,and,detected,no,apparent,differences,by,western,blot,(,Figure,5C,),.}	{NULL}
journal.ppat.1003470.pdf	217	{1.0,‘,EF37,08,Eo,-,‘,-,‘,gégoe,:38,"\\"",‘”,.}	{NULL}
journal.ppat.1003470.pdf	218	{-9,:,:,gcn,:,o.,4,353,o,-,_,I,2,:,0.2,$,13}	{NULL}
journal.ppat.1003470.pdf	219	{>,>,a,E,3,E,I,<,(}	{NULL}
journal.ppat.1003470.pdf	220	{n-jjunur,HSP90}	{NULL}
journal.ppat.1003470.pdf	221	{PRCP}	{NULL}
journal.ppat.1003470.pdf	222	{Nucleocapsid}	{NULL}
journal.ppat.1003470.pdf	223	{1,1,-,:,GAPDH}	{NULL}
journal.ppat.1003470.pdf	224	{Figure,5,.}	{NULL}
journal.ppat.1003470.pdf	225	{Cleavage,of,HK,on,hantavirus-infected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	226	{HUVEC,were,plated,and,mock,—,infected,or,infected,with,HTNV,or,ANDV,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	227	{50,nM,of,HK,in,buffer,was,added,to,the,monolayer,and,incubated,for,1,h,at,37,°,C.,The,cells,were,incubated,an,additional,1,h,with,(,A,),50,nM,FXII,and,50,nM,PK,in,the,absence,or,presence,of,1,uM,CTI,or,(,B,),50,nM,PK,.}	{NULL}
journal.ppat.1003470.pdf	228	{To,examine,cleavage,of,HK,",",cells,were,lysed,and,prepared,for,immunoblotting,.}	{NULL}
journal.ppat.1003470.pdf	229	{Full,length,",",heavy,",",and,light,chain,fragments,of,HK,",",hantavirus,N,",",or,GAPDH,antibodies,were,used,to,detect,protein,.}	{NULL}
journal.ppat.1003470.pdf	230	{Levels,of,full,length,HK,were,analyzed,by,densitometery,.}	{NULL}
journal.ppat.1003470.pdf	231	{(,C,),Samples,were,examined,by,immunoblotting,to,assess,the,levels,of,PRCP,and,HSP90,in,mock,—,",",HTNV,-,",",and,ANDVinfected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	232	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	233	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	234	{g005}	{NULL}
journal.ppat.1003470.pdf	235	{Plasma,factor,enzyme,activity,is,increased,on,the,surface,of,hantavirus,—,infected,endothelial,cells,Increased,levels,of,BK,and,increased,cleavage,of,HK,suggest,that,increased,activation,of,the,enzymes,FXII,and,PK,is,occurring,on,the,surfaces,of,HTNV,-,and,ANDV-infected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	236	{To,assess,enzyme,activities,",",we,incubated,mock,-,or,hantavirusinfected,HUVEC,with,FXII,",",PK,",",and,HK,and,used,a,chromogenic,substrate,",",S2302,",",with,speciﬁcity,for,the,active,enzymes,FXIIa,and,KAL,.}	{NULL}
journal.ppat.1003470.pdf	237	{Consistent,with,our,data,showing,increased,cleavage,of,HK,and,subsequent,release,of,BK,",",we,also,detected,signiﬁcantly,higher,FXIIa/KAL,hydrolytic,activity,in,the,presence,of,HTNV,and,ANDV,when,compared,to,mock,—,infected,samples,(,Figure,6,),.}	{NULL}
journal.ppat.1003470.pdf	238	{In,the,absence,of,FXII,",",no,signiﬁcant,difference,in,KAL,activity,was,detected,between,mock,and,hantavirus,—,infected,HUVEC,",",further,supporting,the,importance,of,FXII,for,the,increase,in,KKS,activation,of,hantavirus,—,infected,EC,(,data,not,shown,),.}	{NULL}
journal.ppat.1003470.pdf	239	{Activation,of,the,ka,|,|,ikrein,—,kinin,system,alters,the,permeability,of,hantavirus,—,infected,endothelial,cells,Our,data,showing,that,HTNV,and,ANDV,can,alter,enzyme,activation,of,FXII,and,PK,",",cleavage,of,HK,",",and,liberation,of,BK,",",led,us,to,hypothesize,that,BK,would,induce,profound,changes,to,EC,and,increase,vascular,permeability,.}	{NULL}
journal.ppat.1003470.pdf	240	{Generally,",",changes,in,permeability,are,identiﬁed,using,transwell,systems,",",in,which,leakage,of,a,tracer,molecule,is,measured,by,passage,from,the,upper,chamber,to,the,lower,chamber,over,a,course,of,l,—,2,h.,However,",",the,biological,half-life,of,BK,is,extremely,short,;,lasting,approximately,15,sec,and,its,effects,are,rapid,[,30,],.}	{NULL}
journal.ppat.1003470.pdf	241	{To,capture,this,rapid,process,",",we,implemented,electric,cell-substrate,impedance,sensing,(,ECIS,),",",which,allows,for,real-time,measurements,of,resistance,and,alterations,in,permeability,of,cultured,cells,.}	{NULL}
journal.ppat.1003470.pdf	242	{Mockor,hantavirus,—,infected,HUVEC,were,cultured,on,ECIS,arrays,and,the,effects,of,added,FXII,",",PK,",",and,HK,on,resistance,measurements,were,continuously,recorded,throughout,the,experiment,.}	{NULL}
journal.ppat.1003470.pdf	243	{Time,o,h,indicates,that,point,at,which,plasma,factors,with,or}	{NULL}
journal.ppat.1003470.pdf	244	{0.6,*,~,k,**,0.5}	{NULL}
journal.ppat.1003470.pdf	245	{"\\\\",<<,?}	{NULL}
journal.ppat.1003470.pdf	246	{>,€,’,"\\\\",of,(,T,$,o}	{NULL}
journal.ppat.1003470.pdf	247	{Figure,6,.}	{NULL}
journal.ppat.1003470.pdf	248	{Enzymatic,activity,of,FX,|,|,a,and,KAL,on,hantavirusinfected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	249	{HUVEC,cells,were,plated,and,mock,—,infected,or,infected,with,HTNV,or,ANDV,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	250	{20,nM,of,HK,in,buffer,was,added,to,the,monolayer,and,incubated,for,1,h,at,37,°,C.,To,measure,enzyme,activity,cells,were,washed,and,incubated,with,20,nM,FXII,",",20,nM,PK,",",and,0.8,mM,52302,for,1,h,at,37,°,C.,The,liberation,of,paranitroanilide,(,pNA,),from,substrate,(,52302,),was,measured,at,405,nm,.}	{NULL}
journal.ppat.1003470.pdf	251	{As,controls,",",FXII,",",PK,",",and,HK,were,also,added,individually,to,wells,.}	{NULL}
journal.ppat.1003470.pdf	252	{Data,are,represented,as,mean,+,/,SEM,",",n,=,12,.}	{NULL}
journal.ppat.1003470.pdf	253	{****,pS0,.0001,.}	{NULL}
journal.ppat.1003470.pdf	254	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	255	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	256	{g006}	{NULL}
journal.ppat.1003470.pdf	257	{without,inhibitors,was,added,to,cells,already,mock,-,",",HTNV,-,",",or,ANDV-infected,.}	{NULL}
journal.ppat.1003470.pdf	258	{An,initial,drop,in,barrier,function,was,observed,",",even,in,mock,—,infected,cells,",",upon,addition,of,plasma,factors,FXII,",",PK,",",and,HK,.}	{NULL}
journal.ppat.1003470.pdf	259	{This,is,expected,as,addition,of,any,type,of,solution,to,the,wells,will,cause,a,negligible,and,transient,drop,in,resistance,due,to,temperature,ﬂuctuations,",",shear,stress,that,is,induced,when,media,is,added,to,wells,",",and,effects,of,the,factors,themselves,.}	{NULL}
journal.ppat.1003470.pdf	260	{The,maximum,decrease,in,resistance,that,we,observed,in,the,mockinfected,cells,was,10,%,(,Figure,7A,),.}	{NULL}
journal.ppat.1003470.pdf	261	{These,ﬁndings,are,consistent,with,previously,reported,changes,on,the,ECIS,after,treatment,of,cells,with,BK,alone,[,31,],.}	{NULL}
journal.ppat.1003470.pdf	262	{In,stark,contrast,",",wells,that,contained,HTNV,-,or,ANDV-infected,HUVECs,exhibited,a,profound,decrease,in,barrier,function,of,approximately,50,%,as,compared,to,the,initial,resistance,measured,at,"4,000",Hz,.}	{NULL}
journal.ppat.1003470.pdf	263	{The,effect,occurred,at,a,more,rapid,rate,than,observed,in,the,mock,—,infected,wells,and,was,seen,immediately,upon,addition,of,the,factors,(,Figure,7A,),.}	{NULL}
journal.ppat.1003470.pdf	264	{To,further,explore,the,role,of,FXII,",",PK,",",and,BK,on,the,reduction,in,barrier,function,",",we,also,treated,cells,with,either,the,FXIIa,and,KAL,inhibitors,CTI,or,PKSI-527,",",respectively,or,the,BK,receptor,antagonist,",",HOE,I40,(,Figure,7B,",",C,",",&,D,),.}	{NULL}
journal.ppat.1003470.pdf	265	{Addition,of,these,compounds,had,a,marked,positive,impact,on,the,ability,of,the,endothelium,to,circumvent,virus-directed,permeability,changes,.}	{NULL}
journal.ppat.1003470.pdf	266	{Indeed,",",CTI,was,able,to,completely,protect,the,endothelial,monolayer,from,decreases,in,barrier,function,(,Figure,7C,&,D,),.}	{NULL}
journal.ppat.1003470.pdf	267	{These,data,support,and,demonstrate,functionally,the,critical,role,of,FXII,in,the,cleavage,events,leading,to,permeability,changes,associated,with,hantavirus,infections,.}	{NULL}
journal.ppat.1003470.pdf	268	{Cells,treated,with,HOE,140,also,exhibited,a,strong,protective,effect,",",with,cells,maintaining,a,greater,percentage,of,initial,barrier,function,over,untreated,controls,and,again,exhibiting,a,more,rapid,recovery,(,Figure,7C,&,D,),.}	{NULL}
journal.ppat.1003470.pdf	269	{Finally,",",addition,of,PKSI-527,is,partially,protective,as,cells,treated,with,this,inhibitor,exhibited,a,reduced,change,in,barrier,function,as,compared,to,untreated,cells,and,they,recovered,faster,as,well,(,Figure,7C,&,D,),.}	{NULL}
journal.ppat.1003470.pdf	270	{Together,these,data,suggest,that,blocking,the,activities,of,F,XIIa,and,the,BK,receptor,itself,have,the,greatest,protective,effect,for,maintaining,endothelial,integrity,of,hantavirus,—,infected,HUVECs,.}	{NULL}
journal.ppat.1003470.pdf	271	{FXII,binding,and,autoactivation,is,increased,on,hantavirus,—,infected,endothelial,cells,Collectively,",",our,data,suggest,that,increased,bradykinin,liberation,during,hantavirus,infection,is,dependent,upon,FXII,.}	{NULL}
journal.ppat.1003470.pdf	272	{We,hypothesized,that,FXII,binding,was,increased,on,the,surface,of,hantavirus,—,infected,EC,allowing,for,more,activated,enzyme,in,the,cascade,loop,to,amplify,the,reaction,.}	{NULL}
journal.ppat.1003470.pdf	273	{We,tested,this,by,mockinfecting,or,infecting,HUVEC,with,HTNV,or,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	274	{Cells,were,then,trypsinized,",",washed,",",and,left,in,suspension,.}	{NULL}
journal.ppat.1003470.pdf	275	{FXII,alone,was,added,to,samples,in,the,presence,and,absence,of,zinc,.}	{NULL}
journal.ppat.1003470.pdf	276	{Western,blot,analysis,indicated,that,FXII,levels,were,markedly,increased,on,HTNV,-,and,ANDV-infected,HUVEC,in,the,presence,of,zinc,concentrations,optimal,for,binding,(,Figure,8A,),.}	{NULL}
journal.ppat.1003470.pdf	277	{However,",",even,in,the,absence,of,zinc,",",we,were,able,to,detect,small,amounts,of,FXII,bound,to,HTNV,-,and,ANDV-infected,HUVEC,(,Figure,8A,),.}	{NULL}
journal.ppat.1003470.pdf	278	{Since,FXII,alone,is,increased,on,the,surface,of,hantavirusinfected,EC,",",we,also,considered,whether,FXII,could,still,autoactivate,and,if,autoactivation,was,increased,over,levels,of,normal,uninfected,EC,.}	{NULL}
journal.ppat.1003470.pdf	279	{Autoactivation,of,FXII,to,FXIIa,requires,60,—,l20,min,.}	{NULL}
journal.ppat.1003470.pdf	280	{incubations,on,the,surface,of,HUVEC,[,32,],.}	{NULL}
journal.ppat.1003470.pdf	281	{HUVEC,that,were,mock,—,infected,or,infected,with,HTNV,or,ANDV,were,incubated,with,FXII,for,2,h.,At,1,h,",",we,detected,no,discernable,difference,in,the,generation,of,FXIIa,as,measured,by,the,chromogenic,substrate,S2302,(,data,not,shown,),.}	{NULL}
journal.ppat.1003470.pdf	282	{However,",",by,2,h,enzyme,activity,was,detectable,in,mock,-,",",HTNV,-,",",and,ANDV-infected,HUVEC,suggesting,that,autoactivation,was}	{NULL}
journal.ppat.1003470.pdf	283	{>,W}	{NULL}
journal.ppat.1003470.pdf	284	{.}	{NULL}
journal.ppat.1003470.pdf	285	{_,x,N,1,1,_,"\\\\",M,1,1,.}	{NULL}
journal.ppat.1003470.pdf	286	{_,x,O}	{NULL}
journal.ppat.1003470.pdf	287	{_,"\\\\",O}	{NULL}
journal.ppat.1003470.pdf	288	{.}	{NULL}
journal.ppat.1003470.pdf	289	{o,oo}	{NULL}
journal.ppat.1003470.pdf	290	{.}	{NULL}
journal.ppat.1003470.pdf	291	{o,oo,1,1}	{NULL}
journal.ppat.1003470.pdf	292	{.}	{NULL}
journal.ppat.1003470.pdf	293	{o,cu,.}	{NULL}
journal.ppat.1003470.pdf	294	{.}	{NULL}
journal.ppat.1003470.pdf	295	{Norm,.}	{NULL}
journal.ppat.1003470.pdf	296	{Resistance,(,4000,Hz,),$}	{NULL}
journal.ppat.1003470.pdf	297	{Norm,.}	{NULL}
journal.ppat.1003470.pdf	298	{Resistance,(,4000,Hz,),o,.}	{NULL}
journal.ppat.1003470.pdf	299	{o,"\\"",.}	{NULL}
journal.ppat.1003470.pdf	300	{’,‘,.}	{NULL}
journal.ppat.1003470.pdf	301	{‘}	{NULL}
journal.ppat.1003470.pdf	302	{Mock}	{NULL}
journal.ppat.1003470.pdf	303	{o,0:2,0:4,056,0:8,1,1f2,1:4,1i6,1-8,2,o,0:2,oi4,0:6,0:8,1,1i2,1:4,1:6,1:8,2}	{NULL}
journal.ppat.1003470.pdf	304	{Time,(,hours,),Time,(,hours,)}	{NULL}
journal.ppat.1003470.pdf	305	{o,U}	{NULL}
journal.ppat.1003470.pdf	306	{1.2,1-2,*,E,‘,E,‘,O,1.0,C,",",1.0,O,C,Q,C,E,"\\"",",",E,"\\"",",",G,",",0.8,-,o,",",0.8,U,Q,C,C,(,U,N,E,0.6,-,E,0.6,U,),U,),CD,OJ,D,:,04,',‘,D,:,04,E,.}	{NULL}
journal.ppat.1003470.pdf	307	{E,.}	{NULL}
journal.ppat.1003470.pdf	308	{O,o,Z,0.2,-,-,Z,0.2,-,o}	{NULL}
journal.ppat.1003470.pdf	309	{". . . . .",". . .",HTNV,o,ANDV,o,02,°,-4,0-5,°,-8,1,‘,-2,‘,-4,‘,-6,‘,-3,2,o,0:2,oi4,0:6,0:8,"\\"",+,1,.,'}	{NULL}
journal.ppat.1003470.pdf	310	{2,1:4,1:6,1:8,2}	{NULL}
journal.ppat.1003470.pdf	311	{Time,(,hours,),Time,(,hours,)}	{NULL}
journal.ppat.1003470.pdf	312	{Figure,7,.}	{NULL}
journal.ppat.1003470.pdf	313	{Kallikrein-kinin,system,activation,and,changes,in,permeability,of,hantavirus-infected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	314	{Mock,—,",",HTNV,—,",",or,ANDV,—,infected,HUVEC,were,trypsinized,",",seeded,onto,ECIS,chamberslides,",",and,cultured,until,confluent,.}	{NULL}
journal.ppat.1003470.pdf	315	{Media,were,removed,and,replaced,with,phenol,red,free,EBM,containing,Zn,"\\"",.}	{NULL}
journal.ppat.1003470.pdf	316	{After,an,equilibration,",",0.2,ml,of,phenol,red,free,EBM,containing,Zn,“,",",FXII,",",PK,",",and,HK,(,100,nM,each,),were,added,to,cells,(,time,zero,),(,black,lines,),(,A,),.}	{NULL}
journal.ppat.1003470.pdf	317	{To,measure,inhibition,of,activation,",",some,samples,were,treated,with,CTI,(,1,uM,),(,blue,line,),",",PKS,|,.}	{NULL}
journal.ppat.1003470.pdf	318	{—,.}	{NULL}
journal.ppat.1003470.pdf	319	{527,(,5,uM,),(,red,line,),",",or,HOE,140,(,1,uM,),(,green,line,),simultaneously,with,factors,(,B,",",C,",",&,D,),.}	{NULL}
journal.ppat.1003470.pdf	320	{Real,time,measurements,frequency,measurements,were,taken,throughout,the,assay,.}	{NULL}
journal.ppat.1003470.pdf	321	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	322	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	323	{g007}	{NULL}
journal.ppat.1003470.pdf	324	{occurring,(,Figure,813,),.}	{NULL}
journal.ppat.1003470.pdf	325	{Furthermore,",",FXIIa,activity,was,signiﬁ,-,stimulation,of,VEGF,release,by,EC,coupled,with,their,sensitizacantly,increased,in,HTNV,-,and,ANDV-infected,HUVEC,when,tion,to,the,effects,of,VEGF,could,result,in,the,loss,of,EC,barrier,compared,to,mock,(,Figure,8B,),.}	{NULL}
journal.ppat.1003470.pdf	326	{This,activity,was,further,increased,function,[,12,],.}	{NULL}
journal.ppat.1003470.pdf	327	{Contrary,to,this,hypothesis,",",our,results,obtained,upon,addition,of,PK,",",suggesting,that,FXIIa,was,present,to,convert,using,an,in,vitra,capillary,blood,vessel,model,comprised,of,both,EC,PK,to,KAL,(,Figure,8B,),.}	{NULL}
journal.ppat.1003470.pdf	328	{In,the,absence,of,FXII,",",PK,alone,was,not,and,VSMC,and,able,to,secrete,VEGF,",",did,not,show,increased,VEsufficient,to,hydrolyze,S2302,.}	{NULL}
journal.ppat.1003470.pdf	329	{Samples,incubated,in,buffer,alone,cadherin,degradation,or,VEGF,levels,after,infection,with,either,revealed,no,increase,in,hydrolytic,activity,of,S2302,between,time,o,the,HFRS-causing,Virus,HTNV,",",or,the,HPS-causing,virus,",",and,2,h,",",demonstrating,that,contaminating,KAL,was,not,present,ANDV,.}	{NULL}
journal.ppat.1003470.pdf	330	{Our,ﬁndings,do,not,preclude,the,importance,of,VEGF,in,our,assay,to,account,for,the,FXIIa,formation,(,Figure,8B,),.}	{NULL}
journal.ppat.1003470.pdf	331	{and,VE'CadhCrin,in,hamaVim5,Permeability,:,but,Suggest,that,additional,studies,are,needed,to,resolve,these,discrepancies,in,the}	{NULL}
journal.ppat.1003470.pdf	332	{Discussion,different,types,of,cell,culture,systems,used,.}	{NULL}
journal.ppat.1003470.pdf	333	{As,we,showed,",",HTNV,and,ANDV,can,infect,VSMC,when,HCTC,W6,Sh0Wtl1,’,c1t,KKS,aCtlVatl0I1,and,BK,llb6Fﬁtl0I1,CllF,€,CtlY,cultured,alone,or,in,the,in,vitm,capillary,blood,vessel,model,.}	{NULL}
journal.ppat.1003470.pdf	334	{increases,EC,permeability,in,vitro,",",and,we,hypothesize,that,21,Endothelial,cells,regulate,barrier,function,and,vascular,tone,in,similar,mechanism,contributes,to,the,vascular,leakage,manifesta,-,close,collaboration,with,VSMC,.}	{NULL}
journal.ppat.1003470.pdf	335	{Endothelial,dysfunction,as,a,result,tions,Of,hantavirus,diseases,in,viva,.}	{NULL}
journal.ppat.1003470.pdf	336	{Previous,studies,suggested,that,of,injury,or,stress,can,trigger,the,production,of,EDHF,",",PGI2,),and,hantavirus,pathogenesis,was,related,to,degradation,Of,VE,-,NO,production,[,33,],",",These,EC-derived,factors,act,directly,on,cadherin,due,to,a,hypersensitization,of,hantavirus-infected,EC,vSMC,to,induce,vasodilation,.}	{NULL}
journal.ppat.1003470.pdf	337	{As,a,response,to,EC-derived,factors,",",to,VEGF,[,"10,11",],.}	{NULL}
journal.ppat.1003470.pdf	338	{In,another,study,",",ANDV,infection,of,cultured,VSMC,can,upregulate,the,transcriptional,activity,of,certain,factors,EC,was,found,to,result,in,increased,levels,of,VEGF,and,VE,-,such,as,VEGF,[,34,],.}	{NULL}
journal.ppat.1003470.pdf	339	{Testing,has,not,been,performed,to,determine,cadherin,degradation,",",leading,investigators,to,postulate,that,the,if,hantavirus-infected,VSMC,respond,appropriately,to,EC-derived}	{NULL}
journal.ppat.1003470.pdf	340	{PLOS,Pathogens,|,www,.}	{NULL}
journal.ppat.1003470.pdf	341	{p,|,ospathogens.org,8,July,2013,|,Volume,9,|,Issue,7,|,e1003470}	{NULL}
journal.ppat.1003470.pdf	342	{+,Zinc,-,Zinc}	{NULL}
journal.ppat.1003470.pdf	343	{No,Factors,Purified,FXII,Mock,HTNV,HTNV,>,E,?}	{NULL}
journal.ppat.1003470.pdf	344	{<,E}	{NULL}
journal.ppat.1003470.pdf	345	{A405}	{NULL}
journal.ppat.1003470.pdf	346	{AN,DV}	{NULL}
journal.ppat.1003470.pdf	347	{6,&,0,‘,?}	{NULL}
journal.ppat.1003470.pdf	348	{fig,Q1,‘,9,+}	{NULL}
journal.ppat.1003470.pdf	349	{90,¢,»,Q,A,Novel,Mechanism,of,Hantavirus,Permeability}	{NULL}
journal.ppat.1003470.pdf	350	{FXII}	{NULL}
journal.ppat.1003470.pdf	351	{Nucleocapsid}	{NULL}
journal.ppat.1003470.pdf	352	{GAPDH}	{NULL}
journal.ppat.1003470.pdf	353	{@,Mock,I,HTNV,Z,ANDV}	{NULL}
journal.ppat.1003470.pdf	354	{Figure,8,.}	{NULL}
journal.ppat.1003470.pdf	355	{FXII,binding,and,autoactivation,on,hantavirus-infected,HUVEC,.}	{NULL}
journal.ppat.1003470.pdf	356	{HUVEC,were,plated,and,mock,—,infected,or,infected,with,HTNV,or,ANDV,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	357	{(,A,),100,nM,of,FXII,in,buffer,was,added,to,trypsinized,cells,in,suspension,and,incubated,for,1,h,at,37,°,C.,To,examine,FXII,protein,levels,",",cells,were,lysed,and,prepared,for,immunoblotting,.}	{NULL}
journal.ppat.1003470.pdf	358	{FXII,",",hantavirus,N,",",or,GAPDH,antibodies,were,used,to,detect,protein,.}	{NULL}
journal.ppat.1003470.pdf	359	{(,B,),To,measure,conversion,of,FXII,to,FX,|,|,a,",",cells,were,washed,and,incubated,with,25,nM,FXII,in,the,absence,or,presence,of,25,nM,PK,and,0.8,mM,52302,for,2,h,at,37,°,C.,The,liberation,of,paranitroanilide,(,pNA,),from,substrate,(,S2302,),was,measured,at,405,nm,.}	{NULL}
journal.ppat.1003470.pdf	360	{Data,are,represented,as,mean,+,/,SEM,",",n,=,6,.}	{NULL}
journal.ppat.1003470.pdf	361	{****,pS0,.0001,.}	{NULL}
journal.ppat.1003470.pdf	362	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	363	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	364	{g008}	{NULL}
journal.ppat.1003470.pdf	365	{mediators,.}	{NULL}
journal.ppat.1003470.pdf	366	{Our,ﬁndings,warrant,additional,studies,on,the,role,that,hantavirus-infected,VSMC,play,during,pathogenesis,.}	{NULL}
journal.ppat.1003470.pdf	367	{This,will,help,to,further,dissect,pathogenic,mechanisms,occurring,locally,in,infected,blood,vessels,.}	{NULL}
journal.ppat.1003470.pdf	368	{The,manifestations,of,HFRS,and,HPS,;,e.g.,",",edema,",",hypotension,",",shock,",",and,coagulation,abnormalities,",",resemble,clinical,symptoms,of,bacterial,diseases,for,which,systemic,KKS,activation,is,thought,to,play,an,important,role,.}	{NULL}
journal.ppat.1003470.pdf	369	{Most,notably,",",excessive,KKS,activation,has,been,observed,during,meningococcal,septic,shock,and,streptococcal,toxic,shock,syndrome,[,"25,35",],.}	{NULL}
journal.ppat.1003470.pdf	370	{Both,gram,positive,and,gram,negative,bacteria,have,the,ability,to,bind,to,one,or,more,of,the,plasma,components,and,directly,cleave,HK,or,proteolytically,activate,FXII,and,/,or,PK,to,indirectly,release,BK,(,reviewed,in,[,36,],),.}	{NULL}
journal.ppat.1003470.pdf	371	{These,types,of,enzymatic,activities,are,not,known,to,be,associated,with,hantavirus,proteins,making,it,unlikely,that,the,virus,itself,is,directly,activating,FXII,or,PK,through,cleavage,mechanisms,.}	{NULL}
journal.ppat.1003470.pdf	372	{Endogenous,activators,of,FXII,have,also,been,identiﬁed,such,as,nucleic,acids,",",misfolded,proteins,",",and,aggregates,[,37,—,39,],.}	{NULL}
journal.ppat.1003470.pdf	373	{Since,hantaviruses,have,no,lytic,effect,on,EC,",",it,seems,improbable,that,viral,RNA,or,misfolded,/,aggregated,proteins,would,be,released,from,cells,initiating,FXII,and,PK,activation,.}	{NULL}
journal.ppat.1003470.pdf	374	{Tissue,factor,and,anionic,phospholipid,is,found,incorporated,into,the,virion,of,Herpes,Simplex,Virus-l,which,allows,for,binding,of,plasma,factors,and,initiation,of,coagulation,cascades,[,40,],.}	{NULL}
journal.ppat.1003470.pdf	375	{We,have,not,observed,any,increase,in,activation,of,the,KKS,with,HTNV,alone,.}	{NULL}
journal.ppat.1003470.pdf	376	{The,more,likely,explanation,is,a,hantavirus-directed,effect,that,increases,KKS,activation,.}	{NULL}
journal.ppat.1003470.pdf	377	{In,addition,to,bacterial,diseases,",",a,rare,genetic,disorder,",",HAE,",",has,been,associated,with,plasma,factor,activation,dysfunctions,.}	{NULL}
journal.ppat.1003470.pdf	378	{HAE,is,characterized,by,recurrent,attacks,of,edema,that,can,occur,in,the,airway,",",extremities,",",face,",",and,abdomen,[,41,],.}	{NULL}
journal.ppat.1003470.pdf	379	{While,the,trigger,for,attacks,is,not,well,understood,",",the,mechanism,that,produces,edema,has,been,very,well,characterized,.}	{14}
journal.ppat.1003470.pdf	380	{Patients,are,deﬁcient,in,C1,esterase,inhibitor,(,Cl-INH,),which,is,important,in,suppressing,FXIIa,[,41,],.}	{NULL}
journal.ppat.1003470.pdf	381	{With,reduced,levels,of,Cl-INH,",",patients,experience,uncontrolled,FXII,activation,and,subsequently,elevated,levels,of,BK,resulting,in,edema,formation,[,41,],.}	{NULL}
journal.ppat.1003470.pdf	382	{Fortunately,",",there,are,three,types,of,FDA,approved,drugs,that,target,individual,components,of,this,pathway,to,treat,disease,.}	{NULL}
journal.ppat.1003470.pdf	383	{C1-INH,concentrate,(,Berinart,",",Cinryze,",",Rhucin,),can,be,administered,to,suppress,FXIIa,and,KAL,activity,",",Ecallantide,(,Kalbitor,),is,a,speciﬁc,inhibitor,of,KAL,",",and,HOE,140,(,Icatibant,",",Firazyr,),targets,the,BKBQR,to,prevent,binding,of,BK,[,42,],.}	{NULL}
journal.ppat.1003470.pdf	384	{Although,most,of,these,drugs,have,not,been,tested,in,HFRS,or,HPS,patients,",",recently,",",the,BKBQR,antagonist,",",icatibant,",",was,given,to,a,single,patient,with,a,severe,case,of,Puumala,virus-associated,HFRS,[,26,],.}	{NULL}
journal.ppat.1003470.pdf	385	{The,patient,improved,and,recovered,after,receiving,one,dose,of,icatibant,",",supporting,the,theory,that,BK,might,play,a,role,in,HFRS,pathogenesis,and,suggesting,that,further,controlled,clinical,studies,of,BK,inhibitors,are,warranted,.}	{NULL}
journal.ppat.1003470.pdf	386	{Our,in,mm,studies,demonstrate,that,increased,cleavage,of,HK,and,permeability,can,be,signiﬁcantly,inhibited,in,the,presence,of,CTI,",",a,speciﬁc,inhibitor,of,FXIIa,.}	{NULL}
journal.ppat.1003470.pdf	387	{Our,data,also,shows,that,FXII,binding,is,increased,on,the,surface,of,hantavirus-infected,EC,.}	{NULL}
journal.ppat.1003470.pdf	388	{FXII,activation,can,occur,by,two,distinct,mechanisms,;,proteolytic,activation,on,the,surface,of,EC,by,formed,KAL,or,autoactivation,through,binding,to,biological,surfaces,.}	{NULL}
journal.ppat.1003470.pdf	389	{Our,data,suggests,that,both,mechanisms,could,be,important,for,increased,KKS,activation,on,the,surface,of,hantavirus-infected,EC,.}	{NULL}
journal.ppat.1003470.pdf	390	{Increased,binding,of,FXII,to,hantavirus-infected,EC,would,facilitate,increased,formation,of,PK,and,subsequent,liberation,of,BK,",",while,binding,of,FXII,alone,could,autoactivate,to,FXIIa,and,initiate,the,KKS,.}	{NULL}
journal.ppat.1003470.pdf	391	{FXII,binding,is,receptor,speciﬁc,on,the,surface,of,EC,with,a,predominant,complex,utilized,for,preferential,binding,of,FXII,that,includes,urokinase,plasminogen,activator,receptor,(,uPAR,),and,cytokeratin,1,(,CK1,),[,43,],.}	{NULL}
journal.ppat.1003470.pdf	392	{FXII,also,autoactivates,upon,binding,to,transiently,expressed,globular,heads,of,complement,Clq,receptor,(,gC1qR,),[,44,],.}	{NULL}
journal.ppat.1003470.pdf	393	{Under,physiologic,conditions,",",binding,of,FXII,is,highly,restricted,by,the,concentration,of,zinc,and,HK,present,in,the,plasma,[,45,],.}	{NULL}
journal.ppat.1003470.pdf	394	{In,zxitm,studies,have,demonstrated,that,activated,platelets,can,serve,as,a,sufﬁcient,source,of,zinc,for,FXII,activation,[,46,],.}	{NULL}
journal.ppat.1003470.pdf	395	{In,zxitm,",",HTNV,and,ANDV,are,known,to,direct,the,adherence,of,platelets,to,the,surface,of,EC,",",but,there,is,yet,no,available,data,on,whether,platelets,are,activated,.}	{NULL}
journal.ppat.1003470.pdf	396	{Future,studies,aim,to,identify,changes,occurring,in,hantavirus-infected,EC,that,facilitates,increased,binding,of,FXII,and,whether,platelets,can,contribute,to,binding,and,activation,of,FXII,.}	{NULL}
journal.ppat.1003470.pdf	397	{There,are,currently,no,data,available,on,FXII,activation,during,hantavirus,infections,;,however,",",clinical,studies,have,already,been,performed,speciﬁcally,examining,KAL,and,vascular,permeability,in,HFRS,patients,",",providing,evidence,that,KKS,activation,is,also,altered,in,vivo,.}	{NULL}
journal.ppat.1003470.pdf	398	{In,one,clinical,study,",",plasmas,from,86,patients,were,collected,over,the,course,of,disease,and,KAL,levels,were,measured,during,each,phase,[,47,],.}	{NULL}
journal.ppat.1003470.pdf	399	{Additionally,",",patients,were,categorized,based,on,the,severity,of,disease,;,mild,",",moderately,grave,",",and,grave,.}	{NULL}
journal.ppat.1003470.pdf	400	{The,ﬁndings,were,dramatic,with,elevated,levels,of,KAL,detected,in,almost,all,of,the,patients,.}	{NULL}
journal.ppat.1003470.pdf	401	{Even,in,mild,cases,",",these,levels,were,8,times,greater,than,the,control,values,[,47,],.}	{NULL}
journal.ppat.1003470.pdf	402	{Moderately,grave,and,grave,cases,demonstrated,10,and,12,fold,increases,in,KAL,activity,providing,a,correlation,to,severity,of,disease,[,47,],.}	{NULL}
journal.ppat.1003470.pdf	403	{In,a,separate,study,",",a,direct,link,between,KAL,and,the,permeability,index,was,identiﬁed,in,56,HFRS,patients,[,48,],.}	{NULL}
journal.ppat.1003470.pdf	404	{Rates,of,ﬂuid,and,protein,loss,were,directly,associated,with,elevated,levels,of,KAL,.}	{NULL}
journal.ppat.1003470.pdf	405	{In,this,study,",",PK,levels,were,also,measured,and,were,determined,to,be,decreased,except,in,patients,with,mild,forms,of,disease,[,48,],.}	{NULL}
journal.ppat.1003470.pdf	406	{Similar,ﬁndings,are,commonly,observed,in,other,diseases,",",such,as,septic,shock,",",where,excessive,activation,of,FXII,and,PK,results,in,consumption,and,thus,decreased,total,levels,of,factor,[,49,],.}	{NULL}
journal.ppat.1003470.pdf	407	{There,are,currently,no,documented,clinical,or,animal,studies,that,have,extensively,examined,FXII,",",PK,",",KAL,",",or,levels,of,BK,during,the,course,HPS,.}	{NULL}
journal.ppat.1003470.pdf	408	{However,",",examination,of,studies,published,from,ANDV-infected,hamsters,and,patients,reveal,indirect,evidence,of,intrinsic,pathway,activity,during,disease,including,prolonged,bleeding,times,",",decreased,ﬁbrinogen,",",and,ﬁbrin,deposition,found,in,pathology,[,50,—,52,],.}	{NULL}
journal.ppat.1003470.pdf	409	{The,hamster,model,accurately,reﬂects,many,aspects,of,HPS,caused,by,ANDV,infection,in,humans,",",it,will,be,extremely,interesting,to,examine,these,pathways,in,detail,in,the,hamsters,and,the,potential,of,drugs,that,impact,them,during,the,course,of,diseases,.}	{NULL}
journal.ppat.1003470.pdf	410	{To,date,",",there,are,no,therapeutics,available,to,counteract,acute,symptoms,of,HFRS,or,HPS,.}	{NULL}
journal.ppat.1003470.pdf	411	{If,",",as,we,conjecture,",",KKS,activation,and,BK,liberation,are,responsible,for,edema,formation,and,hypotension,during,HFRS,and,HPS,",",then,inhibitors,targeting,the,effects,of,BK,would,presumably,be,effective,as,therapeutics,for,patients,that,are,already,presenting,with,symptoms,.}	{NULL}
journal.ppat.1003470.pdf	412	{Figure,9,depicts,three,speciﬁc,pathway,junctions,that,we,were,able,to,target,in,zxitro,to,block,hantavirus-induced,permeability,.}	{NULL}
journal.ppat.1003470.pdf	413	{Our,ﬁndings,suggest,the,possibility,of,identifying,multiple,points,of,intervention,using,therapeutics,.}	{NULL}
journal.ppat.1003470.pdf	414	{Some,of,these,points,can,already,be,targeted,by,existing,drugs,used,for,other,human,diseases,.}	{NULL}
journal.ppat.1003470.pdf	415	{Furthermore,",",identiﬁcation,of,effective,therapeutics,that,are,already,approved,for,use,in,humans,could,shorten,time,and,expense,to,bring,them,to,market,.}	{NULL}
journal.ppat.1003470.pdf	416	{Lastly,",",although,many,hemorrhagic,fever-causing,viruses,induce,coagulation,abnormalities,",",the,underlying,mechanisms,of,pathogenesis,remain,to,be,determined,.}	{NULL}
journal.ppat.1003470.pdf	417	{It,is,possible,that,the,pathways,we,have,identiﬁed,as,contributing,to,hantavirus,pathogenesis,will,also,have,broader,implications,for,other,viral,hemorrhagic,illnesses,.}	{NULL}
journal.ppat.1003470.pdf	418	{Materials,and,Methods}	{NULL}
journal.ppat.1003470.pdf	419	{Cells,",",reagents,",",and,virus,Human,umbilical,vein,endothelial,cells,(,HUVEC,),were,maintained,in,endothelial,cell,basal,growth,media,(,EBM-2,),that,was,supplemented,with,2,%,fetal,bovine,serum,(,FBS,),",",0.2,ml,hydrocortisone,",",2,ml,hFGF-B,",",0.5,ml,VEGF,",",0.5,ml,R3-IGF-1,",",0.5,ml,ascorbic,acid,",",0.5,ml,hEGF,",",0.5,ml,GA-1000,",",0.5,ml,heparin,(,Lonza,),.}	{NULL}
journal.ppat.1003470.pdf	420	{Human,mesenchymal,stem,cells,(,hMSC,),were,maintained,in,mesenchymal,stem,cell,basal,growth,media,(,MSCGM,),supplemented,with,10,%,mesenchymal,cell,growth,serum,(,MCGS,),",",0.5,[,Lg/ml,of,A/B,",",and,100,IU,of,Pen-Strep,(,Lonza,),.}	{NULL}
journal.ppat.1003470.pdf	421	{Human,pulmonary,artery,smooth,muscle,cells,(,PaSMC,),were,maintained,in,smooth,muscle,basal,media,(,SmBM-2,),supplemented,with,5,%,FBS,",",0.5,ml,heparin,",",lml,hFGF-B,",",0.5,ml,GA-1000,",",and,0.5,ml,hEGF,(,Lonza,),.}	{NULL}
journal.ppat.1003470.pdf	422	{All,primary,cells,were,cultured,in,wells,coated,with,0.1,%,gelatin,.}	{NULL}
journal.ppat.1003470.pdf	423	{Cercopit/zecus,aet/ziops,kidney,cells,",",Vero,C1008,clone,E6,cells,(,Vero,E6,),were,maintained,in,Eagle,’s,Minimum,Essential,Medium,-,^,*,supplemented,with,10,%,FBS,.}	{NULL}
journal.ppat.1003470.pdf	424	{All,cells,were,incubated,at,37,°,C,",",5,%,CO2,for,the,indicated,period,of,time,.}	{NULL}
journal.ppat.1003470.pdf	425	{HTNV,strain,76,—,118,[,53,],and,Andes,virus,strain,Chile9717869,(,from,Center,for,Disease,Control,",",4th,pass,of,808034,",",July,24th,",",1998,),were,propagated,in,Vero,E6,cells,.}	{NULL}
journal.ppat.1003470.pdf	426	{Supernatants,were,harvested,and,clariﬁed,by,centrifugation,and,titers,of,aliquots,were,determined,by,plaque,assay,.}	{NULL}
journal.ppat.1003470.pdf	427	{K.,wﬂ}	{NULL}
journal.ppat.1003470.pdf	428	{A,:,"\\"",9}	{NULL}
journal.ppat.1003470.pdf	429	{CTI}	{NULL}
journal.ppat.1003470.pdf	430	{E,J.}	{NULL}
journal.ppat.1003470.pdf	431	{"\\\\","\\\\",/,E,"\\"",',2,@}	{NULL}
journal.ppat.1003470.pdf	432	{lcatibant}	{NULL}
journal.ppat.1003470.pdf	433	{PKSI-527}	{NULL}
journal.ppat.1003470.pdf	434	{mi,’,?}	{NULL}
journal.ppat.1003470.pdf	435	{“,',@,‘,"\\"","\\"",',4Mf}	{NULL}
journal.ppat.1003470.pdf	436	{Figure,9,.}	{NULL}
journal.ppat.1003470.pdf	437	{Kallikrein-kinin,system,and,BK,inhibitors,.}	{NULL}
journal.ppat.1003470.pdf	438	{A,schematic,illustration,of,three,inhibitors,that,impact,BK,—,mediated,increase,in,endothelial,cell,permeability,.}	{NULL}
journal.ppat.1003470.pdf	439	{CTI,(,corn,trypsin,inhibitor,),inhibits,FX,|,|,a,;,PKSI-527,(,plasma,kallikrein,specific,inhibitor,),inhibits,KAL,activity,;,lcatibant,(,HOE,140,),is,a,peptidomimetic,drug,consisting,of,ten,amino,acids,",",which,is,a,selective,and,specific,antagonist,of,BKB2,receptors,and,is,used,in,humans,under,orphan,drug,status,for,symptomatic,treatment,of,hereditary,angioedema,.}	{NULL}
journal.ppat.1003470.pdf	440	{doi,:10.1371,/,journa,|,.}	{NULL}
journal.ppat.1003470.pdf	441	{ppat,.1003470,.}	{NULL}
journal.ppat.1003470.pdf	442	{g009}	{NULL}
journal.ppat.1003470.pdf	443	{Enzymes,",",proteins,",",and,biochemicals,Single,chain,HK,",",PK,(,speciﬁc,activity,of,28,PEU/mg,),",",and,FXII,(,speciﬁc,activity,of,29,U,/,mg,),were,purchased,from,Enzyme,Research,Laboratories,.}	{NULL}
journal.ppat.1003470.pdf	444	{The,substrate,HDProPheArgpnitroanilide,(,S2302,),was,purchased,from,Diapharma,(,Franklin,",",OH,),.}	{NULL}
journal.ppat.1003470.pdf	445	{The,antagonist,",",HOE,140,(,icatibant,),was,used,to,block,the,BKB2R,and,Trandolapril,to,prevent,cleavage,of,BK,(,Sigma,Aldrich,),.}	{NULL}
journal.ppat.1003470.pdf	446	{PKSI-527,is,a,speciﬁc,inhibitor,of,KAL,activity,(,Enzo,Life,Sciences,),and,corn,trypsin,inhibitor,(,CTI,),inhibits,FXIIa,(,Haematologic,Technologies,Inc.,),.}	{NULL}
journal.ppat.1003470.pdf	447	{lmmunohistochemistry,and,immunofluorescence,For,immunohistochemistry,and,immunoﬂuorescence,of,in,vitra,capillaries,",",HUVEC,and,PaSMC,or,hMSC,were,seeded,",",cultured,and,maintained,for,5,days,as,previously,described,[,27,],.}	{NULL}
journal.ppat.1003470.pdf	448	{Samples,were,ﬁxed,with,10,%,formalin,and,permeabilized,with,0.2,%,Triton,X-100,in,PBS,.}	{NULL}
journal.ppat.1003470.pdf	449	{After,blocking,with,10,%,goat,serum,",",samples,were,stained,for,markers,to,speciﬁcally,detect,HUVEC,[,VWF,(,Santa,Cruz,Biotechnology,),],",",smooth,muscle,cells,[,SMA,(,Santa,Cruz,Biotechnology,),],",",or,Collagen,l8Al,(,Santa,Cruz,Biotechnology,),overnight,at,4,°,C.,In,HUVEC,and,PaSMC,cocultures,",",horseradish,peroxidase,(,HRP,),and,alkaline,phosphatase,(,AP,),conjugated,antibodies,were,used,to,visualize,SMC,and,EC,capillary,tubes,",",respectively,.}	{NULL}
journal.ppat.1003470.pdf	450	{DAB,and,vector,blue,(,V,ecta,Labs,)}	{NULL}
journal.ppat.1003470.pdf	451	{were,used,as,chromogenic,substrates,.}	{NULL}
journal.ppat.1003470.pdf	452	{In,HUVEC,and,hMSC,cocultures,",",Alexa,Fluor,568,and,488,secondary,antibodies,were,used,to,detect,vWF,and,Collagen,l8Al,",",respectively,.}	{NULL}
journal.ppat.1003470.pdf	453	{For,hantavirus,infection,",",in,zzitro,capillaries,or,PaSMC,alone,were,seeded,on,chamber,slides,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,a,multiplicity,of,infection,(,MOI,),of,2,.}	{NULL}
journal.ppat.1003470.pdf	454	{For,samples,containing,in,vitra,capillaries,",",the,MOI,was,based,on,the,initial,number,of,HUVEC,and,PaSMC,seeded,in,wells,.}	{NULL}
journal.ppat.1003470.pdf	455	{After,infection,for,3,days,",",samples,were,ﬁxed,",",permeabilized,",",and,blocked,as,described,for,immunohistochemistry,.}	{NULL}
journal.ppat.1003470.pdf	456	{Cells,were,stained,with,antibodies,speciﬁc,for,vWF,(,Santa,Cruz,Biotechnologies,),",",SMA,(,Santa,Cruz,Biotechnologies,),",",or,hantavirus,nucleocapsid,(,N,),(,Abcam,),overnight,at,4,°,C.,Alexa,Fluor,568,and,488,secondary,antibodies,were,used,to,detect,VWF,or,SMA,and,hantavirus,N,",",respectively,.}	{NULL}
journal.ppat.1003470.pdf	457	{All,coverslips,were,mounted,on,slides,using,Prolong,Gold,antifade,reagent,with,DAPI,(,Life,Technologies,),and,examined,with,a,Leica,DMI6000,B,inverted,microscope,.}	{NULL}
journal.ppat.1003470.pdf	458	{Scanning,electron,microscopy,A,co-culture,of,HUVEC,and,PaSMC,or,hMSC,were,grown,(,as,described,above,to,induce,formation,of,capillary,tubes,),on,5,X7,mm,silicon,chips,(,TedPella,),.}	{NULL}
journal.ppat.1003470.pdf	459	{Specimens,were,then,fixed,with,2.5,%,glutaraldehyde,in,0.1,M,sodium,cacodylate,buffer,",",post,ﬁxed,with,1,%,osmium,tetroxide,in,0.1,M,sodium,cacodylate,",",and,dehydrated,with,a,graded,ethanol,series,.}	{NULL}
journal.ppat.1003470.pdf	460	{The,samples,were,critical,point,dried,under,carbon,dioxide,in,a,Bal-Tec,model,cpd,030,Drier,(,Balzers,",",Liechtenstein,),",",mounted,on,aluminum,studs,",",and,sputter,coated,with,100,A,of,iridium,in,a,model,IBSe/SBT,ion,beam,sputterer,(,South,Bay,Technologies,),prior,to,viewing,in,a,Quanta,Field,Emission,Gun,Scanning,Electron,Microscope,(,FEI,),at,5.0,kV,and,a,working,distance,of,10,mm,.}	{NULL}
journal.ppat.1003470.pdf	461	{Western,blots,Mock-infected,",",HTNV,-,or,ANDV-infected,cell,lysates,were,prepared,with,NP-40,lysis,buffer,(,150,mM,NaCl,",",50,mM,TrisHCl,pH,8.0,",",1,%,NP-40,",",and,protease,inhibitor,cocktail,),",",NuPAGE,LDS,sample,buffer,",",and,NuPAGE,reducing,agent,(,Life,Technologies,),.}	{NULL}
journal.ppat.1003470.pdf	462	{Proteins,were,separated,on,4,to,12,%,gradient,polyacrylamide,gels,and,transferred,to,polyvinylidene,diﬂuoride,(,PVDF,),membranes,.}	{NULL}
journal.ppat.1003470.pdf	463	{Blots,were,blocked,with,5,%,non-fat,milk,in,Tris-buffered,saline,(,TBS,),and,subsequently,probed,overnight,at,4,°,C,with,antibodies,directed,against,HK,(,Abnova,),",",FXII,(,Santa,Cruz,Biotechnology,),",",PRCP,(,Santa,Cruz,Biotechnology,),",",HSP90,(,Santa,Cruz,Biotechnology,),",",hantavirus,N,(,ANDV,NR-9673,BEI,Resources,),",",VE-cadherin,(,Santa,Cruz,Biotechnology,),",",or,GAPDH,(,Santa,Cruz,Biotechnology,),.}	{NULL}
journal.ppat.1003470.pdf	464	{Blots,were,then,washed,with,TBS,containing,Tween,20,and,probed,with,the,appropriate,speciesspeciﬁc,HRP-conjugated,secondary,antibody,.}	{NULL}
journal.ppat.1003470.pdf	465	{Blots,were,developed,using,a,femto,substrate,detection,system,(,Pierce,Biotechnology,),and,signal,captured,using,the,G,:,Box,(,Stratagene,),.}	{NULL}
journal.ppat.1003470.pdf	466	{VEGF,ELISA,Capillaries,were,seeded,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,2,for,3,days,.}	{NULL}
journal.ppat.1003470.pdf	467	{Supernatants,were,subsequently,removed,and,measured,using,a,VEGF,ELISA,kit,according,to,the,manufacturer,’s,instructions,(,Life,Technologies,),.}	{NULL}
journal.ppat.1003470.pdf	468	{Bradykinin,enzyme,immunoassay,Capillaries,",",HUVEC,",",or,PaSMC,were,seeded,and,mockinfected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,2,for,3,days,.}	{NULL}
journal.ppat.1003470.pdf	469	{To,accurately,measure,BK,levels,in,our,supernatants,",",cells,were,pre-treated,with,1,uM,HOE,140,and,5,uM,Trandolapril,for,30,min,.}	{NULL}
journal.ppat.1003470.pdf	470	{and,throughout,incubation,with,the,plasma,factors,(,FXII,",",PK,",",and,HK,),to,prevent,receptor,binding,and,degradation,of,BK,.}	{NULL}
journal.ppat.1003470.pdf	471	{FXII,",",PK,",",and,HK,were,diluted,to,50,nM,each,in,HEPES,(,14.7,mM,),-,Tyrodes,’s,buffer,(,Sigma,Aldrich,),containing,8,uM,Zn2,+,",",added,to,cells,",",and,incubated,for,1,h,at,37,°,C.,Supernatants,were,subsequently,removed,and,measured,using,a,BK,EIA,kit,according,to,the,manufacturer,’s,instructions,(,Bachem,),.}	{NULL}
journal.ppat.1003470.pdf	472	{Cleavage,of,HK,on,HUVEC,HUVEC,were,seeded,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,4,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	473	{Media,was,removed,and,cells,were,washed,with,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	474	{HK,was,diluted,to,50,nM,in,the,presence,of,1,uM,Zn2,+,HEPES-Tyrode,’s,buffer,",",added,to,cells,",",and,incubated,at,37,°,C,for,1,h.,Cells,were,washed,and,incubated,with,FXII,(,50,nM,),and,PK,(,50,nM,),diluted,in,8,uM,Zn2,+,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	475	{In,some,experiments,",",CTI,(,1,"}",",","Ll\\\\/I",),was,added,to,inhibit,FXIIa,.}	{NULL}
journal.ppat.1003470.pdf	476	{At,the,end,of,1,h,incubation,at,37,°,C,",",cells,were,washed,and,lysed,in,NP-40,lysis,buffer,and,examined,by,western,blotting,.}	{NULL}
journal.ppat.1003470.pdf	477	{In,certain,experiments,",",only,PK,(,50,nM,),and,HK,(,50,nM,),were,present,in,order,to,measure,HK,cleavage,that,is,independent,of,FXII,.}	{NULL}
journal.ppat.1003470.pdf	478	{These,experiments,were,performed,as,described,above,except,1,uM,Zn2,+,concentrations,were,used,throughout,the,incubation,steps,.}	{NULL}
journal.ppat.1003470.pdf	479	{FXII,and,PK,activation,on,HUVEC,HUVEC,were,seeded,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,4,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	480	{Media,was,removed,and,cells,were,washed,with,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	481	{HK,was,diluted,to,20,nM,in,the,presence,of,1,uM,Zn2,+,HEPES-Tyrode,’s,buffer,",",added,to,cells,",",and,incubated,at,37,°,C,for,1,h.,Cells,were,washed,and,incubated,with,FXII,(,20,nM,),",",PK,(,20,nM,),",",and,S2302,(,0.8,mM,),in,the,presence,of,8,uM,Zn2,+,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	482	{Hydrolysis,of,the,chromogenic,substrate,S2302,was,measured,by,taking,absorbance,readings,at,405,nm,after,1,h,incubation,at,37,°,C.}	{NULL}
journal.ppat.1003470.pdf	483	{Electric,ce,|,|,.}	{NULL}
journal.ppat.1003470.pdf	484	{—,.}	{NULL}
journal.ppat.1003470.pdf	485	{substrate,impedance,sensing,ECIS,8,"\\\\",Nl0E,+,arrays,(,Applied,Biophysics,),were,coated,with,10,ug,/,ml,of,poly-D-lysine,(,PDL,),and,washed,with,sterile,water,.}	{NULL}
journal.ppat.1003470.pdf	486	{EmbryoMax,Ultrapure,water,with,0.1,%,gelatin,(,Millipore,),was,then,added,to,each,well,and,allowed,to,incubate,for,l,h,followed,by,washing,with,sterile,water,.}	{NULL}
journal.ppat.1003470.pdf	487	{After,the,ﬁnal,wash,",",400,1.11,of,EBM2,media,was,added,to,each,well,.}	{NULL}
journal.ppat.1003470.pdf	488	{Arrays,were,then,loaded,into,the,ECIS,16-well,array,station,and,stabilized,using,ECIS,software,vl,.2.92.0,(,Applied,Biophysics,),.}	{NULL}
journal.ppat.1003470.pdf	489	{HUVEC,cells,were,mock-infected,or,infected,with,HTNV,or,ANDV,and,cultured,for,4,days,in,ﬂasks,.}	{NULL}
journal.ppat.1003470.pdf	490	{After,4,days,",",cells,were,trypsinized,and,approximately,1,X105,cells,were,plated,(,per,well,),in,the,coated,arrays,.}	{NULL}
journal.ppat.1003470.pdf	491	{The,array,station,was,placed,in,a,standard,37,°,C,incubator,with,5,%,CO2,.}	{NULL}
journal.ppat.1003470.pdf	492	{ECIS,software,was,used,to,run,a,multi-frequency,time,scan,at,400,",","4,000",",","32,000",",",and,"64,000",Hz,to,allow,for,collection,of,data,related,to,resistance,",",impedance,and,capacitance,.}	{NULL}
journal.ppat.1003470.pdf	493	{After,approximately,18,h,",",data,were,Visualized,at,"64,000",Hz,and,capacitance,levels,were,uniformly,below,10,nF,(,indicative,of,conﬂuent,monolayers,),.}	{NULL}
journal.ppat.1003470.pdf	494	{The,instrument,was,paused,and,the,array,station,moved,to,a,Class,II,BSC,.}	{NULL}
journal.ppat.1003470.pdf	495	{Media,was,removed,from,wells,and,replaced,with,200,pl,of,phenol,red,free,EBM-2,Containing,Zn,?}	{NULL}
journal.ppat.1003470.pdf	496	{’,and,inhibitors,[,CTI,(,1,uM,),",",PKSI-527,(,5,uM,),",",or,HOE,140,(,1,uM,),],.}	{NULL}
journal.ppat.1003470.pdf	497	{Cells,were,allowed,to,re-equilibrate,at,37,°,C,after,which,time,an,additional,200,pl,of,phenol,red,free,EBM-2,containing,Zn2,+,",",FXII,",",PK,",",and,HK,(,100,nM,each,),were,added,to,wells,in,a,Class,II,BSC,.}	{NULL}
journal.ppat.1003470.pdf	498	{Data,were,collected,real-time,throughout,the,experiment,and,analyzed,using,ECIS,Software,.}	{NULL}
journal.ppat.1003470.pdf	499	{FXII,binding,to,HUVEC,HUVEC,were,seeded,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,4,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	500	{Cells,were,trypsinized,and,washed,with,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	501	{FXII,was,added,to,cells,in,suspension,at,100,nM,in,the,presence,or,absence,of,10,uM,Zn2,+,HEPES-Tyrode,’s,buffer,and,incubated,at,37,°,C,for,l,h.,Cells,were,washed,and,prepared,as,described,for,western,blotting,.}	{NULL}
journal.ppat.1003470.pdf	502	{To,exclude,the,possibility,that,FXII,was,non-speciﬁcally,binding,to,extracellular,matrix,proteins,produced,during,culturing,",",cells,were,trypsinized,and,binding,performed,in,suspension,.}	{NULL}
journal.ppat.1003470.pdf	503	{FXII,autoactivation,on,HUVEC,HUVEC,were,seeded,and,mock-infected,or,infected,with,HTNV,or,ANDV,at,an,MOI,of,4,for,4,days,.}	{NULL}
journal.ppat.1003470.pdf	504	{Prior,to,the,addition,of,plasma,factors,",",HUVEC,were,placed,in,serum,free,media,overnight,.}	{NULL}
journal.ppat.1003470.pdf	505	{Cells,were,washed,with,HEPES-Tyrode,’s,buffer,and,incubated,with,FXII,(,25,"nl\\\\/1",),",",PK,(,25,nM,),",",or,FXII,and,PK,",",and,S2302,(,0.8,mM,),in,the,presence,of,8,uM,Zn2,+,HEPES-Tyrode,’s,buffer,.}	{NULL}
journal.ppat.1003470.pdf	506	{Hydrolysis,of,the,chromogenic,substrate,S2302,was,measured,by,taking,absorbance,readings,at,405,nm,after,2,h,incubation,at,37,°,C.}	{NULL}
journal.ppat.1003470.pdf	507	{Statistics,ELISA,and,enzyme,activity,data,were,analyzed,using,a,Student,’s,ttest,to,determine,signiﬁcant,differences,between,mock,and,HTNV,or,mock,and,ANDV,samples,.}	{NULL}
journal.ppat.1003470.pdf	508	{P,values,<,0.05,were,considered,signiﬁcant,.}	{NULL}
journal.ppat.1003470.pdf	509	{Accession,numbers,The,following,GenBank,accession,numbers,refer,to,the,proteins,mentioned,in,the,text,:,FXII,",",AAM97932,.}	{NULL}
journal.ppat.1003470.pdf	510	{1,;,PK,",",AAF79940,.}	{NULL}
journal.ppat.1003470.pdf	511	{1,;,HK,",",AAB59551,.1,;,CTI,",",CAA37998,.1,.}	{NULL}
journal.ppat.1003470.pdf	512	{Acknowledgments}	{NULL}
journal.ppat.1003470.pdf	513	{The,following,reagent,was,obtained,through,the,NIH,Biodefense,and,Emerging,Infections,Research,Resources,Repository,",",NIAID,",",NIH,:}	{NULL}
journal.ppat.1003470.pdf	514	{References}	{NULL}
journal.ppat.1003470.pdf	515	{1,.}	{NULL}
journal.ppat.1003470.pdf	516	{Khaiboullina,SF,",",1,"\\\\",’,Iorzunov,SP,",",St,Jeor,SC,(,2005,),Hantaviruses,:,molecular,biology,",",evolution,and,pathogenesis,.}	{NULL}
journal.ppat.1003470.pdf	517	{Curr,Nfol,1,"\\\\",’,Ied,5,:,7734790,.}	{NULL}
journal.ppat.1003470.pdf	518	{2,.}	{NULL}
journal.ppat.1003470.pdf	519	{Nfuranyi,VV,",",Bahr,U,",",Zeier,1,"\\\\",’,I,",",van,der,I/Voude,FJ,(,2005,),Hantavirus,infection,.}	{NULL}
journal.ppat.1003470.pdf	520	{J,Am,Soc,Nephrol,16,:,366943679,.}	{NULL}
journal.ppat.1003470.pdf	521	{3,.}	{NULL}
journal.ppat.1003470.pdf	522	{Nfacneil,A,",",Nichol,ST,",",Spiropoulou,CF,(,2011,),Hantavirus,pulmonary,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	523	{Virus,Res,162,:,1384147,.}	{NULL}
journal.ppat.1003470.pdf	524	{4,.}	{NULL}
journal.ppat.1003470.pdf	525	{Cosgriff,"T1\\\\/I",(,1991,),1,"\\\\",’,Iechanisms,of,disease,in,Hantavirus,infection,:,pathophysiology,of,hemorrhagic,fever,with,renal,syndrome,.}	{18}
journal.ppat.1003470.pdf	526	{Rev,Infect,Dis,13,:,974107,.}	{NULL}
journal.ppat.1003470.pdf	527	{5,.}	{NULL}
journal.ppat.1003470.pdf	528	{Zaki,SR,",",Greer,PVV,",",Coflield,LIVI,",",Goldsmith,CS,",",Nolte,KB,",",et,al.,(,1995,),Hantavirus,pulmonary,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	529	{Pathogenesis,of,an,emerging,infectious,disease,.}	{NULL}
journal.ppat.1003470.pdf	530	{AmJ,Pathol,146,:,5524579,.}	{NULL}
journal.ppat.1003470.pdf	531	{6,.}	{NULL}
journal.ppat.1003470.pdf	532	{Kanerva,IVI,",",l,"\\\\",’,Iustonen,J,",",Vaheri,A,(,1998,),Pathogenesis,of,puumala,and,other,hantavirus,infections,.}	{NULL}
journal.ppat.1003470.pdf	533	{Rev,1,"\\\\",’,Ied,Virol,8,:,67486,.}	{NULL}
journal.ppat.1003470.pdf	534	{7,.}	{NULL}
journal.ppat.1003470.pdf	535	{Terajima,NI,",",Ennis,FA,(,2011,),T,cells,and,pathogenesis,of,hantavirus,cardiopulmonary,syndrome,and,hemorrhagic,fever,with,renal,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	536	{Viruses,3,:,105941073,.}	{NULL}
journal.ppat.1003470.pdf	537	{8,.}	{NULL}
journal.ppat.1003470.pdf	538	{Hammerbeck,CD,",",Hooper,JVV,(,201,1,),T,cells,are,not,required,for,pathogenesis,in,the,Syrian,hamster,model,of,hantavirus,pulmonary,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	539	{J,Virol,85,:,992949944,.}	{NULL}
journal.ppat.1003470.pdf	540	{9,.}	{NULL}
journal.ppat.1003470.pdf	541	{Gavrilovskaya,IN,",",Gorbunova,EE,",",Nfackow,NA,",",Nfackow,ER,(,2008,),Hantaviruses,direct,endothelial,cell,permeability,by,sensitizing,cells,to,the,vascular,permeability,factor,V,EGF,",",while,angiopoietin,1,and,sphingosine,1phosphate,inhibit,hantavirus-directed,permeability,.}	{NULL}
journal.ppat.1003470.pdf	542	{J,V,irol,82,:,579745806,.}	{NULL}
journal.ppat.1003470.pdf	543	{10,.}	{NULL}
journal.ppat.1003470.pdf	544	{Gorbunova,E,",",Gavrilovskaya,IN,",",1VIackow,ER,(,2010,),Pathogenic,hantaviruses,Andes,virus,and,Hantaan,virus,induce,adherens,junction,disassembly,by,directing,vascular,endothelial,cadherin,internalization,in,human,endothelial,cells,.}	{NULL}
journal.ppat.1003470.pdf	545	{J,Virol,84,:,740547411,.}	{NULL}
journal.ppat.1003470.pdf	546	{11,.}	{NULL}
journal.ppat.1003470.pdf	547	{Li,Y,",",V,"\\\\",lang,VV,",",VVang,JP,",",Pan,L,",",Zhang,Y,",",et,al.,(,2012,),Elevated,vascular,endothelial,growth,factor,levels,induce,hyperpermeability,of,endothelial,cells,in,hantavirus,infection,.}	{NULL}
journal.ppat.1003470.pdf	548	{J,Int,l,"\\\\",’,Ied,Res,40,:,181241821,.}	{NULL}
journal.ppat.1003470.pdf	549	{12,.}	{NULL}
journal.ppat.1003470.pdf	550	{Shrivastava,~,Ranjan,P,",",Rollin,PE,",",Spiropoulou,CF,(,2010,),Andes,virus,disrupts,the,endothelial,cell,barrier,by,induction,of,vascular,endothelial,growth,factor,and,downregulation,of,VE-cadherin,.}	{NULL}
journal.ppat.1003470.pdf	551	{J,Virol,84,:,1,122741,1234,.}	{NULL}
journal.ppat.1003470.pdf	552	{13,.}	{NULL}
journal.ppat.1003470.pdf	553	{Vestweber,D,(,2008,),/,',E-cadherin,:,the,major,endothelial,adhesion,molecule,controlling,cellular,junctions,and,blood,vessel,formation,.}	{NULL}
journal.ppat.1003470.pdf	554	{Arterioscler,Throml,),Vasc,Biol,28,:,2234232,.}	{NULL}
journal.ppat.1003470.pdf	555	{14,.}	{NULL}
journal.ppat.1003470.pdf	556	{Safronetz,D,",",Zivcec,1,"\\\\",’,I,",",Lacasse,R,",",Feldmann,F,",",Rosenke,R,",",et,al.,(,2011,),Pathogenesis,and,host,response,in,Syrian,hamsters,following,intranasal,infection,with,Andes,virus,.}	{NULL}
journal.ppat.1003470.pdf	557	{PLoS,Pathog,7,:,e1002426,.}	{NULL}
journal.ppat.1003470.pdf	558	{15,.}	{NULL}
journal.ppat.1003470.pdf	559	{Schmaier,AH,(,2008,),Assembly,‘,",",activation,",",and,physiologic,inﬂuence,of,the,plasma,kallikrein/kinin,system,.}	{NULL}
journal.ppat.1003470.pdf	560	{Int,Immunopharmacol,8,:,1614165,.}	{NULL}
journal.ppat.1003470.pdf	561	{16,.}	{NULL}
journal.ppat.1003470.pdf	562	{Harris,1,"\\\\",’,IB,",",Ju,H,",",Venema,VJ,",",Blackstone,IVI,",",Venema,RC,(,2000,),Role,of,heat,shock,protein,90,in,bradykinin-stimulated,endothelial,nitric,oxide,release,.}	{NULL}
journal.ppat.1003470.pdf	563	{Gen,Pharmacol,35,:,1654170,.}	{NULL}
journal.ppat.1003470.pdf	564	{17,.}	{NULL}
journal.ppat.1003470.pdf	565	{Joseph,K,",",Tholanikunnel,BG,",",Kaplan,AP,(,2002,),Heat,shock,protein,90,catalyzes,activation,of,the,prekallikrein,~,l,<,ininogen,complex,in,the,absence,of,factor,XII,.}	{NULL}
journal.ppat.1003470.pdf	566	{Proc,Natl,Acad,Sci,U,S,A,99,:,8964900,.}	{NULL}
journal.ppat.1003470.pdf	567	{18,.}	{NULL}
journal.ppat.1003470.pdf	568	{Kaplan,AP,",",Silverberg,NI,(,1987,),The,coagulation-kinin,pathway,of,human,plasma,.}	{NULL}
journal.ppat.1003470.pdf	569	{Blood,70,:,1415,.}	{NULL}
journal.ppat.1003470.pdf	570	{19,.}	{NULL}
journal.ppat.1003470.pdf	571	{Golias,C,",",Charalabopoulos,A,",",Stagikas,D,",",Charalabopoulos,K,",",Batistatou,A,(,2007,),The,kinin,system4bradyl,<,inin,:,biological,effects,and,clinical,implications,.}	{NULL}
journal.ppat.1003470.pdf	572	{Nfultiple,role,of,the,kinin,system4bradykinin,.}	{NULL}
journal.ppat.1003470.pdf	573	{Hippokratia,11,:,1244128,.}	{NULL}
journal.ppat.1003470.pdf	574	{20,.}	{NULL}
journal.ppat.1003470.pdf	575	{Giles,TD,",",Sander,GE,",",Nossaman,BD,",",Kadowitz,PJ,(,2012,),Impaired,vasodilation,in,the,pathogenesis,of,hypertension,:,focus,on,nitric,oxide,",",endothelial-derived,hyperpolarizing,factors,",",and,prostag1andins,.}	{NULL}
journal.ppat.1003470.pdf	576	{J,Clin,Hypertens,(,Greenwich,),14,:,1984205,.}	{NULL}
journal.ppat.1003470.pdf	577	{21,.}	{NULL}
journal.ppat.1003470.pdf	578	{Nfehta,D,",",1Vfalik,AB,(,2006,),Signaling,mechanisms,regulating,endothelial,permeability,.}	{NULL}
journal.ppat.1003470.pdf	579	{Physiol,Rev,86,:,2794367,.}	{NULL}
journal.ppat.1003470.pdf	580	{22,.}	{NULL}
journal.ppat.1003470.pdf	581	{Fuller,RVV,",",Dixon,"C1\\\\/I",",",Cuss,Fl,"\\\\",’,I,",",Barnes,PJ,(,1987,),Bradykinin,~,induced,bronchoconstriction,in,humans,.}	{NULL}
journal.ppat.1003470.pdf	582	{1Vfode,of,action,.}	{NULL}
journal.ppat.1003470.pdf	583	{Am,Rev,Respir,Dis,135,:,1764,180,.}	{NULL}
journal.ppat.1003470.pdf	584	{Po1yclo11a1,A11ti-Andes,Virus,",",CHI-7913,Nucleocapsid,Protein,",",NR-9673,.}	{NULL}
journal.ppat.1003470.pdf	585	{Wle,thank,Jennifer,Cann,a11d,Larry,Faucette,for,technical,assistance,of,immunohistochemistry,and,pathology,.}	{NULL}
journal.ppat.1003470.pdf	586	{W7,e,are,grateful,to,Elizabeth,Fischer,and,Vinod,Nair,for,technical,assistance,with,preparation,of,SEIVI,samples,.}	{NULL}
journal.ppat.1003470.pdf	587	{W7,e,thank,Anna,Clawson,for,translation,of,literature,andJiro,Wlada,for,the,pathway,illustration,.}	{NULL}
journal.ppat.1003470.pdf	588	{All,experiments,involving,infectious,hantaviruses,were,performed,in,a,biosafety,level,—,3,laboratory,at,USAIVIRIID,.}	{NULL}
journal.ppat.1003470.pdf	589	{Opinions,",",interpretations,",",conclusions,",",and,recommendations,are,ours,a11d,are,not,necessarily,endorsed,by,the,U.S.,Army,or,the,Department,of,Defense,.}	{NULL}
journal.ppat.1003470.pdf	590	{Author,Contributions}	{NULL}
journal.ppat.1003470.pdf	591	{Conceived,a11d,designed,the,experiments,:,SLT,V,"\\\\","\\\\",[,],CSS,.}	{NULL}
journal.ppat.1003470.pdf	592	{Performed,the,experiments,:,SLT,VWJ,AIVIC,.}	{NULL}
journal.ppat.1003470.pdf	593	{Analyzed,the,data,:,SLT,VIM,],"Al\\\\/IC",PBJ,CSS,.}	{NULL}
journal.ppat.1003470.pdf	594	{Contributed,reagents/materials/a11alysis,tools,:,SLT,V,"\\\\","\\\\",[,],PBJ,CSS,.}	{NULL}
journal.ppat.1003470.pdf	595	{Wlrote,the,paper,:,SLT,VWJ,CSS,.}	{NULL}
journal.ppat.1003470.pdf	596	{23,.}	{NULL}
journal.ppat.1003470.pdf	597	{GrangerJ,",",Remick,D,(,2005,),Acute,pancreatitis,:,models,",",markers,",",and,mediators,.}	{NULL}
journal.ppat.1003470.pdf	598	{Shock,24,Suppl,1,:,45451,.}	{NULL}
journal.ppat.1003470.pdf	599	{24,.}	{NULL}
journal.ppat.1003470.pdf	600	{Kaplan,AP,",",Joseph,K,(,2010,),The,l,),radykinin-forming,cascade,and,its,role,in,hereditary,angioedema,.}	{NULL}
journal.ppat.1003470.pdf	601	{Ann,Allergy,Asthma,Immunol,104,:,1934204,.}	{2}
journal.ppat.1003470.pdf	602	{25,.}	{NULL}
journal.ppat.1003470.pdf	603	{VVuillemin,VVA,",",Fijnvandraat,K,",",Derkx,BH,",",Peters,NI,",",Vreede,VV,",",et,al.,(,1995,),Activation,of,the,intrinsic,pathway,of,coagulation,in,children,with,meningococcal,septic,shock,.}	{NULL}
journal.ppat.1003470.pdf	604	{Thromb,Haemost,74,:,143641441,.}	{NULL}
journal.ppat.1003470.pdf	605	{26,.}	{NULL}
journal.ppat.1003470.pdf	606	{AntonenJ,",",Leppanen,I,",",TenhunenJ,",",Arvola,P,",",1,"\\\\",’,Ial,<,ela,S,",",et,al.,(,2013,),A,severe,case,of,Puumala,hantavirus,infection,successfully,treated,with,bradykinin,receptor,antagonist,icatibant,.}	{NULL}
journal.ppat.1003470.pdf	607	{ScandJ,Infect,Dis,45,:,49446,.}	{NULL}
journal.ppat.1003470.pdf	608	{27,.}	{NULL}
journal.ppat.1003470.pdf	609	{Evensen,L,",","1\\\\/Iicklem",DR,",",Blois,A,",",Berge,SV,",",Aarsaether,N,",",et,al.,(,2009,),1,"\\\\",’,Iural,cell,associated,V,EGF,is,required,for,organotypic,vessel,formation,.}	{NULL}
journal.ppat.1003470.pdf	610	{PLoS,One,4,:,c5798,.}	{NULL}
journal.ppat.1003470.pdf	611	{28,.}	{NULL}
journal.ppat.1003470.pdf	612	{Crosby,CV,",",Fleming,PA,",",Argraves,VVS,",",Corada,IVI,",",Zanetta,L,",",et,al.,(,2005,),VE,~,cadherin,is,not,required,for,the,formation,of,nascent,blood,vessels,but,acts,to,prevent,their,disassembly,.}	{NULL}
journal.ppat.1003470.pdf	613	{Blood,105,:,277142776,.}	{NULL}
journal.ppat.1003470.pdf	614	{29,.}	{NULL}
journal.ppat.1003470.pdf	615	{Zhang,JC,",",Claffey,K,",",Sakthivel,R,",",Darzynkiewicz,Z,",",Shaw,DE,",",et,al.,(,2000,),Two,—,chain,high,molecular,weight,kininogen,induces,endothelial,cell,apoptosis,and,inhibits,angiogenesis,:,partial,activity,within,domain,5,.}	{NULL}
journal.ppat.1003470.pdf	616	{FASEBJ,14,:,25894,2600,.}	{NULL}
journal.ppat.1003470.pdf	617	{30,.}	{NULL}
journal.ppat.1003470.pdf	618	{Nfaurer,NI,",",Bader,NI,",",Bas,IVI,",",Bossi,F,",",Cicardi,l,"\\\\",’,I,",",et,al.,(,2011,),New,topics,in,bradykinin,research,.}	{NULL}
journal.ppat.1003470.pdf	619	{Allergy,66,:,139741406,.}	{NULL}
journal.ppat.1003470.pdf	620	{31,.}	{NULL}
journal.ppat.1003470.pdf	621	{Riethmuller,C,",",Jungrnann,P,",",VVegener,J,",",Oberleithner,H,(,2006,),Bradykinin,shifts,endothelial,fluid,passage,from,para,»,to,transcellular,routes,.}	{NULL}
journal.ppat.1003470.pdf	622	{Pflugers,Arch,453,:,1574165,.}	{NULL}
journal.ppat.1003470.pdf	623	{32,.}	{NULL}
journal.ppat.1003470.pdf	624	{Shariat,~,l,"\\\\",’,Iadar,Z,",",l,"\\\\",’,Iahdi,F,",",Schmaier,AH,(,2002,),Assembly,and,activation,of,the,plasma,kallikrein/kinin,system,:,a,new,interpretation,.}	{NULL}
journal.ppat.1003470.pdf	625	{Int,Immunopharmacol,2,:,184141849,.}	{NULL}
journal.ppat.1003470.pdf	626	{33,.}	{NULL}
journal.ppat.1003470.pdf	627	{Triggle,CR,",",Samuel,SKI,",",Ravishankar,S,",",l,"\\\\",’,Iarei,I,",",Arunachalam,G,",",et,al.,(,2012,),The,endothelium,:,influencing,vascular,smooth,muscle,in,many,ways,.}	{NULL}
journal.ppat.1003470.pdf	628	{CanJ,Physiol,Pharmacol,90,:,7134738,.}	{NULL}
journal.ppat.1003470.pdf	629	{34,.}	{NULL}
journal.ppat.1003470.pdf	630	{Kimura,H,",",Esumi,H,(,2003,),Reciprocal,regulation,between,nitric,oxide,and,vascular,endothelial,growth,factor,in,angiogenesis,.}	{NULL}
journal.ppat.1003470.pdf	631	{Acta,Biochim,P01,50,:,49459,.}	{NULL}
journal.ppat.1003470.pdf	632	{35,.}	{NULL}
journal.ppat.1003470.pdf	633	{Sriskandan,S,",",CohenJ,(,2000,),Kallikrein-kinin,system,activation,in,streptococcal,toxic,shock,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	634	{Clin,Infect,Dis,30,:,9614962,.}	{NULL}
journal.ppat.1003470.pdf	635	{36,.}	{NULL}
journal.ppat.1003470.pdf	636	{Nickel,KF,",",Renne,T,(,2012,),lrosstalk,of,the,plasma,contact,system,with,bacteria,.}	{NULL}
journal.ppat.1003470.pdf	637	{Thromb,Res,130,Suppl,1,:,S78483,.}	{NULL}
journal.ppat.1003470.pdf	638	{37,.}	{NULL}
journal.ppat.1003470.pdf	639	{Kannemeier,C,",",Shibamiya,A,",",Nakazawa,F,",",Trusheim,H,",",Ruppert,C,",",et,al.,(,2007,),Extracellular,RNA,constitutes,a,natural,procoagulant,cofactor,in,blood,coagulation,.}	{NULL}
journal.ppat.1003470.pdf	640	{Proc,Natl,Acad,Sci,U,S,A,104,:,638846393,.}	{NULL}
journal.ppat.1003470.pdf	641	{38,.}	{NULL}
journal.ppat.1003470.pdf	642	{Nfaas,C,",",Govers,~,Riems1agJVV,",",Bouma,B,",",Schiks,B,",",Hazenl,),erg,BP,",",et,al.,(,2008,),Nfisfolded,proteins,activate,factor,XII,in,humans,",",leading,to,kallikrein,formation,without,initiating,coagulation,.}	{NULL}
journal.ppat.1003470.pdf	643	{J,Clin,Invest,118,:,320843218,.}	{NULL}
journal.ppat.1003470.pdf	644	{39,.}	{NULL}
journal.ppat.1003470.pdf	645	{Renne,T,",",Schuh,K,",",1Vfu11er,~,Esterl,VV,(,2005,),Local,bradykinin,formation,is,controlled,by,g1ycosaminoglycans,.}	{NULL}
journal.ppat.1003470.pdf	646	{J,Immunol,175,:,337743385,.}	{NULL}
journal.ppat.1003470.pdf	647	{40,.}	{NULL}
journal.ppat.1003470.pdf	648	{Gershom,ES,",",Sutherland,l,"\\\\",’,IR,",",Lollar,P,",",Pryzdial,EL,(,2010,),Involvement,of,the,contact,phase,and,intrinsic,pathway,in,herpes,simplex,virus,—,initiated,plasma,coagulation,.}	{NULL}
journal.ppat.1003470.pdf	649	{J,Thromb,Haemost,8,:,103741043,.}	{NULL}
journal.ppat.1003470.pdf	650	{41,.}	{NULL}
journal.ppat.1003470.pdf	651	{Longhurst,H,",",Cicardi,l,"\\\\",’,I,(,2012,),Hereditary,angio-oedema,.}	{NULL}
journal.ppat.1003470.pdf	652	{Lancet,379,:,4744}	{NULL}
journal.ppat.1003470.pdf	653	{42,.}	{NULL}
journal.ppat.1003470.pdf	654	{Caballero,T,(,2012,),Efficacy,Assessments,in,Randomized,Controlled,Studies,of}	{NULL}
journal.ppat.1003470.pdf	655	{Acute,Therapy,for,Hereditary,Angioedema,.}	{NULL}
journal.ppat.1003470.pdf	656	{J,Clin,Immunol,32,:,1204412,.}	{NULL}
journal.ppat.1003470.pdf	657	{43,.}	{NULL}
journal.ppat.1003470.pdf	658	{Kaplan,AP,",",Ghebrehiwet,B,(,2010,),The,plasma,bradykinin,~,forming,pathways,and,its,interrelationships,with,complement,.}	{NULL}
journal.ppat.1003470.pdf	659	{1,"\\\\",’,Iol,Immunol,47,:,216142169,.}	{NULL}
journal.ppat.1003470.pdf	660	{44,.}	{NULL}
journal.ppat.1003470.pdf	661	{Joseph,K,",",Shibayama,Y,",",Ghebrehiwet,B,",",Kaplan,AP,(,2001,),Factor,XII,»,dependent,contact,activation,on,endothelial,cells,and,binding,proteins,gC1qR,and,cytokeratin,1,.}	{NULL}
journal.ppat.1003470.pdf	662	{Throml,),Haemost,85,:,1194124,.}	{NULL}
journal.ppat.1003470.pdf	663	{45,.}	{NULL}
journal.ppat.1003470.pdf	664	{Stavrou,E,",",Schmaier,AH,(,2010,),Factor,XII,:,what,does,it,contribute,to,our,understanding,of,the,physiology,and,pathophysiology,of,hemostasis,&,thrombosis,.}	{NULL}
journal.ppat.1003470.pdf	665	{Thromb,Res,125,:,2104215,.}	{NULL}
journal.ppat.1003470.pdf	666	{i,"\\\\",Iahdi,F,",",l,"\\\\",’,Iadar,ZS,",",Figueroa,CD,",",Schmaier,AH,(,2002,),Factor,Xll,interacts,with,the,multiprotein,assembly,of,urokinase,plasminogen,activator,receptor,",",gClqR,",",and,cytokeratin,l,on,endothelial,cell,membranes,.}	{NULL}
journal.ppat.1003470.pdf	667	{Blood,99,:,358543596,.}	{NULL}
journal.ppat.1003470.pdf	668	{Sidel,’n,ikoV,lu,N,",",Obukhova,CG,(,1990,),[,The,role,of,biologically,active,substances,in,permeability,changes,in,the,blood,Vessels,of,patients,with,hemorrhagic,fever,with,renal,syndrome,],.}	{NULL}
journal.ppat.1003470.pdf	669	{Ter,Arkh,62,:,66,*,68,.}	{NULL}
journal.ppat.1003470.pdf	670	{Fedorehenko,lu,L,",",Sirotin,BZ,",",Rozhkovskaia,EN,(,1990,),[,Vascular,permeability,",",microcireulation,and,biologically,active,substances,in,patients,with,hemorrhagic,fever,with,renal,syndrome,],.}	{NULL}
journal.ppat.1003470.pdf	671	{Ter,Arkh,62,:,7l,—,74,.}	{NULL}
journal.ppat.1003470.pdf	672	{Aasen,Ao,",",Erichsen,NS,",",Gallimore,"l\\\\/I",],",",Amundsen,E,(,l980,),Studies,on,components,of,the,plasma,kallikrein,~,l,<,inin,system,in,plasma,samples,from,normal,individuals,and,patients,with,septic,shock,.}	{NULL}
journal.ppat.1003470.pdf	673	{Adv,Shock,Res,4,:,l,—,lo,.}	{NULL}
journal.ppat.1003470.pdf	674	{Castillo,C,",",Naranjo,J,",",Sepulveda,A,",",Ossa,G,",",Lexy,H,(,2001,),Hantavirus,pulmonary,syndrome,due,to,Andes,virus,in,Temuco,",",Chile,:,clinical,experience,with,l6,adults,.}	{NULL}
journal.ppat.1003470.pdf	675	{Chest,l20,:,548,*,554,.}	{NULL}
journal.ppat.1003470.pdf	676	{Safronetz,D,",",Ebihara,H,",",Feldmann,H,",",Hooper,"\\\\",],"\\\\",/,V,(,2012,),The,Syrian,hamster,model,of,hantavirus,pulmonary,syndrome,.}	{NULL}
journal.ppat.1003470.pdf	677	{Antiviral,Res,95,:,282,—,292,.}	{NULL}
journal.ppat.1003470.pdf	678	{VVahl-Jensen,V,’,",",Chapman,J,",",Asher,L,",",Fisher,R,",",Zimmerman,l,"\\\\",’,I,",",et,al.,(,2007,),Temporal,analysis,of,Andes,Virus,and,Sin,Nombre,Virus,infections,of,Syrian,hamsters,.}	{NULL}
journal.ppat.1003470.pdf	679	{J,Virol,81,:,7449,*,7462,.}	{NULL}
journal.ppat.1003470.pdf	680	{Lee,HVV,",",Lee,PVV,",",Johnson,Kl,"\\\\",’,I,(,l978,),Isolation,of,the,etiologic,agent,ofKorean,Hemorrhagic,feVer,.}	{21}
journal.ppat.1003470.pdf	681	{J,Infect,Dis,137,:,2984508,.}	{NULL}
SCPDFS_1158.pdf	1	{Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	2	{DEW-ZLOPMENTAL,BIOLOGY}	{NULL}
SCPDFS_1158.pdf	3	{Contents,lists,available,at,ScienceDirect}	{NULL}
SCPDFS_1158.pdf	4	{Developmental,Biology}	{NULL}
SCPDFS_1158.pdf	5	{",",_,ELSEVIE}	{NULL}
SCPDFS_1158.pdf	6	{journal,homepage,:,www,.}	{NULL}
SCPDFS_1158.pdf	7	{e,|,sevier.com/Iocate/developmentalbiology}	{NULL}
SCPDFS_1158.pdf	8	{Abnormal,differentiation,of,dopaminergic,neurons,in,zebraﬁsh,trpm7,mutant,larvae,impairs,development,of,the,motor,pattern}	{NULL}
SCPDFS_1158.pdf	9	{©,CrossMark}	{NULL}
SCPDFS_1158.pdf	10	{Amanda,R.,Decker,“,',1,",",Matthew,S.,McNeillb,',1,",",Aaron,M.,Lambert,C,",",Jeffrey,D.,Overton,d,",",Yu-Chia,Chen,e,",",Ramon,A.,Lorca,f,",",Nicolas,A.,Johnson,3,",",Susan,E.,Brockerhoffg,",",Durga,P.,Mohapatraf,",",Heather,MacArthur,“,",",Pertti,Panula,e,",",Mark,A.,Masino,C,",",Loren,W.,Runnels,d,",",Robert,A.,Cornell,"\\"",',b,',*}	{NULL}
SCPDFS_1158.pdf	11	{3,Department,of,Anatomy,and,Cell,Biology,.}	{NULL}
SCPDFS_1158.pdf	12	{University,of,Iowa,",",Iowa,City,",",IA,52242,",",United,States,blnterdisciplinary,Graduate,Program,in,Neuroscience,",",University,of,Iowa,",",Iowa,City,",",IA,52242,",",United,States,‘,Department,of,Neuroscience,",",University,of,Minnesota,",",Minneapolis,.}	{NULL}
SCPDFS_1158.pdf	13	{MN,55455,",",United,States,d,UMDNj,.}	{NULL}
SCPDFS_1158.pdf	14	{—,.}	{NULL}
SCPDFS_1158.pdf	15	{Robert,Wood,johnson,Medical,School,",",Piscataway,",",NJ,08854,",",United,States,9,Neuroscience,Center,and,Institute,of,Biomedicine/Anatomy,",",University,of,Helsinki,",",Helsinki,",",Finland,',Department,of,Pharmacology,",",University,of,Iowa,.}	{NULL}
SCPDFS_1158.pdf	16	{Iowa,City,",",IA,52245,",",United,States,E,Department,of,Biochemistry,",",University,of,Washington,",",Seattle,.}	{NULL}
SCPDFS_1158.pdf	17	{WA,98195,",",United,States,"\\"",Department,of,Pharmacological,and,Physiological,Science,",",St.,Louis,University,",",St.,Louis,",",MO,63104,",",United,States}	{NULL}
SCPDFS_1158.pdf	18	{ARTICLEINFO,ABSTRACT}	{NULL}
SCPDFS_1158.pdf	19	{Article,history,:,Received,9,July,2013,Received,in,revised,form,1,November,2013,Accepted,12,November,2013,Available,online,27,November,2013}	{NULL}
SCPDFS_1158.pdf	20	{Transient,receptor,potential,",",melastatin,—,like,7,(,Trpm7,),is,a,combined,ion,channel,and,kinase,implicated,in,the,differentiation,or,function,of,many,cell,types,.}	{NULL}
SCPDFS_1158.pdf	21	{Early,lethality,in,mice,and,frogs,depleted,of,the,corresponding,gene,impedes,investigation,of,the,functions,of,this,protein,particularly,during,later,stages,of,development,.}	{NULL}
SCPDFS_1158.pdf	22	{By,contrast,",",zebraﬁsh,trpm7,mutant,larvae,undergo,early,morphogenesis,normally,and,thus,do,not,have,this,limitation,.}	{NULL}
SCPDFS_1158.pdf	23	{The,mutant,larvae,are,characterized,by,multiple,defects,including,melanocyte,cell,death,",",transient,paralysis,",",and,an,ion,imbalance,that,leads,to,the,development,of,kidney,Keywords,:,stones,.}	{NULL}
SCPDFS_1158.pdf	24	{Here,we,report,a,requirement,for,Trpm7,in,differentiation,or,function,of,dopaminergic,neurons,P3,”“,“,5,°,“,5,in,vivo,.}	{NULL}
SCPDFS_1158.pdf	25	{First,",",trpm7,mutant,larvae,are,hypomotile,and,fail,to,make,a,dopamine,—,dependent,developgzbr,:,:15,i,:,e,mental,transition,in,swim,—,bout,length,.}	{NULL}
SCPDFS_1158.pdf	26	{Both,of,these,deﬁcits,are,partially,rescued,by,the,application,of,TRIEM7,levodopa,or,dopamine,.}	{NULL}
SCPDFS_1158.pdf	27	{Second,",",histological,analysis,reveals,that,in,trpm7,mutants,a,signiﬁcant,fraction,of,dopaminergic,neurons,lack,expression,of,tyrosine,hydroxylase,",",the,rate,—,limiting,enzyme,in,dopamine,synthesis,.}	{NULL}
SCPDFS_1158.pdf	28	{Third,",",trpm7,mutants,are,unusually,sensitive,to,the,neurotoxin,1,—,methyl,—,4,—,phenylpyridinium,",",an,oxidative,stressor,",",and,their,motility,is,partially,rescued,by,application,of,the,iron,chelator,deferoxamine,",",an,anti,—,oxidant,.}	{NULL}
SCPDFS_1158.pdf	29	{Finally,",",in,SH,.}	{NULL}
SCPDFS_1158.pdf	30	{—,.}	{NULL}
SCPDFS_1158.pdf	31	{SY5Y,cells,",",which,model,aspects,of,human,dopaminergic,neurons,",",forced,expression,of,a,channel,—,dead,variant,of,TRPM7,causes,cell,death,.}	{NULL}
SCPDFS_1158.pdf	32	{In,summary,",",a,forward,genetic,screen,in,zebraﬁsh,has,revealed,that,both,melanocytes,and,dopaminergic,neurons,depend,on,the,ion,channel,Trpm7,.}	{NULL}
SCPDFS_1158.pdf	33	{The,mechanistic,underpinning,of,this,dependence,requires,further,investigation,.}	{NULL}
SCPDFS_1158.pdf	34	{©,2013,Elsevier,Inc.,.}	{NULL}
SCPDFS_1158.pdf	35	{All,rights,reserved,.}	{NULL}
SCPDFS_1158.pdf	36	{Introduction,Trpm7,in,mice,indicates,that,Trpm7,is,essential,for,the,terminal}	{NULL}
SCPDFS_1158.pdf	37	{Transient,receptor,potential,melastatin,—,like,7,(,TRPM7,),",",a,widely,—,expressed,divalent,—,cation,channel,with,intrinsic,kinase,activity,",",has,cell,—,type,—,and,context,—,dependent,roles,in,cell,survival,and,physiology,.}	{NULL}
SCPDFS_1158.pdf	38	{Mouse,and,frog,embryos,depleted,of,the,Trpm7,gene,die,during,early,morphogenesis,(,Jin,et,al.,",",2008,;,Liu,et,al.,",",2011b,;,Ryazanova,et,al.,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	39	{Cell,—,lineage,—,speciﬁc,deletion,of}	{NULL}
SCPDFS_1158.pdf	40	{*,Corresponding,author,.}	{NULL}
SCPDFS_1158.pdf	41	{Fax,:,+1,"319 335 7198",.}	{NULL}
SCPDFS_1158.pdf	42	{E,—,mail,address,:,robert—cornell@uiowa.edu,(,R.A.,Cornell,),.}	{NULL}
SCPDFS_1158.pdf	43	{1,Equal,contribution,.}	{NULL}
SCPDFS_1158.pdf	44	{0012-1606,/,$,.}	{NULL}
SCPDFS_1158.pdf	45	{—,.}	{NULL}
SCPDFS_1158.pdf	46	{see,front,matter,©,2013,Elsevier,Inc.,.}	{NULL}
SCPDFS_1158.pdf	47	{All,rights,reserved,.}	{NULL}
SCPDFS_1158.pdf	48	{http://dx.doi.org/10.1016/j.ydbio.2013.11.015}	{NULL}
SCPDFS_1158.pdf	49	{differentiation,of,thymocytes,and,of,certain,neural,—,crest,derivatives,",",including,melanocytes,and,sensory,neurons,(,Jin,et,al.,",",2008,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	50	{Studies,in,cell,lines,or,primary,cells,in,vitro,have,suggested,roles,for,TRPM7,in,Mg2,+,homeostasis,(,Chubanov,et,al.,",",2004,;,Nadler,et,al.,",",2001,),",",cell,proliferation,(,I-lanano,et,al.,",",2004,),",",cell,adhesion,(,Su,et,al.,",",2006,),",",and,cholinergic,synaptic,transmission,(,Krapivinsky,et,al.,",",2006,),.}	{NULL}
SCPDFS_1158.pdf	51	{The,lack,of,TRPM7,causes,cell,—,death,due,to,a,disruption,of,magnesium,homeostasis,in,some,cell,lines,(,Kim,et,al.,",",2008,;,Nadler,et,al.,",",2001,),.}	{NULL}
SCPDFS_1158.pdf	52	{Conversely,",",its,presence,appears,to,sensitize,at,least,one,cell,type,to,zinc,—,ion,poisoning,(,Inoue,et,al.,",",2010,),",",and,the,reduction,of,TRPM7,expression,in,ﬁbroblasts,decreased,markers,of,oxidative,stress,and,increased,cellular}	{NULL}
SCPDFS_1158.pdf	53	{A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-439 429"}	{NULL}
SCPDFS_1158.pdf	54	{resistance,to,apoptotic,stimuli,(,Chen,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	55	{Moreover,",",when,extracellular,levels,of,divalent,cations,drop,below,normal,physiological,levels,TRPM7,permits,an,inﬂux,of,Ca2,+,which,may,contribute,to,excitotoxicity,(,Aarts,et,al.,",",2003,;,Sun,et,al.,",",2009,;,Wei,et,al.,",",2007,),.}	{NULL}
SCPDFS_1158.pdf	56	{Supporting,this,model,",",reduction,of,Trpm7,expression,in,the,rat,hippocampus,was,found,to,lessen,the,amount,of,neuronal,cell,death,caused,by,ischemia,(,Sun,et,al.,",",2009,),.}	{NULL}
SCPDFS_1158.pdf	57	{In,summary,",",studies,in,cell,lines,and,limited,tissue,speciﬁc,knock,—,outs,in,rodents,indicate,that,the,physiological,role,for,TRPM7,is,cell,—,type,dependent,.}	{NULL}
SCPDFS_1158.pdf	58	{Additional,roles,for,Trpm7,in,vertebrate,development,were,uncovered,through,forward,genetics,in,zebraﬁsh,.}	{NULL}
SCPDFS_1158.pdf	59	{Independent,screens,for,mutations,that,disrupt,melanophore,development,",",early,motility,",",or,adult,growth,each,identiﬁed,trpm7,mutants,(,Arduini,and,Henion,",",2004,;,Cornell,et,al.,",",2004,;,Elizondo,et,al.,",",2005,;,Kelsh,et,al.,",",1996,;,Low,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	60	{In,trpm7,loss,—,of,—,function,mutants,",",embryonic,melanophores,(,the,melanin,—,producing,cells,of,ﬁsh,),succumb,to,cell,death,(,Arduini,and,Henion,",",2004,;,Cornell,et,al.,",",2004,),",",and,the,melanosomes,(,the,organelles,that,conﬁne,melanin,),are,structurally,abnormal,(,McNeill,et,al.,",",2007,),.}	{NULL}
SCPDFS_1158.pdf	61	{Because,Trpm7,is,required,within,melanophores,(,Arduini,and,Henion,",",2004,;,Cornell,et,al.,",",2004,),",",the,melanophore,cell,—,death,in,trpm7,mutants,may,result,from,the,release,of,toxic,intermediates,of,melanin,synthesis,into,the,cytoplasm,(,Hochstein,and,Cohen,",",1963,;,McNeil,],et,al.,",",2007,;,Pawelek,and,Lerner,",",1977,),.}	{NULL}
SCPDFS_1158.pdf	62	{Additionally,",",trpm7,mutant,larvae,are,unresponsive,to,touch,for,a,period,of,about,12,h,during,development,(,Arduini,and,Henion,",",2004,;,Cornell,et,al.,",",2004,;,Kelsh,et,al.,",",1996,;,Low,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	63	{This,phenotype,can,be,alleviated,by,forcing,the,expression,of,trpm7,in,primary,sensory,neurons,",",implying,that,Trpm7,is,required,transiently,for,function,or,differentiation,of,embryonic,primary,sensory,neurons,(,Low,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	64	{Finally,",",global,homeostasis,of,divalent,cations,including,calcium,and,magnesium,is,abnormal,in,trpm7,mutant,larvae,leading,to,aberrant,calciﬁcation,of,developing,bones,.}	{NULL}
SCPDFS_1158.pdf	65	{This,suggests,a,function,for,Trpm7,in,the,l,<,idney,—,associated,Corpuscle,of,Stannius,where,it,is,highly,expressed,(,Elizondo,et,al.,",",2005,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	66	{Consistent,with,conservation,of,Trpm7,function,at,least,in,some,tissues,",",trpm7,mutant,larvae,exhibit,bradycardia,and,mice,with,depletion,of,Trpm7,in,cardiac,myocytes,exhibit,arrythmia,(,Arduini,and,Henion,",",2004,;,Sah,et,al.,",",2013,),.}	{NULL}
SCPDFS_1158.pdf	67	{Analysis,of,zebraﬁsh,trpm7,mutant,larvae,has,complemented,mammalian,studies,.}	{NULL}
SCPDFS_1158.pdf	68	{Here,we,report,additional,analyses,of,a,zebraﬁsh,trpm7,mutant,and,describe,the,consequences,to,a,human,dopaminergic,cell,—,line,of,reducing,TRPM7,activity,.}	{NULL}
SCPDFS_1158.pdf	69	{We,identify,behavioral,and,developmental,defects,in,trpm7,mutants,that,can,be,partially,reversed,by,exogenous,dopamine,.}	{NULL}
SCPDFS_1158.pdf	70	{Further,we,ﬁnd,abnormal,gene,expression,",",and,increased,sensitivity,to,a,toxin,",",in,dopaminergic,neurons,of,such,mutants,.}	{NULL}
SCPDFS_1158.pdf	71	{Dominant,negative,interference,with,TRPM7,causes,death,of,the,human,dopaminergic,cell,line,",",suggesting,a,conserved,role,for,TRPM7,in,dopaminergic,neurons,.}	{NULL}
SCPDFS_1158.pdf	72	{In,summary,",",the,result,of,a,forward,genetic,screen,in,zebraﬁsh,has,identiﬁed,a,previously,unrecognized,genetic,requirement,for,Trpm7,in,function,and,possibly,survival,of,dopaminergic,neurons,.}	{NULL}
SCPDFS_1158.pdf	73	{Methods}	{NULL}
SCPDFS_1158.pdf	74	{Fish,and,embryo,rearing}	{NULL}
SCPDFS_1158.pdf	75	{All,standard,animal,protocols,were,approved,by,the,Institutional,Animal,Care,and,Use,Committee,",",and,comply,with,USDA,laws,as,well,as,PHS,Guidelines,.}	{NULL}
SCPDFS_1158.pdf	76	{Zebraﬁsh,progeny,and,adults,were,reared,under,supervision,of,the,University,of,Iowa,Animal,Care,Unit,",",at,27.5,“,C,on,a,normal,illumination,cycle,(,i.e.,",",14,h,light,",",10,h,dark,),unless,otherwise,noted,.}	{NULL}
SCPDFS_1158.pdf	77	{Embryos,were,generated,and,handled,following,standard,methods,(,Westerﬁeld,",",1993,),",",and,staged,by,hours,post,fertilization,(,hpf,),at,28.5,°,C,(,Kimmel,et,al.,",",1995,),.}	{NULL}
SCPDFS_1158.pdf	78	{The,highly,penetrant,trpm7b5,°,8,(,Elizondo,et,al.,",",2005,),",",and,mitfawz,(,Lister,et,al.,",",1999,),alleles,were,used,for,all,experiments,.}	{NULL}
SCPDFS_1158.pdf	79	{Until,the,beginning,of,each,experiment,",",all,ﬁsh,were,raised,in,ﬁsh,water,(,distilled,water,further,puriﬁed,by,reverse,osmosis,and,then,supplemented,with,0.30,g,Crystal,Seal,"\\"",(,Marinemix,),(,Marine,Enterprises,International,;,Baltimore,",",MD,),per,liter,),.}	{NULL}
SCPDFS_1158.pdf	80	{Motility,assay,.}	{NULL}
SCPDFS_1158.pdf	81	{Motility,was,monitored,using,ZebraBox,and,Viewpoint,software,(,version,"3,10,0,42",;,Viewpoint,Life,Sciences,",",lnc.,;,Montreal,",",Quebec,",",Canada,),under,infrared,light,.}	{NULL}
SCPDFS_1158.pdf	82	{Larvae,were,exposed,to,alternating,cycles,of,light,and,dark,",",invisible,to,the,camera,",",every,30,min,as,described,(,Emran,et,al.,",",2008,),;,each,light,transition,took,approximately,1,ms.,A,96-well,plates,(,Costar,),were,used,for,all,experiments,.}	{NULL}
SCPDFS_1158.pdf	83	{At,4,days,post,fertilization,(,dpf,),",",larvae,were,singly,placed,in,wells,with,300,pl,of,ﬁsh,water,.}	{NULL}
SCPDFS_1158.pdf	84	{Larvae,were,placed,into,a,28.5,“,C,incubator,on,a,normal,light,cycle,overnight,.}	{NULL}
SCPDFS_1158.pdf	85	{All,experiments,were,completed,in,a,quiet,room,at,5,dpf,",",between,10,AM,and,2,PM,.}	{NULL}
SCPDFS_1158.pdf	86	{Larvae,were,allowed,to,acclimate,in,the,Zebrabox,measurement,apparatus,for,2h,before,recording,began,.}	{NULL}
SCPDFS_1158.pdf	87	{Larval,locomotion,was,tracked,with,ViewPoint,software,.}	{NULL}
SCPDFS_1158.pdf	88	{We,deﬁned,motility,as,tracks,moving,less,than,10,cm/s,but,more,than,0.1,cm,/,5,.}	{NULL}
SCPDFS_1158.pdf	89	{Location,and,distance,traveled,were,recorded,and,binned,every,5,min,as,presented,in,Fig,.}	{NULL}
SCPDFS_1158.pdf	90	{2,.}	{NULL}
SCPDFS_1158.pdf	91	{Cultured,melanocytes}	{NULL}
SCPDFS_1158.pdf	92	{The,30,hpf,control,embryos,",",deﬁned,as,the,wild,—,type,and,heterozygous,mutant,siblings,of,trpm7,homozygous,mutants,",",and,trpm7,homozygous,mutant,embryos,(,hereafter,",",trpm7,mutants,),",",identiﬁed,by,the,strong,reduction,of,cutaneous,melanocytes,",",were,transferred,to,calcium,—,free,medium,supplemented,with,0.05,%,trypsin,and,5,mM,EDTA,",",crushed,with,a,plastic,pestle,",",incubated,at,33,°,C,",",and,gently,triturated,every,10,min,for,30,min,.}	{NULL}
SCPDFS_1158.pdf	93	{Cultures,were,gently,spun,",",the,supernatant,discarded,",",and,the,tissue,pellet,resuspended,in,cell,medium,.}	{NULL}
SCPDFS_1158.pdf	94	{Cells,were,cultured,overnight,at,30,°,C,",",and,electrophysiology,carried,out,at,room,temperature,(,RT,),the,next,morning,.}	{NULL}
SCPDFS_1158.pdf	95	{Cell,medium,",",adapted,from,(,Badakov,and,jazwinska,",",2006,),",",is,DMEM,(,Gibco,",",lnvitrogen,",",Carlsbad,",",CA,),supplemented,with,15,%,(,v/v,),fetal,bovine,serum,(,FBS,;,Atlanta,Biologicals,",",Lawrenceville,",",GA,),",",100,units/ml,penicillin,(,Gibco,),",",100,mg/ml,streptomycin,(,Gibco,),",",1,%,(,v/v,),trout,serum,(,Seagrow,",",product,],],80,",",East,Coast,Biologicals,",",North,Berwick,",",ME,),",",20,ng/ml,bovine,insulin,(,Sigma,",",St.,Louis,",",MO,),",",50,ng/ml,basic,ﬁbroblast,growth,factor,(,Sigma,),",",62.5,pg/ml,ampicillin,",",25,ng/ml,epidermal,growth,factor,(,Sigma,),",",1,%,embryo,extract,.}	{NULL}
SCPDFS_1158.pdf	96	{100,%,embryo,extract,consists,of,200,embryos,at,3,dpf,rinsed,in,0.5,%,bleach,for,2min,then,rinsed,in,calcium,—,free,Ringer,'s,solution,(,deﬁned,in,(,Westerﬁeld,",",1993,),),for,2,min,;,the,embryos,were,homogenized,without,liquid,and,suspended,in,1,ml,of,cell,medium,without,fetal,bovine,serum,(,FBS,),.}	{NULL}
SCPDFS_1158.pdf	97	{Cell,culture,and,adenoviruses}	{NULL}
SCPDFS_1158.pdf	98	{The,293,.}	{NULL}
SCPDFS_1158.pdf	99	{—,.}	{NULL}
SCPDFS_1158.pdf	100	{TRPM7,cell,line,was,employed,to,express,hemagglu,—,tinin,(,HA,),.}	{NULL}
SCPDFS_1158.pdf	101	{—,.}	{NULL}
SCPDFS_1158.pdf	102	{tagged,murine,TRPM7,and,has,been,previously,described,(,Su,et,al.,",",2006,),.}	{NULL}
SCPDFS_1158.pdf	103	{293,.}	{NULL}
SCPDFS_1158.pdf	104	{—,.}	{NULL}
SCPDFS_1158.pdf	105	{TRPM7,cells,were,cultured,in,Dulbecco,'s,Modiﬁed,Eagle,Medium,(,D,.}	{NULL}
SCPDFS_1158.pdf	106	{—,.}	{NULL}
SCPDFS_1158.pdf	107	{MEM,),with,10,%,FBS,.}	{NULL}
SCPDFS_1158.pdf	108	{The,overexpression,of,HA,—,tagged,TRPM7,in,293,.}	{NULL}
SCPDFS_1158.pdf	109	{—,.}	{NULL}
SCPDFS_1158.pdf	110	{TRPM7,cells,was,induced,by,the,addition,of,tetracycline,(,1,pg/ml,),to,the,growth,medium,for,24,h.,To,assess,the,dominant,—,negative,potential,of,the,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	111	{—,.}	{NULL}
SCPDFS_1158.pdf	112	{E1047l,(,pore,mutant,(,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	113	{—,.}	{NULL}
SCPDFS_1158.pdf	114	{DN,),",",293,.}	{NULL}
SCPDFS_1158.pdf	115	{—,.}	{NULL}
SCPDFS_1158.pdf	116	{TRPM7,cells,were,treated,with,tetracycline,and,transiently,transfected,with,pcDNA5,/,FRT/TO,.}	{NULL}
SCPDFS_1158.pdf	117	{—,.}	{NULL}
SCPDFS_1158.pdf	118	{HA,.}	{NULL}
SCPDFS_1158.pdf	119	{—,.}	{NULL}
SCPDFS_1158.pdf	120	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	121	{—,.}	{NULL}
SCPDFS_1158.pdf	122	{E1047l,<,",",which,has,been,previously,described,(,Li,et,al.,",",2007,),.}	{NULL}
SCPDFS_1158.pdf	123	{SH,.}	{NULL}
SCPDFS_1158.pdf	124	{—,.}	{NULL}
SCPDFS_1158.pdf	125	{SY5Y,cells,were,maintained,in,D,.}	{NULL}
SCPDFS_1158.pdf	126	{—,.}	{NULL}
SCPDFS_1158.pdf	127	{MEM/F,-12,with,10,%,FBS,and,5,%,horse,serum,",",and,were,differentiated,in,complete,medium,with,10,uM,retinoic,acid,(,RA,),",",as,previously}	{NULL}
SCPDFS_1158.pdf	128	{430,A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	129	{described,with,the,following,modiﬁcations,(,Cheung,et,al.,",",2009,),.}	{NULL}
SCPDFS_1158.pdf	130	{SH,.}	{NULL}
SCPDFS_1158.pdf	131	{—,.}	{NULL}
SCPDFS_1158.pdf	132	{SY5Y,cells,were,placed,in,differentiation,medium,for,3,days,prior,to,viral,transduction,.}	{NULL}
SCPDFS_1158.pdf	133	{After,the,recombinant,adenoviruses,were,applied,at,a,multiplicity,of,infection,(,M.O.l.,),of,30,",",cells,were,cultured,in,differentiation,medium,for,another,3,days,unless,otherwise,speciﬁed,.}	{NULL}
SCPDFS_1158.pdf	134	{Cell,viability,was,quantiﬁed,by,manual,cell,counting,and,trypan,blue,exclusion,.}	{NULL}
SCPDFS_1158.pdf	135	{The,recombinant,adenoviruses,expressing,LacZ,and,GFP,have,been,previously,described,(,Su,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	136	{The,recombinant,adenovirus,expressing,TRPM7,—,DN,was,engineered,as,follows,.}	{NULL}
SCPDFS_1158.pdf	137	{First,",",the,Afel/Bglll,fragment,from,pcDNA5/FRT/TO,.}	{NULL}
SCPDFS_1158.pdf	138	{—,.}	{NULL}
SCPDFS_1158.pdf	139	{HA,.}	{NULL}
SCPDFS_1158.pdf	140	{—,.}	{NULL}
SCPDFS_1158.pdf	141	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	142	{—,.}	{NULL}
SCPDFS_1158.pdf	143	{E1047K,was,exchanged,with,the,Afel,/,Bglll,fragment,from,pENTR/D,.}	{NULL}
SCPDFS_1158.pdf	144	{—,.}	{NULL}
SCPDFS_1158.pdf	145	{TOP0,.}	{NULL}
SCPDFS_1158.pdf	146	{—,.}	{NULL}
SCPDFS_1158.pdf	147	{SR,.}	{NULL}
SCPDFS_1158.pdf	148	{—,.}	{NULL}
SCPDFS_1158.pdf	149	{TRPM7,to,create,pENTR/DTOPO,.}	{NULL}
SCPDFS_1158.pdf	150	{—,.}	{NULL}
SCPDFS_1158.pdf	151	{SR,.}	{NULL}
SCPDFS_1158.pdf	152	{—,.}	{NULL}
SCPDFS_1158.pdf	153	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	154	{—,.}	{NULL}
SCPDFS_1158.pdf	155	{E1047K,.}	{NULL}
SCPDFS_1158.pdf	156	{The,SR,.}	{NULL}
SCPDFS_1158.pdf	157	{—,.}	{NULL}
SCPDFS_1158.pdf	158	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	159	{—,.}	{NULL}
SCPDFS_1158.pdf	160	{E1047K,cassette,was,then,transferred,to,the,destination,vector,pAd/CMV/V5,.}	{NULL}
SCPDFS_1158.pdf	161	{—,.}	{NULL}
SCPDFS_1158.pdf	162	{DEST,(,lnvitrogen,),by,recombination,using,the,Gateway,"\\"",-,"\\"",',1,"\\"",system,(,Invitrogen,),following,the,manufacturer,'s,instructions,.}	{NULL}
SCPDFS_1158.pdf	163	{The,recombinant,adenoviruses,expressing,SR,.}	{NULL}
SCPDFS_1158.pdf	164	{—,.}	{NULL}
SCPDFS_1158.pdf	165	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	166	{—,.}	{NULL}
SCPDFS_1158.pdf	167	{DN,was,then,made,using,pAd/CMV/V5,.}	{NULL}
SCPDFS_1158.pdf	168	{—,.}	{NULL}
SCPDFS_1158.pdf	169	{SR,.}	{NULL}
SCPDFS_1158.pdf	170	{—,.}	{NULL}
SCPDFS_1158.pdf	171	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	172	{—,.}	{NULL}
SCPDFS_1158.pdf	173	{E1047K,and,the,ViraPower,Adenoviral,Expression,System,(,lnvitrogen,),following,the,manufacturer,'s,instructions,.}	{NULL}
SCPDFS_1158.pdf	174	{The,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	175	{—,.}	{NULL}
SCPDFS_1158.pdf	176	{DN,recombinant,adenovirus,was,ampliﬁed,and,concentrated,from,two,150,mm,plates,of,HEl,(,.}	{NULL}
SCPDFS_1158.pdf	177	{—,.}	{NULL}
SCPDFS_1158.pdf	178	{293,A,cells,(,lnvitrogen,),using,the,Adenopack,100,kit,(,Sartorius,Stedim,Biotech,),following,manufacturer,'s,instructions,.}	{NULL}
SCPDFS_1158.pdf	179	{Drug,treatments}	{NULL}
SCPDFS_1158.pdf	180	{All,drugs,were,purchased,from,Sigma,.}	{NULL}
SCPDFS_1158.pdf	181	{—,.}	{NULL}
SCPDFS_1158.pdf	182	{Aldrich,(,St.,Louis,",",MO,),.}	{NULL}
SCPDFS_1158.pdf	183	{Levodopa,(,L,—,dopa,;,20,mM,),was,applied,with,ascorbic,acid,(,100,uM,),to,delay,oxidation,of,the,former,;,ascorbic,acid,alone,was,applied,in,control,experiments,.}	{NULL}
SCPDFS_1158.pdf	184	{L,—,dopa,was,applied,in,the,morning,at,5,dpf,",",and,larvae,were,allowed,to,incubate,for,one,hour,before,behavior,recordings,began,.}	{NULL}
SCPDFS_1158.pdf	185	{Dopamine,(,DA,;,20,uM,),was,applied,to,both,behavioral,(,free,—,swimming,),and,ﬁctive,preparations,and,had,locomotor,effects,within,5,to,20,min,",",similar,to,the,time,course,reported,in,previous,studies,(,Lambert,et,al.,",",2012,;,Souza,and,Tropepe,",",2011,;,Thirumalai,and,Cline,",",2008,),.}	{NULL}
SCPDFS_1158.pdf	186	{The,effect,of,DA,on,episode,duration,was,quantiﬁed,during,20-30,min,into,the,drug,application,.}	{NULL}
SCPDFS_1158.pdf	187	{MPP,+,was,applied,at,500,uM,.}	{NULL}
SCPDFS_1158.pdf	188	{It,was,dissolved,immediately,prior,to,application,at,50,hpf,",",and,refreshed,daily,.}	{NULL}
SCPDFS_1158.pdf	189	{Larvae,were,ﬁxed,for,immunohistochemistry,at,5,dpf,.}	{NULL}
SCPDFS_1158.pdf	190	{All,drugs,were,diluted,in,ﬁsh,water,except,in,the,case,of,peripheral,nerve,recordings,(,see,below,),",",in,which,drugs,were,diluted,in,extracellular,recording,solution,.}	{NULL}
SCPDFS_1158.pdf	191	{Whole,—,cell,voltage,clamp,recordings}	{NULL}
SCPDFS_1158.pdf	192	{The,cells,were,kept,under,continuous,perfusion,of,standard,extracellular,solution,containing,(,in,mM,),:,135,Na,—,methane,—,sulfonate,(,Na,.}	{NULL}
SCPDFS_1158.pdf	193	{—,.}	{NULL}
SCPDFS_1158.pdf	194	{MeSO3,),",",5,CsCl,",",1,CaCl2,and,10,HEPES,",",pH,7.4,(,adjusted,with,NaOH,),.}	{NULL}
SCPDFS_1158.pdf	195	{A,volume,of,1,pM,tetrodotoxin,(,TTX,),was,added,to,the,extracellular,buffer,",",in,order,to,block,voltage,—,gated,Na,+,channel,currents,.}	{NULL}
SCPDFS_1158.pdf	196	{Patch,pipettes,were,pulled,from,borosili,—,cate,glass,tubes,(,TW150F,—,4,",",World,Precision,Instruments,",",Sarasota,",",FL,),and,heat,—,polished,at,the,tip,to,give,a,resistance,of,3-5,mS2,when,ﬁlled,with,the,pipette,solution,containing,(,in,mM,),:,120,Cs,.}	{NULL}
SCPDFS_1158.pdf	197	{—,.}	{NULL}
SCPDFS_1158.pdf	198	{MeSO3,",",5,CsCl,",",2,CaCl2,",",10,EGTA,and,10,HEPES,",",pH,7.2,(,adjusted,with,CsOH,),.}	{NULL}
SCPDFS_1158.pdf	199	{The,free,Ca2,+,concentration,in,the,pipette,solution,was,calculated,as,60,nM,(,MaxChelator,",",Stanford,),.}	{NULL}
SCPDFS_1158.pdf	200	{All,currents,were,recorded,at,room,temperature,using,an,Axopatch,200B,patch,—,clamp,ampliﬁer,(,Molecular,Devices,",",Sunnyvale,",",CA,),",",low,—,pass,ﬁltered,at,5,kHz,and,sampled,at,10,kHz,.}	{NULL}
SCPDFS_1158.pdf	201	{All,current,acquisitions,were,made,with,the,pClamp10,software,(,Molecular,Devices,",",Sunnyvale,",",CA,),and,analyzed,with,Origin,7,software,(,OriginLab,Corporation,",",Northampton,",",MA,),.}	{NULL}
SCPDFS_1158.pdf	202	{The,holding,potential,was,—,70,mV,and,the,currents,were,recorded,by,applying,a,voltage,—,ramp,from,—,120,mV,to,+100,mV,for,500,ms.,To,determine,the,Trpm7,current,component,",",recordings,were,performed,from,cells,superfused,with,extracellular,solution,containing,10,mM,NH4Cl,or,10,mM,MgCl2,for,2,min,after,the,ﬁrst,set,of,recordings,under,standard,extracellular,conditions,.}	{NULL}
SCPDFS_1158.pdf	203	{Whole,—,cell,voltage,clamp,recordings,of,TRPM7,currents,in,293TRPM7,cells,were,elicited,by,voltage,stimuli,lasting,250,ms,delivered,every,second,using,voltage,ramps,from,-120,mV,to,+100,mV,.}	{NULL}
SCPDFS_1158.pdf	204	{Data,were,digitized,at,2,kHz,and,digitally,ﬁltered,at,1kHz,.}	{NULL}
SCPDFS_1158.pdf	205	{The,internal,pipette,solution,for,macroscopic,current,recordings,contained,(,in,mM,),145,Cs,—,methanesulfonate,",",8,NaCl,",",10,EGTA,",",and,10,4,.}	{NULL}
SCPDFS_1158.pdf	206	{—,.}	{NULL}
SCPDFS_1158.pdf	207	{(,2,.}	{NULL}
SCPDFS_1158.pdf	208	{—,.}	{NULL}
SCPDFS_1158.pdf	209	{hydroxyethyl,),.}	{NULL}
SCPDFS_1158.pdf	210	{—,.}	{NULL}
SCPDFS_1158.pdf	211	{1,.}	{NULL}
SCPDFS_1158.pdf	212	{—,.}	{NULL}
SCPDFS_1158.pdf	213	{piperzineethanesulfonic,acid,(,HEPES,),",",pH,adjusted,to,7.2,with,CsOH,.}	{NULL}
SCPDFS_1158.pdf	214	{The,extracellular,solution,for,whole,—,cell,recordings,contained,(,in,mM,),140,NaCl,",",5,l,(,Cl,",",2,CaCl2,",",20,HEPES,",",and,10,glucose,",",pH,adjusted,to,7.4,with,NaOH,.}	{NULL}
SCPDFS_1158.pdf	215	{Peripheral,nerve,recordings}	{NULL}
SCPDFS_1158.pdf	216	{Fictive,swimming,was,assessed,via,peripheral,nerve,recordings,in,vivo,as,described,previously,(,Masino,and,Fetcho,",",2005,),.}	{NULL}
SCPDFS_1158.pdf	217	{Brieﬂy,",",control,and,trpm7,mutants,were,anesthetized,with,0.02,%,Tricaine,—,S,(,Western,Chemical,),in,extracellular,recording,solution,(,Lambert,et,al.,",",2012,),and,paralyzed,with,0.1,%,(,w/v,),(,x,.}	{NULL}
SCPDFS_1158.pdf	218	{—,.}	{NULL}
SCPDFS_1158.pdf	219	{Bungarotoxin,(,Sigma,),.}	{NULL}
SCPDFS_1158.pdf	220	{Larvae,were,pinned,in,a,lateral,position,to,a,Sylgard,—,lined,petri,dish,and,the,skin,was,removed,.}	{NULL}
SCPDFS_1158.pdf	221	{Subsequently,",",larvae,were,transferred,to,the,stage,of,an,Olympus,BX51,WI,microscope,and,extracellular,recording,solution,was,superfused,continuously,at,1,ml/min,at,room,temperature,.}	{NULL}
SCPDFS_1158.pdf	222	{Extracellular,suction,electrode,recording,techniques,(,Masino,and,Fetcho,",",2005,),were,used,to,monitor,the,activity,of,peripheral,nerves,during,ﬁctive,behavior,;,the,tip,of,the,extracellular,suction,electrode,(,6-15,pm,tip,diameter,),was,positioned,near,the,dorsoventral,midline,of,an,intermyotomal,cleft,where,the,skin,had,been,removed,.}	{NULL}
SCPDFS_1158.pdf	223	{Spontaneous,activity,was,acquired,for,a,minimum,of,30,min,for,each,preparation,and,",",for,experiments,in,which,DA,was,applied,",",samples,were,subsequently,perfused,with,20,uM,DA,in,extracellular,recording,solution,.}	{NULL}
SCPDFS_1158.pdf	224	{All,recordings,were,between,body,segments,10,and,20,.}	{NULL}
SCPDFS_1158.pdf	225	{A,MultiClamp,700B,(,Molecular,Devices,",",Sunnyvale,",",CA,),ampliﬁer,was,used,to,monitor,extracellular,voltage,in,current,—,clamp,mode,at,a,gain,of,"2,000",(,Rf,:,50,M9,),",",with,the,low,—,and,high,—,frequency,cut,—,off,at,300,and,1000,Hz,",",respectively,.}	{NULL}
SCPDFS_1158.pdf	226	{Recordings,were,sampled,at,10,kHz,",",digitized,using,a,digitizing,board,(,DigiData,series,1440A,",",Molecular,Devices,",",Sunnyvale,",",CA,),and,acquired,using,pClamp,10,software,.}	{NULL}
SCPDFS_1158.pdf	227	{Analysis,of,peripheral,nerve,activity,was,performed,as,described,previously,(,Lambert,et,al.,",",2012,;,Wiggin,et,al.,",",2012,),",",using,custom,scripts,written,in,MATLAB,(,Mathworks,",",Natick,MA,),.}	{NULL}
SCPDFS_1158.pdf	228	{Brieﬂy,",",the,occurrence,times,of,rhythmic,ﬁctive,locomotor,bursts,were,determined,from,a,rectiﬁed,and,smoothed,version,of,the,voltage,recording,.}	{NULL}
SCPDFS_1158.pdf	229	{These,bursts,were,then,grouped,into,episodes,and,used,to,determine,the,episode,durations,for,each,voltage,trace,.}	{NULL}
SCPDFS_1158.pdf	230	{Values,for,ﬁctive,episode,durations,are,expressed,as,mean,i,SEM,(,standard,error,of,the,mean,),.}	{NULL}
SCPDFS_1158.pdf	231	{Electroretinogram,recordings}	{NULL}
SCPDFS_1158.pdf	232	{Electroretinograms,(,ERGS,),were,recorded,as,described,previously,(,Lewis,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	233	{Brieﬂy,",",6,dpf,larvae,were,anesthetized,in,0.02,%,Tricaine,.}	{NULL}
SCPDFS_1158.pdf	234	{—,.}	{NULL}
SCPDFS_1158.pdf	235	{S,",",and,eyes,were,removed,using,a,ﬁne,tungsten,wire,loop,.}	{NULL}
SCPDFS_1158.pdf	236	{Excised,eyes,were,then,placed,in,an,oxygenated,Ringer,'s,solution,(,in,mM,;,130,NaCl,",",2.5,KC,],",",20,NaHCO3,",",0.7,CaCl2,",",1.0,MgCl2,",",and,20,glucose,),",",and,a,glass,electrode,was,positioned,directly,onto,the,cornea,.}	{NULL}
SCPDFS_1158.pdf	237	{After,3,min,of,dark,adaptation,",",eyes,were,exposed,to,white,light,ﬂashes,in,the,presence,or,absence,of,background,light,",",and,their,electrical,responses,were,recorded,.}	{NULL}
SCPDFS_1158.pdf	238	{Data,were,acquired,and,processed,as,described,previously,(,Van}	{NULL}
SCPDFS_1158.pdf	239	{A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-439 431"}	{NULL}
SCPDFS_1158.pdf	240	{Epps,et,al.,",",2001,),.}	{NULL}
SCPDFS_1158.pdf	241	{Peak,values,are,listed,as,the,meaniSD,(,standard,deviation,),from,at,least,three,animals,.}	{NULL}
SCPDFS_1158.pdf	242	{Free,—,swimming,assay}	{NULL}
SCPDFS_1158.pdf	243	{Video,acquisition,and,analysis,were,performed,as,described,previously,(,Lambert,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	244	{Brieﬂy,",",a,group,of,10,larvae,in,embryo,medium,or,embryo,medium,containing,20,uM,DA,was,placed,in,a,50,mm,watch,glass,(,Fisher,Scientiﬁc,),atop,a,transmitted,light,stage,(,Schott,TLS,and,MC,—,1500,LED,Controller,),.}	{NULL}
SCPDFS_1158.pdf	245	{The,larvae,were,allowed,to,acclimate,to,the,recording,arena,for,5,min,prior,to,the,start,of,video,recording,.}	{NULL}
SCPDFS_1158.pdf	246	{Subsequently,",",spontaneous,free,—,swimming,was,recorded,for,10,min,at,60,frames,per,second,",",using,a,digital,CMOS,camera,(,Point,Grey,",",Fireﬂy,M,),with,an,attached,50mm,macro,lens,(,Sigma,Corporation,",",Ronkonkoma,",",NY,),.}	{NULL}
SCPDFS_1158.pdf	247	{Videos,were,acquired,with,Fview,(,open,—,source,software,;,(,Straw,and,Dickinson,",",2009,),),",",in,uncompressed,Fly,Movie,Format,(,FMF,),.}	{NULL}
SCPDFS_1158.pdf	248	{The,FMF,ﬁles,generated,by,Fview,were,imported,into,the,California,Institute,of,Technology,Fly,Tracker,(,Ctrax,),(,open,—,source,software,;,(,Branson,et,al.,",",2009,),),to,obtain,independent,trajectories,of,each,target,within,the,arena,.}	{NULL}
SCPDFS_1158.pdf	249	{We,subsequently,used,the,opensource,Fix,Errors,MATLAB,Toolbox,",",provided,by,the,creators,of,Ctrax,(,Branson,et,al.,",",2009,),),",",to,identify,and,ﬁx,tracking,errors,(,such,as,swapping,of,target,identities,),.}	{NULL}
SCPDFS_1158.pdf	250	{The,total,number,of,errors,per,10-min,video,was,4.49,i0,.55,(,n,=,23,videos,),and,all,errors,were,corrected,via,the,FEMT,.}	{NULL}
SCPDFS_1158.pdf	251	{Subsequently,",",scripts,from,the,opensource,Behavioral,Microarray,MATLAB,Toolbox,",",provided,by,the,creators,of,Ctrax,(,Branson,et,al.,",",2009,),",",were,implemented,to,compute,descriptive,statistics,of,a,suite,of,behavioral,parameters,for,each,of,the,individual,targets,from,the,ﬁxed,Ctrax,trajectories,.}	{NULL}
SCPDFS_1158.pdf	252	{The,target,speed,function,",",velmag,",",was,extracted,for,each,target,and,custom,scripts,were,written,to,deﬁne,and,detect,swimming,episodes,using,the,same,criteria,as,employed,previously,(,Lambert,et,al.,",",2012,),",",namely,:,signal,threshold,of,1.5,mm/s,",",minimum,episode,duration,of,66.6,ms,(,4,frames,),",",minimum,average,swimming,speed,of,3mm/s,",",and,concatenation,of,signals,within,a,300,ms,(,18,frame,),inter,—,signal,interval,.}	{NULL}
SCPDFS_1158.pdf	253	{Identical,ﬁlters,were,applied,for,all,videos,across,all,ages,and,experimental,groups,.}	{NULL}
SCPDFS_1158.pdf	254	{Once,all,swimming,episodes,were,identiﬁed,",",we,quantiﬁed,the,total,distance,traveled,per,individual,in,centimeters,(,sum,of,instantaneous,speeds,during,swimming,episodes,divided,by,the,frame,rate,),and,mean,swimming,episode,duration,per,individual,in,milliseconds,(,mean,duration,from,the,onset,to,the,offset,of,each,individual,episode,),over,the,10-min,recording,period,.}	{NULL}
SCPDFS_1158.pdf	255	{Sample,sizes,were,ultimately,smaller,for,quantifying,episode,duration,compared,with,total,distance,traveled,because,episode,duration,could,not,be,obtained,from,animals,that,did,not,move,during,the,recording,session,.}	{NULL}
SCPDFS_1158.pdf	256	{Histology}	{NULL}
SCPDFS_1158.pdf	257	{Larvae,were,ﬁxed,in,4,%,paraformaldehyde,overnight,at,4,°,C.,Whole,—,mount,larvae,were,washed,out,of,ﬁxative,with,doubledistilled,water,(,ddH20,),",",permeabilized,by,either,5,h,incubation,at,room,temperature,in,ddH2O,or,30,min,treatment,with,40,mg/ml,ProtI,(,",",blocked,in,PBDT,(,Phosphate,buffered,solution,",",2.5,%,Goat,serum,",",1,%,bovine,serum,albumin,",",1,%,DMSO,",",0.5,%,Tritonx,—,100,),for,1,h,",",and,incubated,in,primary,antibody,[,mouse,anti,—,tyrosine,hydroxylase,(,1:500,",",Sigma,.}	{NULL}
SCPDFS_1158.pdf	258	{—,.}	{NULL}
SCPDFS_1158.pdf	259	{Aldrich,),or,rabbit,anti,—,5HT,],diluted,in,PBDT,overnight,at,4,“,C.,In,experiments,where,we,used,the,peroxidase,anti,—,peroxidase,system,(,lackson,Immunoresearch,Laboratories,",",West,Grove,",",PA,),",",we,subsequently,incubated,embryos,in,2,°,goat,anti,—,mouse,antibodies,and,3,°,mPAP,antibody,.}	{NULL}
SCPDFS_1158.pdf	260	{Samples,were,incubated,in,1,%,hydrogen,peroxide,for,30,min,in,between,application,of,the,2,°,and,3,”,antibodies,",",and,then,developed,using,3,.}	{NULL}
SCPDFS_1158.pdf	261	{—,.}	{NULL}
SCPDFS_1158.pdf	262	{3,’,.}	{NULL}
SCPDFS_1158.pdf	263	{—,.}	{NULL}
SCPDFS_1158.pdf	264	{diaminobenzidene,(,DAB,",",Sigma,Aldrich,),.}	{NULL}
SCPDFS_1158.pdf	265	{"\\\\",Nhole,—,mount,larvae,were,altematively,prepared,using,Alexa,488,conjugated,secondary,antibodies,and,optically,sectioned,using,a,Zeiss,700,confocal,microscope,and,ZEN,2010,software,(,Carl,Zeiss,lnc.,",",Germany,),.}	{NULL}
SCPDFS_1158.pdf	266	{Optical,sections,were,compressed,into,single,images,by,projecting,the,maximum,intensity,signal,of,each,pixel,of,each,section,using,Image,],(,National,Institutes,of,Health,),for,approximately,500,x,500,x,150,um,(,width,x,height,>,<,depth,),at,a,resolution,of,1.087,pixels,per,pm,.}	{NULL}
SCPDFS_1158.pdf	267	{In,situ,hybridization,for,th2,and,dat,were,carried,out,as,described,(,Sallinen,et,al.,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	268	{Reverse,transcriptase,—,polymerase,chain,reaction,(,RT,.}	{NULL}
SCPDFS_1158.pdf	269	{—,.}	{NULL}
SCPDFS_1158.pdf	270	{PCR,)}	{NULL}
SCPDFS_1158.pdf	271	{Whole,—,animal,mRNA,was,isolated,at,5,dpf,using,Trizol,(,Invitro,—,gen,),",",from,which,CDNA,was,synthesized,using,oligo,—,dT,(,16,),primers,and,the,CDNA,Superscript,cDNA,synthesis,kit,(,Qiagen,),.}	{NULL}
SCPDFS_1158.pdf	272	{MMLV,enzyme,(,Promega,),was,used,for,the,reverse,transcriptase,reaction,.}	{NULL}
SCPDFS_1158.pdf	273	{Quantities,of,mRNA,were,calculated,relative,to,levels,of,beta,—,actin,.}	{NULL}
SCPDFS_1158.pdf	274	{Primers,for,beta,—,actin,forward,5,’,.}	{NULL}
SCPDFS_1158.pdf	275	{—,.}	{NULL}
SCPDFS_1158.pdf	276	{gagatgatgcccctcgtg,.}	{NULL}
SCPDFS_1158.pdf	277	{—,.}	{NULL}
SCPDFS_1158.pdf	278	{3,’,reverse,5,’,.}	{NULL}
SCPDFS_1158.pdf	279	{—,.}	{NULL}
SCPDFS_1158.pdf	280	{gctcaatgggg,tatttgagg,—,3,’,;,thl,primers,forward,5,’,.}	{NULL}
SCPDFS_1158.pdf	281	{—,.}	{NULL}
SCPDFS_1158.pdf	282	{catatgtgacccgcatcaag,.}	{NULL}
SCPDFS_1158.pdf	283	{—,.}	{NULL}
SCPDFS_1158.pdf	284	{3,’,reverse,5,’,.}	{NULL}
SCPDFS_1158.pdf	285	{—,.}	{NULL}
SCPDFS_1158.pdf	286	{caacacattcagggcatctg,.}	{NULL}
SCPDFS_1158.pdf	287	{—,.}	{NULL}
SCPDFS_1158.pdf	288	{3,’,;,th2,primers,forward,5,’,.}	{NULL}
SCPDFS_1158.pdf	289	{—,.}	{NULL}
SCPDFS_1158.pdf	290	{agcttcgtgtttgag,gagga,—,3,’,reverse,5,’,.}	{NULL}
SCPDFS_1158.pdf	291	{—,.}	{NULL}
SCPDFS_1158.pdf	292	{ctctttctgctcgctcgact,.}	{NULL}
SCPDFS_1158.pdf	293	{—,.}	{NULL}
SCPDFS_1158.pdf	294	{3,’,;,dat,primers,forward,5,’,.}	{NULL}
SCPDFS_1158.pdf	295	{—,.}	{NULL}
SCPDFS_1158.pdf	296	{agacatctgggaaggtggtg,.}	{NULL}
SCPDFS_1158.pdf	297	{—,.}	{NULL}
SCPDFS_1158.pdf	298	{3,’,reverse,5,’,.}	{NULL}
SCPDFS_1158.pdf	299	{—,.}	{NULL}
SCPDFS_1158.pdf	300	{tgtagctggagaaggcgatt,.}	{NULL}
SCPDFS_1158.pdf	301	{—,.}	{NULL}
SCPDFS_1158.pdf	302	{3,’,;,bdnf,primers,forward,5,’,.}	{NULL}
SCPDFS_1158.pdf	303	{—,.}	{NULL}
SCPDFS_1158.pdf	304	{tggcggcatccaggtagt,.}	{NULL}
SCPDFS_1158.pdf	305	{—,.}	{NULL}
SCPDFS_1158.pdf	306	{3,’,reverse,5,’,.}	{NULL}
SCPDFS_1158.pdf	307	{—,.}	{NULL}
SCPDFS_1158.pdf	308	{tcgaaggacgtt,gacctgtatg,—,3,’,.}	{NULL}
SCPDFS_1158.pdf	309	{Statistics}	{NULL}
SCPDFS_1158.pdf	310	{Levene,'s,test,for,equality,of,variances,was,used,to,test,assumptions,about,error,variances,for,Student,'s,t,—,test,.}	{NULL}
SCPDFS_1158.pdf	311	{For,experiments,that,involved,comparisons,of,two,means,",",one,—,tailed,Student,'s,t,—,tests,were,performed,when,error,variances,were,equal,.}	{NULL}
SCPDFS_1158.pdf	312	{Signiﬁcance,was,determined,at,the,p,<,0.05,level,.}	{NULL}
SCPDFS_1158.pdf	313	{A,Welch,t,—,test,was,used,instead,when,error,variances,were,unequal,.}	{NULL}
SCPDFS_1158.pdf	314	{Multiple,comparisons,of,means,were,made,using,two,—,way,analysis,of,variance,and,Bonferroni,post,—,hoc,tests,.}	{NULL}
SCPDFS_1158.pdf	315	{SPSS,Statistics,(,IBM,version,19,was,used,for,all,above,tests,.}	{NULL}
SCPDFS_1158.pdf	316	{A,12,test,was,conducted,assuming,Mendelian,ratios,of,inheritance,and,3,degrees,of,freedom,",",using,Microsoft,Excel,.}	{NULL}
SCPDFS_1158.pdf	317	{Calciﬁcation,assays}	{NULL}
SCPDFS_1158.pdf	318	{Kidney,stones,were,visualized,as,previously,described,(,Elizondo,et,al.,",",2005,),.}	{NULL}
SCPDFS_1158.pdf	319	{Brieﬂy,",",live,larvae,were,submerged,in,0.004,%,alizarin,red,in,Ringer,'s,solution,overnight,.}	{NULL}
SCPDFS_1158.pdf	320	{They,were,washed,2,>,<,in,Ringer,'s,solution,before,visualizing,live,under,Texas,Red,ﬁlter,.}	{NULL}
SCPDFS_1158.pdf	321	{Results}	{NULL}
SCPDFS_1158.pdf	322	{Sequence,analysis,of,trpm7,cDNA,generated,from,trpm7,”,5,°,3,mutants,indicated,that,the,encoded,TRPM7,protein,is,truncated,in,the,cytoplasmic,carboxy,terminus,upstream,of,the,kinase,domain,;,however,it,did,not,clarify,whether,this,variant,retains,channel,function,(,Elizondo,et,al.,",",2005,),.}	{NULL}
SCPDFS_1158.pdf	323	{Application,of,a,voltage,ramp,to,melanocytes,isolated,from,wild,—,type,embryos,at,48,h,post,fertilization,(,hpf,),produced,currents,characteristic,of,those,mediated,by,TRPM7,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	324	{1A,),.}	{NULL}
SCPDFS_1158.pdf	325	{Subjecting,rare,surviving,melanocytes,isolated,from,48,hpf,trpm7,mutants,to,the,same,procedure,revealed,that,these,produce,virtually,no,such,current,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	326	{1B,),.}	{NULL}
SCPDFS_1158.pdf	327	{These,ﬁndings,suggest,that,",",in,vivo,",",trpm7,"\\"",5,"\\"",8,encodes,a,Trpm7,protein,that,either,lacks,channel,function,or,fails,to,reach,the,plasma,membrane,.}	{NULL}
SCPDFS_1158.pdf	328	{They,are,consistent,with,conclusions,derived,from,forced,expression,of,trpm7,”,5,°,3,in,Xenopus,oocytes,(,Low,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	329	{Because,an,allele,of,TRPM7,was,reported,to,be,associated,with,a,parkinsonian,condition,(,Hermosura,et,al.,",",2005,),",",we,observed}	{NULL}
SCPDFS_1158.pdf	330	{432,A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	331	{A,control,400}	{NULL}
SCPDFS_1158.pdf	332	{350,+,NH4C,|}	{NULL}
SCPDFS_1158.pdf	333	{Untreated}	{NULL}
SCPDFS_1158.pdf	334	{Current,(,pA,)}	{NULL}
SCPDFS_1158.pdf	335	{+,MgCl2}	{NULL}
SCPDFS_1158.pdf	336	{Membrane,Potential,(,mV,)}	{NULL}
SCPDFS_1158.pdf	337	{B,trpm7,’’,5,“,400}	{NULL}
SCPDFS_1158.pdf	338	{A,300,<,E,:,250,‘,E,cl,),200,',5,Q,150}	{NULL}
SCPDFS_1158.pdf	339	{+,NH4CI,:,Untreated,"\\\\",+,MgCl2}	{NULL}
SCPDFS_1158.pdf	340	{-100,-,so,o,50,100}	{NULL}
SCPDFS_1158.pdf	341	{Membrane,Potential,(,mV,)}	{NULL}
SCPDFS_1158.pdf	342	{Fig,.}	{NULL}
SCPDFS_1158.pdf	343	{1,.}	{NULL}
SCPDFS_1158.pdf	344	{The,TRPM7,—,like,current,is,dramatically,reduced,in,trpm7,"\\"",5,"\\"",8,mutants,.}	{NULL}
SCPDFS_1158.pdf	345	{Representative,whole,—,cell,current,recordings,of,melanophores,isolated,at,32,hpf,",",in,(,A,),control,or,(,B,),trpm7,mutant,embryos,",",in,response,to,voltage,ramps,from,—,100,mV,to,+100,mV,for,500,ms,",",(,A,),Control,melanocytes,exhibited,outwardly,rectifying,currents,that,are,potentiated,by,the,extracellular,application,of,10,mM,NH4Cl,",",and,inhibited,by,the,application,of,10,mM,MgCl2,",",properties,that,are,characteristic,of,TRPM7,—,mediated,currents,.}	{NULL}
SCPDFS_1158.pdf	346	{(,B,),The,mutant,melanophores,did,not,exhibit,any,TRPM7,—,lil,<,e,outwardly,rectifying,currents,.}	{NULL}
SCPDFS_1158.pdf	347	{The,slight,outward,rectiﬁca,—,tion,of,currents,in,mutant,melanophores,indicates,that,the,cells,were,alive,.}	{NULL}
SCPDFS_1158.pdf	348	{Control,",",n,=,7,cells,;,mutant,",",n,=,3,cells,.}	{NULL}
SCPDFS_1158.pdf	349	{motility,in,zebraﬁsh,trpm7,mutant,larvae,at,5,days,post,fertilization,(,dpf,),.}	{NULL}
SCPDFS_1158.pdf	350	{We,monitored,motility,in,larvae,in,alternating,30-min,periods,of,light,and,dark,because,the,light,—,to,—,dark,transition,strongly,stimulates,swimming,(,Burgess,and,Granato,",",2007,;,Emran,et,al.,",",2008,),.}	{NULL}
SCPDFS_1158.pdf	351	{In,dark,periods,and,in,light,periods,",",trpm7,homozygous,mutants,traveled,a,shorter,distance,than,their,siblings,(,wild,—,types,and,heterozygous,mutants,;,hereafter,",",control,larvae,),(,Fig,.}	{NULL}
SCPDFS_1158.pdf	352	{2,",",statistical,analysis,in,the,ﬁgure,legend,),.}	{NULL}
SCPDFS_1158.pdf	353	{In,both,mutants,and,control,larvae,",",motility,was,lower,in,light,periods,than,in,dark,periods,;,in,light,periods,mutants,were,virtually,still,.}	{NULL}
SCPDFS_1158.pdf	354	{To,test,whether,a,deﬁcit,in,dopaminergic,signaling,causes,hypomotility,in,trpm7,mutants,",",we,treated,trpm7,mutants,and,control,larvae,with,levodopa,(,L,—,dopa,),",",a,precursor,of,dopamine,(,DA,),",",and,assayed,their,motility,.}	{NULL}
SCPDFS_1158.pdf	355	{In,dark,periods,",",L,—,dopa,—,treated,mutants,moved,signiﬁcantly,more,than,vehicle,—,treated,mutants,",",while,Ldopa,treatment,did,not,affect,the,motility,of,control,larvae,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	356	{2,),.}	{NULL}
SCPDFS_1158.pdf	357	{The,effectiveness,of,the,light,—,to,—,dark,stimulus,depends,on,intact,visual,processing,and,on,non,—,visual,light,sensors,(,Emran,et,al.,",",2008,;,Fernandes,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	358	{To,test,whether,vision,is,grossly,affected,in,trpm7,mutants,we,subjected,larvae,to,microelectroretinography,.}	{NULL}
SCPDFS_1158.pdf	359	{We,found,that,beta,waves,were,indistinguishable,between,mutants,and,control,larvae,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	360	{51,),.}	{NULL}
SCPDFS_1158.pdf	361	{We,conclude,that,hypomotility,of,the,mutants,is,unlikely,to,be,caused,by,abnormal,vision,or,other,gross,defects,.}	{NULL}
SCPDFS_1158.pdf	362	{The,simplest,explanation,of,these,observations,is,that,hypomotility,in,trpm7,larvae,is,at}	{NULL}
SCPDFS_1158.pdf	363	{I,control,_,I,control,+,L,—,dopa,El,trpm7,',/,',El,trpm7,',/,',+,L,—,dopa}	{NULL}
SCPDFS_1158.pdf	364	{W,O,as,o,I}	{NULL}
SCPDFS_1158.pdf	365	{Distance,Moved,(,cm,)}	{NULL}
SCPDFS_1158.pdf	366	{-5,O,I}	{NULL}
SCPDFS_1158.pdf	367	{Time,Elapsed,(,min,)}	{NULL}
SCPDFS_1158.pdf	368	{Fig,.}	{NULL}
SCPDFS_1158.pdf	369	{2,.}	{NULL}
SCPDFS_1158.pdf	370	{The,hypomotility,of,trpm7,mutants,is,levodopa,responsive,.}	{NULL}
SCPDFS_1158.pdf	371	{Bar,chart,showing,results,of,automated,analysis,of,motility,was,carried,out,during,daytime,",",over,one,cycle,of,30,min,exposure,to,light,(,white,horizontal,bar,),followed,by,30,min,of,darkness,(,black,horizontal,bar,),",",Vertical,bars,indicate,average,distance,moved,during,5,min,intervals,.}	{NULL}
SCPDFS_1158.pdf	372	{The,average,movement,of,mutants,over,the,hour,was,signiﬁcantly,lower,than,that,of,controls,(,Welch,t,—,test,",",p,<,0.001,),.}	{NULL}
SCPDFS_1158.pdf	373	{For,each,experiment,",",half,of,a,single,clutch,of,larvae,from,trpm7,heterozygous,adults,was,treated,with,30,pM,L,—,dopa,for,3,h,before,recording,.}	{NULL}
SCPDFS_1158.pdf	374	{The,motility,of,trpm7,mutants,was,signiﬁcantly,increased,by,L,—,dopa,treatment,during,the,ﬁrst,10,min,after,the,light,—,to,—,dark,shift,(,Student,'s,t,—,test,",",p,=,0.004,and,Welch,t,—,test,",",p,=,0.017,for,the,ﬁrst,and,second,5,min,intervals,after,the,light,—,to,—,dark,transition,",",respectively,),.}	{NULL}
SCPDFS_1158.pdf	375	{By,contrast,",",control,larvae,were,unaffected,by,L,—,dopa,(,Student,'s,t,—,test,",",p,=,0.097,and,p,=,0.070,for,the,ﬁrst,and,second,5,min,intervals,after,the,light,—,to,—,dark,transition,",",respectively,),.}	{NULL}
SCPDFS_1158.pdf	376	{Each,group,tested,consisted,of,22-24,animals,.}	{NULL}
SCPDFS_1158.pdf	377	{Error,bars,represent,SEM,in,one,single,hr,.}	{NULL}
SCPDFS_1158.pdf	378	{Asterisks,",",values,signiﬁcantly,different,.}	{NULL}
SCPDFS_1158.pdf	379	{least,partly,the,result,of,sub,—,threshold,dopaminergic,signaling,in,the,central,nervous,system,.}	{NULL}
SCPDFS_1158.pdf	380	{To,test,the,possibility,that,dopaminergic,signaling,is,lower,than,normal,in,trpm7,mutants,",",we,examined,a,developmental,milestone,in,zebraﬁsh,that,depends,on,intact,dopaminergic,signaling,.}	{NULL}
SCPDFS_1158.pdf	381	{Between,3,and,4,dpf,",",wild,—,type,zebraﬁsh,larvae,undergo,a,developmental,switch,in,their,locomotor,pattern,",",transitioning,from,long,to,short,swimming,episodes,(,Buss,and,Drapeau,",",2001,;,Lambert,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	382	{The,latter,pattern,persists,into,adulthood,(,Fuiman,and,Webb,",",1988,;,Muller,et,al.,",",2000,),.}	{NULL}
SCPDFS_1158.pdf	383	{This,developmental,switch,is,mediated,by,central,dopaminergic,signaling,",",which,originates,in,the,caudal,diencephalon,and,acts,in,the,spinal,cord,via,the,diencephalospinal,tract,(,Lambert,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	384	{Using,videography,",",we,measured,swimming,speed,and,episode,duration,before,(,3,dpf,),(,Fig,.}	{NULL}
SCPDFS_1158.pdf	385	{S2,),and,after,(,5-6,dpf,),(,Fig,.}	{NULL}
SCPDFS_1158.pdf	386	{3A,",",top,),the,developmental,switch,.}	{NULL}
SCPDFS_1158.pdf	387	{In,addition,to,these,behavioral,parameters,",",we,measured,the,duration,of,ﬁctive,swimming,episodes,by,carrying,out,extracellular,recording,of,peripheral,nerve,activity,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	388	{3A,",",bottom,),.}	{NULL}
SCPDFS_1158.pdf	389	{At,3,dpf,",",there,was,no,difference,in,episode,duration,between,trpm7,controls,and,mutants,",",regardless,of,whether,examined,in,the,behavioral,or,ﬁctive,swimming,preparations,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	390	{S2,),.}	{NULL}
SCPDFS_1158.pdf	391	{However,",",at,5-6,dpf,",",the,durations,of,behavioral,and,ﬁctive,episodes,in,trpm7,mutants,were,signiﬁcantly,longer,than,those,of,controls,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	392	{3A,and,B,),",",indicating,that,the,mutants,did,not,properly,execute,the,stereotypic,switch,from,long,to,short,episodes,.}	{NULL}
SCPDFS_1158.pdf	393	{By,contrast,",",in,5-6,dpf,trpm7,mutants,treated,with,20,pM,exogenous,DA,",",the,episode,duration,during,both,the,behavioral,and,ﬁctive,assays,was,signiﬁcantly,shorter,than,in,untreated,trpm7,mutants,",",but,not,different,from,that,in,controls,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	394	{3A,and,B,),.}	{NULL}
SCPDFS_1158.pdf	395	{Because,the,long,—,episode,behavioral,phenotype,of,trpm7,mutants,is,recapitulated,in,the,ﬁctive,swimming,preparation,",",and,because,the,exogenous,application,of,DA,is,sufﬁcient,to,rescue,the,developmentally,appropriate,locomotor,pattern,",",we,conclude,that,this,phenotype,is,not,caused,by,a,deﬁcit,in,muscle,or,body,morphology,but,rather,by,to,a,lack,of,central,dopaminergic,signaling,(,Lambert,et,al.,",",2012,),.}	{NULL}
SCPDFS_1158.pdf	396	{A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-439 433"}	{NULL}
SCPDFS_1158.pdf	397	{A,trpm7,trpm7,”’,trpm7,”,',B,oyr}	{NULL}
SCPDFS_1158.pdf	398	{control,+,DA,`,p}	{NULL}
SCPDFS_1158.pdf	399	{5,“’,g,o,3,115,v,1000,',5,E,as,‘,as,.5,.}	{NULL}
SCPDFS_1158.pdf	400	{-2,aoo,-5,1,:,55,E,‘,I,’,3,=,600,E13,",",;,",",_,25,‘,L,o,"\\""}	{NULL}
SCPDFS_1158.pdf	401	{’,". . . .",I,A,_,‘,I,‘,‘,I,.}	{NULL}
SCPDFS_1158.pdf	402	{%,400}	{NULL}
SCPDFS_1158.pdf	403	{_,_,_,.9,200,Time,(,sec,),Time,(,sec,),Time,(,sec,),'30}	{NULL}
SCPDFS_1158.pdf	404	{‘,trpm7,trpm7,',/,',trpm7,‘,/,',.5,control,+,DA,.2,LL}	{NULL}
SCPDFS_1158.pdf	405	{I,1sec,l,:,lBehavior,IFictive}	{NULL}
SCPDFS_1158.pdf	406	{Fig,.}	{NULL}
SCPDFS_1158.pdf	407	{3,.}	{NULL}
SCPDFS_1158.pdf	408	{Dopamine,rescues,behavioral,and,ﬁctive,locomotor,patterns,of,the,trpm7,mutant,.}	{NULL}
SCPDFS_1158.pdf	409	{(,A,),(,Top,row,),Representative,recordings,of,speed,and,(,bottom,row,),extracellular,peripheral,nerve,recordings,in,ﬁctive,swimming,preparations,for,discrete,swimming,episodes,of,5-6,dpf,control,siblings,(,left,),",",trpm7,mutants,(,middle,),",",and,trpm7,mutants,+,DA,(,20,pM,;,right,),.}	{NULL}
SCPDFS_1158.pdf	410	{Grey,bars,below,x,—,axes,of,speed,plots,represent,episode,durations,whose,beginnings,and,ends,are,deﬁned,by,the,ﬁlter,settings,.}	{NULL}
SCPDFS_1158.pdf	411	{(,B,),Summary,plot,of,the,mean,durations,of,behavioral,and,ﬁctive,swimming,episodes,for,each,group,.}	{NULL}
SCPDFS_1158.pdf	412	{Asterisks,indicate,signiﬁcant,difference,;,***,p,<,0.001,",",Numbers,at,the,base,of,bars,in,graph,denote,number,of,larvae,observed,for,each,experimental,group,",",Error,bars,represent,SEM,.}	{NULL}
SCPDFS_1158.pdf	413	{We,next,used,histology,to,determine,if,dopaminergic,neurons,and,other,neuronal,sub,—,types,are,present,in,trpm7,mutants,.}	{NULL}
SCPDFS_1158.pdf	414	{Tyrosine,hydroxylase,is,the,rate,—,limiting,enzyme,in,dopamine,synthesis,.}	{NULL}
SCPDFS_1158.pdf	415	{There,are,two,orthologs,of,tyrosine,hydroxylase,in,zebraﬁsh,",",Th1,and,Th2,(,Chen,et,al.,",",2009,;,Filippi,et,al.,",",2009,;,Holzschuh,et,al.,",",2001,;,Yamamoto,et,al.,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	416	{There,is,recent,evidence,that,Th2,contributes,to,serotonin,synthesis,in,larvae,(,Ren,et,al.,",",2013,),",",although,in,some,cells,Th2,is,detected,together,with,DA,in,the,absence,of,Th1,",",implying,it,contributes,to,dopamine,synthesis,(,Yamamoto,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	417	{Clusters,of,anti,.}	{NULL}
SCPDFS_1158.pdf	418	{—,.}	{NULL}
SCPDFS_1158.pdf	419	{Th1,immunoreactive,(,IR,),cells,(,Thl,IR,cells,",",hereafter,),are,present,in,several,discrete,clusters,within,the,brains,of,5,—,dpf,zebraﬁsh,larvae,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	420	{4M,;,the,labeling,scheme,used,here,(,Sallinen,et,al.,",",2009,),is,compared,to,an,alternative,scheme,(,Rink,and,Wullimann,",",2002,),in,Table,S1,),.}	{NULL}
SCPDFS_1158.pdf	421	{The,number,of,Th1,IR,cells,in,all,of,these,clusters,appeared,grossly,reduced,in,mutants,in,comparison,to,controls,.}	{NULL}
SCPDFS_1158.pdf	422	{To,quantify,this,effect,",",we,focused,on,a,cluster,in,the,pretectum,(,group,7,),",",which,is,well,—,separated,from,the,other,clusters,",",and,on,a,cluster,in,the,periventricular,hypothalamus,(,group,13,),",",because,neurons,here,exhibit,a,high,level,of,immunoreactivity,and,are,less,densely,packed,than,elsewhere,.}	{NULL}
SCPDFS_1158.pdf	423	{We,found,that,the,number,of,Th1,IR,cells,in,both,clusters,trended,lower,in,trpm7,mutants,than,in,control,larvae,;,this,difference,reached,signiﬁcance,in,the,pretectum,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	424	{4A,",",B,),.}	{NULL}
SCPDFS_1158.pdf	425	{The,number,of,cells,expressing,th2,",",which,are,found,only,in,a,preoptic,cluster,(,group,3b,),",",a,diencephalic,cluster,(,group,8b,),",",and,a,posterior,paraventricular,organ,cluster,(,group,10b,),",",was,also,clearly,reduced,in,trpm7,mutants,compared,to,controls,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	426	{4K,and,L,),.}	{NULL}
SCPDFS_1158.pdf	427	{The,reduction,in,the,number,of,th1,—,and,th2,—,expressing,cells,was,mirrored,by,a,reduction,of,the,total,amount,of,thl,and,tli2,mRNA,in,mutants,with,respect,to,siblings,",",as,monitored,by,qRT,.}	{NULL}
SCPDFS_1158.pdf	428	{—,.}	{NULL}
SCPDFS_1158.pdf	429	{PCR,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	430	{5H,),",",In,contrast,to,expression,of,th,paralogs,",",expression,of,dopamine,transporter,(,dat,),",",a,second,marker,of,dopaminergic,neurons,",",appeared,grossly,equivalent,in,trpm7,mutants,and,controls,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	431	{5E,and,F,),.}	{NULL}
SCPDFS_1158.pdf	432	{Conﬁrming,this,impression,",",we,found,the,number,of,cells,expressing,GFP,in,the,Tg,(,dat,:,gfp,),transgenic,line,(,Xi,et,al.,",",2011,),was,not,signiﬁcantly,different,in,trpm7,mutants,relative,to,control,larvae,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	433	{5C,and,D,),.}	{NULL}
SCPDFS_1158.pdf	434	{The,number,of,sensory,neurons,in,the,dorsal,root,ganglia,and,the,number,of,serotoninergic,neurons,in,the,pretectum,",",recognized,by,anti,.}	{NULL}
SCPDFS_1158.pdf	435	{—,.}	{NULL}
SCPDFS_1158.pdf	436	{Hu,and,anti,—,5,—,hydroxytryptophan,(,SHT,),immunoreactivity,",",respectively,",",were,equivalent,in,mutants,and,controls,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	437	{5G,and,legend,to,Fig,.}	{NULL}
SCPDFS_1158.pdf	438	{5,),.}	{NULL}
SCPDFS_1158.pdf	439	{We,also,found,no,difference,between,message,levels,of,brain,derived,neurotrophic,factor,(,bdnf,),",",a,gene,expressed,in,many,regions,of,the,brain,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	440	{SH,),.}	{NULL}
SCPDFS_1158.pdf	441	{These,ﬁndings,indicate,that,",",in,contrast,to,embryonic,melanophores,",",which,undergo,cell,death,",",dopaminergic,neurons,and,other,categories,of,neurons,examined,are,present,in,normal,numbers,in,trpm7,mutants,.}	{NULL}
SCPDFS_1158.pdf	442	{However,",",abnormally,low,expression,of,th,paralogs,in,such,mutants,indicates,faulty,differentiation,or,physiology,of,dopaminergic,neurons,and,possibly,a,subset,of,serotoninergic,neurons,(,i.e.,",",those,expressing,Th2,),.}	{NULL}
SCPDFS_1158.pdf	443	{Embryonic,melanophores,in,trpm7,mutants,are,poisoned,by,the,oxidative,intermediates,of,melanin,synthesis,(,McNeill,et,al.,",",2007,),",",and,such,intermediates,are,related,to,dopamine,;,therefore,we,reasoned,that,dopaminergic,neurons,in,trpm7,mutants,may,similarly,experience,elevated,levels,of,oxidative,stress,.}	{NULL}
SCPDFS_1158.pdf	444	{In,this,case,they,may,be,hypersensitive,to,oxidative,stressors,.}	{NULL}
SCPDFS_1158.pdf	445	{The,neurotoxin,1,—,methyl,—,4,—,phenylpyridinium,ion,(,MPP,+,),is,transported,by,the,dopamine,transporter,into,neurons,",",where,it,interferes,with,complex,I,of,the,mitochondrial,electron,transport,chain,",",depleting,the,cell,of,ATP,and,elevating,levels,of,reactive,oxygen,species,(,ROS,),(,reviewed,in,Segura,Aguilar,and,Kostrzewa,",",2004,),.}	{NULL}
SCPDFS_1158.pdf	446	{We,examined,Th1,IR,neurons,in,control,and,trpm7,mutant,larvae,treated,chronically,with,MPP,+,.}	{NULL}
SCPDFS_1158.pdf	447	{In,control,larvae,",",this,treatment,caused,a,15,%,reduction,(,relative,to,untreated,larvae,),in,the,number,of,Th1,IR,cells,in,the,pretectal,area,",",whereas,in,trpm7,mutants,it,caused,a,50,%,reduction,(,relative,to,untreated,trpm7,mutants,),(,Fig,.}	{NULL}
SCPDFS_1158.pdf	448	{4A,.}	{NULL}
SCPDFS_1158.pdf	449	{—,.}	{NULL}
SCPDFS_1158.pdf	450	{D,",",1,),.}	{NULL}
SCPDFS_1158.pdf	451	{The,increased,sensitivity,of,trpm7,mutants,to,the,effects,of,MP1,“,was,also,apparent,in,the,hypothalamus,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	452	{4E,.}	{NULL}
SCPDFS_1158.pdf	453	{—,.}	{NULL}
SCPDFS_1158.pdf	454	{H,",",J,),.}	{NULL}
SCPDFS_1158.pdf	455	{In,principle,",",abnormally,high,levels,of,dat,expression,might,explain,the,elevated,sensitivity,to,MP1,”,",",but,we,found,that,the,dot,levels,in,mutants,and,siblings,are,comparable,(,as,measured,by,qRT,.}	{NULL}
SCPDFS_1158.pdf	456	{—,.}	{NULL}
SCPDFS_1158.pdf	457	{PCR,",",Fig,.}	{NULL}
SCPDFS_1158.pdf	458	{SH,),.}	{NULL}
SCPDFS_1158.pdf	459	{Instead,",",the,increased,sensitivity,of,trpm7,mutants,versus,control,larvae,to,MPP,+,implies,that,the,absence,of,Trpm7,elevates,oxidative,stress,in,DA,neurons,.}	{NULL}
SCPDFS_1158.pdf	460	{We,next,asked,whether,treatments,that,protect,DA,neurons,from,MP1,”,similarly,protect,them,from,the,absence,of,Trpm7,.}	{NULL}
SCPDFS_1158.pdf	461	{Deferox,—,amine,(,DFO,),chelates,iron,and,thereby,inhibits,the,iron,—,catalyzed,conversion,of,hydrogen,peroxide,to,the,more,highly,reactive,hydroxyl,ion,(,Menasche,et,al.,",",1987,),.}	{NULL}
SCPDFS_1158.pdf	462	{DFO,protects,against,degeneration,of,dopaminergic,neurons,induced,by,6,—,hydroxydopamine,(,6,.}	{NULL}
SCPDFS_1158.pdf	463	{—,.}	{NULL}
SCPDFS_1158.pdf	464	{OHDA,),or,MPTP,(,the,MP1,”,precursor,),in,animal,models,(,BenShachar,et,al.,",",1992,;,Lan,and,jiang,",",1997,),.}	{NULL}
SCPDFS_1158.pdf	465	{We,treated,trpm7,mutants,and,controls,chronically,with,DFO,and,measured,their,motility,.}	{NULL}
SCPDFS_1158.pdf	466	{Mutants,treated,with,DFO,moved,signiﬁcantly,more,than,untreated,mutants,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	467	{6,),",",whereas,control,siblings,were,not,affected,by,DFO,treatment,.}	{NULL}
SCPDFS_1158.pdf	468	{DFO,treatment,did,not,have,a,detectable,effect,on,the,number,of,Th1,IR,cells,or,on,the,quality,of,melanocytes,in,trpm7,mutants,(,data,not,shown,),.}	{NULL}
SCPDFS_1158.pdf	469	{Of,note,",",treatment,of,trpm7,mutant,larvae,with,DFO,",",similar,to,their,treatment,with,L,—,dopa,",",increased,motility,after,the,dark,—,to,—,light,transition,",",but,not,after,the,light,—,to,—,dark,transition,.}	{NULL}
SCPDFS_1158.pdf	470	{This,suggests,that,DFO,treatment,partially,rescues,the,function,of,dopaminergic,neurons,in,trpm7,mutants,",",and,therefore,that,the,defect,in,such,neurons}	{NULL}
SCPDFS_1158.pdf	471	{434,AR,Decker,et,al.,/,Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	472	{caused,by,the,absence,of,Trpm7,is,similar,to,that,induced,by,6,-,the,effects,of,Trpm7,on,dopaminergic,neurons,may,be,indirect,.}	{NULL}
SCPDFS_1158.pdf	473	{As,OHDA,or,MPTP,treatment,.}	{NULL}
SCPDFS_1158.pdf	474	{previously,reported,(,Elizondo,et,al.,",",2010,),",",trpm7,mutant,embryos,Because,parkinsonian,features,can,result,from,the,calciﬁcation,of,had,signiﬁcantly,more,kidney,stones,than,controls,.}	{NULL}
SCPDFS_1158.pdf	475	{However,we,did,basal,ganglia,(,Koller,et,al.,",1979",),",",we,considered,the,possibility,that,not,detect,calciﬁcation,in,the,brains,of,either,genotype,.}	{NULL}
SCPDFS_1158.pdf	476	{We,also,control,+,MPP,"\\"",trpm7,"\\"",',+,MPP,"\\""}	{NULL}
SCPDFS_1158.pdf	477	{control,trpm,7}	{NULL}
SCPDFS_1158.pdf	478	{(,D40,(,D,C,C,o,-,j,o,&,L,3,3,.}	{NULL}
SCPDFS_1158.pdf	479	{.}	{NULL}
SCPDFS_1158.pdf	480	{&,’,3o,—,<,02,%,‘,E,gE,2,"\\"",o,"\\"",030,-,ﬁli020,’,<,90,=,31,:,:81,:,9,',:5,<,10,<,2,:}	{NULL}
SCPDFS_1158.pdf	481	{control,trpm7,control,trpm7}	{NULL}
SCPDFS_1158.pdf	482	{A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-439 435"}	{NULL}
SCPDFS_1158.pdf	483	{Tg,(,dat,.,'}	{NULL}
SCPDFS_1158.pdf	484	{gfp,)}	{NULL}
SCPDFS_1158.pdf	485	{.}	{NULL}
SCPDFS_1158.pdf	486	{/,.}	{NULL}
SCPDFS_1158.pdf	487	{trpm,7}	{NULL}
SCPDFS_1158.pdf	488	{Dorsal,brain}	{NULL}
SCPDFS_1158.pdf	489	{Ventral,brain}	{NULL}
SCPDFS_1158.pdf	490	{CD}	{NULL}
SCPDFS_1158.pdf	491	{I}	{NULL}
SCPDFS_1158.pdf	492	{I,control,I,control,_,/,_,E,],trpm,7}	{NULL}
SCPDFS_1158.pdf	493	{2,‘,z,‘,9,on,3,E,3,:5,To,>,2,-5,O,C,',o,cu,.}	{NULL}
SCPDFS_1158.pdf	494	{",",_,3,o,o2,-,E,E,‘,_,“,:3,an,Z,on}	{NULL}
SCPDFS_1158.pdf	495	{5HT,Tg,(,dat,:,gfp,),th1,th2,dat,bdnf}	{NULL}
SCPDFS_1158.pdf	496	{Fig,.}	{NULL}
SCPDFS_1158.pdf	497	{5,.}	{NULL}
SCPDFS_1158.pdf	498	{Numbers,of,serotonergic,neurons,and,neurons,expressing,dat,are,normal,in,trpm7,mutants,(,A,",",B,;,A,’,",",B,’,),Dorsal,views,of,the,(,A,and,B,),pre,—,tectum,(,Th1,group,7,),and,(,A,’,and,B,’,),hypothalamus,(,Th1,group,13,),in,5,dpf,control,and,trpm,?}	{NULL}
SCPDFS_1158.pdf	499	{mutant,larvae,",",as,indicated,",",processed,to,reveal,anti,—,5HT,(,red,),and,anti,.}	{NULL}
SCPDFS_1158.pdf	500	{—,.}	{NULL}
SCPDFS_1158.pdf	501	{Th1,(,green,),immunoreactivity,(,IR,),",",Th1,IR,cells,were,reduced,in,mutants,(,quantiﬁed,in,),",",SHT,IR,cells,were,normal,in,number,(,below,),.}	{NULL}
SCPDFS_1158.pdf	502	{Scale,bar,inA,=,30,pm,and,applies,to,A,.}	{NULL}
SCPDFS_1158.pdf	503	{—,.}	{NULL}
SCPDFS_1158.pdf	504	{D,;,scale,bar,in,A,’,=,50,pm,and,applies,to,A,’,.}	{NULL}
SCPDFS_1158.pdf	505	{—,.}	{NULL}
SCPDFS_1158.pdf	506	{B,’,and,E,",",F.,(,C,and,D,),Dorsal,views,of,5,dpf,Tg,(,dat,:,gfp,),larvae,focused,on,the,pretectum,(,group,7,),.}	{NULL}
SCPDFS_1158.pdf	507	{GFP,—,expressing,neurons,were,equally,abundant,in,trpm,?}	{NULL}
SCPDFS_1158.pdf	508	{mutants,and,controls,(,control,:,65,+,/,7,;,mutant,:,60,+,/,10,),.}	{NULL}
SCPDFS_1158.pdf	509	{(,E,and,F,),Ventral,view,of,hypothalamus,(,group,13,),in,embryos,of,the,indicated,genotype,processed,to,reveal,dat,expression,by,in,situ,hybridization,.}	{NULL}
SCPDFS_1158.pdf	510	{(,G,),Bar,chart,indicating,numbers,of,5HT,IR,and,GFP,—,expressing,neurons,within,the,pretectum,(,group,7,),of,trpm,?}	{NULL}
SCPDFS_1158.pdf	511	{mutants,(,or,trpm,?}	{NULL}
SCPDFS_1158.pdf	512	{mutant,;,Tg,(,dat,:,gfp,),transgenic,),and,controls,.}	{NULL}
SCPDFS_1158.pdf	513	{Number,of,neurons,was,not,signiﬁcantly,different,between,the,genotypes,.}	{NULL}
SCPDFS_1158.pdf	514	{(,Anti,.}	{NULL}
SCPDFS_1158.pdf	515	{—,.}	{NULL}
SCPDFS_1158.pdf	516	{Hu,lR,—,positive,cells,in,DRG,caudal,to,hindyolk,at,5,dpf,",",control,:,32,4,;,o,",",mutant,:,31,4,;,1,),",",(,H,),qRT-PCR,analysis,of,mRNA,levels,of,th1,",",th2,",",clot,",",and,bdnf,.}	{NULL}
SCPDFS_1158.pdf	517	{Asterisks,indicate,signiﬁcant,difference,;,*,p,<,0001,.}	{NULL}
SCPDFS_1158.pdf	518	{Error,bars,represent,SEM,",",(,For,interpretation,of,the,references,to,color,in,this,ﬁgure,legend,",",the,reader,is,referred,to,the,web,version,of,this,article,.,)}	{NULL}
SCPDFS_1158.pdf	519	{Fig,.}	{NULL}
SCPDFS_1158.pdf	520	{4,.}	{NULL}
SCPDFS_1158.pdf	521	{trpm,?}	{NULL}
SCPDFS_1158.pdf	522	{mutants,are,sensitized,to,MPP,+,.}	{NULL}
SCPDFS_1158.pdf	523	{(,A,.}	{NULL}
SCPDFS_1158.pdf	524	{—,.}	{NULL}
SCPDFS_1158.pdf	525	{H,),Dorsal,views,of,5,—,dpf,larvae,of,the,indicated,genotype,",",treated,with,500,pm,MP1,“,or,vehicle,control,as,indicated,.}	{NULL}
SCPDFS_1158.pdf	526	{Individual,panels,show,distinct,groups,of,Th1,IR,cells,in,the,following,brain,regions,:,(,A,.}	{NULL}
SCPDFS_1158.pdf	527	{—,.}	{NULL}
SCPDFS_1158.pdf	528	{D,),pretectal,diencephalon,(,group,7,),;,(,E,.}	{NULL}
SCPDFS_1158.pdf	529	{—,.}	{NULL}
SCPDFS_1158.pdf	530	{H,),periventricular,hypothalamus,(,group,13,),;,and,I,and,J,),bar,chart,showing,average,numbers,of,Th1,lR,—,positive,cells,in,each,group,(,n,=,11,animals,scored,),.}	{NULL}
SCPDFS_1158.pdf	531	{In,the,untreated,samples,",",the,number,of,Th1,IR,cells,was,signiﬁcantly,lower,in,mutants,than,controls,in,group,7,(,control,avg,.}	{NULL}
SCPDFS_1158.pdf	532	{+,/,SEM,:,44,+,/,2,",",mutant,:,36,+,/,2,;,Two,way,ANOVA,with,Bonferroni,post,—,hoc,test,",",p,<,0.001,),.}	{NULL}
SCPDFS_1158.pdf	533	{.}	{NULL}
SCPDFS_1158.pdf	534	{In,group,13,",",(,control,:,56,+,/,1,",",mutant,:,51,+,/,2,),there,was,not,a,signiﬁcant,difference,in,the,number,of,Th1,IR,cells,between,untreated,controls,and,untreated,mutants,.}	{NULL}
SCPDFS_1158.pdf	535	{In,both,groups,",",MP1,“,treatment,effected,a,larger,reduction,in,the,number,of,Th1,IR,cells,in,mutants,than,in,controls,(,group,7,",",control,+,MPP,*,:,39,+,/,2,",",mutant,+,MPP,*,:,17,+,/,2,;,group,13,",",control,+,MPP,+,:,53,+,/,2,",",mutant,+,MPP,*,:,37,+,/,3,),",",In,group,7,the,effect,of,MRI,“,in,mutants,was,almost,three,times,larger,than,in,controls,",",and,in,group,13,it,was,over,four,times,larger,;,in,both,groups,",",mutants,were,signiﬁcantly,more,sensitive,to,MPP,+,treatment,than,controls,(,p,<,0.001,),.}	{NULL}
SCPDFS_1158.pdf	536	{(,K,and,L,),Dorsal,views,of,dissected,brains,from,(,K,),control,or,(,L,),trpm,?}	{NULL}
SCPDFS_1158.pdf	537	{mutant,larvae,",",processed,to,reveal,th2,mRNA,",",The,pre,—,optic,area,(,group,3b,),is,outlined,in,white,.}	{NULL}
SCPDFS_1158.pdf	538	{(,th2,—,positive,cells,:,control,:,14,+,/,1,",",n,=,9,;,mutant,:,7,+,/,5,",",n,=,12,;,p,<,0.001,),.}	{NULL}
SCPDFS_1158.pdf	539	{Scale,bar,in,A,=,50,pm,",",applies,to,A,.}	{NULL}
SCPDFS_1158.pdf	540	{—,.}	{NULL}
SCPDFS_1158.pdf	541	{H,",",Scale,bar,in,K,",",=,100,um,",",applies,to,I,(,",",L.,(,M,),Schematic,illustrating,the,numbering,scheme,of,Th1,and,th2,positive,(,outlined,in,black,),neuron,clusters,where,darkness,indicates,more,ventral,groups,(,1,olfactory,bulb,;,2,subpallium,;,3-4,preoptic,area,;,5.6.11,diencephalon,;,7,pretectum,;,8,anterior,paraventricular,organ,;,9,interior,paraventricular,organ,;,10,posterior,paraventricular,organ,;,12,posterior,tuberal,nucleus,;,13,hypothalamus,;,14,locus,coeruleus,;,15-16,medulla,oblongata,;,17,area,postrema,;,see,for,additional,details,),(,modiﬁed,from,),","}	{NULL}
SCPDFS_1158.pdf	542	{436,A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	543	{120,-,control}	{NULL}
SCPDFS_1158.pdf	544	{Icontrol,+,DFO,El,trpm7,',/,'}	{NULL}
SCPDFS_1158.pdf	545	{100,IZI,trpm7,',/,‘,+,DFO}	{NULL}
SCPDFS_1158.pdf	546	{G,),O,O,),o}	{NULL}
SCPDFS_1158.pdf	547	{Distance,Moved,(,cm,),8,*,5}	{NULL}
SCPDFS_1158.pdf	548	{I,*,I,*,E,"\\\\","\\\\","\\\\","\\\\","\\\\",‘,_,',_,I,a,=}	{NULL}
SCPDFS_1158.pdf	549	{Time,Elapsed,(,min,)}	{NULL}
SCPDFS_1158.pdf	550	{Fig,.}	{NULL}
SCPDFS_1158.pdf	551	{6,.}	{NULL}
SCPDFS_1158.pdf	552	{DFO,partially,rescues,hypomotility,of,trpm7,mutants,.}	{NULL}
SCPDFS_1158.pdf	553	{DFO,treatment,increased,spontaneous,motility,of,5,—,dpf,",",trpm7,”,5,°,8,mutant,larvae,.}	{NULL}
SCPDFS_1158.pdf	554	{Automated,analysis,of,motility,was,carried,out,as,in,Fig,.}	{NULL}
SCPDFS_1158.pdf	555	{2,.}	{NULL}
SCPDFS_1158.pdf	556	{For,each,experiment,",",half,of,a,single,clutch,of,larvae,from,trpm7,heterozygous,adults,was,treated,with,50,pM,DFO,from,2-5,dpf,.}	{NULL}
SCPDFS_1158.pdf	557	{Motility,of,control,larvae,was,unaffected,by,DFO,treatment,(,Student,'s,t,—,test,",",p,>,0.4,),.}	{NULL}
SCPDFS_1158.pdf	558	{Motility,of,the,trpm7,mutant,was,signiﬁcantly,increased,by,treatment,with,DFO,in,darkness,(,Student,‘,s,t,—,test,",",p,<,"0,05",),",",Each,group,tested,consisted,of,23-24,animals,.}	{NULL}
SCPDFS_1158.pdf	559	{Error,bars,represent,SEM,.}	{NULL}
SCPDFS_1158.pdf	560	{Asterisks,",",signiﬁcantly,different,values,.}	{NULL}
SCPDFS_1158.pdf	561	{found,no,correlation,between,average,distance,moved,in,the,lightdark,analysis,and,the,presence,of,kidney,stones,(,Pearson,correlation,coefﬁcient,of,0.015,",",n,=,43,",",two,—,tailed,p,=,0.51,),.}	{NULL}
SCPDFS_1158.pdf	562	{These,ﬁndings,support,the,possibility,that,Trpm7,is,required,within,dopaminergic,neurons,in,zebraﬁsh,larvae,",",although,this,remains,to,be,tested,experimentally,.}	{NULL}
SCPDFS_1158.pdf	563	{Because,of,distinct,phenotypes,in,zebraﬁsh,and,mouse,Trpm7,loss,—,of,—,function,mutants,",",it,is,unknown,whether,there,is,requirement,for,TRPM7,within,mammalian,dopaminergic,neurons,.}	{NULL}
SCPDFS_1158.pdf	564	{SH,.}	{NULL}
SCPDFS_1158.pdf	565	{—,.}	{NULL}
SCPDFS_1158.pdf	566	{SY5Y,is,a,dopaminergic,",",neuroblastoma,—,derived,cell,line,that,can,be,induced,to,differentiate,in,vitro,(,Encinas,et,al.,",",2000,),.}	{NULL}
SCPDFS_1158.pdf	567	{We,infected,SH,.}	{NULL}
SCPDFS_1158.pdf	568	{—,.}	{NULL}
SCPDFS_1158.pdf	569	{SY5Y,cells,with,adenovirus,encoding,the,TRPM7,—,E1047l,(,channel,—,pore,mutant,form,of,TRPM7,(,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	570	{—,.}	{NULL}
SCPDFS_1158.pdf	571	{DN,),",",or,with,a,control,adenovirus,expressing,LacZ,.}	{NULL}
SCPDFS_1158.pdf	572	{Electrophysiological,recordings,in,HEK,—,293,cells,conﬁrmed,our,expectation,that,TRPM7,—,E1047l,<,acts,in,dominant,—,negative,fashion,",",suppressing,wild,—,type,TRPM7,currents,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	573	{7A,and,B,),.}	{NULL}
SCPDFS_1158.pdf	574	{In,comparison,to,nontransduced,and,LacZ,—,expressing,SH,.}	{NULL}
SCPDFS_1158.pdf	575	{—,.}	{NULL}
SCPDFS_1158.pdf	576	{SY5Y,cells,",",TRPM7,.}	{NULL}
SCPDFS_1158.pdf	577	{—,.}	{NULL}
SCPDFS_1158.pdf	578	{DNexpressing,counterparts,underwent,cell,death,at,an,elevated,rate,",",whether,or,not,they,were,induced,to,differentiate,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	579	{7C,and,D,),.}	{NULL}
SCPDFS_1158.pdf	580	{Treatment,with,DFO,did,not,alleviate,the,toxicity,of,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	581	{—,.}	{NULL}
SCPDFS_1158.pdf	582	{DN,(,Fig,.}	{NULL}
SCPDFS_1158.pdf	583	{S3,),.}	{NULL}
SCPDFS_1158.pdf	584	{These,ﬁndings,suggest,that,survival,of,a,human,dopaminergic,cell,—,line,requires,TRPM7,in,a,cellautonomous,fashion,.}	{NULL}
SCPDFS_1158.pdf	585	{Discussion}	{NULL}
SCPDFS_1158.pdf	586	{The,zebraﬁsh,trpm7,mutant,provides,an,unusual,opportunity,to,explore,the,roles,for,Trpm7,in,cell,differentiation,and,physiology,at,stages,of,development,later,than,gastrulation,",",the,stage,when,mice,and,frogs,depleted,of,Trpm7,die,.}	{NULL}
SCPDFS_1158.pdf	587	{Here,we,have,presented,several,pieces,of,evidence,that,in,zebraﬁsh,trpm7,lossof,—,function,mutants,there,is,defective,function,of,dopaminergic,neurons,leading,to,behavioral,phenotypes,.}	{NULL}
SCPDFS_1158.pdf	588	{First,",",motility,in,trpm7,mutant,larvae,in,the,dark,can,be,elevated,by,a,concentration,of,L,—,dopa,that,has,no,effect,on,sibling,larvae,.}	{NULL}
SCPDFS_1158.pdf	589	{Tonic,application,of,L,—,dopa,probably,poorly,mimics,endogenous,dopamine,(,DA,),signaling,and,may,have,indirect,compensatory,effects,on,Trpm,7,—,dependent,neuronal,populations,controlling,motility,.}	{NULL}
SCPDFS_1158.pdf	590	{Nonetheless,",",these,ﬁndings,suggest,that,within,trpm7,mutants,there,is,a,defect,in,the,production,or,release,of,DA,while,other,elements,of,DA,signaling,relevant,to,motility,remain,intact,.}	{NULL}
SCPDFS_1158.pdf	591	{Second,",",the,observation,that,trpm7,mutants,do,not,undergo,the,stereotypic,",",DA,—,dependent,developmental,switch,from,long,to,short,swimming,episodes,but,will,do,so,if,provided,with,exogenous,DA,also,suggests,there,lower,—,than,—,normal,levels,of,dopaminergic,signaling,in,trpm7,mutants,.}	{NULL}
SCPDFS_1158.pdf	592	{It,also,implies,that,the,signaling,mechanisms,and,neural,circuits,that,result,in,DA,—,mediated,shortening,of,swimming,episodes,",",which,were,previously,shown,to,be,separable,from,those,that,set,motility,levels,(,Lambert,et,al.,",",2012,),",",function,properly,.}	{NULL}
SCPDFS_1158.pdf	593	{Third,",",the,numbers,of,expressing,th1,—,expressing,and,th2,—,expressing,neurons,are,modestly,but,signiﬁcantly,reduced,in,trpm7,mutant,larvae,in,comparison,to,sibling,larvae,.}	{NULL}
SCPDFS_1158.pdf	594	{A,concomitant,reduction,in,DA,production,in,the,brain,may,account,for,motility,defects,in,mutants,.}	{NULL}
SCPDFS_1158.pdf	595	{We,conducted,an,HPLC,analysis,of,biogenic,amines,in,whole,embryo,lysates,but,",",because,of,confounding,effects,of,melanocytes,",",it,was,not,sensitive,enough,to,detect,changes,in,levels,of,biogenic,amines,of,the,magnitude,as,changes,in,th,expression,(,data,not,shown,),.}	{NULL}
SCPDFS_1158.pdf	596	{A,similar,analysis,of,isolated,brains,may,sufﬁce,to,do,so,.}	{NULL}
SCPDFS_1158.pdf	597	{Alternatively,",",the,cause,of,lower,—,than,—,normal,dopaminergic,signaling,in,Trpm7,mutants,may,be,other,than,reduced,DA,production,;,for,instance,there,may,be,a,defect,in,evacuation,of,DA,from,synaptic,vesicles,",",as,has,been,proposed,in,cholinergic,vesicles,(,Brauchi,et,al.,",",2008,;,Krapivinsky,et,al.,",",2006,),.}	{NULL}
SCPDFS_1158.pdf	598	{Because,motility,of,trpm7,mutants,after,a,dark,—,to,—,light,transition,is,not,measurably,restored,by,L,—,dopa,treatment,",",there,may,be,separate,contributions,of,Trpm7,to,motility,other,than,its,role,in,development,or,function,of,DA,neurons,.}	{NULL}
SCPDFS_1158.pdf	599	{There,is,a,recent,report,that,Th2,has,tryptophan,hydroxylase,activity,(,Ren,et,al.,",",2013,),.}	{NULL}
SCPDFS_1158.pdf	600	{While,the,number,of,neurons,that,are,immunoreac,—,tive,for,5HT,appears,to,be,normal,in,Trpm7,mutant,larvae,",",we,can,not,rule,out,a,role,for,Trpm7,in,function,of,serotonergic,neurons,.}	{NULL}
SCPDFS_1158.pdf	601	{In,summary,",",the,physiological,role,of,Trpm7,in,motility,of,5,dpf,zebraﬁsh,larvae,in,dark,periods,is,largely,explained,by,a,direct,or,indirect,requirement,for,Trpm7,in,dopaminergic,neurons,",",while,its,role,in,motility,in,the,light,phase,remains,unexplained,.}	{NULL}
SCPDFS_1158.pdf	602	{The,mechanistic,underpinnings,of,the,defect,in,the,DA,neurons,in,trpm7,mutants,remain,unclear,.}	{NULL}
SCPDFS_1158.pdf	603	{However,",",two,observations,suggest,that,in,DA,neurons,",",as,in,melanocytes,but,in,contrast,to,in,other,cell,types,(,Chen,et,al.,",",2012,),",",loss,of,Trpm7,elevates,oxidative,stress,.}	{NULL}
SCPDFS_1158.pdf	604	{First,",",trpm7,mutants,are,unusually,sensitive,to,treatment,with,MPP,+,",",a,toxin,that,raises,levels,of,reactive,oxygen,species,and,that,prevents,the,differentiation,of,",",and,may,kill,",",dopaminergic,neurons,in,zebraﬁsh,(,Burns,et,al.,",",1983,;,Heikkila,et,al.,",",1985,;,Sallinen,et,al.,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	605	{Second,",",mutants,treated,with,DFO,",",an,iron,chelator,and,anti,—,oxidant,that,halts,the,Fenton,reaction,",",were,more,motile,than,untreated,animals,.}	{NULL}
SCPDFS_1158.pdf	606	{How,might,the,loss,of,Trpm7,lead,to,increased,oxidative,stress,in,dopaminergic,neurons,in,vivo,?}	{NULL}
SCPDFS_1158.pdf	607	{The,primary,defect,may,be,a,disruption,of,cellular,magnesium,homeostasis,",",as,organismal,magnesium,levels,are,abnormal,in,zebraﬁsh,trpm7,mutants,(,Elizondo,et,al.,",",2010,),",",and,there,is,some,evidence,connecting,abnormal,cellular,magnesium,homeostasis,and,risk,for,Parkinson,'s,disease,(,see,references,in,Kolisek,et,al.,",",2013,),.}	{NULL}
SCPDFS_1158.pdf	608	{In,zebraﬁsh,trpm7,mutants,",",melanocytes,have,abnormally,shaped,melanosomes,and,undergo,cell,death,that,is,rescued,by,inhibition,of,tyrosinase,(,McNeill,et,al.,",",2007,),.}	{NULL}
SCPDFS_1158.pdf	609	{Perhaps,in,the,absence,of,Trpm7,the,integrity,of,dopaminergic,vesicles,is,also,compromised,",",and,the,toxic,molecule,dopamine,is,released,into,the,cytoplasm,.}	{NULL}
SCPDFS_1158.pdf	610	{How,Trpm7,affects,the,integrity,of,these,vesicles,is,unknown,",",but,it,is,noteworthy,that,calcium,channel,blockers,can,cause,a,loss,of,the,ATP,—,dependent,proton}	{NULL}
SCPDFS_1158.pdf	611	{A.R.,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-439 437"}	{NULL}
SCPDFS_1158.pdf	612	{A,PA/PF}	{NULL}
SCPDFS_1158.pdf	613	{200,1,75,1,50,1,25,1,Oo,75,50,TRPM7,+,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	614	{—,.}	{NULL}
SCPDFS_1158.pdf	615	{DN}	{NULL}
SCPDFS_1158.pdf	616	{NT}	{NULL}
SCPDFS_1158.pdf	617	{LacZ,B,PA/PF,200}	{NULL}
SCPDFS_1158.pdf	618	{+100,mV}	{NULL}
SCPDFS_1158.pdf	619	{-50,TRPM7,TRPM7,+,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	620	{—,.}	{NULL}
SCPDFS_1158.pdf	621	{DN}	{NULL}
SCPDFS_1158.pdf	622	{TRPM7-DN}	{NULL}
SCPDFS_1158.pdf	623	{TRPM7,.}	{NULL}
SCPDFS_1158.pdf	624	{—,.}	{NULL}
SCPDFS_1158.pdf	625	{DN}	{NULL}
SCPDFS_1158.pdf	626	{Fig,.}	{NULL}
SCPDFS_1158.pdf	627	{7,.}	{NULL}
SCPDFS_1158.pdf	628	{Expression,of,TRPM7,dominant,—,negative,(,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	629	{—,.}	{NULL}
SCPDFS_1158.pdf	630	{DN,),suppresses,differentiation,by,causing,cell,death,.}	{NULL}
SCPDFS_1158.pdf	631	{(,A,),Representative,traces,show,the,current,—,voltage,relationship,in,HEK,—,293,cells,with,expression,of,wild,—,type,TRPM7,alone,or,with,coexpression,of,wild,—,type,TRPM7,and,the,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	632	{—,.}	{NULL}
SCPDFS_1158.pdf	633	{E1047l,(,pore,mutant,(,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	634	{—,.}	{NULL}
SCPDFS_1158.pdf	635	{DN,),.}	{NULL}
SCPDFS_1158.pdf	636	{(,B,),Coexpression,of,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	637	{—,.}	{NULL}
SCPDFS_1158.pdf	638	{DN,with,wild,—,type,TRPM7,in,HEl,(,.}	{NULL}
SCPDFS_1158.pdf	639	{—,.}	{NULL}
SCPDFS_1158.pdf	640	{293,cells,suppressed,TRPM7,current,densities,at,—,120,mV,and,+100,mV,.}	{NULL}
SCPDFS_1158.pdf	641	{(,C,),Representative,phase,—,contrast,images,of,SH,.}	{NULL}
SCPDFS_1158.pdf	642	{—,.}	{NULL}
SCPDFS_1158.pdf	643	{SY5Y,cells,treated,with,retinoic,acid,(,RA,),",",at,4,and,6,days,after,plating,.}	{NULL}
SCPDFS_1158.pdf	644	{Shown,are,non,—,transduced,(,NT,),cells,",",cells,transduced,with,lacZ,for,2,and,4,days,",",and,cells,transduced,with,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	645	{—,.}	{NULL}
SCPDFS_1158.pdf	646	{DN,for,2,and,4,days,.}	{NULL}
SCPDFS_1158.pdf	647	{Scale,bar,=,200,pm,.}	{NULL}
SCPDFS_1158.pdf	648	{(,D,),Cell,viability,of,non,—,transduced,(,NT,),",",LacZ,expressing,",",and,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	649	{—,.}	{NULL}
SCPDFS_1158.pdf	650	{DN,expressing,SH,.}	{NULL}
SCPDFS_1158.pdf	651	{—,.}	{NULL}
SCPDFS_1158.pdf	652	{SY5Y,cells,treated,with,RA,6,days,after,plating,and,3,days,post,—,transduction,.}	{NULL}
SCPDFS_1158.pdf	653	{Viability,of,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	654	{—,.}	{NULL}
SCPDFS_1158.pdf	655	{DN,transduced,and,NT,cells,was,signiﬁcantly,different,(,Student,'s,t,—,test,",",p,=,0.006,),.}	{NULL}
SCPDFS_1158.pdf	656	{Viability,was,expressed,as,percent,of,non,—,transduced,(,%,NT,),cells,.}	{NULL}
SCPDFS_1158.pdf	657	{gradient,in,catecholaminergic,vesicles,",",reduce,DA,content,",",and,can,promote,cell,death,among,dopaminergic,neurons,(,Terland,and,Flatmark,",",1999,),.}	{NULL}
SCPDFS_1158.pdf	658	{In,summary,",",a,plausible,model,that,warrants,further,testing,is,that,in,the,absence,of,Trpm7,",",defective,cation,homeostasis,leads,to,elevated,oxidative,stress,which,disrupts,function,",",differentiation,",",and,survival,of,dopaminergic,neurons,.}	{NULL}
SCPDFS_1158.pdf	659	{While,there,is,no,clear,link,between,TRPM7,and,any,human,disorder,",",the,mechanisms,by,which,DA,neurons,are,compromised,in,the,zebraﬁsh,trpm7,mutants,may,be,relevant,to,clinical,conditions,.}	{NULL}
SCPDFS_1158.pdf	660	{Amyotrophic,lateral,sclerosis/parkinsonian,dementia,complex,(,ALS/PDC,),is,a,disease,to,which,epidemiologists,have,long,ascribed,an,environmental,cause,(,Banack,and,Cox,",",2003,),.}	{NULL}
SCPDFS_1158.pdf	661	{A,variant,of,TRPM7,with,increased,sensitivity,to,inhibition,by,magnesium,was,found,to,be,over,—,represented,in,families,with,ALS/PDC,in,Guam,(,Hermosura,et,al.,",",2005,),but,not,in,the,Kii,peninsula,of,japan,(,l-lara,et,al.,",",2010,),.}	{NULL}
SCPDFS_1158.pdf	662	{Evidence,of,a,role,for,this,ion,channel,in,function,and,maintenance,of,dopaminergic,neurons,presented,here,supports,further,investigation,into,the,possibility,that,mutations,in,TRPM7,predispose,individuals,to,ALS/PDC,.}	{NULL}
SCPDFS_1158.pdf	663	{Indeed,",",zebraﬁsh,trpm7,mutants,may,serve,as,a,model,for,the}	{NULL}
SCPDFS_1158.pdf	664	{438,All,Decker,et,al.,/,Developmental,Biology,386,(,2014,),428-439}	{NULL}
SCPDFS_1158.pdf	665	{gene-environment,interaction,underlying,ALS/PDC,.}	{NULL}
SCPDFS_1158.pdf	666	{Also,",",there,is,an,association,between,risks,for,Parkinson,'s,disease,and,metastatic}	{NULL}
SCPDFS_1158.pdf	667	{melanoma,(,Liu,et,al.,",",2011a,;,Pan,et,al.,",",2011,),.}	{NULL}
SCPDFS_1158.pdf	668	{This,association,has,been,proposed,to,result,from,failure,of,a,mechanism,used,to,contain,quinone-related,toxins,in,both,dopaminergic,neurons,and,melanocytes,(,Hernandez,",",2009,),;,TRPM7,may,contribute,to,such,a,mechanism,.}	{NULL}
SCPDFS_1158.pdf	669	{Finally,",",stem,cell-based,therapies,have,the,potential,to,restore,the,damage,caused,by,neurodegenerative,diseases,.}	{NULL}
SCPDFS_1158.pdf	670	{Such,therapies,require,a,clear,understanding,of,the,mechanisms,that,govern,the,differentiation,and,survival,of,dopaminergic,neurons,",",including,the,role,of,TRPM7,in,these,processes,(,Hegarty,et,al.,",",2013,),.}	{NULL}
SCPDFS_1158.pdf	671	{Acknowledgements}	{NULL}
SCPDFS_1158.pdf	672	{We,are,grateful,to,Austin,Keeler,",",Hayley,Martin,",",Christine,Roenitz,",",Melina,Hale,",",and,Jonathan,Doorn,for,preliminary,work,on,this,project,.}	{NULL}
SCPDFS_1158.pdf	673	{We,thank,James,Gambrell,for,statistical,consultation,and,Alan,Kay,for,useful,discussions,and,for,chelators,.}	{NULL}
SCPDFS_1158.pdf	674	{This,work,was,supported,by,the,following,grants,:,NIEHS/NIH,P30,ES05605,(,University,of,Iowa,Environmental,Health,Sciences,Research,Center,),(,seed,grant,to,RAC,),",",GMO67841,(,RAC,),",",NSF,lOS1147221,(,RAC,),",",R01EYO18814,(,SEB,),",",R01EY015165,(,SEB,),",",Core,Grant,P3OEY001730,(,UW,),",",NSO69898,(,DPM,),",",NS065054,(,MAM,),",",RO1GMO80753,(,LWR,),",",Academy,of,Finland,116177,(,PP,),",",Sigrid,Juselius,Foundation,(,PP,),.}	{NULL}
SCPDFS_1158.pdf	675	{Matthew,McNeill,'s,current,address,:,Institute,for,Genomic,Biology,",",1206W,.}	{NULL}
SCPDFS_1158.pdf	676	{Gregory,",",RM,2401G,",",University,of,Illinois,",",Urbana,",",IL,.}	{NULL}
SCPDFS_1158.pdf	677	{Appendix,A.,Supplementary,materials}	{NULL}
SCPDFS_1158.pdf	678	{Supplementary,data,associated,with,this,article,can,be,found,in,the,online,version,at,http://dx.doi.org/10.1016/j.ydbio.2013.11.015,.}	{NULL}
SCPDFS_1158.pdf	679	{References}	{NULL}
SCPDFS_1158.pdf	680	{Aarts,",",M.,",",lihara,",",K.,",",Wei,",",W.L.,",",Xiong,",",Z.G.,",",Arundine,",",M.,",",Cerwinski,",",W.,",",MacDonald,",",J,",",F.,",",Tymianski,",",M.,",",2003,.}	{NULL}
SCPDFS_1158.pdf	681	{A,key,role,for,TRPM7,channels,in,anoxic,neuronal,death,.}	{NULL}
SCPDFS_1158.pdf	682	{Cell,115,",",863-877,.}	{NULL}
SCPDFS_1158.pdf	683	{Arduini,",",B.L.,",",Henion,",",PD,",",2004,",",Melanophore,sublineage,—,speciﬁc,requirement,for,zebraﬁsh,touchtone,during,neural,crest,development,.}	{NULL}
SCPDFS_1158.pdf	684	{Mech,.}	{NULL}
SCPDFS_1158.pdf	685	{Dev,",",121,",",1353-1364,.}	{NULL}
SCPDFS_1158.pdf	686	{Badakov,",",R.,",",Jazwinska,",",A.,",",2006,.}	{NULL}
SCPDFS_1158.pdf	687	{Efﬁcient,transfection,of,primary,zebraﬁsh,ﬁbroblasts,by,nucleofection,.}	{NULL}
SCPDFS_1158.pdf	688	{Cytotechnology,51,",",105-110,.}	{NULL}
SCPDFS_1158.pdf	689	{Banack,",",S.A.,",",Cox,",",PA,",",2003,",",Biomagniﬁcation,of,cycad,neurotoxins,in,ﬂying,foxes,:}	{NULL}
SCPDFS_1158.pdf	690	{implications,for,ALS,.}	{NULL}
SCPDFS_1158.pdf	691	{—,.}	{NULL}
SCPDFS_1158.pdf	692	{PDC,in,Guam,",",Neurology,61,",",387-389,.}	{NULL}
SCPDFS_1158.pdf	693	{Ben,.}	{NULL}
SCPDFS_1158.pdf	694	{—,.}	{NULL}
SCPDFS_1158.pdf	695	{Shachar,",",D.,",",Eshel,",",G.,",",Riederer,",",P.,",",Youdim,",",M.B.,",",1992,.}	{NULL}
SCPDFS_1158.pdf	696	{Role,of,iron,and,iron,chelation,in,dopaminergic,—,induced,neurodegeneration,:,implication,for,Parkinson,'s,disease,",",Ann,.}	{NULL}
SCPDFS_1158.pdf	697	{Neurol,",",32,(,Suppl,.,)}	{NULL}
SCPDFS_1158.pdf	698	{",",S105,—,110,.}	{NULL}
SCPDFS_1158.pdf	699	{Branson,",",K.,",",Robie,",",A.A.,",",Bender,",",J.,",",Perona,",",P.,",",Dickinson,",",MH.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	700	{Highthroughput,ethomics,in,large,groups,of,Drosophila,.}	{NULL}
SCPDFS_1158.pdf	701	{Nat,.}	{NULL}
SCPDFS_1158.pdf	702	{Methods,6,",",451-457,.}	{NULL}
SCPDFS_1158.pdf	703	{Brauchi,",",S.,",",Krapivinsky,",",G.,",",Krapivinsky,",",L.,",",Clapham,",",D.E.,",",2008,.}	{NULL}
SCPDFS_1158.pdf	704	{TRPM7,facilitates,cholinergic,vesicle,fusion,with,the,plasma,membrane,.}	{NULL}
SCPDFS_1158.pdf	705	{Proc,.}	{NULL}
SCPDFS_1158.pdf	706	{Nat,.}	{NULL}
SCPDFS_1158.pdf	707	{Acad,.}	{NULL}
SCPDFS_1158.pdf	708	{Sci,.}	{NULL}
SCPDFS_1158.pdf	709	{U.S.,A.,105,",",8304-8308,.}	{NULL}
SCPDFS_1158.pdf	710	{Burgess,",",H.A.,",",Granato,",",M.,",",2007,",",Modulation,of,locomotor,activity,in,larval,zebraﬁsh,during,light,adaptation,],.}	{NULL}
SCPDFS_1158.pdf	711	{Exp,.}	{NULL}
SCPDFS_1158.pdf	712	{Biol,.}	{NULL}
SCPDFS_1158.pdf	713	{210,",",2526-2539,.}	{NULL}
SCPDFS_1158.pdf	714	{Burns,",",R.,S,",",",",Chiueh,",",C.C.,",",Markey,",",S.P.,",",Ebert,",",M.,H,",",",",Jacobowitz,",",D.M.,",",Kopin,",",l.J.,",",1983,.}	{NULL}
SCPDFS_1158.pdf	715	{A,primate,model,of,parkinsonism,:,selective,destruction,of,dopaminergic,neurons,in,the,pars,compacta,of,the,substantia,nigra,by,N,—,methyl,—,4,—,phenyl,—,"1,2,3,6",—,tetrahydropyridine,.}	{NULL}
SCPDFS_1158.pdf	716	{Proc,.}	{NULL}
SCPDFS_1158.pdf	717	{Nat,.}	{NULL}
SCPDFS_1158.pdf	718	{Acad,.}	{NULL}
SCPDFS_1158.pdf	719	{Sci,.}	{NULL}
SCPDFS_1158.pdf	720	{U.S.A.,80,",",4546-4550,.}	{NULL}
SCPDFS_1158.pdf	721	{Buss,",",R.R.,",",Drapeau,",",P.,",",2001,.}	{NULL}
SCPDFS_1158.pdf	722	{Synaptic,drive,to,motoneurons,during,ﬁctive,swimming,in,the,developing,zebraﬁsh,",",J,",",Neurophysiol,.}	{NULL}
SCPDFS_1158.pdf	723	{86,",",197-210,.}	{NULL}
SCPDFS_1158.pdf	724	{Chen,",",H,",",C.,",",Su,",",L.T.,",",Gonzalez,.}	{NULL}
SCPDFS_1158.pdf	725	{—,.}	{NULL}
SCPDFS_1158.pdf	726	{Pagan,",",o.,",",Overton,",",J.,D,",",",",Runnels,",",L,",",W.,",",2012,",",A,key,role,for,Mg,(,2,+,),in,TRPM7,'s,control,of,ROS,levels,during,cell,stress,",",Biochem,.}	{NULL}
SCPDFS_1158.pdf	727	{J.,445,",",441-448,.}	{NULL}
SCPDFS_1158.pdf	728	{Chen,",",Y,",",C.,",",Priyadarshini,",",M.,",",Panula,",",P.,",",2009,",",Complementary,developmental,expression,of,the,two,tyrosine,hydroxylase,transcripts,in,zebraﬁsh,",",Histochem,.}	{NULL}
SCPDFS_1158.pdf	729	{Cell,Biol,.}	{NULL}
SCPDFS_1158.pdf	730	{132,",",375-381,.}	{NULL}
SCPDFS_1158.pdf	731	{Cheung,",",Y.T.,",",Lau,",",W.K.,",",Yu,",",M.S.,",",Lai,",",C.S.,",",Yeung,",",S.C.,",",So,",",K.F.,",",Chang,",",RC.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	732	{Effects,of,all,—,trans,—,retinoic,acid,on,human,SH,.}	{NULL}
SCPDFS_1158.pdf	733	{—,.}	{NULL}
SCPDFS_1158.pdf	734	{SY5Y,neuroblastoma,as,in,vitro,model,in,neurotoxicity,research,",",Neurotoxicology,30,",",127-135,.}	{NULL}
SCPDFS_1158.pdf	735	{Chubanov,",",V.,",",Waldegger,",",S.,",",Mederos,y,Schnitzler,",",M.,",",Vitzthum,",",H.,",",Sassen,",",M.C.,",",Seyberth,",",H.,W,",",",",Konrad,",",M.,",",Gudermann,",",T.,",",2004,.}	{NULL}
SCPDFS_1158.pdf	736	{Disruption,of,TRPM6/TRPM7,complex,formation,by,a,mutation,in,the,TRPM6,gene,causes,hypomagnesemia,with,secondary,hypocalcemia,.}	{NULL}
SCPDFS_1158.pdf	737	{Proc,.}	{NULL}
SCPDFS_1158.pdf	738	{Nat,",",Acad,.}	{NULL}
SCPDFS_1158.pdf	739	{Sci,.}	{NULL}
SCPDFS_1158.pdf	740	{U.S.A.,101,",",2894-2899,.}	{NULL}
SCPDFS_1158.pdf	741	{Cornell,",",R.A.,",",Yemm,",",E.,",",Bonde,",",G.,",",Li,",",W.,",",d'Alencon,",",C,",",",",Wegman,",",L.,",",Eisen,",",J.,",",Zahs,",",A.,",",2004,.}	{NULL}
SCPDFS_1158.pdf	742	{Touchtone,promotes,survival,of,embryonic,melanophores,in,zebraﬁsh,",",Mech,.}	{NULL}
SCPDFS_1158.pdf	743	{Dev,.}	{NULL}
SCPDFS_1158.pdf	744	{121,",",1365-1376,.}	{NULL}
SCPDFS_1158.pdf	745	{Elizondo,",",M,",",R.,",",Arduini,",",B.L.,",",Paulsen,",",J.,",",MacDonald,",",E.L.,",",Sabel,",",J,",",L.,",",Henion,",",P,",",D.,",",Cornell,",",R.,A,",",",",Parichy,",",D.M.,",",2005,.}	{NULL}
SCPDFS_1158.pdf	746	{Defective,sl,<,eletogenesis,with,kidney,stone,formation,in,dwarf,zebraﬁsh,mutant,for,trpm7,.}	{NULL}
SCPDFS_1158.pdf	747	{Curr,.}	{NULL}
SCPDFS_1158.pdf	748	{Biol,",",15,",",667-671,.}	{NULL}
SCPDFS_1158.pdf	749	{Elizondo,",",M.R.,",",Budi,",",E.,H,",",",",Parichy,",",DM.,",",2010,.}	{NULL}
SCPDFS_1158.pdf	750	{trpm7,regulation,of,in,vivo,cation,homeostasis,and,kidney,function,involves,stanniocalcin,1,and,fgt23,.}	{NULL}
SCPDFS_1158.pdf	751	{Endocrinology,151,",",5700-5709,.}	{NULL}
SCPDFS_1158.pdf	752	{Emran,",",F.,",",Rihel,",",J.,",",Dowling,",",JE,",",",",2008,.}	{NULL}
SCPDFS_1158.pdf	753	{A,behavioral,assay,to,measure,responsiveness,of,zebraﬁsh,to,changes,in,light,intensities,.}	{NULL}
SCPDFS_1158.pdf	754	{J.,Vis,.}	{NULL}
SCPDFS_1158.pdf	755	{Exp,.}	{NULL}
SCPDFS_1158.pdf	756	{.}	{NULL}
SCPDFS_1158.pdf	757	{Encinas,",",M.,",",lglesias,",",M.,",",Liu,",",Y.,",",Wang,",",H.,",",Muhaisen,",",A.,",",Cena,",",V.,",",Gallego,",",C.,",",Comella,",",J.X.,",",2000,.}	{NULL}
SCPDFS_1158.pdf	758	{Sequential,treatment,of,SH,.}	{NULL}
SCPDFS_1158.pdf	759	{—,.}	{NULL}
SCPDFS_1158.pdf	760	{SY5Y,cells,with,retinoic,acid,and,brain,—,derived,neurotrophic,factor,gives,rise,to,fully,differentiated,",",neurotrophic,factor,—,dependent,",",human,neuron,—,like,cells,.}	{NULL}
SCPDFS_1158.pdf	761	{J.,Neurochem,.}	{NULL}
SCPDFS_1158.pdf	762	{75,",",991-1003,.}	{NULL}
SCPDFS_1158.pdf	763	{Fernandes,",",A.M.,",",Fero,",",K.,",",Arrenberg,",",A,",",B.,",",Bergeron,",",S.A.,",",Driever,",",W.,",",Burgess,",",HA,",",2012,.}	{NULL}
SCPDFS_1158.pdf	764	{Deep,brain,photoreceptors,control,light,—,seel,<,ing,behavior,in,zebraﬁsh,larvae,.}	{NULL}
SCPDFS_1158.pdf	765	{Curr,",",Biol,.}	{NULL}
SCPDFS_1158.pdf	766	{CB,22,",",2042-2047,.}	{NULL}
SCPDFS_1158.pdf	767	{Filippi,",",A.,",",Mahler,",",J.,",",Schweitzer,",",J.,",",Driever,",",W.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	768	{Expression,of,the,paralogous,tyrosine,hydroxylase,encoding,genes,th1,and,th2,reveals,the,full,complement,of,dopaminergic,and,noradrenergic,neurons,in,zebraﬁsh,larval,and,juvenile,brain,",",J.,Comp,.}	{NULL}
SCPDFS_1158.pdf	769	{Neurol,",",518,",",423-438,.}	{NULL}
SCPDFS_1158.pdf	770	{Fuiman,",",L,",",A.,",",Webb,",",P.W.,",",1988,.}	{NULL}
SCPDFS_1158.pdf	771	{Ontogeny,of,routine,swimming,activity,and,performance,in,Zebra,Danios,(,Teleostei,",",Cyprinidae,),",",Anim,.}	{NULL}
SCPDFS_1158.pdf	772	{Behav,.}	{NULL}
SCPDFS_1158.pdf	773	{36,",",250-261,.}	{NULL}
SCPDFS_1158.pdf	774	{Hanano,",",T.,",",Hara,",",Y.,",",Shi,",",J,",",",",Morita,",",H.,",",Umebayashi,",",C.,",",Mori,",",E.,",",Sumimoto,",",H.,",",Ito,",",Y.,",",Mori,",",Y.,",",lnoue,",",R.,",",2004,.}	{NULL}
SCPDFS_1158.pdf	775	{Involvement,of,TRPM7,in,cell,growth,as,a,spontaneously,activated,Ca2,+,entry,pathway,in,human,retinoblastoma,cells,.}	{NULL}
SCPDFS_1158.pdf	776	{J.,Pharmacol,.}	{NULL}
SCPDFS_1158.pdf	777	{Sci,.}	{NULL}
SCPDFS_1158.pdf	778	{95,",",403-419,.}	{NULL}
SCPDFS_1158.pdf	779	{Hara,",",K.,",",Kokubo,",",Y.,",",lshiura,",",H.,",",Fukuda,",",Y.,",",Miyashita,",",A.,",",Kuwano,",",R.,",",Sasaki,",",R.,",",Goto,",",J.,",",Nishizawa,",",M.,",",Kuzuhara,",",S.,",",Tsuji,",",S.,",",2010,",",TRPM7,is,not,associated,with,amyotrophic,lateral,sclerosis,—,parl,<,insonism,dementia,complex,in,the,Kii,peninsula,of,Japan,.}	{NULL}
SCPDFS_1158.pdf	780	{Am,.}	{NULL}
SCPDFS_1158.pdf	781	{J.,Med,.}	{NULL}
SCPDFS_1158.pdf	782	{Genet,Part,B,",",Neuropsychiatric,Genet,.}	{NULL}
SCPDFS_1158.pdf	783	{153B,",",310-313,.}	{NULL}
SCPDFS_1158.pdf	784	{Hegarty,",",S.,V,",",",",Sullivan,",",A.M.,",",O'Keeffe,",",G.,W,",",",",2013,.}	{NULL}
SCPDFS_1158.pdf	785	{Midbrain,dopaminergic,neurons,:,a,review,of,the,molecular,circuitry,that,regulates,their,development,",",Dev,.}	{NULL}
SCPDFS_1158.pdf	786	{Biol,.}	{NULL}
SCPDFS_1158.pdf	787	{.}	{NULL}
SCPDFS_1158.pdf	788	{Heikkila,",",R.E.,",",Nicklas,",",W.J.,",",Vyas,",",1.,",",Duvoisin,",",R.,C,",",",",1985,.}	{NULL}
SCPDFS_1158.pdf	789	{Dopaminergic,toxicity,of,rotenone,and,the,1,—,methyl,—,4,—,phenylpyridinium,ion,after,their,stereotaxic,administration,to,rats,:,implication,for,the,mechanism,of,1,—,methyl,—,4,—,phenyl,—,"1,2,3,6",—,tetrahydropyridine,toxicity,.}	{NULL}
SCPDFS_1158.pdf	790	{Neurosci,.}	{NULL}
SCPDFS_1158.pdf	791	{Lett,.}	{NULL}
SCPDFS_1158.pdf	792	{62,",",389-394,.}	{NULL}
SCPDFS_1158.pdf	793	{Hermosura,",",M.C.,",",Nayakanti,",",H.,",",Dorovkov,",",M.,V,",",",",Calderon,",",F.R.,",",Ryazanov,",",A.G.,",",Haymer,",",D,",",S.,",",Garruto,",",R.M.,",",2005,.}	{NULL}
SCPDFS_1158.pdf	794	{A,TRPM7,variant,shows,altered,sensitivity,to,magnesium,that,may,contribute,to,the,pathogenesis,of,two,Guamanian,neurodegenerative,disorders,.}	{NULL}
SCPDFS_1158.pdf	795	{Proc,.}	{NULL}
SCPDFS_1158.pdf	796	{Nat,",",Acad,.}	{NULL}
SCPDFS_1158.pdf	797	{Sci,.}	{NULL}
SCPDFS_1158.pdf	798	{U.S.A.,102,",",11510-11515,.}	{NULL}
SCPDFS_1158.pdf	799	{Hernandez,",",EH,",",2009,",",Pigmentation,genes,link,Parkinson,'s,disease,to,melanoma,",",opening,a,window,on,both,etiologies,.}	{NULL}
SCPDFS_1158.pdf	800	{Med,.}	{NULL}
SCPDFS_1158.pdf	801	{Hypotheses,72,",",280-284,.}	{NULL}
SCPDFS_1158.pdf	802	{Hochstein,",",P.,",",Cohen,",",G.,",",1963,.}	{NULL}
SCPDFS_1158.pdf	803	{The,cytotoxicity,of,melanin,precursors,.}	{NULL}
SCPDFS_1158.pdf	804	{Ann,",",NY,",",Acad,.}	{NULL}
SCPDFS_1158.pdf	805	{Sci,.}	{NULL}
SCPDFS_1158.pdf	806	{100,",",876-886,.}	{NULL}
SCPDFS_1158.pdf	807	{Holzschuh,",",J.,",",Ryu,",",S.,",",Aberger,",",F.,",",Driever,",",W.,",",2001,.}	{NULL}
SCPDFS_1158.pdf	808	{Dopamine,transporter,expression,distinguishes,dopaminergic,neurons,from,other,catecholaminergic,neurons,in,the,developing,zebraﬁsh,embryo,.}	{NULL}
SCPDFS_1158.pdf	809	{Mech,.}	{NULL}
SCPDFS_1158.pdf	810	{Dev,",",101,",",237-243,.}	{NULL}
SCPDFS_1158.pdf	811	{lnoue,",",K.,",",Branigan,",",D.,",",Xiong,",",Z.G.,",",2010,.}	{NULL}
SCPDFS_1158.pdf	812	{Zinc,—,induced,neurotoxicity,mediated,by,transient,receptor,potential,melastatin,7,channels,",",J.,Biol,.}	{NULL}
SCPDFS_1158.pdf	813	{Chem,.}	{NULL}
SCPDFS_1158.pdf	814	{285,",",7430-7439,.}	{NULL}
SCPDFS_1158.pdf	815	{Jin,",",J.,",",Desai,",",B.,N,",",",",Navarro,",",B.,",",Donovan,",",A.,",",Andrews,",",N.C.,",",Clapham,",",D.E.,",",2008,",",Deletion,of,Trpm7,disrupts,embryonic,development,and,thymopoiesis,without,altering,Mg,“,homeostasis,",",Science,322,",",756-760,.}	{NULL}
SCPDFS_1158.pdf	816	{Jin,",",J.,",",Wu,",",L.J.,",",Jun,",",J.,",",Cheng,",",X.,",",Xu,",",H.,",",Andrews,",",N.C.,",",Clapham,",",D.E.,",",2012,",",The,channel,kinase,",",TRPM7,",",is,required,for,early,embryonic,development,",",Proc,.}	{NULL}
SCPDFS_1158.pdf	817	{Nat,.}	{NULL}
SCPDFS_1158.pdf	818	{Acad,.}	{NULL}
SCPDFS_1158.pdf	819	{Sci,.}	{NULL}
SCPDFS_1158.pdf	820	{U.S.A.,109,",",E225-233,.}	{NULL}
SCPDFS_1158.pdf	821	{Kelsh,",",R,",",N.,",",Brand,",",M.,",",Jiang,",",Y.J.,",",Heisenberg,",",C.P.,",",Lin,",",5.,",",Haffter,",",P,",",",",Odenthal,",",J.,",",Mullins,",",M.C.,",",van,Eeden,",",E.J.,",",Furutani,.}	{NULL}
SCPDFS_1158.pdf	822	{—,.}	{NULL}
SCPDFS_1158.pdf	823	{Seiki,",",M.,",",Granato,",",M.,",",Hammerschmidt,",",M.,",",Kane,",",D.A.,",",Warga,",",R.M.,",",Beuchle,",",D.,",",Vogelsang,",",L.,",",Nusslein,.}	{NULL}
SCPDFS_1158.pdf	824	{—,.}	{NULL}
SCPDFS_1158.pdf	825	{Volhard,",",C.,",",1996,.}	{NULL}
SCPDFS_1158.pdf	826	{Zebraﬁsh,pigmentation,mutations,and,the,processes,of,neural,crest,development,.}	{NULL}
SCPDFS_1158.pdf	827	{Development,123,",",369-389,.}	{NULL}
SCPDFS_1158.pdf	828	{Kim,",",B.,J,",",",",Park,",",E.J.,",",Lee,",",J.,H,",",",",Jeon,",",J.H.,",",Kim,",",S.J.,",",So,",",1,",",",",2008,.}	{NULL}
SCPDFS_1158.pdf	829	{Suppression,of,transient,receptor,potential,melastatin,7,channel,induces,cell,death,in,gastric,cancer,.}	{NULL}
SCPDFS_1158.pdf	830	{Cancer,Sci,.}	{NULL}
SCPDFS_1158.pdf	831	{99,",",2502-2509,.}	{NULL}
SCPDFS_1158.pdf	832	{Kimmel,",",C.B.,",",Ballard,",",W,",",W.,",",Kimmel,",",S.R.,",",Ullmann,",",B.,",",Schilling,",",T.F.,",",1995,.}	{NULL}
SCPDFS_1158.pdf	833	{Stages,of,embryonic,development,of,the,zebraﬁsh,.}	{NULL}
SCPDFS_1158.pdf	834	{Dev,.}	{NULL}
SCPDFS_1158.pdf	835	{Dyn,.}	{NULL}
SCPDFS_1158.pdf	836	{203,",",253-310,.}	{NULL}
SCPDFS_1158.pdf	837	{Kolisek,",",M.,",",Sponder,",",G.,",",Mastrototaro,",",L.,",",Smorodchenko,",",A.,",",Launay,",",P.,",",Vormann,",",J.,",",Schweigel,.}	{NULL}
SCPDFS_1158.pdf	838	{—,.}	{NULL}
SCPDFS_1158.pdf	839	{Rontgen,",",M.,",",2013,",",Substitution,p.,A350V,in,Na,(,+,),/,Mg,(,2,),(,+,),exchanger,SLC41A1,",",potentially,associated,with,Parkinson,'s,disease,",",is,a,gainof,—,function,mutation,.}	{NULL}
SCPDFS_1158.pdf	840	{Pbos,One,8,",",e71096,.}	{NULL}
SCPDFS_1158.pdf	841	{Koller,",",W,",",C.,",",Cochran,",",J.,W,",",",",Klawans,",",H.L.,",",1979,.}	{NULL}
SCPDFS_1158.pdf	842	{Calciﬁcation,of,the,basal,ganglia,:,computerized,tomography,and,clinical,correlation,.}	{NULL}
SCPDFS_1158.pdf	843	{Neurology,29,",",328-333,.}	{NULL}
SCPDFS_1158.pdf	844	{Krapivinsky,",",G.,",",Mochida,",",S.,",",Krapivinsky,",",L.,",",Cibulsky,",",S.M.,",",Clapham,",",D.E.,",",2006,",",The,TRPM7,ion,channel,functions,in,cholinergic,synaptic,vesicles,and,affects,transmitter,release,.}	{NULL}
SCPDFS_1158.pdf	845	{Neuron,52,",",485-496,.}	{NULL}
SCPDFS_1158.pdf	846	{Lambert,",",A.M.,",",Bonkowsky,",",J,",",L.,",",Masino,",",MA,",",2012,.}	{NULL}
SCPDFS_1158.pdf	847	{The,conserved,dopaminergic,diencephalospinal,tract,mediates,vertebrate,locomotor,development,in,zebraﬁsh,larvae,.}	{NULL}
SCPDFS_1158.pdf	848	{J.,Neurosci,.}	{NULL}
SCPDFS_1158.pdf	849	{32,",",13488-13500,.}	{NULL}
SCPDFS_1158.pdf	850	{Lan,",",J.,",",Jiang,",",D.,H,",",",",1997,.}	{NULL}
SCPDFS_1158.pdf	851	{Desferrioxamine,and,vitamin,E,protect,against,iron,and,MPTP,—,induced,neurodegeneration,in,mice,.}	{NULL}
SCPDFS_1158.pdf	852	{J.,Neural,.}	{NULL}
SCPDFS_1158.pdf	853	{Transm,",",104,",",469-481,.}	{NULL}
SCPDFS_1158.pdf	854	{A.R,Decker,et,al.,/,Developmental,Biology,386,(,2014,),"428-139 439"}	{NULL}
SCPDFS_1158.pdf	855	{Lewis,",",A,",",",",Wilson,",",N.,",",Stearns,",",G,",",",",Johnson,",",N.,",",Nelson,",",R.,",",Brockerhoff,",",S.E.,",",2011,.}	{NULL}
SCPDFS_1158.pdf	856	{Celsr3,is,required,for,normal,development,of,GABA,circuits,in,the,inner,retina,.}	{NULL}
SCPDFS_1158.pdf	857	{Pbos,Genet,.}	{NULL}
SCPDFS_1158.pdf	858	{7,",",e1002239,.}	{NULL}
SCPDFS_1158.pdf	859	{Li,",",M.,",",Du,",",J.,",",Jiang,",",J.,",",Ratzan,",",W.,",",Su,.}	{NULL}
SCPDFS_1158.pdf	860	{L.T.,",",Runnels,",",L.,W,",",",",Yue,",",L.,",",2007,.}	{NULL}
SCPDFS_1158.pdf	861	{Molecular,determinants,of,Mg,“,and,Ca,“,permeability,and,pH,sensitivity,in,TRPM6,and,TRPM7,.}	{NULL}
SCPDFS_1158.pdf	862	{J.,Biol,.}	{NULL}
SCPDFS_1158.pdf	863	{Chem,.}	{NULL}
SCPDFS_1158.pdf	864	{282,",",25817-25830,.}	{NULL}
SCPDFS_1158.pdf	865	{Lister,",",J.A.,",",Robertson,",",C.P.,",",Lepage,",",T.,",",Johnson,",",S.L.,",",Raible,",",D.W.,",",1999,.}	{NULL}
SCPDFS_1158.pdf	866	{Nacre,encodes,a,zebraﬁsh,microphthalmia,—,related,protein,that,regulates,neuralcrest,—,derived,pigment,cell,fate,",",Development,126,",",3757-3767,.}	{NULL}
SCPDFS_1158.pdf	867	{Liu,",",R,",",",",Gao,",",X.,",",Lu,",",Y.,",",Chen,",",H,",",L.,",",2011a,.}	{NULL}
SCPDFS_1158.pdf	868	{Meta,—,analysis,of,the,relationship,between,Parkinson,disease,and,melanoma,",",Neurology,76,",",2002-2009,.}	{NULL}
SCPDFS_1158.pdf	869	{Liu,",",W.,",",Su,.}	{NULL}
SCPDFS_1158.pdf	870	{L.T.,",",Khadka,",",D.,I,(,",",",",Mezzacappa,",",C,",",",",Komiya,",",Y.,",",Sato,",",A.,",",Habas,",",R,",",",",Runnels,",",L,",",W.,",",2011b,.}	{NULL}
SCPDFS_1158.pdf	871	{TRPM7,regulates,gastrulation,during,vertebrate,embryogenesis,.}	{NULL}
SCPDFS_1158.pdf	872	{Dev,.}	{NULL}
SCPDFS_1158.pdf	873	{Biol,",",350,",",348-357,.}	{NULL}
SCPDFS_1158.pdf	874	{Low,",",S.E.,",",Amburgey,",",I,(,.}	{NULL}
SCPDFS_1158.pdf	875	{",",Horstick,",",E.,",",Linsley,",",J.,",",Sprague,",",S.,M,",",",",Cui,",",W.W.,",",Zhou,",",W,",",.}	{NULL}
SCPDFS_1158.pdf	876	{Hirata,",",H.,",",Saint,.}	{NULL}
SCPDFS_1158.pdf	877	{—,.}	{NULL}
SCPDFS_1158.pdf	878	{Amant,",",L.,",",Hume,",",R.I.,",",Kuwada,",",J.,Y,",",",",2011,.}	{NULL}
SCPDFS_1158.pdf	879	{TRPM7,is,required,within,zebraﬁsh,sensory,neurons,for,the,activation,of,touch,—,evol,<,ed,escape,behaviors,.}	{NULL}
SCPDFS_1158.pdf	880	{J.,Neurosci,.}	{NULL}
SCPDFS_1158.pdf	881	{31,",",11633-11644,.}	{NULL}
SCPDFS_1158.pdf	882	{Masino,",",M,",",A.,",",Fetcho,",",J.R.,",",2005,.}	{NULL}
SCPDFS_1158.pdf	883	{Fictive,swimming,motor,patterns,in,wild,type,and,mutant,larval,zebraﬁsh,.}	{NULL}
SCPDFS_1158.pdf	884	{J.,Neurophysiol,.}	{NULL}
SCPDFS_1158.pdf	885	{93,",",3177-3188,.}	{NULL}
SCPDFS_1158.pdf	886	{McNeill,",",M.,S,",",",",Paulsen,",",J,",",",",Bonde,",",G,",",",",Burnight,",",E.,",",Hsu,",",M.Y.,",",Cornell,",",R.A.,",",2007,.}	{NULL}
SCPDFS_1158.pdf	887	{Cell,death,of,melanophores,in,zebraﬁsh,trpm7,mutant,embryos,depends,on,melanin,synthesis,.}	{NULL}
SCPDFS_1158.pdf	888	{J.,Invest,.}	{NULL}
SCPDFS_1158.pdf	889	{Dermatol,.}	{NULL}
SCPDFS_1158.pdf	890	{127,",",2020-2030,.}	{NULL}
SCPDFS_1158.pdf	891	{Menasche,",",P.,",",Grousset,",",C.,",",Gauduel,",",Y.,",",Mouas,",",C.,",",Piwnica,",",A.,",",1987,.}	{NULL}
SCPDFS_1158.pdf	892	{Prevention,of,hydroxyl,radical,formation,:,a,critical,concept,for,improving,cardioplegia,",",Protective,effects,of,deferoxamine,",",Circulation,76,",",V180-185,.}	{NULL}
SCPDFS_1158.pdf	893	{Muller,",",U.,I,(,.}	{NULL}
SCPDFS_1158.pdf	894	{",",Stamhuis,",",E.J.,",",Videler,",",J.J.,",",2000,.}	{NULL}
SCPDFS_1158.pdf	895	{Hydrodynamics,of,unsteady,ﬁsh,swimming,and,the,effects,of,body,size,:,comparing,the,ﬂow,ﬁelds,of,ﬁsh,larvae,and,adults,",",J,",",Exp,.}	{NULL}
SCPDFS_1158.pdf	896	{Biol,.}	{NULL}
SCPDFS_1158.pdf	897	{203,",",193-206,.}	{NULL}
SCPDFS_1158.pdf	898	{Nadler,",",M.J.,",",Hermosura,",",M.C.,",",Inabe,",",I,(,.}	{NULL}
SCPDFS_1158.pdf	899	{",",Perraud,",",A.L.,",",Zhu,",",Q.,",",Stokes,",",A.J.,",",Kurosaki,",",T.,",",I,(,inet,",",J.,P,",",",",Penner,",",R.,",",Scharenberg,",",A.M.,",",Fleig,",",A,",",",",2001,.}	{NULL}
SCPDFS_1158.pdf	900	{LTRPC7,is,a,MgATP,—,regulated,divalent,cation,channel,required,for,cell,viability,.}	{NULL}
SCPDFS_1158.pdf	901	{Nature,411,",",590-595,.}	{NULL}
SCPDFS_1158.pdf	902	{Pan,",",T.H.,",",Li,",",X.Q.,",",Jankovic,",",J.,",",2011,.}	{NULL}
SCPDFS_1158.pdf	903	{The,association,between,Parkinson,'s,disease,and,melanoma,",",Int,.}	{7}
SCPDFS_1158.pdf	904	{J.,Cancer,128,",",2251,-2260,.}	{NULL}
SCPDFS_1158.pdf	905	{Pawelek,",",J.M.,",",Lerner,",",A.B.,",",1977,",",Cytotoxicity,of,melanin,precursors,",",Yale,.}	{NULL}
SCPDFS_1158.pdf	906	{J,",",Biol,",",Med,.}	{NULL}
SCPDFS_1158.pdf	907	{50,",",(,576-576,),.}	{NULL}
SCPDFS_1158.pdf	908	{Ren,",",G.,",",Li,",",S.,",",Zhong,",",H.,",",Lin,",",5.,",",2013,.}	{NULL}
SCPDFS_1158.pdf	909	{Zebraﬁsh,tyrosine,hydroxylase,2,gene,encodes,tryptophan,hydroxylase,.}	{NULL}
SCPDFS_1158.pdf	910	{J,",",Biol,.}	{NULL}
SCPDFS_1158.pdf	911	{Chem,",",288,",",22451-22459,.}	{NULL}
SCPDFS_1158.pdf	912	{Rink,",",E.,",",Wullimann,",",M.F.,",",2002,.}	{NULL}
SCPDFS_1158.pdf	913	{Connections,of,the,ventral,telencephalon,and,tyrosine,hydroxylase,distribution,in,the,zebraﬁsh,brain,(,Danio,rerio,),lead,to,identiﬁcation,of,an,ascending,dopaminergic,system,in,a,teleost,.}	{NULL}
SCPDFS_1158.pdf	914	{Brain,Res,.}	{NULL}
SCPDFS_1158.pdf	915	{Bull,57,",",385-387,.}	{NULL}
SCPDFS_1158.pdf	916	{Ryazanova,",",L.V.,",",Rondon,",",L.,J,",",",",Zierler,",",S,",",",",Hu,",",Z.,",",Galli,",",J.,",",Yamaguchi,",",T,",",P.,",",Mazur,",",A,",",",",Fleig,",",A.,",",Ryazanov,",",A,",",G.,",",2010,",",TRPM7,is,essential,for,Mg,(,2,+,),homeostasis,in,mammals,.}	{NULL}
SCPDFS_1158.pdf	917	{Nat,.}	{NULL}
SCPDFS_1158.pdf	918	{Commun,.}	{NULL}
SCPDFS_1158.pdf	919	{1,",",109,.}	{NULL}
SCPDFS_1158.pdf	920	{Sah,",",R.,",",Mesirca,",",P,",",",",Van,den,Boogert,",",M.,",",Rosen,",",J,",",",",Mably,",",J.,",",Mangoni,",",M,",",E,",",.}	{NULL}
SCPDFS_1158.pdf	921	{Clapham,",",D,",",E.,",",2013,.}	{NULL}
SCPDFS_1158.pdf	922	{Ion,channel,—,l,<,inase,TRPM7,is,required,for,maintaining,cardiac,automaticity,.}	{NULL}
SCPDFS_1158.pdf	923	{Proc,.}	{NULL}
SCPDFS_1158.pdf	924	{Nat,.}	{NULL}
SCPDFS_1158.pdf	925	{Acad,.}	{NULL}
SCPDFS_1158.pdf	926	{Sci,.}	{NULL}
SCPDFS_1158.pdf	927	{U.,S,",",A.,110,",",E3037-3046,.}	{NULL}
SCPDFS_1158.pdf	928	{Sallinen,",",V.,",",Kolehmainen,",",J.,",",Priyadarshini,",",M,",",",",Toleikyte,",",G,",",",",Chen,",",Y.C.,",",Panula,",",P.,",",2010,",",Dopaminergic,cell,damage,and,vulnerability,to,MPTP,in,Pink1,l,<,nock,—,down,zebraﬁsh,.}	{NULL}
SCPDFS_1158.pdf	929	{Neurobiol,",",Dis,.}	{NULL}
SCPDFS_1158.pdf	930	{40,",",93-101,.}	{NULL}
SCPDFS_1158.pdf	931	{Sallinen,",",V.,",",Torkko,",",V.,",",Sundvik,",",M,",",",",Reenila,",",I,",",",",Khrustalyov,",",D.,",",I,(,aslin,",",J.,",",Panula,",",P.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	932	{MPTP,and,MPP,+,target,speciﬁc,aminergic,cell,populations,in,larval,zebraﬁsh,.}	{NULL}
SCPDFS_1158.pdf	933	{J.,Neurochem,.}	{NULL}
SCPDFS_1158.pdf	934	{108,",",719-731,.}	{NULL}
SCPDFS_1158.pdf	935	{Segura,Aguilar,",",J.,",",I,(,ostrzewa,",",R.M.,",",2004,.}	{NULL}
SCPDFS_1158.pdf	936	{Neurotoxins,and,neurotoxic,species,implicated,in,neurodegeneration,.}	{NULL}
SCPDFS_1158.pdf	937	{Neurotox,.}	{NULL}
SCPDFS_1158.pdf	938	{Res,.}	{NULL}
SCPDFS_1158.pdf	939	{6,",",615-630,.}	{NULL}
SCPDFS_1158.pdf	940	{Souza,",",B.,R,",",",",Tropepe,",",V,",",",",2011,.}	{NULL}
SCPDFS_1158.pdf	941	{The,role,of,dopaminergic,signalling,during,larval,zebraﬁsh,brain,development,:,a,tool,for,investigating,the,developmental,basis,of,neuropsychiatric,disorders,.}	{NULL}
SCPDFS_1158.pdf	942	{Rev.,Neurosci,",",22,",",107-119,.}	{NULL}
SCPDFS_1158.pdf	943	{Straw,",",A.D.,",",Dickinson,",",M.H.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	944	{Motmot,",",an,open,—,source,toolkit,for,realtime,video,acquisition,and,analysis,.}	{NULL}
SCPDFS_1158.pdf	945	{Source,Code,Biol,.}	{NULL}
SCPDFS_1158.pdf	946	{Med,.}	{NULL}
SCPDFS_1158.pdf	947	{4,",",5,.}	{NULL}
SCPDFS_1158.pdf	948	{Su,.}	{NULL}
SCPDFS_1158.pdf	949	{L.T.,",",Agapito,",",M.A.,",",Li,",",M,",",",",Simonson,",",W.T.,",",Huttenlocher,",",A.,",",Habas,",",R.,",",Yue,",",L.,",",Runnels,",",L,",",W.,",",2006,.}	{NULL}
SCPDFS_1158.pdf	950	{TRPM7,regulates,cell,adhesion,by,controlling,the,calciumdependent,protease,calpain,.}	{NULL}
SCPDFS_1158.pdf	951	{J.,Biol,",",Chem,.}	{NULL}
SCPDFS_1158.pdf	952	{281,",",11260-11270,.}	{NULL}
SCPDFS_1158.pdf	953	{Su,.}	{NULL}
SCPDFS_1158.pdf	954	{L,",",T,",",",",Liu,",",W,",",",",Chen,",",H.C.,",",Gonzalez,.}	{NULL}
SCPDFS_1158.pdf	955	{—,.}	{NULL}
SCPDFS_1158.pdf	956	{Pagan,",",o.,",",Habas,",",R,",",",",Runnels,",",L.,W,",",",",2011,",",TRPM7,regulates,polarized,cell,movements,",",Biochem,",",J,",",434,",",513-521,.}	{NULL}
SCPDFS_1158.pdf	957	{Sun,",",H.,S,",",",",Jackson,",",M.,F,",",",",Martin,",",L.J.,",",Jansen,",",I,(,.}	{NULL}
SCPDFS_1158.pdf	958	{",",Teves,",",L.,",",Cui,",",H.,",",I,(,iyonal,<,a,",",S.,",",Mori,",",Y.,",",Jones,",",M.,",",Forder,",",J.P.,",",Golde,",",T.E.,",",Orser,",",B.A.,",",Macdonald,",",J.F.,",",Tymianski,",",M.,",",2009,.}	{NULL}
SCPDFS_1158.pdf	959	{Suppression,of,hippocampal,TRPM7,protein,prevents,delayed,neuronal,death,in,brain,ischemia,.}	{NULL}
SCPDFS_1158.pdf	960	{Nat,.}	{NULL}
SCPDFS_1158.pdf	961	{Neurosci,.}	{NULL}
SCPDFS_1158.pdf	962	{12,",",1300-1307,.}	{NULL}
SCPDFS_1158.pdf	963	{Terland,",",o.,",",Flatmark,",",T.,",",1999,",",Drug,—,induced,parkinsonism,:,cinnarizine,and,ﬂunarizine,are,potent,uncouplers,of,the,vacuolar,H,+,.}	{NULL}
SCPDFS_1158.pdf	964	{—,.}	{NULL}
SCPDFS_1158.pdf	965	{ATPase,in,catecholamine,storage,vesicles,.}	{NULL}
SCPDFS_1158.pdf	966	{Neuropharmacology,38,",",879-882,.}	{NULL}
SCPDFS_1158.pdf	967	{Thirumalai,",",V.,",",Cline,",",H,",",T.,",",2008,.}	{NULL}
SCPDFS_1158.pdf	968	{Endogenous,dopamine,suppresses,initiation,of,swimming,in,prefeeding,zebraﬁsh,larvae,",",J,",",Neurophysiol,.}	{NULL}
SCPDFS_1158.pdf	969	{100,",",1635-1648,.}	{NULL}
SCPDFS_1158.pdf	970	{Van,Epps,",",H.,A,",",",",Yim,",",C,",",M,",",",",Hurley,",",J.,B,",",",",Brockerhoff,",",S.E.,",",2001,",",Investigations,of,photoreceptor,synaptic,transmission,and,light,adaptation,in,the,zebraﬁsh,visual,mutant,nrc,.}	{NULL}
SCPDFS_1158.pdf	971	{Invest,.}	{NULL}
SCPDFS_1158.pdf	972	{Ophthal,.}	{NULL}
SCPDFS_1158.pdf	973	{Vis,.}	{NULL}
SCPDFS_1158.pdf	974	{Sci,.}	{NULL}
SCPDFS_1158.pdf	975	{42,",",868-874,.}	{NULL}
SCPDFS_1158.pdf	976	{Wei,",",W,",",L.,",",Sun,",",H.S.,",",Olah,",",M.E.,",",Sun,",",X.,",",Czerwinska,",",E.,",",Czerwinski,",",W,",",",",Mori,",",Y.,",",Orser,",",B.A.,",",Xiong,",",Z,",",G.,",",Jackson,",",M.,F,",",",",Tymianski,",",M.,",",MacDonald,",",J.F.,",",2007,.}	{NULL}
SCPDFS_1158.pdf	977	{TRPM7,channels,in,hippocampal,neurons,detect,levels,of,extracellular,divalent,cations,.}	{NULL}
SCPDFS_1158.pdf	978	{Proc,.}	{NULL}
SCPDFS_1158.pdf	979	{Nat,.}	{NULL}
SCPDFS_1158.pdf	980	{Acad,",",Sci,",",U.,S,",",A.,104,",",16323-16328,.}	{NULL}
SCPDFS_1158.pdf	981	{Westerﬁeld,",",M.,",",1993,.}	{NULL}
SCPDFS_1158.pdf	982	{The,Zebraﬁsh,Book,.}	{NULL}
SCPDFS_1158.pdf	983	{University,of,Oregon,Press,",",Eugene,",",OR,.}	{NULL}
SCPDFS_1158.pdf	984	{Wiggin,",",T.D.,",",Anderson,",",T.M.,",",Eian,",",J.,",",Peck,",",J.H.,",",Masino,",",M.A.,",",2012,.}	{NULL}
SCPDFS_1158.pdf	985	{Episodic,swimming,in,the,larval,zebraﬁsh,is,generated,by,a,spatially,distributed,spinal,network,with,modular,functional,organization,.}	{NULL}
SCPDFS_1158.pdf	986	{J,",",Neurophysiol,.}	{NULL}
SCPDFS_1158.pdf	987	{108,",",925-934,.}	{NULL}
SCPDFS_1158.pdf	988	{Xi,",",Y.,",",Yu,",",M.,",",Godoy,",",R.,",",Hatch,",",G.,",",Poitras,",",L,",",",",Ekker,",",M.,",",2011,",",Transgenic,zebraﬁsh,expressing,green,ﬂuorescent,protein,in,dopaminergic,neurons,of,the,ventral,diencephalon,.}	{NULL}
SCPDFS_1158.pdf	989	{Dev,.}	{NULL}
SCPDFS_1158.pdf	990	{Dyn,.}	{NULL}
SCPDFS_1158.pdf	991	{240,",",2539-2547,.}	{NULL}
SCPDFS_1158.pdf	992	{Yamamoto,",",K,",",Ruuskanen,",",J.O.,",",Wullimann,",",M,",",F.,",",Vernier,",",P.,",",2010,.}	{NULL}
SCPDFS_1158.pdf	993	{Two,tyrosine,hydroxylase,genes,in,vertebrates,new,dopaminergic,territories,revealed,in,the,zebraﬁsh,brain,",",Mol,.}	{NULL}
SCPDFS_1158.pdf	994	{Cell,",",Neurosci,",",43,",",394-402,.}	{NULL}
SCPDFS_1158.pdf	995	{Yamamoto,",",I,(,",",",",Ruuskanen,",",J.O.,",",Wullimann,",",M.F.,",",Vernier,",",P.,",",2011,",",Differential,expression,of,dopaminergic,cell,markers,in,the,adult,zebraﬁsh,forebrain,.}	{NULL}
SCPDFS_1158.pdf	996	{J.,Comp,.}	{NULL}
SCPDFS_1158.pdf	997	{Neurol,.}	{NULL}
SCPDFS_1158.pdf	998	{519,",",576-598,.}	{NULL}
SCPDFS_26333.pdf	1	{J,J,',",",.4,.}	{NULL}
SCPDFS_26333.pdf	2	{‘,*,',1,-,:,',LsE1E}	{NULL}
SCPDFS_26333.pdf	3	{GENE}	{NULL}
SCPDFS_26333.pdf	4	{AN,INTERNATIONAL,-,JOURNAL,ON}	{NULL}
SCPDFS_26333.pdf	5	{GENES,AND,GENOMES}	{NULL}
SCPDFS_26333.pdf	6	{Gene,238,(,1999,),445,—,453}	{NULL}
SCPDFS_26333.pdf	7	{wwW.elsevier.com/locate/,gene}	{NULL}
SCPDFS_26333.pdf	8	{A6-Fatty,acid,desaturase,from,an,arachidonic,acid,—,producing}	{NULL}
SCPDFS_26333.pdf	9	{Mortierella,fungus}	{NULL}
SCPDFS_26333.pdf	10	{Gene,cloning,and,its,heterologous,expression,in,a,fungus,",",Aspergillus}	{NULL}
SCPDFS_26333.pdf	11	{Eiji,Sakuradani,",",Michihiko,Kobayashi,*,",",Sakayu,Shimizu}	{NULL}
SCPDFS_26333.pdf	12	{Division,of,Applied,Life,Sciences,",",Graduate,School,of,Agriculture,",",Kyoto,University,",",Kitashirakawa-oiwakecho,",",Sakyo-ku,",",Kyoto,606-8502,",",Japan}	{NULL}
SCPDFS_26333.pdf	13	{Received,30,April,1999,;,received,in,revised,form,28,July,1999,;,accepted,6,August,1999,;,Received,by,A.,Nakazawa}	{NULL}
SCPDFS_26333.pdf	14	{Abstract}	{NULL}
SCPDFS_26333.pdf	15	{A,DNA,fragment,was,cloned,from,the,fungal,strain,",",Mortierella,alpina,1S-4,(,which,is,used,industrially,to,produce,arachidonic,acid,),",",after,PCR,ampliﬁcation,with,oligonucleotide,primers,designed,based,on,the,sequence,information,for,A6-desaturase,genes,(,from,borage,and,Caenorhabditis,elegans,),",",which,are,involved,in,the,desaturation,of,linoleic,acid,(,A9,",",A12,—,18:2,),to,y-linolenic,acid,(,A6,",",A9,",",A12,—,18:3,),.}	{NULL}
SCPDFS_26333.pdf	16	{This,fragment,was,used,as,a,probe,to,isolate,a,cDNA,clone,with,an,open,reading,frame,encoding,457,amino,acids,from,a,M.,alpina,1S-4,library,.}	{NULL}
SCPDFS_26333.pdf	17	{The,predicted,amino-acid,sequence,showed,similarity,to,those,of,the,above,A6-desaturases,",",and,contained,a,cytochrome,Z75-like,domain,at,the,N-terminus,",",being,different,from,the,yeast,A9-desaturase,which,has,the,corresponding,domain,at,the,C-terminus,.}	{NULL}
SCPDFS_26333.pdf	18	{The,full-length,cDNA,clone,was,expressed,under,the,control,of,the,amyB,promoter,in,a,ﬁlamentous,fungus,",",Aspergillus,oryzae,",",resulting,in,the,accumulation,of,y-linolenic,acid,(,which,was,not,detected,in,the,control,Aspergillus,),to,the,level,of,25.2,%,of,the,total,fatty,acids,.}	{NULL}
SCPDFS_26333.pdf	19	{These,ﬁndings,revealed,that,the,recombinant,product,has,A6-desaturase,activity,.}	{NULL}
SCPDFS_26333.pdf	20	{The,Mortierella,A6-desaturase,is,the,ﬁrst,to,be,reported,in,fungi,.}	{NULL}
SCPDFS_26333.pdf	21	{©,1999,Elsevier,Science,B.V.,All,rights,reserved,.}	{NULL}
SCPDFS_26333.pdf	22	{Keywords,.}	{NULL}
SCPDFS_26333.pdf	23	{‘,Fatty,acid,desaturation,;,y-Linolenic,acid,;,Mortierella,alpina,;,Polyunsaturated,fatty,acid}	{NULL}
SCPDFS_26333.pdf	24	{1,.}	{NULL}
SCPDFS_26333.pdf	25	{Introduction}	{NULL}
SCPDFS_26333.pdf	26	{Polyunsaturated,fatty,acids,(,PUFAs,),play,important,roles,as,structural,components,of,membrane,phospholi,—,pids,",",and,as,precursors,of,the,eicosanoids,of,signaling,molecules,including,prostaglandins,",",thromboxanes,and,leukotrienes,(,Needleman,et,al.,",",1986,;,Smith,and,Borgeat,",",1985,),.}	{NULL}
SCPDFS_26333.pdf	27	{The,principal,PUFAs,are,dihomo,—,y,—,linolenic,acid,(,n,—,6,PUFA,",",A8,",",A11,",",A14,—,20:3,),",",arachidonic,acid,(,n,—,6,PUFA,",",A5,",",A8,",",A11,",",A14,—,20:4,),",",and,eicosapentaenoic,acid,(,n,—,3,PUFA,",",A5,",",A8,",",A11,",",A14,",",A17,—,20:5,),.}	{NULL}
SCPDFS_26333.pdf	28	{All,mammals,synthesize,eicosanoids,which,are,involved,in,the,inﬂammatory,response,",",reproductive,function,",",immune,response,",",and,regulation,of,blood,pressure,(,Horrobin,",",1992,),.}	{NULL}
SCPDFS_26333.pdf	29	{Therefore,",",studies,on,PUFAs,are,important,in,both,the,medical,and,pharmaceutical,ﬁelds,.}	{NULL}
SCPDFS_26333.pdf	30	{Abbreviations,:,ACP,",",acyl,carrier,protein,;,CoA,",",coenzyme,A,;,FAMe,",",fatty,acid,methyl,ester,;,GC,",",gas,chromatography,;,GC,.}	{NULL}
SCPDFS_26333.pdf	31	{—,.}	{NULL}
SCPDFS_26333.pdf	32	{MS,",",gas,chromatography,—,mass,spectrometry,;,GLA,",",y-linolenic,acid,;,PUFA,",",polyunsaturated,fatty,acid,.}	{NULL}
SCPDFS_26333.pdf	33	{*,Corresponding,author,.}	{NULL}
SCPDFS_26333.pdf	34	{Tel.,:,+,81-75-753-6114,;,fax,:,+81-75-753-6128,.}	{NULL}
SCPDFS_26333.pdf	35	{E-mail,address,.}	{NULL}
SCPDFS_26333.pdf	36	{‘,kobay@kais.kyoto-u.ac.jp,(,M.,Kobayashi,)}	{NULL}
SCPDFS_26333.pdf	37	{We,screened,for,microorganisms,capable,of,accumulating,lipids,containing,PUFAs,(,Yamada,et,al.,",",1987,),",",and,found,a,ﬁlamentous,fungus,",",Mortierella,alpina,1S-4,",",belonging,to,the,Zygomycetes,.}	{NULL}
SCPDFS_26333.pdf	38	{This,strain,is,unique,in,that,it,produces,some,C-20,PUFAs,(,e.g.,",",dihomo,—,y,—,linolenic,acid,",",arachidonic,acid,and,eicosapentaenoic,acid,),.}	{NULL}
SCPDFS_26333.pdf	39	{We,have,studied,the,fatty,—,acid,metabolism,in,this,strain,and,succeeded,in,its,application,to,the,industrial,production,of,arachidonic,acid,(,Shimizu,et,al.,",",1997,),.}	{NULL}
SCPDFS_26333.pdf	40	{Therefore,",",this,fungi,is,a,good,model,for,analyzing,a,fatty,—,acid,desaturation,system,from,both,the,fundamental,and,applied,standpoints,.}	{NULL}
SCPDFS_26333.pdf	41	{In,particular,",",y,—,linolenic,acid,(,GLA,:,A6,",",A9,",",A12,—,18:3,),is,an,intermediate,in,the,metabolic,pathway,of,(,n,—,6,),essential,fatty,acids,from,linoleic,acid,to,arachidonic,acid,in,mammals,.}	{NULL}
SCPDFS_26333.pdf	42	{GLA,is,also,the,direct,precursor,of,dihomo,—,y,—,linolenic,acid,",",which,is,a,precursor,of,antiinﬂammatory,1,—,series,eicosanoids,.}	{NULL}
SCPDFS_26333.pdf	43	{A,deﬁciency,of,GLA,may,have,occurred,when,A6,—,desaturation,activity,decreases,in,aging,",",stress,",",diabetes,",",eczema,",",and,some,infections,",",or,when,GLA,contents,are,catabolized,resulting,from,oxidation,or,more,rapid,cell,division,(,e.g.,",",in,cancer,or,inﬂammation,),(,Horrobin,",",1992,),.}	{20}
SCPDFS_26333.pdf	44	{Dietary,sup0378-1119,/,99,/,$}	{NULL}
SCPDFS_26333.pdf	45	{~,see,front,matter,©,1999,Elsevier,Science,B.V.,All,rights,reserved,.}	{NULL}
SCPDFS_26333.pdf	46	{PII,:,S0378-1119,(,99,),00359-5}	{NULL}
SCPDFS_26333.pdf	47	{446,E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453}	{NULL}
SCPDFS_26333.pdf	48	{plementation,with,GLA,is,reported,to,be,effective,in,treating,a,number,of,such,conditions,(,e.g.,",",atopic,eczema,",",diabetic,neuropathy,",",viral,infections,",",and,cancer,),(,Horrobin,",",1992,),.}	{NULL}
SCPDFS_26333.pdf	49	{These,indicate,that,GLA,is,useful,as,an,ingredient,of,functional,foods,and,pharmaceutical,products,.}	{NULL}
SCPDFS_26333.pdf	50	{GLA,is,a,rare,fatty,acid,in,plants,",",because,it,is,synthesized,only,in,a,limited,number,of,higher,plants,[,e.g.,",",borage,(,Borago,oﬁicinalis,L.,),and,evening,primrose,(,oenolhera,biennis,L.,),],",",which,often,produce,GLA,in,their,seeds,(,Gunstone,",",1992,;,Stymne,and,Stobart,",",1986,),.}	{NULL}
SCPDFS_26333.pdf	51	{These,plants,",",however,",",can,not,supply,high,enough,yields,of,GLA,for,pharmaceutical,use,.}	{NULL}
SCPDFS_26333.pdf	52	{A6,.}	{NULL}
SCPDFS_26333.pdf	53	{—,.}	{NULL}
SCPDFS_26333.pdf	54	{Desaturase,genes,have,been,cloned,from,various,organisms,except,for,fungi,:,borage,(,Sayanova,et,al.,",",1997,),",",a,nematode,worm,(,Caenorhabdilis,elegans,),(,Napier,et,al.,",",1998,),",",Synecnocyslis,(,Reddy,et,al.,",",1993,),",",the,moss,Physcomilrella,palens,(,Girke,et,al.,",",1998,),",",the,rat,(,Aki,et,al.,",",1999,),",",and,human,(,Cho,et,al.,",",1999,),.}	{NULL}
SCPDFS_26333.pdf	55	{Although,investigation,as,to,fatty,acid,desaturases,had,never,been,extended,to,ﬁlamentous,fungi,",",a,A5,—,desaturase,gene,was,isolated,very,recently,from,M.,alpina,1S,—,4,CBS,210.32,",",and,expression,of,the,gene,in,a,yeast,",",Saccharomyces,cerevisiae,",",resulted,in,the,accumulation,of,arachidonic,acid,with,the,exogenous,addition,of,dihomo,—,y,—,linolenic,acid,(,Michaelson,et,al.,",",1998,),.}	{NULL}
SCPDFS_26333.pdf	56	{Moreover,",",expression,of,the,M.,alpina,A5,—,desaturase,cDNA,in,transgenic,canola,seeds,was,reported,very,recently,(,Knutzon,et,al.,",",1998,),.}	{NULL}
SCPDFS_26333.pdf	57	{Therefore,",",the,Mortierella,genes,involved,in,the,biosynthesis,of,PUFAs,have,received,increasing,attention,",",not,only,in,academic,but,also,applied,areas,.}	{NULL}
SCPDFS_26333.pdf	58	{As,an,initial,step,toward,elucidation,of,fatty,acid,biosynthesis,",",we,report,here,the,isolation,and,characterization,of,a,A6,—,desaturase,cDNA,from,M.,alpina,1S,—,4,",",and,its,expression,in,Aspergillus,oryzae,",",as,a,heterologous,host,.}	{NULL}
SCPDFS_26333.pdf	59	{2,.}	{NULL}
SCPDFS_26333.pdf	60	{Materials,and,methods}	{NULL}
SCPDFS_26333.pdf	61	{2.1,.}	{NULL}
SCPDFS_26333.pdf	62	{Enzymes,and,chemicals}	{NULL}
SCPDFS_26333.pdf	63	{Restriction,endonucleases,and,other,DNA,—,modifying,enzymes,were,obtained,from,Takara,Shuzo,",",and,Toyobo,(,Japan,),.}	{NULL}
SCPDFS_26333.pdf	64	{[,Ot-32P,],C1CTP,(,110,TBq/mmol,),and,[,y,—,32P,],ATP,(,180,TBq/mmol,),were,from,Amersham,Japan,(,Tokyo,),.}	{NULL}
SCPDFS_26333.pdf	65	{The,methyl,esters,of,palmitic,",",palmitoleic,",",stearic,and,oleic,acids,",",and,those,of,linoleic,and,oc,—,linolenic,acids,(,A9,",",A12,",",A15,—,18:3,),were,purchased,from,Nacalai,Tesque,(,Kyoto,",",Japan,),",",and,Sigma,(,St.,Louis,",",USA,),",",respectively,.}	{NULL}
SCPDFS_26333.pdf	66	{All,other,chemicals,were,of,the,highest,purity,commercially,available,.}	{NULL}
SCPDFS_26333.pdf	67	{2.2,.}	{NULL}
SCPDFS_26333.pdf	68	{Filamenlousfungal,strains,and,growth,media}	{NULL}
SCPDFS_26333.pdf	69	{For,the,cloning,of,the,A6,—,desaturase,gene,",",M.,alpina,1S-4,(,Yamada,et,a1.,",",1987,),was,used,.}	{NULL}
SCPDFS_26333.pdf	70	{Aspergillas,oryzae,M,—,2,—,3,(,argB,',),was,used,as,the,recipient,strain,in,transformation,experiments,(,Ozeki,et,al.,",",1996,),.}	{NULL}
SCPDFS_26333.pdf	71	{Escherichia,coli,JM109,and,DH5oc,",",and,plasmid,vector,pBluescript,II,(,Stratagene,",",USA,),were,used,for,DNA,manipulation,",",unless,otherwise,speciﬁed,.}	{NULL}
SCPDFS_26333.pdf	72	{pTAex3,is,a,shuttle,vector,carrying,the,ampicillin,resistance,gene,(,for,selection,in,E.,coli,),and,the,argB,gene,of,Aspergillus,nidulans,(,for,arginine,prototrophy,selection,in,Aspergillas,),(,Fujii,et,al.,",",1995,),.}	{NULL}
SCPDFS_26333.pdf	73	{This,plasmid,also,carries,the,promoter,and,terminator,regions,of,the,Takaamylase,A,gene,(,amyB,),of,A.,oryzae,ﬂanking,unique,EcoRI,and,Smal,cloning,sites,(,Tada,et,al.,",",1991,),.}	{NULL}
SCPDFS_26333.pdf	74	{M,alpina,1S,—,4,was,cultured,in,medium,(,GY,medium,),containing,20,g,glucose,and,10,g,yeast,extract,(,pH,6.0,),/,L.,The,minimal,and,complete,media,for,A.,oryzae,were,Czapek,.}	{NULL}
SCPDFS_26333.pdf	75	{—,.}	{NULL}
SCPDFS_26333.pdf	76	{Dox,medium,[,consisting,of,3,%,sucrose,",",0.2,%,NaNO3,",",0.1,%,KHZPO4,",",0.05,%,KCl,",",0.05,%,MgSO4-7H2O,",",and,0.001,%,FeSO4-7H2O,(,pH,5.5,),],and,Dextrin,.}	{NULL}
SCPDFS_26333.pdf	77	{—,.}	{NULL}
SCPDFS_26333.pdf	78	{Pepton,medium,[,consisting,of,2,%,dextrin,",",1,%,polypepton,",",0.5,%,KHZPO4,",",0.1,%,NaNO3,and,0.05,%,MgSO4,-,7H2O,],",",respectively,.}	{NULL}
SCPDFS_26333.pdf	79	{2.3,.}	{NULL}
SCPDFS_26333.pdf	80	{PCR-based,cloning}	{NULL}
SCPDFS_26333.pdf	81	{Two,highly,degenerate,primers,were,synthesized,for,screening,of,the,cDNA,of,the,Mortierella,A6,—,desaturase,by,means,of,PCR,",",with,the,following,primers,:,sense,primer,",",5,’,.}	{NULL}
SCPDFS_26333.pdf	82	{—,.}	{NULL}
SCPDFS_26333.pdf	83	{TGGTGGAA,(,A/G,),(,G/T,),(,A/G,),GAAICA,(,C/T,),AA,(,C/T,),(,A/G,),CICA,(,C/T,),CA,—,3,’,[,fully,degenerate,to,the,conserved,amino,—,acid,sequence,",",WWKD,—,(,D/W,),KHN,(,A/T,),HH,],",",and,antisense,primer,",",5,’,.}	{NULL}
SCPDFS_26333.pdf	84	{—,.}	{NULL}
SCPDFS_26333.pdf	85	{CAT,(,C/T,),GTIGG,(,A/G,),AAIA,(,A/G,),(,A/G,),TG,(,A/G,),TG,—,(,C/T,),TCIAT,(,C/T,),TG,—,3,’,[,fully,degenerate,to,the,conserved,amino,—,acid,sequence,",",QIEHHLFPTM,],",",where,‘,I,’,indicates,inosine,",",although,‘,I,’,in,the,amino,—,acid,sequence,represents,isoleucine,.}	{NULL}
SCPDFS_26333.pdf	86	{These,primers,were,run,on,a,Perkin,.}	{NULL}
SCPDFS_26333.pdf	87	{—,.}	{NULL}
SCPDFS_26333.pdf	88	{Elmer,Cetus,DNA,thermal,cycler,using,a,program,of,1,min,at,94,°,C,",",1,min,at,55,°,C,",",and,2,min,at,72,°,C,for,35,cycles,",",followed,by,extension,for,10,min,at,72,°,C.,The,PCR,—,ampliﬁed,products,were,ligated,into,pCR@2.1,using,an,‘,Original,TA,cloning,kit,’,(,Invitrogen,",",Netherlands,),",",and,then,transformed,into,INVOLF,’,E.,coli,cells,.}	{NULL}
SCPDFS_26333.pdf	89	{2.4,.}	{NULL}
SCPDFS_26333.pdf	90	{Screening,of,the,cDNA,library}	{NULL}
SCPDFS_26333.pdf	91	{Total,RNA,was,extracted,by,the,AGPC,(,acid,guanidi,—,nium,—,phenol,—,chloroform,),method,(,Chomczynski,and,Sacchi,",",1987,),.}	{NULL}
SCPDFS_26333.pdf	92	{Poly,(,A,),+,RNA,and,cDNA,library,were,prepared,according,to,the,method,described,in,the,previous,report,(,Sakuradani,et,al.,",",1999b,),.}	{NULL}
SCPDFS_26333.pdf	93	{To,clone,the,full,—,length,A6,—,desaturase,cDNA,",",the,PCR,—,ampliﬁed,product,(,mentioned,above,),incorporating,[,Ot-32P,],C1CTP,was,used,as,a,radiolabeled,probe,.}	{NULL}
SCPDFS_26333.pdf	94	{Plaque,hybridization,against,the,cDNA,library,was,performed,according,to,the,standard,method,(,Ausubel,et,al.,",",1996,),.}	{NULL}
SCPDFS_26333.pdf	95	{The,positive}	{NULL}
SCPDFS_26333.pdf	96	{E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453,447}	{NULL}
SCPDFS_26333.pdf	97	{recombinant,which,contained,the,longest,cDNA,of,the,A6,—,desaturase,was,selected,.}	{NULL}
SCPDFS_26333.pdf	98	{The,EcoRI,insert,from,the,puriﬁed,positive,XDNA,was,then,subcloned,into,pBluescript,II,for,the,large,—,scale,preparation,of,DNA,.}	{NULL}
SCPDFS_26333.pdf	99	{2.5,.}	{NULL}
SCPDFS_26333.pdf	100	{Construction,of,plasmids,for,the,expression,of,A6-desatarase,in,A.,oryzae}	{NULL}
SCPDFS_26333.pdf	101	{To,express,the,full,—,length,form,of,the,A6,—,desaturase,cDNA,",",we,improved,the,sequence,upstream,from,the,ATG,codon,by,PCR,",",with,this,cDNA,as,a,template,and,the,following,two,oligonucleotides,as,primers,.}	{NULL}
SCPDFS_26333.pdf	102	{The,sense,primer,(,5,’,.}	{NULL}
SCPDFS_26333.pdf	103	{—,.}	{NULL}
SCPDFS_26333.pdf	104	{AAAGAATTCCCACCATGGCTGCTG,CTCCC,—,3,’,",",—,14,—,15,nucleotide,positions,in,Fig,.}	{NULL}
SCPDFS_26333.pdf	105	{1,),contained,an,EcoRI,recognition,site,(,underlined,),and,29,nucleotides,of,the,A6,—,desaturase,cDNA,starting,with,the,ATG,start,codon,.}	{NULL}
SCPDFS_26333.pdf	106	{In,addition,",",the,sequence,around,the,start,codon,was,modiﬁed,to,CCACCATGG,",",which,is,usually,observed,at,the,translational,start,point,in,eukaryotes,(,Kozak,",",1984,),.}	{NULL}
SCPDFS_26333.pdf	107	{The,antisense,primer,(,5,’,.}	{NULL}
SCPDFS_26333.pdf	108	{—,.}	{NULL}
SCPDFS_26333.pdf	109	{ACAGAATTCTTTACTGTGCCTTGCCCATC,.}	{NULL}
SCPDFS_26333.pdf	110	{—,.}	{NULL}
SCPDFS_26333.pdf	111	{3,’,",",1356,—,1384,positions,in,Fig,.}	{NULL}
SCPDFS_26333.pdf	112	{1,),contained,an,EcoRI,recognition,site,(,underlined,),and,29,nucleotides,of,the,A6,—,desaturase,cDNA,(,complementary,to,the,nucleotide,sequence,),terminating,with,a,TAA,stop,codon,.}	{NULL}
SCPDFS_26333.pdf	113	{The,PCR,—,ampliﬁed,products,with,EcoRI,ends,were,ligated,into,pTAex3/EcoRI,",",resulting,in,the,construction,of,pMLD30,.}	{NULL}
SCPDFS_26333.pdf	114	{pMLD30,was,transformed,into,E.,coli,DH5oc,and,then,highly,puriﬁed,by,CsCl/ethidium,bromide,equilibrium,centrifugation,for,the,transformation,of,A.,oryzae,.}	{NULL}
SCPDFS_26333.pdf	115	{2.6,.}	{NULL}
SCPDFS_26333.pdf	116	{Transformation,of,A.,oryzae}	{NULL}
SCPDFS_26333.pdf	117	{Transformation,was,performed,using,protoplasts,of,A.,oryzae,according,to,the,procedures,described,by,Gomi,et,al.,(,1987,),.}	{NULL}
SCPDFS_26333.pdf	118	{Stable,transformants,were,isolated,by,repeated,transfer,of,sporulating,colonies,on,selection,plates,containing,Czapek,.}	{NULL}
SCPDFS_26333.pdf	119	{—,.}	{NULL}
SCPDFS_26333.pdf	120	{Dox,medium,.}	{NULL}
SCPDFS_26333.pdf	121	{2,.}	{NULL}
SCPDFS_26333.pdf	122	{7,.}	{NULL}
SCPDFS_26333.pdf	123	{DNA,sequence,analysis}	{NULL}
SCPDFS_26333.pdf	124	{All,DNA,fragments,containing,the,A6,—,desaturase,cDNA,were,cloned,into,pBluescript,II,vectors,.}	{NULL}
SCPDFS_26333.pdf	125	{DNA,sequence,analysis,was,performed,by,dideoxy,chain,termination,",",as,described,in,the,previous,report,(,Sakuradani,et,al.,",",1999b,),.}	{NULL}
SCPDFS_26333.pdf	126	{2.8,.}	{NULL}
SCPDFS_26333.pdf	127	{Fatty-acid,analysis}	{NULL}
SCPDFS_26333.pdf	128	{The,A.,oryzae,recombinant,containing,the,M.,alpina,A6,—,desaturase,cDNA,was,inoculated,into,a,20,ml,Erlenmeyer,ﬂask,containing,4,ml,of,medium,(,Medium,A,),consisting,of,2,%,glucose,",",1,%,polypepton,",",0.5,%}	{NULL}
SCPDFS_26333.pdf	129	{CCCATCTCTTCTCCTCATCCCCTCATCCTCTCGPCCGACACCCTCTCTCACTCTCGTCTTAGTCCTICICAACCCCCCCCCTCGACAAAGACAACAAACC,-,1}	{NULL}
SCPDFS_26333.pdf	130	{A,G,',.}	{NULL}
SCPDFS_26333.pdf	131	{l.,"\\"",.}	{NULL}
SCPDFS_26333.pdf	132	{I,"\\"",l'ACTCGGGCCGAGAITITGAATGCCGAOGCCCTGAATGAGGGCAAGAAOGATGCCGAGGCACCC1,"\\"",1,"\\"",l.,',C'lGA,',l‘GNl,.,'}	{NULL}
SCPDFS_26333.pdf	133	{CA,’,.}	{NULL}
SCPDFS_26333.pdf	134	{l,"\\"",.}	{NULL}
SCPDFS_26333.pdf	135	{l‘GACAhCAAGG,’,.}	{NULL}
SCPDFS_26333.pdf	136	{l,‘,G,IIAAAPSVRTFTRABILNAEALNIGKKDAIAPPLHIIDNRV}	{NULL}
SCPDFS_26333.pdf	137	{ucanmwccacmcnwarcccranrcucccearaoumaraurcrcncecxconaocuoomoocxcroacorcmrancncrnccnccccamacmcmooamacmcm,YDVRBFVPDHPGGSVILTHVGKDGTDVFDTIHPIAAWITL}	{NULL}
SCPDFS_26333.pdf	138	{GCCAAC,‘,1,"\\"",1,"\\"",l',.}	{NULL}
SCPDFS_26333.pdf	139	{l'AC,®,"\\"",1,',GG,',l'GA,',1,',A,',1,"\\"",l‘GA,',1,',GAGAGCGATCGTGCCATCAAOAATGAIKIACTTTGCGGCCGAGGTTCGCLAGCTGCGCACCTTGPTCCAUICCCTTGGCTACTACGACTCG,‘,1,‘,CC,ADITYVGDIDESDRAIKNDDFAAIVRKLRTLIQSLGYYDSS}	{NULL}
SCPDFS_26333.pdf	140	{H,%,CATETAT,%,KGTTCAACCTCTGCATCTGGGGCTTGICGACTHCAHGTTGCCAAGTGGGGCCAGACCTCGICCC,',.}	{NULL}
SCPDFS_26333.pdf	141	{l'CGCCAACGl,',®,',.}	{NULL}
SCPDFS_26333.pdf	142	{l',C,',l.,‘,CGGC,',.}	{NULL}
SCPDFS_26333.pdf	143	{|,.}	{NULL}
SCPDFS_26333.pdf	144	{‘,GCGC,',1,',C,',1,"\\"",l',G,KAYYAPRVSINLCIWGLSTIIVAKWGQTSTLAIIVLSAALL}	{NULL}
SCPDFS_26333.pdf	145	{%,',l’,C,',1,',C,',l,"\\"",1,‘,C,',l,‘,%,CAGCAO,',l'OCGGA,',l‘GG,',1,"\\"",1,',GGCGCACGAC,CACCA,%,KﬂCCAﬂGECGTHC,KTHKGGCGCC,GLIWQQCGWLAHDFLHHQVFQDRIWGDLFGAFLGGVCQGP}	{NULL}
SCPDFS_26333.pdf	146	{KMCCK,ACKKCACKlUCKCﬂACGTCCKGGCGAOGAKCCGACAHGACKKECCKTGTTGE,TG,3SSWNKDKENTHEAAPNVEGIDPDIDTHPLLTWBIHALIII}	{NULL}
SCPDFS_26333.pdf	147	{TTCTCOGATGITCCTGACGAGGAGCTGACCCGTATGIQGTCGCGCT,‘,rCATGG1,‘,CCTCAACCAGACCTGG,',!,'}	{NULL}
SCPDFS_26333.pdf	148	{l'CTAC1,',PCCCCN1,"\\"",I,',CTCTCG1,‘,T,',l‘GCCCG,',1,‘,C,',.}	{NULL}
SCPDFS_26333.pdf	149	{l,‘,G,',l.,',CC,',.}	{NULL}
SCPDFS_26333.pdf	150	{l'GCfl,',GCC,',.}	{NULL}
SCPDFS_26333.pdf	151	{l‘CCAG,',l'CC,I,‘,SDVPDIILTRIIWSRFIIVLNQTWFYFPILSFARLSWCLQS}	{NULL}
SCPDFS_26333.pdf	152	{A,',l,"\\"",1,‘,A,',1,',G,',.}	{NULL}
SCPDFS_26333.pdf	153	{l',1,"\\"",1V,',l,"\\"",1,‘,C,’,1,‘,xCCAACG,<,?}	{NULL}
SCPDFS_26333.pdf	154	{l'CAGGCCCACAAGCCCTCTGGAGCGCG,',.}	{NULL}
SCPDFS_26333.pdf	155	{I,',G,',1,‘,GCCCA,',.}	{NULL}
SCPDFS_26333.pdf	156	{l,"\\"",l.,"\\"",.}	{NULL}
SCPDFS_26333.pdf	157	{l.,',CG,',J.,"\\"",l,‘,x,',I,',CGAGCAGCTGTCTCTGGCTATGCACTGGICCTGGTACCTCGCCLCCATGTTC,IIIFVLPNGQAEKPSGARVPISLVEQLSLAIIHWTIIYLATIII,’}	{NULL}
SCPDFS_26333.pdf	158	{crmucnmuammccmcnmnrmmmormnwnmwomocaaocmnmcomncmmwmccmmvmncmccmamcacucaccnrcccromarcrccam,Ll,‘,IKDPVNMIVYPLVSQAVCGNLLAIVFSLNENGMPVISK}	{NULL}
SCPDFS_26333.pdf	159	{Gl0GAL,%,%,',.}	{NULL}
SCPDFS_26333.pdf	160	{l'CGl,',.}	{NULL}
SCPDFS_26333.pdf	161	{|,.,'}	{NULL}
SCPDFS_26333.pdf	162	{A,',.}	{NULL}
SCPDFS_26333.pdf	163	{I,',GGAC,',.}	{NULL}
SCPDFS_26333.pdf	164	{l,‘,1,',C,’,1,"\\"",1,',CACCAAGCAGATCATCACGGGICMGAIGHCACCCTGGKIOHTGCCHCTGGHCACGGMGGAHGAACTACCAGAMGABCACCACTTG,IIAVDIIDFFTKQIITGRDVHPGLFANWPTGGLNYQIIEEL}	{NULL}
SCPDFS_26333.pdf	165	{ITCCCTTCGATGCCCCXCACAACTTTTCAAAGATCQGCCTGCTGrCGWK,MKGGlGKCGATE,&,TKCKTGGTAT,®,KGAGGGHC,PPSKPRENESRIQPAVBTLCKKYGVRYHTTGIIIIGTAIVE}	{NULL}
SCPDFS_26333.pdf	166	{AGCCG,',.}	{NULL}
SCPDFS_26333.pdf	167	{l,"\\"",1,',1,',GAACGl,%,',1,',C,',l.,’,CCAAGGCGOCCTCCAAGATGGGCAAGGCACAGTAAACAAGCCTGTCCTFCTCAAACCCATCCTCCGAGAGAACTITTCATAGGACGGATCTAGTCTCCAAT,SRI,.}	{NULL}
SCPDFS_26333.pdf	168	{NlV,',SKAASKIlGKAQ,“}	{NULL}
SCPDFS_26333.pdf	169	{ATCTCCATICATTTCATTCATTA,HCATGTTKCTACK}	{NULL}
SCPDFS_26333.pdf	170	{I080,360}	{NULL}
SCPDFS_26333.pdf	171	{I200,400}	{NULL}
SCPDFS_26333.pdf	172	{I320,440}	{NULL}
SCPDFS_26333.pdf	173	{Fig,.}	{NULL}
SCPDFS_26333.pdf	174	{1,.}	{NULL}
SCPDFS_26333.pdf	175	{Nucleotide,and,deduced,amino-acid,sequences,of,the,A6-desaturase,from,M.,alpina,.}	{NULL}
SCPDFS_26333.pdf	176	{The,putative,polyadenylation,signal,is,boxed,and,the,poly,(,A,),tail,is,underlined,.}	{NULL}
SCPDFS_26333.pdf	177	{448,E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453}	{NULL}
SCPDFS_26333.pdf	178	{KHZPO4,",",0.1,%,NaNO3,and,0.05,%,MgSO4-7H2O,",",and,cultured,at,30,°,C,with,reciprocal,shaking,(,120,strokes,/,min,),for,3,days,.}	{NULL}
SCPDFS_26333.pdf	179	{The,fatty,acid,methyl,esters,(,FAMes,),were,prepared,and,analyzed,by,the,method,described,in,the,previous,report,(,Sakuradani,et,al.,",",1999b,),.}	{NULL}
SCPDFS_26333.pdf	180	{Fatty,acids,were,identiﬁed,by,both,comparison,of,their,retention,times,with,those,of,FAMe,standards,(,Sigma,",",USA,),separated,on,the,same,gas,chromatography,(,GC,),",",and,gas,chromatography,—,mass,spectrometry,(,GC,.}	{NULL}
SCPDFS_26333.pdf	181	{—,.}	{NULL}
SCPDFS_26333.pdf	182	{MS,),using,a,GCMS,.}	{NULL}
SCPDFS_26333.pdf	183	{—,.}	{NULL}
SCPDFS_26333.pdf	184	{QP5050,(,Shimadzu,",",Japan,),operating,at,an,ionization,voltage,of,70,eV,",",with,a,scan,range,of,40,—,500,Da,.}	{NULL}
SCPDFS_26333.pdf	185	{Quantitation,was,carried,out,using,peak,height,area,integrals,expressed,as,a,total,of,all,integrals,.}	{NULL}
SCPDFS_26333.pdf	186	{2.9,.}	{NULL}
SCPDFS_26333.pdf	187	{Extraction,and,fractionation,of,the,fungal,lipids}	{NULL}
SCPDFS_26333.pdf	188	{The,A.,oryzae,recombinant,was,inoculated,into,a,300,ml,Erlenmeyer,ﬂask,containing,50,ml,of,Medium,A,and,then,cultured,at,30,°,C,for,3,days,.}	{NULL}
SCPDFS_26333.pdf	189	{Extraction,and,fractionation,of,the,fungal,lipids,were,performed,by,the,method,described,in,the,previous,report,(,Sakuradani,et,al.,",",1999b,),.}	{NULL}
SCPDFS_26333.pdf	190	{2.10,.}	{NULL}
SCPDFS_26333.pdf	191	{Southern,blot,analysis}	{NULL}
SCPDFS_26333.pdf	192	{Southern,blotting,against,the,restriction,endonucle,—,ase,—,digested,total,DNA,was,performed,essentially,as,described,by,Sambrook,et,al.,(,1989,),.}	{NULL}
SCPDFS_26333.pdf	193	{The,1.6,kb,EcoRI,fragment,of,pMLD30,",",labeled,with,[,oc,—,32P,],dCTP,",",was,used,as,the,probe,.}	{NULL}
SCPDFS_26333.pdf	194	{Prehybridization,and,hybridization,were,performed,under,the,same,conditions,as,in,the,previous,report,(,Sakuradani,et,al.,",",1999b,),.}	{NULL}
SCPDFS_26333.pdf	195	{3,.}	{NULL}
SCPDFS_26333.pdf	196	{Results}	{NULL}
SCPDFS_26333.pdf	197	{3.1,.}	{NULL}
SCPDFS_26333.pdf	198	{Cloning,ofthe,M.,alpina,A6-desaturase,CDNA}	{NULL}
SCPDFS_26333.pdf	199	{Two,conserved,amino,—,acid,sequences,found,in,the,borage,(,Sayanova,et,al.,",",1997,),and,C.,elegans,(,Napier,et,al.,",",1998,),A6,—,desaturases,were,used,as,the,basis,for,the,design,of,two,primers,for,PCR,.}	{NULL}
SCPDFS_26333.pdf	200	{The,sequence,WWKD,(,D/W,),KHN,(,A/T,),HH,(,amino,—,acid,positions,191,—,200,in,borage,and,200,—,209,in,C.,elegans,),was,chosen,for,the,5,’,primer,",",while,QIEHHLFPTM,(,positions,373,—,382,in,borage,and,383,—,392,in,C.,elegans,),was,chosen,for,the,3,’,primer,.}	{NULL}
SCPDFS_26333.pdf	201	{A,638,bp,fragment,was,ampliﬁed,by,PCR,using,these,primers,and,M.,alpina,1S,—,4,genomic,DNA,as,a,template,.}	{NULL}
SCPDFS_26333.pdf	202	{The,ampliﬁed,fragment,was,subcloned,into,pCR@2.1,(,Invitrogen,),to,construct,pMLD1,",",and,the,sequence,was,determined,.}	{NULL}
SCPDFS_26333.pdf	203	{The,deduced,amino,—,acid,sequence,of,the,ampliﬁed,fragment,showed,high,similarity,to,those,of,the,borage,and,C.,elegans,A6,—,desaturases,.}	{NULL}
SCPDFS_26333.pdf	204	{Using,this,32P,—,labeled,638,bp,fragment,as,the,probe,",",M.,alpina,A6,—,desaturase,cDNA,was,isolated,from,the,?}	{NULL}
SCPDFS_26333.pdf	205	{tgt10,cDNA,library,.}	{NULL}
SCPDFS_26333.pdf	206	{An,EcoRI,fragment,derived,from,the,positive,?}	{NULL}
SCPDFS_26333.pdf	207	{tgt10,clone,was,subcloned,into,pBluescript,II,",",and,then,sequenced,(,accession,No.,.}	{NULL}
SCPDFS_26333.pdf	208	{AB020032,in,EMBL,/,GenBank/DDBJ,nucleotide,sequence,databases,),.}	{NULL}
SCPDFS_26333.pdf	209	{This,EcoRI,fragment,contained,an,open,reading,frame,",",which,would,encode,a,protein,of,457,amino,acids,with,a,molecular,mass,of,51,815,(,Fig,.}	{NULL}
SCPDFS_26333.pdf	210	{1,),.}	{NULL}
SCPDFS_26333.pdf	211	{A,putative,polyadeny,—,lation,signal,",",ATTAAA,",",was,present,18,bp,upstream,of,the,poly,(,A,),.}	{NULL}
SCPDFS_26333.pdf	212	{3.2,.}	{NULL}
SCPDFS_26333.pdf	213	{Comparison,of,the,A6-desaturase,sequence,of,M.,alpina,1,S-4,with,those,of,other,organisms}	{NULL}
SCPDFS_26333.pdf	214	{The,deduced,amino,—,acid,sequence,of,the,Mortierella,A6,—,desaturase,cDNA,was,compared,with,all,the,A6,—,fatty,acid,desaturase,sequences,known,to,date,(,Fig,.2,),.}	{NULL}
SCPDFS_26333.pdf	215	{The,A6,—,desaturases,of,M.,alpina,1S,—,4,and,borage,(,Sayanova,et,al.,",",1997,),exhibit,30.5,%,sequence,identity,",",and,those,of,M,alpina,1S,—,4,and,C.,elegans,(,Napier,et,al.,",",1998,),34.2,%,.}	{NULL}
SCPDFS_26333.pdf	216	{In,particular,",",three,histidine,—,cluster,motifs,(,Shanklin,et,al.,",",1994,),",",which,comprise,the,consensus,sequence,of,fatty,—,acid,desaturases,",",are,well,conserved,in,the,A6,—,desaturase,of,M.,alpina1S,—,4,(,amino,—,acid,positions,172,—,176,",",209,—,213,",",and,395,—,399,),.}	{NULL}
SCPDFS_26333.pdf	217	{Hydrophobicity,plots,of,the,Mortierella,A6desaturase,show,that,two,conserved,hydrophobic,regions,which,are,known,to,form,two,membrane,—,span,—,ning,domains,in,the,endoplasmic,reticulum,(,Shanklin,et,al.,",",1994,),are,present,in,this,Mortierella,desaturase,.}	{NULL}
SCPDFS_26333.pdf	218	{In,addition,",",a,computer,—,aided,search,of,protein,sequence,databases,revealed,30.8,%,identity,over,the,N,—,terminal,78,amino,—,acid,residues,of,the,Mortierella,A6,—,desaturase,with,microsomal,cytochrome,b5,from,rat,(,Mitoma,and,Ito,",",1992,),.}	{NULL}
SCPDFS_26333.pdf	219	{These,ﬁndings,suggest,that,this,domain,in,the,desaturase,would,play,the,role,of,a,unique,electron,transport,system,",",binding,a,heme,group,",",and,therefore,belonging,to,the,cytochrome,b5,superfamily,.}	{NULL}
SCPDFS_26333.pdf	220	{3.3,.}	{NULL}
SCPDFS_26333.pdf	221	{Expression,of,the,Mortierella,A6-desaturase,cDNA,in,A.,oryzae}	{NULL}
SCPDFS_26333.pdf	222	{The,Mortierella,A6,—,desaturase,cDNA,was,ligated,to,the,fungal,expression,vector,",",pTAex3,.}	{NULL}
SCPDFS_26333.pdf	223	{In,the,resultant,plasmid,",",designated,as,pMLD30,",",expression,of,the,cloned,A6,—,desaturase,gene,was,controlled,by,the,amyB,promoter,of,A.,oryzae,(,Tada,et,al.,",",1991,),.}	{NULL}
SCPDFS_26333.pdf	224	{After,transformation,",",several,transformants,were,obtained,on,selective,medium,plates,as,described,under,Materials,and,methods,.}	{NULL}
SCPDFS_26333.pdf	225	{To,examine,the,expression,of,the,Mortierella,A6,—,desaturase,in,A.,oryzae,",",the,fatty,—,acid,compositions,of,these,transformants,",",which,were,cultured,on,glucose,medium,at,30,"\\"",C,for,3,days,",",were,analyzed,as,described,under,Materials,and,methods,.}	{NULL}
SCPDFS_26333.pdf	226	{The,fatty,—,acid,composition,of,a,selected,transformant,",",MLD,—,1,",",determined,by,GC,analysis,",",was,different,from,that,of,the,control,strain,involving,only,the,pTAex3,vector,without,any}	{NULL}
SCPDFS_26333.pdf	227	{E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453,449}	{NULL}
SCPDFS_26333.pdf	228	{Morfd6,Borfdﬁ,Caefd6,Synfd6}	{NULL}
SCPDFS_26333.pdf	229	{Morfd6,------,--,nﬁ,-,------,--,-,s,-,-,H2,-,133,Borfdﬁ,------,—,-,svsxvs,-,------,--,--,um,»,-,rc,:,-,L,:,*,'',~,170,Caefd6,mxvnzxvsa,svﬂonxnlvisr,-,xum,«,ﬁr,-,Is,-,na,-----,mt,:,s-Lu,"\\"",Lv,.}	{NULL}
SCPDFS_26333.pdf	230	{_,1,-,179,synfda,at-uvmon,-,",",---------------,—,-,-,ronnups,LII,rsm,ﬂu-Arvzrrvzu,.}	{NULL}
SCPDFS_26333.pdf	231	{e,1,D,"\\"",.}	{NULL}
SCPDFS_26333.pdf	232	{vssm,99}	{NULL}
SCPDFS_26333.pdf	233	{His,box,[,I}	{NULL}
SCPDFS_26333.pdf	234	{Morfdﬁ,or,»,P,:,Go,CQ,`,-,',',-,D,-,WSRF-VI,-,‘,QH,.}	{NULL}
SCPDFS_26333.pdf	235	{nrﬁ,283,Bo,:,-,"{",d6,-,an,GI,I,:,-,_,A,~,',-,--,l,<,l',l'GsL,Ds,sRF,~,:,Q,:,I,In,.}	{NULL}
SCPDFS_26333.pdf	236	{273,Caefdé,ruﬁus,F,G,-,',QGI,-,‘,S,’,-,~,~,',',»,D-DID,PLI,uzpa,-,cx,!,'}	{NULL}
SCPDFS_26333.pdf	237	{n.,sr,:,xAn.-x,:,-----,u9,:,275,Synfd6,nmv1@rnr-nr--,C555,‘,1,I,encavmﬁnqmvc,----------,--,:,!}	{NULL}
SCPDFS_26333.pdf	238	{-,@QQrv1wa,:,.}	{NULL}
SCPDFS_26333.pdf	239	{ﬂ,--,-,ﬁn,184}	{NULL}
SCPDFS_26333.pdf	240	{Morfdé,neu,scnﬂvﬁz,ma,-,.}	{NULL}
SCPDFS_26333.pdf	241	{—,.}	{NULL}
SCPDFS_26333.pdf	242	{-,u,-,z,-,379,Borfd6,-----,--,s,s,:,--,-,rnnvscnr,IA,-,-,357,Caefdo,n,:,nI,-,-,@Iz,!}	{NULL}
SCPDFS_26333.pdf	243	{xw@-,-,TI,-,-,-,-,Q,rrvﬁx,.}	{NULL}
SCPDFS_26333.pdf	244	{-,nv,I,-,367,Synfdﬁ,1rprQ-ﬁ,:,.}	{NULL}
SCPDFS_26333.pdf	245	{ﬂAs,1,:,wraz,.}	{NULL}
SCPDFS_26333.pdf	246	{IPIVLIGA,YGI,I,.}	{NULL}
SCPDFS_26333.pdf	247	{287}	{NULL}
SCPDFS_26333.pdf	248	{Morfdﬁ,457,Borfdﬁ,448,Caefd6,443,synrao,359}	{NULL}
SCPDFS_26333.pdf	249	{Fig,.}	{NULL}
SCPDFS_26333.pdf	250	{2,.}	{NULL}
SCPDFS_26333.pdf	251	{Comparison,of,the,deduced,amino,—,acid,sequences,of,A6-desaturases,from,Mortierella,",",borage,(,B.,oﬂicialis,),",",C.,elegans,and,Synecliocystis,.}	{NULL}
SCPDFS_26333.pdf	252	{Abbreviations,:,Morfd6,",",Mortierella,A6-desaturase,;,Borfd6,",",borage,A6-desaturase,;,Caefd6,",",C.,elegans,A6-desaturase,;,Synfd6,",",Synetliocystis,A6-desaturase,.}	{NULL}
SCPDFS_26333.pdf	253	{insert,DNA,(,Fig,.}	{NULL}
SCPDFS_26333.pdf	254	{3,),.}	{NULL}
SCPDFS_26333.pdf	255	{The,novel,peak,in,the,chromatogram,of,FAMes,from,MLD,—,l,had,an,identical,retention,time,to,the,FAMe,standard,of,GLA,.}	{NULL}
SCPDFS_26333.pdf	256	{As,shown,in,Table,1,",",the,percentage,of,GLA,in,MLD,—,1,increased,to,25.2,%,in,contrast,to,that,(,o,%,),in,the,control,strain,.}	{NULL}
SCPDFS_26333.pdf	257	{The,increase,of,GLA,caused,a,decrease,in,linoleic,acid,on,desaturation,at,the,A6,—,position,.}	{NULL}
SCPDFS_26333.pdf	258	{The,percentage,of,oc-linolenic,acid,to,total,fatty,acids,in,MLD,—,l,decreased,in,comparison,with,the,control,strain,.}	{NULL}
SCPDFS_26333.pdf	259	{Furthermore,",",GC,.}	{NULL}
SCPDFS_26333.pdf	260	{—,.}	{NULL}
SCPDFS_26333.pdf	261	{MS,analysis,of,the,fatty,acid,pyrrolidide,derivative,from,MLD,—,l,(,Fig,.}	{NULL}
SCPDFS_26333.pdf	262	{4,),demonstrated,that,the,novel,peak,in,Fig,.}	{NULL}
SCPDFS_26333.pdf	263	{3,was,GLA,methyl,ester,.}	{NULL}
SCPDFS_26333.pdf	264	{The,m/z,331,indicated,the,molecular,mass,of,the,pyrrolidide,—,derivatized,GLA,.}	{NULL}
SCPDFS_26333.pdf	265	{The,spectrum,included,abundant,m/z,113,(,McLafferty,rearrangement,ion,),and,126,peaks,typical,of,fatty,—,acid,pyrrolidide,derivatives,.}	{NULL}
SCPDFS_26333.pdf	266	{The,spectrum,of,the,putative,GLA,derivative,had,a,molecular,ion,at,m/z,331,",",suggesting,an,octadecatrienoic,acid,;,the,gaps,of,26,amu,(,atomic,mass,units,),between,m/z,154,and,180,",",m/z,194,and,220,",",and,m/z,234,and,260,",",indicated,double,bonds,at,C6,",",C9,",",and,C12,",",respectively,.}	{NULL}
SCPDFS_26333.pdf	267	{3.4,.}	{NULL}
SCPDFS_26333.pdf	268	{Lipid,analysis,of,the,fungal,lransformanls}	{NULL}
SCPDFS_26333.pdf	269	{The,fatty,—,acid,proﬁles,of,lipid,classes,of,the,control,strain,and,MLD,—,l,(,Table,2,),.}	{NULL}
SCPDFS_26333.pdf	270	{The,major,lipids,in,both,strains,were,triacylglycerol,(,TG,),",",free,fatty,acid,(,FA,),",",diacylglycerol,(,DG,),",",phosphatidylethanolamine,(,PE,),",",phosphatidylcholine,(,PC,),",",phosphatidylserine,(,PS,),",",and,phosphatidylamine,(,PA,),.}	{NULL}
SCPDFS_26333.pdf	271	{TG,and,PC,in,both,the,control,strain,and,MLD,—,l,accounted,for,most,of,lipids,;,in,particular,",",PC,in,MLD,—,l,was,almost,half,of,the,lipids,.}	{NULL}
SCPDFS_26333.pdf	272	{The,18:3,co6,(,GLA,),composition,in,MLD,—,l,was,59.8,mol,%,",",whereas,that,in,the,other,lipids,was,between,12.7,and,31.7,mol,%,.}	{NULL}
SCPDFS_26333.pdf	273	{3.5,.}	{NULL}
SCPDFS_26333.pdf	274	{Genomic,Southern,blot,analysis,of,the,Aspergillus,lransformanls}	{NULL}
SCPDFS_26333.pdf	275	{The,genomic,DNAs,of,MLD,—,l,and,the,control,strain,were,analyzed,by,Southern,blot,hybridization,using,the,Mortierella,A6,—,desaturase,gene,as,a,probe,.}	{NULL}
SCPDFS_26333.pdf	276	{As,shown,in,Fig,.}	{NULL}
SCPDFS_26333.pdf	277	{5,",",the,patterns,of,the,EcoRI,—,digested,genomic,DNA,were,similar,to,each,other,.}	{NULL}
SCPDFS_26333.pdf	278	{A,single,positive,band,(,1.6,kb,),was,observed,for,MLD,—,l,",",but,not,for,the,control,strain,",",demonstrating,that,the,Morlierella,A6,—,desaturase,cDNA,in,pMLD30,constructed,for,its,expression,in,A.,oryzae,was,integrated,into,the,genome,of,MLD,—,l.}	{NULL}
SCPDFS_26333.pdf	279	{4,.}	{NULL}
SCPDFS_26333.pdf	280	{Discussion}	{NULL}
SCPDFS_26333.pdf	281	{The,industrial,strain,",",M.,alpina,1S,—,4,",",accumulates,unsaturated,C-18,and,C-20,fatty,acids,in,its,membrane,and,lipid,bodies,(,Shimizu,et,al.,",",1997,),.}	{NULL}
SCPDFS_26333.pdf	282	{In,this,strain,",",linoleic,acid,can,be,successively,desaturated,to,GLA,but,not,to,oc,—,linolenic,acid,.}	{NULL}
SCPDFS_26333.pdf	283	{In,the,biosynthesis,of,PUFAs,",",including,dihomo,—,y,—,linolenic,acid,and,arachidonic,acid,",",A6,—,desaturation,is,the,ﬁrst,principal,step,for,the,synthesis,of,n,—,6,fatty,acids,.}	{NULL}
SCPDFS_26333.pdf	284	{Here,",",we,isolated,the,A6,—,desaturase,cDNA,from,M.,alpina,1S,—,4,using,a,degenerate,PCR,approach,based,on,the,amino,—,acid,sequence,motifs,conserved,in,other,microsomal,fatty,acid,desaturases,.}	{NULL}
SCPDFS_26333.pdf	285	{450,E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453}	{NULL}
SCPDFS_26333.pdf	286	{(,A,)}	{NULL}
SCPDFS_26333.pdf	287	{8,1,:,§,2,‘,é,U,%,Q}	{NULL}
SCPDFS_26333.pdf	288	{Retention,time,(,min,)}	{NULL}
SCPDFS_26333.pdf	289	{(,B,)}	{NULL}
SCPDFS_26333.pdf	290	{2,1-1,9,8,o,C,’,),2,66,8,.}	{NULL}
SCPDFS_26333.pdf	291	{_,.}	{NULL}
SCPDFS_26333.pdf	292	{2,/,§,§,o,Q}	{NULL}
SCPDFS_26333.pdf	293	{T,‘,.}	{NULL}
SCPDFS_26333.pdf	294	{—,.}	{NULL}
SCPDFS_26333.pdf	295	{I,5,7,9,11,13,15}	{NULL}
SCPDFS_26333.pdf	296	{Retention,time,(,min,)}	{NULL}
SCPDFS_26333.pdf	297	{(,C,)}	{NULL}
SCPDFS_26333.pdf	298	{7,5,3,P@[��}	{NULL}
SCPDFS_26333.pdf	299	{1,‘,‘,4,”’,1x,(,Linoleic,acid,)}	{NULL}
SCPDFS_26333.pdf	300	{1,A6-Desaturation}	{NULL}
SCPDFS_26333.pdf	301	{7,6,4,2,1,:,COOH}	{NULL}
SCPDFS_26333.pdf	302	{8,5,3,18:3,(,.}	{NULL}
SCPDFS_26333.pdf	303	{o6,11,14,16,",8",(,GLA,)}	{NULL}
SCPDFS_26333.pdf	304	{Fig,.}	{NULL}
SCPDFS_26333.pdf	305	{3,.}	{NULL}
SCPDFS_26333.pdf	306	{GC,chromatograms,of,fatty-acid,methyl,esters,obtained,from,the,control,strain,and,MLD-1,and,A6-desaturataion,model,.}	{NULL}
SCPDFS_26333.pdf	307	{(,A,),The,control,strain,is,the,recombinant,that,contains,pTAex3,.}	{NULL}
SCPDFS_26333.pdf	308	{(,B,),MLD-1,including,pMLD30,for,A6-desaturase,expression,accumulated,18:30,),6,(,GLA,),.}	{NULL}
SCPDFS_26333.pdf	309	{Abbreviations,:,16:0,",",palmitic,acid,;,18:0,",",stearic,acid,;,l8,:1,u,),9,",",oleic,acid,;,l8,:2,u,),6,",",linoleic,acid,;,l8,:3,u,),6,",",y-linolenic,acid,;,l8,:3,u,),3,",",01-linolenic,acid,.}	{NULL}
SCPDFS_26333.pdf	310	{(,C,),A6-Desaturase,catalyzes,the,conversion,of,l8,:2,(,n6,(,linolenic,acid,),to,18:30,),6,(,GLA,),by,addition,of,a,double,bond,at,the,A6-position,.}	{NULL}
SCPDFS_26333.pdf	311	{Table,1,Fatty-acid,compositions,of,Aspergillus,transformantsa}	{NULL}
SCPDFS_26333.pdf	312	{Fatty,acid,Fatty-acid,composition,(,mol,%,),"\\""}	{NULL}
SCPDFS_26333.pdf	313	{Control,strain,MLD-1}	{NULL}
SCPDFS_26333.pdf	314	{16:0,13.7,18.0,18:0,7.7,5.4,18:10,),9,18.8,13.2,18:20,),6,58.1,37.1,18:30,),6,N.D.,°,25.2,18:30,),3,1.4,0.7,"\\""}	{NULL}
SCPDFS_26333.pdf	315	{The,fungus,was,grown,at,30,°,C,for,3,days,in,Medium,A.,b,These,Values,are,the,means,of,duplicate,experiments,in,which,the,values,were,consistent,to,within,i2,%,.}	{NULL}
SCPDFS_26333.pdf	316	{°,N.D.,",",not,detected,.}	{NULL}
SCPDFS_26333.pdf	317	{This,is,the,ﬁrst,report,to,our,knowledge,of,the,cloning,of,a,gene,encoding,a,A6,—,fatty,acid,desaturase,from,a,fungus,.}	{NULL}
SCPDFS_26333.pdf	318	{The,sequence,of,A6,—,desaturase,of,M.,alpina,1S,—,4,exhibits,similarity,to,those,of,borage,(,Sayanova,et,al.,",",1997,),",",C.,elegans,(,Napier,et,al.,",",1998,),",",and,Synechocyslis,(,Reddy,et,al.,",",1993,),",",although,the,homology,between,the,last,enzyme,and,that,of,Mortierella,is,weak,but,signiﬁcant,",",particularly,around,the,three,histi,—,dine,—,cluster,motifs,which,are,located,at,the,corresponding,position,in,each,sequence,.}	{NULL}
SCPDFS_26333.pdf	319	{The,phylogenetic,tree,of,the,homologous,desaturases,indicate,that,the,A6,—,desaturases,are,evolutionarily,close,to,the,A5desaturases,(,data,not,shown,),.}	{NULL}
SCPDFS_26333.pdf	320	{An,HPGG,(,amino,—,acid,positions,50,—,53,),cytochrome,b5,motif,exists,in,the,N,—,terminus,of,the,M.,alpina,1S,—,4,A6,—,desaturase,",",as,also,seen,in,the,borage,and,C.,elegans,A6,—,desaturases,",",and,the,M.,alpina,CBS,210.32,A5,—,desaturase,(,Michaelson,et,al.,",",1998,),.}	{NULL}
SCPDFS_26333.pdf	321	{This,also,supports,the,same,superfamily,consisting,of,the,A5,—,and,A6,—,desaturases,.}	{NULL}
SCPDFS_26333.pdf	322	{In,contrast,",",the,cytochrome,b5,motif,of,the,yeast,(,S.,cerevisiae,),A9,—,desaturase,(,OLEI,),is,present,in,the,form,of,a,113,—,amino,acid,C,—,terminal,fusion,(,Stukey,et,al.,",",1990,),.}	{NULL}
SCPDFS_26333.pdf	323	{The,M,alpina,1S,—,4,A6,—,desaturase,has,three,conserved,histidine,boxes,(,amino,—,acid,positions,172,—,176,",",209,—,213,",",and,395,—,399,),similar,to,other,types,of,fatty,—,acid,desaturases,(,i.e.,",",A5,—,",",A9,—,",",A12,—,and,A15,—,desaturases,),from,other,sources,",",but,the,histidine,residue,that,is,conserved,in,all,of,the,other,types,of,enzymes,(,except,acyl,.}	{NULL}
SCPDFS_26333.pdf	324	{—,.}	{NULL}
SCPDFS_26333.pdf	325	{ACP,type,A9,—,desaturases,",",which,do,not,contain,such,histidine,motifs,),is,replaced,by,glutamine,(,i.e.,",",Gln,—,395,),in,the,third,histidine,box,at,the,C,—,terminus,of,the,M,alpina,1S,—,4,A6,—,desaturase,.}	{NULL}
SCPDFS_26333.pdf	326	{This,phenomenon,is,also,present,in,the,A6,—,desaturases,of,borage,and,C.,elegans,",",and,the,A5,—,desaturase,of,M,alpina,CBS,210.32,.}	{NULL}
SCPDFS_26333.pdf	327	{Although,three,histidine,boxes,are,thought,to,be,located,near,an,active,site,of,the,enzyme,(,Shanklin,et,al.,",",1994,),",",the,function,of,the,replaced,glutamine,residue,is,unclear,.}	{NULL}
SCPDFS_26333.pdf	328	{In,general,",",it,is,difficult,for,the,genes,of,ﬁlamentous,fungi,to,be,expressed,in,bacteria,and,yeasts,as,microbial}	{NULL}
SCPDFS_26333.pdf	329	{E,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453,451}	{NULL}
SCPDFS_26333.pdf	330	{I13,"126 154 180 194","220 234 260"}	{NULL}
SCPDFS_26333.pdf	331	{<,1,),o,E,"\\"",U,ﬁ,5,.}	{NULL}
SCPDFS_26333.pdf	332	{-,D,<}	{NULL}
SCPDFS_26333.pdf	333	{331,274,age,302,316,L333,o,V,n,4,*,‘,?}	{NULL}
SCPDFS_26333.pdf	334	{r,14,*,‘,?}	{NULL}
SCPDFS_26333.pdf	335	{I,1,V,‘,n}	{NULL}
SCPDFS_26333.pdf	336	{1oo,"150 200 250 300"}	{NULL}
SCPDFS_26333.pdf	337	{n1/z}	{NULL}
SCPDFS_26333.pdf	338	{Fig,.}	{NULL}
SCPDFS_26333.pdf	339	{4,.}	{NULL}
SCPDFS_26333.pdf	340	{GC,.}	{NULL}
SCPDFS_26333.pdf	341	{—,.}	{NULL}
SCPDFS_26333.pdf	342	{MS,analysis,of,the,pyrrolidide-derivative,fatty,acid,.}	{NULL}
SCPDFS_26333.pdf	343	{The,spectrum,of,the,pyrrolidide,derivative,of,the,novel,fatty,acid,in,Fig,.}	{NULL}
SCPDFS_26333.pdf	344	{3,indicated,a,GLA,derivative,.}	{NULL}
SCPDFS_26333.pdf	345	{The,details,of,the,interpretation,of,the,spectrum,are,given,in,the,text,.}	{NULL}
SCPDFS_26333.pdf	346	{The,deduced,structure,of,the,fatty,—,acid,derivative,is,shown,in,the,spectrum,.}	{NULL}
SCPDFS_26333.pdf	347	{hosts,.}	{NULL}
SCPDFS_26333.pdf	348	{A,ﬁlamentous,fungus,is,a,suitable,host,for,the,expression,of,ﬁlamentous,fungal,genes,(,Huang,et,al.,",",1995,),.}	{NULL}
SCPDFS_26333.pdf	349	{Here,",",we,succeeded,in,both,the,expression,of,the,Mortierella,A6,—,desaturase,in,A.,oryzae,and,the,production,of,GLA,in,the,resultant,recombinant,",",MLD,—,l.,We,used,Aspergillus,as,the,heterologous,host,for,such,expression,",",because,there,have,been,almost,no,effective,host,—,vector,systems,in,fungi,except,for,this,one,(,Stukey,et,al.,",",1990,),.}	{NULL}
SCPDFS_26333.pdf	350	{The,expression,of,pMLD30,in,the,MLD-l,recombinant,led,to,the,accumulation,of,GLA,.}	{NULL}
SCPDFS_26333.pdf	351	{.}	{NULL}
SCPDFS_26333.pdf	352	{o,.3,?}	{NULL}
SCPDFS_26333.pdf	353	{<,t,~,c2,<,r.,"\\"",ac,.}	{NULL}
SCPDFS_26333.pdf	354	{~,=,2,-44,N,one,<,r,mm,o}	{NULL}
SCPDFS_26333.pdf	355	{7LHindIIl}	{NULL}
SCPDFS_26333.pdf	356	{(,A,),Control,MLD-l}	{NULL}
SCPDFS_26333.pdf	357	{(,B,),Control}	{NULL}
SCPDFS_26333.pdf	358	{MLD-I,'}	{NULL}
SCPDFS_26333.pdf	359	{Fig,.}	{NULL}
SCPDFS_26333.pdf	360	{5,.}	{NULL}
SCPDFS_26333.pdf	361	{Genomic,Southern,blot,analysis,of,Aspergillus,transformants,.}	{NULL}
SCPDFS_26333.pdf	362	{(,A,),Agarose,gel,electrophoresis,.}	{NULL}
SCPDFS_26333.pdf	363	{Total,DNAs,(,4,pg,),from,the,control,strain,and,MLD-1,were,digested,with,EcoRI,(,whose,site,is,not,present,in,the,A6,—,desaturase,CDNA,),",",and,then,separated,by,electrophoresis,on,a,1.0,%,agarose,gel,.}	{NULL}
SCPDFS_26333.pdf	364	{Fragment,sizes,are,shown,in,kilobase,pairs,according,to,that,of,a,standard,marker,",",kHindIII,.}	{NULL}
SCPDFS_26333.pdf	365	{(,B,),Genomic,Southern,blot,hybridization,on,a,nylon,membrane,.}	{NULL}
SCPDFS_26333.pdf	366	{After,electrophoresis,",",the,digested,DNA,was,transferred,to,a,nylon,membrane,and,then,hybridized,with,the,radiolabeled,Morlierella,A6,—,desaturase,CDNA,as,a,probe,.}	{NULL}
SCPDFS_26333.pdf	367	{Accompanying,a,decrease,in,the,linoleic,acid,content,in,MLD-l,",",the,GLA,content,increased,up,to,25.2,%,of,the,total,fatty,—,acid,content,",",whereas,no,GLA,was,detected,in,the,control,strain,.}	{NULL}
SCPDFS_26333.pdf	368	{According,to,the,fatty,—,acid,proﬁles,in,Table,2,",",the,PC,fraction,in,MLD-1,highly,contained,GLA,comprising,59.8,mol,%,of,fatty,acid,composition,.}	{NULL}
SCPDFS_26333.pdf	369	{In,Arabidopsis,",",as,reported,by,Somerville,and,Browse,(,1991,),",",the,A6,—,desaturase,acts,on,linoleic,acid,(,18:2,),in,PC,in,endoplasmic,reticulum,.}	{NULL}
SCPDFS_26333.pdf	370	{PC,containing,linoleic,acid,",",which,is,a,component,of,membrane,bilayers,in,A.,oryzae,",",may,be,a,substrate,for,the,A6,—,desaturase,of,M.,alpina,1S,—,4,",",resulting,in,the,accumulation,of,GLA,.}	{NULL}
SCPDFS_26333.pdf	371	{We,assume,that,",",after,synthesis,of,GLA,in,PC,",",it,is,transferred,into,other,lipids,by,acyltransferase,.}	{NULL}
SCPDFS_26333.pdf	372	{On,the,other,hand,",",A6,—,desaturases,are,also,able,to,synthesize,octade,—,catetraenoic,acid,(,A6,",",A9,",",A12,",",A15,—,l8,:4,),through,the,addition,of,a,double,bond,at,the,A6,—,position,of,oc-linolenic,acid,.}	{NULL}
SCPDFS_26333.pdf	373	{However,",",octadecatetraenoic,acid,was,not,accumulated,in,MLD,—,l.,Therefore,",",we,tried,to,determine,the,fatty,acid,composition,of,MLD-l,which,was,cultivated,in,medium,supplemented,with,linseed,oil,methyl,ester,",",including,plenty,of,oc,—,linolenic,acid,methyl,ester,.}	{NULL}
SCPDFS_26333.pdf	374	{Octadecatetraenoic,acid,was,consequently,accumulated,in,MLD-l,but,not,in,the,control,strain,(,data,not,shown,),.}	{NULL}
SCPDFS_26333.pdf	375	{This,suggests,that,the,M.,aZpinalS,—,4,A6,—,desaturase,acts,on,not,only,linoleic,acid,as,a,substrate,but,also,oc,—,linolenic,acid,",",and,that,the,amount,of,octade,—,catetraenoic,acid,synthesized,by,the,M.,alpina,1S,—,4,A6,—,desaturase,was,too,little,to,be,detected,owing,to,the,low,amount,of,oc,—,linolenic,acid,(,0.7,%,),as,the,substrate,of,this,enzyme,in,MLD-l,",",that,was,cultured,in,the,glucose,medium,.}	{NULL}
SCPDFS_26333.pdf	376	{Table,2,Fatty-acid,proﬁles,of,the,lipid,classes,in,Aspergillus,transformantsa}	{NULL}
SCPDFS_26333.pdf	377	{E.,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453}	{NULL}
SCPDFS_26333.pdf	378	{Lipid,”,Lipid,composition,Fatty,acid,composition,(,mol,%,),°}	{NULL}
SCPDFS_26333.pdf	379	{(,mol,%,)}	{NULL}
SCPDFS_26333.pdf	380	{16:0,18:0,18:1,u,),9,1822036,18:3,u,),6,18:3,a,(,n3}	{NULL}
SCPDFS_26333.pdf	381	{Control,strain,TG,36.4,11.1,8.2,20.1,58.2,N.D.,“,2.5,FA,6.0,30.6,6.3,17.4,44.8,N.D.,0.9,DG,4.0,28.1,3.5,18.6,48.7,N.D.,1.1,PE,6.7,7.2,1.4,16.5,71.9,N.D.,3.0,PC,36.5,9.1,1.5,11.4,74.9,N.D.,3.1,PS,6.3,41.5,1.9,9.5,45.8,N.D.,1.3,PA,4.1,32.8,1.9,12.6,51.0,N.D.,1.7,MLD-1,TG,21.4,21.7,19.3,16.1,16.9,25.6,0.4,FA,7.2,38.3,17.1,20.1,11.8,12.7,o.o,DG,8.5,37.5,5.2,16.6,20.4,20.3,o.o,PE,4.0,5.8,1.6,18.0,41.7,31.7,1.2,PC,45.2,13.0,3.3,6.8,16.6,59.8,0.5,PS,9.3,45.5,2.4,10.7,23.8,17.4,0.2,PA,4.4,38.0,4.5,14.0,22.4,21.1,o.o}	{NULL}
SCPDFS_26333.pdf	382	{3,The,fungus,was,grown,at,30,°,C,for,3,days,in,Medium,A.,"\\"",Major,lipid,composition,.}	{NULL}
SCPDFS_26333.pdf	383	{Other,minor,lipids,",",such,as,sterol,",",sterol,ester,",",and,glycolipid,",",were,not,included,for,the,calculation,.}	{NULL}
SCPDFS_26333.pdf	384	{TG,",",triacylglycerol,;,FA,",",free,fatty,acid,;,DG,",",diacylglycerol,;,PE,",",phosphatidylethanolamine,;,PC,",",phosphatidylcholine,;,PS,",",phosphatidylserine,;,PA,",",phosphatidylamine,.}	{NULL}
SCPDFS_26333.pdf	385	{°,These,values,are,the,means,of,duplicate,experiments,in,which,values,were,consistent,with,each,other,to,within,3,%,.}	{NULL}
SCPDFS_26333.pdf	386	{d,N.D.,",",not,detected,.}	{NULL}
SCPDFS_26333.pdf	387	{A.,oryzae,has,been,used,for,the,fermentation,of,food,and,beverages,for,a,long,period,",",and,thus,is,a,safe,host,for,mammals,.}	{NULL}
SCPDFS_26333.pdf	388	{MLD,—,1,is,expected,to,be,a,safe,producer,of,GLA,for,food,and,health,applications,.}	{NULL}
SCPDFS_26333.pdf	389	{Our,ﬁndings,indicate,that,",",in,the,future,",",the,genes,encoding,proteins,involved,in,the,PUFA,biosynthesis,by,M.,alpina,can,be,expressed,with,this,host,—,vector,system,of,Aspergillus,.}	{NULL}
SCPDFS_26333.pdf	390	{In,this,case,",",it,is,possible,to,modify,the,fatty,—,acid,composition,and,to,produce,speciﬁc,lipids,industrially,with,the,fungi,.}	{NULL}
SCPDFS_26333.pdf	391	{Furthermore,",",the,oleaginous,fungus,",",M.,alpina,1S,—,4,",",will,become,a,more,powerful,producer,of,speciﬁc,lipids,",",provided,that,a,transformation,and,expression,system,for,this,species,becomes,available,.}	{NULL}
SCPDFS_26333.pdf	392	{We,are,now,developing,such,a,system,and,recently,cloned,A9,—,desaturase,(,Sakuradani,et,al.,",",1999b,),",",A12desaturase,(,Sakuradani,et,al.,",",1999a,),and,cytochrome,b5,(,Kobayashi,et,al.,",",1999,),genes,from,M.,alpina,1S,—,4,.}	{NULL}
SCPDFS_26333.pdf	393	{There,is,an,increasing,industrial,demand,for,tailor,—,made,lipids,for,both,food,and,non,—,food,applications,.}	{NULL}
SCPDFS_26333.pdf	394	{In,the,future,",",various,useful,PUFAs,can,be,produced,using,such,genetic,tools,together,with,the,several,desaturase,—,defective,mutants,derived,from,M,alpina,1S,—,4,that,we,have,already,obtained,.}	{NULL}
SCPDFS_26333.pdf	395	{Acknowledgements}	{NULL}
SCPDFS_26333.pdf	396	{The,continuous,encouragement,by,Professor,Chris,R.,Somerville,(,Carnegie,Institution,of,Washington,",",Stanford,),during,the,writing,of,the,manuscript,is,gratefully,acknowledged,.}	{NULL}
SCPDFS_26333.pdf	397	{We,also,wish,to,thank,Professor,K.,Gomi,(,Tohoku,University,",",Japan,),for,providing,the,Aspergillus,host,—,vector,system,.}	{NULL}
SCPDFS_26333.pdf	398	{E.S.,is,a,research,fellow,of,the,Japan,Society,for,the,Promotion,of,Science,.}	{NULL}
SCPDFS_26333.pdf	399	{References}	{NULL}
SCPDFS_26333.pdf	400	{Aki,",",T.,",",Shimada,",",Y.,",",Inagaki,",",K.,",",Higashimoto,",",H.,",",Kawamoto,",",S.,",",Shigeta,",",S.,",",Ono,",",K.,",",Suzuki,",",o.,",",1999,.}	{NULL}
SCPDFS_26333.pdf	401	{Molecular,cloning,and,functional,characterization,of,rat,delta-6,fatty,acid,desaturase,.}	{NULL}
SCPDFS_26333.pdf	402	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	403	{Biophys,Res,.}	{NULL}
SCPDFS_26333.pdf	404	{Commun,.}	{NULL}
SCPDFS_26333.pdf	405	{255,",",575,—,579,.}	{NULL}
SCPDFS_26333.pdf	406	{Ausubel,",",F.M.,",",Brent,",",R.,",",Kingston,",",R.E.,",",Moore,",",D.D.,",",Seidoman,",",J.G.,",",Smith,",",J.A.,",",Struhl,",",K.,",",1996,.}	{NULL}
SCPDFS_26333.pdf	407	{Screening,of,recombinant,DNA,libraries,in,:,Current,Protocols,in,Molecular,Biology,.}	{NULL}
SCPDFS_26333.pdf	408	{Green,Publishing,and,Wiley-Interscience,",",New,York,",",pp,.}	{NULL}
SCPDFS_26333.pdf	409	{6.1.1,—,6.3.5,.}	{NULL}
SCPDFS_26333.pdf	410	{Cho,",",H.P.,",",Nakamura,",",M.T.,",",Clarke,",",S.D.,",",1999,.}	{NULL}
SCPDFS_26333.pdf	411	{Cloning,expression,",",and,nutritional,regulation,of,the,mammalian,A-6,desaturase,.}	{NULL}
SCPDFS_26333.pdf	412	{J.,Biol,.}	{NULL}
SCPDFS_26333.pdf	413	{Chem,.}	{NULL}
SCPDFS_26333.pdf	414	{274,",",47l,—,477,.}	{NULL}
SCPDFS_26333.pdf	415	{Chomczynski,",",P.,",",Sacchi,",",N.,",",1987,.}	{NULL}
SCPDFS_26333.pdf	416	{Single-step,method,of,RNA,isolation,by,acid,guanidinium,thiocyanate,—,phenol,—,chloroform,extraction,.}	{NULL}
SCPDFS_26333.pdf	417	{Anal,.}	{NULL}
SCPDFS_26333.pdf	418	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	419	{162,",",156,—,159,.}	{NULL}
SCPDFS_26333.pdf	420	{Fujii,",",T.,",",Yamaoka,",",H.,",",Gomi,",",K.,",",Kitamoto,",",K.,",",Kumagai,",",K.,",",1995,.}	{NULL}
SCPDFS_26333.pdf	421	{Cloning,and,nucleotide,sequence,of,the,ribonuclease,T1,gene,(,rm,‘,A,),from,Aspergillus,oryzae,and,its,expression,in,Saccharomyces,cerevisiaeand,Aspergillus,oryzae,.}	{NULL}
SCPDFS_26333.pdf	422	{Biotech,.}	{NULL}
SCPDFS_26333.pdf	423	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	424	{59,",",1869,—,1874,.}	{NULL}
SCPDFS_26333.pdf	425	{Girke,",",T.,",",Schmidt,",",H.,",",Zahringer,",",U.,",",Reski,",",R.,",",Heinz,",",E.,",",1998,.}	{NULL}
SCPDFS_26333.pdf	426	{Identiﬁcation,of,a,novel,delta,6-acyl-group,desaturase,by,targeted,gene,disruption,in,Physcomitrella,patens,.}	{NULL}
SCPDFS_26333.pdf	427	{Plant,J.,15,",",39,—,48,.}	{NULL}
SCPDFS_26333.pdf	428	{Gomi,",",K.,",",Iimura,",",Y.,",",Hara,",",S.,",",1987,.}	{NULL}
SCPDFS_26333.pdf	429	{Integrative,transformation,of,Aspergillus,oryzae,with,a,plasmid,containing,the,Aspergillus,nidulans,argB,gene,.}	{NULL}
SCPDFS_26333.pdf	430	{Agric,.}	{NULL}
SCPDFS_26333.pdf	431	{Biol,.}	{NULL}
SCPDFS_26333.pdf	432	{Chem,.}	{NULL}
SCPDFS_26333.pdf	433	{51,",",2549,—,2555,.}	{NULL}
SCPDFS_26333.pdf	434	{Biosci,.}	{NULL}
SCPDFS_26333.pdf	435	{E,Sakuradani,et,al.,/,Gene,238,(,1999,),445,—,453,453}	{NULL}
SCPDFS_26333.pdf	436	{Gunstone,",",F.D.,",",1992,.}	{NULL}
SCPDFS_26333.pdf	437	{Gamma,linolenic,acid,:,occurrence,and,physical,and,chemical,properties,.}	{NULL}
SCPDFS_26333.pdf	438	{Prog,.}	{NULL}
SCPDFS_26333.pdf	439	{Lipid,Res,.}	{NULL}
SCPDFS_26333.pdf	440	{31,",",l45,—,l61,.}	{NULL}
SCPDFS_26333.pdf	441	{Horrobin,",",D.F.,",",1992,.}	{NULL}
SCPDFS_26333.pdf	442	{Nutritional,and,medical,importance,of,gammalinolenic,acid,.}	{NULL}
SCPDFS_26333.pdf	443	{Prog,.}	{NULL}
SCPDFS_26333.pdf	444	{Lipid,Res,.}	{NULL}
SCPDFS_26333.pdf	445	{31,",",l63,—,l94,.}	{NULL}
SCPDFS_26333.pdf	446	{Huang,",",K.X.,",",Fujii,",",I.,",",Ebizuka,",",Y.,",",Gomi,",",K.,",",Sankawa,",",U.,",",1995,.}	{NULL}
SCPDFS_26333.pdf	447	{Molecular,cloning,and,heterologous,expression,of,the,gene,encoding,dihydrogeodin,oxidase,",",a,multicopper,blue,enzyme,from,Aspergillus,lerreus,.}	{NULL}
SCPDFS_26333.pdf	448	{J.,Biol,.}	{NULL}
SCPDFS_26333.pdf	449	{Chem,.}	{NULL}
SCPDFS_26333.pdf	450	{270,",",21495,—,21502,.}	{NULL}
SCPDFS_26333.pdf	451	{Knutzon,",",D.S.,",",Thurmond,",",J.M.,",",Huang,",",Y.S.,",",Chaudhary,",",S.,",",Bobik,",",E.G.,",",Chan,",",G.M.,",",Kirchner,",",S.J.,",",Mukerji,",",P.,",",1998,.}	{NULL}
SCPDFS_26333.pdf	452	{Identiﬁcation,of,Delta5-desaturase,from,Mortierella,alpina,by,heterologous,expression,in,Bakers,’,yeast,and,canola,.}	{NULL}
SCPDFS_26333.pdf	453	{J.,Biol,.}	{NULL}
SCPDFS_26333.pdf	454	{Chem,.}	{NULL}
SCPDFS_26333.pdf	455	{273,",",29360,—,29366,.}	{NULL}
SCPDFS_26333.pdf	456	{Kobayashi,",",M.,",",Sakuradani,",",E.,",",Shimizu,",",S.,",",1999,.}	{NULL}
SCPDFS_26333.pdf	457	{Genetic,analysis,of,cytochrome,b5,from,arachidonic,acid-producing,fungus,",",Mortierella,alpina,1S-4,:,cloning,",",RNA,editing,and,expression,of,the,gene,in,Escherichia,coli,",",and,puriﬁcation,and,characterization,of,the,gene,product,.}	{NULL}
SCPDFS_26333.pdf	458	{J.,Biochem,.}	{NULL}
SCPDFS_26333.pdf	459	{125,",",1094,—,1103,.}	{NULL}
SCPDFS_26333.pdf	460	{Kozak,",",M.,",",1984,.}	{NULL}
SCPDFS_26333.pdf	461	{Compilation,and,analysis,of,sequences,upstream,from,the,translational,start,site,in,eukaryotic,mRNAs,.}	{NULL}
SCPDFS_26333.pdf	462	{Nucleic,Acids,Res,.}	{NULL}
SCPDFS_26333.pdf	463	{12,",",857,—,872,.}	{NULL}
SCPDFS_26333.pdf	464	{Michaelson,",",L.V.,",",Lazarus,",",C.M.,",",Grifﬁths,",",G.,",",Napier,",",J.A.,",",Stobart,",",A.K.,",",1998,.}	{NULL}
SCPDFS_26333.pdf	465	{Isolation,of,a,Delta5-fatty,acid,desaturase,gene,from,Mortierella,alpina,.}	{NULL}
SCPDFS_26333.pdf	466	{J.,Biol,.}	{NULL}
SCPDFS_26333.pdf	467	{Chem,.}	{NULL}
SCPDFS_26333.pdf	468	{273,",",19055,—,l9059,.}	{NULL}
SCPDFS_26333.pdf	469	{Mitoma,",",J,.}	{NULL}
SCPDFS_26333.pdf	470	{",",Ito,",",A.,",",1992,.}	{NULL}
SCPDFS_26333.pdf	471	{The,carboxy-terminal,10,amino,acid,residues,of,cytochrome,b5,are,necessary,for,its,targeting,to,the,endoplasmic,reticulum,.}	{NULL}
SCPDFS_26333.pdf	472	{EMBO,J.,11,",",4197,—,4203,.}	{NULL}
SCPDFS_26333.pdf	473	{Napier,",",J.A.,",",Hey,",",S.J.,",",Lacey,",",D.J.,",",Shewry,",",P.R.,",",1998,.}	{NULL}
SCPDFS_26333.pdf	474	{Identiﬁcation,of,a,Caenorhabditis,elegans,Delta6-fatty-acid-desaturase,by,heterologous,expression,in,Saccharomyces,cerevisiae,.}	{NULL}
SCPDFS_26333.pdf	475	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	476	{J.,330,",",611,—,614,.}	{NULL}
SCPDFS_26333.pdf	477	{Needleman,",",P.,",",Turk,",",J.,",",Jackshik,",",B.A.,",",Morrison,",",A.R.,",",Lefkowith,",",J.B.,",",1986,.}	{NULL}
SCPDFS_26333.pdf	478	{Arachidonic,acid,metabolism,.}	{NULL}
SCPDFS_26333.pdf	479	{Annu,.}	{NULL}
SCPDFS_26333.pdf	480	{Rev.,Biochem,.}	{NULL}
SCPDFS_26333.pdf	481	{55,",",69,—,102,.}	{NULL}
SCPDFS_26333.pdf	482	{Ozeki,",",K.,",",Kanda,",",A.,",",Hamachi,",",M.,",",Nunokawa,",",Y.,",",1996,.}	{NULL}
SCPDFS_26333.pdf	483	{Construction,of,a,promoter,probe,vector,autonomously,maintained,in,Aspergillus,and,characterization,of,promoter,regions,derived,from,A.,niger,and,A.,oryzae,genomes,.}	{NULL}
SCPDFS_26333.pdf	484	{Biosci,.}	{NULL}
SCPDFS_26333.pdf	485	{Biotech,.}	{NULL}
SCPDFS_26333.pdf	486	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	487	{60,",",383,—,389,.}	{NULL}
SCPDFS_26333.pdf	488	{Reddy,",",A.S.,",",Nuccio,",",M.L.,",",Gross,",",L.M.,",",Thomas,",",T.L.,",",1993,.}	{NULL}
SCPDFS_26333.pdf	489	{Isolation,of,a,delta,6-desaturase,gene,from,the,cyanobacterium,S,ynechocystis,sp,.}	{NULL}
SCPDFS_26333.pdf	490	{strain,PCC,6803,by,gain-of-function,expression,in,Anabaena,sp,.}	{NULL}
SCPDFS_26333.pdf	491	{strain,PCC,7120,.}	{NULL}
SCPDFS_26333.pdf	492	{Plant,Mol,.}	{NULL}
SCPDFS_26333.pdf	493	{Biol,.}	{NULL}
SCPDFS_26333.pdf	494	{27,",",293,—,300,.}	{NULL}
SCPDFS_26333.pdf	495	{Sakuradani,",",E.,",",Kobayashi,",",M.,",",Ashikari,",",T.,",",Shimizu,",",S.,",",1999a,.}	{NULL}
SCPDFS_26333.pdf	496	{Identiﬁcation}	{NULL}
SCPDFS_26333.pdf	497	{of,A12-fatty,acid,desaturase,from,arachidonic,acidproducing,Mortierella,fungus,by,heterologous,expression,in,the,yeast,Saccharomyces,cerevisiae,and,the,fungus,Aspergillus,oryzae,.}	{NULL}
SCPDFS_26333.pdf	498	{Eur,.}	{NULL}
SCPDFS_26333.pdf	499	{J.,Biochem,.}	{NULL}
SCPDFS_26333.pdf	500	{261,",",812,—,820,.}	{NULL}
SCPDFS_26333.pdf	501	{Sakuradani,",",E.,",",Kobayashi,",",M.,",",Shimizu,",",S.,",",1999b,.}	{NULL}
SCPDFS_26333.pdf	502	{A9-Fatty,acid,desaturase,from,arachidonic,acid-produing,fungus,:,unique,gene,sequence,and,its,heterologous,expression,in,a,fungus,",",Aspergillus,.}	{NULL}
SCPDFS_26333.pdf	503	{Eur,.}	{NULL}
SCPDFS_26333.pdf	504	{J.,Biochem,.}	{NULL}
SCPDFS_26333.pdf	505	{260,",",208,—,216,.}	{NULL}
SCPDFS_26333.pdf	506	{Sambrook,",",J.,",",Fritsch,",",E.F.,",",Maniatis,",",T.,",",1989,.}	{NULL}
SCPDFS_26333.pdf	507	{Molecular,Cloning,:,A,Laboratory,Manual,.}	{NULL}
SCPDFS_26333.pdf	508	{2nd,ed.,",",Cold,Spring,Harbor,Laboratory,Press,",",Cold,Spring,Harbor,",",NY,.}	{NULL}
SCPDFS_26333.pdf	509	{Sayanova,",",o.,",",Smith,",",M.A.,",",Lapinskas,",",P.,",",Stobart,",",A.K.,",",Dobson,",",G.,",",Christie,",",W.W.,",",Shewry,",",P.R.,",",Napier,",",J.A.,",",1997,.}	{NULL}
SCPDFS_26333.pdf	510	{Expression,of,a,borage,desaturase,cDNA,containing,an,N-terminal,cytochrome,[,75,domain,results,in,the,accumulation,of,high,levels,of,A6-desaturated,fatty,acid,in,transgenic,tobacco,.}	{NULL}
SCPDFS_26333.pdf	511	{Proc,.}	{NULL}
SCPDFS_26333.pdf	512	{Natl.,Acad,.}	{NULL}
SCPDFS_26333.pdf	513	{Sci,.}	{NULL}
SCPDFS_26333.pdf	514	{USA,94,",",4211,—,4216,.}	{NULL}
SCPDFS_26333.pdf	515	{Shanklin,",",J.,",",Whittle,",",E.,",",Fox,",",B.G.,",",1994,.}	{NULL}
SCPDFS_26333.pdf	516	{Eight,histidine,residues,are,catalytically,essential,in,a,membrane-associated,iron,enzyme,",",stearoyl-CoA,desaturase,",",and,are,conserved,in,alkane,hydroxylase,and,xylene,monooxygenase,.}	{NULL}
SCPDFS_26333.pdf	517	{Biochemistry,33,",",12787,—,12794,.}	{NULL}
SCPDFS_26333.pdf	518	{Shimizu,",",S.,",",Ogawa,",",J.,",",Kataoka,",",M.,",",Kobayashi,",",M.,",",1997,.}	{NULL}
SCPDFS_26333.pdf	519	{Screening,of,novel,microbial,enzymes,for,the,production,of,biologically,and,chemically,useful,compounds,",",Schepter,",",T.,(,Ed,.,)}	{NULL}
SCPDFS_26333.pdf	520	{",",Advances,in,Biochemical,Engineering/Biotechnology,58,",",45,—,87,.}	{NULL}
SCPDFS_26333.pdf	521	{Smith,",",W.L.,",",Borgeat,",",P.,",",1985,.}	{NULL}
SCPDFS_26333.pdf	522	{The,eicosanoids,:,prostaglandins,",",thromboxanes,",",leukotrienes,",",and,hydroxy-eicosaenoic,acids,.}	{NULL}
SCPDFS_26333.pdf	523	{In,:,Vance,",",D.E.,",",Vance,",",J.E.,(,Eds,.,)}	{NULL}
SCPDFS_26333.pdf	524	{",",Biochemistry,of,Lipids,and,Membranes,.}	{NULL}
SCPDFS_26333.pdf	525	{Benjamin/Cummings,",",Menlo,Park,",",CA,",",pp,.}	{NULL}
SCPDFS_26333.pdf	526	{325,—,360,.}	{NULL}
SCPDFS_26333.pdf	527	{Somerville,",",C.,",",Browse,",",J.,",",1991,.}	{NULL}
SCPDFS_26333.pdf	528	{Plant,lipids,:,metabolism,",",mutants,","}	{NULL}
SCPDFS_26333.pdf	529	{and,membranes,.}	{NULL}
SCPDFS_26333.pdf	530	{Science,252,",",80,—,87,.}	{NULL}
SCPDFS_26333.pdf	531	{Stukey,",",J.E.,",",McDonough,",",V.M.,",",Martin,",",C.E.,",",1990,.}	{NULL}
SCPDFS_26333.pdf	532	{The,OLE1,gene,of,Saccharomyces,cerevisiae,encodes,the,A-9,fatty,acid,desaturase,and,can,be,functionally,replaced,by,the,rat,stearoyl-CoA,desaturase,gene,.}	{NULL}
SCPDFS_26333.pdf	533	{J.,Biol,.}	{NULL}
SCPDFS_26333.pdf	534	{Chem,.}	{NULL}
SCPDFS_26333.pdf	535	{265,",",20144,—,20149,.}	{NULL}
SCPDFS_26333.pdf	536	{Stymne,",",S.,",",Stobart,",",A.K.,",",1986,.}	{NULL}
SCPDFS_26333.pdf	537	{Biosynthesis,of,gamma-linolenic,acid,in,cotyledons,and,microsomal,preparations,of,the,developing,seeds,of,common,borage,(,Borago,oﬂicinalis,),.}	{NULL}
SCPDFS_26333.pdf	538	{Biochem,.}	{NULL}
SCPDFS_26333.pdf	539	{J.,240,",",385,—,393,.}	{NULL}
SCPDFS_26333.pdf	540	{Tada,",",S.,",",Gomi,",",K.,",",Kitamoto,",",K.,",",Kumagai,",",C.,",",Tamura,",",G.,",",Hara,",",S.,",",1991,.}	{NULL}
SCPDFS_26333.pdf	541	{Identiﬁcation,of,the,promoter,region,of,the,Taka-amylase,A,gene,required,for,starch,induction,.}	{NULL}
SCPDFS_26333.pdf	542	{Agric,.}	{NULL}
SCPDFS_26333.pdf	543	{Biol,.}	{NULL}
SCPDFS_26333.pdf	544	{Chem,.}	{NULL}
SCPDFS_26333.pdf	545	{55,",",1939,—,1941,.}	{NULL}
SCPDFS_26333.pdf	546	{Yamada,",",H.,",",Shimizu,",",S.,",",Shinmen,",",Y.,",",1987,.}	{NULL}
SCPDFS_26333.pdf	547	{Production,of,arachidonic,acid,by,Mortierella,elongata,1S-5,.}	{NULL}
SCPDFS_26333.pdf	548	{Agric,.}	{NULL}
SCPDFS_26333.pdf	549	{Biol,.}	{NULL}
SCPDFS_26333.pdf	550	{Chem,.}	{NULL}
SCPDFS_26333.pdf	551	{S,51,",",785,—,790,.}	{NULL}
